data_6s2d_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6s2d _Structure_validation_residue.Date_analyzed 2020-07-10 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.9 mtp85 . . . . . 1 N--CA 1.315 -7.197 0 CA-C-O 121.596 0.712 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -43.38 -21.1 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.79 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' C ' ' A' ' 4' ' ' ARG . 22.3 mt -99.74 -23.04 15.13 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.885 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.4 tt0 -66.35 -15.55 63.35 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.208 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -63.18 94.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.314 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.0 tt -58.02 -38.45 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.44 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.71 -44.48 2.03 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.096 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.515 ' C ' ' H ' ' A' ' 13' ' ' GLY . 47.1 tttp -86.28 77.21 9.57 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.77 0.319 . . . . 0.0 110.427 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.29 37.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.231 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 67.74 61.2 5.15 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 59.9 t80 57.08 36.54 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.931 0.396 . . . . 0.0 110.297 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.5 mm 59.36 66.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.391 0.615 . . . . 0.0 110.219 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -132.24 -51.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.006 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 mm -65.9 -43.94 92.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.47 -36.69 10.39 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.97 -33.25 86.74 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.28 -0.486 . . . . 0.0 111.889 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.52 -22.51 61.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.763 0.316 . . . . 0.0 110.638 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -76.62 -15.26 59.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.541 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -50.86 -42.13 58.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.582 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -169.68 -13.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.722 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.47 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 8.1 mp . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.047 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 7' ' ' GLU . 43.2 mtm180 . . . . . 1 N--CA 1.325 -6.696 0 CA-C-O 122.572 1.177 . . . . 0.0 112.055 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 44.2 t-105 -42.78 -18.84 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.194 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 4' ' ' ARG . 42.4 tp -113.76 -21.44 10.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.122 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 4' ' ' ARG . 13.6 tp10 -110.99 46.73 1.04 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.981 0.42 . . . . 0.0 109.87 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.489 ' C ' ' H ' ' A' ' 10' ' ' GLY . 36.9 ttt-85 -63.64 126.59 28.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.569 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' LYS . 4.1 tp -54.05 -10.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . -37.08 -26.52 0.01 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.569 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' GLY . 14.4 pttp -70.46 99.75 1.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.82 -3.17 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.747 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 47.21 49.31 19.26 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.066 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -160.97 -47.46 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.608 0.242 . . . . 0.0 110.471 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.8 pt -156.02 55.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.15 0.5 . . . . 0.0 110.598 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.502 ' C ' ' H ' ' A' ' 18' ' ' GLY . 3.8 mm -141.28 -48.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.437 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -69.36 5.76 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.462 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -175.54 -19.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.809 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -67.3 -57.28 9.52 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.142 -0.551 . . . . 0.0 111.875 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.1 7.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.333 . . . . 0.0 110.596 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 23' ' ' HIS . 12.9 mt 53.92 14.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.47 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -75.99 36.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.787 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.488 ' H ' ' C ' ' A' ' 21' ' ' LEU . 49.7 t-80 54.52 21.4 3.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.564 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 tp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.24 -179.886 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER . . . . . 1 N--CA 1.319 -7.021 0 CA-C-O 121.413 0.625 . . . . 0.0 110.428 . . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 17.8 m0 -44.08 -19.09 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.541 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.494 ' H ' ' C ' ' A' ' 4' ' ' ARG . 21.9 mt -110.66 -17.98 13.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.617 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.5 mt-10 -110.17 13.21 23.19 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.93 0.395 . . . . 0.0 110.096 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 4' ' ' ARG . 56.9 ttt-85 -52.56 102.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.575 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 tp -56.54 109.16 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.098 0.475 . . . . 0.0 110.154 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.82 -38.28 4.45 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.982 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 13' ' ' GLY . 62.9 mttp -65.97 103.97 1.03 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.894 0.378 . . . . 0.0 110.624 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.63 1.67 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.003 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 48.32 53.68 15.07 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.133 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -163.08 -48.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.682 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.3 pt -155.74 59.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.337 0.589 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.5 mm -135.23 -72.37 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.51 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -71.85 -38.94 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.04 -45.62 11.47 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.71 -42.54 38.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.918 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.97 37.37 28.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.775 0.321 . . . . 0.0 110.46 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 23' ' ' HIS . 21.4 mt -75.81 114.95 15.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.636 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 58.55 -76.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.326 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 21' ' ' LEU . 69.1 m-70 -38.55 -32.74 0.08 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.026 0.441 . . . . 0.0 110.868 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.7 tp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.98 178.986 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.51 ' C ' ' H ' ' A' ' 6' ' ' LEU . 58.6 mtp180 . . . . . 1 N--CA 1.324 -6.749 0 CA-C-O 122.563 1.173 . . . . 0.0 111.931 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -43.2 -18.97 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.916 -1.947 . . . . 0.0 109.999 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 4' ' ' ARG . 2.2 pp -111.3 -22.49 11.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.639 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.6 tt0 -88.35 1.05 55.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.032 0.444 . . . . 0.0 110.219 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -58.98 140.45 55.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.621 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.9 tp -75.74 113.68 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.943 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.1 14.18 6.28 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -91.27 105.86 18.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.7 0.286 . . . . 0.0 110.431 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.46 62.2 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.52 53.51 24.58 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.7 t80 60.46 38.06 19.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.07 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.2 mt 61.18 70.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.358 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -140.28 -50.65 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.89 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.457 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 4.2 tp -76.58 -29.46 18.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.76 -50.75 3.63 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.65 -42.2 94.11 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.652 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.26 52.81 1.16 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 110.489 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 tt -156.92 61.91 0.52 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -160.33 -34.85 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.656 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -164.94 -24.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 0.0 110.262 179.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER . . . . . 1 N--CA 1.328 -6.555 0 CA-C-O 122.534 1.159 . . . . 0.0 112.191 . . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -41.24 -20.11 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 112.846 -1.979 . . . . 0.0 110.412 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.7 mt -115.84 -20.05 10.19 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.347 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.7 tt0 -96.2 30.47 2.47 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.999 0.428 . . . . 0.0 110.208 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.17 146.77 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.472 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.421 ' C ' ' H ' ' A' ' 11' ' ' LYS . 2.0 tp -165.16 96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.188 0.518 . . . . 0.0 110.266 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.55 24.79 3.02 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.156 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 9' ' ' ILE . 65.9 mttm -151.41 72.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.769 0.319 . . . . 0.0 110.375 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.9 45.35 0.9 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.056 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.5 33.76 54.37 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 18.9 t80 71.1 54.32 0.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.691 0.282 . . . . 0.0 110.56 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 mt 63.93 68.09 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.415 0.626 . . . . 0.0 110.94 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.0 mm -135.04 -51.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.662 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.5 mm -70.92 -42.01 77.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.68 -51.57 7.09 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -64.95 -36.3 92.92 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.815 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.08 7.17 0.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.646 0.26 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.494 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.7 mt 45.31 78.42 0.06 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.726 0.298 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -168.49 39.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.496 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 57.47 36.97 27.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.498 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.17 -179.942 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 7' ' ' GLU . 89.5 mtt180 . . . . . 1 N--CA 1.325 -6.72 0 CA-C-O 122.47 1.128 . . . . 0.0 111.9 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -41.09 -20.49 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.327 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.2 tp -108.51 -26.15 10.57 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.173 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' ARG . 27.2 mp0 -99.83 8.73 43.95 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.84 0.352 . . . . 0.0 110.398 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.9 ttp180 -52.11 118.47 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.463 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.0 pt -61.92 -29.26 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.62 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.44 52.69 27.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.608 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -161.69 80.71 0.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.478 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.97 52.35 2.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.335 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.27 49.1 32.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.855 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.6 t80 61.15 48.73 6.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.897 0.38 . . . . 0.0 110.379 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 mt 61.22 70.87 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.732 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -135.03 -67.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -69.86 -25.07 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.05 -58.75 2.28 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.494 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.41 -32.46 68.16 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.936 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 50.73 34.97 10.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.773 0.321 . . . . 0.0 110.68 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -65.89 1.64 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.952 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 20' ' ' ALA . 8.1 t70 -58.75 -30.15 67.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.392 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.441 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 4.0 t60 -171.47 23.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.159 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.077 -179.792 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' LEU . 38.0 mtm-85 . . . . . 1 N--CA 1.325 -6.68 0 CA-C-O 122.447 1.118 . . . . 0.0 111.941 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.404 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 41.9 t-105 -41.36 -19.51 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 112.938 -1.937 . . . . 0.0 110.433 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.1 tp -114.57 -20.62 10.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.593 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 66.2 mm-40 -87.02 20.48 2.65 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 110.452 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -53.47 -21.11 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.111 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 11' ' ' LYS . 3.6 tp -165.09 -41.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.837 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.84 -82.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.263 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.512 ' C ' ' H ' ' A' ' 13' ' ' GLY . 55.8 mttm -51.06 101.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.823 0.344 . . . . 0.0 110.795 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.85 3.27 3.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 45.3 40.43 7.83 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.45 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -167.51 -20.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.314 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.8 pt -155.85 50.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 120.925 0.393 . . . . 0.0 111.275 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.491 ' C ' ' H ' ' A' ' 18' ' ' GLY . 2.8 mm -143.77 -51.04 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.65 8.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.299 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -167.48 -31.69 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.001 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.79 -30.99 60.41 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.135 -0.555 . . . . 0.0 111.856 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.43 -68.23 0.39 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.735 0.302 . . . . 0.0 110.477 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 tp 52.79 49.44 20.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.448 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -167.23 88.25 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.528 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.6 m80 53.76 25.91 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.466 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.163 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.8 OUTLIER . . . . . 1 N--CA 1.32 -6.943 0 CA-C-O 121.466 0.651 . . . . 0.0 110.414 . . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -43.48 -19.09 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.937 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 4' ' ' ARG . 43.3 tp -108.28 -20.78 13.02 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.284 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.6 mm-40 -109.34 13.8 24.03 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.5 ttt85 -79.64 -69.09 0.61 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.574 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.1 pt -68.31 -33.65 61.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.4 55.82 23.42 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.944 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -168.26 67.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.481 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.71 76.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.364 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.93 62.68 3.63 Favored Glycine 0 CA--C 1.517 0.218 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.929 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 55.24 34.77 23.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.913 0.387 . . . . 0.0 109.96 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.0 mm 59.8 69.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.541 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.8 tp -137.51 -34.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.1 mm -92.43 -41.1 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.68 -45.63 10.62 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.63 -37.78 57.65 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.663 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.81 52.21 11.66 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.714 0.293 . . . . 0.0 110.961 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.12 114.12 2.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.034 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 53.73 15.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.454 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.424 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 3.4 t60 54.39 25.83 6.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.465 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.201 179.971 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 7' ' ' GLU . 78.0 mtm180 . . . . . 1 N--CA 1.323 -6.786 0 CA-C-O 122.525 1.155 . . . . 0.0 111.966 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -42.12 -24.56 0.05 OUTLIER 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.718 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.9 mm? -96.42 -30.21 13.49 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.938 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 4' ' ' ARG . 60.3 mt-10 -112.46 49.8 0.9 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.79 0.328 . . . . 0.0 110.545 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -60.32 148.44 36.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.431 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.501 ' C ' ' H ' ' A' ' 11' ' ' LYS . 15.7 pt -152.93 -31.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.399 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.26 -17.13 1.94 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.949 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 9' ' ' ILE . 55.0 mttp -69.55 105.88 2.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.687 0.279 . . . . 0.0 110.539 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -70.65 0.51 6.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 62.58 -0.77 1.94 Allowed Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.845 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' A' ' 12' ' ' ALA . 62.1 t80 -101.58 -31.78 10.68 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.559 ' O ' ' N ' ' A' ' 17' ' ' ILE . 5.2 pt -153.31 -112.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.225 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 mm 47.61 -81.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 111.355 0.132 . . . . 0.0 111.355 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 15' ' ' ILE . 3.7 tp -69.69 -42.25 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.077 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.63 -42.53 17.25 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.033 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.46 -41.1 31.09 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.087 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.03 53.74 12.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 0.0 110.719 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 8.4 mp -60.6 89.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.168 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 50.01 46.24 24.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.69 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.442 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 20.9 t-80 53.57 52.01 14.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.555 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.186 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 7' ' ' GLU . 51.5 mtm180 . . . . . 1 N--CA 1.323 -6.78 0 CA-C-O 122.466 1.127 . . . . 0.0 111.996 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -41.28 -21.34 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.043 -1.889 . . . . 0.0 110.272 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 57.6 tp -105.79 -26.89 11.58 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.219 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.3 mt-10 -90.75 8.88 32.39 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.951 0.405 . . . . 0.0 110.166 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -63.33 82.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.576 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 16.4 tt -65.99 -45.25 91.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.356 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.423 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . 41.78 45.29 4.65 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.361 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -164.56 71.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.33 . . . . 0.0 110.542 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.27 70.95 1.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.374 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.53 64.51 4.0 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.829 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 50.5 t80 57.53 28.39 15.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.772 0.32 . . . . 0.0 110.476 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.2 mt 62.43 64.71 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.646 0.736 . . . . 0.0 110.161 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -132.54 -49.47 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.786 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.506 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -69.72 -44.84 78.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.74 -43.82 11.21 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.72 -43.33 99.22 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.987 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.46 40.66 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.665 0.269 . . . . 0.0 110.703 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 19' ' ' GLY . 10.6 tp -52.95 96.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.229 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 53.02 52.55 13.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.432 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.465 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 16.4 t-160 53.8 47.2 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.334 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.005 -179.883 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.509 ' C ' ' H ' ' A' ' 6' ' ' LEU . 93.3 mtt180 . . . . . 1 N--CA 1.325 -6.722 0 CA-C-O 122.593 1.187 . . . . 0.0 112.039 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 23.1 t90 -42.96 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 112.791 -2.004 . . . . 0.0 110.455 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' A' ' 4' ' ' ARG . 37.7 mt -117.13 -16.31 10.44 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.87 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.4 tt0 -48.52 -26.87 2.38 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.661 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -50.01 148.66 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.634 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.0 tt -167.63 -40.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.494 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.81 -58.64 3.47 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.187 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.511 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.0 mttt -52.85 102.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.707 0.289 . . . . 0.0 110.507 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.28 -1.13 2.13 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 44.81 36.05 4.65 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.197 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -168.97 -17.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.284 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.0 pt -155.71 50.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.718 0.294 . . . . 0.0 111.057 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 mm -144.31 -47.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 pp -85.29 24.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.186 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.62 -45.84 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.092 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.32 -40.23 98.34 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.039 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -78.49 50.71 0.98 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.839 0.352 . . . . 0.0 110.541 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 pp -59.22 -4.88 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.715 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 20' ' ' ALA . 2.2 m-20 -52.23 -39.62 60.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.452 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.408 ' CD2' ' N ' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -168.06 10.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.433 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.826 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 6' ' ' LEU . 73.4 mtt-85 . . . . . 1 N--CA 1.324 -6.747 0 CA-C-O 122.656 1.217 . . . . 0.0 112.047 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -43.07 -18.61 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.854 -1.975 . . . . 0.0 110.337 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 4' ' ' ARG . 19.6 mt -114.32 -18.04 11.66 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.802 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.6 tt0 -48.02 -20.87 0.37 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.76 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 54.35 61.45 3.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.62 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 tp -54.47 113.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.078 0.466 . . . . 0.0 110.126 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.51 34.18 1.28 Allowed Glycine 0 C--N 1.332 0.354 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -150.98 38.51 0.66 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.161 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.68 56.79 2.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.52 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.9 67.13 2.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.979 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 54.44 30.55 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.781 0.324 . . . . 0.0 110.706 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 mt 62.14 65.28 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.552 0.692 . . . . 0.0 110.281 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.2 mm -133.34 -51.65 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.691 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.3 mm -66.59 -42.89 90.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.74 -42.17 9.22 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.23 95.69 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.031 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.47 -30.87 0.61 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.667 0.27 . . . . 0.0 111.179 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.486 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 8.0 mp -74.44 -47.81 31.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.316 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -50.55 -72.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.608 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -169.98 63.91 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.384 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.303 -179.887 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.506 ' C ' ' H ' ' A' ' 6' ' ' LEU . 47.5 mtt85 . . . . . 1 N--CA 1.325 -6.675 0 CA-C-O 122.567 1.175 . . . . 0.0 111.997 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 66.4 t-105 -43.36 -18.31 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.249 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 4' ' ' ARG . 24.4 mt -115.82 -16.45 11.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.812 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.3 tt0 -45.43 -28.08 0.82 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -71.69 -137.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.307 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.426 ' CG1' ' H ' ' A' ' 10' ' ' GLY . 5.2 pt -59.77 -113.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.437 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.426 ' H ' ' CG1' ' A' ' 9' ' ' ILE . . . 69.26 39.59 82.0 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -57.13 -31.95 65.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.669 0.271 . . . . 0.0 110.541 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.72 -25.53 0.27 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.058 0.456 . . . . 0.0 110.442 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' C ' ' CG ' ' A' ' 14' ' ' PHE . . . 150.97 54.99 0.01 OUTLIER Glycine 0 CA--C 1.509 -0.31 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.442 ' CG ' ' C ' ' A' ' 13' ' ' GLY . 3.4 m-85 75.63 17.46 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.2 mt 61.55 60.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 10.1 tp -128.0 -48.69 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.465 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 3.9 tp -66.25 -36.25 76.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.38 -44.65 4.59 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.27 -33.0 51.93 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.662 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.72 -46.81 41.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.75 0.309 . . . . 0.0 110.863 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 23' ' ' HIS . 40.9 mt 52.49 20.04 1.35 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 0.0 110.278 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 24' ' ' LEU . 66.2 m-20 -76.08 38.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.375 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.494 ' H ' ' C ' ' A' ' 21' ' ' LEU . 32.3 m80 57.67 6.52 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.252 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.279 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 6' ' ' LEU . 79.1 mtm180 . . . . . 1 N--CA 1.324 -6.739 0 CA-C-O 122.492 1.139 . . . . 0.0 112.094 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -41.16 -19.18 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 112.79 -2.005 . . . . 0.0 110.61 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.4 mt -121.99 -14.06 8.09 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.748 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 4' ' ' ARG . 37.1 mt-10 -88.95 -11.18 45.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 110.307 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.9 tpm_? -83.13 106.45 14.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.255 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.6 tt -63.19 111.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.078 0.466 . . . . 0.0 110.224 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.7 -19.18 79.3 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.147 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.1 mttt -69.96 99.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.713 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -62.47 -2.65 1.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.161 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 59.18 5.15 2.99 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.493 ' H ' ' C ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -85.51 -71.48 0.53 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.5 pt -158.14 53.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.402 0.62 . . . . 0.0 110.217 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.61 -63.95 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.79 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -70.35 -35.01 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.31 -49.66 7.25 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -66.51 -46.35 77.81 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.73 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 50.4 15.09 0.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.765 0.317 . . . . 0.0 110.7 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 19' ' ' GLY . 13.9 mt 55.26 11.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.592 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 20' ' ' ALA . 38.8 t70 -78.41 49.07 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.506 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 51.82 20.97 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.542 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.221 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 11.2 mtp180 . . . . . 1 N--CA 1.312 -7.365 0 CA-C-O 121.556 0.693 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -44.24 -19.73 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.743 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.496 ' N ' ' C ' ' A' ' 4' ' ' ARG . 20.2 mt -103.77 -21.18 13.72 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.711 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 35.5 tp10 -68.39 -25.98 65.32 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.337 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 10' ' ' GLY . 19.9 ttm180 68.09 163.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.003 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.2 pt -53.49 -9.09 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.779 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . 54.42 59.78 9.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.769 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -167.32 73.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.309 . . . . 0.0 110.405 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.63 53.64 2.85 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.058 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.35 33.25 86.73 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 67.0 72.81 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.637 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.3 pt 35.25 56.5 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.989 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.2 tp -135.63 -43.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.579 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.8 mm -81.33 -45.42 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.99 -24.78 54.39 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.2 -37.32 21.84 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.25 -72.89 0.08 Allowed 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.667 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.7 mt 58.62 24.73 12.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.471 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.21 -103.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.471 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -71.24 -4.76 27.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 110.649 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.1 -179.993 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' GLU . 61.2 mtm180 . . . . . 1 N--CA 1.324 -6.775 0 CA-C-O 122.47 1.128 . . . . 0.0 111.946 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -41.3 -20.03 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 112.981 -1.918 . . . . 0.0 110.415 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.8 tp -110.38 -24.58 10.55 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.334 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' ARG . 55.2 mm-40 -96.81 33.91 1.79 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.768 0.318 . . . . 0.0 110.249 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -64.47 -74.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.715 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 pp -68.64 -2.87 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.788 0.328 . . . . 0.0 110.66 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.93 70.38 2.92 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 112.068 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -50.27 -32.53 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.107 0.48 . . . . 0.0 109.893 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.88 -0.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.124 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.3 32.84 5.38 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.931 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.401 ' H ' ' H ' ' A' ' 15' ' ' ILE . 25.5 t80 -149.87 -11.79 0.28 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.906 0.384 . . . . 0.0 110.007 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.401 ' H ' ' H ' ' A' ' 14' ' ' PHE . 21.8 pt -154.88 40.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.078 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.4 tp -151.36 -25.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.0 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.51 4.93 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.497 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.79 -13.76 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.953 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.94 -10.16 86.42 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.051 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.67 53.96 1.81 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.727 0.298 . . . . 0.0 110.573 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.1 mt -56.97 110.38 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.367 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 3.1 m-20 52.88 21.54 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.615 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.466 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 19.6 t60 53.75 46.52 25.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.582 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.33 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.0 mtm180 . . . . . 1 N--CA 1.324 -6.772 0 CA-C-O 122.626 1.203 . . . . 0.0 112.006 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -42.53 -24.25 0.05 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.058 -1.883 . . . . 0.0 109.838 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.463 ' N ' ' C ' ' A' ' 4' ' ' ARG . 10.3 mp -95.82 -28.03 14.93 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.406 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 4' ' ' ARG . 38.3 tt0 -48.42 -29.07 3.67 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.686 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 7' ' ' GLU . 11.8 tpp180 60.36 129.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.68 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.2 tt -54.29 -37.95 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.404 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.04 59.05 11.04 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.0 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -169.15 68.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.792 0.329 . . . . 0.0 110.512 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.78 67.78 1.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.486 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 56.16 41.88 86.86 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.99 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.6 43.0 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 0.0 109.826 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.2 mt 54.95 61.64 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.372 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.4 mm -129.81 -42.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.009 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.7 mm -87.79 -37.3 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.0 -49.07 10.13 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.501 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -75.09 -37.4 43.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.811 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.67 5.58 0.35 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 0.0 110.586 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 19' ' ' GLY . 9.0 tp 46.62 63.16 2.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.748 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -158.67 47.44 0.33 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.548 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 1.7 t60 51.98 20.78 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.474 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.7 tp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.257 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.587 ' O ' ' N ' ' A' ' 7' ' ' GLU . 6.7 mtt-85 . . . . . 1 N--CA 1.321 -6.882 0 CA-C-O 121.308 0.575 . . . . 0.0 111.303 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -42.68 -19.62 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.643 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.9 tp -107.66 -21.54 12.84 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.987 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.587 ' N ' ' O ' ' A' ' 4' ' ' ARG . 94.8 mt-10 -115.73 30.32 7.42 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 ptt85 -50.3 143.64 8.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.968 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.467 ' C ' ' H ' ' A' ' 11' ' ' LYS . 14.8 pt -64.93 -23.92 34.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.357 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.86 7.18 1.52 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.354 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' A' ' 9' ' ' ILE . 56.3 mttp -144.84 75.66 1.46 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.953 0.406 . . . . 0.0 110.226 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.86 62.92 2.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.647 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.62 68.92 1.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.091 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 61.8 t80 55.29 27.98 10.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.591 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.2 mt 61.51 63.55 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.652 0.739 . . . . 0.0 110.035 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 mm -131.65 -48.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.762 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.497 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -69.79 -46.1 75.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.28 -43.29 13.33 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.78 -44.59 96.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.676 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.54 82.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.372 . . . . 0.0 110.405 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp 55.43 57.81 5.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.393 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.0 t70 58.0 45.82 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.683 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 49.64 52.37 14.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.7 tp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.211 179.94 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 6' ' ' LEU . 75.3 mtt85 . . . . . 1 N--CA 1.325 -6.684 0 CA-C-O 122.526 1.155 . . . . 0.0 112.161 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 23.5 t90 -42.37 -16.86 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.63 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.1 tp -125.22 -12.19 6.89 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.984 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -76.11 -25.91 55.89 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.812 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -75.88 -135.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.29 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.6 pt -143.68 127.9 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.258 0.552 . . . . 0.0 110.117 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.0 -11.42 78.86 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.942 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.414 ' C ' ' H ' ' A' ' 13' ' ' GLY . 46.8 mtmt -60.19 110.94 1.34 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.94 4.6 6.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 39.25 38.48 0.88 Allowed Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.634 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -168.05 -15.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.693 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 pt -152.71 46.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.192 0.52 . . . . 0.0 110.228 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.451 ' C ' ' H ' ' A' ' 18' ' ' GLY . 10.0 tp -145.73 -41.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.256 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.415 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 1.8 pp -69.02 2.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.222 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -172.26 -30.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.873 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.89 -37.06 52.13 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.864 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -26.07 59.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.754 0.311 . . . . 0.0 110.508 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.5 tp 57.25 63.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.38 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER 52.31 46.54 26.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.555 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 52.03 60.67 3.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.495 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.15 -180.0 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 7' ' ' GLU . 16.1 mtp180 . . . . . 1 N--CA 1.316 -7.163 0 CA-C-O 121.492 0.663 . . . . 0.0 110.523 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -43.7 -21.48 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.682 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 4' ' ' ARG . 16.7 mt -96.83 -24.54 15.85 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.677 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.7 tm-20 -68.0 -28.84 67.77 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.267 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -58.21 128.89 39.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.467 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 pt -75.32 115.39 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.401 0.62 . . . . 0.0 110.239 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.56 -2.1 79.15 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.775 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 13' ' ' GLY . 59.6 mttp -75.4 98.33 3.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.701 0.286 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.68 37.39 0.23 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.478 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 73.34 63.11 2.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.916 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 63.8 t80 56.1 32.56 20.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.814 0.34 . . . . 0.0 110.773 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.0 mt 61.01 63.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.588 0.708 . . . . 0.0 109.948 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.0 mm -132.43 -51.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.93 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.8 mm -68.94 -41.18 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.07 -48.77 6.31 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -66.82 -31.95 79.75 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.037 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 62.27 1.64 0.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.775 0.321 . . . . 0.0 110.568 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.1 tp 61.02 5.42 1.0 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 20' ' ' ALA . 3.2 m-20 -62.37 -97.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.211 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -88.97 -36.86 15.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.885 0.374 . . . . 0.0 110.361 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.508 -179.94 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 7' ' ' GLU . 12.1 mtt85 . . . . . 1 N--CA 1.317 -7.076 0 CA-C-O 121.538 0.685 . . . . 0.0 110.563 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -43.83 -18.4 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.519 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.528 ' H ' ' C ' ' A' ' 4' ' ' ARG . 30.2 mt -114.43 -16.04 11.99 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.728 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 4' ' ' ARG . 90.6 mt-10 -118.5 31.1 6.84 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -51.97 -18.41 1.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.97 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.5 ' C ' ' H ' ' A' ' 11' ' ' LYS . 18.3 pt -154.45 -24.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.603 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.68 -35.07 1.01 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.874 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 9' ' ' ILE . 58.0 mttp -54.38 108.27 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.07 2.84 3.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.036 0.446 . . . . 0.0 110.09 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.23 34.73 0.65 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.535 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -166.26 -17.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.2 pt -152.23 50.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.139 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.4 tp -145.73 -39.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.078 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.63 4.64 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.13 -30.86 0.02 OUTLIER Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.69 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.65 -35.95 47.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.592 179.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.39 47.22 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.729 0.3 . . . . 0.0 110.822 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 23' ' ' HIS . 9.8 mp -60.37 114.55 2.99 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.7 t0 58.22 -78.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.696 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' LEU . 55.3 t-80 -166.81 30.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.534 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.153 -179.961 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.515 ' C ' ' H ' ' A' ' 6' ' ' LEU . 12.7 mtt180 . . . . . 1 N--CA 1.312 -7.329 0 CA-C-O 121.549 0.69 . . . . 0.0 110.058 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -45.34 -17.37 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.947 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 4' ' ' ARG . 32.1 mt -114.09 -12.51 12.55 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.997 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 4' ' ' ARG . 12.3 tm-20 -64.26 -22.35 66.92 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.778 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -43.4 96.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.18 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 11' ' ' LYS . 16.4 pt -64.49 -17.96 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.417 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.09 -37.14 1.09 Allowed Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 9' ' ' ILE . 9.1 mtpm? -71.85 107.23 4.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.802 0.334 . . . . 0.0 110.297 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.84 45.71 0.53 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.646 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.32 66.79 2.28 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.188 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 58.1 t80 54.44 30.9 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.748 0.309 . . . . 0.0 110.663 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mt 61.98 65.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.626 0.727 . . . . 0.0 110.271 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -132.29 -48.28 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.934 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.504 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -70.83 -45.75 71.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.92 -42.74 15.69 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 178.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.99 -47.42 90.82 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.652 179.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -60.86 -48.89 79.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.789 0.328 . . . . 0.0 110.244 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tp 62.07 1.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.34 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 20' ' ' ALA . 70.0 m-20 -85.79 37.61 0.71 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.366 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.475 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 0.7 OUTLIER 54.18 24.42 4.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.527 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.127 -179.921 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.5 mtm180 . . . . . 1 N--CA 1.325 -6.72 0 CA-C-O 122.564 1.173 . . . . 0.0 111.973 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -40.89 -21.21 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.317 179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 8.1 tp -106.8 -26.43 11.27 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.455 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' ARG . 50.5 tt0 -90.1 -0.34 57.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.23 0.538 . . . . 0.0 109.736 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.6 ptt85 -45.93 147.89 0.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 mt -79.9 -64.61 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.109 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 79.02 -13.8 17.5 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.936 179.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.513 ' C ' ' H ' ' A' ' 13' ' ' GLY . 2.4 ttmp? -70.31 7.14 1.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.263 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 15' ' ' ILE . . . 75.72 -20.68 0.34 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.344 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 35.21 65.77 0.4 Allowed Glycine 0 C--N 1.339 0.708 0 N-CA-C 112.254 -0.338 . . . . 0.0 112.254 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 56.04 36.67 27.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -178.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' ALA . 11.9 mm 64.24 80.49 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.765 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 8.7 tp -145.84 -54.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.194 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.438 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 3.7 tp -74.77 -33.8 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.15 -47.69 4.88 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 178.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.14 96.76 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.08 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.21 -64.86 0.68 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.759 0.314 . . . . 0.0 110.543 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.9 tp 55.4 74.59 0.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.569 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -165.3 41.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.558 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.466 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 3.5 m80 53.31 48.92 20.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.488 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.6 tp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.319 -179.966 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.8 mmt180 . . . . . 1 N--CA 1.324 -6.753 0 CA-C-O 122.51 1.148 . . . . 0.0 111.943 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 31.3 t90 -41.05 -20.24 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.298 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 4' ' ' ARG . 27.8 mt -109.69 -24.86 10.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.562 179.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 4' ' ' ARG . 22.2 tt0 -101.71 14.08 33.02 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.993 0.425 . . . . 0.0 110.026 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.7 ttp85 -72.06 -50.15 30.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.491 ' C ' ' H ' ' A' ' 11' ' ' LYS . 21.0 pt -62.34 -23.54 32.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.705 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.45 -32.11 1.17 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.249 -0.5 . . . . 0.0 111.898 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 9' ' ' ILE . 93.7 mttt -73.66 108.99 6.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.161 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.03 8.51 4.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.209 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 43.99 30.71 1.81 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.101 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -155.68 -76.71 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.653 0.263 . . . . 0.0 110.34 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.1 tt -90.41 47.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.951 0.881 . . . . 0.0 110.087 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 3.9 tp -142.33 -44.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.378 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.453 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 3.1 tp -82.55 -39.47 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.109 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.58 -45.54 4.89 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -58.26 -36.22 81.92 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.909 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.13 39.63 0.19 Allowed 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.69 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.465 ' H ' ' C ' ' A' ' 19' ' ' GLY . 21.2 tp -68.05 -51.98 40.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.117 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -54.42 -45.47 73.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.609 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.534 ' HD1' ' N ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -48.48 -36.86 15.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.32 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.648 179.547 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 6' ' ' LEU . 73.1 mtp180 . . . . . 1 N--CA 1.324 -6.774 0 CA-C-O 122.597 1.189 . . . . 0.0 112.182 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -40.67 -20.51 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 112.828 -1.987 . . . . 0.0 110.797 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.7 tp -112.06 -19.29 12.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.088 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.3 tp10 -60.81 -27.87 68.36 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.31 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -57.78 153.37 13.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.599 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 pt -155.89 8.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.121 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.24 29.53 5.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.288 -0.482 . . . . 0.0 111.94 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -161.75 55.35 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.954 0.407 . . . . 0.0 110.382 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.14 -0.45 31.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.932 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.42 54.31 0.23 Allowed Glycine 0 C--N 1.332 0.316 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 41.1 t80 63.22 29.09 15.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.755 0.312 . . . . 0.0 110.341 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.6 mt 61.25 60.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.632 0.729 . . . . 0.0 109.353 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.6 mm -126.44 -47.96 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.249 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.51 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.4 mp -66.7 -38.91 82.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.86 -40.26 6.3 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 178.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.14 79.56 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.983 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.7 -39.45 73.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.72 0.295 . . . . 0.0 110.691 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.2 mt 51.25 71.45 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.485 -179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.464 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 1.9 m-20 50.98 37.67 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.507 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.8 m80 53.7 61.4 3.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.684 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 tp . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.308 179.975 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 87.4 mtm180 . . . . . 1 N--CA 1.323 -6.784 0 CA-C-O 122.564 1.173 . . . . 0.0 112.001 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -43.22 -18.26 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 113.002 -1.908 . . . . 0.0 110.178 179.72 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.2 tt -114.17 -19.5 11.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.711 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.4 tp10 -82.0 16.99 1.69 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.394 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -70.3 178.35 2.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.619 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.6 tt -170.82 130.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.453 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.99 17.2 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.837 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.58 -2.76 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.269 -0.172 . . . . 0.0 110.788 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 58.94 62.94 1.75 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.34 85.97 0.01 OUTLIER Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.469 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 12' ' ' ALA . 29.4 t80 64.14 38.27 8.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.966 0.413 . . . . 0.0 110.043 -179.085 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.4 mm 61.41 73.7 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.095 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -133.72 -53.39 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.081 179.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.479 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -70.44 -51.32 38.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.787 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.09 -42.44 51.29 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 178.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.46 -45.42 96.43 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.024 179.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.72 -16.2 62.76 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.813 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.8 mt 51.87 79.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.289 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.8 p30 42.45 32.58 0.36 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.157 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 15.3 m80 58.96 61.76 2.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.583 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 -179.931 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 6' ' ' LEU . 52.0 mtm-85 . . . . . 1 N--CA 1.324 -6.754 0 CA-C-O 122.488 1.137 . . . . 0.0 112.004 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -41.92 -19.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.149 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 24.0 mt -118.66 -16.29 9.42 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.581 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.7 tt0 -87.96 -6.03 58.22 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 120.92 0.39 . . . . 0.0 110.181 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.435 ' CG ' ' H ' ' A' ' 9' ' ' ILE . 12.7 tpt180 62.12 -131.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.247 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.435 ' H ' ' CG ' ' A' ' 8' ' ' ARG . 14.8 tt -163.43 123.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 110.371 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.89 27.9 4.23 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.191 -179.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -101.12 100.84 11.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.774 0.321 . . . . 0.0 110.309 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.55 57.64 3.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.004 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.54 49.25 53.22 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.495 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 48.1 t80 59.05 45.06 15.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 110.533 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 mt 62.42 68.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.167 0.508 . . . . 0.0 110.628 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -134.04 -65.79 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 tp -71.19 -21.89 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.3 -45.16 5.09 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.613 179.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.67 -39.6 34.02 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.398 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.58 -75.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.638 0.256 . . . . 0.0 111.327 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.6 mt 59.76 14.03 3.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.146 -179.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 19.1 m-20 -74.33 -83.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.652 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.462 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 96.9 m-70 -156.52 56.28 0.56 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.469 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.127 -179.924 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.0 mtt180 . . . . . 1 N--CA 1.325 -6.688 0 CA-C-O 122.472 1.13 . . . . 0.0 112.082 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 66.9 t-105 -41.81 -19.28 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 112.892 -1.958 . . . . 0.0 110.358 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 mt -117.04 -18.36 10.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.549 179.301 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 4' ' ' ARG . 57.5 mm-40 -89.68 18.58 5.37 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.843 0.354 . . . . 0.0 110.411 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -55.25 -173.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 pt -150.09 124.28 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.967 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.44 -3.32 31.95 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.898 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' C ' ' H ' ' A' ' 13' ' ' GLY . 46.2 mttp -77.01 96.28 4.36 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.822 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.489 ' O ' ' CD1' ' A' ' 14' ' ' PHE . . . -57.87 -9.87 1.48 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 109.998 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 59.47 34.61 81.81 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.029 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 12' ' ' ALA . 61.4 m-85 -142.8 -53.21 0.39 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.795 -0.238 . . . . 0.0 110.404 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 pt -153.97 61.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.081 0.467 . . . . 0.0 110.589 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.4 mm -136.2 -39.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.416 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 pp -96.87 14.59 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.32 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.17 -48.28 0.02 OUTLIER Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.135 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.05 -43.47 93.23 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.895 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -62.98 -53.22 57.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.796 0.331 . . . . 0.0 110.427 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tp 63.13 1.38 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.389 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 20' ' ' ALA . 30.7 t70 -78.3 56.76 1.76 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.625 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 54.6 t-80 55.59 17.98 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.602 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.1 tp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.215 -179.967 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 7' ' ' GLU . 1.2 mtm-85 . . . . . 1 N--CA 1.319 -6.987 0 CA-C-O 121.503 0.668 . . . . 0.0 110.041 . . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -43.4 -18.74 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.141 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.1 mt -111.32 -18.0 13.02 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.744 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.7 mp0 -105.56 29.24 6.7 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 120.886 0.374 . . . . 0.0 110.112 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.494 ' C ' ' H ' ' A' ' 10' ' ' GLY . 85.6 mtm180 -47.72 -71.5 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.768 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 pt -57.88 -6.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.453 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . 50.51 51.06 33.81 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.928 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -166.97 74.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.409 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.27 62.89 3.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.203 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.69 49.66 16.01 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 -179.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.4 t80 63.88 48.66 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 110.121 -179.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mm 51.45 65.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.401 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.4 mm -132.7 -62.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.373 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 tp -67.67 -31.02 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.16 -48.87 4.67 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.82 -44.17 97.28 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.12 -71.82 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.18 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.9 tp 52.62 80.24 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.57 179.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -158.86 -69.53 0.09 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.442 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -165.62 37.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.593 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.096 179.958 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 7' ' ' GLU . 94.6 mtt180 . . . . . 1 N--CA 1.324 -6.732 0 CA-C-O 122.594 1.188 . . . . 0.0 111.996 . . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -42.0 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.435 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.0 mt -110.13 -21.08 12.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.912 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 38.4 tt0 -47.54 -19.85 0.21 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.911 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -52.02 -71.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.493 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.516 ' CG2' ' H ' ' A' ' 10' ' ' GLY . 14.6 tt -70.1 -59.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.332 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.516 ' H ' ' CG2' ' A' ' 9' ' ' ILE . . . 44.3 38.61 5.13 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.431 179.089 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' GLY . 61.5 mttp -96.15 -1.05 49.23 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 76.06 -30.28 0.19 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.156 -179.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.8 68.33 0.48 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 63.24 58.74 1.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 pt 38.77 81.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.998 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.3 mm -134.17 -41.45 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.471 178.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.92 -73.31 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.687 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.25 -44.0 98.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.719 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -77.47 -47.12 9.19 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 121.302 -0.475 . . . . 0.0 111.95 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.5 8.02 0.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 110.477 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.496 ' H ' ' C ' ' A' ' 19' ' ' GLY . 12.7 tp 52.82 75.81 0.22 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.399 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.1 p30 -168.3 49.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.1 t60 52.39 20.41 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.43 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.242 -179.995 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 52.7 mtp85 . . . . . 1 N--CA 1.324 -6.745 0 CA-C-O 122.56 1.172 . . . . 0.0 112.026 . . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.414 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 45.2 t-105 -41.95 -18.03 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.642 -179.881 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.6 tp -128.47 -8.42 5.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.625 179.622 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.8 tt0 -87.93 -7.68 56.8 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 110.174 179.819 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.443 ' C ' ' H ' ' A' ' 10' ' ' GLY . 38.5 ttm180 -54.33 -83.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.523 179.886 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 11' ' ' LYS . 22.5 pt -78.31 16.48 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.812 0.339 . . . . 0.0 110.541 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . -44.21 90.43 0.01 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.234 -179.821 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.504 ' HZ1' ' CB ' ' A' ' 11' ' ' LYS . 9.8 mtmp? -154.34 -2.42 0.18 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.69 57.09 5.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.198 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.1 88.38 0.01 OUTLIER Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.834 -179.648 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 12' ' ' ALA . 98.0 m-85 53.54 44.63 29.59 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.15 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.4 mt 61.9 76.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.643 -179.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 tp -142.73 -28.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.346 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 mm -104.26 -39.89 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.378 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.52 -59.88 4.28 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.413 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -72.41 -36.64 59.18 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.554 179.542 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.9 16.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.663 0.268 . . . . 0.0 111.053 179.734 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.437 ' C ' ' N ' ' A' ' 23' ' ' HIS . 23.7 mt 54.08 -123.7 2.14 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.048 -179.735 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 t0 46.05 17.6 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.761 0.315 . . . . 0.0 110.876 179.801 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.459 ' HD1' ' N ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER 51.78 41.69 29.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.339 -179.862 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.7 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.256 -179.923 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' GLU . 58.8 mtm180 . . . . . 1 N--CA 1.325 -6.714 0 CA-C-O 122.436 1.113 . . . . 0.0 111.949 . . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -42.19 -18.93 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.294 179.932 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 4' ' ' ARG . 23.5 mt -112.21 -23.09 10.61 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.379 179.077 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 82.3 mt-10 -97.24 14.26 26.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.85 0.357 . . . . 0.0 110.328 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -62.86 -37.2 85.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.709 -179.857 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 11' ' ' LYS . 4.1 tp -170.04 -11.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.96 0.409 . . . . 0.0 109.915 -179.799 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -37.4 -25.98 0.02 OUTLIER Glycine 0 C--N 1.335 0.482 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.634 179.615 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 13' ' ' GLY . 85.9 mttt -71.2 103.29 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.31 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.7 2.87 0.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.64 -179.813 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.75 45.42 3.61 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.557 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -163.47 -41.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.663 0.268 . . . . 0.0 110.65 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 pt -154.26 60.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.105 0.479 . . . . 0.0 110.442 179.998 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 mm -147.58 -30.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.4 mm -112.39 -49.45 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.447 179.206 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.51 -41.99 49.71 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.344 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.09 -38.25 7.41 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 179.52 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.6 67.46 1.0 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.332 . . . . 0.0 110.499 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 23' ' ' HIS . 9.7 tp -49.61 120.83 4.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.514 179.889 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 52.58 -85.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.694 179.864 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.581 ' HD1' ' H ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -156.91 45.07 0.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.36 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.26 -179.841 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 7' ' ' GLU . 10.3 mtm180 . . . . . 1 N--CA 1.319 -7.0 0 CA-C-O 121.389 0.614 . . . . 0.0 110.658 . . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -43.53 -18.63 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.312 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.533 ' N ' ' C ' ' A' ' 4' ' ' ARG . 36.3 mt -115.2 -14.9 11.7 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.937 178.919 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.1 mt-10 -118.2 25.95 9.97 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.413 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -66.93 152.22 46.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.565 -179.903 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.0 tt -68.93 -42.99 82.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.363 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.69 -129.71 7.59 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.232 -179.987 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.515 ' C ' ' H ' ' A' ' 13' ' ' GLY . 90.4 mttt 49.79 18.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.302 . . . . 0.0 110.532 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 16' ' ' ILE . . . 71.9 -13.6 0.57 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.775 -179.918 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.97 56.59 2.14 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 112.211 -0.355 . . . . 0.0 112.211 179.99 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 67.43 46.99 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.07 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.2 mm 62.68 77.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.891 -179.945 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' ALA . 7.6 mm -131.77 -73.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.4 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -74.47 -29.77 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.418 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.85 -53.12 8.4 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.18 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -77.15 -45.21 11.85 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.526 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.59 10.72 0.24 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.768 0.318 . . . . 0.0 110.537 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' HIS . 8.6 mp 53.85 -111.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.016 -179.97 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 t70 54.91 -82.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.708 0.289 . . . . 0.0 110.757 179.924 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' LEU . 15.4 t60 -160.67 4.31 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.425 179.922 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.538 179.894 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 7' ' ' GLU . 10.1 mtp180 . . . . . 1 N--CA 1.314 -7.235 0 CA-C-O 121.557 0.694 . . . . 0.0 110.593 . . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -44.37 -21.62 0.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.387 -179.773 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.476 ' N ' ' C ' ' A' ' 4' ' ' ARG . 17.1 mt -99.81 -21.26 15.82 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.634 179.713 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.3 tp10 -68.83 -28.19 66.52 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.467 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -66.15 155.73 36.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.575 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.8 tt -165.87 121.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.478 179.919 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.26 -25.34 19.41 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.476 ' C ' ' H ' ' A' ' 13' ' ' GLY . 45.9 mttp -83.3 87.66 6.95 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.947 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.07 17.58 1.21 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.586 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 57.61 22.3 45.65 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.452 -179.531 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.488 ' C ' ' H ' ' A' ' 16' ' ' ILE . 45.5 t80 -146.06 -55.29 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.8 pt -80.37 31.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 179.71 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.488 ' H ' ' C ' ' A' ' 14' ' ' PHE . 9.6 tp -148.54 -46.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.924 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.455 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 3.5 tp -79.26 -32.33 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.188 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.78 -47.75 3.86 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 178.655 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.42 -38.39 86.72 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.408 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -75.01 -68.64 0.53 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.845 0.355 . . . . 0.0 110.285 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 23' ' ' HIS . 0.7 OUTLIER 59.03 5.96 0.6 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.052 179.879 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 20' ' ' ALA . 8.4 m-20 -77.58 23.0 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.531 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.498 ' H ' ' C ' ' A' ' 21' ' ' LEU . 37.8 m-70 52.86 35.67 19.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.427 179.964 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.251 -179.988 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.602 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.9 mtt-85 . . . . . 1 N--CA 1.314 -7.254 0 CA-C-O 121.586 0.707 . . . . 0.0 110.175 . . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -41.28 -24.21 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.957 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.4 mm? -92.33 -29.3 16.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.209 179.459 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.7 tt0 -71.3 -19.02 62.38 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.126 179.715 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.44 131.78 51.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.525 179.947 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.8 pt -64.16 -34.51 69.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.529 -179.901 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.51 47.02 92.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.074 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -154.18 73.19 0.91 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.782 0.325 . . . . 0.0 110.254 179.988 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.01 49.65 1.11 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.612 179.908 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.73 65.71 2.91 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.166 179.897 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 54.77 31.63 15.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.701 0.286 . . . . 0.0 110.923 179.785 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 61.26 64.08 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.578 0.704 . . . . 0.0 110.277 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 mm -133.01 -47.28 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.717 179.923 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -72.13 -46.18 59.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.858 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.92 -48.7 9.6 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.082 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.53 -42.45 99.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.857 179.618 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.468 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 59.95 3.39 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.743 0.306 . . . . 0.0 110.784 -179.958 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.2 mt 49.71 13.41 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.736 179.91 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 20' ' ' ALA . 47.6 t0 -62.83 -73.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.565 179.984 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.413 ' C ' ' HD1' ' A' ' 23' ' ' HIS . 2.0 p80 -169.62 20.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.548 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 10.1 mp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.079 179.908 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 7' ' ' GLU . 65.5 mtt-85 . . . . . 1 N--CA 1.321 -6.897 0 CA-C-O 122.633 1.206 . . . . 0.0 111.949 . . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -43.03 -19.04 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.151 179.876 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.497 ' N ' ' C ' ' A' ' 4' ' ' ARG . 20.6 mt -111.89 -19.66 12.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.75 179.788 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.2 tt0 -49.04 -24.58 1.62 Allowed 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.71 -179.844 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 56.5 99.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.231 -179.913 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 11' ' ' LYS . 2.3 pt -62.59 113.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.411 0.624 . . . . 0.0 110.279 -179.845 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.82 8.25 8.03 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.648 179.854 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 9' ' ' ILE . 57.5 mttp -67.28 108.37 2.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.694 0.283 . . . . 0.0 110.64 -179.924 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.91 4.76 5.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.064 0.459 . . . . 0.0 109.783 179.536 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 14' ' ' PHE . . . 59.99 22.89 58.55 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.998 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 63.9 m-85 -158.6 -100.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.738 0.304 . . . . 0.0 111.166 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.8 pt -78.05 60.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.988 0.423 . . . . 0.0 111.739 -178.834 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.7 mm -149.26 -44.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.036 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.03 -50.07 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.805 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.56 -43.61 67.79 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.059 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.1 -42.62 7.96 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 179.386 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.35 50.38 18.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.767 0.318 . . . . 0.0 110.649 179.861 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.3 mt -75.19 -26.76 59.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.416 179.931 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 24' ' ' LEU . 16.3 m-20 -77.2 -67.77 0.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.42 1.4 0.79 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.709 -179.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' A' ' 22' ' ' ASP . 1.6 tt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.351 179.992 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 7' ' ' GLU . 88.0 mtt180 . . . . . 1 N--CA 1.324 -6.76 0 CA-C-O 122.536 1.16 . . . . 0.0 111.855 . . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -42.7 -21.34 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.836 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.483 ' N ' ' C ' ' A' ' 4' ' ' ARG . 11.0 mp -105.27 -26.32 12.07 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.995 179.151 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 4' ' ' ARG . 22.4 mm-40 -93.34 37.65 1.05 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.694 0.283 . . . . 0.0 110.607 -179.855 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -69.9 172.36 7.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.446 179.988 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 tp -170.4 124.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.192 179.849 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.36 25.26 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.769 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -69.62 -5.81 27.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 55.54 60.72 3.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.015 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.66 87.59 0.01 OUTLIER Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -179.657 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 12' ' ' ALA . 98.8 m-85 54.01 42.05 31.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -178.621 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.5 mt 62.66 83.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.465 -179.576 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.47 ' CG2' ' H ' ' A' ' 17' ' ' ILE . 5.2 tp -143.66 -58.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.398 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.47 ' H ' ' CG2' ' A' ' 16' ' ' ILE . 3.7 tp -86.15 -26.34 6.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.505 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.18 -55.29 4.42 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 178.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.16 -43.28 40.19 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.632 179.299 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.34 38.76 30.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.694 0.283 . . . . 0.0 110.778 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.1 mt -99.8 -20.07 16.39 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.481 179.839 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -50.09 -50.9 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -165.28 -20.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.46 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.499 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.6 mp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.169 179.923 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 7' ' ' GLU . 71.1 mtm180 . . . . . 1 N--CA 1.325 -6.71 0 CA-C-O 122.467 1.127 . . . . 0.0 112.057 . . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -41.19 -20.05 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 112.924 -1.944 . . . . 0.0 110.334 179.834 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.0 tp -112.93 -22.62 10.53 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.342 179.351 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.2 mm-40 -102.06 38.77 1.59 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.657 0.265 . . . . 0.0 110.563 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -51.47 139.23 20.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.383 179.981 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.463 ' C ' ' H ' ' A' ' 11' ' ' LYS . 2.7 tp -52.64 -56.08 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.406 -179.797 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.49 -38.92 1.04 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.073 179.902 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 9' ' ' ILE . 37.0 mtmt -78.12 105.42 9.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.745 0.307 . . . . 0.0 110.389 179.987 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.85 9.17 3.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.192 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.13 34.43 12.25 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.114 179.878 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.454 ' C ' ' H ' ' A' ' 16' ' ' ILE . 12.5 t80 -161.96 -73.85 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.826 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 pt -81.48 38.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.207 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.454 ' H ' ' C ' ' A' ' 14' ' ' PHE . 4.0 tp -146.23 -42.72 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.087 -179.656 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.431 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 2.2 pp -77.04 0.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.043 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -158.15 -42.64 0.02 OUTLIER Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.686 -179.808 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -61.23 -36.34 92.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.69 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 56.29 6.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.748 0.308 . . . . 0.0 110.704 179.918 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.5 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.0 tp 49.97 14.09 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.411 179.99 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 20' ' ' ALA . 18.3 t70 -71.73 -40.96 69.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.441 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.592 ' HD1' ' N ' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -165.78 12.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.343 179.9 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.226 -179.988 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 7' ' ' GLU . 94.8 mtt180 . . . . . 1 N--CA 1.326 -6.634 0 CA-C-O 122.672 1.225 . . . . 0.0 111.966 . . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -42.11 -20.12 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.964 -1.925 . . . . 0.0 110.38 179.83 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.3 mt -110.18 -20.48 12.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.995 179.93 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.6 tt0 -46.99 -22.02 0.28 Allowed 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.823 -179.917 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 -79.61 -44.05 21.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.4 mm -70.28 -6.88 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 -179.64 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.37 -25.57 6.18 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.739 -0.744 . . . . 0.0 111.35 179.542 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 13' ' ' GLY . 98.0 mttt -116.68 76.45 1.03 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.228 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.92 84.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.381 -179.535 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . 47.18 54.65 9.62 Favored Glycine 0 C--N 1.33 0.209 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -179.593 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.1 t80 57.68 39.91 26.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.885 0.374 . . . . 0.0 110.285 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 mt 60.85 67.59 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.482 -179.979 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 10.2 tp -137.89 -47.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.387 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.422 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 28.9 mm -77.63 -36.68 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.297 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.12 -50.68 6.64 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 178.884 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -67.61 -36.86 88.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.568 179.342 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 73.17 -35.68 0.33 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.635 0.255 . . . . 0.0 111.06 179.865 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 19' ' ' GLY . 2.4 mm? 53.35 10.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.953 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 20' ' ' ALA . 15.8 t0 -79.56 -37.42 36.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.623 -179.913 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -167.6 -22.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.806 -179.942 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.145 -179.958 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 7' ' ' GLU . 58.0 mtm180 . . . . . 1 N--CA 1.323 -6.802 0 CA-C-O 122.391 1.091 . . . . 0.0 112.001 . . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -38.48 -26.56 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.118 -1.856 . . . . 0.0 110.354 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.4 mm? -94.18 -33.54 13.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.077 179.334 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.5 mt-10 -96.1 14.14 24.87 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.708 0.289 . . . . 0.0 110.437 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 4' ' ' ARG . 0.6 OUTLIER -70.04 -68.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.322 -179.795 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.5 pt -98.59 -33.34 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.63 179.894 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.01 59.89 6.52 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.841 -179.724 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -162.75 83.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.34 . . . . 0.0 110.241 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.33 57.03 2.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 -179.825 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 57.31 64.47 4.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.057 179.993 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 47.0 t80 54.89 33.27 19.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.797 0.332 . . . . 0.0 110.467 179.918 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 mt 59.52 64.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.575 0.702 . . . . 0.0 110.113 -179.831 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -132.18 -51.87 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.847 -179.941 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 mm -68.87 -44.37 81.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.764 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.99 -44.36 12.13 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.936 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.19 -43.3 99.57 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.892 179.543 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.08 -22.24 49.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.838 0.351 . . . . 0.0 110.495 -179.898 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.3 tp -56.55 -19.12 14.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.413 179.994 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 79.4 m-20 -51.04 -51.99 47.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.666 179.903 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.488 ' ND1' ' O ' ' A' ' 22' ' ' ASP . 77.1 m-70 -153.89 39.62 0.48 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.246 179.956 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.134 -179.932 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 7' ' ' GLU . 83.8 mtm180 . . . . . 1 N--CA 1.323 -6.81 0 CA-C-O 122.379 1.085 . . . . 0.0 112.072 . . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -38.4 -23.99 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.569 -179.901 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.0 tp -102.43 -29.89 11.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.412 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.4 mm-40 -97.38 43.99 1.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -50.97 -39.09 54.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 -179.851 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.509 ' C ' ' H ' ' A' ' 11' ' ' LYS . 11.2 pt -155.83 -35.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.428 179.903 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.34 -12.99 1.64 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.225 179.886 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 9' ' ' ILE . 31.9 mtmm -89.76 105.49 17.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.749 0.309 . . . . 0.0 110.201 179.903 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.02 61.2 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.806 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.62 50.91 13.4 Favored Glycine 0 C--N 1.331 0.27 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -179.236 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.9 t80 60.24 63.54 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.713 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.5 pt 35.26 62.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.346 -179.342 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 4.5 tp -129.15 -48.71 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.459 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 4.1 tp -82.31 -33.77 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.518 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.86 -35.64 6.72 Favored Glycine 0 C--N 1.331 0.262 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.23 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.66 -37.83 61.56 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.016 179.805 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.54 -68.16 0.45 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.824 0.345 . . . . 0.0 110.5 179.993 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.21 85.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.132 -179.97 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.9 t0 51.19 35.62 13.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.7 179.967 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.431 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 7.0 t60 53.24 46.21 26.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.565 179.871 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.127 179.922 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 7' ' ' GLU . 80.0 mtm180 . . . . . 1 N--CA 1.323 -6.806 0 CA-C-O 122.574 1.178 . . . . 0.0 111.921 . . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -42.3 -20.22 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.065 -1.88 . . . . 0.0 110.218 179.81 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 4' ' ' ARG . 24.0 mt -107.05 -24.98 11.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.375 179.446 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' ARG . 11.8 mp0 -89.24 -3.78 58.42 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.645 0.26 . . . . 0.0 110.318 -179.981 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -73.66 -29.72 62.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.52 -179.943 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.2 tt -48.67 99.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.227 0.537 . . . . 0.0 110.653 -179.805 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.14 -14.45 82.27 Favored Glycine 0 C--N 1.329 0.18 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.978 -179.927 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.461 ' C ' ' H ' ' A' ' 13' ' ' GLY . 53.6 mtpt -73.95 97.98 2.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.815 0.34 . . . . 0.0 110.464 -179.983 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.8 -3.27 1.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.803 -179.906 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 61.7 14.2 42.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.703 -179.888 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -163.79 -46.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.929 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.6 mm -99.77 52.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.339 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -149.74 -45.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.208 -179.827 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.437 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 1.0 OUTLIER -79.77 5.37 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.765 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.14 -44.11 0.02 OUTLIER Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.648 -179.916 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.41 -35.38 61.07 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.948 179.843 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.74 -29.47 59.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 0.0 110.507 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.3 mt -81.98 -27.14 33.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.633 -179.944 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -50.56 -59.91 3.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.603 179.983 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.416 ' H ' ' H ' ' A' ' 24' ' ' LEU . 11.4 t-80 -170.03 -4.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.539 179.935 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.416 ' H ' ' H ' ' A' ' 23' ' ' HIS . 17.2 mt . . . . . 0 N--CA 1.468 0.45 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.393 179.923 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 7' ' ' GLU . 52.3 mtm-85 . . . . . 1 N--CA 1.324 -6.75 0 CA-C-O 122.54 1.162 . . . . 0.0 112.048 . . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -41.07 -25.06 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.999 -1.91 . . . . 0.0 109.989 179.914 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.451 ' N ' ' C ' ' A' ' 4' ' ' ARG . 3.3 mm? -96.75 -29.0 14.02 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.424 179.508 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 4' ' ' ARG . 2.3 mp0 -86.39 -8.22 57.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.656 -179.498 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -80.26 -114.86 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.491 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.516 ' C ' ' H ' ' A' ' 11' ' ' LYS . 6.9 mm -83.09 -74.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.762 0.315 . . . . 0.0 110.171 179.742 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.85 -33.15 0.88 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.21 179.982 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 9' ' ' ILE . 40.8 mtmt -117.12 74.97 0.94 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.871 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.33 77.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.191 179.977 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . 51.62 54.6 23.94 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.544 -179.532 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 60.38 35.74 20.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.33 -179.644 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.3 mt 60.48 62.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.442 -179.988 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.4 tp -132.28 -41.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.552 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.4 mm -81.27 -43.55 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.541 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.5 -47.83 26.21 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 178.834 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.0 -37.62 87.83 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.703 179.301 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.42 51.18 11.93 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.88 0.371 . . . . 0.0 110.753 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.5 103.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.552 -179.914 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t70 54.53 44.16 29.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.616 -179.997 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.3 m80 51.56 31.84 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 179.923 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.358 179.971 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' GLU . 71.7 mtm-85 . . . . . 1 N--CA 1.325 -6.7 0 CA-C-O 122.478 1.132 . . . . 0.0 111.933 . . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -41.85 -19.8 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.224 179.896 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.6 tp -112.11 -23.01 10.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.226 179.371 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.5 mt-10 -94.61 20.92 7.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.844 0.354 . . . . 0.0 110.463 179.946 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.4 ttt85 -68.77 122.09 17.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.555 -179.965 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.416 ' H ' ' H ' ' A' ' 10' ' ' GLY . 20.8 pt -157.01 -9.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.309 -179.891 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 9' ' ' ILE . . . 53.93 38.57 60.47 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.973 -179.97 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 13' ' ' GLY . 67.5 mttm -148.71 77.27 1.38 Allowed 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.989 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.91 33.53 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.591 179.978 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 52.32 48.48 53.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.896 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.8 t80 67.78 50.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.692 0.282 . . . . 0.0 110.946 179.894 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.5 mm 60.66 73.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.333 0.587 . . . . 0.0 111.334 179.301 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.3 mm -136.05 -51.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.001 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.479 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -70.45 -54.05 20.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.859 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.62 -50.98 22.65 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.475 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.76 -45.8 95.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.865 179.684 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.63 -0.65 0.52 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.636 0.255 . . . . 0.0 110.896 -179.927 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 19' ' ' GLY . 16.0 mt 47.26 73.76 0.18 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 110.712 179.787 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.9 p-10 -170.68 35.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.621 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 51.36 42.59 29.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.535 179.973 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.195 -179.985 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 6' ' ' LEU . 97.5 mtt180 . . . . . 1 N--CA 1.323 -6.777 0 CA-C-O 122.426 1.108 . . . . 0.0 111.978 . . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -41.67 -18.99 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.004 -1.907 . . . . 0.0 110.455 -179.912 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.3 mp -117.34 -17.91 10.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.646 179.374 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 4' ' ' ARG . 68.4 mm-40 -90.71 -9.99 44.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.719 0.295 . . . . 0.0 110.752 -179.844 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -83.45 68.45 9.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.521 -179.983 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.22 81.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.548 -179.872 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.33 -32.42 14.39 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.201 -0.523 . . . . 0.0 111.874 179.856 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 13' ' ' GLY . 56.9 mtpt -59.43 106.53 0.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.32 . . . . 0.0 110.298 179.881 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.91 1.45 3.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.037 -179.954 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 43.23 38.15 3.56 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.463 179.859 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -169.42 -15.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.053 179.988 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.0 pt -157.06 49.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.826 0.346 . . . . 0.0 111.06 179.826 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 18' ' ' GLY . 1.5 mm -143.78 -50.25 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.559 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.9 15.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.222 179.876 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -171.99 -31.87 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.157 -0.544 . . . . 0.0 111.855 -179.963 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.31 -23.86 69.87 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 -180.0 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.66 -50.32 58.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 0.0 110.575 -179.902 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.7 mt 56.09 56.49 5.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.116 -179.93 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -157.87 68.63 0.51 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.567 -179.943 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.466 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 49.5 t-80 51.82 39.61 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.608 179.856 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.2 tp . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.211 179.953 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER . . . . . 1 N--CA 1.312 -7.367 0 CA-C-O 121.546 0.688 . . . . 0.0 109.951 . . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.6 t90 -42.4 -23.5 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.896 -179.943 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' N ' ' C ' ' A' ' 4' ' ' ARG . 5.0 mp -92.87 -27.63 17.0 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.61 179.765 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.5 mt-10 -79.21 -14.61 58.95 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.737 -179.928 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -70.17 -179.91 2.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 0.0 110.594 -179.881 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 tp -60.05 105.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.262 0.553 . . . . 0.0 110.409 -179.712 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.77 42.76 0.02 OUTLIER Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.831 179.995 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -50.29 -31.36 14.1 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.604 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.67 -9.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.622 -179.876 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.57 33.35 71.62 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.7 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -154.32 -9.79 0.14 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.915 0.388 . . . . 0.0 110.14 -179.926 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.5 pt -156.81 40.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.01 179.425 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 tp -150.49 -26.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.254 -179.683 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.5 6.71 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.837 179.484 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.79 -28.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.952 -179.978 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.83 -47.64 38.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.161 -0.542 . . . . 0.0 111.987 179.96 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.08 36.72 25.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.722 0.296 . . . . 0.0 110.583 179.958 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.59 -5.26 27.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.418 179.853 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -51.63 -35.51 42.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.619 179.981 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -168.48 21.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.702 179.967 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.21 179.979 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.533 ' C ' ' H ' ' A' ' 6' ' ' LEU . 13.8 mtp180 . . . . . 1 N--CA 1.318 -7.044 0 CA-C-O 121.315 0.578 . . . . 0.0 110.583 . . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -43.81 -18.12 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.682 -179.975 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.533 ' H ' ' C ' ' A' ' 4' ' ' ARG . 63.3 mt -120.6 -9.14 9.44 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.184 179.236 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.1 mt-10 -116.43 32.33 6.19 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.096 0.474 . . . . 0.0 109.749 179.626 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -49.03 92.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.534 179.76 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.458 ' C ' ' H ' ' A' ' 11' ' ' LYS . 16.4 pt -71.59 -32.58 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 -179.891 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.35 6.58 1.56 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.029 -179.978 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.499 ' C ' ' H ' ' A' ' 13' ' ' GLY . 78.6 tttt -68.83 -7.45 34.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 110.217 179.976 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 16' ' ' ILE . . . 74.89 -21.54 0.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.607 -179.85 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 42.64 52.64 5.39 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.627 -179.816 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.8 t80 70.91 44.61 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.993 0.425 . . . . 0.0 109.978 -179.124 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.8 mt 61.22 74.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.46 -179.99 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.7 mm -136.0 -71.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.693 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 tp -72.46 -23.52 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.136 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.16 -54.99 3.63 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.383 179.253 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -40.65 41.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.78 179.688 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.15 59.27 4.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.833 0.349 . . . . 0.0 110.245 -179.951 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.422 ' CD1' ' H ' ' A' ' 21' ' ' LEU . 10.1 mp -48.32 117.3 1.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.338 -179.827 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t0 55.16 51.93 12.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.986 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.1 m170 53.28 35.01 19.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.689 179.927 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.331 179.906 . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 59.4 mtt85 . . . . . 1 N--CA 1.325 -6.717 0 CA-C-O 122.499 1.142 . . . . 0.0 111.999 . . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -40.8 -21.1 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.387 -179.934 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.9 mt -108.44 -24.92 11.22 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.676 179.365 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.1 mm-40 -89.89 33.8 0.85 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-O 120.928 0.394 . . . . 0.0 110.34 179.876 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -146.63 70.47 1.21 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.128 179.961 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.8 tt -61.04 120.79 7.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 179.963 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.87 -31.5 67.13 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.893 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' C ' ' H ' ' A' ' 13' ' ' GLY . 93.5 mttt -69.46 95.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 110.159 179.62 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -54.16 -8.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.39 -179.993 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 67.43 0.41 11.39 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.479 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.461 ' H ' ' C ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -80.86 -68.26 0.7 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.949 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.6 pt -158.25 42.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.771 179.42 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 18' ' ' GLY . 1.5 mp -85.66 -49.79 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.142 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.455 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -75.41 18.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.747 179.891 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -152.69 -58.1 0.01 OUTLIER Glycine 0 C--N 1.334 0.455 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 -179.938 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.43 -33.0 65.09 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.895 -179.994 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.99 -66.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 110.521 179.951 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.81 73.07 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.166 0.508 . . . . 0.0 109.899 179.898 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -160.87 32.51 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.306 179.984 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 50.5 t-80 55.48 39.51 31.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.285 -179.816 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.091 -179.76 . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' A' ' 6' ' ' LEU . 66.8 mtp180 . . . . . 1 N--CA 1.325 -6.71 0 CA-C-O 122.58 1.181 . . . . 0.0 112.059 . . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -42.91 -18.44 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.887 -1.96 . . . . 0.0 110.214 179.85 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 4' ' ' ARG . 49.4 tp -114.8 -20.24 10.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.422 179.469 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 45.0 mm-40 -89.99 19.16 5.09 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.556 -179.998 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -78.68 56.32 1.83 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.183 179.952 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.61 83.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.658 -179.774 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.5 -25.11 75.03 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.119 -0.562 . . . . 0.0 111.716 179.625 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -78.39 107.92 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.776 0.322 . . . . 0.0 110.245 179.814 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.91 55.43 1.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.835 179.754 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 53.11 47.64 60.27 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.371 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 t80 61.0 45.55 9.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.029 0.443 . . . . 0.0 110.008 -179.392 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 mt 60.99 70.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.583 -179.803 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -135.8 -64.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.5 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -70.74 -26.76 28.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.352 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.07 -56.2 2.77 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.409 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.37 82.62 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 179.666 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.61 47.8 12.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.726 0.298 . . . . 0.0 110.675 179.829 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.2 tp -72.85 -34.6 66.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.022 179.854 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.45 44.14 0.59 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.568 179.998 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 42.3 m80 51.6 17.32 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.564 179.994 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.1 tp . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.262 -179.93 . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 66.1 mtp180 . . . . . 1 N--CA 1.324 -6.77 0 CA-C-O 122.624 1.202 . . . . 0.0 111.966 . . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -44.39 -20.02 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 112.984 -1.917 . . . . 0.0 109.908 179.675 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 4' ' ' ARG . 42.6 tp -105.34 -22.84 12.96 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.431 179.791 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.8 tt0 -48.26 -36.2 13.56 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.7 mtt85 -77.06 -63.89 1.26 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.559 179.839 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.4 tt -170.42 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.447 -179.998 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.84 -50.39 3.3 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -179.796 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -81.25 96.58 7.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.696 0.284 . . . . 0.0 110.261 179.761 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.9 47.61 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.771 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.7 54.39 33.33 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.676 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 55.2 49.1 17.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.497 -179.698 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.6 mt 60.58 70.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.67 179.921 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.6 mm -136.35 -68.31 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.609 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -68.49 -22.99 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.654 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.24 -59.89 1.8 Allowed Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.486 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.52 -31.63 79.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.715 179.774 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.13 57.91 5.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 110.407 179.959 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.0 mt -56.75 90.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.386 179.954 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 24' ' ' LEU . 8.2 m-20 54.33 -135.1 1.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.354 -179.93 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -76.41 21.3 0.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.789 0.328 . . . . 0.0 110.744 179.885 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.496 ' H ' ' C ' ' A' ' 22' ' ' ASP . 15.9 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.145 -179.997 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 6' ' ' LEU . 93.9 mtt180 . . . . . 1 N--CA 1.324 -6.735 0 CA-C-O 122.441 1.115 . . . . 0.0 112.044 . . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -39.84 -20.61 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 112.919 -1.946 . . . . 0.0 110.66 -179.802 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.5 tp -117.55 -19.15 9.54 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.501 179.406 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.0 mt-10 -89.5 24.56 2.23 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.777 0.322 . . . . 0.0 110.53 -179.978 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -76.36 -63.69 1.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.721 -179.984 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.2 tt -49.66 109.77 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.196 0.522 . . . . 0.0 110.558 -179.8 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.74 -27.58 64.71 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.933 -179.754 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' A' ' 13' ' ' GLY . 3.8 mptp? -54.96 111.2 0.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.714 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.12 3.53 3.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.96 0.41 . . . . 0.0 110.308 -179.61 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.38 38.48 0.63 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.796 179.586 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -168.38 -19.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 110.663 179.87 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 pt -151.17 48.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.123 0.487 . . . . 0.0 109.991 179.562 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.8 tp -146.4 -35.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.09 -179.892 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.51 4.8 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.813 179.423 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.39 -33.88 0.02 OUTLIER Glycine 0 C--N 1.33 0.248 0 N-CA-C 111.779 -0.529 . . . . 0.0 111.779 -179.856 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.13 -42.96 97.35 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.148 -0.549 . . . . 0.0 111.806 179.967 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.46 -51.36 60.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.724 0.297 . . . . 0.0 110.45 -179.955 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 tp 55.76 100.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.276 -179.953 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -164.72 -36.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.597 -179.954 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -170.32 1.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.71 -179.922 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.196 -179.857 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 84.0 mtm180 . . . . . 1 N--CA 1.324 -6.763 0 CA-C-O 122.529 1.157 . . . . 0.0 111.923 . . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -42.08 -19.27 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.943 -1.935 . . . . 0.0 110.366 179.889 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.7 mt -114.12 -19.51 11.33 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.953 179.799 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.7 mm-40 -86.19 -16.23 38.44 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.721 -179.658 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -80.47 103.94 10.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.419 179.783 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.3 pt -65.31 -31.19 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.593 -179.854 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.21 28.35 4.3 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.04 179.966 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 13' ' ' GLY . 21.8 ttpp -79.09 -19.26 51.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.545 0.212 . . . . 0.0 110.769 -179.692 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 15' ' ' ILE . . . 78.5 -21.42 0.33 Allowed 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.164 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.11 36.43 0.87 Allowed Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -179.831 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.4 t80 73.69 48.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.647 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 12' ' ' ALA . 33.6 mt 64.6 70.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.517 -179.714 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.42 ' C ' ' H ' ' A' ' 18' ' ' GLY . 8.3 mm -134.66 -76.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.846 179.752 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.36 -6.53 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.143 -179.86 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -106.09 -65.8 0.65 Allowed Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.982 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.2 -19.95 74.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.683 179.668 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 63.05 9.75 4.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.629 0.252 . . . . 0.0 110.835 179.681 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 52.47 12.38 0.23 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.088 0.47 . . . . 0.0 109.783 -179.965 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 20' ' ' ALA . 25.1 t70 -70.19 -102.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.274 179.975 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.478 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 57.5 t-80 -67.41 2.08 1.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 110.103 179.582 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.492 ' H ' ' C ' ' A' ' 22' ' ' ASP . 1.4 tt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.129 -179.923 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.8 mtt180 . . . . . 1 N--CA 1.325 -6.704 0 CA-C-O 122.383 1.087 . . . . 0.0 112.047 . . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -40.99 -18.93 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.639 -179.954 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.8 tp -123.47 -13.27 7.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.632 179.492 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.0 tt0 -82.93 -8.62 59.55 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.556 -179.806 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -50.11 115.49 1.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.466 179.774 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 11' ' ' LYS . 17.6 tt -70.68 -23.17 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.608 -179.837 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -47.13 87.43 0.01 OUTLIER Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.344 -179.887 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 9' ' ' ILE . 9.6 mtpm? -149.55 4.76 0.6 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.768 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 53.17 56.39 7.53 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.285 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -41.1 88.17 0.01 OUTLIER Glycine 0 C--N 1.335 0.523 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.019 -179.847 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 12' ' ' ALA . 89.6 m-85 53.26 48.19 22.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.815 0.34 . . . . 0.0 110.091 -179.108 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.7 mt 62.13 80.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.626 -179.835 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.0 tp -146.57 -35.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.249 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 mm -98.96 -37.24 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.007 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.02 -57.81 5.06 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.226 179.358 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.86 86.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.671 179.545 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.04 40.58 17.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.7 179.814 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 23' ' ' HIS . 22.8 mt -68.71 -25.98 65.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.579 -179.957 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.42 34.0 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.942 -179.74 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.496 ' H ' ' C ' ' A' ' 21' ' ' LEU . 12.0 t-80 54.85 27.87 9.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.574 179.31 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.238 179.527 . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' GLU . 74.4 mtm180 . . . . . 1 N--CA 1.323 -6.813 0 CA-C-O 122.477 1.132 . . . . 0.0 111.835 . . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -42.17 -19.73 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.095 -1.866 . . . . 0.0 110.262 179.862 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.498 ' N ' ' C ' ' A' ' 4' ' ' ARG . 31.0 mt -108.82 -24.2 11.39 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.531 179.568 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 4' ' ' ARG . 27.6 tt0 -89.5 -5.41 57.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.057 0.456 . . . . 0.0 110.008 179.905 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -67.57 -51.27 52.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.644 179.987 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.437 ' C ' ' H ' ' A' ' 11' ' ' LYS . 10.5 tt -167.32 -44.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.666 -179.9 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.431 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . 75.9 -39.85 1.38 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.159 179.981 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.486 ' C ' ' H ' ' A' ' 13' ' ' GLY . 86.4 mttt -79.77 81.14 6.08 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.768 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.38 15.34 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.8 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 65.45 19.25 66.49 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.616 -179.623 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.48 ' C ' ' H ' ' A' ' 16' ' ' ILE . 65.4 m-85 -147.18 -52.82 0.21 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.767 0.317 . . . . 0.0 110.207 179.879 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.3 pt -80.18 32.54 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 121.045 0.45 . . . . 0.0 110.53 179.815 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 14' ' ' PHE . 4.2 tp -148.97 -44.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.429 -179.787 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.45 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 2.2 pp -71.3 1.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.294 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -163.89 -40.69 0.02 OUTLIER Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.946 -179.899 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -73.27 -29.14 64.75 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.92 179.989 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.18 8.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.653 0.263 . . . . 0.0 110.908 179.978 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 23' ' ' HIS . 8.3 tp 49.66 -115.26 0.79 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.299 179.933 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 57.05 -79.72 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.746 0.308 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 21' ' ' LEU . 14.8 p-80 -156.78 -1.66 0.12 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.623 -179.969 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.399 179.756 . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.593 ' O ' ' N ' ' A' ' 7' ' ' GLU . 20.8 mtp180 . . . . . 1 N--CA 1.315 -7.175 0 CA-C-O 121.399 0.619 . . . . 0.0 110.646 . . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -40.79 -23.71 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.112 -179.397 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 4' ' ' ARG . 10.5 mp -97.67 -26.04 14.9 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.444 179.558 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.3 tp10 -119.53 35.4 4.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.075 0.464 . . . . 0.0 109.906 179.9 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.523 ' NH2' ' CZ ' ' A' ' 4' ' ' ARG . 6.8 tpm_? -80.6 88.56 5.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.216 179.994 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.407 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 17.4 tt -53.8 -45.06 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.479 -179.921 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . 71.01 -70.56 0.77 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.276 179.747 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' A' ' 13' ' ' GLY . 51.6 mttp -51.79 108.15 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 110.605 -179.738 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.35 37.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.351 179.683 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 70.04 72.52 0.86 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.98 -179.832 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 51.4 t80 52.36 28.62 5.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.766 0.317 . . . . 0.0 110.459 179.979 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.5 mt 61.19 62.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.651 0.739 . . . . 0.0 109.77 -179.737 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -130.92 -50.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.046 -179.674 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.505 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.4 mp -66.29 -45.56 89.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.989 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.49 -41.08 10.27 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.721 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -58.86 -39.73 94.29 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.969 179.477 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.38 37.74 0.13 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.814 0.34 . . . . 0.0 110.744 -179.778 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 19' ' ' GLY . 16.7 tp -70.67 110.53 5.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.132 179.819 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.1 t0 55.76 39.18 30.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.559 -179.908 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 60.5 t60 52.09 50.03 19.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.519 179.983 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.945 179.955 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 7' ' ' GLU . 28.0 mtt180 . . . . . 1 N--CA 1.316 -7.164 0 CA-C-O 121.409 0.623 . . . . 0.0 110.846 . . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -44.1 -21.17 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.78 -179.647 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.492 ' N ' ' C ' ' A' ' 4' ' ' ARG . 26.7 mt -97.34 -23.86 15.92 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.536 179.663 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.3 tt0 -66.67 -18.5 65.41 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.234 179.869 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -81.9 47.68 1.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.261 179.734 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -50.0 120.86 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 110.48 -179.685 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.38 39.82 0.46 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.718 -179.842 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -50.64 -33.4 22.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.612 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.96 -15.93 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.383 179.932 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' O ' ' CG ' ' A' ' 14' ' ' PHE . . . 69.33 31.1 71.33 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.616 -179.788 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.404 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 67.0 m-85 -155.91 -10.3 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.703 0.287 . . . . 0.0 110.269 179.983 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.0 pt -153.98 42.37 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.096 0.474 . . . . 0.0 110.476 179.644 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 10.4 tp -147.94 -43.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.792 179.782 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.425 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 3.4 tp -77.44 -37.98 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.696 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.57 -39.79 6.58 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.166 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.02 -38.24 95.75 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 179.682 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.0 -73.42 0.05 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 tt 63.59 87.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 109.984 179.797 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 23' ' ' HIS . 30.0 p-10 -168.78 -120.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.023 -179.75 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.471 ' H ' ' CG ' ' A' ' 22' ' ' ASP . 17.1 m170 -67.92 -12.56 60.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.0 0.429 . . . . 0.0 109.879 179.451 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.6 mt . . . . . 0 C--O 1.232 0.181 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.331 179.858 . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' GLU . 38.1 mtt85 . . . . . 1 N--CA 1.326 -6.673 0 CA-C-O 122.634 1.207 . . . . 0.0 112.085 . . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -43.09 -19.81 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.223 179.858 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 mt -108.11 -21.51 12.77 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.93 179.932 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.4 tp10 -72.55 -9.41 58.55 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.116 -179.828 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -54.9 122.35 10.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.505 -179.983 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.36 -2.42 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.725 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.91 71.61 1.91 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.227 -179.898 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -51.82 -31.17 26.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.022 0.439 . . . . 0.0 109.892 179.523 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.433 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -164.99 -2.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.336 179.931 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.433 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 49.17 32.29 12.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.838 -179.924 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -145.84 -10.35 0.52 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 110.232 -179.969 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 pt -156.94 36.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.018 179.4 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.0 tp -150.67 -21.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.943 -179.79 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 pp -88.81 4.41 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.836 179.347 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.93 -36.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.82 -179.944 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.19 -5.1 75.43 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.901 179.852 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -67.54 -56.52 9.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 0.0 110.47 -179.94 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 23' ' ' HIS . 5.0 tp 64.27 -0.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.447 179.965 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' ALA . 34.6 t70 -77.6 30.81 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.628 -179.94 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.486 ' H ' ' C ' ' A' ' 21' ' ' LEU . 66.3 m80 51.45 65.69 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.465 179.966 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 tt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.144 -179.973 . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 7' ' ' GLU . 19.8 mtt180 . . . . . 1 N--CA 1.315 -7.212 0 CA-C-O 121.609 0.718 . . . . 0.0 110.455 . . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -40.97 -22.59 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.296 -179.616 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -97.47 -26.64 14.76 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.364 179.873 . . . . . . . . 3 3 . 1 . 058 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.9 tp10 -67.21 -32.01 72.78 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.176 179.748 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -53.12 -70.13 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 -179.973 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.2 tt -66.12 -39.97 85.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.355 -179.888 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.26 60.19 4.75 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.315 179.847 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -170.89 74.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.772 0.32 . . . . 0.0 110.473 179.925 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.95 65.12 5.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.007 179.855 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.02 53.09 19.93 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -179.576 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 60.68 38.67 18.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.898 0.38 . . . . 0.0 110.258 -179.519 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 mt 60.92 69.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.374 -179.862 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 9.9 tp -139.2 -50.51 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.91 179.688 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.456 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 4.1 tp -79.27 -27.39 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.73 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.0 -50.89 3.54 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 178.97 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.39 -42.23 99.72 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.075 179.635 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.89 -52.23 58.32 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.447 -179.945 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 23' ' ' HIS . 12.2 tp -60.57 -34.03 73.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.362 179.993 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -76.86 35.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.621 -179.872 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.494 ' H ' ' C ' ' A' ' 21' ' ' LEU . 16.9 m80 49.97 44.95 25.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.543 179.892 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.347 -179.872 . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 46.3 mtt85 . . . . . 1 N--CA 1.324 -6.755 0 CA-C-O 122.434 1.112 . . . . 0.0 111.97 . . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 71.6 t-105 -41.14 -20.32 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.111 -1.859 . . . . 0.0 110.394 -179.874 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.6 tp -111.27 -23.21 10.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.315 179.528 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 14.9 mm-40 -92.77 -1.65 56.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.838 0.351 . . . . 0.0 110.534 179.998 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.456 ' CG ' ' H ' ' A' ' 9' ' ' ILE . 14.8 tpp180 -82.5 -133.46 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.291 -179.912 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 11' ' ' LYS . 18.8 tt -167.94 -21.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.482 -179.986 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.24 86.8 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.008 -179.948 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 9' ' ' ILE . 63.1 mttm -153.32 0.9 0.26 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.992 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 54.81 62.07 2.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.54 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.38 90.8 0.01 OUTLIER Glycine 0 C--N 1.333 0.382 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 -179.92 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.5 ' N ' ' O ' ' A' ' 12' ' ' ALA . 78.1 m-85 55.35 47.04 22.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.926 0.394 . . . . 0.0 110.089 -179.326 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 60.61 77.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.513 -179.966 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.408 ' CG2' ' H ' ' A' ' 17' ' ' ILE . 6.2 tp -142.91 -56.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.709 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.408 ' H ' ' CG2' ' A' ' 16' ' ' ILE . 1.2 mp -77.81 -33.2 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.637 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.95 -48.67 9.62 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 178.361 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.76 -45.99 91.08 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.76 179.161 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.8 -72.63 0.05 OUTLIER 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.414 -179.934 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.6 tp 52.43 94.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.287 179.981 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -157.92 -28.44 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.326 179.99 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -168.0 -27.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 -179.958 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 8.0 mp . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.208 179.926 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 7' ' ' GLU . 2.9 mtp85 . . . . . 1 N--CA 1.311 -7.381 0 CA-C-O 121.629 0.728 . . . . 0.0 109.984 . . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.42 ' CZ2' ' NH2' ' A' ' 8' ' ' ARG . 74.2 t-105 -42.77 -23.17 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.795 179.996 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.475 ' N ' ' C ' ' A' ' 4' ' ' ARG . 28.8 mt -92.85 -27.68 16.98 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.748 179.902 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.573 ' N ' ' O ' ' A' ' 4' ' ' ARG . 71.5 mt-10 -79.78 10.87 3.62 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.606 179.965 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.42 ' NH2' ' CZ2' ' A' ' 5' ' ' TRP . 54.8 ttp180 -77.92 85.52 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.555 -179.978 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.405 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 16.7 tt -73.86 -42.82 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.383 179.913 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . 60.73 53.05 48.54 Favored Glycine 0 N--CA 1.453 -0.204 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.365 179.744 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -171.13 67.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 0.0 110.644 179.771 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.79 45.07 0.78 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.439 179.944 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.87 67.38 2.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.131 -0.556 . . . . 0.0 111.895 -179.977 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 52.6 t80 52.37 31.19 9.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.766 0.317 . . . . 0.0 110.555 -179.988 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 61.7 64.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.547 0.689 . . . . 0.0 110.263 -179.819 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.2 mm -131.8 -48.96 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.651 179.912 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.505 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.4 mp -69.55 -47.29 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.633 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.78 -42.3 21.32 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 178.978 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.43 -48.31 86.6 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.866 179.537 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.88 -47.45 71.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.732 0.301 . . . . 0.0 110.503 -179.863 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.4 36.53 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.893 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -81.17 -86.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.631 -179.712 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.429 ' CD2' ' H ' ' A' ' 23' ' ' HIS . 12.1 p80 -73.8 -27.0 60.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.626 -179.933 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.121 179.999 . . . . . . . . 0 0 . 1 . 061 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 6' ' ' LEU . 93.9 mtt180 . . . . . 1 N--CA 1.325 -6.698 0 CA-C-O 122.462 1.125 . . . . 0.0 111.965 . . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -42.71 -18.46 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.291 -179.95 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.8 mt -118.01 -16.89 9.8 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.632 179.31 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 19.4 mm-40 -88.65 -1.14 57.91 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 120.887 0.375 . . . . 0.0 110.402 179.971 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 55.81 106.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 179.859 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 tp -114.2 87.68 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 121.526 0.679 . . . . 0.0 110.024 179.946 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.9 -1.82 60.04 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.781 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.461 ' C ' ' H ' ' A' ' 13' ' ' GLY . 18.9 pttm 33.86 35.68 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.4 -0.4 . . . . 0.0 111.93 179.889 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.72 32.94 0.36 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.039 179.483 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 76.23 60.46 3.07 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.769 -179.755 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.492 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 66.9 t80 55.53 33.77 21.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.954 0.406 . . . . 0.0 110.191 -179.786 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.2 mm 61.85 66.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.509 0.671 . . . . 0.0 110.15 -179.802 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 mm -133.77 -51.09 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.715 179.624 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.474 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -68.18 -46.28 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.577 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.26 -48.11 8.52 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.429 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.38 -43.77 98.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.606 179.573 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.77 9.19 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.737 0.303 . . . . 0.0 110.92 179.761 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 23' ' ' HIS . 8.0 mp 53.85 -97.78 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.807 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 72.1 m-20 50.24 -87.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.676 179.79 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 21' ' ' LEU . 75.4 m80 -156.44 11.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.509 179.922 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 N--CA 1.465 0.279 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.355 179.958 . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 7' ' ' GLU . 79.0 mtt180 . . . . . 1 N--CA 1.325 -6.698 0 CA-C-O 122.511 1.148 . . . . 0.0 112.048 . . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 85.1 t90 -39.62 -21.63 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.521 179.936 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 10.8 tp -107.83 -26.99 10.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.455 179.347 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' ARG . 90.3 mt-10 -100.44 22.33 11.84 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.806 0.336 . . . . 0.0 110.29 179.79 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -53.29 -57.17 11.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.654 -179.809 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.509 ' C ' ' H ' ' A' ' 11' ' ' LYS . 14.0 pt -71.29 -35.2 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.666 -179.862 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.7 -19.19 1.21 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.07 -179.953 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 9' ' ' ILE . 41.9 mtmt -73.99 95.16 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.567 -179.978 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.96 -6.46 0.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.315 179.829 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 60.53 15.73 41.04 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.772 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -164.67 -39.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.942 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.5 mt -111.24 57.48 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.709 179.38 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 9.1 tp -151.78 -45.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.485 -0.78 . . . . 0.0 108.911 -179.988 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.409 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 1.1 pp -91.17 4.98 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.749 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.14 -57.03 0.06 OUTLIER Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.631 -179.761 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.5 -46.07 94.53 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.702 179.895 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.99 44.98 28.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 110.691 179.922 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.7 mm? -63.15 103.09 0.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.926 179.766 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 35.3 t70 56.26 56.17 6.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 -179.849 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 19.8 p-80 40.82 39.5 0.81 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.349 -179.935 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.9 tp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.256 179.826 . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 6' ' ' LEU . 95.7 mtt180 . . . . . 1 N--CA 1.324 -6.746 0 CA-C-O 122.507 1.146 . . . . 0.0 112.066 . . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -40.26 -19.85 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.66 -179.985 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.5 mt -120.37 -15.46 8.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.013 179.499 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.6 mm-40 -87.95 -7.04 57.68 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.645 -179.91 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -68.92 88.93 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.254 179.774 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.4 pt -60.22 -34.71 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.962 -179.627 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.38 17.51 1.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.696 -179.671 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -70.25 -5.16 25.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.888 -0.156 . . . . 0.0 110.827 -179.779 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.99 52.02 9.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.64 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.49 87.45 0.01 OUTLIER Glycine 0 C--N 1.335 0.498 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.868 -179.337 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 12' ' ' ALA . 89.4 m-85 52.74 41.75 31.6 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.074 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 mm 61.16 77.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.183 -179.416 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.515 ' CG2' ' H ' ' A' ' 17' ' ' ILE . 6.6 tp -140.37 -59.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.883 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.515 ' H ' ' CG2' ' A' ' 16' ' ' ILE . 3.7 tp -74.98 -31.02 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.011 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.02 -48.13 5.27 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 179.011 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.7 -44.84 96.92 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.037 -0.602 . . . . 0.0 111.706 179.612 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.44 -65.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.402 179.875 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.7 79.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.866 179.953 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -159.77 33.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.483 -179.791 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.42 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 33.8 t-80 55.18 22.91 4.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.659 179.948 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 tp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.209 179.972 . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' GLU . 3.6 mmt180 . . . . . 1 N--CA 1.318 -7.044 0 CA-C-O 121.329 0.585 . . . . 0.0 110.428 . . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -44.19 -18.67 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.961 -179.63 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.497 ' N ' ' C ' ' A' ' 4' ' ' ARG . 9.3 mp -109.74 -19.28 13.22 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.067 179.235 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 4' ' ' ARG . 15.1 mp0 -112.27 12.88 20.36 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 120.71 0.29 . . . . 0.0 110.328 -179.89 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 4' ' ' ARG . 61.0 ttp180 -52.32 123.67 11.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.378 179.795 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 tp -54.79 92.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.344 0.593 . . . . 0.0 110.16 -179.883 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.12 -30.83 10.44 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.787 -179.974 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.452 ' C ' ' H ' ' A' ' 13' ' ' GLY . 27.7 mmtp -60.37 104.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.07 179.851 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.88 -4.01 4.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.691 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 45.71 34.19 5.16 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.139 179.722 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -170.2 -17.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.9 pt -155.55 55.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.13 0.491 . . . . 0.0 110.361 179.787 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.434 ' C ' ' H ' ' A' ' 18' ' ' GLY . 10.4 tp -144.16 -42.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.061 179.792 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.428 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 1.0 OUTLIER -71.87 4.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.901 179.676 . . . . . . . . 3 3 . 1 . 064 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -175.89 -22.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.033 179.999 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.47 -31.84 79.97 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.991 179.993 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.38 -59.35 2.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.766 0.317 . . . . 0.0 110.567 -179.978 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tp 54.98 37.62 29.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.351 -179.943 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.61 -33.28 58.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.602 179.992 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -164.66 6.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.437 -179.98 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.161 179.989 . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 6' ' ' LEU . 48.5 mtp180 . . . . . 1 N--CA 1.324 -6.752 0 CA-C-O 122.513 1.149 . . . . 0.0 111.988 . . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -42.78 -17.59 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 112.828 -1.987 . . . . 0.0 110.393 179.904 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 4' ' ' ARG . 30.4 mt -121.28 -14.38 8.33 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.933 179.621 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.2 tt0 -82.64 0.05 44.9 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.181 -179.974 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -50.26 163.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 180.0 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.6 pt -54.0 -43.03 57.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.458 -179.922 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.83 -48.59 2.35 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.771 179.39 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.548 ' CB ' ' HZ2' ' A' ' 11' ' ' LYS . 9.5 mtpm? -75.44 -75.52 0.17 Allowed 'General case' 0 C--N 1.331 -0.217 0 O-C-N 122.741 -0.27 . . . . 0.0 110.817 -179.572 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 66.81 30.7 7.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.525 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -36.54 -39.82 0.39 Allowed Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.782 179.537 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.487 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 74.0 t80 179.78 54.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.296 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 pt 38.95 53.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.005 -177.816 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -113.83 -47.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.075 -178.847 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.462 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 1.0 OUTLIER -78.31 6.5 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.176 . . . . . . . . 3 3 . 1 . 065 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.97 -50.99 0.04 OUTLIER Glycine 0 C--N 1.333 0.406 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.935 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.33 -44.72 84.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.712 179.618 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.48 10.41 4.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.8 0.333 . . . . 0.0 110.41 179.913 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' HIS . 19.5 tp 53.35 101.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.092 -179.995 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 56.75 -79.8 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 21' ' ' LEU . 34.0 t-80 -162.25 29.16 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 110.396 179.901 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.203 179.977 . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' GLU . 22.0 mtt180 . . . . . 1 N--CA 1.319 -7.02 0 CA-C-O 121.317 0.58 . . . . 0.0 110.966 . . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 33.9 t90 -43.99 -18.3 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.723 -179.981 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' A' ' 4' ' ' ARG . 44.0 mt -113.25 -15.9 12.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.646 179.091 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.5 mt-10 -116.03 15.08 16.16 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.772 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 ttm180 -76.85 126.28 30.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.474 179.885 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 tp -56.28 108.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.253 0.549 . . . . 0.0 109.962 179.852 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.54 38.96 0.48 Allowed Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.865 -179.871 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.14 -26.74 63.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.38 . . . . 0.0 110.316 179.846 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.96 31.36 0.21 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.158 179.9 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.62 53.76 11.67 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.967 -179.945 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 61.03 33.43 19.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.725 0.297 . . . . 0.0 110.323 -179.979 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 mt 63.24 64.96 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.576 0.703 . . . . 0.0 110.226 -179.74 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -133.01 -50.41 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.776 179.755 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.494 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -70.46 -43.6 77.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.733 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.25 -48.17 9.9 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.092 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.503 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -63.49 -52.28 47.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.636 179.45 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.472 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 58.25 4.5 0.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.717 0.294 . . . . 0.0 110.931 179.749 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 19' ' ' GLY . 8.2 mp 50.66 13.47 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.357 179.883 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.472 ' H ' ' C ' ' A' ' 20' ' ' ALA . 72.8 m-20 -75.69 37.01 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.615 -179.936 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.5 ' H ' ' C ' ' A' ' 21' ' ' LEU . 6.4 t60 49.91 37.71 14.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 110.555 179.985 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.9 tp . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.101 -179.903 . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' C ' ' H ' ' A' ' 6' ' ' LEU . 5.5 mtp85 . . . . . 1 N--CA 1.317 -7.112 0 CA-C-O 121.475 0.655 . . . . 0.0 110.629 . . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -43.55 -17.91 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.933 -179.84 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -118.34 -12.82 9.85 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.104 179.133 . . . . . . . . 3 3 . 1 . 067 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 45.2 mm-40 -122.18 29.41 7.03 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-O 120.784 0.326 . . . . 0.0 110.319 179.877 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.6 ttp85 -72.42 89.01 1.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.387 179.908 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 tp -55.64 101.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.167 0.508 . . . . 0.0 110.288 -179.98 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.0 -35.33 12.77 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.921 -179.888 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' GLY . 66.2 mttm -69.39 82.75 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 0.0 110.469 -179.849 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.455 ' O ' ' CD2' ' A' ' 14' ' ' PHE . . . -55.73 -7.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.032 179.46 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 62.72 52.2 50.29 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.971 -179.967 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.455 ' CD2' ' O ' ' A' ' 12' ' ' ALA . 65.4 m-85 -156.53 -61.88 0.1 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.698 0.285 . . . . 0.0 110.668 179.813 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 pt -155.76 57.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.305 0.574 . . . . 0.0 110.457 -179.906 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.4 -69.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.235 179.665 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -73.62 -35.68 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.349 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.71 -47.04 10.34 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 179.46 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -74.22 -44.55 28.37 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.108 -0.567 . . . . 0.0 111.872 179.714 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.88 6.3 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.668 0.27 . . . . 0.0 110.918 179.844 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.1 mt 45.86 70.96 0.32 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -158.99 53.85 0.41 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.435 179.901 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.479 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 12.7 t60 52.2 23.89 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.396 -179.913 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.377 179.959 . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 56.5 mtt85 . . . . . 1 N--CA 1.325 -6.712 0 CA-C-O 122.588 1.185 . . . . 0.0 111.92 . . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -40.98 -20.78 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 112.995 -1.911 . . . . 0.0 110.594 179.988 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.3 tp -108.06 -22.96 12.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.725 179.956 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.2 tp10 -46.26 -43.79 15.89 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.892 -179.755 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -62.31 179.58 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.409 179.863 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.5 tt -49.49 -35.48 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.745 -179.923 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.51 64.1 3.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.9 179.979 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -168.44 74.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 110.479 -179.877 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.7 70.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.265 179.903 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.33 62.25 5.25 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.771 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 55.74 32.72 19.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.786 0.326 . . . . 0.0 110.523 -179.755 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 mm 60.6 66.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.405 0.622 . . . . 0.0 110.101 -179.902 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -133.41 -46.04 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.883 179.935 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.1 mm -75.34 -46.98 36.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.975 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.25 -50.41 7.55 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.454 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.22 -36.78 93.25 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.95 179.749 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 51.6 37.17 19.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.757 0.313 . . . . 0.0 110.62 179.99 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.0 mt -54.84 -12.76 0.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.407 179.916 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 20' ' ' ALA . 10.5 t0 -57.79 -76.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.356 179.951 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -84.42 -27.01 27.88 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.583 -179.998 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.9 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.435 -179.803 . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' GLU . 41.7 mtp180 . . . . . 1 N--CA 1.323 -6.782 0 CA-C-O 122.677 1.227 . . . . 0.0 111.984 . . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -41.0 -21.71 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.934 -1.939 . . . . 0.0 110.493 179.834 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' ARG . 47.9 tp -104.4 -25.04 12.98 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.712 -179.838 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.1 tm-20 -51.14 -35.28 34.9 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.351 -179.899 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -48.84 128.77 16.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.609 -180.0 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 13.6 tt -66.19 -51.77 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.547 -179.814 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.459 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . 42.04 76.64 0.1 OUTLIER Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.484 -0.389 . . . . 0.0 112.801 179.522 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -148.16 -9.61 0.38 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.565 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 55.63 62.18 2.53 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.38 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.3 86.84 0.01 OUTLIER Glycine 0 C--N 1.333 0.372 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.025 -179.598 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 12' ' ' ALA . 28.7 t80 64.98 44.35 3.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.814 0.34 . . . . 0.0 110.526 -179.618 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.2 mm 60.43 76.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.54 179.448 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 mm -135.86 -55.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.914 179.129 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 mm -69.9 -49.28 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.619 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.51 -43.75 35.92 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 178.833 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -59.09 -48.62 85.02 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.571 179.292 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.75 -14.6 0.96 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.0 110.224 179.745 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' HIS . 8.0 tp 58.3 112.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.192 179.966 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 57.5 -78.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.546 -179.728 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' LEU . 2.3 t60 -168.62 24.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.392 179.827 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.464 0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.461 179.902 . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.525 ' C ' ' H ' ' A' ' 6' ' ' LEU . 51.2 mtt85 . . . . . 1 N--CA 1.325 -6.677 0 CA-C-O 122.565 1.174 . . . . 0.0 112.051 . . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -44.66 -15.62 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.918 -1.946 . . . . 0.0 110.305 179.673 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.525 ' H ' ' C ' ' A' ' 4' ' ' ARG . 0.7 OUTLIER -129.9 -6.94 4.48 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.452 179.782 . . . . . . . . 3 3 . 1 . 070 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -84.2 -25.86 29.19 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.313 179.926 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -49.18 156.23 0.58 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.628 179.698 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.3 tp -168.5 126.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.196 179.829 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.61 20.81 0.05 OUTLIER Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.726 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -73.44 3.4 6.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.229 -0.188 . . . . 0.0 110.904 -179.768 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.33 36.92 28.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.81 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -34.24 88.86 0.01 OUTLIER Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.926 -179.561 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 12' ' ' ALA . 59.2 t80 56.9 57.4 4.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.063 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.1 pt 35.0 79.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.342 -179.012 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 9.2 tp -135.61 -51.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.076 179.665 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.445 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 3.5 tp -89.06 -36.12 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.003 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.62 -32.07 16.75 Favored Glycine 0 C--N 1.331 0.293 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 178.833 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.28 -47.17 13.41 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.505 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.72 -28.43 14.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.929 0.395 . . . . 0.0 110.265 179.658 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.5 tp 55.39 70.8 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.676 179.816 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 52.11 46.29 26.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.791 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 50.19 52.34 14.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.679 179.81 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.293 179.984 . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 7' ' ' GLU . 54.7 mtt85 . . . . . 1 N--CA 1.325 -6.7 0 CA-C-O 122.528 1.156 . . . . 0.0 112.075 . . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -41.39 -25.83 0.05 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.107 -1.861 . . . . 0.0 109.822 179.907 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.7 mm? -93.57 -30.46 14.97 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.336 179.682 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.0 tt0 -87.86 -5.4 58.61 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.959 0.409 . . . . 0.0 110.259 -179.799 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -66.68 -24.74 66.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.438 179.864 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.9 pt -50.33 -31.87 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.69 -179.853 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.07 66.05 3.05 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.682 -179.814 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.555 ' NZ ' ' CD1' ' A' ' 14' ' ' PHE . 20.9 tptp -158.29 83.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.874 0.369 . . . . 0.0 110.135 -179.881 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.32 63.25 4.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.353 -179.831 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 47.4 58.07 6.84 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -179.74 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.555 ' CD1' ' NZ ' ' A' ' 11' ' ' LYS . 43.5 m-85 59.2 38.01 23.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.563 0.22 . . . . 0.0 110.458 -179.512 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt 59.62 69.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.85 0.357 . . . . 0.0 110.196 -179.93 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.463 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 8.5 tp -139.08 -48.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.121 179.811 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.463 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 4.3 tp -80.7 -26.86 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.946 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.52 -57.63 1.95 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.145 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.01 84.58 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.499 179.246 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 54.7 15.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.613 0.244 . . . . 0.0 110.875 179.657 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.7 mt -66.21 4.17 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.758 0.313 . . . . 0.0 110.583 179.855 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 20' ' ' ALA . 30.0 t0 -66.93 -24.73 66.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.82 -179.825 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -169.39 -8.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.174 -179.767 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.2 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.236 -179.865 . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 7' ' ' GLU . 54.2 mtp180 . . . . . 1 N--CA 1.325 -6.695 0 CA-C-O 122.506 1.146 . . . . 0.0 112.033 . . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 27.3 t-105 -41.08 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.544 -179.906 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.8 tp -113.17 -22.13 10.66 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.36 179.457 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.9 mt-10 -101.95 13.01 35.99 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.655 0.264 . . . . 0.0 110.54 -179.994 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -75.03 -74.57 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.769 -179.93 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.497 ' C ' ' H ' ' A' ' 11' ' ' LYS . 15.7 tt -75.37 -25.02 17.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.752 -179.707 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . -52.45 -8.28 0.5 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.265 -179.821 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 9' ' ' ILE . 24.3 mtpp -76.96 22.95 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.861 -179.818 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 15' ' ' ILE . . . 57.29 40.24 27.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.218 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -34.47 89.01 0.01 OUTLIER Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.449 -179.508 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 12' ' ' ALA . 35.0 t80 66.65 53.78 0.89 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.748 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 12' ' ' ALA . 9.7 pt 37.86 82.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.759 -179.493 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.0 mm -132.93 -60.29 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.846 178.844 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.485 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -69.43 -55.47 15.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.779 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.64 -37.19 52.65 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.024 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.09 -51.46 55.03 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 179.569 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.5 -68.75 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.844 0.354 . . . . 0.0 110.314 179.898 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.0 tp 49.91 95.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.62 179.821 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -168.01 -31.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.53 179.996 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.409 ' H ' ' H ' ' A' ' 24' ' ' LEU . 73.0 t60 -171.49 -16.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.52 179.958 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.486 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 8.1 mp . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.195 179.958 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 49.2 mtp180 . . . . . 1 N--CA 1.325 -6.718 0 CA-C-O 122.518 1.151 . . . . 0.0 111.968 . . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -42.43 -18.82 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.93 -1.941 . . . . 0.0 110.446 179.959 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.6 mt -113.86 -18.64 11.74 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.908 179.884 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.9 tt0 -50.01 -20.44 0.95 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.651 -179.736 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -56.61 144.56 31.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.563 -179.872 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 11' ' ' LYS . 18.2 tt -68.42 -37.14 77.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.521 -179.946 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 80.23 -32.64 2.27 Favored Glycine 0 C--N 1.331 0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.071 179.843 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 9' ' ' ILE . 1.8 ttmp? -76.82 23.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.335 179.984 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 48.44 67.05 0.91 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.288 -179.517 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -40.48 86.41 0.01 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.52 -179.54 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 12' ' ' ALA . 17.6 m-85 63.14 53.29 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.683 0.278 . . . . 0.0 110.964 -179.699 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 mt 62.54 76.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.335 -0.059 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.591 179.217 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.5 mm -134.39 -64.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.872 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.7 mm -78.19 -32.87 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.35 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.475 ' H ' ' CB ' ' A' ' 12' ' ' ALA . . . -68.74 -53.74 18.43 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.519 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.35 -47.95 15.69 Favored Glycine 0 C--N 1.332 0.314 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.111 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.88 27.4 1.13 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.723 0.296 . . . . 0.0 110.917 179.783 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.4 tp -62.96 96.47 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.197 179.963 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 23.5 m-20 55.35 47.08 22.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.517 -179.834 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.501 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 50.0 p-80 41.2 52.62 3.52 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.17 -179.935 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.133 179.951 . . . . . . . . 0 0 . 1 . 074 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 80.8 mtt180 . . . . . 1 N--CA 1.323 -6.78 0 CA-C-O 122.544 1.164 . . . . 0.0 111.911 . . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -41.9 -19.78 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.32 179.908 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.1 mt -108.71 -25.3 10.91 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.32 179.373 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.7 mt-10 -93.27 26.52 2.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -62.44 -144.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.444 -179.997 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.401 ' C ' ' N ' ' A' ' 11' ' ' LYS . 23.2 pt -50.14 -24.33 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.461 179.93 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.1 18.26 0.43 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.049 -179.965 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 9' ' ' ILE . 25.4 mmtp -133.73 44.84 2.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.728 0.299 . . . . 0.0 110.302 -179.892 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.72 52.91 1.52 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.569 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.69 30.64 72.81 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.348 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 70.57 69.38 0.2 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.47 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.1 pt 35.34 60.52 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.673 -179.72 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -138.48 -47.36 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.547 179.036 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.438 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 38.0 mm -73.82 -53.21 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.817 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.76 -29.43 59.36 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.425 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -72.06 -37.59 60.04 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.786 -0.526 . . . . 0.0 111.786 179.441 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.77 35.28 0.15 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.843 0.354 . . . . 0.0 110.395 179.796 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 19' ' ' GLY . 21.5 tp -55.44 119.32 5.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.184 -179.961 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 52.02 24.76 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.501 179.966 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 51.52 46.66 26.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.454 -179.953 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.203 -179.994 . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 7' ' ' GLU . 68.0 mtp180 . . . . . 1 N--CA 1.324 -6.765 0 CA-C-O 122.586 1.184 . . . . 0.0 112.032 . . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -42.55 -24.57 0.06 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.649 -179.966 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.455 ' N ' ' C ' ' A' ' 4' ' ' ARG . 10.4 mp -98.0 -27.94 14.01 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.196 179.389 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 4' ' ' ARG . 17.7 tt0 -87.85 38.43 0.84 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.036 0.446 . . . . 0.0 110.238 -179.873 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -64.15 -31.99 73.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 179.988 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -167.74 -32.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.381 179.935 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.05 87.23 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.238 179.701 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' C ' ' H ' ' A' ' 13' ' ' GLY . 39.5 tttm -168.72 -17.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.236 179.645 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 15' ' ' ILE . . . 71.72 -11.4 0.74 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.59 179.95 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 35.85 55.0 1.12 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 179.932 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 t80 68.32 40.31 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.568 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 12' ' ' ALA . 18.1 mt 63.65 79.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.749 -179.711 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 12' ' ' ALA . 4.4 tp -148.21 -19.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.186 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 29.0 mm -114.25 -38.21 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.598 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.96 -53.98 5.05 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.245 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.55 -28.99 37.36 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 179.627 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.483 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 49.84 19.53 0.45 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.88 0.372 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' C ' ' H ' ' A' ' 23' ' ' HIS . 16.3 mt 57.7 6.23 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.475 -179.886 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 20' ' ' ALA . 88.9 m-20 -80.83 19.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.471 179.957 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.409 ' H ' ' C ' ' A' ' 21' ' ' LEU . 16.7 m80 54.0 44.05 29.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.478 -179.845 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.132 -179.955 . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 6' ' ' LEU . 78.9 mtp180 . . . . . 1 N--CA 1.325 -6.703 0 CA-C-O 122.552 1.168 . . . . 0.0 111.981 . . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -42.62 -18.53 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 112.93 -1.941 . . . . 0.0 110.371 179.847 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.504 ' H ' ' C ' ' A' ' 4' ' ' ARG . 34.4 mt -114.62 -18.01 11.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.96 179.597 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.3 tt0 -47.22 -34.02 6.01 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.705 -179.816 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 50.59 85.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 179.935 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -46.58 -21.37 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.918 . . . . . . . . 3 3 . 1 . 076 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 34.61 28.37 0.01 OUTLIER Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.483 179.209 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 9' ' ' ILE . 21.0 tptp -51.5 -30.73 21.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.084 179.726 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.6 -42.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.152 179.897 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.79 -44.87 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.785 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 64.2 t80 -173.93 33.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.615 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.2 mt 64.88 58.63 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 121.811 0.815 . . . . 0.0 109.461 -178.765 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.3 mm -119.49 -56.08 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.328 -179.784 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 35.1 mm -73.98 -50.31 29.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.771 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.85 -49.98 72.64 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.034 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.76 -53.33 31.71 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.227 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.63 35.79 12.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.559 0.219 . . . . 0.0 110.895 179.607 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.2 mt -73.83 84.64 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.197 179.816 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 51.38 59.15 4.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.472 -179.91 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 33.9 m170 53.55 55.81 8.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.542 -179.863 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 tt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.075 -179.897 . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 6' ' ' LEU . 44.7 mtt85 . . . . . 1 N--CA 1.324 -6.748 0 CA-C-O 122.406 1.098 . . . . 0.0 111.954 . . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 42.3 t-105 -41.14 -19.98 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.443 -179.972 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 8.1 tp -115.79 -20.28 10.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.294 179.323 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 52.3 mt-10 -91.72 21.33 4.84 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.744 0.307 . . . . 0.0 110.636 179.977 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -50.81 -32.79 21.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.513 179.896 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 pt -47.66 119.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.411 0.624 . . . . 0.0 110.638 -179.625 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.03 -6.95 61.46 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.899 -179.87 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' C ' ' H ' ' A' ' 13' ' ' GLY . 9.5 mtmp? -60.69 98.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.0 110.475 179.976 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -54.89 -8.28 0.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.296 179.625 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 61.05 4.36 4.47 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.641 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -82.8 -70.98 0.51 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.973 . . . . . . . . 3 3 . 1 . 077 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 pt -158.85 46.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.139 0.495 . . . . 0.0 110.145 179.1 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -80.37 -67.82 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.99 179.374 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.07 1.31 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.035 179.743 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.53 -67.8 0.81 Allowed Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.796 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -81.46 -37.96 15.97 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.632 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.95 11.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.741 179.898 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.489 ' H ' ' C ' ' A' ' 19' ' ' GLY . 33.3 mt 48.58 77.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.751 179.821 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 8.9 p-10 -174.82 23.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.102 179.735 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.406 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 76.0 t60 57.12 32.26 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.652 -179.859 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.08 179.933 . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 68.2 mtt85 . . . . . 1 N--CA 1.325 -6.716 0 CA-C-O 122.489 1.138 . . . . 0.0 111.994 . . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -42.08 -18.88 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.992 -1.913 . . . . 0.0 110.43 -179.988 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.2 mp -112.82 -21.72 11.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.536 179.215 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.1 tt0 -91.4 -5.68 54.04 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.06 0.457 . . . . 0.0 110.317 -179.832 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -71.95 148.59 45.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.62 179.859 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 tp -52.71 97.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.206 0.526 . . . . 0.0 110.129 179.878 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.99 30.2 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.793 -179.809 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -49.69 -18.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.69 -179.961 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.409 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -161.57 -10.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.158 -179.851 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 127.11 57.96 0.13 Allowed Glycine 0 C--N 1.333 0.404 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.636 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.4 t80 69.31 22.77 6.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.802 0.334 . . . . 0.0 110.31 -179.428 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 mt 62.18 65.27 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.583 0.706 . . . . 0.0 110.308 179.956 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 mm -132.72 -49.71 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.627 179.766 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -71.53 -45.94 65.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.673 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.78 -46.33 24.29 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 178.969 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -67.31 -56.57 11.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.924 179.537 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.48 15.44 0.14 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.877 0.37 . . . . 0.0 110.606 -179.968 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 23' ' ' HIS . 6.7 tp -83.76 -13.52 53.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.287 -179.856 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -75.0 36.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.714 179.886 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.507 ' H ' ' C ' ' A' ' 21' ' ' LEU . 61.8 t60 52.56 28.47 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.556 179.963 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.057 179.989 . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 85.4 mtt180 . . . . . 1 N--CA 1.325 -6.719 0 CA-C-O 122.479 1.133 . . . . 0.0 111.999 . . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 27.5 t90 -41.37 -19.66 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.425 -179.966 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.0 mt -114.77 -21.16 10.32 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.273 179.032 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 tt0 -92.21 31.93 1.23 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.978 0.418 . . . . 0.0 109.942 179.905 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -51.44 -63.9 0.98 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.753 -179.739 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 tp -51.13 100.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.19 0.519 . . . . 0.0 110.261 -179.762 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.73 -43.52 7.71 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.111 -179.801 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 13' ' ' GLY . 60.8 mttp -57.5 106.91 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.233 -179.971 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.76 0.94 4.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.661 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 42.06 35.29 1.64 Allowed Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.306 179.858 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.413 ' H ' ' H ' ' A' ' 15' ' ' ILE . 61.4 t80 -168.35 -13.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.957 -179.888 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.413 ' H ' ' H ' ' A' ' 14' ' ' PHE . 11.9 pt -157.78 52.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.061 0.458 . . . . 0.0 110.245 179.371 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.505 ' C ' ' H ' ' A' ' 18' ' ' GLY . 10.6 tp -143.82 -43.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.215 179.994 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -62.22 -2.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.082 179.396 . . . . . . . . 3 3 . 1 . 079 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . 178.2 -10.49 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.966 -179.925 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.4 90.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.141 -179.979 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -12.6 61.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.739 0.304 . . . . 0.0 110.698 -179.815 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.4 tt 60.3 109.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.149 -179.977 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 57.52 23.84 9.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.756 179.93 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 21.2 t-160 50.79 37.59 17.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.648 179.807 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.166 179.922 . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.509 ' C ' ' H ' ' A' ' 6' ' ' LEU . 27.8 mtp85 . . . . . 1 N--CA 1.322 -6.831 0 CA-C-O 122.667 1.223 . . . . 0.0 111.983 . . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -43.54 -18.18 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 112.885 -1.962 . . . . 0.0 110.232 179.894 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' A' ' 4' ' ' ARG . 37.0 mt -116.83 -14.86 10.72 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.075 179.861 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.3 tp10 -63.36 -23.27 67.34 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.201 -179.931 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.9 ttt85 -47.14 107.72 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.709 179.881 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -50.2 98.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.17 0.509 . . . . 0.0 110.484 -179.791 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.69 -17.85 13.99 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.874 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 13' ' ' GLY . 57.7 mttm -64.18 100.46 0.34 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 110.478 -179.987 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -59.91 -4.93 0.82 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.047 179.742 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 57.08 8.81 3.48 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.646 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.46 ' H ' ' C ' ' A' ' 12' ' ' ALA . 7.4 t80 -87.17 -61.47 1.72 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.885 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 pt -155.18 40.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.167 0.508 . . . . 0.0 110.283 179.506 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.49 ' C ' ' H ' ' A' ' 18' ' ' GLY . 1.5 mp -89.73 -45.41 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.435 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.455 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -75.19 17.81 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.363 179.522 . . . . . . . . 3 3 . 1 . 080 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -157.37 -39.6 0.02 OUTLIER Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.466 -179.756 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.89 -3.48 70.52 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.306 -0.473 . . . . 0.0 112.415 -179.582 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.05 45.62 0.54 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.533 -179.96 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.87 6.66 3.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.152 179.959 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -76.61 -23.93 53.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.326 179.822 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -166.68 -39.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.499 -179.993 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.185 -179.898 . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 7' ' ' GLU . 91.2 mtt180 . . . . . 1 N--CA 1.324 -6.73 0 CA-C-O 122.572 1.177 . . . . 0.0 112.115 . . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -39.13 -23.84 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.713 -179.942 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.7 tp -101.82 -25.95 13.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.068 -179.535 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.2 tp10 -58.81 -35.23 72.52 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.277 -179.808 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -69.11 177.01 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.671 -179.822 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.3 tp -174.05 131.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.938 179.906 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.88 -23.05 0.19 Allowed Glycine 0 C--N 1.333 0.417 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -179.773 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 13' ' ' GLY . 92.2 mttt -61.96 110.32 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.028 179.712 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.72 2.7 7.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.799 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 39.38 31.95 0.23 Allowed Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.327 -179.962 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 66.6 t80 -162.72 -10.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.79 0.328 . . . . 0.0 110.571 -179.794 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.8 tt -161.58 54.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.753 0.787 . . . . 0.0 109.926 179.824 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.4 tp -149.0 -39.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.462 -179.757 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.416 ' O ' ' CE1' ' A' ' 23' ' ' HIS . 1.1 pp -92.04 16.71 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 179.614 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.38 -57.51 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 179.888 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.69 -38.77 37.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.1 -0.571 . . . . 0.0 111.995 -179.676 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.84 -70.56 0.3 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.86 0.362 . . . . 0.0 110.376 179.99 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 23' ' ' HIS . 2.1 tt -170.89 96.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.988 -179.996 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.494 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 32.4 t70 55.09 -84.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.519 -179.815 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.494 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 94.0 m-70 -157.77 36.3 0.26 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.57 179.948 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.16 179.959 . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 7' ' ' GLU . 29.1 mmt180 . . . . . 1 N--CA 1.324 -6.739 0 CA-C-O 122.569 1.176 . . . . 0.0 111.861 . . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -42.85 -22.57 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.98 179.76 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 4' ' ' ARG . 41.8 tp -100.0 -25.92 14.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.487 179.901 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.9 tt0 -50.58 -31.3 15.42 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.313 179.869 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.0 ttt85 57.85 64.2 1.6 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.548 -179.942 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -55.86 111.35 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.174 0.511 . . . . 0.0 109.954 179.937 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.93 35.11 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.691 -179.687 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -50.1 -41.42 48.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.779 -179.86 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.88 -39.28 1.23 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.014 -179.872 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.2 60.95 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.651 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 23.6 t80 69.0 23.61 6.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.76 0.314 . . . . 0.0 110.184 -179.074 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.2 mt 62.14 71.71 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.591 0.71 . . . . 0.0 110.448 -179.986 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.5 mm -132.82 -51.97 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.699 179.603 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.2 mm -82.87 -41.31 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.569 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.22 -50.77 42.91 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.086 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -73.84 -50.44 11.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.941 179.504 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.75 1.04 0.27 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.557 0.218 . . . . 0.0 110.985 -179.961 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.511 ' H ' ' C ' ' A' ' 19' ' ' GLY . 2.3 mm? 52.42 96.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.831 0.348 . . . . 0.0 110.218 179.852 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -171.79 -54.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.297 179.793 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.412 ' H ' ' H ' ' A' ' 24' ' ' LEU . 49.9 t-80 -171.39 -10.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.406 179.965 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.412 ' H ' ' H ' ' A' ' 23' ' ' HIS . 18.8 mt . . . . . 0 N--CA 1.463 0.225 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.394 179.979 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 6' ' ' LEU . 77.8 mtm180 . . . . . 1 N--CA 1.323 -6.808 0 CA-C-O 122.492 1.139 . . . . 0.0 111.956 . . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 57.3 t90 -41.43 -19.89 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.225 179.766 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.1 tp -119.72 -17.65 8.53 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.883 179.254 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.2 tt0 -91.96 22.95 3.95 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 120.978 0.418 . . . . 0.0 110.03 179.85 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -52.6 132.56 35.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.614 -179.819 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.7 tt -72.15 120.92 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.05 0.453 . . . . 0.0 110.129 179.749 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.08 -26.7 57.52 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.03 -179.692 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 13' ' ' GLY . 27.2 mtmm -66.79 103.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.381 -179.973 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.39 -2.75 4.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.727 179.511 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 46.64 29.44 4.12 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.728 -179.742 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -162.45 -15.42 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.166 -0.214 . . . . 0.0 110.922 -179.587 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.9 pt -156.68 54.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 110.353 179.541 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.43 ' C ' ' H ' ' A' ' 18' ' ' GLY . 9.3 tp -143.21 -42.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.039 179.733 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.438 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -65.49 -3.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.95 179.289 . . . . . . . . 3 3 . 1 . 083 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -170.79 -24.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.839 -179.869 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.4 4.43 55.57 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.306 -0.473 . . . . 0.0 111.925 179.994 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.3 -20.21 57.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.323 . . . . 0.0 110.716 -179.88 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.6 mt 56.42 15.41 1.99 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.503 -179.798 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.33 -60.7 2.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.603 179.951 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 76.4 t60 -170.15 1.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.569 179.989 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.4 mm? . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.114 179.976 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 6' ' ' LEU . 87.8 mtt180 . . . . . 1 N--CA 1.323 -6.78 0 CA-C-O 122.559 1.171 . . . . 0.0 112.083 . . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -41.82 -18.96 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.928 -1.942 . . . . 0.0 110.541 -179.974 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.6 tp -114.68 -19.29 11.14 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.716 179.941 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.0 tt0 -85.84 -14.56 44.63 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.736 -179.716 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 10' ' ' GLY . 26.6 ttp85 -74.27 -81.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.904 -179.981 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.8 tp -62.9 79.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.722 0.773 . . . . 0.0 110.004 -179.803 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -82.75 -18.99 64.47 Favored Glycine 0 CA--C 1.517 0.17 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.976 -179.515 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 13' ' ' GLY . 34.0 mtmm -75.59 100.47 4.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.781 0.324 . . . . 0.0 110.763 -179.828 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.14 -1.34 4.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.103 179.641 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 50.4 47.51 43.55 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.214 179.985 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -169.23 -40.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.768 179.855 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.6 pt -154.34 61.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.899 0.381 . . . . 0.0 110.571 179.977 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.479 ' C ' ' H ' ' A' ' 18' ' ' GLY . 17.6 mm -149.42 -48.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.572 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.85 9.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.924 179.781 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -172.82 -38.99 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.875 179.951 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -54.7 -35.73 58.13 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.021 179.94 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.17 7.13 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.525 -179.975 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.4 tp 51.17 23.82 1.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.235 -179.972 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -73.09 -53.99 9.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.611 -179.954 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -166.62 -9.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.745 -179.944 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.324 179.908 . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.9 mtm180 . . . . . 1 N--CA 1.324 -6.764 0 CA-C-O 122.493 1.14 . . . . 0.0 112.023 . . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -40.96 -21.1 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.014 -1.903 . . . . 0.0 110.325 -179.915 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.1 mt -108.49 -25.1 11.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.44 179.247 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.0 mp0 -93.98 2.8 56.02 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.141 179.789 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 4' ' ' ARG . 60.9 ttt180 -54.28 -71.38 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.408 179.966 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 tp -171.27 87.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.351 0.596 . . . . 0.0 110.18 179.789 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.01 -53.15 3.8 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.999 -179.78 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' C ' ' H ' ' A' ' 13' ' ' GLY . 57.2 mttp -57.06 101.24 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.794 0.331 . . . . 0.0 110.635 -179.89 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -63.84 -1.3 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.015 179.514 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 55.8 7.55 1.66 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.767 -179.873 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 12' ' ' ALA . 50.5 t80 -127.1 -19.68 4.31 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.542 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 17' ' ' ILE . 4.5 mt -147.14 -135.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.715 179.359 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.415 ' H ' ' CG2' ' A' ' 15' ' ' ILE . 21.2 mm 52.76 -82.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 121.276 -0.17 . . . . 0.0 110.872 179.323 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 15' ' ' ILE . 3.7 tp -73.74 -38.28 50.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.675 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.51 -50.14 45.74 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.482 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.98 -47.64 7.51 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.779 -0.529 . . . . 0.0 111.779 179.627 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.86 47.88 15.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.935 179.881 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.3 mt -68.33 -19.28 64.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.547 -179.979 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -53.04 -92.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.584 -179.977 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.472 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 2.0 t60 -80.51 11.08 3.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.785 -179.81 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.211 -179.985 . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.576 ' O ' ' N ' ' A' ' 7' ' ' GLU . 55.4 mtp85 . . . . . 1 N--CA 1.323 -6.807 0 CA-C-O 122.542 1.163 . . . . 0.0 112.016 . . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -40.89 -24.84 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.02 -1.9 . . . . 0.0 109.843 179.763 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.5 mm? -96.69 -31.24 12.79 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.947 179.218 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 4' ' ' ARG . 52.5 mm-40 -90.68 43.36 1.14 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.782 0.325 . . . . 0.0 110.28 179.723 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -145.85 22.9 1.41 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.392 -179.79 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 pt -51.48 121.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.232 0.539 . . . . 0.0 110.327 -179.98 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.44 -18.28 79.93 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.865 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -80.05 109.2 14.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.764 0.316 . . . . 0.0 110.366 179.974 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.45 10.45 7.16 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.507 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.84 37.53 7.29 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.97 -179.768 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -159.24 -68.67 0.08 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.773 0.32 . . . . 0.0 110.171 -179.902 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.5 tt -93.69 44.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.784 0.802 . . . . 0.0 109.899 179.721 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.1 tp -145.11 -43.8 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.326 -179.896 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 pp -88.49 13.85 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.422 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.86 -48.54 0.01 OUTLIER Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.773 -179.823 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.67 -15.12 66.06 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.05 -179.986 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.72 -28.32 61.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.619 -179.887 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 8.8 mp -55.92 116.39 2.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.145 179.951 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.87 25.93 4.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.979 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 8.5 t60 53.08 52.17 14.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.527 -179.982 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.157 179.999 . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.505 ' C ' ' H ' ' A' ' 6' ' ' LEU . 62.5 mtp180 . . . . . 1 N--CA 1.324 -6.761 0 CA-C-O 122.518 1.151 . . . . 0.0 111.998 . . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -42.82 -18.88 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.915 -1.948 . . . . 0.0 110.16 179.731 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 4' ' ' ARG . 21.5 mt -113.49 -20.19 11.38 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.764 179.547 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.0 tt0 -83.23 24.33 0.81 Allowed 'General case' 0 C--N 1.342 0.269 0 CA-C-O 121.138 0.494 . . . . 0.0 110.047 179.924 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 6' ' ' LEU . 81.8 mtp180 -66.09 -96.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.908 -179.789 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 11' ' ' LYS . 14.2 pt -75.08 -35.39 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.03 -179.525 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.41 17.05 0.37 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.9 -179.714 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 9' ' ' ILE . 46.5 tttm -75.71 -4.95 43.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.834 0.35 . . . . 0.0 110.53 -179.745 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 16' ' ' ILE . . . 71.76 8.73 6.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.284 -179.943 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 40.51 48.96 3.9 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 179.979 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 t80 78.13 49.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.831 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.2 mt 61.46 75.55 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.765 179.895 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 12' ' ' ALA . 7.5 mm -130.92 -57.59 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.652 179.703 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.499 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.3 mp -69.17 -52.5 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.524 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.11 -48.04 68.24 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 178.621 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.55 -56.98 17.3 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.666 179.091 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.0 -67.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.77 0.319 . . . . 0.0 110.496 -179.944 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.5 tt 62.18 86.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.122 0.487 . . . . 0.0 110.142 -179.837 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -170.65 51.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.282 -179.957 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 74.8 t60 56.24 25.39 9.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.264 -179.829 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.051 -179.906 . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' LEU . 94.7 mtt180 . . . . . 1 N--CA 1.323 -6.777 0 CA-C-O 122.496 1.141 . . . . 0.0 111.911 . . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 56.6 t-105 -41.96 -18.55 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.453 179.946 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.4 mp -117.7 -17.09 9.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.839 179.358 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' ARG . 14.2 tp10 -81.66 -6.02 58.63 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.049 0.452 . . . . 0.0 110.093 -179.955 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -56.09 -20.87 19.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.742 -179.916 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.7 mm -70.28 73.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -179.989 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . -78.84 -9.37 87.15 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 179.644 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 13' ' ' GLY . 58.5 mmtt -75.05 8.46 2.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 110.688 -179.859 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . 72.66 -11.71 0.82 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.55 179.91 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 39.9 54.33 3.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.471 -0.395 . . . . 0.0 112.218 179.976 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CG ' ' C ' ' A' ' 13' ' ' GLY . 3.9 m-85 74.81 45.34 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.782 0.325 . . . . 0.0 110.16 -179.272 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.8 mt 61.4 79.4 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.427 0.632 . . . . 0.0 111.179 179.807 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -135.74 -61.81 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.95 179.434 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.482 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -71.84 -49.03 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.508 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.35 -56.36 22.32 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.452 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.58 -48.64 61.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.968 179.657 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.17 37.34 14.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.761 0.315 . . . . 0.0 110.545 -179.955 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.0 mt -70.49 109.69 4.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.55 179.988 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.29 32.29 18.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.706 179.903 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.8 m170 50.72 48.94 21.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 -179.975 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.107 -179.89 . . . . . . . . 0 0 . 1 . 089 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 6' ' ' LEU . 95.9 mtt180 . . . . . 1 N--CA 1.326 -6.626 0 CA-C-O 122.464 1.126 . . . . 0.0 112.066 . . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -41.0 -19.98 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.55 -179.963 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 45.8 mt -115.03 -20.58 10.43 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.51 179.197 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.4 mm-40 -91.63 17.13 9.25 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.959 0.409 . . . . 0.0 110.162 179.668 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -57.45 -50.06 74.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.913 -179.893 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 13.6 tt -52.81 -44.37 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.643 -179.663 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.428 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . 77.82 -50.67 3.33 Favored Glycine 0 C--N 1.331 0.266 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 -179.954 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 13' ' ' GLY . 94.2 mttt -66.54 100.45 0.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.318 179.836 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.15 5.9 2.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.063 179.933 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 43.53 48.51 7.17 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.042 -179.86 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -162.5 -31.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.586 0.231 . . . . 0.0 110.885 -179.702 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.413 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 16.4 tt -166.98 61.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 110.724 179.922 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 18' ' ' GLY . 22.1 mm -145.45 -61.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.864 179.584 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -69.32 3.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.035 179.479 . . . . . . . . 3 3 . 1 . 089 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -135.91 -55.05 0.06 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 179.889 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -74.38 -56.44 5.12 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.519 -0.633 . . . . 0.0 111.519 179.486 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 61.74 -1.93 0.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.599 0.238 . . . . 0.0 111.329 179.566 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 19' ' ' GLY . 8.2 mp 51.42 12.12 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.733 0.301 . . . . 0.0 110.256 179.938 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 20' ' ' ALA . 14.6 t0 -68.27 -55.72 11.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.617 -179.904 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -167.62 -17.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.567 -179.992 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.5 mt . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.501 179.876 . . . . . . . . 0 0 . 1 . 090 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 6' ' ' LEU . 1.7 mtm180 . . . . . 1 N--CA 1.32 -6.926 0 CA-C-O 121.354 0.597 . . . . 0.0 110.077 . . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -42.2 -18.55 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.363 -179.566 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.2 tp -114.47 -17.54 11.71 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.628 179.467 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.3 mt-10 -107.55 15.32 24.89 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 120.819 0.343 . . . . 0.0 110.264 179.958 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -53.64 163.08 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.534 179.921 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.502 ' C ' ' H ' ' A' ' 11' ' ' LYS . 11.1 pt -76.19 -36.69 31.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.426 179.921 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.25 -5.44 1.43 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.195 179.958 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' H ' ' C ' ' A' ' 9' ' ' ILE . 67.0 mmtt -87.73 105.38 17.34 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.672 -179.922 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.59 46.71 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.235 179.676 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.68 67.18 2.03 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.768 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 53.8 t80 55.2 26.93 8.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.016 -179.731 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 mt 62.14 62.32 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.679 0.752 . . . . 0.0 109.639 -179.453 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.8 mm -129.38 -46.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.025 -179.817 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.509 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -70.96 -46.94 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.809 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.41 -39.2 23.03 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 178.652 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.49 -52.75 50.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.081 -0.581 . . . . 0.0 111.73 179.369 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.443 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -62.73 -58.18 8.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.332 179.8 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 tp 53.35 12.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.236 179.891 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 20' ' ' ALA . 77.9 m-20 -66.36 -107.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.335 -179.994 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -68.64 -30.18 68.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 110.429 179.938 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.429 179.896 . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.9 mtm180 . . . . . 1 N--CA 1.325 -6.705 0 CA-C-O 122.654 1.216 . . . . 0.0 112.09 . . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -41.46 -24.66 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.957 -1.929 . . . . 0.0 109.912 179.796 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' N ' ' C ' ' A' ' 4' ' ' ARG . 17.2 mt -96.55 -27.82 14.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.75 179.853 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.6 tt0 -51.31 -22.73 3.02 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.38 179.934 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 59.46 64.87 1.25 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.648 -179.861 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 11' ' ' LYS . 18.3 pt -80.01 -31.97 13.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.347 179.807 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.78 15.75 0.56 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.123 -0.561 . . . . 0.0 111.942 -179.98 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 13' ' ' GLY . 55.3 tttp -77.0 -45.8 26.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.697 0.284 . . . . 0.0 110.777 -179.868 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 16' ' ' ILE . . . 56.54 10.36 0.68 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.155 -179.918 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 41.38 53.54 4.14 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.839 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 t80 73.89 48.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -178.996 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mt 63.1 76.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.034 179.924 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.6 mm -131.06 -67.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.401 179.497 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 47.1 mm -78.8 -31.61 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.584 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.77 -51.71 23.54 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.678 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.36 -47.61 6.81 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.254 -0.498 . . . . 0.0 111.903 179.296 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.63 43.48 16.42 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.792 0.329 . . . . 0.0 110.759 -179.981 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.5 mt -75.16 116.31 15.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.675 -179.801 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 47.36 36.02 4.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.98 179.829 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.2 m80 52.72 62.57 2.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.578 -179.957 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.219 179.99 . . . . . . . . 0 0 . 1 . 092 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 7' ' ' GLU . 35.1 mtt180 . . . . . 1 N--CA 1.312 -7.355 0 CA-C-O 121.519 0.676 . . . . 0.0 110.459 . . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -43.8 -22.83 0.06 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.669 -179.687 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.491 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 8.2 mp -90.74 -28.38 18.32 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.865 179.289 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.7 tt0 -78.42 -21.32 49.4 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.275 179.715 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 10' ' ' GLY . 1.2 tpm_? -68.41 -58.93 3.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.9 -179.457 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -48.81 92.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.398 0.618 . . . . 0.0 110.318 -179.794 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 156.84 38.16 0.02 OUTLIER Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.593 -179.677 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -46.65 -29.54 1.91 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.825 0.345 . . . . 0.0 110.46 179.834 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.436 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -164.84 -3.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.492 -179.921 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.436 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 52.82 27.79 29.54 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.742 -179.842 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -144.9 -11.91 0.57 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.901 0.382 . . . . 0.0 110.065 179.951 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.2 pt -155.44 42.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.904 179.448 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.1 tp -152.91 -27.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.004 -179.778 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 pp -81.5 9.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.679 179.516 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.86 -28.36 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.839 -179.901 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.51 -43.88 67.23 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.854 179.979 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.18 -39.91 74.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 110.415 179.882 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 23' ' ' HIS . 2.3 tt 65.49 -76.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.015 -179.863 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 42.73 -90.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 111.092 179.799 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' LEU . 59.1 t-80 -122.96 -14.78 7.54 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.225 179.759 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 21' ' ' LEU . 24.5 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.392 179.958 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.8 mtt180 . . . . . 1 N--CA 1.323 -6.797 0 CA-C-O 122.502 1.144 . . . . 0.0 111.95 . . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -41.38 -19.47 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.041 -1.89 . . . . 0.0 110.486 -179.957 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 mt -114.4 -20.39 10.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.659 179.377 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.8 mt-10 -89.82 -8.32 52.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.671 0.272 . . . . 0.0 110.763 -179.872 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -69.88 -91.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.208 179.831 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 tp -60.15 91.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 0.0 110.108 -179.97 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.05 29.85 11.61 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.896 -179.79 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -149.62 62.01 1.01 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.719 0.295 . . . . 0.0 110.372 -179.964 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.53 52.08 1.58 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.39 179.853 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.86 60.14 8.56 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.847 -179.844 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.492 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 57.9 t80 57.09 32.98 22.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.883 0.373 . . . . 0.0 110.653 -179.818 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 mt 61.26 61.78 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.599 0.714 . . . . 0.0 109.892 -179.818 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mm -129.96 -51.21 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.75 -179.838 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.9 mm -69.14 -41.41 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.473 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.421 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . -82.21 -38.07 13.8 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.166 179.193 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.05 -37.22 73.16 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.452 179.855 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.34 -64.64 1.09 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.663 0.268 . . . . 0.0 111.357 -179.26 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' HIS . 23.6 mt 53.76 -99.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.175 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 80.4 m-20 50.18 -87.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.746 179.758 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' LEU . 78.7 m-70 -153.96 13.17 0.45 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.494 -179.88 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.455 179.885 . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 32.5 mtt180 . . . . . 1 N--CA 1.313 -7.295 0 CA-C-O 121.693 0.758 . . . . 0.0 110.297 . . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.6 t90 -43.63 -20.46 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.73 179.973 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.502 ' N ' ' C ' ' A' ' 4' ' ' ARG . 19.3 mt -102.89 -21.2 14.03 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.908 179.864 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.8 tm-20 -67.49 -25.76 66.03 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.124 179.878 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -63.44 163.47 10.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.894 -179.963 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.5 tt -162.42 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.964 179.915 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.7 -46.33 2.3 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.117 179.778 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.466 ' C ' ' H ' ' A' ' 13' ' ' GLY . 54.7 mtpt -77.55 93.73 4.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.745 0.307 . . . . 0.0 110.857 -179.926 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.46 -4.84 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.973 0.415 . . . . 0.0 109.98 179.517 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 52.94 51.52 45.19 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.011 179.928 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -168.83 -45.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.214 179.814 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.9 pt -155.3 58.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.241 0.544 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.7 mm -140.11 -65.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.621 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 tp -70.5 -39.37 76.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.498 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.07 -42.81 8.52 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.7 179.601 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.95 -38.04 64.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.106 -0.568 . . . . 0.0 111.898 179.868 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 53.13 15.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.814 0.34 . . . . 0.0 110.583 179.892 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 7.6 mp 54.01 9.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.276 -179.963 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 20' ' ' ALA . 28.9 t70 -78.31 -103.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.329 179.921 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.499 ' HD1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -73.22 9.69 1.19 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 110.377 179.815 . . . . . . . . 3 3 . 1 . 094 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.485 ' H ' ' C ' ' A' ' 22' ' ' ASP . 17.8 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.353 -179.936 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.2 mtt-85 . . . . . 1 N--CA 1.325 -6.725 0 CA-C-O 122.551 1.167 . . . . 0.0 112.067 . . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -41.15 -20.32 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.394 179.859 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.4 tt -109.24 -25.33 10.66 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.359 179.279 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.4 mt-10 -99.43 25.43 7.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.388 179.875 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -50.77 140.55 14.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.639 -179.87 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.3 tt -72.62 -40.45 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.368 179.867 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.04 -56.07 3.94 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.048 179.914 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 13' ' ' GLY . 52.0 mtpt -60.98 101.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 110.518 -179.911 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.34 1.93 2.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.926 179.711 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 46.0 38.41 8.22 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.181 -179.996 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -166.81 -26.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 pt -154.45 59.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.914 0.388 . . . . 0.0 110.981 179.863 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.496 ' C ' ' H ' ' A' ' 18' ' ' GLY . 13.6 mm -150.67 -50.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.327 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.78 10.61 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.041 179.798 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -173.35 -20.46 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.216 -0.516 . . . . 0.0 111.971 179.902 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.73 -28.57 46.35 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.095 -179.899 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -66.58 -76.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.737 0.303 . . . . 0.0 110.85 -179.795 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.1 mt 59.88 3.92 0.53 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.579 -179.639 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 24' ' ' LEU . 56.4 p-10 -76.72 -133.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.196 179.711 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.575 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 1.2 m-70 -76.41 35.77 0.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 110.428 179.682 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' A' ' 22' ' ' ASP . 15.5 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.179 -179.797 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 7' ' ' GLU . 7.0 mtm105 . . . . . 1 N--CA 1.319 -7.004 0 CA-C-O 121.511 0.672 . . . . 0.0 110.624 . . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -39.82 -23.29 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.258 -179.294 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 4' ' ' ARG . 10.0 mp -97.3 -27.45 14.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.242 179.15 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.1 mp0 -117.87 34.23 5.26 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.715 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 4' ' ' ARG . 56.6 ttm-85 -67.38 126.59 29.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.559 -179.989 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.8 pt -73.26 -30.76 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.56 56.4 20.22 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.898 -179.86 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -164.75 78.67 0.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.811 0.339 . . . . 0.0 110.553 -179.903 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.37 46.48 0.63 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.609 179.976 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.91 59.69 7.27 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.964 179.989 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 52.2 t80 57.34 35.03 25.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.621 0.248 . . . . 0.0 110.759 179.91 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt 62.19 71.94 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.482 0.658 . . . . 0.0 110.421 179.769 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.476 ' O ' ' N ' ' A' ' 20' ' ' ALA . 14.4 mt -146.75 -57.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.525 179.674 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.47 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -58.9 -29.64 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.344 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.43 -45.83 2.9 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.147 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.55 -64.36 2.39 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.05 179.336 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 57.54 27.54 14.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.628 0.251 . . . . 0.0 110.628 -179.842 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.8 mt 53.43 -124.05 2.22 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.026 -179.747 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -82.87 63.96 7.24 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 179.692 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 50.3 t-80 56.49 19.02 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.141 -179.54 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.8 tp . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.424 -179.915 . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.0 mtm180 . . . . . 1 N--CA 1.325 -6.725 0 CA-C-O 122.46 1.124 . . . . 0.0 112.032 . . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -39.56 -21.7 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.798 -179.733 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.8 mt -107.83 -24.44 11.67 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.84 179.646 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 15.0 mp0 -86.87 29.38 0.81 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.63 0.252 . . . . 0.0 110.51 -179.894 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -87.74 -33.18 18.79 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.686 179.838 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 11' ' ' LYS . 3.6 tp -166.91 -3.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.157 0.503 . . . . 0.0 109.908 -179.568 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -36.17 -27.4 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.839 179.708 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 9' ' ' ILE . 63.2 mttp -54.64 107.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.381 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -67.65 3.9 1.26 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.6 -179.592 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 46.51 14.03 0.1 OUTLIER Glycine 0 C--N 1.329 0.183 0 C-N-CA 121.312 -0.47 . . . . 0.0 112.25 -179.945 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 12' ' ' ALA . 73.6 t80 -138.29 -4.4 1.68 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.577 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 17' ' ' ILE . 3.3 mt -146.13 -137.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.038 179.604 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.559 ' C ' ' H ' ' A' ' 18' ' ' GLY . 47.5 mm 41.54 -87.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.333 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.543 ' N ' ' O ' ' A' ' 15' ' ' ILE . 2.4 pp -55.11 -1.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.416 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -132.59 -70.97 0.09 OUTLIER Glycine 0 C--N 1.338 0.655 0 N-CA-C 112.326 -0.31 . . . . 0.0 112.326 -179.855 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -51.82 -25.27 15.34 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.693 -179.382 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.89 -11.84 0.1 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.612 179.999 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 23' ' ' HIS . 27.2 tp -44.52 123.86 3.84 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.479 179.841 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 56.02 -81.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.611 -179.541 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 21' ' ' LEU . 23.2 t-80 -163.79 43.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.676 179.97 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 30.8 mt . . . . . 0 N--CA 1.469 0.513 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.262 179.852 . . . . . . . . 0 0 . 1 . 098 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 7' ' ' GLU . 69.4 mtm180 . . . . . 1 N--CA 1.325 -6.725 0 CA-C-O 122.463 1.125 . . . . 0.0 112.007 . . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -39.59 -21.86 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.521 -179.944 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.5 tp -107.74 -26.24 10.9 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.724 179.615 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.9 tt0 -89.28 -3.01 58.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.103 0.477 . . . . 0.0 109.934 179.88 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.457 ' C ' ' H ' ' A' ' 10' ' ' GLY . 40.3 ttm180 -83.55 152.48 24.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.469 179.902 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.5 pt -55.72 -9.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.567 -179.979 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . 46.22 31.32 4.52 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.145 179.96 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -151.4 70.37 0.96 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.972 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.03 48.98 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.567 -179.888 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.02 40.28 20.16 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.865 -179.976 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 t80 70.49 54.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.92 0.391 . . . . 0.0 110.493 -179.776 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 mm 62.05 75.57 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.157 179.703 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.9 mm -137.14 -51.65 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.686 179.244 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 mm -74.48 -49.86 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.042 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.01 -51.55 18.09 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.367 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -63.7 -43.02 98.45 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.796 179.62 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 70.11 -13.79 0.41 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.581 0.229 . . . . 0.0 110.957 179.943 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.526 ' H ' ' C ' ' A' ' 19' ' ' GLY . 4.8 tp 61.13 2.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.0 110.446 179.98 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 20' ' ' ALA . 74.7 m-20 -74.29 84.93 1.92 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.45 179.975 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 27.7 m170 56.73 5.92 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 -179.858 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 22' ' ' ASP . 37.6 mt . . . . . 0 N--CA 1.469 0.519 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.052 179.69 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' GLU . 70.7 mtp180 . . . . . 1 N--CA 1.325 -6.703 0 CA-C-O 122.66 1.219 . . . . 0.0 112.08 . . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -42.25 -20.36 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.121 179.68 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.8 tp -107.54 -25.12 11.52 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.363 179.618 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' ARG . 78.0 mt-10 -90.17 35.32 0.86 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -146.39 -37.2 0.24 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.25 -179.996 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.458 ' CG1' ' H ' ' A' ' 10' ' ' GLY . 3.3 pt -149.38 -105.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 65.22 -132.47 36.08 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.966 179.95 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 tttp 73.11 -35.56 0.33 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.611 0.243 . . . . 0.0 110.824 179.979 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . -163.91 13.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.931 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.14 66.02 2.66 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.419 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 68.5 t80 57.83 32.33 21.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.075 -179.15 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 mt 62.03 63.69 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.584 0.707 . . . . 0.0 110.083 -179.73 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mm -130.19 -52.64 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.414 -179.827 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.57 -44.78 79.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.625 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.35 -48.08 15.3 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.873 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -59.79 -43.59 97.77 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.619 179.29 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 69.05 -14.91 0.28 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.509 0.195 . . . . 0.0 111.383 179.815 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.539 ' H ' ' C ' ' A' ' 19' ' ' GLY . 2.5 mm? 47.27 75.11 0.13 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.755 0.312 . . . . 0.0 110.429 179.934 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -171.17 -109.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.315 179.879 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -60.02 -28.17 67.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.834 0.349 . . . . 0.0 110.105 179.719 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.569 179.774 . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.522 ' C ' ' H ' ' A' ' 6' ' ' LEU . 82.2 mtm180 . . . . . 1 N--CA 1.325 -6.723 0 CA-C-O 122.555 1.169 . . . . 0.0 112.069 . . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -44.0 -17.03 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.321 179.922 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 4' ' ' ARG . 30.0 mt -130.71 -4.78 4.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.857 179.561 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -84.71 -11.07 56.6 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.074 179.829 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 61.08 131.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.627 179.701 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.7 pt -61.3 -23.85 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.447 179.879 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.04 60.01 8.66 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.872 -179.909 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -169.65 57.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 110.421 -179.931 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.15 64.49 2.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.406 179.98 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 55.19 55.7 26.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.802 -179.857 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 58.59 36.51 25.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.474 -179.832 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 mt 61.18 62.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.405 -179.957 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.403 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 4.1 tp -131.19 -44.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.447 179.672 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.403 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 35.8 mm -77.22 -44.89 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.5 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.58 -43.05 38.09 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 178.448 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.78 -43.4 99.0 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.091 -0.575 . . . . 0.0 111.696 179.233 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.88 -55.54 6.06 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.396 179.895 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.1 tp 51.47 96.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 179.832 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 50.79 29.85 4.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.866 179.782 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 52.35 51.71 15.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.661 179.876 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 tp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.158 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 111.956 -0.457 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -67.92 -129.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.141 -0.223 . . . . 0.0 110.515 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.429 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 49.23 71.0 0.67 Allowed Glycine 1 CA--C 1.385 -8.078 0 CA-C-O 126.193 3.107 . . . . 0.0 112.851 -178.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.9 mtp85 157.93 -11.46 0.0 OUTLIER 'General case' 1 N--CA 1.315 -7.197 1 CA-C-N 100.791 -7.704 . . . . 0.0 110.364 160.684 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -43.38 -21.1 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.79 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' C ' ' A' ' 4' ' ' ARG . 22.3 mt -99.74 -23.04 15.13 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.885 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.4 tt0 -66.35 -15.55 63.35 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.208 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -63.18 94.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.314 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.0 tt -58.02 -38.45 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.44 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.71 -44.48 2.03 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.096 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.515 ' C ' ' H ' ' A' ' 13' ' ' GLY . 47.1 tttp -86.28 77.21 9.57 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.77 0.319 . . . . 0.0 110.427 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.29 37.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.231 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 67.74 61.2 5.15 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 59.9 t80 57.08 36.54 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.931 0.396 . . . . 0.0 110.297 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.5 mm 59.36 66.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.391 0.615 . . . . 0.0 110.219 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -132.24 -51.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.006 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 mm -65.9 -43.94 92.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.47 -36.69 10.39 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.97 -33.25 86.74 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.28 -0.486 . . . . 0.0 111.889 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.52 -22.51 61.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.763 0.316 . . . . 0.0 110.638 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -76.62 -15.26 59.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.541 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -50.86 -42.13 58.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.582 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -169.68 -13.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.722 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.47 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 8.1 mp . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.047 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.486 ' HZ1' ' CB ' ' A' ' 2' ' ' LYS . 8.2 mtpm? -76.71 40.25 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.419 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -49.06 -57.53 8.76 Favored Glycine 1 CA--C 1.356 -9.862 0 CA-C-O 123.593 1.663 . . . . 0.0 115.736 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 7' ' ' GLU . 43.2 mtm180 -60.15 -10.98 5.06 Favored 'General case' 1 N--CA 1.325 -6.696 1 CA-C-N 105.443 -5.379 . . . . 0.0 112.055 -157.469 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.516 ' H ' ' C ' ' A' ' 3' ' ' GLY . 44.2 t-105 -42.78 -18.84 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.194 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 4' ' ' ARG . 42.4 tp -113.76 -21.44 10.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.122 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 4' ' ' ARG . 13.6 tp10 -110.99 46.73 1.04 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.981 0.42 . . . . 0.0 109.87 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.489 ' C ' ' H ' ' A' ' 10' ' ' GLY . 36.9 ttt-85 -63.64 126.59 28.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.569 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' LYS . 4.1 tp -54.05 -10.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . -37.08 -26.52 0.01 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.569 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' GLY . 14.4 pttp -70.46 99.75 1.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.82 -3.17 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.747 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 47.21 49.31 19.26 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.066 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -160.97 -47.46 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.608 0.242 . . . . 0.0 110.471 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.8 pt -156.02 55.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.15 0.5 . . . . 0.0 110.598 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.502 ' C ' ' H ' ' A' ' 18' ' ' GLY . 3.8 mm -141.28 -48.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.437 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -69.36 5.76 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.462 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -175.54 -19.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.809 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -67.3 -57.28 9.52 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.142 -0.551 . . . . 0.0 111.875 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.1 7.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.333 . . . . 0.0 110.596 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 23' ' ' HIS . 12.9 mt 53.92 14.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.47 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -75.99 36.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.787 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.488 ' H ' ' C ' ' A' ' 21' ' ' LEU . 49.7 t-80 54.52 21.4 3.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.564 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 tp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.24 -179.886 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 84.5 mttt 57.75 -147.03 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.677 0.275 . . . . 0.0 110.586 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 52.74 68.71 1.47 Allowed Glycine 1 CA--C 1.381 -8.308 0 CA-C-O 125.48 2.711 . . . . 0.0 113.402 -178.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.535 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER 163.55 -11.94 0.0 OUTLIER 'General case' 1 N--CA 1.319 -7.021 1 CA-C-N 101.338 -7.431 . . . . 0.0 110.428 159.4 . . . . . . . . 5 4 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 17.8 m0 -44.08 -19.09 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.541 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.494 ' H ' ' C ' ' A' ' 4' ' ' ARG . 21.9 mt -110.66 -17.98 13.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.617 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.5 mt-10 -110.17 13.21 23.19 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.93 0.395 . . . . 0.0 110.096 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 4' ' ' ARG . 56.9 ttt-85 -52.56 102.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.575 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 tp -56.54 109.16 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.098 0.475 . . . . 0.0 110.154 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.82 -38.28 4.45 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.982 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 13' ' ' GLY . 62.9 mttp -65.97 103.97 1.03 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.894 0.378 . . . . 0.0 110.624 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.63 1.67 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.003 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 48.32 53.68 15.07 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.133 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -163.08 -48.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.682 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.3 pt -155.74 59.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.337 0.589 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.5 mm -135.23 -72.37 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.51 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -71.85 -38.94 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.04 -45.62 11.47 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.71 -42.54 38.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.918 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.97 37.37 28.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.775 0.321 . . . . 0.0 110.46 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 23' ' ' HIS . 21.4 mt -75.81 114.95 15.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.636 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 58.55 -76.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.326 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 21' ' ' LEU . 69.1 m-70 -38.55 -32.74 0.08 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.026 0.441 . . . . 0.0 110.868 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.7 tp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.98 178.986 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -149.4 50.71 0.95 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.739 0.304 . . . . 0.0 110.363 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -55.7 -58.18 15.25 Favored Glycine 1 CA--C 1.355 -9.941 0 CA-C-O 123.599 1.666 . . . . 0.0 115.178 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.51 ' C ' ' H ' ' A' ' 6' ' ' LEU . 58.6 mtp180 -59.87 -11.5 5.6 Favored 'General case' 1 N--CA 1.324 -6.749 1 CA-C-N 105.417 -5.392 . . . . 0.0 111.931 -157.599 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.513 ' H ' ' C ' ' A' ' 3' ' ' GLY . 37.1 t-105 -43.2 -18.97 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.916 -1.947 . . . . 0.0 109.999 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 4' ' ' ARG . 2.2 pp -111.3 -22.49 11.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.639 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.6 tt0 -88.35 1.05 55.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.032 0.444 . . . . 0.0 110.219 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -58.98 140.45 55.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.621 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.9 tp -75.74 113.68 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.943 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.1 14.18 6.28 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -91.27 105.86 18.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.7 0.286 . . . . 0.0 110.431 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.46 62.2 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.52 53.51 24.58 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.7 t80 60.46 38.06 19.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.07 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.2 mt 61.18 70.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.358 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -140.28 -50.65 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.89 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.457 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 4.2 tp -76.58 -29.46 18.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.76 -50.75 3.63 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.65 -42.2 94.11 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.652 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.26 52.81 1.16 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 110.489 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 tt -156.92 61.91 0.52 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -160.33 -34.85 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.656 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -164.94 -24.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 0.0 110.262 179.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HZ1' ' CB ' ' A' ' 2' ' ' LYS . 5.1 ttpm? -78.86 48.28 0.82 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.019 0.438 . . . . 0.0 110.288 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.529 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -49.09 -54.29 15.5 Favored Glycine 1 CA--C 1.358 -9.73 0 CA-C-O 123.689 1.716 . . . . 0.0 115.793 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -59.36 -11.31 4.07 Favored 'General case' 1 N--CA 1.328 -6.555 1 CA-C-N 105.249 -5.475 . . . . 0.0 112.191 -157.055 . . . . . . . . 5 4 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.529 ' H ' ' C ' ' A' ' 3' ' ' GLY . 27.3 t90 -41.24 -20.11 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 112.846 -1.979 . . . . 0.0 110.412 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.7 mt -115.84 -20.05 10.19 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.347 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.7 tt0 -96.2 30.47 2.47 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.999 0.428 . . . . 0.0 110.208 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.17 146.77 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.472 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.421 ' C ' ' H ' ' A' ' 11' ' ' LYS . 2.0 tp -165.16 96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.188 0.518 . . . . 0.0 110.266 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.55 24.79 3.02 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.156 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 9' ' ' ILE . 65.9 mttm -151.41 72.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.769 0.319 . . . . 0.0 110.375 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.9 45.35 0.9 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.056 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.5 33.76 54.37 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 18.9 t80 71.1 54.32 0.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.691 0.282 . . . . 0.0 110.56 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 mt 63.93 68.09 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.415 0.626 . . . . 0.0 110.94 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.0 mm -135.04 -51.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.662 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.5 mm -70.92 -42.01 77.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.68 -51.57 7.09 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -64.95 -36.3 92.92 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.815 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.08 7.17 0.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.646 0.26 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.494 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.7 mt 45.31 78.42 0.06 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.726 0.298 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -168.49 39.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.496 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 57.47 36.97 27.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.498 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.17 -179.942 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp 50.71 178.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.821 0.343 . . . . 0.0 110.588 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 116.77 -58.88 0.47 Allowed Glycine 1 CA--C 1.356 -9.891 0 CA-C-O 123.722 1.735 . . . . 0.0 114.934 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 7' ' ' GLU . 89.5 mtt180 -60.66 -10.12 4.84 Favored 'General case' 1 N--CA 1.325 -6.72 1 CA-C-N 105.296 -5.452 . . . . 0.0 111.9 -157.667 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.515 ' H ' ' C ' ' A' ' 3' ' ' GLY . 70.0 t-105 -41.09 -20.49 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.327 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.2 tp -108.51 -26.15 10.57 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.173 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' ARG . 27.2 mp0 -99.83 8.73 43.95 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.84 0.352 . . . . 0.0 110.398 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.9 ttp180 -52.11 118.47 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.463 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.0 pt -61.92 -29.26 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.62 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.44 52.69 27.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.608 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -161.69 80.71 0.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.478 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.97 52.35 2.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.335 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.27 49.1 32.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.855 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.6 t80 61.15 48.73 6.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.897 0.38 . . . . 0.0 110.379 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 mt 61.22 70.87 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.732 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -135.03 -67.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -69.86 -25.07 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.05 -58.75 2.28 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.494 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.41 -32.46 68.16 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.936 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 50.73 34.97 10.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.773 0.321 . . . . 0.0 110.68 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -65.89 1.64 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.952 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 20' ' ' ALA . 8.1 t70 -58.75 -30.15 67.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.392 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.441 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 4.0 t60 -171.47 23.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.159 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.077 -179.792 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 111.969 -0.453 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.9 tttt 59.74 13.32 3.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.004 0.431 . . . . 0.0 110.118 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -49.89 -57.7 9.47 Favored Glycine 1 CA--C 1.357 -9.793 0 CA-C-O 123.715 1.73 . . . . 0.0 115.514 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' LEU . 38.0 mtm-85 -60.33 -10.87 5.26 Favored 'General case' 1 N--CA 1.325 -6.68 1 CA-C-N 105.33 -5.435 . . . . 0.0 111.941 -157.453 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.504 ' H ' ' C ' ' A' ' 3' ' ' GLY . 41.9 t-105 -41.36 -19.51 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 112.938 -1.937 . . . . 0.0 110.433 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.1 tp -114.57 -20.62 10.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.593 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 66.2 mm-40 -87.02 20.48 2.65 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 110.452 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -53.47 -21.11 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.111 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 11' ' ' LYS . 3.6 tp -165.09 -41.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.837 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.84 -82.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.263 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.512 ' C ' ' H ' ' A' ' 13' ' ' GLY . 55.8 mttm -51.06 101.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.823 0.344 . . . . 0.0 110.795 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.85 3.27 3.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 45.3 40.43 7.83 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.45 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -167.51 -20.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.314 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.8 pt -155.85 50.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 120.925 0.393 . . . . 0.0 111.275 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.491 ' C ' ' H ' ' A' ' 18' ' ' GLY . 2.8 mm -143.77 -51.04 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.65 8.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.299 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -167.48 -31.69 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.001 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.79 -30.99 60.41 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.135 -0.555 . . . . 0.0 111.856 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.43 -68.23 0.39 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.735 0.302 . . . . 0.0 110.477 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 tp 52.79 49.44 20.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.448 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -167.23 88.25 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.528 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.6 m80 53.76 25.91 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.466 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.163 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.4 mtmm -61.79 -141.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.524 0.202 . . . . 0.0 110.498 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.533 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 53.92 69.02 1.36 Allowed Glycine 1 CA--C 1.379 -8.435 0 CA-C-O 125.403 2.668 . . . . 0.0 113.572 -179.09 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.8 OUTLIER 164.83 -11.24 0.0 OUTLIER 'General case' 1 N--CA 1.32 -6.943 1 CA-C-N 101.503 -7.348 . . . . 0.0 110.414 159.15 . . . . . . . . 5 4 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -43.48 -19.09 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.937 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 4' ' ' ARG . 43.3 tp -108.28 -20.78 13.02 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.284 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.6 mm-40 -109.34 13.8 24.03 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.5 ttt85 -79.64 -69.09 0.61 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.574 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.1 pt -68.31 -33.65 61.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.4 55.82 23.42 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.944 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -168.26 67.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.481 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.71 76.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.364 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.93 62.68 3.63 Favored Glycine 0 CA--C 1.517 0.218 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.929 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 55.24 34.77 23.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.913 0.387 . . . . 0.0 109.96 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.0 mm 59.8 69.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.541 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.8 tp -137.51 -34.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.1 mm -92.43 -41.1 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.68 -45.63 10.62 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.63 -37.78 57.65 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.663 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.81 52.21 11.66 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.714 0.293 . . . . 0.0 110.961 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.12 114.12 2.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.034 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 53.73 15.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.454 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.424 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 3.4 t60 54.39 25.83 6.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.465 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.201 179.971 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -78.15 57.61 1.86 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.782 0.325 . . . . 0.0 110.544 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -51.57 -58.05 10.89 Favored Glycine 1 CA--C 1.355 -9.964 0 CA-C-O 123.617 1.676 . . . . 0.0 115.37 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 7' ' ' GLU . 78.0 mtm180 -61.18 -9.67 5.24 Favored 'General case' 1 N--CA 1.323 -6.786 1 CA-C-N 105.438 -5.381 . . . . 0.0 111.966 -157.543 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.532 ' H ' ' C ' ' A' ' 3' ' ' GLY . 24.9 t90 -42.12 -24.56 0.05 OUTLIER 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.718 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.9 mm? -96.42 -30.21 13.49 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.938 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 4' ' ' ARG . 60.3 mt-10 -112.46 49.8 0.9 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.79 0.328 . . . . 0.0 110.545 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -60.32 148.44 36.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.431 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.501 ' C ' ' H ' ' A' ' 11' ' ' LYS . 15.7 pt -152.93 -31.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.399 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.26 -17.13 1.94 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.949 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 9' ' ' ILE . 55.0 mttp -69.55 105.88 2.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.687 0.279 . . . . 0.0 110.539 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -70.65 0.51 6.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 62.58 -0.77 1.94 Allowed Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.845 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' A' ' 12' ' ' ALA . 62.1 t80 -101.58 -31.78 10.68 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.559 ' O ' ' N ' ' A' ' 17' ' ' ILE . 5.2 pt -153.31 -112.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.225 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 mm 47.61 -81.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 111.355 0.132 . . . . 0.0 111.355 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 15' ' ' ILE . 3.7 tp -69.69 -42.25 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.077 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.63 -42.53 17.25 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.033 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.46 -41.1 31.09 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.087 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.03 53.74 12.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 0.0 110.719 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 8.4 mp -60.6 89.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.168 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 50.01 46.24 24.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.69 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.442 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 20.9 t-80 53.57 52.01 14.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.555 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.186 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 80.4 mttt 52.22 174.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.509 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 127.62 -57.32 0.71 Allowed Glycine 1 CA--C 1.355 -9.915 0 CA-C-O 123.775 1.764 . . . . 0.0 115.134 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 7' ' ' GLU . 51.5 mtm180 -60.67 -10.12 4.84 Favored 'General case' 1 N--CA 1.323 -6.78 1 CA-C-N 105.308 -5.446 . . . . 0.0 111.996 -157.522 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.525 ' H ' ' C ' ' A' ' 3' ' ' GLY . 42.7 t-105 -41.28 -21.34 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.043 -1.889 . . . . 0.0 110.272 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 57.6 tp -105.79 -26.89 11.58 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.219 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.3 mt-10 -90.75 8.88 32.39 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.951 0.405 . . . . 0.0 110.166 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -63.33 82.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.576 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 16.4 tt -65.99 -45.25 91.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.356 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.423 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . 41.78 45.29 4.65 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.361 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -164.56 71.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.33 . . . . 0.0 110.542 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.27 70.95 1.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.374 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.53 64.51 4.0 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.829 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 50.5 t80 57.53 28.39 15.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.772 0.32 . . . . 0.0 110.476 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.2 mt 62.43 64.71 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.646 0.736 . . . . 0.0 110.161 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -132.54 -49.47 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.786 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.506 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -69.72 -44.84 78.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.74 -43.82 11.21 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.72 -43.33 99.22 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.987 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.46 40.66 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.665 0.269 . . . . 0.0 110.703 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 19' ' ' GLY . 10.6 tp -52.95 96.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.229 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 53.02 52.55 13.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.432 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.465 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 16.4 t-160 53.8 47.2 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.334 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.005 -179.883 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -74.63 -99.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.724 0.297 . . . . 0.0 110.528 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 90.05 -61.46 3.34 Favored Glycine 1 CA--C 1.356 -9.866 0 CA-C-O 123.681 1.712 . . . . 0.0 115.455 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.509 ' C ' ' H ' ' A' ' 6' ' ' LEU . 93.3 mtt180 -60.17 -11.05 5.25 Favored 'General case' 1 N--CA 1.325 -6.722 1 CA-C-N 105.392 -5.404 . . . . 0.0 112.039 -157.663 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.515 ' H ' ' C ' ' A' ' 3' ' ' GLY . 23.1 t90 -42.96 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 112.791 -2.004 . . . . 0.0 110.455 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' A' ' 4' ' ' ARG . 37.7 mt -117.13 -16.31 10.44 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.87 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.4 tt0 -48.52 -26.87 2.38 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.661 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -50.01 148.66 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.634 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.0 tt -167.63 -40.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.494 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.81 -58.64 3.47 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.187 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.511 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.0 mttt -52.85 102.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.707 0.289 . . . . 0.0 110.507 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.28 -1.13 2.13 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 44.81 36.05 4.65 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.197 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -168.97 -17.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.284 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.0 pt -155.71 50.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.718 0.294 . . . . 0.0 111.057 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 mm -144.31 -47.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 pp -85.29 24.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.186 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.62 -45.84 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.092 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.32 -40.23 98.34 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.039 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -78.49 50.71 0.98 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.839 0.352 . . . . 0.0 110.541 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 pp -59.22 -4.88 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.715 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 20' ' ' ALA . 2.2 m-20 -52.23 -39.62 60.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.452 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.408 ' CD2' ' N ' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -168.06 10.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.433 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.826 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.442 ' H ' ' H2 ' ' A' ' 1' ' ' GLY . 53.4 mttp -77.16 22.75 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.794 0.331 . . . . 0.0 110.645 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 1' ' ' GLY . . . -52.55 -57.68 13.24 Favored Glycine 1 CA--C 1.356 -9.887 0 CA-C-O 123.835 1.797 . . . . 0.0 115.293 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 6' ' ' LEU . 73.4 mtt-85 -60.05 -11.53 6.12 Favored 'General case' 1 N--CA 1.324 -6.747 1 CA-C-N 105.225 -5.487 . . . . 0.0 112.047 -157.51 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.495 ' N ' ' C ' ' A' ' 3' ' ' GLY . 65.6 t-105 -43.07 -18.61 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.854 -1.975 . . . . 0.0 110.337 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 4' ' ' ARG . 19.6 mt -114.32 -18.04 11.66 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.802 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.6 tt0 -48.02 -20.87 0.37 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.76 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 54.35 61.45 3.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.62 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 tp -54.47 113.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.078 0.466 . . . . 0.0 110.126 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.51 34.18 1.28 Allowed Glycine 0 C--N 1.332 0.354 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -150.98 38.51 0.66 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.161 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.68 56.79 2.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.52 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.9 67.13 2.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.979 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 54.44 30.55 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.781 0.324 . . . . 0.0 110.706 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 mt 62.14 65.28 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.552 0.692 . . . . 0.0 110.281 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.2 mm -133.34 -51.65 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.691 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.3 mm -66.59 -42.89 90.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.74 -42.17 9.22 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.23 95.69 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.031 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.47 -30.87 0.61 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.667 0.27 . . . . 0.0 111.179 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.486 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 8.0 mp -74.44 -47.81 31.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.316 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -50.55 -72.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.608 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -169.98 63.91 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.384 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.303 -179.887 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -75.62 66.41 1.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 0.0 110.573 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -54.63 -57.91 15.61 Favored Glycine 1 CA--C 1.357 -9.799 0 CA-C-O 123.715 1.731 . . . . 0.0 115.384 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.506 ' C ' ' H ' ' A' ' 6' ' ' LEU . 47.5 mtt85 -60.07 -11.31 5.65 Favored 'General case' 1 N--CA 1.325 -6.675 1 CA-C-N 105.203 -5.498 . . . . 0.0 111.997 -157.439 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.52 ' H ' ' C ' ' A' ' 3' ' ' GLY . 66.4 t-105 -43.36 -18.31 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.249 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 4' ' ' ARG . 24.4 mt -115.82 -16.45 11.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.812 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.3 tt0 -45.43 -28.08 0.82 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -71.69 -137.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.307 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' CG1' ' H ' ' A' ' 10' ' ' GLY . 5.2 pt -59.77 -113.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.437 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' H ' ' CG1' ' A' ' 9' ' ' ILE . . . 69.26 39.59 82.0 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -57.13 -31.95 65.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.669 0.271 . . . . 0.0 110.541 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.72 -25.53 0.27 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.058 0.456 . . . . 0.0 110.442 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' C ' ' CG ' ' A' ' 14' ' ' PHE . . . 150.97 54.99 0.01 OUTLIER Glycine 0 CA--C 1.509 -0.31 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.442 ' CG ' ' C ' ' A' ' 13' ' ' GLY . 3.4 m-85 75.63 17.46 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.2 mt 61.55 60.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 10.1 tp -128.0 -48.69 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.465 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 3.9 tp -66.25 -36.25 76.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.38 -44.65 4.59 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.27 -33.0 51.93 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.662 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.72 -46.81 41.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.75 0.309 . . . . 0.0 110.863 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 23' ' ' HIS . 40.9 mt 52.49 20.04 1.35 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 0.0 110.278 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 24' ' ' LEU . 66.2 m-20 -76.08 38.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.375 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.494 ' H ' ' C ' ' A' ' 21' ' ' LEU . 32.3 m80 57.67 6.52 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.252 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.279 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 80.3 mttt 50.75 -169.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 110.596 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 116.99 -59.45 0.46 Allowed Glycine 1 CA--C 1.357 -9.789 0 CA-C-O 123.768 1.76 . . . . 0.0 115.266 179.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 6' ' ' LEU . 79.1 mtm180 -60.26 -11.06 5.43 Favored 'General case' 1 N--CA 1.324 -6.739 1 CA-C-N 105.322 -5.439 . . . . 0.0 112.094 -157.585 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.52 ' H ' ' C ' ' A' ' 3' ' ' GLY . 74.6 t-105 -41.16 -19.18 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 112.79 -2.005 . . . . 0.0 110.61 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.4 mt -121.99 -14.06 8.09 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.748 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 4' ' ' ARG . 37.1 mt-10 -88.95 -11.18 45.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 110.307 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.9 tpm_? -83.13 106.45 14.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.255 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.6 tt -63.19 111.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.078 0.466 . . . . 0.0 110.224 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.7 -19.18 79.3 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.147 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.1 mttt -69.96 99.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.713 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -62.47 -2.65 1.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.161 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 59.18 5.15 2.99 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.493 ' H ' ' C ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -85.51 -71.48 0.53 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.5 pt -158.14 53.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.402 0.62 . . . . 0.0 110.217 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.61 -63.95 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.79 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -70.35 -35.01 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.31 -49.66 7.25 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -66.51 -46.35 77.81 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.73 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 50.4 15.09 0.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.765 0.317 . . . . 0.0 110.7 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 19' ' ' GLY . 13.9 mt 55.26 11.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.592 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 20' ' ' ALA . 38.8 t70 -78.41 49.07 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.506 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 51.82 20.97 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.542 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.221 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 50.21 -134.82 1.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.759 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.43 ' O ' ' CB ' ' A' ' 4' ' ' ARG . . . 48.6 70.42 0.77 Allowed Glycine 1 CA--C 1.386 -7.995 0 CA-C-O 126.438 3.243 . . . . 0.0 112.38 -178.051 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 11.2 mtp180 154.73 -12.08 0.0 OUTLIER 'General case' 1 N--CA 1.312 -7.365 1 CA-C-N 100.527 -7.836 . . . . 0.0 110.301 161.265 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -44.24 -19.73 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.743 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.496 ' N ' ' C ' ' A' ' 4' ' ' ARG . 20.2 mt -103.77 -21.18 13.72 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.711 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 35.5 tp10 -68.39 -25.98 65.32 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.337 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 10' ' ' GLY . 19.9 ttm180 68.09 163.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.003 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.2 pt -53.49 -9.09 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.779 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . 54.42 59.78 9.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.769 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -167.32 73.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.309 . . . . 0.0 110.405 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.63 53.64 2.85 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.058 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.35 33.25 86.73 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 67.0 72.81 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.637 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.3 pt 35.25 56.5 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.989 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.2 tp -135.63 -43.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.579 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.8 mm -81.33 -45.42 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.99 -24.78 54.39 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.2 -37.32 21.84 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.25 -72.89 0.08 Allowed 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.667 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.7 mt 58.62 24.73 12.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.471 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.21 -103.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.471 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -71.24 -4.76 27.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 110.649 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.1 -179.993 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 111.989 -0.445 . . . . 0.0 111.989 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -77.28 31.67 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.701 0.286 . . . . 0.0 110.655 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -51.88 -57.25 13.1 Favored Glycine 1 CA--C 1.355 -9.934 0 CA-C-O 123.821 1.789 . . . . 0.0 115.235 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' GLU . 61.2 mtm180 -60.76 -10.39 5.38 Favored 'General case' 1 N--CA 1.324 -6.775 1 CA-C-N 105.232 -5.484 . . . . 0.0 111.946 -157.462 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.513 ' H ' ' C ' ' A' ' 3' ' ' GLY . 85.0 t90 -41.3 -20.03 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 112.981 -1.918 . . . . 0.0 110.415 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.8 tp -110.38 -24.58 10.55 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.334 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' ARG . 55.2 mm-40 -96.81 33.91 1.79 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.768 0.318 . . . . 0.0 110.249 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -64.47 -74.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.715 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 pp -68.64 -2.87 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.788 0.328 . . . . 0.0 110.66 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.93 70.38 2.92 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 112.068 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -50.27 -32.53 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.107 0.48 . . . . 0.0 109.893 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.88 -0.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.124 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.3 32.84 5.38 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.931 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.401 ' H ' ' H ' ' A' ' 15' ' ' ILE . 25.5 t80 -149.87 -11.79 0.28 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.906 0.384 . . . . 0.0 110.007 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.401 ' H ' ' H ' ' A' ' 14' ' ' PHE . 21.8 pt -154.88 40.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.078 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.4 tp -151.36 -25.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.0 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.51 4.93 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.497 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.79 -13.76 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.953 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.94 -10.16 86.42 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.051 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.67 53.96 1.81 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.727 0.298 . . . . 0.0 110.573 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.1 mt -56.97 110.38 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.367 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.456 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 3.1 m-20 52.88 21.54 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.615 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.466 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 19.6 t60 53.75 46.52 25.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.582 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.33 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -59.32 159.77 7.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.85 0.357 . . . . 0.0 110.382 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 107.34 -56.53 0.48 Allowed Glycine 1 CA--C 1.354 -9.973 0 CA-C-O 123.836 1.798 . . . . 0.0 114.688 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.0 mtm180 -61.03 -9.49 4.47 Favored 'General case' 1 N--CA 1.324 -6.772 1 CA-C-N 105.169 -5.516 . . . . 0.0 112.006 -157.595 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.539 ' H ' ' C ' ' A' ' 3' ' ' GLY . 96.3 m95 -42.53 -24.25 0.05 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.058 -1.883 . . . . 0.0 109.838 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.463 ' N ' ' C ' ' A' ' 4' ' ' ARG . 10.3 mp -95.82 -28.03 14.93 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.406 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 4' ' ' ARG . 38.3 tt0 -48.42 -29.07 3.67 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.686 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 7' ' ' GLU . 11.8 tpp180 60.36 129.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.68 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.2 tt -54.29 -37.95 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.404 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.04 59.05 11.04 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.0 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -169.15 68.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.792 0.329 . . . . 0.0 110.512 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.78 67.78 1.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.486 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 56.16 41.88 86.86 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.99 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.6 43.0 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 0.0 109.826 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.2 mt 54.95 61.64 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.372 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.4 mm -129.81 -42.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.009 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.7 mm -87.79 -37.3 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.0 -49.07 10.13 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.501 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -75.09 -37.4 43.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.811 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.67 5.58 0.35 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 0.0 110.586 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 19' ' ' GLY . 9.0 tp 46.62 63.16 2.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.748 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -158.67 47.44 0.33 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.548 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 1.7 t60 51.98 20.78 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.474 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.7 tp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.257 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -59.65 -158.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.583 0.23 . . . . 0.0 110.489 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 54.23 71.21 0.74 Allowed Glycine 1 CA--C 1.375 -8.667 0 CA-C-O 125.555 2.753 . . . . 0.0 113.228 -178.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.587 ' O ' ' N ' ' A' ' 7' ' ' GLU . 6.7 mtt-85 164.79 -10.89 0.0 OUTLIER 'General case' 1 N--CA 1.321 -6.882 1 CA-C-N 101.807 -7.197 . . . . 0.0 111.303 159.423 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -42.68 -19.62 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.643 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.9 tp -107.66 -21.54 12.84 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.987 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.587 ' N ' ' O ' ' A' ' 4' ' ' ARG . 94.8 mt-10 -115.73 30.32 7.42 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 ptt85 -50.3 143.64 8.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.968 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.467 ' C ' ' H ' ' A' ' 11' ' ' LYS . 14.8 pt -64.93 -23.92 34.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.357 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.86 7.18 1.52 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.354 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' A' ' 9' ' ' ILE . 56.3 mttp -144.84 75.66 1.46 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.953 0.406 . . . . 0.0 110.226 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.86 62.92 2.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.647 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.62 68.92 1.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.091 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 61.8 t80 55.29 27.98 10.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.591 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.2 mt 61.51 63.55 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.652 0.739 . . . . 0.0 110.035 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 mm -131.65 -48.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.762 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.497 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -69.79 -46.1 75.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.28 -43.29 13.33 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.78 -44.59 96.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.676 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.54 82.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.372 . . . . 0.0 110.405 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp 55.43 57.81 5.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.393 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.0 t70 58.0 45.82 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.683 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 49.64 52.37 14.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.7 tp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.211 179.94 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -146.2 179.08 7.74 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.777 0.322 . . . . 0.0 110.234 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.514 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 137.45 -57.46 0.66 Allowed Glycine 1 CA--C 1.357 -9.791 0 CA-C-O 123.665 1.703 . . . . 0.0 115.404 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 6' ' ' LEU . 75.3 mtt85 -59.92 -11.48 5.67 Favored 'General case' 1 N--CA 1.325 -6.684 1 CA-C-N 105.24 -5.48 . . . . 0.0 112.161 -157.379 . . . . . . . . 4 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.514 ' H ' ' C ' ' A' ' 3' ' ' GLY . 23.5 t90 -42.37 -16.86 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.63 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.1 tp -125.22 -12.19 6.89 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.984 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -76.11 -25.91 55.89 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.812 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -75.88 -135.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.29 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.6 pt -143.68 127.9 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.258 0.552 . . . . 0.0 110.117 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.0 -11.42 78.86 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.942 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.414 ' C ' ' H ' ' A' ' 13' ' ' GLY . 46.8 mtmt -60.19 110.94 1.34 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.94 4.6 6.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 39.25 38.48 0.88 Allowed Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.634 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -168.05 -15.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.693 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 pt -152.71 46.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.192 0.52 . . . . 0.0 110.228 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.451 ' C ' ' H ' ' A' ' 18' ' ' GLY . 10.0 tp -145.73 -41.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.256 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.415 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 1.8 pp -69.02 2.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.222 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -172.26 -30.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.873 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.89 -37.06 52.13 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.864 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -26.07 59.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.754 0.311 . . . . 0.0 110.508 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.5 tp 57.25 63.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.38 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER 52.31 46.54 26.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.555 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 52.03 60.67 3.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.495 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.15 -180.0 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt 56.3 -150.08 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.667 0.27 . . . . 0.0 110.692 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.434 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 52.43 70.38 0.92 Allowed Glycine 1 CA--C 1.381 -8.31 0 CA-C-O 126.122 3.068 . . . . 0.0 112.749 -178.41 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 7' ' ' GLU . 16.1 mtp180 159.35 -11.0 0.0 OUTLIER 'General case' 1 N--CA 1.316 -7.163 1 CA-C-N 100.983 -7.609 . . . . 0.0 110.523 160.309 . . . . . . . . 4 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -43.7 -21.48 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.682 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 4' ' ' ARG . 16.7 mt -96.83 -24.54 15.85 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.677 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.7 tm-20 -68.0 -28.84 67.77 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.267 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -58.21 128.89 39.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.467 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 pt -75.32 115.39 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.401 0.62 . . . . 0.0 110.239 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.56 -2.1 79.15 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.775 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 13' ' ' GLY . 59.6 mttp -75.4 98.33 3.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.701 0.286 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.68 37.39 0.23 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.478 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 73.34 63.11 2.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.916 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 63.8 t80 56.1 32.56 20.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.814 0.34 . . . . 0.0 110.773 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.0 mt 61.01 63.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.588 0.708 . . . . 0.0 109.948 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.0 mm -132.43 -51.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.93 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.8 mm -68.94 -41.18 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.07 -48.77 6.31 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -66.82 -31.95 79.75 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.037 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 62.27 1.64 0.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.775 0.321 . . . . 0.0 110.568 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.1 tp 61.02 5.42 1.0 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 20' ' ' ALA . 3.2 m-20 -62.37 -97.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.211 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -88.97 -36.86 15.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.885 0.374 . . . . 0.0 110.361 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.508 -179.94 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.418 ' H2 ' ' H ' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 111.901 -0.479 . . . . 0.0 111.901 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.418 ' H ' ' H2 ' ' A' ' 1' ' ' GLY . 53.7 mttp -146.56 -129.64 0.07 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 4' ' ' ARG . . . 49.84 69.83 0.96 Allowed Glycine 1 CA--C 1.383 -8.194 0 CA-C-O 126.072 3.04 . . . . 0.0 113.072 -178.658 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 7' ' ' GLU . 12.1 mtt85 160.56 -11.8 0.0 OUTLIER 'General case' 1 N--CA 1.317 -7.076 1 CA-C-N 101.116 -7.542 . . . . 0.0 110.563 159.995 . . . . . . . . 4 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -43.83 -18.4 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.519 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.528 ' H ' ' C ' ' A' ' 4' ' ' ARG . 30.2 mt -114.43 -16.04 11.99 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.728 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 4' ' ' ARG . 90.6 mt-10 -118.5 31.1 6.84 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -51.97 -18.41 1.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.97 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.5 ' C ' ' H ' ' A' ' 11' ' ' LYS . 18.3 pt -154.45 -24.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.603 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.68 -35.07 1.01 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.874 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 9' ' ' ILE . 58.0 mttp -54.38 108.27 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.07 2.84 3.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.036 0.446 . . . . 0.0 110.09 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.23 34.73 0.65 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.535 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -166.26 -17.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.2 pt -152.23 50.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.139 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.4 tp -145.73 -39.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.078 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.63 4.64 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.13 -30.86 0.02 OUTLIER Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.69 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.65 -35.95 47.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.592 179.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.39 47.22 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.729 0.3 . . . . 0.0 110.822 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 23' ' ' HIS . 9.8 mp -60.37 114.55 2.99 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.7 t0 58.22 -78.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.696 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' LEU . 55.3 t-80 -166.81 30.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.534 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.153 -179.961 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -62.94 -130.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.131 -0.227 . . . . 0.0 110.457 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 44.96 70.97 0.53 Allowed Glycine 1 CA--C 1.387 -7.952 0 CA-C-O 126.496 3.275 . . . . 0.0 112.907 -178.168 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.515 ' C ' ' H ' ' A' ' 6' ' ' LEU . 12.7 mtt180 155.27 -12.67 0.0 OUTLIER 'General case' 1 N--CA 1.312 -7.329 1 CA-C-N 100.431 -7.885 . . . . 0.0 110.058 161.221 . . . . . . . . 4 3 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -45.34 -17.37 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.947 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 4' ' ' ARG . 32.1 mt -114.09 -12.51 12.55 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.997 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 4' ' ' ARG . 12.3 tm-20 -64.26 -22.35 66.92 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.778 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -43.4 96.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.18 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 11' ' ' LYS . 16.4 pt -64.49 -17.96 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.417 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.09 -37.14 1.09 Allowed Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 9' ' ' ILE . 9.1 mtpm? -71.85 107.23 4.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.802 0.334 . . . . 0.0 110.297 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.84 45.71 0.53 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.646 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.32 66.79 2.28 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.188 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 58.1 t80 54.44 30.9 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.748 0.309 . . . . 0.0 110.663 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mt 61.98 65.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.626 0.727 . . . . 0.0 110.271 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -132.29 -48.28 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.934 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.504 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -70.83 -45.75 71.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.92 -42.74 15.69 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 178.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.99 -47.42 90.82 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.652 179.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -60.86 -48.89 79.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.789 0.328 . . . . 0.0 110.244 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tp 62.07 1.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.34 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 20' ' ' ALA . 70.0 m-20 -85.79 37.61 0.71 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.366 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.475 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 0.7 OUTLIER 54.18 24.42 4.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.527 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.127 -179.921 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -60.93 -171.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.532 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 106.39 -59.42 0.4 Allowed Glycine 1 CA--C 1.355 -9.913 0 CA-C-O 123.713 1.729 . . . . 0.0 115.159 -179.954 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.5 mtm180 -60.67 -10.31 5.12 Favored 'General case' 1 N--CA 1.325 -6.72 1 CA-C-N 105.37 -5.415 . . . . 0.0 111.973 -157.659 . . . . . . . . 4 3 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.51 ' H ' ' C ' ' A' ' 3' ' ' GLY . 67.3 t-105 -40.89 -21.21 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.317 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 8.1 tp -106.8 -26.43 11.27 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.455 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' ARG . 50.5 tt0 -90.1 -0.34 57.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.23 0.538 . . . . 0.0 109.736 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.6 ptt85 -45.93 147.89 0.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 mt -79.9 -64.61 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.109 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 79.02 -13.8 17.5 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.936 179.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.513 ' C ' ' H ' ' A' ' 13' ' ' GLY . 2.4 ttmp? -70.31 7.14 1.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.263 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 15' ' ' ILE . . . 75.72 -20.68 0.34 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.344 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 35.21 65.77 0.4 Allowed Glycine 0 C--N 1.339 0.708 0 N-CA-C 112.254 -0.338 . . . . 0.0 112.254 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 56.04 36.67 27.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -178.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' ALA . 11.9 mm 64.24 80.49 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.765 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 8.7 tp -145.84 -54.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.194 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.438 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 3.7 tp -74.77 -33.8 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.15 -47.69 4.88 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 178.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.14 96.76 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.08 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.21 -64.86 0.68 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.759 0.314 . . . . 0.0 110.543 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.9 tp 55.4 74.59 0.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.569 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -165.3 41.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.558 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.466 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 3.5 m80 53.31 48.92 20.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.488 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.6 tp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.319 -179.966 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.425 ' H3 ' ' H ' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.425 ' H ' ' H3 ' ' A' ' 1' ' ' GLY . 50.1 mttp -55.34 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.799 0.333 . . . . 0.0 110.553 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 96.4 -59.16 1.34 Allowed Glycine 1 CA--C 1.354 -9.972 0 CA-C-O 123.824 1.791 . . . . 0.0 114.842 -179.742 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.8 mmt180 -60.19 -10.88 5.02 Favored 'General case' 1 N--CA 1.324 -6.753 1 CA-C-N 105.187 -5.506 . . . . 0.0 111.943 -157.659 . . . . . . . . 4 3 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.515 ' H ' ' C ' ' A' ' 3' ' ' GLY . 31.3 t90 -41.05 -20.24 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.298 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 4' ' ' ARG . 27.8 mt -109.69 -24.86 10.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.562 179.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 4' ' ' ARG . 22.2 tt0 -101.71 14.08 33.02 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.993 0.425 . . . . 0.0 110.026 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.7 ttp85 -72.06 -50.15 30.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.491 ' C ' ' H ' ' A' ' 11' ' ' LYS . 21.0 pt -62.34 -23.54 32.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.705 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.45 -32.11 1.17 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.249 -0.5 . . . . 0.0 111.898 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 9' ' ' ILE . 93.7 mttt -73.66 108.99 6.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.161 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.03 8.51 4.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.209 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 43.99 30.71 1.81 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.101 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -155.68 -76.71 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.653 0.263 . . . . 0.0 110.34 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.1 tt -90.41 47.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.951 0.881 . . . . 0.0 110.087 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 3.9 tp -142.33 -44.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.378 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.453 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 3.1 tp -82.55 -39.47 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.109 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.58 -45.54 4.89 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -58.26 -36.22 81.92 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.909 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.13 39.63 0.19 Allowed 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.69 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.465 ' H ' ' C ' ' A' ' 19' ' ' GLY . 21.2 tp -68.05 -51.98 40.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.117 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -54.42 -45.47 73.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.609 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.534 ' HD1' ' N ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -48.48 -36.86 15.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.32 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.648 179.547 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 111.949 -0.461 . . . . 0.0 111.949 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -76.96 172.79 12.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.867 0.365 . . . . 0.0 110.54 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.503 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 122.01 -58.77 0.59 Allowed Glycine 1 CA--C 1.357 -9.831 0 CA-C-O 123.812 1.785 . . . . 0.0 115.159 -179.944 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 6' ' ' LEU . 73.1 mtp180 -60.24 -11.2 5.77 Favored 'General case' 1 N--CA 1.324 -6.774 1 CA-C-N 105.142 -5.529 . . . . 0.0 112.182 -157.524 . . . . . . . . 4 3 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.503 ' N ' ' C ' ' A' ' 3' ' ' GLY . 77.0 t-105 -40.67 -20.51 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 112.828 -1.987 . . . . 0.0 110.797 -179.744 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.7 tp -112.06 -19.29 12.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.088 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.3 tp10 -60.81 -27.87 68.36 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.31 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -57.78 153.37 13.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.599 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 pt -155.89 8.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.121 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.24 29.53 5.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.288 -0.482 . . . . 0.0 111.94 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -161.75 55.35 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.954 0.407 . . . . 0.0 110.382 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.14 -0.45 31.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.932 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.42 54.31 0.23 Allowed Glycine 0 C--N 1.332 0.316 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 41.1 t80 63.22 29.09 15.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.755 0.312 . . . . 0.0 110.341 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.6 mt 61.25 60.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.632 0.729 . . . . 0.0 109.353 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.6 mm -126.44 -47.96 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.249 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.51 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.4 mp -66.7 -38.91 82.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.86 -40.26 6.3 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 178.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.14 79.56 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.983 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.7 -39.45 73.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.72 0.295 . . . . 0.0 110.691 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.2 mt 51.25 71.45 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.485 -179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.464 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 1.9 m-20 50.98 37.67 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.507 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.8 m80 53.7 61.4 3.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.684 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 tp . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.308 179.975 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -60.88 155.23 20.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.343 . . . . 0.0 110.428 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 116.97 -57.09 0.52 Allowed Glycine 1 CA--C 1.355 -9.954 0 CA-C-O 123.948 1.86 . . . . 0.0 114.687 -179.58 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 87.4 mtm180 -60.35 -10.92 5.36 Favored 'General case' 1 N--CA 1.323 -6.784 1 CA-C-N 104.946 -5.627 . . . . 0.0 112.001 -157.573 . . . . . . . . 4 3 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.505 ' H ' ' C ' ' A' ' 3' ' ' GLY . 81.6 m95 -43.22 -18.26 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 113.002 -1.908 . . . . 0.0 110.178 179.72 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.2 tt -114.17 -19.5 11.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.711 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.4 tp10 -82.0 16.99 1.69 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.394 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -70.3 178.35 2.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.619 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.6 tt -170.82 130.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.453 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.99 17.2 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.837 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.58 -2.76 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.269 -0.172 . . . . 0.0 110.788 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 58.94 62.94 1.75 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.34 85.97 0.01 OUTLIER Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.469 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 12' ' ' ALA . 29.4 t80 64.14 38.27 8.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.966 0.413 . . . . 0.0 110.043 -179.085 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.4 mm 61.41 73.7 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.095 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -133.72 -53.39 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.081 179.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.479 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -70.44 -51.32 38.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.787 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.09 -42.44 51.29 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 178.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.46 -45.42 96.43 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.024 179.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.72 -16.2 62.76 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.813 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.8 mt 51.87 79.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.289 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.8 p30 42.45 32.58 0.36 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.157 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 15.3 m80 58.96 61.76 2.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.583 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 -179.931 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -78.4 50.14 0.91 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.79 0.329 . . . . 0.0 110.591 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -59.69 -58.14 15.84 Favored Glycine 1 CA--C 1.355 -9.925 0 CA-C-O 123.76 1.755 . . . . 0.0 115.302 179.854 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 6' ' ' LEU . 52.0 mtm-85 -59.97 -11.61 6.1 Favored 'General case' 1 N--CA 1.324 -6.754 1 CA-C-N 105.233 -5.483 . . . . 0.0 112.004 -157.549 . . . . . . . . 4 3 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.504 ' H ' ' C ' ' A' ' 3' ' ' GLY . 68.0 t-105 -41.92 -19.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.149 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 24.0 mt -118.66 -16.29 9.42 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.581 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.7 tt0 -87.96 -6.03 58.22 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 120.92 0.39 . . . . 0.0 110.181 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.435 ' CG ' ' H ' ' A' ' 9' ' ' ILE . 12.7 tpt180 62.12 -131.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.247 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.435 ' H ' ' CG ' ' A' ' 8' ' ' ARG . 14.8 tt -163.43 123.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 110.371 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.89 27.9 4.23 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.191 -179.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -101.12 100.84 11.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.774 0.321 . . . . 0.0 110.309 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.55 57.64 3.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.004 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.54 49.25 53.22 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.495 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 48.1 t80 59.05 45.06 15.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 110.533 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 mt 62.42 68.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.167 0.508 . . . . 0.0 110.628 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -134.04 -65.79 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 tp -71.19 -21.89 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.3 -45.16 5.09 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.613 179.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.67 -39.6 34.02 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.398 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.58 -75.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.638 0.256 . . . . 0.0 111.327 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.6 mt 59.76 14.03 3.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.146 -179.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 19.1 m-20 -74.33 -83.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.652 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.462 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 96.9 m-70 -156.52 56.28 0.56 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.469 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.127 -179.924 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -76.92 63.33 2.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.501 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -53.5 -56.31 20.55 Favored Glycine 1 CA--C 1.357 -9.805 0 CA-C-O 123.715 1.73 . . . . 0.0 115.419 179.897 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.0 mtt180 -60.16 -10.92 5.02 Favored 'General case' 1 N--CA 1.325 -6.688 1 CA-C-N 105.318 -5.441 . . . . 0.0 112.082 -157.35 . . . . . . . . 4 3 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.52 ' H ' ' C ' ' A' ' 3' ' ' GLY . 66.9 t-105 -41.81 -19.28 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 112.892 -1.958 . . . . 0.0 110.358 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 mt -117.04 -18.36 10.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.549 179.301 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 4' ' ' ARG . 57.5 mm-40 -89.68 18.58 5.37 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.843 0.354 . . . . 0.0 110.411 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -55.25 -173.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 pt -150.09 124.28 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.967 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.44 -3.32 31.95 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.898 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' C ' ' H ' ' A' ' 13' ' ' GLY . 46.2 mttp -77.01 96.28 4.36 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.822 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.489 ' O ' ' CD1' ' A' ' 14' ' ' PHE . . . -57.87 -9.87 1.48 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 109.998 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 59.47 34.61 81.81 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.029 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 12' ' ' ALA . 61.4 m-85 -142.8 -53.21 0.39 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.795 -0.238 . . . . 0.0 110.404 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 pt -153.97 61.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.081 0.467 . . . . 0.0 110.589 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.4 mm -136.2 -39.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.416 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 pp -96.87 14.59 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.32 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.17 -48.28 0.02 OUTLIER Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.135 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.05 -43.47 93.23 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.895 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -62.98 -53.22 57.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.796 0.331 . . . . 0.0 110.427 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tp 63.13 1.38 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.389 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 20' ' ' ALA . 30.7 t70 -78.3 56.76 1.76 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.625 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 54.6 t-80 55.59 17.98 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.602 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.1 tp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.215 -179.967 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -71.12 -141.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.473 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.537 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 52.91 68.17 1.75 Allowed Glycine 1 CA--C 1.38 -8.402 0 CA-C-O 125.135 2.52 . . . . 0.0 113.786 -179.157 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 1.2 mtm-85 166.65 -11.83 0.0 OUTLIER 'General case' 1 N--CA 1.319 -6.987 1 CA-C-N 101.53 -7.335 . . . . 0.0 110.041 158.771 . . . . . . . . 4 3 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -43.4 -18.74 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.141 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.1 mt -111.32 -18.0 13.02 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.744 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.7 mp0 -105.56 29.24 6.7 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 120.886 0.374 . . . . 0.0 110.112 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.494 ' C ' ' H ' ' A' ' 10' ' ' GLY . 85.6 mtm180 -47.72 -71.5 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.768 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 pt -57.88 -6.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.453 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . 50.51 51.06 33.81 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.928 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -166.97 74.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.409 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.27 62.89 3.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.203 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.69 49.66 16.01 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 -179.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.4 t80 63.88 48.66 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 110.121 -179.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mm 51.45 65.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.401 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.4 mm -132.7 -62.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.373 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 tp -67.67 -31.02 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.16 -48.87 4.67 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.82 -44.17 97.28 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.12 -71.82 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.18 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.9 tp 52.62 80.24 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.57 179.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -158.86 -69.53 0.09 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.442 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -165.62 37.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.593 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.096 179.958 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.8 mttm 52.61 -163.71 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.726 0.298 . . . . 0.0 110.463 179.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.505 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 92.23 -59.1 2.71 Favored Glycine 1 CA--C 1.357 -9.8 0 CA-C-O 123.626 1.681 . . . . 0.0 115.222 179.955 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 7' ' ' GLU . 94.6 mtt180 -60.24 -10.77 4.96 Favored 'General case' 1 N--CA 1.324 -6.732 1 CA-C-N 105.395 -5.403 . . . . 0.0 111.996 -157.551 . . . . . . . . 4 3 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.505 ' N ' ' C ' ' A' ' 3' ' ' GLY . 83.7 m95 -42.0 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.435 179.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.0 mt -110.13 -21.08 12.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.912 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 38.4 tt0 -47.54 -19.85 0.21 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.911 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -52.02 -71.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.493 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.516 ' CG2' ' H ' ' A' ' 10' ' ' GLY . 14.6 tt -70.1 -59.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.332 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.516 ' H ' ' CG2' ' A' ' 9' ' ' ILE . . . 44.3 38.61 5.13 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.431 179.089 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' GLY . 61.5 mttp -96.15 -1.05 49.23 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 76.06 -30.28 0.19 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.156 -179.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.8 68.33 0.48 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 63.24 58.74 1.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 pt 38.77 81.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.998 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.3 mm -134.17 -41.45 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.471 178.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.92 -73.31 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.687 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.25 -44.0 98.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.719 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -77.47 -47.12 9.19 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 121.302 -0.475 . . . . 0.0 111.95 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.5 8.02 0.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 110.477 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.496 ' H ' ' C ' ' A' ' 19' ' ' GLY . 12.7 tp 52.82 75.81 0.22 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.399 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.1 p30 -168.3 49.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.1 t60 52.39 20.41 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.43 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.242 -179.995 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -77.35 27.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.727 0.299 . . . . 0.0 110.638 179.993 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -51.65 -58.88 9.29 Favored Glycine 1 CA--C 1.356 -9.899 0 CA-C-O 123.737 1.743 . . . . 0.0 115.283 179.859 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 52.7 mtp85 -60.52 -10.58 5.23 Favored 'General case' 1 N--CA 1.324 -6.745 1 CA-C-N 105.276 -5.462 . . . . 0.0 112.026 -157.633 . . . . . . . . 4 3 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.511 ' H ' ' C ' ' A' ' 3' ' ' GLY . 45.2 t-105 -41.95 -18.03 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.642 -179.881 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.6 tp -128.47 -8.42 5.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.625 179.622 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.8 tt0 -87.93 -7.68 56.8 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 110.174 179.819 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.443 ' C ' ' H ' ' A' ' 10' ' ' GLY . 38.5 ttm180 -54.33 -83.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.523 179.886 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 11' ' ' LYS . 22.5 pt -78.31 16.48 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.812 0.339 . . . . 0.0 110.541 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . -44.21 90.43 0.01 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.234 -179.821 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.504 ' HZ1' ' CB ' ' A' ' 11' ' ' LYS . 9.8 mtmp? -154.34 -2.42 0.18 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.69 57.09 5.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.198 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.1 88.38 0.01 OUTLIER Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.834 -179.648 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 12' ' ' ALA . 98.0 m-85 53.54 44.63 29.59 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.15 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.4 mt 61.9 76.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.643 -179.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 tp -142.73 -28.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.346 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 mm -104.26 -39.89 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.378 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.52 -59.88 4.28 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.413 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -72.41 -36.64 59.18 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.554 179.542 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.9 16.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.663 0.268 . . . . 0.0 111.053 179.734 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.437 ' C ' ' N ' ' A' ' 23' ' ' HIS . 23.7 mt 54.08 -123.7 2.14 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.048 -179.735 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 t0 46.05 17.6 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.761 0.315 . . . . 0.0 110.876 179.801 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.459 ' HD1' ' N ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER 51.78 41.69 29.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.339 -179.862 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.7 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.256 -179.923 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt 51.33 20.67 0.99 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.75 0.309 . . . . 0.0 110.452 -179.989 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.513 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -49.97 -57.51 9.81 Favored Glycine 1 CA--C 1.356 -9.863 0 CA-C-O 123.74 1.745 . . . . 0.0 115.332 179.861 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' GLU . 58.8 mtm180 -60.58 -10.32 4.99 Favored 'General case' 1 N--CA 1.325 -6.714 1 CA-C-N 105.23 -5.485 . . . . 0.0 111.949 -157.604 . . . . . . . . 4 3 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.513 ' N ' ' C ' ' A' ' 3' ' ' GLY . 27.6 t90 -42.19 -18.93 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.294 179.932 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 4' ' ' ARG . 23.5 mt -112.21 -23.09 10.61 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.379 179.077 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 82.3 mt-10 -97.24 14.26 26.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.85 0.357 . . . . 0.0 110.328 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -62.86 -37.2 85.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.709 -179.857 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 11' ' ' LYS . 4.1 tp -170.04 -11.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.96 0.409 . . . . 0.0 109.915 -179.799 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -37.4 -25.98 0.02 OUTLIER Glycine 0 C--N 1.335 0.482 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.634 179.615 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 13' ' ' GLY . 85.9 mttt -71.2 103.29 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.31 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.7 2.87 0.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.64 -179.813 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.75 45.42 3.61 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.557 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -163.47 -41.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.663 0.268 . . . . 0.0 110.65 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 pt -154.26 60.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.105 0.479 . . . . 0.0 110.442 179.998 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 mm -147.58 -30.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.4 mm -112.39 -49.45 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.447 179.206 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.51 -41.99 49.71 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.344 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.09 -38.25 7.41 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 179.52 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.6 67.46 1.0 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.332 . . . . 0.0 110.499 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 23' ' ' HIS . 9.7 tp -49.61 120.83 4.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.514 179.889 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 52.58 -85.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.694 179.864 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.581 ' HD1' ' H ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -156.91 45.07 0.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.36 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.26 -179.841 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.229 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -69.89 -141.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.999 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.414 ' O ' ' NE ' ' A' ' 4' ' ' ARG . . . 44.51 70.2 0.62 Allowed Glycine 1 CA--C 1.383 -8.181 0 CA-C-O 125.784 2.88 . . . . 0.0 113.57 -179.051 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 7' ' ' GLU . 10.3 mtm180 163.24 -11.83 0.0 OUTLIER 'General case' 1 N--CA 1.319 -7.0 1 CA-C-N 101.468 -7.366 . . . . 0.0 110.658 159.621 . . . . . . . . 4 3 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -43.53 -18.63 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.312 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.533 ' N ' ' C ' ' A' ' 4' ' ' ARG . 36.3 mt -115.2 -14.9 11.7 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.937 178.919 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.1 mt-10 -118.2 25.95 9.97 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.413 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -66.93 152.22 46.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.565 -179.903 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.0 tt -68.93 -42.99 82.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.363 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.69 -129.71 7.59 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.232 -179.987 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.515 ' C ' ' H ' ' A' ' 13' ' ' GLY . 90.4 mttt 49.79 18.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.302 . . . . 0.0 110.532 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 16' ' ' ILE . . . 71.9 -13.6 0.57 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.775 -179.918 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.97 56.59 2.14 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 112.211 -0.355 . . . . 0.0 112.211 179.99 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 67.43 46.99 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.07 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.2 mm 62.68 77.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.891 -179.945 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' ALA . 7.6 mm -131.77 -73.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.4 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -74.47 -29.77 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.418 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.85 -53.12 8.4 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.18 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -77.15 -45.21 11.85 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.526 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.59 10.72 0.24 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.768 0.318 . . . . 0.0 110.537 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' HIS . 8.6 mp 53.85 -111.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.016 -179.97 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 t70 54.91 -82.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.708 0.289 . . . . 0.0 110.757 179.924 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' LEU . 15.4 t60 -160.67 4.31 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.425 179.922 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.538 179.894 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -71.53 -154.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.191 -0.204 . . . . 0.0 110.531 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 58.11 71.77 0.7 Allowed Glycine 1 CA--C 1.381 -8.327 0 CA-C-O 126.129 3.071 . . . . 0.0 112.207 -178.176 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 7' ' ' GLU . 10.1 mtp180 158.31 -11.44 0.0 OUTLIER 'General case' 1 N--CA 1.314 -7.235 1 CA-C-N 100.894 -7.653 . . . . 0.0 110.593 160.655 . . . . . . . . 4 3 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -44.37 -21.62 0.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.387 -179.773 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.476 ' N ' ' C ' ' A' ' 4' ' ' ARG . 17.1 mt -99.81 -21.26 15.82 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.634 179.713 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.3 tp10 -68.83 -28.19 66.52 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.467 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -66.15 155.73 36.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.575 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.8 tt -165.87 121.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.478 179.919 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.26 -25.34 19.41 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.476 ' C ' ' H ' ' A' ' 13' ' ' GLY . 45.9 mttp -83.3 87.66 6.95 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.947 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.07 17.58 1.21 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.586 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 57.61 22.3 45.65 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.452 -179.531 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.488 ' C ' ' H ' ' A' ' 16' ' ' ILE . 45.5 t80 -146.06 -55.29 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.8 pt -80.37 31.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 179.71 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.488 ' H ' ' C ' ' A' ' 14' ' ' PHE . 9.6 tp -148.54 -46.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.924 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.455 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 3.5 tp -79.26 -32.33 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.188 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.78 -47.75 3.86 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 178.655 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.42 -38.39 86.72 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.408 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -75.01 -68.64 0.53 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.845 0.355 . . . . 0.0 110.285 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 23' ' ' HIS . 0.7 OUTLIER 59.03 5.96 0.6 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.052 179.879 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 20' ' ' ALA . 8.4 m-20 -77.58 23.0 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.531 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.498 ' H ' ' C ' ' A' ' 21' ' ' LEU . 37.8 m-70 52.86 35.67 19.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.427 179.964 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.251 -179.988 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.019 -0.433 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 51.72 -158.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -179.997 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 55.43 70.3 1.0 Allowed Glycine 1 CA--C 1.381 -8.302 0 CA-C-O 126.392 3.218 . . . . 0.0 112.251 -178.002 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.602 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.9 mtt-85 157.33 -10.03 0.0 OUTLIER 'General case' 1 N--CA 1.314 -7.254 1 CA-C-N 100.612 -7.794 . . . . 0.0 110.175 160.903 . . . . . . . . 4 3 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -41.28 -24.21 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.957 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.4 mm? -92.33 -29.3 16.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.209 179.459 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.7 tt0 -71.3 -19.02 62.38 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.126 179.715 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.44 131.78 51.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.525 179.947 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.8 pt -64.16 -34.51 69.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.529 -179.901 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.51 47.02 92.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.074 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -154.18 73.19 0.91 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.782 0.325 . . . . 0.0 110.254 179.988 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.01 49.65 1.11 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.612 179.908 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.73 65.71 2.91 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.166 179.897 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 54.77 31.63 15.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.701 0.286 . . . . 0.0 110.923 179.785 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 61.26 64.08 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.578 0.704 . . . . 0.0 110.277 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 mm -133.01 -47.28 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.717 179.923 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -72.13 -46.18 59.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.858 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.92 -48.7 9.6 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.082 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.53 -42.45 99.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.857 179.618 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.468 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 59.95 3.39 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.743 0.306 . . . . 0.0 110.784 -179.958 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.2 mt 49.71 13.41 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.736 179.91 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 20' ' ' ALA . 47.6 t0 -62.83 -73.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.565 179.984 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.413 ' C ' ' HD1' ' A' ' 23' ' ' HIS . 2.0 p80 -169.62 20.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.548 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 10.1 mp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.079 179.908 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.254 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -168.43 160.33 11.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.397 -179.981 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 144.33 -56.05 0.55 Allowed Glycine 1 CA--C 1.353 -10.073 0 CA-C-O 123.965 1.87 . . . . 0.0 114.571 -179.491 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 7' ' ' GLU . 65.5 mtt-85 -60.48 -10.73 5.37 Favored 'General case' 1 N--CA 1.321 -6.897 1 CA-C-N 104.923 -5.639 . . . . 0.0 111.949 -157.671 . . . . . . . . 4 3 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.52 ' H ' ' C ' ' A' ' 3' ' ' GLY . 69.9 t-105 -43.03 -19.04 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.151 179.876 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.497 ' N ' ' C ' ' A' ' 4' ' ' ARG . 20.6 mt -111.89 -19.66 12.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.75 179.788 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.2 tt0 -49.04 -24.58 1.62 Allowed 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.71 -179.844 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 56.5 99.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.231 -179.913 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 11' ' ' LYS . 2.3 pt -62.59 113.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.411 0.624 . . . . 0.0 110.279 -179.845 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.82 8.25 8.03 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.648 179.854 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 9' ' ' ILE . 57.5 mttp -67.28 108.37 2.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.694 0.283 . . . . 0.0 110.64 -179.924 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.91 4.76 5.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.064 0.459 . . . . 0.0 109.783 179.536 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 14' ' ' PHE . . . 59.99 22.89 58.55 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.998 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 63.9 m-85 -158.6 -100.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.738 0.304 . . . . 0.0 111.166 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.8 pt -78.05 60.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.988 0.423 . . . . 0.0 111.739 -178.834 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.7 mm -149.26 -44.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.036 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.03 -50.07 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.805 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.56 -43.61 67.79 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.059 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.1 -42.62 7.96 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 179.386 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.35 50.38 18.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.767 0.318 . . . . 0.0 110.649 179.861 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.3 mt -75.19 -26.76 59.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.416 179.931 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 24' ' ' LEU . 16.3 m-20 -77.2 -67.77 0.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.42 1.4 0.79 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.709 -179.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' A' ' 22' ' ' ASP . 1.6 tt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.351 179.992 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 111.994 -0.443 . . . . 0.0 111.994 . . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.403 ' H ' ' H2 ' ' A' ' 1' ' ' GLY . 85.5 mttt -77.14 38.34 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 0.0 110.568 179.989 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -49.69 -58.06 8.83 Favored Glycine 1 CA--C 1.356 -9.884 0 CA-C-O 123.656 1.698 . . . . 0.0 115.299 179.806 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 7' ' ' GLU . 88.0 mtt180 -60.6 -10.98 5.91 Favored 'General case' 1 N--CA 1.324 -6.76 1 CA-C-N 105.317 -5.441 . . . . 0.0 111.855 -157.626 . . . . . . . . 4 3 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.505 ' H ' ' C ' ' A' ' 3' ' ' GLY . 26.6 t90 -42.7 -21.34 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.836 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.483 ' N ' ' C ' ' A' ' 4' ' ' ARG . 11.0 mp -105.27 -26.32 12.07 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.995 179.151 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 4' ' ' ARG . 22.4 mm-40 -93.34 37.65 1.05 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.694 0.283 . . . . 0.0 110.607 -179.855 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -69.9 172.36 7.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.446 179.988 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 tp -170.4 124.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.192 179.849 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.36 25.26 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.769 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -69.62 -5.81 27.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 55.54 60.72 3.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.015 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.66 87.59 0.01 OUTLIER Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -179.657 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 12' ' ' ALA . 98.8 m-85 54.01 42.05 31.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -178.621 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.5 mt 62.66 83.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.465 -179.576 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.47 ' CG2' ' H ' ' A' ' 17' ' ' ILE . 5.2 tp -143.66 -58.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.398 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.47 ' H ' ' CG2' ' A' ' 16' ' ' ILE . 3.7 tp -86.15 -26.34 6.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.505 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.18 -55.29 4.42 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 178.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.16 -43.28 40.19 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.632 179.299 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.34 38.76 30.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.694 0.283 . . . . 0.0 110.778 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.1 mt -99.8 -20.07 16.39 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.481 179.839 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -50.09 -50.9 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -165.28 -20.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.46 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.499 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.6 mp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.169 179.923 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -149.63 -179.48 7.14 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.786 0.326 . . . . 0.0 110.155 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 97.21 -58.33 1.18 Allowed Glycine 1 CA--C 1.357 -9.842 0 CA-C-O 123.639 1.688 . . . . 0.0 115.454 179.924 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 7' ' ' GLU . 71.1 mtm180 -60.47 -10.51 5.06 Favored 'General case' 1 N--CA 1.325 -6.71 1 CA-C-N 105.445 -5.378 . . . . 0.0 112.057 -157.454 . . . . . . . . 4 3 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.518 ' H ' ' C ' ' A' ' 3' ' ' GLY . 58.3 m95 -41.19 -20.05 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 112.924 -1.944 . . . . 0.0 110.334 179.834 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.0 tp -112.93 -22.62 10.53 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.342 179.351 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.2 mm-40 -102.06 38.77 1.59 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.657 0.265 . . . . 0.0 110.563 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -51.47 139.23 20.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.383 179.981 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.463 ' C ' ' H ' ' A' ' 11' ' ' LYS . 2.7 tp -52.64 -56.08 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.406 -179.797 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.49 -38.92 1.04 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.073 179.902 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 9' ' ' ILE . 37.0 mtmt -78.12 105.42 9.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.745 0.307 . . . . 0.0 110.389 179.987 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.85 9.17 3.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.192 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.13 34.43 12.25 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.114 179.878 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.454 ' C ' ' H ' ' A' ' 16' ' ' ILE . 12.5 t80 -161.96 -73.85 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.826 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 pt -81.48 38.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.207 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.454 ' H ' ' C ' ' A' ' 14' ' ' PHE . 4.0 tp -146.23 -42.72 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.087 -179.656 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.431 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 2.2 pp -77.04 0.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.043 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -158.15 -42.64 0.02 OUTLIER Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.686 -179.808 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -61.23 -36.34 92.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.69 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 56.29 6.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.748 0.308 . . . . 0.0 110.704 179.918 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.5 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.0 tp 49.97 14.09 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.411 179.99 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 20' ' ' ALA . 18.3 t70 -71.73 -40.96 69.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.441 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.592 ' HD1' ' N ' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -165.78 12.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.343 179.9 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.226 -179.988 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -57.45 171.95 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.36 . . . . 0.0 110.62 -179.998 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.521 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 91.88 -58.77 2.87 Favored Glycine 1 CA--C 1.355 -9.908 0 CA-C-O 123.778 1.766 . . . . 0.0 115.174 -179.855 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 7' ' ' GLU . 94.8 mtt180 -60.43 -10.59 5.09 Favored 'General case' 1 N--CA 1.326 -6.634 1 CA-C-N 105.266 -5.467 . . . . 0.0 111.966 -157.524 . . . . . . . . 4 3 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.521 ' H ' ' C ' ' A' ' 3' ' ' GLY . 56.3 m95 -42.11 -20.12 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.964 -1.925 . . . . 0.0 110.38 179.83 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.3 mt -110.18 -20.48 12.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.995 179.93 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.6 tt0 -46.99 -22.02 0.28 Allowed 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.823 -179.917 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 -79.61 -44.05 21.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.4 mm -70.28 -6.88 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 -179.64 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.37 -25.57 6.18 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.739 -0.744 . . . . 0.0 111.35 179.542 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 13' ' ' GLY . 98.0 mttt -116.68 76.45 1.03 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.228 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.92 84.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.381 -179.535 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . 47.18 54.65 9.62 Favored Glycine 0 C--N 1.33 0.209 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -179.593 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.1 t80 57.68 39.91 26.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.885 0.374 . . . . 0.0 110.285 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 mt 60.85 67.59 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.482 -179.979 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 10.2 tp -137.89 -47.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.387 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.422 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 28.9 mm -77.63 -36.68 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.297 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.12 -50.68 6.64 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 178.884 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -67.61 -36.86 88.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.568 179.342 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 73.17 -35.68 0.33 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.635 0.255 . . . . 0.0 111.06 179.865 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 19' ' ' GLY . 2.4 mm? 53.35 10.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.953 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 20' ' ' ALA . 15.8 t0 -79.56 -37.42 36.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.623 -179.913 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -167.6 -22.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.806 -179.942 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.145 -179.958 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.79 176.98 4.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 110.619 -179.989 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 127.72 -57.82 0.7 Allowed Glycine 1 CA--C 1.355 -9.964 0 CA-C-O 123.83 1.794 . . . . 0.0 114.86 -179.737 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 7' ' ' GLU . 58.0 mtm180 -61.12 -9.41 4.62 Favored 'General case' 1 N--CA 1.323 -6.802 1 CA-C-N 105.22 -5.49 . . . . 0.0 112.001 -157.688 . . . . . . . . 4 3 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.519 ' H ' ' C ' ' A' ' 3' ' ' GLY . 95.5 m95 -38.48 -26.56 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.118 -1.856 . . . . 0.0 110.354 -179.913 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.4 mm? -94.18 -33.54 13.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.077 179.334 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.5 mt-10 -96.1 14.14 24.87 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.708 0.289 . . . . 0.0 110.437 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 4' ' ' ARG . 0.6 OUTLIER -70.04 -68.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.322 -179.795 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.5 pt -98.59 -33.34 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.63 179.894 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.01 59.89 6.52 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.841 -179.724 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -162.75 83.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.34 . . . . 0.0 110.241 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.33 57.03 2.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 -179.825 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 57.31 64.47 4.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.057 179.993 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 47.0 t80 54.89 33.27 19.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.797 0.332 . . . . 0.0 110.467 179.918 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 mt 59.52 64.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.575 0.702 . . . . 0.0 110.113 -179.831 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -132.18 -51.87 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.847 -179.941 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 mm -68.87 -44.37 81.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.764 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.99 -44.36 12.13 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.936 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.19 -43.3 99.57 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.892 179.543 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.08 -22.24 49.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.838 0.351 . . . . 0.0 110.495 -179.898 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.3 tp -56.55 -19.12 14.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.413 179.994 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 79.4 m-20 -51.04 -51.99 47.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.666 179.903 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.488 ' ND1' ' O ' ' A' ' 22' ' ' ASP . 77.1 m-70 -153.89 39.62 0.48 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.246 179.956 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.134 -179.932 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -169.37 157.96 7.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.0 110.322 179.987 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 118.76 -56.03 0.58 Allowed Glycine 1 CA--C 1.354 -9.97 0 CA-C-O 123.849 1.805 . . . . 0.0 114.652 -179.568 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 7' ' ' GLU . 83.8 mtm180 -60.99 -9.08 3.75 Favored 'General case' 1 N--CA 1.323 -6.81 1 CA-C-N 105.093 -5.553 . . . . 0.0 112.072 -157.644 . . . . . . . . 4 3 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.518 ' H ' ' C ' ' A' ' 3' ' ' GLY . 97.8 m95 -38.4 -23.99 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.569 -179.901 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.0 tp -102.43 -29.89 11.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.412 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.4 mm-40 -97.38 43.99 1.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -50.97 -39.09 54.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 -179.851 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.509 ' C ' ' H ' ' A' ' 11' ' ' LYS . 11.2 pt -155.83 -35.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.428 179.903 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.34 -12.99 1.64 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.225 179.886 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 9' ' ' ILE . 31.9 mtmm -89.76 105.49 17.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.749 0.309 . . . . 0.0 110.201 179.903 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.02 61.2 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.806 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.62 50.91 13.4 Favored Glycine 0 C--N 1.331 0.27 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -179.236 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.9 t80 60.24 63.54 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.713 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.5 pt 35.26 62.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.346 -179.342 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 4.5 tp -129.15 -48.71 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.459 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 4.1 tp -82.31 -33.77 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.518 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.86 -35.64 6.72 Favored Glycine 0 C--N 1.331 0.262 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.23 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.66 -37.83 61.56 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.016 179.805 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.54 -68.16 0.45 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.824 0.345 . . . . 0.0 110.5 179.993 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.21 85.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.132 -179.97 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.9 t0 51.19 35.62 13.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.7 179.967 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.431 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 7.0 t60 53.24 46.21 26.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.565 179.871 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.127 179.922 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.008 -0.437 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -170.11 65.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.765 0.317 . . . . 0.0 110.409 -179.954 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -50.68 -57.84 10.11 Favored Glycine 1 CA--C 1.356 -9.9 0 CA-C-O 123.729 1.739 . . . . 0.0 115.218 179.843 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 7' ' ' GLU . 80.0 mtm180 -60.7 -10.34 5.22 Favored 'General case' 1 N--CA 1.323 -6.806 1 CA-C-N 105.27 -5.465 . . . . 0.0 111.921 -157.619 . . . . . . . . 4 3 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.497 ' H ' ' C ' ' A' ' 3' ' ' GLY . 27.3 t90 -42.3 -20.22 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.065 -1.88 . . . . 0.0 110.218 179.81 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 4' ' ' ARG . 24.0 mt -107.05 -24.98 11.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.375 179.446 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' ARG . 11.8 mp0 -89.24 -3.78 58.42 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.645 0.26 . . . . 0.0 110.318 -179.981 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -73.66 -29.72 62.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.52 -179.943 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.2 tt -48.67 99.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.227 0.537 . . . . 0.0 110.653 -179.805 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.14 -14.45 82.27 Favored Glycine 0 C--N 1.329 0.18 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.978 -179.927 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.461 ' C ' ' H ' ' A' ' 13' ' ' GLY . 53.6 mtpt -73.95 97.98 2.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.815 0.34 . . . . 0.0 110.464 -179.983 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.8 -3.27 1.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.803 -179.906 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 61.7 14.2 42.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.703 -179.888 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -163.79 -46.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.929 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.6 mm -99.77 52.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.339 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -149.74 -45.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.208 -179.827 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.437 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 1.0 OUTLIER -79.77 5.37 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.765 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.14 -44.11 0.02 OUTLIER Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.648 -179.916 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.41 -35.38 61.07 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.948 179.843 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.74 -29.47 59.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 0.0 110.507 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.3 mt -81.98 -27.14 33.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.633 -179.944 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -50.56 -59.91 3.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.603 179.983 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.416 ' H ' ' H ' ' A' ' 24' ' ' LEU . 11.4 t-80 -170.03 -4.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.539 179.935 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.416 ' H ' ' H ' ' A' ' 23' ' ' HIS . 17.2 mt . . . . . 0 N--CA 1.468 0.45 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.393 179.923 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 111.896 -0.481 . . . . 0.0 111.896 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.0 mttm 51.72 -166.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.771 0.32 . . . . 0.0 110.482 179.991 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 128.42 -58.02 0.71 Allowed Glycine 1 CA--C 1.356 -9.883 0 CA-C-O 123.718 1.732 . . . . 0.0 115.129 -179.924 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 7' ' ' GLU . 52.3 mtm-85 -60.6 -10.31 5.0 Favored 'General case' 1 N--CA 1.324 -6.75 1 CA-C-N 105.265 -5.467 . . . . 0.0 112.048 -157.534 . . . . . . . . 4 3 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.515 ' H ' ' C ' ' A' ' 3' ' ' GLY . 65.4 t-105 -41.07 -25.06 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.999 -1.91 . . . . 0.0 109.989 179.914 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.451 ' N ' ' C ' ' A' ' 4' ' ' ARG . 3.3 mm? -96.75 -29.0 14.02 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.424 179.508 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 4' ' ' ARG . 2.3 mp0 -86.39 -8.22 57.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.656 -179.498 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -80.26 -114.86 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.491 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.516 ' C ' ' H ' ' A' ' 11' ' ' LYS . 6.9 mm -83.09 -74.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.762 0.315 . . . . 0.0 110.171 179.742 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.85 -33.15 0.88 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.21 179.982 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 9' ' ' ILE . 40.8 mtmt -117.12 74.97 0.94 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.871 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.33 77.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.191 179.977 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . 51.62 54.6 23.94 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.544 -179.532 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 60.38 35.74 20.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.33 -179.644 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.3 mt 60.48 62.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.442 -179.988 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.4 tp -132.28 -41.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.552 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.4 mm -81.27 -43.55 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.541 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.5 -47.83 26.21 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 178.834 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.0 -37.62 87.83 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.703 179.301 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.42 51.18 11.93 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.88 0.371 . . . . 0.0 110.753 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.5 103.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.552 -179.914 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t70 54.53 44.16 29.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.616 -179.997 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.3 m80 51.56 31.84 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 179.923 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.358 179.971 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -149.98 -179.24 7.0 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 110.31 179.971 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 96.57 -58.88 1.31 Allowed Glycine 1 CA--C 1.354 -9.974 0 CA-C-O 123.675 1.708 . . . . 0.0 115.161 -179.886 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' GLU . 71.7 mtm-85 -60.55 -10.46 5.12 Favored 'General case' 1 N--CA 1.325 -6.7 1 CA-C-N 105.365 -5.418 . . . . 0.0 111.933 -157.684 . . . . . . . . 4 3 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.516 ' H ' ' C ' ' A' ' 3' ' ' GLY . 76.2 m95 -41.85 -19.8 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.224 179.896 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.6 tp -112.11 -23.01 10.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.226 179.371 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.5 mt-10 -94.61 20.92 7.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.844 0.354 . . . . 0.0 110.463 179.946 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.4 ttt85 -68.77 122.09 17.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.555 -179.965 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.416 ' H ' ' H ' ' A' ' 10' ' ' GLY . 20.8 pt -157.01 -9.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.309 -179.891 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 9' ' ' ILE . . . 53.93 38.57 60.47 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.973 -179.97 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 13' ' ' GLY . 67.5 mttm -148.71 77.27 1.38 Allowed 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.989 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.91 33.53 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.591 179.978 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 52.32 48.48 53.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.896 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.8 t80 67.78 50.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.692 0.282 . . . . 0.0 110.946 179.894 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.5 mm 60.66 73.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.333 0.587 . . . . 0.0 111.334 179.301 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.3 mm -136.05 -51.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.001 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.479 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -70.45 -54.05 20.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.859 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.62 -50.98 22.65 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.475 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.76 -45.8 95.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.865 179.684 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.63 -0.65 0.52 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.636 0.255 . . . . 0.0 110.896 -179.927 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 19' ' ' GLY . 16.0 mt 47.26 73.76 0.18 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 110.712 179.787 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.9 p-10 -170.68 35.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.621 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 51.36 42.59 29.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.535 179.973 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.195 -179.985 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -75.76 -173.68 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.854 0.359 . . . . 0.0 110.629 -179.932 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.509 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 131.6 -58.31 0.71 Allowed Glycine 1 CA--C 1.356 -9.848 0 CA-C-O 123.769 1.76 . . . . 0.0 115.01 -179.91 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 6' ' ' LEU . 97.5 mtt180 -60.5 -10.64 5.26 Favored 'General case' 1 N--CA 1.323 -6.777 1 CA-C-N 105.203 -5.499 . . . . 0.0 111.978 -157.612 . . . . . . . . 4 3 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.509 ' H ' ' C ' ' A' ' 3' ' ' GLY . 74.6 t-105 -41.67 -18.99 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.004 -1.907 . . . . 0.0 110.455 -179.912 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.3 mp -117.34 -17.91 10.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.646 179.374 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 4' ' ' ARG . 68.4 mm-40 -90.71 -9.99 44.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.719 0.295 . . . . 0.0 110.752 -179.844 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -83.45 68.45 9.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.521 -179.983 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.22 81.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.548 -179.872 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.33 -32.42 14.39 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.201 -0.523 . . . . 0.0 111.874 179.856 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 13' ' ' GLY . 56.9 mtpt -59.43 106.53 0.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.32 . . . . 0.0 110.298 179.881 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.91 1.45 3.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.037 -179.954 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 43.23 38.15 3.56 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.463 179.859 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -169.42 -15.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.053 179.988 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.0 pt -157.06 49.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.826 0.346 . . . . 0.0 111.06 179.826 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 18' ' ' GLY . 1.5 mm -143.78 -50.25 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.559 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.9 15.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.222 179.876 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -171.99 -31.87 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.157 -0.544 . . . . 0.0 111.855 -179.963 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.31 -23.86 69.87 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 -180.0 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.66 -50.32 58.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 0.0 110.575 -179.902 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.7 mt 56.09 56.49 5.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.116 -179.93 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -157.87 68.63 0.51 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.567 -179.943 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.466 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 49.5 t-80 51.82 39.61 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.608 179.856 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.2 tp . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.211 179.953 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -169.59 -146.29 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.977 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.455 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 56.73 72.58 0.56 Allowed Glycine 1 CA--C 1.383 -8.17 0 CA-C-O 126.319 3.177 . . . . 0.0 112.192 -178.07 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER 156.18 -10.46 0.0 OUTLIER 'General case' 1 N--CA 1.312 -7.367 1 CA-C-N 100.548 -7.826 . . . . 0.0 109.951 161.25 . . . . . . . . 5 4 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.6 t90 -42.4 -23.5 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.896 -179.943 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' N ' ' C ' ' A' ' 4' ' ' ARG . 5.0 mp -92.87 -27.63 17.0 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.61 179.765 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.5 mt-10 -79.21 -14.61 58.95 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.737 -179.928 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -70.17 -179.91 2.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 0.0 110.594 -179.881 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 tp -60.05 105.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.262 0.553 . . . . 0.0 110.409 -179.712 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.77 42.76 0.02 OUTLIER Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.831 179.995 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -50.29 -31.36 14.1 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.604 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.67 -9.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.622 -179.876 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.57 33.35 71.62 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.7 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -154.32 -9.79 0.14 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.915 0.388 . . . . 0.0 110.14 -179.926 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.5 pt -156.81 40.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.01 179.425 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 tp -150.49 -26.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.254 -179.683 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.5 6.71 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.837 179.484 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.79 -28.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.952 -179.978 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.83 -47.64 38.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.161 -0.542 . . . . 0.0 111.987 179.96 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.08 36.72 25.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.722 0.296 . . . . 0.0 110.583 179.958 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.59 -5.26 27.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.418 179.853 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -51.63 -35.51 42.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.619 179.981 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -168.48 21.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.702 179.967 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.21 179.979 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.214 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 81.6 mttt 52.07 -143.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.56 179.988 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.424 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 51.4 69.53 1.11 Allowed Glycine 1 CA--C 1.381 -8.298 0 CA-C-O 125.826 2.903 . . . . 0.0 113.095 -178.758 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.533 ' C ' ' H ' ' A' ' 6' ' ' LEU . 13.8 mtp180 162.38 -13.06 0.0 OUTLIER 'General case' 1 N--CA 1.318 -7.044 1 CA-C-N 101.345 -7.427 . . . . 0.0 110.583 159.656 . . . . . . . . 4 3 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -43.81 -18.12 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.682 -179.975 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.533 ' H ' ' C ' ' A' ' 4' ' ' ARG . 63.3 mt -120.6 -9.14 9.44 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.184 179.236 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.1 mt-10 -116.43 32.33 6.19 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.096 0.474 . . . . 0.0 109.749 179.626 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -49.03 92.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.534 179.76 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.458 ' C ' ' H ' ' A' ' 11' ' ' LYS . 16.4 pt -71.59 -32.58 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 -179.891 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.35 6.58 1.56 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.029 -179.978 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.499 ' C ' ' H ' ' A' ' 13' ' ' GLY . 78.6 tttt -68.83 -7.45 34.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 110.217 179.976 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 16' ' ' ILE . . . 74.89 -21.54 0.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.607 -179.85 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 42.64 52.64 5.39 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.627 -179.816 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.8 t80 70.91 44.61 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.993 0.425 . . . . 0.0 109.978 -179.124 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.8 mt 61.22 74.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.46 -179.99 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.7 mm -136.0 -71.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.693 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 tp -72.46 -23.52 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.136 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.16 -54.99 3.63 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.383 179.253 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -40.65 41.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.78 179.688 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.15 59.27 4.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.833 0.349 . . . . 0.0 110.245 -179.951 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.422 ' CD1' ' H ' ' A' ' 21' ' ' LEU . 10.1 mp -48.32 117.3 1.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.338 -179.827 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t0 55.16 51.93 12.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.986 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.1 m170 53.28 35.01 19.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.689 179.927 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.331 179.906 . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -62.92 178.29 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.534 179.905 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.514 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 119.6 -58.75 0.54 Allowed Glycine 1 CA--C 1.356 -9.891 0 CA-C-O 123.758 1.754 . . . . 0.0 115.23 179.99 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 59.4 mtt85 -60.59 -10.32 4.99 Favored 'General case' 1 N--CA 1.325 -6.717 1 CA-C-N 105.272 -5.464 . . . . 0.0 111.999 -157.609 . . . . . . . . 4 3 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.514 ' H ' ' C ' ' A' ' 3' ' ' GLY . 67.7 t-105 -40.8 -21.1 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.387 -179.934 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.9 mt -108.44 -24.92 11.22 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.676 179.365 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.1 mm-40 -89.89 33.8 0.85 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-O 120.928 0.394 . . . . 0.0 110.34 179.876 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -146.63 70.47 1.21 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.128 179.961 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.8 tt -61.04 120.79 7.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 179.963 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.87 -31.5 67.13 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.893 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' C ' ' H ' ' A' ' 13' ' ' GLY . 93.5 mttt -69.46 95.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 110.159 179.62 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -54.16 -8.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.39 -179.993 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 67.43 0.41 11.39 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.479 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.461 ' H ' ' C ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -80.86 -68.26 0.7 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.949 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.6 pt -158.25 42.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.771 179.42 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 18' ' ' GLY . 1.5 mp -85.66 -49.79 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.142 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.455 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -75.41 18.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.747 179.891 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -152.69 -58.1 0.01 OUTLIER Glycine 0 C--N 1.334 0.455 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 -179.938 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.43 -33.0 65.09 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.895 -179.994 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.99 -66.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 110.521 179.951 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.81 73.07 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.166 0.508 . . . . 0.0 109.899 179.898 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -160.87 32.51 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.306 179.984 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 50.5 t-80 55.48 39.51 31.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.285 -179.816 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.091 -179.76 . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.491 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -50.33 -179.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.768 0.318 . . . . 0.0 110.744 -179.886 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 110.29 -59.2 0.36 Allowed Glycine 1 CA--C 1.356 -9.869 0 CA-C-O 123.628 1.682 . . . . 0.0 115.232 179.875 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' A' ' 6' ' ' LEU . 66.8 mtp180 -60.2 -11.24 5.77 Favored 'General case' 1 N--CA 1.325 -6.71 1 CA-C-N 105.435 -5.382 . . . . 0.0 112.059 -157.467 . . . . . . . . 4 3 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.504 ' H ' ' C ' ' A' ' 3' ' ' GLY . 50.0 t90 -42.91 -18.44 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.887 -1.96 . . . . 0.0 110.214 179.85 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 4' ' ' ARG . 49.4 tp -114.8 -20.24 10.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.422 179.469 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 45.0 mm-40 -89.99 19.16 5.09 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.556 -179.998 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -78.68 56.32 1.83 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.183 179.952 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.61 83.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.658 -179.774 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.5 -25.11 75.03 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.119 -0.562 . . . . 0.0 111.716 179.625 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -78.39 107.92 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.776 0.322 . . . . 0.0 110.245 179.814 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.91 55.43 1.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.835 179.754 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 53.11 47.64 60.27 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.371 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 t80 61.0 45.55 9.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.029 0.443 . . . . 0.0 110.008 -179.392 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 mt 60.99 70.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.583 -179.803 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -135.8 -64.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.5 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -70.74 -26.76 28.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.352 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.07 -56.2 2.77 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.409 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.37 82.62 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 179.666 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.61 47.8 12.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.726 0.298 . . . . 0.0 110.675 179.829 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.2 tp -72.85 -34.6 66.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.022 179.854 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.45 44.14 0.59 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.568 179.998 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 42.3 m80 51.6 17.32 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.564 179.994 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.1 tp . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.262 -179.93 . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.56 -146.94 0.22 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.794 0.331 . . . . 0.0 110.241 179.987 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 102.33 -58.88 0.58 Allowed Glycine 1 CA--C 1.355 -9.947 0 CA-C-O 123.693 1.718 . . . . 0.0 115.013 -179.801 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 66.1 mtp180 -60.57 -10.68 5.45 Favored 'General case' 1 N--CA 1.324 -6.77 1 CA-C-N 105.38 -5.41 . . . . 0.0 111.966 -157.592 . . . . . . . . 4 3 . 1 . 050 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.517 ' H ' ' C ' ' A' ' 3' ' ' GLY . 33.2 t90 -44.39 -20.02 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 112.984 -1.917 . . . . 0.0 109.908 179.675 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 4' ' ' ARG . 42.6 tp -105.34 -22.84 12.96 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.431 179.791 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.8 tt0 -48.26 -36.2 13.56 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.7 mtt85 -77.06 -63.89 1.26 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.559 179.839 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.4 tt -170.42 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.447 -179.998 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.84 -50.39 3.3 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -179.796 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -81.25 96.58 7.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.696 0.284 . . . . 0.0 110.261 179.761 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.9 47.61 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.771 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.7 54.39 33.33 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.676 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 55.2 49.1 17.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.497 -179.698 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.6 mt 60.58 70.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.67 179.921 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.6 mm -136.35 -68.31 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.609 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -68.49 -22.99 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.654 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.24 -59.89 1.8 Allowed Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.486 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.52 -31.63 79.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.715 179.774 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.13 57.91 5.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 110.407 179.959 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.0 mt -56.75 90.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.386 179.954 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 24' ' ' LEU . 8.2 m-20 54.33 -135.1 1.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.354 -179.93 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -76.41 21.3 0.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.789 0.328 . . . . 0.0 110.744 179.885 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.496 ' H ' ' C ' ' A' ' 22' ' ' ASP . 15.9 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.145 -179.997 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 111.954 -0.459 . . . . 0.0 111.954 . . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.49 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -76.8 35.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 110.18 -179.963 . . . . . . . . 3 3 . 1 . 051 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -53.77 -57.92 14.33 Favored Glycine 1 CA--C 1.356 -9.9 0 CA-C-O 123.782 1.768 . . . . 0.0 115.094 179.796 . . . . . . . . 3 3 . 1 . 051 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 6' ' ' LEU . 93.9 mtt180 -60.73 -10.26 5.14 Favored 'General case' 1 N--CA 1.324 -6.735 1 CA-C-N 105.178 -5.511 . . . . 0.0 112.044 -157.609 . . . . . . . . 4 3 . 1 . 051 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.523 ' H ' ' C ' ' A' ' 3' ' ' GLY . 48.6 t-105 -39.84 -20.61 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 112.919 -1.946 . . . . 0.0 110.66 -179.802 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.5 tp -117.55 -19.15 9.54 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.501 179.406 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.0 mt-10 -89.5 24.56 2.23 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.777 0.322 . . . . 0.0 110.53 -179.978 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -76.36 -63.69 1.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.721 -179.984 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.2 tt -49.66 109.77 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.196 0.522 . . . . 0.0 110.558 -179.8 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.74 -27.58 64.71 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.933 -179.754 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' A' ' 13' ' ' GLY . 3.8 mptp? -54.96 111.2 0.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.714 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.12 3.53 3.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.96 0.41 . . . . 0.0 110.308 -179.61 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.38 38.48 0.63 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.796 179.586 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -168.38 -19.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 110.663 179.87 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 pt -151.17 48.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.123 0.487 . . . . 0.0 109.991 179.562 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.8 tp -146.4 -35.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.09 -179.892 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.51 4.8 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.813 179.423 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.39 -33.88 0.02 OUTLIER Glycine 0 C--N 1.33 0.248 0 N-CA-C 111.779 -0.529 . . . . 0.0 111.779 -179.856 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.13 -42.96 97.35 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.148 -0.549 . . . . 0.0 111.806 179.967 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.46 -51.36 60.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.724 0.297 . . . . 0.0 110.45 -179.955 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 tp 55.76 100.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.276 -179.953 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -164.72 -36.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.597 -179.954 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -170.32 1.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.71 -179.922 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.196 -179.857 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -149.79 178.64 8.7 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.865 0.364 . . . . 0.0 110.383 179.941 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.501 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 132.06 -58.8 0.7 Allowed Glycine 1 CA--C 1.354 -9.995 0 CA-C-O 123.797 1.776 . . . . 0.0 114.912 -179.784 . . . . . . . . 3 3 . 1 . 052 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 84.0 mtm180 -60.32 -11.22 5.96 Favored 'General case' 1 N--CA 1.324 -6.763 1 CA-C-N 105.247 -5.476 . . . . 0.0 111.923 -157.61 . . . . . . . . 4 3 . 1 . 052 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.501 ' H ' ' C ' ' A' ' 3' ' ' GLY . 67.0 m95 -42.08 -19.27 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.943 -1.935 . . . . 0.0 110.366 179.889 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.7 mt -114.12 -19.51 11.33 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.953 179.799 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.7 mm-40 -86.19 -16.23 38.44 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.721 -179.658 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -80.47 103.94 10.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.419 179.783 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.3 pt -65.31 -31.19 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.593 -179.854 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.21 28.35 4.3 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.04 179.966 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 13' ' ' GLY . 21.8 ttpp -79.09 -19.26 51.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.545 0.212 . . . . 0.0 110.769 -179.692 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 15' ' ' ILE . . . 78.5 -21.42 0.33 Allowed 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.164 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.11 36.43 0.87 Allowed Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -179.831 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.4 t80 73.69 48.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.647 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 12' ' ' ALA . 33.6 mt 64.6 70.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.517 -179.714 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.42 ' C ' ' H ' ' A' ' 18' ' ' GLY . 8.3 mm -134.66 -76.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.846 179.752 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.36 -6.53 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.143 -179.86 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -106.09 -65.8 0.65 Allowed Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.982 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.2 -19.95 74.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.683 179.668 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 63.05 9.75 4.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.629 0.252 . . . . 0.0 110.835 179.681 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 52.47 12.38 0.23 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.088 0.47 . . . . 0.0 109.783 -179.965 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 20' ' ' ALA . 25.1 t70 -70.19 -102.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.274 179.975 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.478 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 57.5 t-80 -67.41 2.08 1.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 110.103 179.582 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.492 ' H ' ' C ' ' A' ' 22' ' ' ASP . 1.4 tt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.129 -179.923 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 . . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -78.79 68.24 4.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 110.571 -179.878 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -57.82 -57.75 18.2 Favored Glycine 1 CA--C 1.355 -9.908 0 CA-C-O 123.751 1.75 . . . . 0.0 115.286 179.894 . . . . . . . . 3 3 . 1 . 053 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.8 mtt180 -60.21 -10.89 5.06 Favored 'General case' 1 N--CA 1.325 -6.704 1 CA-C-N 105.263 -5.469 . . . . 0.0 112.047 -157.48 . . . . . . . . 4 3 . 1 . 053 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.496 ' H ' ' C ' ' A' ' 3' ' ' GLY . 43.4 t90 -40.99 -18.93 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.639 -179.954 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.8 tp -123.47 -13.27 7.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.632 179.492 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.0 tt0 -82.93 -8.62 59.55 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.556 -179.806 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -50.11 115.49 1.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.466 179.774 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 11' ' ' LYS . 17.6 tt -70.68 -23.17 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.608 -179.837 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -47.13 87.43 0.01 OUTLIER Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.344 -179.887 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 9' ' ' ILE . 9.6 mtpm? -149.55 4.76 0.6 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.768 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 53.17 56.39 7.53 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.285 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -41.1 88.17 0.01 OUTLIER Glycine 0 C--N 1.335 0.523 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.019 -179.847 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 12' ' ' ALA . 89.6 m-85 53.26 48.19 22.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.815 0.34 . . . . 0.0 110.091 -179.108 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.7 mt 62.13 80.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.626 -179.835 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.0 tp -146.57 -35.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.249 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 mm -98.96 -37.24 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.007 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.02 -57.81 5.06 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.226 179.358 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.86 86.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.671 179.545 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.04 40.58 17.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.7 179.814 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 23' ' ' HIS . 22.8 mt -68.71 -25.98 65.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.579 -179.957 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.42 34.0 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.942 -179.74 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.496 ' H ' ' C ' ' A' ' 21' ' ' LEU . 12.0 t-80 54.85 27.87 9.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.574 179.31 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.238 179.527 . . . . . . . . 0 0 . 1 . 054 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.459 ' H1 ' ' H ' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.452 -0.26 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 . . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.459 ' H ' ' H1 ' ' A' ' 1' ' ' GLY . 22.1 mtmm -145.55 -159.74 1.05 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 110.489 -179.974 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 129.74 -59.86 0.68 Allowed Glycine 1 CA--C 1.354 -10.012 0 CA-C-O 123.794 1.775 . . . . 0.0 114.932 -179.938 . . . . . . . . 3 3 . 1 . 054 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' GLU . 74.4 mtm180 -60.7 -10.49 5.4 Favored 'General case' 1 N--CA 1.323 -6.813 1 CA-C-N 105.273 -5.464 . . . . 0.0 111.835 -157.727 . . . . . . . . 4 3 . 1 . 054 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.512 ' H ' ' C ' ' A' ' 3' ' ' GLY . 19.4 t90 -42.17 -19.73 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.095 -1.866 . . . . 0.0 110.262 179.862 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.498 ' N ' ' C ' ' A' ' 4' ' ' ARG . 31.0 mt -108.82 -24.2 11.39 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.531 179.568 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 4' ' ' ARG . 27.6 tt0 -89.5 -5.41 57.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.057 0.456 . . . . 0.0 110.008 179.905 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -67.57 -51.27 52.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.644 179.987 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.437 ' C ' ' H ' ' A' ' 11' ' ' LYS . 10.5 tt -167.32 -44.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.666 -179.9 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . 75.9 -39.85 1.38 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.159 179.981 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.486 ' C ' ' H ' ' A' ' 13' ' ' GLY . 86.4 mttt -79.77 81.14 6.08 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.768 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.38 15.34 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.8 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 65.45 19.25 66.49 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.616 -179.623 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.48 ' C ' ' H ' ' A' ' 16' ' ' ILE . 65.4 m-85 -147.18 -52.82 0.21 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.767 0.317 . . . . 0.0 110.207 179.879 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.3 pt -80.18 32.54 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 121.045 0.45 . . . . 0.0 110.53 179.815 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 14' ' ' PHE . 4.2 tp -148.97 -44.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.429 -179.787 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.45 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 2.2 pp -71.3 1.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.294 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -163.89 -40.69 0.02 OUTLIER Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.946 -179.899 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -73.27 -29.14 64.75 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.92 179.989 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.18 8.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.653 0.263 . . . . 0.0 110.908 179.978 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 23' ' ' HIS . 8.3 tp 49.66 -115.26 0.79 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.299 179.933 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 57.05 -79.72 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.746 0.308 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 21' ' ' LEU . 14.8 p-80 -156.78 -1.66 0.12 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.623 -179.969 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.399 179.756 . . . . . . . . 0 0 . 1 . 055 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 055 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.2 mttp 50.86 -142.57 0.68 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.575 0.226 . . . . 0.0 110.745 179.958 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 51.64 69.66 1.09 Allowed Glycine 1 CA--C 1.383 -8.211 0 CA-C-O 126.312 3.173 . . . . 0.0 112.576 -178.117 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.593 ' O ' ' N ' ' A' ' 7' ' ' GLU . 20.8 mtp180 157.15 -10.87 0.0 OUTLIER 'General case' 1 N--CA 1.315 -7.175 1 CA-C-N 100.771 -7.714 . . . . 0.0 110.646 160.469 . . . . . . . . 4 3 . 1 . 055 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -40.79 -23.71 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.112 -179.397 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 4' ' ' ARG . 10.5 mp -97.67 -26.04 14.9 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.444 179.558 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.3 tp10 -119.53 35.4 4.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.075 0.464 . . . . 0.0 109.906 179.9 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.523 ' NH2' ' CZ ' ' A' ' 4' ' ' ARG . 6.8 tpm_? -80.6 88.56 5.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.216 179.994 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.407 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 17.4 tt -53.8 -45.06 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.479 -179.921 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . 71.01 -70.56 0.77 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.276 179.747 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' A' ' 13' ' ' GLY . 51.6 mttp -51.79 108.15 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 110.605 -179.738 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.35 37.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.351 179.683 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 70.04 72.52 0.86 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.98 -179.832 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 51.4 t80 52.36 28.62 5.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.766 0.317 . . . . 0.0 110.459 179.979 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.5 mt 61.19 62.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.651 0.739 . . . . 0.0 109.77 -179.737 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -130.92 -50.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.046 -179.674 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.505 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.4 mp -66.29 -45.56 89.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.989 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.49 -41.08 10.27 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.721 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -58.86 -39.73 94.29 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.969 179.477 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.38 37.74 0.13 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.814 0.34 . . . . 0.0 110.744 -179.778 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 19' ' ' GLY . 16.7 tp -70.67 110.53 5.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.132 179.819 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.1 t0 55.76 39.18 30.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.559 -179.908 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 60.5 t60 52.09 50.03 19.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.519 179.983 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.945 179.955 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 056 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.442 ' CG ' ' H ' ' A' ' 3' ' ' GLY . 0.7 OUTLIER -62.48 -145.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -179.994 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.442 ' H ' ' CG ' ' A' ' 2' ' ' LYS . . . 43.62 69.44 0.67 Allowed Glycine 1 CA--C 1.383 -8.158 0 CA-C-O 126.088 3.049 . . . . 0.0 113.029 -178.359 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 7' ' ' GLU . 28.0 mtt180 157.89 -11.72 0.0 OUTLIER 'General case' 1 N--CA 1.316 -7.164 1 CA-C-N 100.9 -7.65 . . . . 0.0 110.846 160.507 . . . . . . . . 4 3 . 1 . 056 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -44.1 -21.17 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.78 -179.647 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.492 ' N ' ' C ' ' A' ' 4' ' ' ARG . 26.7 mt -97.34 -23.86 15.92 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.536 179.663 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.3 tt0 -66.67 -18.5 65.41 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.234 179.869 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -81.9 47.68 1.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.261 179.734 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -50.0 120.86 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 110.48 -179.685 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.38 39.82 0.46 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.718 -179.842 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -50.64 -33.4 22.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.612 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.96 -15.93 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.383 179.932 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' O ' ' CG ' ' A' ' 14' ' ' PHE . . . 69.33 31.1 71.33 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.616 -179.788 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.404 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 67.0 m-85 -155.91 -10.3 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.703 0.287 . . . . 0.0 110.269 179.983 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.0 pt -153.98 42.37 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.096 0.474 . . . . 0.0 110.476 179.644 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 10.4 tp -147.94 -43.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.792 179.782 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.425 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 3.4 tp -77.44 -37.98 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.696 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.57 -39.79 6.58 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.166 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.02 -38.24 95.75 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 179.682 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.0 -73.42 0.05 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 tt 63.59 87.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 109.984 179.797 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 23' ' ' HIS . 30.0 p-10 -168.78 -120.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.023 -179.75 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.471 ' H ' ' CG ' ' A' ' 22' ' ' ASP . 17.1 m170 -67.92 -12.56 60.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.0 0.429 . . . . 0.0 109.879 179.451 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.6 mt . . . . . 0 C--O 1.232 0.181 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.331 179.858 . . . . . . . . 0 0 . 1 . 057 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 057 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -69.9 -173.77 0.68 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.85 0.357 . . . . 0.0 110.539 179.978 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 115.69 -59.18 0.44 Allowed Glycine 1 CA--C 1.356 -9.877 0 CA-C-O 123.875 1.82 . . . . 0.0 115.129 -179.964 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' GLU . 38.1 mtt85 -60.14 -11.35 5.9 Favored 'General case' 1 N--CA 1.326 -6.673 1 CA-C-N 105.214 -5.493 . . . . 0.0 112.085 -157.531 . . . . . . . . 4 3 . 1 . 057 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.499 ' H ' ' C ' ' A' ' 3' ' ' GLY . 68.9 t-105 -43.09 -19.81 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.223 179.858 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 mt -108.11 -21.51 12.77 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.93 179.932 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.4 tp10 -72.55 -9.41 58.55 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.116 -179.828 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -54.9 122.35 10.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.505 -179.983 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.36 -2.42 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.725 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.91 71.61 1.91 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.227 -179.898 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -51.82 -31.17 26.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.022 0.439 . . . . 0.0 109.892 179.523 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.433 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -164.99 -2.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.336 179.931 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.433 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 49.17 32.29 12.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.838 -179.924 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -145.84 -10.35 0.52 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 110.232 -179.969 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 pt -156.94 36.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.018 179.4 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.0 tp -150.67 -21.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.943 -179.79 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 pp -88.81 4.41 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.836 179.347 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.93 -36.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.82 -179.944 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.19 -5.1 75.43 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.901 179.852 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -67.54 -56.52 9.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 0.0 110.47 -179.94 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 23' ' ' HIS . 5.0 tp 64.27 -0.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.447 179.965 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' ALA . 34.6 t70 -77.6 30.81 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.628 -179.94 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.486 ' H ' ' C ' ' A' ' 21' ' ' LEU . 66.3 m80 51.45 65.69 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.465 179.966 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 tt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.144 -179.973 . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -165.18 -138.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.933 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.436 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 43.31 70.53 0.52 Allowed Glycine 1 CA--C 1.385 -8.087 0 CA-C-O 126.22 3.122 . . . . 0.0 113.138 -178.588 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 7' ' ' GLU . 19.8 mtt180 157.47 -10.54 0.0 OUTLIER 'General case' 1 N--CA 1.315 -7.212 1 CA-C-N 100.835 -7.682 . . . . 0.0 110.455 160.671 . . . . . . . . 4 3 . 1 . 058 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -40.97 -22.59 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.296 -179.616 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -97.47 -26.64 14.76 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.364 179.873 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.9 tp10 -67.21 -32.01 72.78 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.176 179.748 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -53.12 -70.13 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 -179.973 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.2 tt -66.12 -39.97 85.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.355 -179.888 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.26 60.19 4.75 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.315 179.847 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -170.89 74.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.772 0.32 . . . . 0.0 110.473 179.925 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.95 65.12 5.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.007 179.855 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.02 53.09 19.93 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -179.576 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 60.68 38.67 18.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.898 0.38 . . . . 0.0 110.258 -179.519 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 mt 60.92 69.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.374 -179.862 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 9.9 tp -139.2 -50.51 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.91 179.688 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.456 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 4.1 tp -79.27 -27.39 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.73 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.0 -50.89 3.54 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 178.97 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.39 -42.23 99.72 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.075 179.635 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.89 -52.23 58.32 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.447 -179.945 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 23' ' ' HIS . 12.2 tp -60.57 -34.03 73.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.362 179.993 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -76.86 35.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.621 -179.872 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.494 ' H ' ' C ' ' A' ' 21' ' ' LEU . 16.9 m80 49.97 44.95 25.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.543 179.892 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.347 -179.872 . . . . . . . . 0 0 . 1 . 059 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.027 -0.429 . . . . 0.0 112.027 . . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -78.54 28.12 0.2 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.762 0.315 . . . . 0.0 110.631 -179.967 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -51.16 -57.89 10.6 Favored Glycine 1 CA--C 1.356 -9.881 0 CA-C-O 123.629 1.683 . . . . 0.0 115.403 179.997 . . . . . . . . 3 3 . 1 . 059 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 46.3 mtt85 -60.67 -10.31 5.12 Favored 'General case' 1 N--CA 1.324 -6.755 1 CA-C-N 105.362 -5.419 . . . . 0.0 111.97 -157.555 . . . . . . . . 4 3 . 1 . 059 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.526 ' H ' ' C ' ' A' ' 3' ' ' GLY . 71.6 t-105 -41.14 -20.32 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.111 -1.859 . . . . 0.0 110.394 -179.874 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.6 tp -111.27 -23.21 10.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.315 179.528 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 14.9 mm-40 -92.77 -1.65 56.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.838 0.351 . . . . 0.0 110.534 179.998 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.456 ' CG ' ' H ' ' A' ' 9' ' ' ILE . 14.8 tpp180 -82.5 -133.46 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.291 -179.912 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 11' ' ' LYS . 18.8 tt -167.94 -21.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.482 -179.986 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.24 86.8 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.008 -179.948 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 9' ' ' ILE . 63.1 mttm -153.32 0.9 0.26 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.992 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 54.81 62.07 2.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.54 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.38 90.8 0.01 OUTLIER Glycine 0 C--N 1.333 0.382 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 -179.92 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.5 ' N ' ' O ' ' A' ' 12' ' ' ALA . 78.1 m-85 55.35 47.04 22.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.926 0.394 . . . . 0.0 110.089 -179.326 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 60.61 77.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.513 -179.966 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.408 ' CG2' ' H ' ' A' ' 17' ' ' ILE . 6.2 tp -142.91 -56.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.709 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.408 ' H ' ' CG2' ' A' ' 16' ' ' ILE . 1.2 mp -77.81 -33.2 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.637 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.95 -48.67 9.62 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 178.361 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.76 -45.99 91.08 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.76 179.161 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.8 -72.63 0.05 OUTLIER 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.414 -179.934 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.6 tp 52.43 94.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.287 179.981 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -157.92 -28.44 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.326 179.99 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -168.0 -27.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 -179.958 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 8.0 mp . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.208 179.926 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 060 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -165.22 -153.35 0.19 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 121.066 -0.254 . . . . 0.0 110.555 179.969 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 57.33 71.68 0.71 Allowed Glycine 1 CA--C 1.384 -8.126 0 CA-C-O 126.549 3.305 . . . . 0.0 111.835 -177.705 . . . . . . . . 3 3 . 1 . 060 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 7' ' ' GLU . 2.9 mtp85 154.91 -10.77 0.0 OUTLIER 'General case' 1 N--CA 1.311 -7.381 1 CA-C-N 100.354 -7.923 . . . . 0.0 109.984 161.484 . . . . . . . . 4 3 . 1 . 060 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.42 ' CZ2' ' NH2' ' A' ' 8' ' ' ARG . 74.2 t-105 -42.77 -23.17 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.795 179.996 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.475 ' N ' ' C ' ' A' ' 4' ' ' ARG . 28.8 mt -92.85 -27.68 16.98 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.748 179.902 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.573 ' N ' ' O ' ' A' ' 4' ' ' ARG . 71.5 mt-10 -79.78 10.87 3.62 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.606 179.965 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.42 ' NH2' ' CZ2' ' A' ' 5' ' ' TRP . 54.8 ttp180 -77.92 85.52 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.555 -179.978 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.405 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 16.7 tt -73.86 -42.82 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.383 179.913 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . 60.73 53.05 48.54 Favored Glycine 0 N--CA 1.453 -0.204 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.365 179.744 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -171.13 67.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 0.0 110.644 179.771 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.79 45.07 0.78 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.439 179.944 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.87 67.38 2.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.131 -0.556 . . . . 0.0 111.895 -179.977 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 52.6 t80 52.37 31.19 9.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.766 0.317 . . . . 0.0 110.555 -179.988 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 61.7 64.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.547 0.689 . . . . 0.0 110.263 -179.819 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.2 mm -131.8 -48.96 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.651 179.912 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.505 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.4 mp -69.55 -47.29 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.633 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.78 -42.3 21.32 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 178.978 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.43 -48.31 86.6 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.866 179.537 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.88 -47.45 71.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.732 0.301 . . . . 0.0 110.503 -179.863 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.4 36.53 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.893 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -81.17 -86.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.631 -179.712 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.429 ' CD2' ' H ' ' A' ' 23' ' ' HIS . 12.1 p80 -73.8 -27.0 60.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.626 -179.933 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.121 179.999 . . . . . . . . 0 0 . 1 . 061 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 061 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.407 ' CB ' ' NZ ' ' A' ' 2' ' ' LYS . 9.0 mtmp? -79.61 53.0 1.5 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.786 0.327 . . . . 0.0 110.705 179.965 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -55.06 -58.4 13.9 Favored Glycine 1 CA--C 1.356 -9.874 0 CA-C-O 123.701 1.723 . . . . 0.0 115.417 -179.97 . . . . . . . . 3 3 . 1 . 061 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 6' ' ' LEU . 93.9 mtt180 -60.25 -11.48 6.48 Favored 'General case' 1 N--CA 1.325 -6.698 1 CA-C-N 105.318 -5.441 . . . . 0.0 111.965 -157.439 . . . . . . . . 4 3 . 1 . 061 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.498 ' H ' ' C ' ' A' ' 3' ' ' GLY . 19.4 t90 -42.71 -18.46 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.291 -179.95 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.8 mt -118.01 -16.89 9.8 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.632 179.31 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 19.4 mm-40 -88.65 -1.14 57.91 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 120.887 0.375 . . . . 0.0 110.402 179.971 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 55.81 106.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 179.859 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 tp -114.2 87.68 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 121.526 0.679 . . . . 0.0 110.024 179.946 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.9 -1.82 60.04 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.781 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.461 ' C ' ' H ' ' A' ' 13' ' ' GLY . 18.9 pttm 33.86 35.68 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.4 -0.4 . . . . 0.0 111.93 179.889 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.72 32.94 0.36 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.039 179.483 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 76.23 60.46 3.07 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.769 -179.755 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.492 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 66.9 t80 55.53 33.77 21.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.954 0.406 . . . . 0.0 110.191 -179.786 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.2 mm 61.85 66.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.509 0.671 . . . . 0.0 110.15 -179.802 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 mm -133.77 -51.09 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.715 179.624 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.474 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -68.18 -46.28 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.577 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.26 -48.11 8.52 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.429 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.38 -43.77 98.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.606 179.573 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.77 9.19 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.737 0.303 . . . . 0.0 110.92 179.761 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 23' ' ' HIS . 8.0 mp 53.85 -97.78 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.807 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 72.1 m-20 50.24 -87.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.676 179.79 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 21' ' ' LEU . 75.4 m80 -156.44 11.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.509 179.922 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 N--CA 1.465 0.279 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.355 179.958 . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -56.91 -106.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.559 0.219 . . . . 0.0 110.413 -179.959 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 93.4 -59.84 2.23 Favored Glycine 1 CA--C 1.355 -9.934 0 CA-C-O 123.677 1.71 . . . . 0.0 115.371 179.937 . . . . . . . . 3 3 . 1 . 062 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 7' ' ' GLU . 79.0 mtt180 -60.52 -10.37 4.95 Favored 'General case' 1 N--CA 1.325 -6.698 1 CA-C-N 105.434 -5.383 . . . . 0.0 112.048 -157.588 . . . . . . . . 4 3 . 1 . 062 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.524 ' H ' ' C ' ' A' ' 3' ' ' GLY . 85.1 t90 -39.62 -21.63 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.521 179.936 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 10.8 tp -107.83 -26.99 10.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.455 179.347 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' ARG . 90.3 mt-10 -100.44 22.33 11.84 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.806 0.336 . . . . 0.0 110.29 179.79 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -53.29 -57.17 11.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.654 -179.809 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.509 ' C ' ' H ' ' A' ' 11' ' ' LYS . 14.0 pt -71.29 -35.2 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.666 -179.862 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.7 -19.19 1.21 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.07 -179.953 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 9' ' ' ILE . 41.9 mtmt -73.99 95.16 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.567 -179.978 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.96 -6.46 0.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.315 179.829 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 60.53 15.73 41.04 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.772 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -164.67 -39.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.942 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.5 mt -111.24 57.48 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.709 179.38 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 9.1 tp -151.78 -45.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.485 -0.78 . . . . 0.0 108.911 -179.988 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.409 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 1.1 pp -91.17 4.98 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.749 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.14 -57.03 0.06 OUTLIER Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.631 -179.761 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.5 -46.07 94.53 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.702 179.895 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.99 44.98 28.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 110.691 179.922 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.7 mm? -63.15 103.09 0.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.926 179.766 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 35.3 t70 56.26 56.17 6.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 -179.849 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 19.8 p-80 40.82 39.5 0.81 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.349 -179.935 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.9 tp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.256 179.826 . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.21 -172.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.826 0.346 . . . . 0.0 110.509 -179.968 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 127.09 -58.81 0.69 Allowed Glycine 1 CA--C 1.357 -9.794 0 CA-C-O 123.778 1.766 . . . . 0.0 115.111 -179.984 . . . . . . . . 3 3 . 1 . 063 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 6' ' ' LEU . 95.7 mtt180 -60.33 -10.74 5.1 Favored 'General case' 1 N--CA 1.324 -6.746 1 CA-C-N 105.222 -5.489 . . . . 0.0 112.066 -157.591 . . . . . . . . 4 3 . 1 . 063 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.526 ' H ' ' C ' ' A' ' 3' ' ' GLY . 77.4 t-105 -40.26 -19.85 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.66 -179.985 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.5 mt -120.37 -15.46 8.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.013 179.499 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.6 mm-40 -87.95 -7.04 57.68 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.645 -179.91 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -68.92 88.93 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.254 179.774 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.4 pt -60.22 -34.71 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.962 -179.627 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.38 17.51 1.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.696 -179.671 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -70.25 -5.16 25.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.888 -0.156 . . . . 0.0 110.827 -179.779 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.99 52.02 9.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.64 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.49 87.45 0.01 OUTLIER Glycine 0 C--N 1.335 0.498 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.868 -179.337 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 12' ' ' ALA . 89.4 m-85 52.74 41.75 31.6 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.074 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 mm 61.16 77.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.183 -179.416 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.515 ' CG2' ' H ' ' A' ' 17' ' ' ILE . 6.6 tp -140.37 -59.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.883 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.515 ' H ' ' CG2' ' A' ' 16' ' ' ILE . 3.7 tp -74.98 -31.02 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.011 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.02 -48.13 5.27 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 179.011 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.7 -44.84 96.92 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.037 -0.602 . . . . 0.0 111.706 179.612 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.44 -65.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.402 179.875 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.7 79.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.866 179.953 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -159.77 33.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.483 -179.791 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.42 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 33.8 t-80 55.18 22.91 4.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.659 179.948 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 tp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.209 179.972 . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' CG ' ' H ' ' A' ' 3' ' ' GLY . 60.7 tttt -168.88 -135.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.938 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 42.01 68.91 0.63 Allowed Glycine 1 CA--C 1.382 -8.26 0 CA-C-O 125.453 2.696 . . . . 0.0 114.003 -179.095 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.546 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 3.6 mmt180 163.14 -12.13 0.0 OUTLIER 'General case' 1 N--CA 1.318 -7.044 1 CA-C-N 101.362 -7.419 . . . . 0.0 110.428 159.443 . . . . . . . . 4 3 . 1 . 064 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -44.19 -18.67 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.961 -179.63 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.497 ' N ' ' C ' ' A' ' 4' ' ' ARG . 9.3 mp -109.74 -19.28 13.22 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.067 179.235 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 4' ' ' ARG . 15.1 mp0 -112.27 12.88 20.36 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 120.71 0.29 . . . . 0.0 110.328 -179.89 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 4' ' ' ARG . 61.0 ttp180 -52.32 123.67 11.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.378 179.795 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 tp -54.79 92.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.344 0.593 . . . . 0.0 110.16 -179.883 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.12 -30.83 10.44 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.787 -179.974 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' C ' ' H ' ' A' ' 13' ' ' GLY . 27.7 mmtp -60.37 104.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.07 179.851 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.88 -4.01 4.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.691 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 45.71 34.19 5.16 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.139 179.722 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -170.2 -17.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.9 pt -155.55 55.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.13 0.491 . . . . 0.0 110.361 179.787 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.434 ' C ' ' H ' ' A' ' 18' ' ' GLY . 10.4 tp -144.16 -42.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.061 179.792 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.428 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 1.0 OUTLIER -71.87 4.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.901 179.676 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -175.89 -22.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.033 179.999 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.47 -31.84 79.97 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.991 179.993 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.38 -59.35 2.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.766 0.317 . . . . 0.0 110.567 -179.978 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tp 54.98 37.62 29.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.351 -179.943 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.61 -33.28 58.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.602 179.992 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -164.66 6.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.437 -179.98 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.161 179.989 . . . . . . . . 0 0 . 1 . 065 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 065 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -73.86 -171.07 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.545 -179.956 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.504 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 106.23 -60.23 0.38 Allowed Glycine 1 CA--C 1.356 -9.851 0 CA-C-O 123.678 1.71 . . . . 0.0 115.141 -179.95 . . . . . . . . 3 3 . 1 . 065 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 6' ' ' LEU . 48.5 mtp180 -60.18 -11.23 5.7 Favored 'General case' 1 N--CA 1.324 -6.752 1 CA-C-N 105.358 -5.421 . . . . 0.0 111.988 -157.588 . . . . . . . . 4 3 . 1 . 065 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.504 ' N ' ' C ' ' A' ' 3' ' ' GLY . 30.7 t-105 -42.78 -17.59 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 112.828 -1.987 . . . . 0.0 110.393 179.904 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 4' ' ' ARG . 30.4 mt -121.28 -14.38 8.33 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.933 179.621 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.2 tt0 -82.64 0.05 44.9 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.181 -179.974 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -50.26 163.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 180.0 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.6 pt -54.0 -43.03 57.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.458 -179.922 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.83 -48.59 2.35 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.771 179.39 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.548 ' CB ' ' HZ2' ' A' ' 11' ' ' LYS . 9.5 mtpm? -75.44 -75.52 0.17 Allowed 'General case' 0 C--N 1.331 -0.217 0 O-C-N 122.741 -0.27 . . . . 0.0 110.817 -179.572 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 66.81 30.7 7.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.525 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -36.54 -39.82 0.39 Allowed Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.782 179.537 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.487 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 74.0 t80 179.78 54.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.296 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 pt 38.95 53.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.005 -177.816 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -113.83 -47.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.075 -178.847 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.462 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 1.0 OUTLIER -78.31 6.5 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.176 . . . . . . . . 3 3 . 1 . 065 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.97 -50.99 0.04 OUTLIER Glycine 0 C--N 1.333 0.406 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.935 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.33 -44.72 84.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.712 179.618 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.48 10.41 4.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.8 0.333 . . . . 0.0 110.41 179.913 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' HIS . 19.5 tp 53.35 101.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.092 -179.995 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 56.75 -79.8 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 21' ' ' LEU . 34.0 t-80 -162.25 29.16 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 110.396 179.901 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.203 179.977 . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.211 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 . . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -70.14 -147.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.627 0.251 . . . . 0.0 110.643 179.991 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.421 ' O ' ' CB ' ' A' ' 4' ' ' ARG . . . 52.38 69.77 1.09 Allowed Glycine 1 CA--C 1.38 -8.364 0 CA-C-O 126.039 3.022 . . . . 0.0 112.913 -178.421 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' GLU . 22.0 mtt180 160.79 -12.3 0.0 OUTLIER 'General case' 1 N--CA 1.319 -7.02 1 CA-C-N 101.192 -7.504 . . . . 0.0 110.966 159.966 . . . . . . . . 4 3 . 1 . 066 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 33.9 t90 -43.99 -18.3 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.723 -179.981 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' A' ' 4' ' ' ARG . 44.0 mt -113.25 -15.9 12.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.646 179.091 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.5 mt-10 -116.03 15.08 16.16 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.772 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 ttm180 -76.85 126.28 30.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.474 179.885 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 tp -56.28 108.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.253 0.549 . . . . 0.0 109.962 179.852 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.54 38.96 0.48 Allowed Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.865 -179.871 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.14 -26.74 63.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.38 . . . . 0.0 110.316 179.846 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.96 31.36 0.21 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.158 179.9 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.62 53.76 11.67 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.967 -179.945 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 61.03 33.43 19.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.725 0.297 . . . . 0.0 110.323 -179.979 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 mt 63.24 64.96 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.576 0.703 . . . . 0.0 110.226 -179.74 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -133.01 -50.41 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.776 179.755 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.494 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -70.46 -43.6 77.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.733 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.25 -48.17 9.9 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.092 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.503 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -63.49 -52.28 47.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.636 179.45 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.472 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 58.25 4.5 0.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.717 0.294 . . . . 0.0 110.931 179.749 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 19' ' ' GLY . 8.2 mp 50.66 13.47 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.357 179.883 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.472 ' H ' ' C ' ' A' ' 20' ' ' ALA . 72.8 m-20 -75.69 37.01 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.615 -179.936 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.5 ' H ' ' C ' ' A' ' 21' ' ' LEU . 6.4 t60 49.91 37.71 14.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 110.555 179.985 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.9 tp . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.101 -179.903 . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -67.26 -120.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.709 -179.884 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.421 ' O ' ' CB ' ' A' ' 4' ' ' ARG . . . 48.12 69.07 1.02 Allowed Glycine 1 CA--C 1.383 -8.199 0 CA-C-O 126.167 3.093 . . . . 0.0 112.993 -178.4 . . . . . . . . 3 3 . 1 . 067 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' C ' ' H ' ' A' ' 6' ' ' LEU . 5.5 mtp85 159.21 -11.81 0.0 OUTLIER 'General case' 1 N--CA 1.317 -7.112 1 CA-C-N 101.014 -7.593 . . . . 0.0 110.629 160.194 . . . . . . . . 4 3 . 1 . 067 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -43.55 -17.91 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.933 -179.84 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -118.34 -12.82 9.85 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.104 179.133 . . . . . . . . 3 3 . 1 . 067 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 45.2 mm-40 -122.18 29.41 7.03 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-O 120.784 0.326 . . . . 0.0 110.319 179.877 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.6 ttp85 -72.42 89.01 1.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.387 179.908 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 tp -55.64 101.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.167 0.508 . . . . 0.0 110.288 -179.98 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.0 -35.33 12.77 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.921 -179.888 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' GLY . 66.2 mttm -69.39 82.75 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 0.0 110.469 -179.849 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.455 ' O ' ' CD2' ' A' ' 14' ' ' PHE . . . -55.73 -7.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.032 179.46 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 62.72 52.2 50.29 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.971 -179.967 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.455 ' CD2' ' O ' ' A' ' 12' ' ' ALA . 65.4 m-85 -156.53 -61.88 0.1 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.698 0.285 . . . . 0.0 110.668 179.813 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 pt -155.76 57.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.305 0.574 . . . . 0.0 110.457 -179.906 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.4 -69.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.235 179.665 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -73.62 -35.68 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.349 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.71 -47.04 10.34 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 179.46 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -74.22 -44.55 28.37 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.108 -0.567 . . . . 0.0 111.872 179.714 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.88 6.3 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.668 0.27 . . . . 0.0 110.918 179.844 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.1 mt 45.86 70.96 0.32 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -158.99 53.85 0.41 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.435 179.901 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.479 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 12.7 t60 52.2 23.89 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.396 -179.913 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.377 179.959 . . . . . . . . 0 0 . 1 . 068 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.614 ' H3 ' ' NH1' ' A' ' 4' ' ' ARG . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 . . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -70.26 155.88 40.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.732 0.301 . . . . 0.0 110.355 179.997 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 129.0 -56.62 0.74 Allowed Glycine 1 CA--C 1.354 -9.97 0 CA-C-O 123.899 1.833 . . . . 0.0 114.846 -179.543 . . . . . . . . 3 3 . 1 . 068 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.614 ' NH1' ' H3 ' ' A' ' 1' ' ' GLY . 56.5 mtt85 -60.81 -9.57 4.28 Favored 'General case' 1 N--CA 1.325 -6.712 1 CA-C-N 105.044 -5.578 . . . . 0.0 111.92 -157.606 . . . . . . . . 4 3 . 1 . 068 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.524 ' H ' ' C ' ' A' ' 3' ' ' GLY . 36.5 t90 -40.98 -20.78 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 112.995 -1.911 . . . . 0.0 110.594 179.988 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.3 tp -108.06 -22.96 12.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.725 179.956 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.2 tp10 -46.26 -43.79 15.89 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.892 -179.755 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -62.31 179.58 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.409 179.863 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.5 tt -49.49 -35.48 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.745 -179.923 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.51 64.1 3.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.9 179.979 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -168.44 74.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 110.479 -179.877 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.7 70.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.265 179.903 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.33 62.25 5.25 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.771 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 55.74 32.72 19.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.786 0.326 . . . . 0.0 110.523 -179.755 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 mm 60.6 66.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.405 0.622 . . . . 0.0 110.101 -179.902 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -133.41 -46.04 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.883 179.935 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.1 mm -75.34 -46.98 36.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.975 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.25 -50.41 7.55 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.454 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.22 -36.78 93.25 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.95 179.749 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 51.6 37.17 19.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.757 0.313 . . . . 0.0 110.62 179.99 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.0 mt -54.84 -12.76 0.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.407 179.916 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 20' ' ' ALA . 10.5 t0 -57.79 -76.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.356 179.951 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -84.42 -27.01 27.88 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.583 -179.998 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.9 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.435 -179.803 . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -63.3 -177.0 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.574 -179.956 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 115.2 -59.5 0.42 Allowed Glycine 1 CA--C 1.355 -9.94 0 CA-C-O 123.833 1.796 . . . . 0.0 114.92 -179.838 . . . . . . . . 3 3 . 1 . 069 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' GLU . 41.7 mtp180 -60.73 -10.14 4.97 Favored 'General case' 1 N--CA 1.323 -6.782 1 CA-C-N 105.222 -5.489 . . . . 0.0 111.984 -157.739 . . . . . . . . 4 3 . 1 . 069 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.512 ' H ' ' C ' ' A' ' 3' ' ' GLY . 30.4 t90 -41.0 -21.71 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.934 -1.939 . . . . 0.0 110.493 179.834 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' ARG . 47.9 tp -104.4 -25.04 12.98 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.712 -179.838 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.1 tm-20 -51.14 -35.28 34.9 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.351 -179.899 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -48.84 128.77 16.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.609 -180.0 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 13.6 tt -66.19 -51.77 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.547 -179.814 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . 42.04 76.64 0.1 OUTLIER Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.484 -0.389 . . . . 0.0 112.801 179.522 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -148.16 -9.61 0.38 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.565 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 55.63 62.18 2.53 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.38 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.3 86.84 0.01 OUTLIER Glycine 0 C--N 1.333 0.372 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.025 -179.598 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 12' ' ' ALA . 28.7 t80 64.98 44.35 3.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.814 0.34 . . . . 0.0 110.526 -179.618 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.2 mm 60.43 76.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.54 179.448 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 mm -135.86 -55.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.914 179.129 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 mm -69.9 -49.28 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.619 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.51 -43.75 35.92 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 178.833 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -59.09 -48.62 85.02 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.571 179.292 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.75 -14.6 0.96 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.0 110.224 179.745 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' HIS . 8.0 tp 58.3 112.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.192 179.966 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 57.5 -78.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.546 -179.728 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' LEU . 2.3 t60 -168.62 24.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.392 179.827 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.464 0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.461 179.902 . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -69.12 -168.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.508 -179.981 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 91.9 -59.41 2.82 Favored Glycine 1 CA--C 1.357 -9.799 0 CA-C-O 123.572 1.651 . . . . 0.0 115.495 179.778 . . . . . . . . 3 3 . 1 . 070 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.525 ' C ' ' H ' ' A' ' 6' ' ' LEU . 51.2 mtt85 -59.81 -11.93 6.34 Favored 'General case' 1 N--CA 1.325 -6.677 1 CA-C-N 105.569 -5.315 . . . . 0.0 112.051 -157.375 . . . . . . . . 4 3 . 1 . 070 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.499 ' H ' ' C ' ' A' ' 3' ' ' GLY . 99.0 m95 -44.66 -15.62 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.918 -1.946 . . . . 0.0 110.305 179.673 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.525 ' H ' ' C ' ' A' ' 4' ' ' ARG . 0.7 OUTLIER -129.9 -6.94 4.48 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.452 179.782 . . . . . . . . 3 3 . 1 . 070 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -84.2 -25.86 29.19 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.313 179.926 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -49.18 156.23 0.58 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.628 179.698 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.3 tp -168.5 126.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.196 179.829 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.61 20.81 0.05 OUTLIER Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.726 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -73.44 3.4 6.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.229 -0.188 . . . . 0.0 110.904 -179.768 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.33 36.92 28.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.81 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -34.24 88.86 0.01 OUTLIER Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.926 -179.561 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 12' ' ' ALA . 59.2 t80 56.9 57.4 4.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.063 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.1 pt 35.0 79.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.342 -179.012 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 9.2 tp -135.61 -51.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.076 179.665 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.445 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 3.5 tp -89.06 -36.12 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.003 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.62 -32.07 16.75 Favored Glycine 0 C--N 1.331 0.293 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 178.833 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.28 -47.17 13.41 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.505 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.72 -28.43 14.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.929 0.395 . . . . 0.0 110.265 179.658 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.5 tp 55.39 70.8 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.676 179.816 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 52.11 46.29 26.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.791 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 50.19 52.34 14.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.679 179.81 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.293 179.984 . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -59.81 -177.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 0.0 110.393 179.958 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 133.04 -57.07 0.72 Allowed Glycine 1 CA--C 1.356 -9.863 0 CA-C-O 123.653 1.696 . . . . 0.0 115.217 -179.838 . . . . . . . . 3 3 . 1 . 071 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 7' ' ' GLU . 54.7 mtt85 -60.72 -10.0 4.76 Favored 'General case' 1 N--CA 1.325 -6.7 1 CA-C-N 105.273 -5.464 . . . . 0.0 112.075 -157.552 . . . . . . . . 4 3 . 1 . 071 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.53 ' H ' ' C ' ' A' ' 3' ' ' GLY . 64.9 t-105 -41.39 -25.83 0.05 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.107 -1.861 . . . . 0.0 109.822 179.907 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.7 mm? -93.57 -30.46 14.97 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.336 179.682 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.0 tt0 -87.86 -5.4 58.61 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.959 0.409 . . . . 0.0 110.259 -179.799 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -66.68 -24.74 66.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.438 179.864 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.9 pt -50.33 -31.87 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.69 -179.853 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.07 66.05 3.05 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.682 -179.814 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.555 ' NZ ' ' CD1' ' A' ' 14' ' ' PHE . 20.9 tptp -158.29 83.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.874 0.369 . . . . 0.0 110.135 -179.881 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.32 63.25 4.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.353 -179.831 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 47.4 58.07 6.84 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -179.74 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.555 ' CD1' ' NZ ' ' A' ' 11' ' ' LYS . 43.5 m-85 59.2 38.01 23.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.563 0.22 . . . . 0.0 110.458 -179.512 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt 59.62 69.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.85 0.357 . . . . 0.0 110.196 -179.93 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.463 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 8.5 tp -139.08 -48.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.121 179.811 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.463 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 4.3 tp -80.7 -26.86 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.946 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.52 -57.63 1.95 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.145 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.01 84.58 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.499 179.246 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 54.7 15.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.613 0.244 . . . . 0.0 110.875 179.657 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.7 mt -66.21 4.17 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.758 0.313 . . . . 0.0 110.583 179.855 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 20' ' ' ALA . 30.0 t0 -66.93 -24.73 66.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.82 -179.825 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -169.39 -8.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.174 -179.767 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.2 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.236 -179.865 . . . . . . . . 0 0 . 1 . 072 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 072 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -64.6 175.98 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 110.536 179.945 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 129.01 -57.3 0.72 Allowed Glycine 1 CA--C 1.355 -9.939 0 CA-C-O 123.752 1.751 . . . . 0.0 115.005 -179.77 . . . . . . . . 3 3 . 1 . 072 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 7' ' ' GLU . 54.2 mtp180 -60.75 -9.99 4.79 Favored 'General case' 1 N--CA 1.325 -6.695 1 CA-C-N 105.168 -5.516 . . . . 0.0 112.033 -157.54 . . . . . . . . 4 3 . 1 . 072 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.53 ' H ' ' C ' ' A' ' 3' ' ' GLY . 27.3 t-105 -41.08 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.544 -179.906 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.8 tp -113.17 -22.13 10.66 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.36 179.457 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.9 mt-10 -101.95 13.01 35.99 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.655 0.264 . . . . 0.0 110.54 -179.994 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -75.03 -74.57 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.769 -179.93 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.497 ' C ' ' H ' ' A' ' 11' ' ' LYS . 15.7 tt -75.37 -25.02 17.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.752 -179.707 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . -52.45 -8.28 0.5 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.265 -179.821 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 9' ' ' ILE . 24.3 mtpp -76.96 22.95 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.861 -179.818 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 15' ' ' ILE . . . 57.29 40.24 27.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.218 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -34.47 89.01 0.01 OUTLIER Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.449 -179.508 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 12' ' ' ALA . 35.0 t80 66.65 53.78 0.89 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.748 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 12' ' ' ALA . 9.7 pt 37.86 82.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.759 -179.493 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.0 mm -132.93 -60.29 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.846 178.844 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.485 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -69.43 -55.47 15.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.779 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.64 -37.19 52.65 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.024 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.09 -51.46 55.03 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 179.569 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.5 -68.75 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.844 0.354 . . . . 0.0 110.314 179.898 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.0 tp 49.91 95.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.62 179.821 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -168.01 -31.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.53 179.996 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.409 ' H ' ' H ' ' A' ' 24' ' ' LEU . 73.0 t60 -171.49 -16.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.52 179.958 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.486 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 8.1 mp . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.195 179.958 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -59.91 179.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 110.577 -179.996 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 100.85 -59.72 0.66 Allowed Glycine 1 CA--C 1.356 -9.855 0 CA-C-O 123.735 1.742 . . . . 0.0 115.238 179.999 . . . . . . . . 3 3 . 1 . 073 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 49.2 mtp180 -60.32 -11.03 5.49 Favored 'General case' 1 N--CA 1.325 -6.718 1 CA-C-N 105.307 -5.447 . . . . 0.0 111.968 -157.494 . . . . . . . . 4 3 . 1 . 073 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.511 ' H ' ' C ' ' A' ' 3' ' ' GLY . 78.1 m95 -42.43 -18.82 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.93 -1.941 . . . . 0.0 110.446 179.959 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.6 mt -113.86 -18.64 11.74 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.908 179.884 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.9 tt0 -50.01 -20.44 0.95 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.651 -179.736 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -56.61 144.56 31.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.563 -179.872 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 11' ' ' LYS . 18.2 tt -68.42 -37.14 77.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.521 -179.946 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 80.23 -32.64 2.27 Favored Glycine 0 C--N 1.331 0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.071 179.843 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 9' ' ' ILE . 1.8 ttmp? -76.82 23.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.335 179.984 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 48.44 67.05 0.91 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.288 -179.517 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -40.48 86.41 0.01 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.52 -179.54 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 12' ' ' ALA . 17.6 m-85 63.14 53.29 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.683 0.278 . . . . 0.0 110.964 -179.699 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 mt 62.54 76.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.335 -0.059 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.591 179.217 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.5 mm -134.39 -64.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.872 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.7 mm -78.19 -32.87 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.35 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.475 ' H ' ' CB ' ' A' ' 12' ' ' ALA . . . -68.74 -53.74 18.43 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.519 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.35 -47.95 15.69 Favored Glycine 0 C--N 1.332 0.314 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.111 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.88 27.4 1.13 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.723 0.296 . . . . 0.0 110.917 179.783 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.4 tp -62.96 96.47 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.197 179.963 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 23.5 m-20 55.35 47.08 22.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.517 -179.834 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.501 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 50.0 p-80 41.2 52.62 3.52 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.17 -179.935 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.133 179.951 . . . . . . . . 0 0 . 1 . 074 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.056 -0.417 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 074 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -82.09 40.59 0.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.667 0.27 . . . . 0.0 110.638 -179.93 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -51.06 -58.86 8.86 Favored Glycine 1 CA--C 1.355 -9.944 0 CA-C-O 123.724 1.736 . . . . 0.0 115.14 179.977 . . . . . . . . 3 3 . 1 . 074 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 80.8 mtt180 -60.87 -10.31 5.44 Favored 'General case' 1 N--CA 1.323 -6.78 1 CA-C-N 105.29 -5.455 . . . . 0.0 111.911 -157.706 . . . . . . . . 4 3 . 1 . 074 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.52 ' H ' ' C ' ' A' ' 3' ' ' GLY . 28.5 t90 -41.9 -19.78 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.32 179.908 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.1 mt -108.71 -25.3 10.91 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.32 179.373 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.7 mt-10 -93.27 26.52 2.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -62.44 -144.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.444 -179.997 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.401 ' C ' ' N ' ' A' ' 11' ' ' LYS . 23.2 pt -50.14 -24.33 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.461 179.93 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.1 18.26 0.43 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.049 -179.965 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 9' ' ' ILE . 25.4 mmtp -133.73 44.84 2.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.728 0.299 . . . . 0.0 110.302 -179.892 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.72 52.91 1.52 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.569 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.69 30.64 72.81 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.348 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 70.57 69.38 0.2 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.47 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.1 pt 35.34 60.52 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.673 -179.72 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -138.48 -47.36 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.547 179.036 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.438 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 38.0 mm -73.82 -53.21 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.817 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.76 -29.43 59.36 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.425 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -72.06 -37.59 60.04 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.786 -0.526 . . . . 0.0 111.786 179.441 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.77 35.28 0.15 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.843 0.354 . . . . 0.0 110.395 179.796 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 19' ' ' GLY . 21.5 tp -55.44 119.32 5.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.184 -179.961 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 52.02 24.76 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.501 179.966 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 51.52 46.66 26.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.454 -179.953 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.203 -179.994 . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 . . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -62.76 -176.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.848 0.356 . . . . 0.0 110.591 -179.915 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 130.98 -59.11 0.7 Allowed Glycine 1 CA--C 1.355 -9.945 0 CA-C-O 123.86 1.811 . . . . 0.0 115.058 -179.923 . . . . . . . . 3 3 . 1 . 075 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 7' ' ' GLU . 68.0 mtp180 -60.69 -10.48 5.38 Favored 'General case' 1 N--CA 1.324 -6.765 1 CA-C-N 105.117 -5.542 . . . . 0.0 112.032 -157.751 . . . . . . . . 4 3 . 1 . 075 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.515 ' H ' ' C ' ' A' ' 3' ' ' GLY . 11.7 t-105 -42.55 -24.57 0.06 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.649 -179.966 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.455 ' N ' ' C ' ' A' ' 4' ' ' ARG . 10.4 mp -98.0 -27.94 14.01 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.196 179.389 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 4' ' ' ARG . 17.7 tt0 -87.85 38.43 0.84 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.036 0.446 . . . . 0.0 110.238 -179.873 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -64.15 -31.99 73.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 179.988 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -167.74 -32.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.381 179.935 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.05 87.23 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.238 179.701 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' C ' ' H ' ' A' ' 13' ' ' GLY . 39.5 tttm -168.72 -17.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.236 179.645 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 15' ' ' ILE . . . 71.72 -11.4 0.74 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.59 179.95 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 35.85 55.0 1.12 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 179.932 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 t80 68.32 40.31 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.568 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 12' ' ' ALA . 18.1 mt 63.65 79.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.749 -179.711 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 12' ' ' ALA . 4.4 tp -148.21 -19.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.186 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 29.0 mm -114.25 -38.21 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.598 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.96 -53.98 5.05 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.245 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.55 -28.99 37.36 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 179.627 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.483 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 49.84 19.53 0.45 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.88 0.372 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' C ' ' H ' ' A' ' 23' ' ' HIS . 16.3 mt 57.7 6.23 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.475 -179.886 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 20' ' ' ALA . 88.9 m-20 -80.83 19.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.471 179.957 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.409 ' H ' ' C ' ' A' ' 21' ' ' LEU . 16.7 m80 54.0 44.05 29.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.478 -179.845 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.132 -179.955 . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -169.7 169.47 8.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.31 . . . . 0.0 110.464 179.947 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 131.1 -57.44 0.72 Allowed Glycine 1 CA--C 1.355 -9.928 0 CA-C-O 123.825 1.792 . . . . 0.0 115.044 -179.7 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 6' ' ' LEU . 78.9 mtp180 -60.31 -10.62 4.93 Favored 'General case' 1 N--CA 1.325 -6.703 1 CA-C-N 105.145 -5.528 . . . . 0.0 111.981 -157.582 . . . . . . . . 4 3 . 1 . 076 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.517 ' H ' ' C ' ' A' ' 3' ' ' GLY . 27.8 t90 -42.62 -18.53 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 112.93 -1.941 . . . . 0.0 110.371 179.847 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.504 ' H ' ' C ' ' A' ' 4' ' ' ARG . 34.4 mt -114.62 -18.01 11.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.96 179.597 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.3 tt0 -47.22 -34.02 6.01 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.705 -179.816 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 50.59 85.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 179.935 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -46.58 -21.37 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.918 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 34.61 28.37 0.01 OUTLIER Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.483 179.209 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 9' ' ' ILE . 21.0 tptp -51.5 -30.73 21.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.084 179.726 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.6 -42.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.152 179.897 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.79 -44.87 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.785 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 64.2 t80 -173.93 33.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.615 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.2 mt 64.88 58.63 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 121.811 0.815 . . . . 0.0 109.461 -178.765 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.3 mm -119.49 -56.08 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.328 -179.784 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 35.1 mm -73.98 -50.31 29.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.771 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.85 -49.98 72.64 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.034 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.76 -53.33 31.71 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.227 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.63 35.79 12.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.559 0.219 . . . . 0.0 110.895 179.607 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.2 mt -73.83 84.64 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.197 179.816 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 51.38 59.15 4.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.472 -179.91 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 33.9 m170 53.55 55.81 8.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.542 -179.863 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 tt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.075 -179.897 . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -60.71 -171.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 110.633 179.955 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 124.83 -59.36 0.64 Allowed Glycine 1 CA--C 1.355 -9.945 0 CA-C-O 123.781 1.767 . . . . 0.0 115.208 180.0 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 6' ' ' LEU . 44.7 mtt85 -60.66 -10.39 5.22 Favored 'General case' 1 N--CA 1.324 -6.748 1 CA-C-N 105.259 -5.471 . . . . 0.0 111.954 -157.665 . . . . . . . . 4 3 . 1 . 077 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.526 ' H ' ' C ' ' A' ' 3' ' ' GLY . 42.3 t-105 -41.14 -19.98 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.443 -179.972 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 8.1 tp -115.79 -20.28 10.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.294 179.323 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 52.3 mt-10 -91.72 21.33 4.84 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.744 0.307 . . . . 0.0 110.636 179.977 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -50.81 -32.79 21.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.513 179.896 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 pt -47.66 119.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.411 0.624 . . . . 0.0 110.638 -179.625 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.03 -6.95 61.46 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.899 -179.87 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' C ' ' H ' ' A' ' 13' ' ' GLY . 9.5 mtmp? -60.69 98.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.0 110.475 179.976 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -54.89 -8.28 0.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.296 179.625 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 61.05 4.36 4.47 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.641 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -82.8 -70.98 0.51 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.973 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 pt -158.85 46.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.139 0.495 . . . . 0.0 110.145 179.1 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -80.37 -67.82 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.99 179.374 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.07 1.31 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.035 179.743 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.53 -67.8 0.81 Allowed Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.796 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -81.46 -37.96 15.97 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.632 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.95 11.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.741 179.898 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.489 ' H ' ' C ' ' A' ' 19' ' ' GLY . 33.3 mt 48.58 77.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.751 179.821 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 8.9 p-10 -174.82 23.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.102 179.735 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.406 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 76.0 t60 57.12 32.26 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.652 -179.859 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.08 179.933 . . . . . . . . 0 0 . 1 . 078 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 078 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -53.47 -173.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.756 0.313 . . . . 0.0 110.652 179.972 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.511 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 110.25 -59.34 0.36 Allowed Glycine 1 CA--C 1.356 -9.905 0 CA-C-O 123.724 1.736 . . . . 0.0 115.268 -179.942 . . . . . . . . 3 3 . 1 . 078 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 68.2 mtt85 -60.41 -10.84 5.38 Favored 'General case' 1 N--CA 1.325 -6.716 1 CA-C-N 105.316 -5.442 . . . . 0.0 111.994 -157.605 . . . . . . . . 4 3 . 1 . 078 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.511 ' N ' ' C ' ' A' ' 3' ' ' GLY . 76.9 t-105 -42.08 -18.88 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.992 -1.913 . . . . 0.0 110.43 -179.988 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.2 mp -112.82 -21.72 11.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.536 179.215 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.1 tt0 -91.4 -5.68 54.04 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.06 0.457 . . . . 0.0 110.317 -179.832 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -71.95 148.59 45.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.62 179.859 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 tp -52.71 97.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.206 0.526 . . . . 0.0 110.129 179.878 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.99 30.2 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.793 -179.809 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -49.69 -18.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.69 -179.961 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.409 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -161.57 -10.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.158 -179.851 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 127.11 57.96 0.13 Allowed Glycine 0 C--N 1.333 0.404 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.636 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.4 t80 69.31 22.77 6.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.802 0.334 . . . . 0.0 110.31 -179.428 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 mt 62.18 65.27 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.583 0.706 . . . . 0.0 110.308 179.956 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 mm -132.72 -49.71 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.627 179.766 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -71.53 -45.94 65.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.673 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.78 -46.33 24.29 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 178.969 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -67.31 -56.57 11.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.924 179.537 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.48 15.44 0.14 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.877 0.37 . . . . 0.0 110.606 -179.968 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 23' ' ' HIS . 6.7 tp -83.76 -13.52 53.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.287 -179.856 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -75.0 36.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.714 179.886 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.507 ' H ' ' C ' ' A' ' 21' ' ' LEU . 61.8 t60 52.56 28.47 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.556 179.963 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.057 179.989 . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -164.49 -178.94 5.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.77 0.319 . . . . 0.0 110.472 -179.966 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.521 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 119.09 -58.3 0.54 Allowed Glycine 1 CA--C 1.355 -9.956 0 CA-C-O 123.74 1.744 . . . . 0.0 115.198 -179.935 . . . . . . . . 3 3 . 1 . 079 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 85.4 mtt180 -60.74 -10.17 5.02 Favored 'General case' 1 N--CA 1.325 -6.719 1 CA-C-N 105.303 -5.449 . . . . 0.0 111.999 -157.552 . . . . . . . . 4 3 . 1 . 079 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.521 ' H ' ' C ' ' A' ' 3' ' ' GLY . 27.5 t90 -41.37 -19.66 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.425 -179.966 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.0 mt -114.77 -21.16 10.32 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.273 179.032 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 tt0 -92.21 31.93 1.23 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.978 0.418 . . . . 0.0 109.942 179.905 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -51.44 -63.9 0.98 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.753 -179.739 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 tp -51.13 100.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.19 0.519 . . . . 0.0 110.261 -179.762 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.73 -43.52 7.71 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.111 -179.801 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 13' ' ' GLY . 60.8 mttp -57.5 106.91 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.233 -179.971 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.76 0.94 4.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.661 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 42.06 35.29 1.64 Allowed Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.306 179.858 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.413 ' H ' ' H ' ' A' ' 15' ' ' ILE . 61.4 t80 -168.35 -13.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.957 -179.888 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.413 ' H ' ' H ' ' A' ' 14' ' ' PHE . 11.9 pt -157.78 52.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.061 0.458 . . . . 0.0 110.245 179.371 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.505 ' C ' ' H ' ' A' ' 18' ' ' GLY . 10.6 tp -143.82 -43.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.215 179.994 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -62.22 -2.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.082 179.396 . . . . . . . . 3 3 . 1 . 079 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . 178.2 -10.49 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.966 -179.925 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.4 90.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.141 -179.979 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -12.6 61.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.739 0.304 . . . . 0.0 110.698 -179.815 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.4 tt 60.3 109.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.149 -179.977 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 57.52 23.84 9.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.756 179.93 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 21.2 t-160 50.79 37.59 17.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.648 179.807 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.166 179.922 . . . . . . . . 0 0 . 1 . 080 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 080 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -68.75 74.97 0.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.445 179.953 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -52.23 -57.66 12.75 Favored Glycine 1 CA--C 1.356 -9.85 0 CA-C-O 123.775 1.764 . . . . 0.0 114.981 179.728 . . . . . . . . 3 3 . 1 . 080 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.509 ' C ' ' H ' ' A' ' 6' ' ' LEU . 27.8 mtp85 -59.94 -12.05 7.0 Favored 'General case' 1 N--CA 1.322 -6.831 1 CA-C-N 105.118 -5.541 . . . . 0.0 111.983 -157.543 . . . . . . . . 4 3 . 1 . 080 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.496 ' H ' ' C ' ' A' ' 3' ' ' GLY . 20.1 t90 -43.54 -18.18 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 112.885 -1.962 . . . . 0.0 110.232 179.894 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' A' ' 4' ' ' ARG . 37.0 mt -116.83 -14.86 10.72 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.075 179.861 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.3 tp10 -63.36 -23.27 67.34 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.201 -179.931 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.9 ttt85 -47.14 107.72 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.709 179.881 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -50.2 98.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.17 0.509 . . . . 0.0 110.484 -179.791 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.69 -17.85 13.99 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.874 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 13' ' ' GLY . 57.7 mttm -64.18 100.46 0.34 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 110.478 -179.987 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -59.91 -4.93 0.82 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.047 179.742 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 57.08 8.81 3.48 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.646 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.46 ' H ' ' C ' ' A' ' 12' ' ' ALA . 7.4 t80 -87.17 -61.47 1.72 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.885 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 pt -155.18 40.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.167 0.508 . . . . 0.0 110.283 179.506 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.49 ' C ' ' H ' ' A' ' 18' ' ' GLY . 1.5 mp -89.73 -45.41 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.435 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.455 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -75.19 17.81 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.363 179.522 . . . . . . . . 3 3 . 1 . 080 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -157.37 -39.6 0.02 OUTLIER Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.466 -179.756 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.89 -3.48 70.52 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.306 -0.473 . . . . 0.0 112.415 -179.582 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.05 45.62 0.54 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.533 -179.96 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.87 6.66 3.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.152 179.959 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -76.61 -23.93 53.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.326 179.822 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -166.68 -39.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.499 -179.993 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.185 -179.898 . . . . . . . . 0 0 . 1 . 081 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.223 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 081 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.7 mttp 53.03 60.59 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 110.649 179.962 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.535 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -59.49 -57.38 19.92 Favored Glycine 1 CA--C 1.357 -9.812 0 CA-C-O 123.715 1.731 . . . . 0.0 115.298 179.849 . . . . . . . . 3 3 . 1 . 081 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 7' ' ' GLU . 91.2 mtt180 -60.61 -10.1 4.74 Favored 'General case' 1 N--CA 1.324 -6.73 1 CA-C-N 105.184 -5.508 . . . . 0.0 112.115 -157.439 . . . . . . . . 4 3 . 1 . 081 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.535 ' H ' ' C ' ' A' ' 3' ' ' GLY . 76.2 t-105 -39.13 -23.84 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.713 -179.942 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.7 tp -101.82 -25.95 13.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.068 -179.535 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.2 tp10 -58.81 -35.23 72.52 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.277 -179.808 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -69.11 177.01 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.671 -179.822 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.3 tp -174.05 131.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.938 179.906 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.88 -23.05 0.19 Allowed Glycine 0 C--N 1.333 0.417 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -179.773 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 13' ' ' GLY . 92.2 mttt -61.96 110.32 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.028 179.712 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.72 2.7 7.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.799 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 39.38 31.95 0.23 Allowed Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.327 -179.962 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 66.6 t80 -162.72 -10.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.79 0.328 . . . . 0.0 110.571 -179.794 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.8 tt -161.58 54.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.753 0.787 . . . . 0.0 109.926 179.824 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.4 tp -149.0 -39.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.462 -179.757 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.416 ' O ' ' CE1' ' A' ' 23' ' ' HIS . 1.1 pp -92.04 16.71 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 179.614 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.38 -57.51 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 179.888 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.69 -38.77 37.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.1 -0.571 . . . . 0.0 111.995 -179.676 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.84 -70.56 0.3 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.86 0.362 . . . . 0.0 110.376 179.99 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 23' ' ' HIS . 2.1 tt -170.89 96.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.988 -179.996 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.494 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 32.4 t70 55.09 -84.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.519 -179.815 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.494 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 94.0 m-70 -157.77 36.3 0.26 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.57 179.948 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.16 179.959 . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -167.19 47.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.8 0.334 . . . . 0.0 110.504 179.996 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -50.23 -58.43 8.84 Favored Glycine 1 CA--C 1.355 -9.933 0 CA-C-O 123.604 1.669 . . . . 0.0 115.515 179.936 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 7' ' ' GLU . 29.1 mmt180 -60.57 -10.32 4.97 Favored 'General case' 1 N--CA 1.324 -6.739 1 CA-C-N 105.404 -5.398 . . . . 0.0 111.861 -157.607 . . . . . . . . 4 3 . 1 . 082 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.512 ' H ' ' C ' ' A' ' 3' ' ' GLY . 89.2 t90 -42.85 -22.57 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.98 179.76 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 4' ' ' ARG . 41.8 tp -100.0 -25.92 14.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.487 179.901 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.9 tt0 -50.58 -31.3 15.42 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.313 179.869 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.0 ttt85 57.85 64.2 1.6 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.548 -179.942 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -55.86 111.35 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.174 0.511 . . . . 0.0 109.954 179.937 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.93 35.11 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.691 -179.687 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -50.1 -41.42 48.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.779 -179.86 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.88 -39.28 1.23 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.014 -179.872 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.2 60.95 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.651 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 23.6 t80 69.0 23.61 6.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.76 0.314 . . . . 0.0 110.184 -179.074 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.2 mt 62.14 71.71 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.591 0.71 . . . . 0.0 110.448 -179.986 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.5 mm -132.82 -51.97 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.699 179.603 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.2 mm -82.87 -41.31 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.569 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.22 -50.77 42.91 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.086 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -73.84 -50.44 11.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.941 179.504 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.75 1.04 0.27 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.557 0.218 . . . . 0.0 110.985 -179.961 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.511 ' H ' ' C ' ' A' ' 19' ' ' GLY . 2.3 mm? 52.42 96.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.831 0.348 . . . . 0.0 110.218 179.852 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -171.79 -54.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.297 179.793 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.412 ' H ' ' H ' ' A' ' 24' ' ' LEU . 49.9 t-80 -171.39 -10.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.406 179.965 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.412 ' H ' ' H ' ' A' ' 23' ' ' HIS . 18.8 mt . . . . . 0 N--CA 1.463 0.225 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.394 179.979 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 083 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -72.3 -163.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 0.0 110.583 -179.923 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 131.19 -57.87 0.72 Allowed Glycine 1 CA--C 1.356 -9.879 0 CA-C-O 123.78 1.766 . . . . 0.0 114.864 -179.74 . . . . . . . . 3 3 . 1 . 083 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 6' ' ' LEU . 77.8 mtm180 -60.52 -10.54 5.19 Favored 'General case' 1 N--CA 1.323 -6.808 1 CA-C-N 105.202 -5.499 . . . . 0.0 111.956 -157.632 . . . . . . . . 4 3 . 1 . 083 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.517 ' H ' ' C ' ' A' ' 3' ' ' GLY . 57.3 t90 -41.43 -19.89 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.225 179.766 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.1 tp -119.72 -17.65 8.53 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.883 179.254 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.2 tt0 -91.96 22.95 3.95 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 120.978 0.418 . . . . 0.0 110.03 179.85 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -52.6 132.56 35.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.614 -179.819 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.7 tt -72.15 120.92 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.05 0.453 . . . . 0.0 110.129 179.749 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.08 -26.7 57.52 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.03 -179.692 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 13' ' ' GLY . 27.2 mtmm -66.79 103.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.381 -179.973 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.39 -2.75 4.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.727 179.511 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 46.64 29.44 4.12 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.728 -179.742 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -162.45 -15.42 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.166 -0.214 . . . . 0.0 110.922 -179.587 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.9 pt -156.68 54.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 110.353 179.541 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.43 ' C ' ' H ' ' A' ' 18' ' ' GLY . 9.3 tp -143.21 -42.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.039 179.733 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.438 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -65.49 -3.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.95 179.289 . . . . . . . . 3 3 . 1 . 083 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -170.79 -24.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.839 -179.869 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.4 4.43 55.57 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.306 -0.473 . . . . 0.0 111.925 179.994 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.3 -20.21 57.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.323 . . . . 0.0 110.716 -179.88 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.6 mt 56.42 15.41 1.99 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.503 -179.798 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.33 -60.7 2.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.603 179.951 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 76.4 t60 -170.15 1.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.569 179.989 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.4 mm? . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.114 179.976 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 084 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -69.45 78.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.804 0.335 . . . . 0.0 110.603 -179.965 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -49.0 -57.07 9.14 Favored Glycine 1 CA--C 1.357 -9.839 0 CA-C-O 123.838 1.799 . . . . 0.0 115.109 179.662 . . . . . . . . 3 3 . 1 . 084 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 6' ' ' LEU . 87.8 mtt180 -60.38 -10.95 5.46 Favored 'General case' 1 N--CA 1.323 -6.78 1 CA-C-N 105.126 -5.537 . . . . 0.0 112.083 -157.623 . . . . . . . . 4 3 . 1 . 084 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.522 ' H ' ' C ' ' A' ' 3' ' ' GLY . 29.5 t90 -41.82 -18.96 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.928 -1.942 . . . . 0.0 110.541 -179.974 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.6 tp -114.68 -19.29 11.14 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.716 179.941 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.0 tt0 -85.84 -14.56 44.63 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.736 -179.716 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 10' ' ' GLY . 26.6 ttp85 -74.27 -81.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.904 -179.981 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.8 tp -62.9 79.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.722 0.773 . . . . 0.0 110.004 -179.803 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -82.75 -18.99 64.47 Favored Glycine 0 CA--C 1.517 0.17 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.976 -179.515 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 13' ' ' GLY . 34.0 mtmm -75.59 100.47 4.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.781 0.324 . . . . 0.0 110.763 -179.828 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.14 -1.34 4.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.103 179.641 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 50.4 47.51 43.55 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.214 179.985 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -169.23 -40.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.768 179.855 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.6 pt -154.34 61.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.899 0.381 . . . . 0.0 110.571 179.977 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.479 ' C ' ' H ' ' A' ' 18' ' ' GLY . 17.6 mm -149.42 -48.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.572 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.85 9.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.924 179.781 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -172.82 -38.99 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.875 179.951 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -54.7 -35.73 58.13 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.021 179.94 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.17 7.13 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.525 -179.975 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.4 tp 51.17 23.82 1.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.235 -179.972 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -73.09 -53.99 9.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.611 -179.954 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -166.62 -9.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.745 -179.944 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.324 179.908 . . . . . . . . 0 0 . 1 . 085 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.233 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 085 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' CG ' ' H ' ' A' ' 3' ' ' GLY . 17.5 tptp -167.44 -129.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.989 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.521 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 96.43 -59.17 1.34 Allowed Glycine 1 CA--C 1.356 -9.869 0 CA-C-O 123.619 1.677 . . . . 0.0 115.259 -179.944 . . . . . . . . 3 3 . 1 . 085 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.9 mtm180 -60.7 -10.42 5.3 Favored 'General case' 1 N--CA 1.324 -6.764 1 CA-C-N 105.449 -5.375 . . . . 0.0 112.023 -157.576 . . . . . . . . 4 3 . 1 . 085 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.521 ' H ' ' C ' ' A' ' 3' ' ' GLY . 29.7 t90 -40.96 -21.1 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.014 -1.903 . . . . 0.0 110.325 -179.915 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.1 mt -108.49 -25.1 11.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.44 179.247 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.0 mp0 -93.98 2.8 56.02 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.141 179.789 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 4' ' ' ARG . 60.9 ttt180 -54.28 -71.38 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.408 179.966 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 tp -171.27 87.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.351 0.596 . . . . 0.0 110.18 179.789 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.01 -53.15 3.8 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.999 -179.78 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' C ' ' H ' ' A' ' 13' ' ' GLY . 57.2 mttp -57.06 101.24 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.794 0.331 . . . . 0.0 110.635 -179.89 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -63.84 -1.3 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.015 179.514 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 55.8 7.55 1.66 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.767 -179.873 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 12' ' ' ALA . 50.5 t80 -127.1 -19.68 4.31 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.542 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 17' ' ' ILE . 4.5 mt -147.14 -135.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.715 179.359 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.415 ' H ' ' CG2' ' A' ' 15' ' ' ILE . 21.2 mm 52.76 -82.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 121.276 -0.17 . . . . 0.0 110.872 179.323 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 15' ' ' ILE . 3.7 tp -73.74 -38.28 50.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.675 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.51 -50.14 45.74 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.482 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.98 -47.64 7.51 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.779 -0.529 . . . . 0.0 111.779 179.627 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.86 47.88 15.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.935 179.881 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.3 mt -68.33 -19.28 64.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.547 -179.979 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -53.04 -92.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.584 -179.977 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.472 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 2.0 t60 -80.51 11.08 3.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.785 -179.81 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.211 -179.985 . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.42 ' NZ ' ' CB ' ' A' ' 2' ' ' LYS . 0.3 OUTLIER -166.51 34.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.699 0.285 . . . . 0.0 110.567 -179.924 . . . . . . . . 3 3 . 1 . 086 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -50.87 -58.49 9.29 Favored Glycine 1 CA--C 1.355 -9.918 0 CA-C-O 123.647 1.693 . . . . 0.0 115.313 179.996 . . . . . . . . 3 3 . 1 . 086 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.576 ' O ' ' N ' ' A' ' 7' ' ' GLU . 55.4 mtp85 -60.94 -9.78 4.75 Favored 'General case' 1 N--CA 1.323 -6.807 1 CA-C-N 105.388 -5.406 . . . . 0.0 112.016 -157.612 . . . . . . . . 4 3 . 1 . 086 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.532 ' H ' ' C ' ' A' ' 3' ' ' GLY . 23.2 t90 -40.89 -24.84 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.02 -1.9 . . . . 0.0 109.843 179.763 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.5 mm? -96.69 -31.24 12.79 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.947 179.218 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 4' ' ' ARG . 52.5 mm-40 -90.68 43.36 1.14 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.782 0.325 . . . . 0.0 110.28 179.723 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -145.85 22.9 1.41 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.392 -179.79 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 pt -51.48 121.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.232 0.539 . . . . 0.0 110.327 -179.98 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.44 -18.28 79.93 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.865 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -80.05 109.2 14.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.764 0.316 . . . . 0.0 110.366 179.974 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.45 10.45 7.16 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.507 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.84 37.53 7.29 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.97 -179.768 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -159.24 -68.67 0.08 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.773 0.32 . . . . 0.0 110.171 -179.902 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.5 tt -93.69 44.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.784 0.802 . . . . 0.0 109.899 179.721 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.1 tp -145.11 -43.8 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.326 -179.896 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 pp -88.49 13.85 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.422 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.86 -48.54 0.01 OUTLIER Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.773 -179.823 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.67 -15.12 66.06 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.05 -179.986 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.72 -28.32 61.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.619 -179.887 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 8.8 mp -55.92 116.39 2.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.145 179.951 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.87 25.93 4.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.979 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 8.5 t60 53.08 52.17 14.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.527 -179.982 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.157 179.999 . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.244 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -167.69 176.7 6.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.792 0.33 . . . . 0.0 110.629 179.958 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.502 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 122.59 -59.13 0.59 Allowed Glycine 1 CA--C 1.355 -9.937 0 CA-C-O 123.72 1.733 . . . . 0.0 115.164 179.993 . . . . . . . . 3 3 . 1 . 087 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.505 ' C ' ' H ' ' A' ' 6' ' ' LEU . 62.5 mtp180 -59.99 -11.65 6.25 Favored 'General case' 1 N--CA 1.324 -6.761 1 CA-C-N 105.371 -5.415 . . . . 0.0 111.998 -157.513 . . . . . . . . 4 3 . 1 . 087 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.502 ' N ' ' C ' ' A' ' 3' ' ' GLY . 97.5 m95 -42.82 -18.88 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.915 -1.948 . . . . 0.0 110.16 179.731 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 4' ' ' ARG . 21.5 mt -113.49 -20.19 11.38 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.764 179.547 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.0 tt0 -83.23 24.33 0.81 Allowed 'General case' 0 C--N 1.342 0.269 0 CA-C-O 121.138 0.494 . . . . 0.0 110.047 179.924 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 6' ' ' LEU . 81.8 mtp180 -66.09 -96.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.908 -179.789 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 11' ' ' LYS . 14.2 pt -75.08 -35.39 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.03 -179.525 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.41 17.05 0.37 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.9 -179.714 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 9' ' ' ILE . 46.5 tttm -75.71 -4.95 43.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.834 0.35 . . . . 0.0 110.53 -179.745 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 16' ' ' ILE . . . 71.76 8.73 6.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.284 -179.943 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 40.51 48.96 3.9 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 179.979 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 t80 78.13 49.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.831 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.2 mt 61.46 75.55 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.765 179.895 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 12' ' ' ALA . 7.5 mm -130.92 -57.59 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.652 179.703 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.499 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.3 mp -69.17 -52.5 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.524 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.11 -48.04 68.24 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 178.621 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.55 -56.98 17.3 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.666 179.091 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.0 -67.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.77 0.319 . . . . 0.0 110.496 -179.944 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.5 tt 62.18 86.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.122 0.487 . . . . 0.0 110.142 -179.837 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -170.65 51.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.282 -179.957 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 74.8 t60 56.24 25.39 9.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.264 -179.829 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.051 -179.906 . . . . . . . . 0 0 . 1 . 088 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 088 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -58.13 156.75 9.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.868 0.366 . . . . 0.0 110.44 179.946 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.521 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 141.38 -56.23 0.6 Allowed Glycine 1 CA--C 1.354 -9.979 0 CA-C-O 123.918 1.843 . . . . 0.0 114.796 -179.464 . . . . . . . . 3 3 . 1 . 088 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' LEU . 94.7 mtt180 -60.36 -10.81 5.24 Favored 'General case' 1 N--CA 1.323 -6.777 1 CA-C-N 105.023 -5.589 . . . . 0.0 111.911 -157.569 . . . . . . . . 4 3 . 1 . 088 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.521 ' H ' ' C ' ' A' ' 3' ' ' GLY . 56.6 t-105 -41.96 -18.55 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.453 179.946 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.4 mp -117.7 -17.09 9.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.839 179.358 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' ARG . 14.2 tp10 -81.66 -6.02 58.63 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.049 0.452 . . . . 0.0 110.093 -179.955 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -56.09 -20.87 19.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.742 -179.916 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.7 mm -70.28 73.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -179.989 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . -78.84 -9.37 87.15 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 179.644 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 13' ' ' GLY . 58.5 mmtt -75.05 8.46 2.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 110.688 -179.859 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . 72.66 -11.71 0.82 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.55 179.91 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 39.9 54.33 3.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.471 -0.395 . . . . 0.0 112.218 179.976 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CG ' ' C ' ' A' ' 13' ' ' GLY . 3.9 m-85 74.81 45.34 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.782 0.325 . . . . 0.0 110.16 -179.272 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.8 mt 61.4 79.4 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.427 0.632 . . . . 0.0 111.179 179.807 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -135.74 -61.81 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.95 179.434 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.482 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -71.84 -49.03 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.508 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.35 -56.36 22.32 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.452 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.58 -48.64 61.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.968 179.657 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.17 37.34 14.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.761 0.315 . . . . 0.0 110.545 -179.955 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.0 mt -70.49 109.69 4.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.55 179.988 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.29 32.29 18.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.706 179.903 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.8 m170 50.72 48.94 21.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 -179.975 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.107 -179.89 . . . . . . . . 0 0 . 1 . 089 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 . . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.74 36.0 0.16 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.791 0.329 . . . . 0.0 110.553 179.864 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . -52.95 -57.3 15.02 Favored Glycine 1 CA--C 1.357 -9.809 0 CA-C-O 123.608 1.671 . . . . 0.0 115.658 -179.93 . . . . . . . . 3 3 . 1 . 089 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 6' ' ' LEU . 95.9 mtt180 -60.33 -10.46 4.76 Favored 'General case' 1 N--CA 1.326 -6.626 1 CA-C-N 105.42 -5.39 . . . . 0.0 112.066 -157.384 . . . . . . . . 4 3 . 1 . 089 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.532 ' H ' ' C ' ' A' ' 3' ' ' GLY . 29.0 t90 -41.0 -19.98 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.55 -179.963 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 45.8 mt -115.03 -20.58 10.43 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.51 179.197 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.4 mm-40 -91.63 17.13 9.25 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.959 0.409 . . . . 0.0 110.162 179.668 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -57.45 -50.06 74.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.913 -179.893 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 13.6 tt -52.81 -44.37 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.643 -179.663 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.428 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . 77.82 -50.67 3.33 Favored Glycine 0 C--N 1.331 0.266 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 -179.954 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 13' ' ' GLY . 94.2 mttt -66.54 100.45 0.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.318 179.836 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.15 5.9 2.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.063 179.933 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 43.53 48.51 7.17 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.042 -179.86 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -162.5 -31.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.586 0.231 . . . . 0.0 110.885 -179.702 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.413 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 16.4 tt -166.98 61.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 110.724 179.922 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 18' ' ' GLY . 22.1 mm -145.45 -61.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.864 179.584 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -69.32 3.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.035 179.479 . . . . . . . . 3 3 . 1 . 089 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -135.91 -55.05 0.06 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 179.889 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -74.38 -56.44 5.12 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.519 -0.633 . . . . 0.0 111.519 179.486 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 61.74 -1.93 0.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.599 0.238 . . . . 0.0 111.329 179.566 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 19' ' ' GLY . 8.2 mp 51.42 12.12 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.733 0.301 . . . . 0.0 110.256 179.938 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 20' ' ' ALA . 14.6 t0 -68.27 -55.72 11.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.617 -179.904 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -167.62 -17.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.567 -179.992 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.5 mt . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.501 179.876 . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -63.0 -144.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.592 0.234 . . . . 0.0 110.55 179.976 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 52.23 68.36 1.61 Allowed Glycine 1 CA--C 1.381 -8.311 0 CA-C-O 125.48 2.711 . . . . 0.0 113.437 -178.959 . . . . . . . . 3 3 . 1 . 090 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 1.7 mtm180 163.65 -10.94 0.0 OUTLIER 'General case' 1 N--CA 1.32 -6.926 1 CA-C-N 101.252 -7.474 . . . . 0.0 110.077 159.266 . . . . . . . . 4 3 . 1 . 090 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -42.2 -18.55 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.363 -179.566 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.2 tp -114.47 -17.54 11.71 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.628 179.467 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.3 mt-10 -107.55 15.32 24.89 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 120.819 0.343 . . . . 0.0 110.264 179.958 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -53.64 163.08 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.534 179.921 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.502 ' C ' ' H ' ' A' ' 11' ' ' LYS . 11.1 pt -76.19 -36.69 31.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.426 179.921 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.25 -5.44 1.43 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.195 179.958 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' H ' ' C ' ' A' ' 9' ' ' ILE . 67.0 mmtt -87.73 105.38 17.34 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.672 -179.922 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.59 46.71 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.235 179.676 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.68 67.18 2.03 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.768 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 53.8 t80 55.2 26.93 8.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.016 -179.731 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 mt 62.14 62.32 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.679 0.752 . . . . 0.0 109.639 -179.453 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.8 mm -129.38 -46.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.025 -179.817 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.509 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -70.96 -46.94 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.809 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.41 -39.2 23.03 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 178.652 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.49 -52.75 50.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.081 -0.581 . . . . 0.0 111.73 179.369 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.443 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -62.73 -58.18 8.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.332 179.8 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 tp 53.35 12.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.236 179.891 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 20' ' ' ALA . 77.9 m-20 -66.36 -107.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.335 -179.994 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -68.64 -30.18 68.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 110.429 179.938 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.429 179.896 . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm 50.23 -177.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.796 0.331 . . . . 0.0 110.624 -179.977 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 102.28 -59.24 0.57 Allowed Glycine 1 CA--C 1.356 -9.877 0 CA-C-O 123.747 1.748 . . . . 0.0 115.243 -179.961 . . . . . . . . 3 3 . 1 . 091 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.9 mtm180 -60.7 -9.86 4.54 Favored 'General case' 1 N--CA 1.325 -6.705 1 CA-C-N 105.38 -5.41 . . . . 0.0 112.09 -157.676 . . . . . . . . 4 3 . 1 . 091 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.523 ' H ' ' C ' ' A' ' 3' ' ' GLY . 38.2 m0 -41.46 -24.66 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.957 -1.929 . . . . 0.0 109.912 179.796 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' N ' ' C ' ' A' ' 4' ' ' ARG . 17.2 mt -96.55 -27.82 14.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.75 179.853 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.6 tt0 -51.31 -22.73 3.02 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.38 179.934 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 59.46 64.87 1.25 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.648 -179.861 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 11' ' ' LYS . 18.3 pt -80.01 -31.97 13.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.347 179.807 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.78 15.75 0.56 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.123 -0.561 . . . . 0.0 111.942 -179.98 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 13' ' ' GLY . 55.3 tttp -77.0 -45.8 26.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.697 0.284 . . . . 0.0 110.777 -179.868 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 16' ' ' ILE . . . 56.54 10.36 0.68 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.155 -179.918 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 41.38 53.54 4.14 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.839 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 t80 73.89 48.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -178.996 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mt 63.1 76.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.034 179.924 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.6 mm -131.06 -67.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.401 179.497 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 47.1 mm -78.8 -31.61 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.584 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.77 -51.71 23.54 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.678 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.36 -47.61 6.81 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.254 -0.498 . . . . 0.0 111.903 179.296 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.63 43.48 16.42 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.792 0.329 . . . . 0.0 110.759 -179.981 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.5 mt -75.16 116.31 15.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.675 -179.801 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 47.36 36.02 4.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.98 179.829 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.2 m80 52.72 62.57 2.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.578 -179.957 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.219 179.99 . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 77.7 mttt 58.99 -135.94 0.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.166 -0.214 . . . . 0.0 110.697 -179.94 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.435 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 48.96 70.54 0.76 Allowed Glycine 1 CA--C 1.385 -8.091 0 CA-C-O 126.475 3.264 . . . . 0.0 112.52 -178.056 . . . . . . . . 3 3 . 1 . 092 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 7' ' ' GLU . 35.1 mtt180 155.03 -10.59 0.0 OUTLIER 'General case' 1 N--CA 1.312 -7.355 1 CA-C-N 100.472 -7.864 . . . . 0.0 110.459 161.152 . . . . . . . . 4 3 . 1 . 092 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -43.8 -22.83 0.06 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.669 -179.687 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.491 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 8.2 mp -90.74 -28.38 18.32 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.865 179.289 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.7 tt0 -78.42 -21.32 49.4 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.275 179.715 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 10' ' ' GLY . 1.2 tpm_? -68.41 -58.93 3.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.9 -179.457 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -48.81 92.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.398 0.618 . . . . 0.0 110.318 -179.794 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 156.84 38.16 0.02 OUTLIER Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.593 -179.677 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -46.65 -29.54 1.91 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.825 0.345 . . . . 0.0 110.46 179.834 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.436 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -164.84 -3.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.492 -179.921 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.436 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 52.82 27.79 29.54 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.742 -179.842 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -144.9 -11.91 0.57 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.901 0.382 . . . . 0.0 110.065 179.951 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.2 pt -155.44 42.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.904 179.448 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.1 tp -152.91 -27.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.004 -179.778 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 pp -81.5 9.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.679 179.516 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.86 -28.36 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.839 -179.901 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.51 -43.88 67.23 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.854 179.979 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.18 -39.91 74.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 110.415 179.882 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 23' ' ' HIS . 2.3 tt 65.49 -76.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.015 -179.863 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 42.73 -90.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 111.092 179.799 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' LEU . 59.1 t-80 -122.96 -14.78 7.54 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.225 179.759 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 21' ' ' LEU . 24.5 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.392 179.958 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 093 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -52.03 157.57 1.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 0.0 110.392 179.985 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.533 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 133.91 -55.79 0.74 Allowed Glycine 1 CA--C 1.355 -9.967 0 CA-C-O 123.922 1.846 . . . . 0.0 114.818 -179.543 . . . . . . . . 3 3 . 1 . 093 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.8 mtt180 -60.77 -10.04 4.89 Favored 'General case' 1 N--CA 1.323 -6.797 1 CA-C-N 104.974 -5.613 . . . . 0.0 111.95 -157.563 . . . . . . . . 4 3 . 1 . 093 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.533 ' H ' ' C ' ' A' ' 3' ' ' GLY . 98.2 m95 -41.38 -19.47 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.041 -1.89 . . . . 0.0 110.486 -179.957 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 mt -114.4 -20.39 10.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.659 179.377 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.8 mt-10 -89.82 -8.32 52.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.671 0.272 . . . . 0.0 110.763 -179.872 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -69.88 -91.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.208 179.831 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 tp -60.15 91.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 0.0 110.108 -179.97 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.05 29.85 11.61 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.896 -179.79 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -149.62 62.01 1.01 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.719 0.295 . . . . 0.0 110.372 -179.964 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.53 52.08 1.58 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.39 179.853 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.86 60.14 8.56 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.847 -179.844 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.492 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 57.9 t80 57.09 32.98 22.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.883 0.373 . . . . 0.0 110.653 -179.818 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 mt 61.26 61.78 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.599 0.714 . . . . 0.0 109.892 -179.818 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mm -129.96 -51.21 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.75 -179.838 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.9 mm -69.14 -41.41 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.473 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.421 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . -82.21 -38.07 13.8 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.166 179.193 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.05 -37.22 73.16 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.452 179.855 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.34 -64.64 1.09 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.663 0.268 . . . . 0.0 111.357 -179.26 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' HIS . 23.6 mt 53.76 -99.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.175 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 80.4 m-20 50.18 -87.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.746 179.758 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' LEU . 78.7 m-70 -153.96 13.17 0.45 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.494 -179.88 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.455 179.885 . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -145.54 -141.39 0.12 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.604 0.24 . . . . 0.0 110.508 179.968 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.436 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 50.87 70.84 0.75 Allowed Glycine 1 CA--C 1.384 -8.129 0 CA-C-O 126.377 3.21 . . . . 0.0 112.493 -178.199 . . . . . . . . 3 3 . 1 . 094 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 32.5 mtt180 156.47 -11.66 0.0 OUTLIER 'General case' 1 N--CA 1.313 -7.295 1 CA-C-N 100.656 -7.772 . . . . 0.0 110.297 161.025 . . . . . . . . 4 3 . 1 . 094 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.6 t90 -43.63 -20.46 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.73 179.973 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.502 ' N ' ' C ' ' A' ' 4' ' ' ARG . 19.3 mt -102.89 -21.2 14.03 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.908 179.864 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.8 tm-20 -67.49 -25.76 66.03 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.124 179.878 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -63.44 163.47 10.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.894 -179.963 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.5 tt -162.42 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.964 179.915 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.7 -46.33 2.3 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.117 179.778 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.466 ' C ' ' H ' ' A' ' 13' ' ' GLY . 54.7 mtpt -77.55 93.73 4.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.745 0.307 . . . . 0.0 110.857 -179.926 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.46 -4.84 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.973 0.415 . . . . 0.0 109.98 179.517 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 52.94 51.52 45.19 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.011 179.928 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -168.83 -45.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.214 179.814 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.9 pt -155.3 58.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.241 0.544 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.7 mm -140.11 -65.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.621 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 tp -70.5 -39.37 76.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.498 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.07 -42.81 8.52 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.7 179.601 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.95 -38.04 64.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.106 -0.568 . . . . 0.0 111.898 179.868 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 53.13 15.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.814 0.34 . . . . 0.0 110.583 179.892 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 7.6 mp 54.01 9.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.276 -179.963 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 20' ' ' ALA . 28.9 t70 -78.31 -103.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.329 179.921 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.499 ' HD1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -73.22 9.69 1.19 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 110.377 179.815 . . . . . . . . 3 3 . 1 . 094 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.485 ' H ' ' C ' ' A' ' 22' ' ' ASP . 17.8 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.353 -179.936 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 . . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? 56.28 -124.19 1.89 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.982 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 101.16 -58.12 0.68 Allowed Glycine 1 CA--C 1.355 -9.928 0 CA-C-O 123.685 1.714 . . . . 0.0 115.259 179.941 . . . . . . . . 3 3 . 1 . 095 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.2 mtt-85 -60.66 -10.02 4.71 Favored 'General case' 1 N--CA 1.325 -6.725 1 CA-C-N 105.397 -5.402 . . . . 0.0 112.067 -157.537 . . . . . . . . 4 3 . 1 . 095 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.519 ' H ' ' C ' ' A' ' 3' ' ' GLY . 85.9 t90 -41.15 -20.32 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.394 179.859 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.4 tt -109.24 -25.33 10.66 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.359 179.279 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.4 mt-10 -99.43 25.43 7.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.388 179.875 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -50.77 140.55 14.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.639 -179.87 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.3 tt -72.62 -40.45 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.368 179.867 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.04 -56.07 3.94 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.048 179.914 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 13' ' ' GLY . 52.0 mtpt -60.98 101.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 110.518 -179.911 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.34 1.93 2.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.926 179.711 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 46.0 38.41 8.22 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.181 -179.996 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -166.81 -26.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 pt -154.45 59.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.914 0.388 . . . . 0.0 110.981 179.863 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.496 ' C ' ' H ' ' A' ' 18' ' ' GLY . 13.6 mm -150.67 -50.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.327 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.78 10.61 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.041 179.798 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -173.35 -20.46 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.216 -0.516 . . . . 0.0 111.971 179.902 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.73 -28.57 46.35 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.095 -179.899 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -66.58 -76.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.737 0.303 . . . . 0.0 110.85 -179.795 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.1 mt 59.88 3.92 0.53 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.579 -179.639 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 24' ' ' LEU . 56.4 p-10 -76.72 -133.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.196 179.711 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.575 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 1.2 m-70 -76.41 35.77 0.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 110.428 179.682 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' A' ' 22' ' ' ASP . 15.5 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.179 -179.797 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.064 -0.414 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -69.09 -134.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.515 179.866 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.494 ' O ' ' NE ' ' A' ' 4' ' ' ARG . . . 52.38 70.44 0.9 Allowed Glycine 1 CA--C 1.382 -8.251 0 CA-C-O 125.956 2.976 . . . . 0.0 112.955 -178.679 . . . . . . . . 3 3 . 1 . 096 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 7' ' ' GLU . 7.0 mtm105 160.25 -10.04 0.0 OUTLIER 'General case' 1 N--CA 1.319 -7.004 1 CA-C-N 101.131 -7.535 . . . . 0.0 110.624 160.132 . . . . . . . . 4 3 . 1 . 096 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -39.82 -23.29 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.258 -179.294 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 4' ' ' ARG . 10.0 mp -97.3 -27.45 14.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.242 179.15 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.1 mp0 -117.87 34.23 5.26 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.715 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 4' ' ' ARG . 56.6 ttm-85 -67.38 126.59 29.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.559 -179.989 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.8 pt -73.26 -30.76 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.56 56.4 20.22 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.898 -179.86 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -164.75 78.67 0.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.811 0.339 . . . . 0.0 110.553 -179.903 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.37 46.48 0.63 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.609 179.976 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.91 59.69 7.27 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.964 179.989 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 52.2 t80 57.34 35.03 25.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.621 0.248 . . . . 0.0 110.759 179.91 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt 62.19 71.94 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.482 0.658 . . . . 0.0 110.421 179.769 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.476 ' O ' ' N ' ' A' ' 20' ' ' ALA . 14.4 mt -146.75 -57.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.525 179.674 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.47 ' CD1' ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -58.9 -29.64 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.344 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.43 -45.83 2.9 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.147 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.55 -64.36 2.39 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.05 179.336 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 57.54 27.54 14.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.628 0.251 . . . . 0.0 110.628 -179.842 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.8 mt 53.43 -124.05 2.22 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.026 -179.747 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -82.87 63.96 7.24 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 179.692 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 50.3 t-80 56.49 19.02 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.141 -179.54 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.8 tp . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.424 -179.915 . . . . . . . . 0 0 . 1 . 097 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 097 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt 53.02 -100.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.725 0.298 . . . . 0.0 110.589 -179.988 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.514 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 95.89 -60.62 1.42 Allowed Glycine 1 CA--C 1.356 -9.895 0 CA-C-O 123.74 1.744 . . . . 0.0 115.279 -179.954 . . . . . . . . 3 3 . 1 . 097 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.0 mtm180 -60.68 -10.39 5.24 Favored 'General case' 1 N--CA 1.325 -6.725 1 CA-C-N 105.297 -5.452 . . . . 0.0 112.032 -157.572 . . . . . . . . 4 3 . 1 . 097 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.514 ' H ' ' C ' ' A' ' 3' ' ' GLY . 27.3 t90 -39.56 -21.7 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.798 -179.733 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.8 mt -107.83 -24.44 11.67 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.84 179.646 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 15.0 mp0 -86.87 29.38 0.81 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.63 0.252 . . . . 0.0 110.51 -179.894 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -87.74 -33.18 18.79 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.686 179.838 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 11' ' ' LYS . 3.6 tp -166.91 -3.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.157 0.503 . . . . 0.0 109.908 -179.568 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -36.17 -27.4 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.839 179.708 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 9' ' ' ILE . 63.2 mttp -54.64 107.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.381 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -67.65 3.9 1.26 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.6 -179.592 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 46.51 14.03 0.1 OUTLIER Glycine 0 C--N 1.329 0.183 0 C-N-CA 121.312 -0.47 . . . . 0.0 112.25 -179.945 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 12' ' ' ALA . 73.6 t80 -138.29 -4.4 1.68 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.577 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 17' ' ' ILE . 3.3 mt -146.13 -137.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.038 179.604 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.559 ' C ' ' H ' ' A' ' 18' ' ' GLY . 47.5 mm 41.54 -87.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.333 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.543 ' N ' ' O ' ' A' ' 15' ' ' ILE . 2.4 pp -55.11 -1.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.416 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -132.59 -70.97 0.09 OUTLIER Glycine 0 C--N 1.338 0.655 0 N-CA-C 112.326 -0.31 . . . . 0.0 112.326 -179.855 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -51.82 -25.27 15.34 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.693 -179.382 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.89 -11.84 0.1 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.612 179.999 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 23' ' ' HIS . 27.2 tp -44.52 123.86 3.84 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.479 179.841 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 56.02 -81.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.611 -179.541 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 21' ' ' LEU . 23.2 t-80 -163.79 43.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.676 179.97 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 30.8 mt . . . . . 0 N--CA 1.469 0.513 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.262 179.852 . . . . . . . . 0 0 . 1 . 098 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 . . . . . . . . . 0 0 . 1 . 098 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -65.77 -169.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.831 0.348 . . . . 0.0 110.547 -179.981 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.527 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 97.84 -59.15 1.05 Allowed Glycine 1 CA--C 1.357 -9.823 0 CA-C-O 123.627 1.682 . . . . 0.0 115.332 -179.981 . . . . . . . . 3 3 . 1 . 098 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 7' ' ' GLU . 69.4 mtm180 -60.59 -10.24 4.89 Favored 'General case' 1 N--CA 1.325 -6.725 1 CA-C-N 105.399 -5.401 . . . . 0.0 112.007 -157.484 . . . . . . . . 4 3 . 1 . 098 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.527 ' H ' ' C ' ' A' ' 3' ' ' GLY . 57.6 t-105 -39.59 -21.86 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.521 -179.944 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.5 tp -107.74 -26.24 10.9 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.724 179.615 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.9 tt0 -89.28 -3.01 58.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.103 0.477 . . . . 0.0 109.934 179.88 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.457 ' C ' ' H ' ' A' ' 10' ' ' GLY . 40.3 ttm180 -83.55 152.48 24.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.469 179.902 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.5 pt -55.72 -9.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.567 -179.979 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . 46.22 31.32 4.52 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.145 179.96 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -151.4 70.37 0.96 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.972 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.03 48.98 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.567 -179.888 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.02 40.28 20.16 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.865 -179.976 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 t80 70.49 54.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.92 0.391 . . . . 0.0 110.493 -179.776 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 mm 62.05 75.57 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.157 179.703 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.9 mm -137.14 -51.65 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.686 179.244 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 mm -74.48 -49.86 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.042 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.01 -51.55 18.09 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.367 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -63.7 -43.02 98.45 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.796 179.62 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 70.11 -13.79 0.41 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.581 0.229 . . . . 0.0 110.957 179.943 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.526 ' H ' ' C ' ' A' ' 19' ' ' GLY . 4.8 tp 61.13 2.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.0 110.446 179.98 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 20' ' ' ALA . 74.7 m-20 -74.29 84.93 1.92 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.45 179.975 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 27.7 m170 56.73 5.92 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 -179.858 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 22' ' ' ASP . 37.6 mt . . . . . 0 N--CA 1.469 0.519 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.052 179.69 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.425 ' H2 ' ' H ' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.452 -0.237 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 . . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.425 ' H ' ' H2 ' ' A' ' 1' ' ' GLY . 20.5 pttp -55.58 170.37 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.321 . . . . 0.0 110.461 179.959 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 104.14 -57.75 0.52 Allowed Glycine 1 CA--C 1.355 -9.911 0 CA-C-O 123.768 1.76 . . . . 0.0 115.203 -179.917 . . . . . . . . 3 3 . 1 . 099 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' GLU . 70.7 mtp180 -60.22 -10.94 5.13 Favored 'General case' 1 N--CA 1.325 -6.703 1 CA-C-N 105.323 -5.438 . . . . 0.0 112.08 -157.486 . . . . . . . . 4 3 . 1 . 099 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.516 ' H ' ' C ' ' A' ' 3' ' ' GLY . 5.3 m-90 -42.25 -20.36 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.121 179.68 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.8 tp -107.54 -25.12 11.52 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.363 179.618 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' ARG . 78.0 mt-10 -90.17 35.32 0.86 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -146.39 -37.2 0.24 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.25 -179.996 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.458 ' CG1' ' H ' ' A' ' 10' ' ' GLY . 3.3 pt -149.38 -105.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 65.22 -132.47 36.08 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.966 179.95 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 tttp 73.11 -35.56 0.33 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.611 0.243 . . . . 0.0 110.824 179.979 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . -163.91 13.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.931 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.14 66.02 2.66 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.419 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 68.5 t80 57.83 32.33 21.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.075 -179.15 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 mt 62.03 63.69 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.584 0.707 . . . . 0.0 110.083 -179.73 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mm -130.19 -52.64 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.414 -179.827 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.57 -44.78 79.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.625 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.35 -48.08 15.3 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.873 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -59.79 -43.59 97.77 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.619 179.29 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 69.05 -14.91 0.28 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.509 0.195 . . . . 0.0 111.383 179.815 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.539 ' H ' ' C ' ' A' ' 19' ' ' GLY . 2.5 mm? 47.27 75.11 0.13 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.755 0.312 . . . . 0.0 110.429 179.934 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -171.17 -109.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.315 179.879 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -60.02 -28.17 67.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.834 0.349 . . . . 0.0 110.105 179.719 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.569 179.774 . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 . . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm 51.79 -151.59 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.5 -179.97 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 5' ' ' TRP . . . 107.38 -61.22 0.32 Allowed Glycine 1 CA--C 1.356 -9.866 0 CA-C-O 123.651 1.695 . . . . 0.0 115.423 179.753 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.522 ' C ' ' H ' ' A' ' 6' ' ' LEU . 82.2 mtm180 -59.96 -12.26 7.52 Favored 'General case' 1 N--CA 1.325 -6.723 1 CA-C-N 105.462 -5.369 . . . . 0.0 112.069 -157.481 . . . . . . . . 4 3 . 1 . 100 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.489 ' H ' ' C ' ' A' ' 3' ' ' GLY . 72.6 t-105 -44.0 -17.03 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.321 179.922 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 4' ' ' ARG . 30.0 mt -130.71 -4.78 4.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.857 179.561 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -84.71 -11.07 56.6 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.074 179.829 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 61.08 131.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.627 179.701 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.7 pt -61.3 -23.85 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.447 179.879 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.04 60.01 8.66 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.872 -179.909 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -169.65 57.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 110.421 -179.931 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.15 64.49 2.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.406 179.98 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 55.19 55.7 26.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.802 -179.857 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 58.59 36.51 25.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.474 -179.832 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 mt 61.18 62.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.405 -179.957 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.403 ' CG2' ' N ' ' A' ' 17' ' ' ILE . 4.1 tp -131.19 -44.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.447 179.672 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.403 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 35.8 mm -77.22 -44.89 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.5 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.58 -43.05 38.09 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 178.448 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.78 -43.4 99.0 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.091 -0.575 . . . . 0.0 111.696 179.233 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.88 -55.54 6.06 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.396 179.895 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.1 tp 51.47 96.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 179.832 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 50.79 29.85 4.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.866 179.782 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 52.35 51.71 15.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.661 179.876 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 tp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.158 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.9 mtp85 . . . . . 1 N--CA 1.315 -7.197 0 CA-C-O 121.596 0.712 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -43.38 -21.1 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.79 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' C ' ' A' ' 4' ' ' ARG . 22.3 mt -99.74 -23.04 15.13 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.885 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.4 tt0 -66.35 -15.55 63.35 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.208 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -63.18 94.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.314 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.0 tt -58.02 -38.45 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.44 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 76.71 -44.48 2.03 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.096 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 13' ' ' GLY . 47.1 tttp -86.28 77.21 9.57 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.77 0.319 . . . . 0.0 110.427 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.463 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -76.29 37.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.231 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 67.74 61.2 5.15 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 59.9 t80 57.08 36.54 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.931 0.396 . . . . 0.0 110.297 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.5 mm 59.36 66.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.391 0.615 . . . . 0.0 110.219 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -132.24 -51.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.006 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 mm -65.9 -43.94 92.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -85.47 -36.69 10.39 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.97 -33.25 86.74 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.28 -0.486 . . . . 0.0 111.889 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.52 -22.51 61.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.763 0.316 . . . . 0.0 110.638 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -76.62 -15.26 59.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.541 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -50.86 -42.13 58.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.582 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -169.68 -13.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.722 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.1 mp . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.047 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 7' ' ' GLU . 43.2 mtm180 . . . . . 1 N--CA 1.325 -6.696 0 CA-C-O 122.572 1.177 . . . . 0.0 112.055 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 44.2 t-105 -42.78 -18.84 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.194 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.502 ' N ' ' C ' ' A' ' 4' ' ' ARG . 42.4 tp -113.76 -21.44 10.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.122 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 4' ' ' ARG . 13.6 tp10 -110.99 46.73 1.04 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.981 0.42 . . . . 0.0 109.87 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.438 ' C ' ' H ' ' A' ' 10' ' ' GLY . 36.9 ttt-85 -63.64 126.59 28.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.569 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' LYS . 4.1 tp -54.05 -10.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . -37.08 -26.52 0.01 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.569 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 9' ' ' ILE . 14.4 pttp -70.46 99.75 1.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.82 -3.17 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.747 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 47.21 49.31 19.26 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.066 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.408 ' O ' HG23 ' A' ' 15' ' ' ILE . 20.2 t80 -160.97 -47.46 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.608 0.242 . . . . 0.0 110.471 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 14' ' ' PHE . 14.8 pt -156.02 55.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.15 0.5 . . . . 0.0 110.598 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 18' ' ' GLY . 3.8 mm -141.28 -48.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -69.36 5.76 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.462 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -175.54 -19.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.809 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -67.3 -57.28 9.52 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.142 -0.551 . . . . 0.0 111.875 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.1 7.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.333 . . . . 0.0 110.596 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 23' ' ' HIS . 12.9 mt 53.92 14.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.47 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -75.99 36.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.787 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.43 ' H ' ' C ' ' A' ' 21' ' ' LEU . 49.7 t-80 54.52 21.4 3.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.564 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 tp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.24 -179.886 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER . . . . . 1 N--CA 1.319 -7.021 0 CA-C-O 121.413 0.625 . . . . 0.0 110.428 . . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 17.8 m0 -44.08 -19.09 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.541 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.9 mt -110.66 -17.98 13.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.617 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.5 mt-10 -110.17 13.21 23.19 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.93 0.395 . . . . 0.0 110.096 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 4' ' ' ARG . 56.9 ttt-85 -52.56 102.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.575 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 tp -56.54 109.16 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.098 0.475 . . . . 0.0 110.154 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.82 -38.28 4.45 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.982 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -65.97 103.97 1.03 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.894 0.378 . . . . 0.0 110.624 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.63 1.67 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.003 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.32 53.68 15.07 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.133 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' O ' HG23 ' A' ' 15' ' ' ILE . 20.7 t80 -163.08 -48.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.682 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 14' ' ' PHE . 8.3 pt -155.74 59.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.337 0.589 . . . . 0.0 110.867 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.5 mm -135.23 -72.37 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.51 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -71.85 -38.94 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.04 -45.62 11.47 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.71 -42.54 38.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.918 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.97 37.37 28.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.775 0.321 . . . . 0.0 110.46 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 23' ' ' HIS . 21.4 mt -75.81 114.95 15.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.636 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 58.55 -76.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.326 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 21' ' ' LEU . 69.1 m-70 -38.55 -32.74 0.08 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.026 0.441 . . . . 0.0 110.868 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.7 tp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.98 178.986 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 7' ' ' GLU . 58.6 mtp180 . . . . . 1 N--CA 1.324 -6.749 0 CA-C-O 122.563 1.173 . . . . 0.0 111.931 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -43.2 -18.97 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.916 -1.947 . . . . 0.0 109.999 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' C ' ' A' ' 4' ' ' ARG . 2.2 pp -111.3 -22.49 11.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.639 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.6 tt0 -88.35 1.05 55.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.032 0.444 . . . . 0.0 110.219 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -58.98 140.45 55.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.621 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 9' ' ' ILE . 5.9 tp -75.74 113.68 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.943 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.1 14.18 6.28 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -91.27 105.86 18.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.7 0.286 . . . . 0.0 110.431 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.46 62.2 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 50.52 53.51 24.58 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.7 t80 60.46 38.06 19.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.07 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.2 mt 61.18 70.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.358 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.59 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -140.28 -50.65 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.89 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.59 ' N ' HG23 ' A' ' 16' ' ' ILE . 4.2 tp -76.58 -29.46 18.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.76 -50.75 3.63 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.65 -42.2 94.11 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.652 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.26 52.81 1.16 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 110.489 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 tt -156.92 61.91 0.52 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -160.33 -34.85 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.656 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -164.94 -24.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.904 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 0.0 110.262 179.946 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER . . . . . 1 N--CA 1.328 -6.555 0 CA-C-O 122.534 1.159 . . . . 0.0 112.191 . . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.437 ' CE3' HD21 ' A' ' 6' ' ' LEU . 27.3 t90 -41.24 -20.11 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 112.846 -1.979 . . . . 0.0 110.412 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.7 mt -115.84 -20.05 10.19 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.347 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.7 tt0 -96.2 30.47 2.47 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.999 0.428 . . . . 0.0 110.208 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.17 146.77 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.472 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 tp -165.16 96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.188 0.518 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.55 24.79 3.02 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.156 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -151.41 72.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.769 0.319 . . . . 0.0 110.375 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.9 45.35 0.9 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.056 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.5 33.76 54.37 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 18.9 t80 71.1 54.32 0.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.691 0.282 . . . . 0.0 110.56 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 mt 63.93 68.09 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.415 0.626 . . . . 0.0 110.94 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.0 mm -135.04 -51.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.662 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.5 mm -70.92 -42.01 77.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.68 -51.57 7.09 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -64.95 -36.3 92.92 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.815 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.08 7.17 0.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.646 0.26 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.7 mt 45.31 78.42 0.06 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.726 0.298 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -168.49 39.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.496 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 57.47 36.97 27.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.498 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.456 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.17 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 7' ' ' GLU . 89.5 mtt180 . . . . . 1 N--CA 1.325 -6.72 0 CA-C-O 122.47 1.128 . . . . 0.0 111.9 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -41.09 -20.49 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.327 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.2 tp -108.51 -26.15 10.57 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.173 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' ARG . 27.2 mp0 -99.83 8.73 43.95 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.84 0.352 . . . . 0.0 110.398 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.9 ttp180 -52.11 118.47 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.463 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.0 pt -61.92 -29.26 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.62 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.44 52.69 27.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.608 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -161.69 80.71 0.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.478 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.415 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -83.97 52.35 2.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.335 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.27 49.1 32.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.855 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.6 t80 61.15 48.73 6.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.897 0.38 . . . . 0.0 110.379 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 mt 61.22 70.87 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.732 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -135.03 -67.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -69.86 -25.07 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.415 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -83.05 -58.75 2.28 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.494 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.41 -32.46 68.16 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.936 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.73 34.97 10.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.773 0.321 . . . . 0.0 110.68 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.483 ' N ' HD23 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -65.89 1.64 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.952 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -58.75 -30.15 67.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.392 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.441 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 4.0 t60 -171.47 23.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.159 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.077 -179.792 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' LEU . 38.0 mtm-85 . . . . . 1 N--CA 1.325 -6.68 0 CA-C-O 122.447 1.118 . . . . 0.0 111.941 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.404 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 41.9 t-105 -41.36 -19.51 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 112.938 -1.937 . . . . 0.0 110.433 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.1 tp -114.57 -20.62 10.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.593 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 66.2 mm-40 -87.02 20.48 2.65 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 110.452 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -53.47 -21.11 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.111 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 11' ' ' LYS . 3.6 tp -165.09 -41.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.837 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 53.84 -82.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.263 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 9' ' ' ILE . 55.8 mttm -51.06 101.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.823 0.344 . . . . 0.0 110.795 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.85 3.27 3.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 45.3 40.43 7.83 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.45 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 15' ' ' ILE . 23.3 t80 -167.51 -20.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.314 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 14' ' ' PHE . 21.8 pt -155.85 50.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 120.925 0.393 . . . . 0.0 111.275 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.419 ' C ' ' H ' ' A' ' 18' ' ' GLY . 2.8 mm -143.77 -51.04 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.4 ' C ' HD12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -71.65 8.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.299 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -167.48 -31.69 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.001 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.79 -30.99 60.41 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.135 -0.555 . . . . 0.0 111.856 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.43 -68.23 0.39 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.735 0.302 . . . . 0.0 110.477 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 tp 52.79 49.44 20.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.448 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -167.23 88.25 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.528 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.6 m80 53.76 25.91 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.466 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.163 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.8 OUTLIER . . . . . 1 N--CA 1.32 -6.943 0 CA-C-O 121.466 0.651 . . . . 0.0 110.414 . . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -43.48 -19.09 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.937 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.5 ' N ' ' C ' ' A' ' 4' ' ' ARG . 43.3 tp -108.28 -20.78 13.02 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.284 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.6 mm-40 -109.34 13.8 24.03 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.5 ttt85 -79.64 -69.09 0.61 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.574 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.1 pt -68.31 -33.65 61.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.4 55.82 23.42 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.944 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -168.26 67.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.481 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.529 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -68.71 76.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.364 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.629 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 46.93 62.68 3.63 Favored Glycine 0 CA--C 1.517 0.218 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.929 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 55.24 34.77 23.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.913 0.387 . . . . 0.0 109.96 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.0 mm 59.8 69.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.541 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 13' ' ' GLY . 9.8 tp -137.51 -34.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.1 mm -92.43 -41.1 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.529 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -77.68 -45.63 10.62 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.63 -37.78 57.65 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.663 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.81 52.21 11.66 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.714 0.293 . . . . 0.0 110.961 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.12 114.12 2.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.034 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 53.73 15.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.454 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.424 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 3.4 t60 54.39 25.83 6.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.465 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.201 179.971 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 7' ' ' GLU . 78.0 mtm180 . . . . . 1 N--CA 1.323 -6.786 0 CA-C-O 122.525 1.155 . . . . 0.0 111.966 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -42.12 -24.56 0.05 OUTLIER 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.718 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.9 mm? -96.42 -30.21 13.49 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.938 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 4' ' ' ARG . 60.3 mt-10 -112.46 49.8 0.9 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.79 0.328 . . . . 0.0 110.545 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -60.32 148.44 36.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.431 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 11' ' ' LYS . 15.7 pt -152.93 -31.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.399 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.26 -17.13 1.94 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.949 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 9' ' ' ILE . 55.0 mttp -69.55 105.88 2.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.687 0.279 . . . . 0.0 110.539 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.454 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -70.65 0.51 6.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.58 -0.77 1.94 Allowed Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.845 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' A' ' 12' ' ' ALA . 62.1 t80 -101.58 -31.78 10.68 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.559 ' O ' ' N ' ' A' ' 17' ' ' ILE . 5.2 pt -153.31 -112.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.225 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 mm 47.61 -81.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 111.355 0.132 . . . . 0.0 111.355 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 15' ' ' ILE . 3.7 tp -69.69 -42.25 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.077 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 17' ' ' ILE . . . -77.63 -42.53 17.25 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.033 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.46 -41.1 31.09 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.087 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.03 53.74 12.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 0.0 110.719 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 21' ' ' LEU . 8.4 mp -60.6 89.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.168 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 50.01 46.24 24.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.69 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.442 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 20.9 t-80 53.57 52.01 14.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.555 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.186 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 7' ' ' GLU . 51.5 mtm180 . . . . . 1 N--CA 1.323 -6.78 0 CA-C-O 122.466 1.127 . . . . 0.0 111.996 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -41.28 -21.34 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.043 -1.889 . . . . 0.0 110.272 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 57.6 tp -105.79 -26.89 11.58 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.219 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.3 mt-10 -90.75 8.88 32.39 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.951 0.405 . . . . 0.0 110.166 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -63.33 82.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.576 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.544 HG23 ' N ' ' A' ' 10' ' ' GLY . 16.4 tt -65.99 -45.25 91.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.356 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.544 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 41.78 45.29 4.65 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.361 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -164.56 71.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.33 . . . . 0.0 110.542 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.27 70.95 1.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.374 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.53 64.51 4.0 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.829 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 50.5 t80 57.53 28.39 15.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.772 0.32 . . . . 0.0 110.476 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.2 mt 62.43 64.71 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.646 0.736 . . . . 0.0 110.161 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -132.54 -49.47 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.786 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.617 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.5 mp -69.72 -44.84 78.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.74 -43.82 11.21 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.72 -43.33 99.22 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.987 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.46 40.66 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.665 0.269 . . . . 0.0 110.703 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.6 tp -52.95 96.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.229 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 53.02 52.55 13.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.432 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.465 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 16.4 t-160 53.8 47.2 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.334 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.005 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 93.3 mtt180 . . . . . 1 N--CA 1.325 -6.722 0 CA-C-O 122.593 1.187 . . . . 0.0 112.039 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CE3' HD21 ' A' ' 6' ' ' LEU . 23.1 t90 -42.96 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 112.791 -2.004 . . . . 0.0 110.455 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 37.7 mt -117.13 -16.31 10.44 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.87 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.4 tt0 -48.52 -26.87 2.38 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.661 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -50.01 148.66 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.634 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 10' ' ' GLY . 16.0 tt -167.63 -40.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.494 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 76.81 -58.64 3.47 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.187 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.0 mttt -52.85 102.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.707 0.289 . . . . 0.0 110.507 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.28 -1.13 2.13 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 44.81 36.05 4.65 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.197 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 15' ' ' ILE . 58.9 t80 -168.97 -17.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.284 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' PHE . 15.0 pt -155.71 50.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.718 0.294 . . . . 0.0 111.057 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 mm -144.31 -47.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.419 ' C ' HD12 ' A' ' 17' ' ' ILE . 1.1 pp -85.29 24.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.186 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.62 -45.84 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.092 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.32 -40.23 98.34 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.039 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -78.49 50.71 0.98 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.839 0.352 . . . . 0.0 110.541 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 pp -59.22 -4.88 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.715 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 2.2 m-20 -52.23 -39.62 60.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.452 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.06 10.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.433 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.826 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 6' ' ' LEU . 73.4 mtt-85 . . . . . 1 N--CA 1.324 -6.747 0 CA-C-O 122.656 1.217 . . . . 0.0 112.047 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -43.07 -18.61 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.854 -1.975 . . . . 0.0 110.337 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 4' ' ' ARG . 19.6 mt -114.32 -18.04 11.66 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.802 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.6 tt0 -48.02 -20.87 0.37 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.76 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 54.35 61.45 3.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.62 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 9' ' ' ILE . 3.2 tp -54.47 113.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.078 0.466 . . . . 0.0 110.126 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.51 34.18 1.28 Allowed Glycine 0 C--N 1.332 0.354 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -150.98 38.51 0.66 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.161 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.498 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -79.68 56.79 2.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.52 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.9 67.13 2.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.979 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 54.44 30.55 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.781 0.324 . . . . 0.0 110.706 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 mt 62.14 65.28 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.552 0.692 . . . . 0.0 110.281 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.2 mm -133.34 -51.65 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.691 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.3 mm -66.59 -42.89 90.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.498 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -81.74 -42.17 9.22 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.23 95.69 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.031 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.47 -30.87 0.61 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.667 0.27 . . . . 0.0 111.179 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 21' ' ' LEU . 8.0 mp -74.44 -47.81 31.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.316 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -50.55 -72.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.608 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -169.98 63.91 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.384 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.303 -179.887 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 6' ' ' LEU . 47.5 mtt85 . . . . . 1 N--CA 1.325 -6.675 0 CA-C-O 122.567 1.175 . . . . 0.0 111.997 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 66.4 t-105 -43.36 -18.31 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.249 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 4' ' ' ARG . 24.4 mt -115.82 -16.45 11.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.812 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.3 tt0 -45.43 -28.08 0.82 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -71.69 -137.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.307 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.2 pt -59.77 -113.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.437 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.26 39.59 82.0 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -57.13 -31.95 65.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.669 0.271 . . . . 0.0 110.541 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.72 -25.53 0.27 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.058 0.456 . . . . 0.0 110.442 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' C ' ' CG ' ' A' ' 14' ' ' PHE . . . 150.97 54.99 0.01 OUTLIER Glycine 0 CA--C 1.509 -0.31 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.442 ' CG ' ' C ' ' A' ' 13' ' ' GLY . 3.4 m-85 75.63 17.46 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.2 mt 61.55 60.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.558 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.1 tp -128.0 -48.69 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.558 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.9 tp -66.25 -36.25 76.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.38 -44.65 4.59 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.27 -33.0 51.93 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.662 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.72 -46.81 41.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.75 0.309 . . . . 0.0 110.863 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' C ' ' H ' ' A' ' 23' ' ' HIS . 40.9 mt 52.49 20.04 1.35 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 0.0 110.278 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 24' ' ' LEU . 66.2 m-20 -76.08 38.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.375 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.426 ' H ' ' C ' ' A' ' 21' ' ' LEU . 32.3 m80 57.67 6.52 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.252 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.279 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 6' ' ' LEU . 79.1 mtm180 . . . . . 1 N--CA 1.324 -6.739 0 CA-C-O 122.492 1.139 . . . . 0.0 112.094 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -41.16 -19.18 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 112.79 -2.005 . . . . 0.0 110.61 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.4 mt -121.99 -14.06 8.09 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.748 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 4' ' ' ARG . 37.1 mt-10 -88.95 -11.18 45.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 110.307 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.9 tpm_? -83.13 106.45 14.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.255 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.496 HG23 ' O ' ' A' ' 9' ' ' ILE . 14.6 tt -63.19 111.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.078 0.466 . . . . 0.0 110.224 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.7 -19.18 79.3 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.147 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.1 mttt -69.96 99.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.713 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.426 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -62.47 -2.65 1.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.161 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 59.18 5.15 2.99 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -85.51 -71.48 0.53 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 14' ' ' PHE . 17.5 pt -158.14 53.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.402 0.62 . . . . 0.0 110.217 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.61 -63.95 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.79 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -70.35 -35.01 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.31 -49.66 7.25 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.412 ' C ' ' N ' ' A' ' 21' ' ' LEU . . . -66.51 -46.35 77.81 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.73 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.4 15.09 0.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.765 0.317 . . . . 0.0 110.7 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.412 ' N ' ' C ' ' A' ' 19' ' ' GLY . 13.9 mt 55.26 11.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.592 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.41 49.07 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.506 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 51.82 20.97 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.542 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.221 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 11.2 mtp180 . . . . . 1 N--CA 1.312 -7.365 0 CA-C-O 121.556 0.693 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -44.24 -19.73 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.743 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.496 ' N ' ' C ' ' A' ' 4' ' ' ARG . 20.2 mt -103.77 -21.18 13.72 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.711 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 35.5 tp10 -68.39 -25.98 65.32 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.337 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.43 ' C ' ' H ' ' A' ' 10' ' ' GLY . 19.9 ttm180 68.09 163.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.003 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.2 pt -53.49 -9.09 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.779 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . 54.42 59.78 9.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.769 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -167.32 73.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.309 . . . . 0.0 110.405 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.494 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -87.63 53.64 2.85 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.058 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.435 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 64.35 33.25 86.73 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 67.0 72.81 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.637 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.3 pt 35.25 56.5 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.989 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 13' ' ' GLY . 4.2 tp -135.63 -43.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.579 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.401 ' N ' HG23 ' A' ' 16' ' ' ILE . 40.8 mm -81.33 -45.42 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.494 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -81.99 -24.78 54.39 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.2 -37.32 21.84 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.25 -72.89 0.08 Allowed 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.667 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.7 mt 58.62 24.73 12.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.471 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.21 -103.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.471 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -71.24 -4.76 27.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 110.649 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.412 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.1 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' GLU . 61.2 mtm180 . . . . . 1 N--CA 1.324 -6.775 0 CA-C-O 122.47 1.128 . . . . 0.0 111.946 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -41.3 -20.03 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 112.981 -1.918 . . . . 0.0 110.415 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.8 tp -110.38 -24.58 10.55 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.334 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' ARG . 55.2 mm-40 -96.81 33.91 1.79 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.768 0.318 . . . . 0.0 110.249 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -64.47 -74.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.715 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.594 ' C ' HD12 ' A' ' 9' ' ' ILE . 2.4 pp -68.64 -2.87 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.788 0.328 . . . . 0.0 110.66 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.57 ' N ' HD12 ' A' ' 9' ' ' ILE . . . -86.93 70.38 2.92 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 112.068 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -50.27 -32.53 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.107 0.48 . . . . 0.0 109.893 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -163.88 -0.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.124 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 46.3 32.84 5.38 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.931 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -149.87 -11.79 0.28 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.906 0.384 . . . . 0.0 110.007 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.8 pt -154.88 40.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.078 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.4 tp -151.36 -25.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.0 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -81.51 4.93 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.497 179.147 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.486 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -177.79 -13.76 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.953 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.94 -10.16 86.42 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.051 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.67 53.96 1.81 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.727 0.298 . . . . 0.0 110.573 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.1 mt -56.97 110.38 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.367 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 3.1 m-20 52.88 21.54 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.615 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.466 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 19.6 t60 53.75 46.52 25.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.582 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.33 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.0 mtm180 . . . . . 1 N--CA 1.324 -6.772 0 CA-C-O 122.626 1.203 . . . . 0.0 112.006 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -42.53 -24.25 0.05 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.058 -1.883 . . . . 0.0 109.838 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 6' ' ' LEU . 10.3 mp -95.82 -28.03 14.93 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.406 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 4' ' ' ARG . 38.3 tt0 -48.42 -29.07 3.67 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.686 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 7' ' ' GLU . 11.8 tpp180 60.36 129.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.68 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.2 tt -54.29 -37.95 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.404 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 55.04 59.05 11.04 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.0 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -169.15 68.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.792 0.329 . . . . 0.0 110.512 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.78 67.78 1.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.486 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 56.16 41.88 86.86 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.99 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.6 43.0 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 0.0 109.826 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.2 mt 54.95 61.64 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.372 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.4 mm -129.81 -42.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.009 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.7 mm -87.79 -37.3 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.0 -49.07 10.13 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -75.09 -37.4 43.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.811 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.67 5.58 0.35 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 0.0 110.586 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' A' ' 19' ' ' GLY . 9.0 tp 46.62 63.16 2.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.748 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -158.67 47.44 0.33 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.548 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 1.7 t60 51.98 20.78 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.474 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.7 tp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.257 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.587 ' O ' ' N ' ' A' ' 7' ' ' GLU . 6.7 mtt-85 . . . . . 1 N--CA 1.321 -6.882 0 CA-C-O 121.308 0.575 . . . . 0.0 111.303 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -42.68 -19.62 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.643 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.9 tp -107.66 -21.54 12.84 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.987 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.587 ' N ' ' O ' ' A' ' 4' ' ' ARG . 94.8 mt-10 -115.73 30.32 7.42 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 ptt85 -50.3 143.64 8.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.968 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.412 ' C ' ' H ' ' A' ' 11' ' ' LYS . 14.8 pt -64.93 -23.92 34.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.357 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.86 7.18 1.52 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.354 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' H ' ' C ' ' A' ' 9' ' ' ILE . 56.3 mttp -144.84 75.66 1.46 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.953 0.406 . . . . 0.0 110.226 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.542 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -76.86 62.92 2.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.647 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.62 68.92 1.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.091 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 61.8 t80 55.29 27.98 10.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.591 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.2 mt 61.51 63.55 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.652 0.739 . . . . 0.0 110.035 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 mm -131.65 -48.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.762 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.631 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.5 mp -69.79 -46.1 75.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.542 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -78.28 -43.29 13.33 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.78 -44.59 96.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.676 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.54 82.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.372 . . . . 0.0 110.405 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp 55.43 57.81 5.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.393 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.0 t70 58.0 45.82 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.683 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 49.64 52.37 14.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.7 tp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.211 179.94 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 6' ' ' LEU . 75.3 mtt85 . . . . . 1 N--CA 1.325 -6.684 0 CA-C-O 122.526 1.155 . . . . 0.0 112.161 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 23.5 t90 -42.37 -16.86 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.63 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.1 tp -125.22 -12.19 6.89 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.984 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -76.11 -25.91 55.89 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.812 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -75.88 -135.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.29 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.6 pt -143.68 127.9 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.258 0.552 . . . . 0.0 110.117 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.0 -11.42 78.86 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.942 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -60.19 110.94 1.34 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.94 4.6 6.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 39.25 38.48 0.88 Allowed Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.634 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -168.05 -15.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.693 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 pt -152.71 46.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.192 0.52 . . . . 0.0 110.228 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -145.73 -41.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.256 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.539 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.8 pp -69.02 2.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.222 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.539 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -172.26 -30.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.873 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.89 -37.06 52.13 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.864 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -26.07 59.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.754 0.311 . . . . 0.0 110.508 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.5 tp 57.25 63.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.38 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER 52.31 46.54 26.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.555 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 52.03 60.67 3.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.495 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.15 -180.0 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 7' ' ' GLU . 16.1 mtp180 . . . . . 1 N--CA 1.316 -7.163 0 CA-C-O 121.492 0.663 . . . . 0.0 110.523 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -43.7 -21.48 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.682 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 4' ' ' ARG . 16.7 mt -96.83 -24.54 15.85 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.677 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.7 tm-20 -68.0 -28.84 67.77 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.267 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -58.21 128.89 39.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.467 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 pt -75.32 115.39 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.401 0.62 . . . . 0.0 110.239 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.56 -2.1 79.15 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.775 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 13' ' ' GLY . 59.6 mttp -75.4 98.33 3.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.701 0.286 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.403 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -77.68 37.39 0.23 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.478 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 73.34 63.11 2.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.916 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 63.8 t80 56.1 32.56 20.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.814 0.34 . . . . 0.0 110.773 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.0 mt 61.01 63.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.588 0.708 . . . . 0.0 109.948 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.0 mm -132.43 -51.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.93 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.8 mm -68.94 -41.18 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.403 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -80.07 -48.77 6.31 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -66.82 -31.95 79.75 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.037 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.27 1.64 0.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.775 0.321 . . . . 0.0 110.568 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.1 tp 61.02 5.42 1.0 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.37 -97.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.211 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -88.97 -36.86 15.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.885 0.374 . . . . 0.0 110.361 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.508 -179.94 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 7' ' ' GLU . 12.1 mtt85 . . . . . 1 N--CA 1.317 -7.076 0 CA-C-O 121.538 0.685 . . . . 0.0 110.563 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.52 ' CE3' HD21 ' A' ' 6' ' ' LEU . 26.3 t90 -43.83 -18.4 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.519 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.52 HD21 ' CE3' ' A' ' 5' ' ' TRP . 30.2 mt -114.43 -16.04 11.99 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.728 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 4' ' ' ARG . 90.6 mt-10 -118.5 31.1 6.84 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -51.97 -18.41 1.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.97 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.437 ' C ' ' H ' ' A' ' 11' ' ' LYS . 18.3 pt -154.45 -24.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.603 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.68 -35.07 1.01 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.874 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 9' ' ' ILE . 58.0 mttp -54.38 108.27 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.07 2.84 3.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.036 0.446 . . . . 0.0 110.09 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.23 34.73 0.65 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.535 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -166.26 -17.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.2 pt -152.23 50.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.139 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.451 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.4 tp -145.73 -39.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.078 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -78.63 4.64 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.214 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.475 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -159.13 -30.86 0.02 OUTLIER Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.69 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.65 -35.95 47.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.592 179.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.39 47.22 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.729 0.3 . . . . 0.0 110.822 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 21' ' ' LEU . 9.8 mp -60.37 114.55 2.99 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.7 t0 58.22 -78.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.696 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' LEU . 55.3 t-80 -166.81 30.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.534 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.448 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.6 tt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.153 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.5 ' C ' ' N ' ' A' ' 6' ' ' LEU . 12.7 mtt180 . . . . . 1 N--CA 1.312 -7.329 0 CA-C-O 121.549 0.69 . . . . 0.0 110.058 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CE3' HD21 ' A' ' 6' ' ' LEU . 23.0 t90 -45.34 -17.37 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.947 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.5 ' N ' ' C ' ' A' ' 4' ' ' ARG . 32.1 mt -114.09 -12.51 12.55 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.997 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 4' ' ' ARG . 12.3 tm-20 -64.26 -22.35 66.92 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.778 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -43.4 96.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.18 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 11' ' ' LYS . 16.4 pt -64.49 -17.96 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.417 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.09 -37.14 1.09 Allowed Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 9' ' ' ILE . 9.1 mtpm? -71.85 107.23 4.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.802 0.334 . . . . 0.0 110.297 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.562 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -77.84 45.71 0.53 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.646 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.32 66.79 2.28 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.188 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 58.1 t80 54.44 30.9 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.748 0.309 . . . . 0.0 110.663 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mt 61.98 65.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.626 0.727 . . . . 0.0 110.271 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -132.29 -48.28 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.934 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.5 mp -70.83 -45.75 71.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.562 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -77.92 -42.74 15.69 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 178.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.99 -47.42 90.82 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.652 179.238 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -60.86 -48.89 79.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.789 0.328 . . . . 0.0 110.244 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tp 62.07 1.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.34 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 20' ' ' ALA . 70.0 m-20 -85.79 37.61 0.71 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.366 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.475 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 0.7 OUTLIER 54.18 24.42 4.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.527 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.9 tt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.127 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.5 mtm180 . . . . . 1 N--CA 1.325 -6.72 0 CA-C-O 122.564 1.173 . . . . 0.0 111.973 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -40.89 -21.21 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.317 179.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 8.1 tp -106.8 -26.43 11.27 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.455 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' ARG . 50.5 tt0 -90.1 -0.34 57.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.23 0.538 . . . . 0.0 109.736 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.6 ptt85 -45.93 147.89 0.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 mt -79.9 -64.61 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.109 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 79.02 -13.8 17.5 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.936 179.308 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.548 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 2.4 ttmp? -70.31 7.14 1.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.263 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 75.72 -20.68 0.34 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.344 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 35.21 65.77 0.4 Allowed Glycine 0 C--N 1.339 0.708 0 N-CA-C 112.254 -0.338 . . . . 0.0 112.254 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 56.04 36.67 27.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -178.553 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' ALA . 11.9 mm 64.24 80.49 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.765 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.624 HG23 ' N ' ' A' ' 17' ' ' ILE . 8.7 tp -145.84 -54.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.194 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.624 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.7 tp -74.77 -33.8 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.807 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.15 -47.69 4.88 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 178.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.14 96.76 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.08 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.21 -64.86 0.68 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.759 0.314 . . . . 0.0 110.543 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.9 tp 55.4 74.59 0.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.569 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -165.3 41.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.558 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.466 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 3.5 m80 53.31 48.92 20.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.488 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.6 tp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.319 -179.966 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.8 mmt180 . . . . . 1 N--CA 1.324 -6.753 0 CA-C-O 122.51 1.148 . . . . 0.0 111.943 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.529 ' CE3' HD21 ' A' ' 6' ' ' LEU . 31.3 t90 -41.05 -20.24 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.298 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.529 HD21 ' CE3' ' A' ' 5' ' ' TRP . 27.8 mt -109.69 -24.86 10.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.562 179.264 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 4' ' ' ARG . 22.2 tt0 -101.71 14.08 33.02 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.993 0.425 . . . . 0.0 110.026 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.7 ttp85 -72.06 -50.15 30.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 11' ' ' LYS . 21.0 pt -62.34 -23.54 32.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.705 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.45 -32.11 1.17 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.249 -0.5 . . . . 0.0 111.898 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 9' ' ' ILE . 93.7 mttt -73.66 108.99 6.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.161 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.03 8.51 4.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.209 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 43.99 30.71 1.81 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.101 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -155.68 -76.71 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.653 0.263 . . . . 0.0 110.34 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.565 ' O ' HG23 ' A' ' 15' ' ' ILE . 17.1 tt -90.41 47.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.951 0.881 . . . . 0.0 110.087 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.511 HG23 ' N ' ' A' ' 17' ' ' ILE . 3.9 tp -142.33 -44.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.378 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.511 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.1 tp -82.55 -39.47 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.109 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.58 -45.54 4.89 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.568 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -58.26 -36.22 81.92 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.909 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.13 39.63 0.19 Allowed 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.69 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.402 ' H ' ' C ' ' A' ' 19' ' ' GLY . 21.2 tp -68.05 -51.98 40.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.117 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -54.42 -45.47 73.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.609 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.418 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -48.48 -36.86 15.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.32 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.648 179.547 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 6' ' ' LEU . 73.1 mtp180 . . . . . 1 N--CA 1.324 -6.774 0 CA-C-O 122.597 1.189 . . . . 0.0 112.182 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -40.67 -20.51 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 112.828 -1.987 . . . . 0.0 110.797 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.7 tp -112.06 -19.29 12.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.088 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.3 tp10 -60.81 -27.87 68.36 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.31 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -57.78 153.37 13.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.599 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 pt -155.89 8.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.121 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.24 29.53 5.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.288 -0.482 . . . . 0.0 111.94 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -161.75 55.35 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.954 0.407 . . . . 0.0 110.382 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.14 -0.45 31.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.932 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.42 54.31 0.23 Allowed Glycine 0 C--N 1.332 0.316 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 41.1 t80 63.22 29.09 15.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.755 0.312 . . . . 0.0 110.341 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.6 mt 61.25 60.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.632 0.729 . . . . 0.0 109.353 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.6 mm -126.44 -47.96 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.249 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.596 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.4 mp -66.7 -38.91 82.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.828 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.86 -40.26 6.3 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 178.394 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.14 79.56 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.983 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.7 -39.45 73.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.72 0.295 . . . . 0.0 110.691 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.2 mt 51.25 71.45 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.485 -179.837 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.464 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 1.9 m-20 50.98 37.67 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.507 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.8 m80 53.7 61.4 3.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.684 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 tp . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.308 179.975 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 87.4 mtm180 . . . . . 1 N--CA 1.323 -6.784 0 CA-C-O 122.564 1.173 . . . . 0.0 112.001 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -43.22 -18.26 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 113.002 -1.908 . . . . 0.0 110.178 179.72 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.2 tt -114.17 -19.5 11.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.711 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.4 tp10 -82.0 16.99 1.69 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.394 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -70.3 178.35 2.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.619 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 9' ' ' ILE . 16.6 tt -170.82 130.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.453 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.99 17.2 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.837 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.58 -2.76 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.269 -0.172 . . . . 0.0 110.788 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 58.94 62.94 1.75 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.982 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.34 85.97 0.01 OUTLIER Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.469 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 12' ' ' ALA . 29.4 t80 64.14 38.27 8.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.966 0.413 . . . . 0.0 110.043 -179.085 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.4 mm 61.41 73.7 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.095 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -133.72 -53.39 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.081 179.341 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.6 mp -70.44 -51.32 38.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.787 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.09 -42.44 51.29 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 178.926 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.46 -45.42 96.43 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.024 179.413 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.72 -16.2 62.76 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.813 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.8 mt 51.87 79.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.289 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.8 p30 42.45 32.58 0.36 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.157 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 15.3 m80 58.96 61.76 2.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.583 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 -179.931 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 6' ' ' LEU . 52.0 mtm-85 . . . . . 1 N--CA 1.324 -6.754 0 CA-C-O 122.488 1.137 . . . . 0.0 112.004 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -41.92 -19.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.149 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 24.0 mt -118.66 -16.29 9.42 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.581 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.7 tt0 -87.96 -6.03 58.22 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 120.92 0.39 . . . . 0.0 110.181 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 62.12 -131.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.247 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 9' ' ' ILE . 14.8 tt -163.43 123.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 110.371 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.89 27.9 4.23 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.191 -179.625 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -101.12 100.84 11.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.774 0.321 . . . . 0.0 110.309 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.55 57.64 3.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.004 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.54 49.25 53.22 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.495 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 48.1 t80 59.05 45.06 15.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 110.533 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 mt 62.42 68.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.167 0.508 . . . . 0.0 110.628 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -134.04 -65.79 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 tp -71.19 -21.89 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.867 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.3 -45.16 5.09 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.613 179.717 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.67 -39.6 34.02 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.398 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.58 -75.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.638 0.256 . . . . 0.0 111.327 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.6 mt 59.76 14.03 3.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.146 -179.228 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 19.1 m-20 -74.33 -83.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.652 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.462 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 96.9 m-70 -156.52 56.28 0.56 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.469 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.127 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.0 mtt180 . . . . . 1 N--CA 1.325 -6.688 0 CA-C-O 122.472 1.13 . . . . 0.0 112.082 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 66.9 t-105 -41.81 -19.28 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 112.892 -1.958 . . . . 0.0 110.358 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 mt -117.04 -18.36 10.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.549 179.301 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 4' ' ' ARG . 57.5 mm-40 -89.68 18.58 5.37 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.843 0.354 . . . . 0.0 110.411 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -55.25 -173.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 pt -150.09 124.28 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.967 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.44 -3.32 31.95 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.898 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -77.01 96.28 4.36 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.489 ' O ' ' CD1' ' A' ' 14' ' ' PHE . . . -57.87 -9.87 1.48 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 109.998 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.47 34.61 81.81 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.029 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 12' ' ' ALA . 61.4 m-85 -142.8 -53.21 0.39 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.795 -0.238 . . . . 0.0 110.404 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 pt -153.97 61.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.081 0.467 . . . . 0.0 110.589 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.4 mm -136.2 -39.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.416 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.429 ' C ' HD12 ' A' ' 17' ' ' ILE . 1.2 pp -96.87 14.59 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.32 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.17 -48.28 0.02 OUTLIER Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.135 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.05 -43.47 93.23 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.895 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -62.98 -53.22 57.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.796 0.331 . . . . 0.0 110.427 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tp 63.13 1.38 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.389 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 20' ' ' ALA . 30.7 t70 -78.3 56.76 1.76 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.625 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 54.6 t-80 55.59 17.98 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.602 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.1 tp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.215 -179.967 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 7' ' ' GLU . 1.2 mtm-85 . . . . . 1 N--CA 1.319 -6.987 0 CA-C-O 121.503 0.668 . . . . 0.0 110.041 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -43.4 -18.74 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.141 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.1 mt -111.32 -18.0 13.02 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.744 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.7 mp0 -105.56 29.24 6.7 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 120.886 0.374 . . . . 0.0 110.112 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 10' ' ' GLY . 85.6 mtm180 -47.72 -71.5 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.768 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 pt -57.88 -6.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.453 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . 50.51 51.06 33.81 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.928 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -166.97 74.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.409 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.27 62.89 3.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.203 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.69 49.66 16.01 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 -179.682 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.4 t80 63.88 48.66 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 110.121 -179.539 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mm 51.45 65.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.401 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.4 mm -132.7 -62.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.373 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 tp -67.67 -31.02 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.271 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.16 -48.87 4.67 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.82 -44.17 97.28 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.12 -71.82 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.18 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.9 tp 52.62 80.24 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.57 179.707 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -158.86 -69.53 0.09 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.442 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -165.62 37.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.593 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.452 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.9 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.096 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 7' ' ' GLU . 94.6 mtt180 . . . . . 1 N--CA 1.324 -6.732 0 CA-C-O 122.594 1.188 . . . . 0.0 111.996 . . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -42.0 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.435 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.0 mt -110.13 -21.08 12.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.912 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 38.4 tt0 -47.54 -19.85 0.21 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.911 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -52.02 -71.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.493 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.668 HG23 ' H ' ' A' ' 10' ' ' GLY . 14.6 tt -70.1 -59.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.332 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.668 ' H ' HG23 ' A' ' 9' ' ' ILE . . . 44.3 38.61 5.13 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.431 179.089 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 61.5 mttp -96.15 -1.05 49.23 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 76.06 -30.28 0.19 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.156 -179.276 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.8 68.33 0.48 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 63.24 58.74 1.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.599 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 pt 38.77 81.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.998 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.3 mm -134.17 -41.45 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.471 178.648 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.92 -73.31 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.687 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.25 -44.0 98.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.719 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -77.47 -47.12 9.19 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 121.302 -0.475 . . . . 0.0 111.95 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.5 8.02 0.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 110.477 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.434 ' H ' ' C ' ' A' ' 19' ' ' GLY . 12.7 tp 52.82 75.81 0.22 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.399 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.1 p30 -168.3 49.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.1 t60 52.39 20.41 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.43 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.242 -179.995 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 52.7 mtp85 . . . . . 1 N--CA 1.324 -6.745 0 CA-C-O 122.56 1.172 . . . . 0.0 112.026 . . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.414 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 45.2 t-105 -41.95 -18.03 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.642 -179.881 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.6 tp -128.47 -8.42 5.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.625 179.622 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.8 tt0 -87.93 -7.68 56.8 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 110.174 179.819 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -54.33 -83.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.523 179.886 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 11' ' ' LYS . 22.5 pt -78.31 16.48 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.812 0.339 . . . . 0.0 110.541 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.21 90.43 0.01 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.234 -179.821 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' ILE . 9.8 mtmp? -154.34 -2.42 0.18 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.69 57.09 5.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.198 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.486 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -43.1 88.38 0.01 OUTLIER Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.834 -179.648 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 12' ' ' ALA . 98.0 m-85 53.54 44.63 29.59 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.15 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.4 mt 61.9 76.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.643 -179.84 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 13' ' ' GLY . 7.4 tp -142.73 -28.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.346 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 mm -104.26 -39.89 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.378 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.52 -59.88 4.28 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.413 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.414 ' C ' ' N ' ' A' ' 21' ' ' LEU . . . -72.41 -36.64 59.18 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.554 179.542 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.9 16.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.663 0.268 . . . . 0.0 111.053 179.734 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.437 ' C ' ' N ' ' A' ' 23' ' ' HIS . 23.7 mt 54.08 -123.7 2.14 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.048 -179.735 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 t0 46.05 17.6 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.761 0.315 . . . . 0.0 110.876 179.801 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.437 ' N ' ' C ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER 51.78 41.69 29.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.339 -179.862 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.7 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.256 -179.923 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' GLU . 58.8 mtm180 . . . . . 1 N--CA 1.325 -6.714 0 CA-C-O 122.436 1.113 . . . . 0.0 111.949 . . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.459 ' CE3' HD21 ' A' ' 6' ' ' LEU . 27.6 t90 -42.19 -18.93 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.294 179.932 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.5 mt -112.21 -23.09 10.61 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.379 179.077 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 82.3 mt-10 -97.24 14.26 26.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.85 0.357 . . . . 0.0 110.328 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -62.86 -37.2 85.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.709 -179.857 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 11' ' ' LYS . 4.1 tp -170.04 -11.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.96 0.409 . . . . 0.0 109.915 -179.799 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 9' ' ' ILE . . . -37.4 -25.98 0.02 OUTLIER Glycine 0 C--N 1.335 0.482 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.634 179.615 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 9' ' ' ILE . 85.9 mttt -71.2 103.29 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.31 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.7 2.87 0.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.64 -179.813 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.75 45.42 3.61 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.557 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -163.47 -41.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.663 0.268 . . . . 0.0 110.65 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 pt -154.26 60.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.105 0.479 . . . . 0.0 110.442 179.998 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 mm -147.58 -30.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.4 mm -112.39 -49.45 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.447 179.206 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.51 -41.99 49.71 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.344 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.09 -38.25 7.41 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 179.52 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.6 67.46 1.0 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.332 . . . . 0.0 110.499 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 23' ' ' HIS . 9.7 tp -49.61 120.83 4.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.514 179.889 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 52.58 -85.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.694 179.864 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -156.91 45.07 0.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.36 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.26 -179.841 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 7' ' ' GLU . 10.3 mtm180 . . . . . 1 N--CA 1.319 -7.0 0 CA-C-O 121.389 0.614 . . . . 0.0 110.658 . . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -43.53 -18.63 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.312 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.533 ' N ' ' C ' ' A' ' 4' ' ' ARG . 36.3 mt -115.2 -14.9 11.7 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.937 178.919 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.1 mt-10 -118.2 25.95 9.97 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.413 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -66.93 152.22 46.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.565 -179.903 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.511 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.0 tt -68.93 -42.99 82.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.363 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.511 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 44.69 -129.71 7.59 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.232 -179.987 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 90.4 mttt 49.79 18.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.302 . . . . 0.0 110.532 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 71.9 -13.6 0.57 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.775 -179.918 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.97 56.59 2.14 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 112.211 -0.355 . . . . 0.0 112.211 179.99 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 67.43 46.99 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.07 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.2 mm 62.68 77.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.891 -179.945 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' ALA . 7.6 mm -131.77 -73.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.4 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -74.47 -29.77 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.418 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.85 -53.12 8.4 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.18 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -77.15 -45.21 11.85 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.526 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.59 10.72 0.24 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.768 0.318 . . . . 0.0 110.537 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 21' ' ' LEU . 8.6 mp 53.85 -111.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.016 -179.97 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 t70 54.91 -82.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.708 0.289 . . . . 0.0 110.757 179.924 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' LEU . 15.4 t60 -160.67 4.31 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.425 179.922 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.538 179.894 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 7' ' ' GLU . 10.1 mtp180 . . . . . 1 N--CA 1.314 -7.235 0 CA-C-O 121.557 0.694 . . . . 0.0 110.593 . . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -44.37 -21.62 0.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.387 -179.773 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.476 ' N ' ' C ' ' A' ' 4' ' ' ARG . 17.1 mt -99.81 -21.26 15.82 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.634 179.713 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.3 tp10 -68.83 -28.19 66.52 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.467 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -66.15 155.73 36.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.575 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.52 HG23 ' O ' ' A' ' 9' ' ' ILE . 16.8 tt -165.87 121.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.478 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.26 -25.34 19.41 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 13' ' ' GLY . 45.9 mttp -83.3 87.66 6.95 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.947 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.07 17.58 1.21 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.586 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 57.61 22.3 45.65 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.452 -179.531 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.421 ' C ' ' H ' ' A' ' 16' ' ' ILE . 45.5 t80 -146.06 -55.29 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.8 pt -80.37 31.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 179.71 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.538 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.6 tp -148.54 -46.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.924 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.538 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.5 tp -79.26 -32.33 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.188 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.78 -47.75 3.86 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 178.655 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.42 -38.39 86.72 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.408 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -75.01 -68.64 0.53 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.845 0.355 . . . . 0.0 110.285 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.432 ' C ' ' H ' ' A' ' 23' ' ' HIS . 0.7 OUTLIER 59.03 5.96 0.6 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.052 179.879 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 20' ' ' ALA . 8.4 m-20 -77.58 23.0 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.531 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.432 ' H ' ' C ' ' A' ' 21' ' ' LEU . 37.8 m-70 52.86 35.67 19.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.427 179.964 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.251 -179.988 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.602 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.9 mtt-85 . . . . . 1 N--CA 1.314 -7.254 0 CA-C-O 121.586 0.707 . . . . 0.0 110.175 . . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -41.28 -24.21 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.957 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.4 mm? -92.33 -29.3 16.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.209 179.459 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.7 tt0 -71.3 -19.02 62.38 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.126 179.715 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.44 131.78 51.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.525 179.947 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.8 pt -64.16 -34.51 69.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.529 -179.901 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.51 47.02 92.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.074 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -154.18 73.19 0.91 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.782 0.325 . . . . 0.0 110.254 179.988 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.514 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -80.01 49.65 1.11 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.612 179.908 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.73 65.71 2.91 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.166 179.897 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 54.77 31.63 15.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.701 0.286 . . . . 0.0 110.923 179.785 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 61.26 64.08 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.578 0.704 . . . . 0.0 110.277 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 mm -133.01 -47.28 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.717 179.923 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.5 mp -72.13 -46.18 59.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.858 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.514 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -75.92 -48.7 9.6 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.082 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.53 -42.45 99.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.857 179.618 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 59.95 3.39 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.743 0.306 . . . . 0.0 110.784 -179.958 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.2 mt 49.71 13.41 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.736 179.91 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.439 ' N ' ' C ' ' A' ' 20' ' ' ALA . 47.6 t0 -62.83 -73.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.565 179.984 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -169.62 20.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.548 179.942 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 24' ' ' LEU . 10.1 mp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.079 179.908 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 7' ' ' GLU . 65.5 mtt-85 . . . . . 1 N--CA 1.321 -6.897 0 CA-C-O 122.633 1.206 . . . . 0.0 111.949 . . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -43.03 -19.04 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.151 179.876 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.497 ' N ' ' C ' ' A' ' 4' ' ' ARG . 20.6 mt -111.89 -19.66 12.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.75 179.788 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.2 tt0 -49.04 -24.58 1.62 Allowed 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.71 -179.844 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 56.5 99.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.231 -179.913 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 pt -62.59 113.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.411 0.624 . . . . 0.0 110.279 -179.845 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.82 8.25 8.03 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.648 179.854 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.457 ' HA ' HG21 ' A' ' 16' ' ' ILE . 57.5 mttp -67.28 108.37 2.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.694 0.283 . . . . 0.0 110.64 -179.924 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.91 4.76 5.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.064 0.459 . . . . 0.0 109.783 179.536 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 14' ' ' PHE . . . 59.99 22.89 58.55 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.998 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 63.9 m-85 -158.6 -100.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.738 0.304 . . . . 0.0 111.166 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.8 pt -78.05 60.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.988 0.423 . . . . 0.0 111.739 -178.834 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.457 HG21 ' HA ' ' A' ' 11' ' ' LYS . 16.7 mm -149.26 -44.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.036 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.03 -50.07 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.805 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.56 -43.61 67.79 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.059 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.1 -42.62 7.96 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 179.386 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.35 50.38 18.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.767 0.318 . . . . 0.0 110.649 179.861 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.3 mt -75.19 -26.76 59.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.416 179.931 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 24' ' ' LEU . 16.3 m-20 -77.2 -67.77 0.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.42 1.4 0.79 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.709 -179.798 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 22' ' ' ASP . 1.6 tt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.351 179.992 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 7' ' ' GLU . 88.0 mtt180 . . . . . 1 N--CA 1.324 -6.76 0 CA-C-O 122.536 1.16 . . . . 0.0 111.855 . . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -42.7 -21.34 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.836 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.483 ' N ' ' C ' ' A' ' 4' ' ' ARG . 11.0 mp -105.27 -26.32 12.07 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.995 179.151 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 4' ' ' ARG . 22.4 mm-40 -93.34 37.65 1.05 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.694 0.283 . . . . 0.0 110.607 -179.855 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -69.9 172.36 7.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.446 179.988 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 tp -170.4 124.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.192 179.849 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.36 25.26 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.769 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -69.62 -5.81 27.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 55.54 60.72 3.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.015 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.66 87.59 0.01 OUTLIER Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -179.657 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 12' ' ' ALA . 98.8 m-85 54.01 42.05 31.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -178.621 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.5 mt 62.66 83.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.465 -179.576 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.633 HG23 ' H ' ' A' ' 17' ' ' ILE . 5.2 tp -143.66 -58.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.398 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.633 ' H ' HG23 ' A' ' 16' ' ' ILE . 3.7 tp -86.15 -26.34 6.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.505 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.18 -55.29 4.42 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 178.871 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.16 -43.28 40.19 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.632 179.299 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.34 38.76 30.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.694 0.283 . . . . 0.0 110.778 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.1 mt -99.8 -20.07 16.39 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.481 179.839 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -50.09 -50.9 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -165.28 -20.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.46 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.6 mp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.169 179.923 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 7' ' ' GLU . 71.1 mtm180 . . . . . 1 N--CA 1.325 -6.71 0 CA-C-O 122.467 1.127 . . . . 0.0 112.057 . . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -41.19 -20.05 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 112.924 -1.944 . . . . 0.0 110.334 179.834 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.0 tp -112.93 -22.62 10.53 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.342 179.351 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.2 mm-40 -102.06 38.77 1.59 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.657 0.265 . . . . 0.0 110.563 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -51.47 139.23 20.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.383 179.981 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.554 HG23 ' H ' ' A' ' 10' ' ' GLY . 2.7 tp -52.64 -56.08 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.406 -179.797 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.554 ' H ' HG23 ' A' ' 9' ' ' ILE . . . 74.49 -38.92 1.04 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.073 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -78.12 105.42 9.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.745 0.307 . . . . 0.0 110.389 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.85 9.17 3.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.192 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.13 34.43 12.25 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.114 179.878 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -161.96 -73.85 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.826 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 pt -81.48 38.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.207 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 17' ' ' ILE . 4.0 tp -146.23 -42.72 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.087 -179.656 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.56 ' C ' HD12 ' A' ' 17' ' ' ILE . 2.2 pp -77.04 0.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.043 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.55 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -158.15 -42.64 0.02 OUTLIER Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.686 -179.808 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -61.23 -36.34 92.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.69 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.438 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 56.29 6.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.748 0.308 . . . . 0.0 110.704 179.918 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.436 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.0 tp 49.97 14.09 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.411 179.99 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.438 ' N ' ' C ' ' A' ' 20' ' ' ALA . 18.3 t70 -71.73 -40.96 69.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.441 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.466 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -165.78 12.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.343 179.9 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.226 -179.988 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 7' ' ' GLU . 94.8 mtt180 . . . . . 1 N--CA 1.326 -6.634 0 CA-C-O 122.672 1.225 . . . . 0.0 111.966 . . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -42.11 -20.12 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.964 -1.925 . . . . 0.0 110.38 179.83 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.3 mt -110.18 -20.48 12.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.995 179.93 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.6 tt0 -46.99 -22.02 0.28 Allowed 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.823 -179.917 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 -79.61 -44.05 21.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 9' ' ' ILE . 26.4 mm -70.28 -6.88 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 -179.64 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.37 -25.57 6.18 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.739 -0.744 . . . . 0.0 111.35 179.542 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 13' ' ' GLY . 98.0 mttt -116.68 76.45 1.03 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.228 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.92 84.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.381 -179.535 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . 47.18 54.65 9.62 Favored Glycine 0 C--N 1.33 0.209 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -179.593 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.1 t80 57.68 39.91 26.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.885 0.374 . . . . 0.0 110.285 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 mt 60.85 67.59 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.482 -179.979 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.524 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.2 tp -137.89 -47.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.387 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.524 ' N ' HG23 ' A' ' 16' ' ' ILE . 28.9 mm -77.63 -36.68 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.297 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.12 -50.68 6.64 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 178.884 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . -67.61 -36.86 88.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.568 179.342 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 73.17 -35.68 0.33 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.635 0.255 . . . . 0.0 111.06 179.865 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.4 mm? 53.35 10.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.953 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 20' ' ' ALA . 15.8 t0 -79.56 -37.42 36.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.623 -179.913 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -167.6 -22.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.806 -179.942 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.418 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.145 -179.958 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 7' ' ' GLU . 58.0 mtm180 . . . . . 1 N--CA 1.323 -6.802 0 CA-C-O 122.391 1.091 . . . . 0.0 112.001 . . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -38.48 -26.56 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.118 -1.856 . . . . 0.0 110.354 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.4 mm? -94.18 -33.54 13.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.077 179.334 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.5 mt-10 -96.1 14.14 24.87 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.708 0.289 . . . . 0.0 110.437 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 4' ' ' ARG . 0.6 OUTLIER -70.04 -68.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.322 -179.795 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.5 pt -98.59 -33.34 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.63 179.894 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.01 59.89 6.52 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.841 -179.724 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -162.75 83.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.34 . . . . 0.0 110.241 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.474 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -79.33 57.03 2.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 -179.825 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 57.31 64.47 4.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.057 179.993 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 47.0 t80 54.89 33.27 19.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.797 0.332 . . . . 0.0 110.467 179.918 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 mt 59.52 64.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.575 0.702 . . . . 0.0 110.113 -179.831 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -132.18 -51.87 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.847 -179.941 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 mm -68.87 -44.37 81.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.764 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.474 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -77.99 -44.36 12.13 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.936 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.19 -43.3 99.57 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.892 179.543 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.08 -22.24 49.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.838 0.351 . . . . 0.0 110.495 -179.898 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.3 tp -56.55 -19.12 14.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.413 179.994 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 79.4 m-20 -51.04 -51.99 47.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.666 179.903 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.488 ' ND1' ' O ' ' A' ' 22' ' ' ASP . 77.1 m-70 -153.89 39.62 0.48 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.246 179.956 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.134 -179.932 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 7' ' ' GLU . 83.8 mtm180 . . . . . 1 N--CA 1.323 -6.81 0 CA-C-O 122.379 1.085 . . . . 0.0 112.072 . . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -38.4 -23.99 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.569 -179.901 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.0 tp -102.43 -29.89 11.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.412 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.4 mm-40 -97.38 43.99 1.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -50.97 -39.09 54.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 -179.851 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.447 ' C ' ' H ' ' A' ' 11' ' ' LYS . 11.2 pt -155.83 -35.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.428 179.903 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.34 -12.99 1.64 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.225 179.886 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 9' ' ' ILE . 31.9 mtmm -89.76 105.49 17.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.749 0.309 . . . . 0.0 110.201 179.903 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.02 61.2 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.806 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.461 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 46.62 50.91 13.4 Favored Glycine 0 C--N 1.331 0.27 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -179.236 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.9 t80 60.24 63.54 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.713 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.5 pt 35.26 62.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.346 -179.342 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.56 HG23 ' N ' ' A' ' 17' ' ' ILE . 4.5 tp -129.15 -48.71 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.56 ' N ' HG23 ' A' ' 16' ' ' ILE . 4.1 tp -82.31 -33.77 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.518 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.86 -35.64 6.72 Favored Glycine 0 C--N 1.331 0.262 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.23 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.66 -37.83 61.56 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.016 179.805 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.54 -68.16 0.45 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.824 0.345 . . . . 0.0 110.5 179.993 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.21 85.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.132 -179.97 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.9 t0 51.19 35.62 13.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.7 179.967 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.431 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 7.0 t60 53.24 46.21 26.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.565 179.871 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.438 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.127 179.922 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 7' ' ' GLU . 80.0 mtm180 . . . . . 1 N--CA 1.323 -6.806 0 CA-C-O 122.574 1.178 . . . . 0.0 111.921 . . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -42.3 -20.22 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.065 -1.88 . . . . 0.0 110.218 179.81 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 4' ' ' ARG . 24.0 mt -107.05 -24.98 11.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.375 179.446 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' ARG . 11.8 mp0 -89.24 -3.78 58.42 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.645 0.26 . . . . 0.0 110.318 -179.981 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -73.66 -29.72 62.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.52 -179.943 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 9' ' ' ILE . 13.2 tt -48.67 99.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.227 0.537 . . . . 0.0 110.653 -179.805 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.14 -14.45 82.27 Favored Glycine 0 C--N 1.329 0.18 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.978 -179.927 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -73.95 97.98 2.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.815 0.34 . . . . 0.0 110.464 -179.983 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.8 -3.27 1.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.803 -179.906 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.7 14.2 42.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.703 -179.888 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -163.79 -46.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.929 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.6 mm -99.77 52.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.339 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.546 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -149.74 -45.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.208 -179.827 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.546 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -79.77 5.37 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.765 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.478 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -152.14 -44.11 0.02 OUTLIER Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.648 -179.916 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.41 -35.38 61.07 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.948 179.843 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.74 -29.47 59.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 0.0 110.507 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.3 mt -81.98 -27.14 33.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.633 -179.944 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -50.56 -59.91 3.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.603 179.983 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.4 ' H ' ' H ' ' A' ' 24' ' ' LEU . 11.4 t-80 -170.03 -4.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.539 179.935 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' H ' ' H ' ' A' ' 23' ' ' HIS . 17.2 mt . . . . . 0 N--CA 1.468 0.45 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.393 179.923 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 7' ' ' GLU . 52.3 mtm-85 . . . . . 1 N--CA 1.324 -6.75 0 CA-C-O 122.54 1.162 . . . . 0.0 112.048 . . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -41.07 -25.06 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.999 -1.91 . . . . 0.0 109.989 179.914 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.451 ' N ' ' C ' ' A' ' 4' ' ' ARG . 3.3 mm? -96.75 -29.0 14.02 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.424 179.508 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 4' ' ' ARG . 2.3 mp0 -86.39 -8.22 57.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.656 -179.498 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -80.26 -114.86 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.491 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.449 ' C ' ' H ' ' A' ' 11' ' ' LYS . 6.9 mm -83.09 -74.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.762 0.315 . . . . 0.0 110.171 179.742 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.85 -33.15 0.88 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.21 179.982 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 13' ' ' GLY . 40.8 mtmt -117.12 74.97 0.94 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.871 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.33 77.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.191 179.977 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 51.62 54.6 23.94 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.544 -179.532 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 60.38 35.74 20.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.33 -179.644 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.3 mt 60.48 62.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.442 -179.988 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 13' ' ' GLY . 4.4 tp -132.28 -41.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.552 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.42 ' N ' HG23 ' A' ' 16' ' ' ILE . 40.4 mm -81.27 -43.55 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.541 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.5 -47.83 26.21 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 178.834 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.0 -37.62 87.83 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.703 179.301 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.42 51.18 11.93 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.88 0.371 . . . . 0.0 110.753 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.5 103.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.552 -179.914 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t70 54.53 44.16 29.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.616 -179.997 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.3 m80 51.56 31.84 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 179.923 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.358 179.971 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' GLU . 71.7 mtm-85 . . . . . 1 N--CA 1.325 -6.7 0 CA-C-O 122.478 1.132 . . . . 0.0 111.933 . . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -41.85 -19.8 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.224 179.896 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.6 tp -112.11 -23.01 10.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.226 179.371 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.5 mt-10 -94.61 20.92 7.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.844 0.354 . . . . 0.0 110.463 179.946 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.411 ' O ' HG23 ' A' ' 9' ' ' ILE . 43.4 ttt85 -68.77 122.09 17.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.555 -179.965 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.414 ' H ' ' H ' ' A' ' 10' ' ' GLY . 20.8 pt -157.01 -9.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.309 -179.891 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 9' ' ' ILE . . . 53.93 38.57 60.47 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.973 -179.97 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 13' ' ' GLY . 67.5 mttm -148.71 77.27 1.38 Allowed 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.989 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.438 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -76.91 33.53 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.591 179.978 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 52.32 48.48 53.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.896 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.8 t80 67.78 50.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.692 0.282 . . . . 0.0 110.946 179.894 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.5 mm 60.66 73.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.333 0.587 . . . . 0.0 111.334 179.301 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.3 mm -136.05 -51.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.001 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.6 mp -70.45 -54.05 20.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.859 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.438 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -70.62 -50.98 22.65 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.475 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.76 -45.8 95.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.865 179.684 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.63 -0.65 0.52 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.636 0.255 . . . . 0.0 110.896 -179.927 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 19' ' ' GLY . 16.0 mt 47.26 73.76 0.18 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 110.712 179.787 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.9 p-10 -170.68 35.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.621 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 51.36 42.59 29.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.535 179.973 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.452 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.195 -179.985 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 6' ' ' LEU . 97.5 mtt180 . . . . . 1 N--CA 1.323 -6.777 0 CA-C-O 122.426 1.108 . . . . 0.0 111.978 . . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -41.67 -18.99 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.004 -1.907 . . . . 0.0 110.455 -179.912 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.3 mp -117.34 -17.91 10.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.646 179.374 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 4' ' ' ARG . 68.4 mm-40 -90.71 -9.99 44.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.719 0.295 . . . . 0.0 110.752 -179.844 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -83.45 68.45 9.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.521 -179.983 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.22 81.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.548 -179.872 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.33 -32.42 14.39 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.201 -0.523 . . . . 0.0 111.874 179.856 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -59.43 106.53 0.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.32 . . . . 0.0 110.298 179.881 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.91 1.45 3.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.037 -179.954 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 43.23 38.15 3.56 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.463 179.859 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 15' ' ' ILE . 31.2 t80 -169.42 -15.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.053 179.988 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 14' ' ' PHE . 19.0 pt -157.06 49.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.826 0.346 . . . . 0.0 111.06 179.826 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.417 ' C ' ' H ' ' A' ' 18' ' ' GLY . 1.5 mm -143.78 -50.25 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.559 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.4 ' C ' HD12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -75.9 15.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.222 179.876 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -171.99 -31.87 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.157 -0.544 . . . . 0.0 111.855 -179.963 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.31 -23.86 69.87 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 -180.0 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.66 -50.32 58.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 0.0 110.575 -179.902 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.7 mt 56.09 56.49 5.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.116 -179.93 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -157.87 68.63 0.51 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.567 -179.943 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.466 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 49.5 t-80 51.82 39.61 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.608 179.856 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.2 tp . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.211 179.953 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER . . . . . 1 N--CA 1.312 -7.367 0 CA-C-O 121.546 0.688 . . . . 0.0 109.951 . . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.6 t90 -42.4 -23.5 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.896 -179.943 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' N ' ' C ' ' A' ' 4' ' ' ARG . 5.0 mp -92.87 -27.63 17.0 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.61 179.765 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.5 mt-10 -79.21 -14.61 58.95 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.737 -179.928 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -70.17 -179.91 2.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 0.0 110.594 -179.881 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 tp -60.05 105.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.262 0.553 . . . . 0.0 110.409 -179.712 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.77 42.76 0.02 OUTLIER Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.831 179.995 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -50.29 -31.36 14.1 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.604 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.403 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -162.67 -9.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.622 -179.876 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 58.57 33.35 71.62 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.7 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -154.32 -9.79 0.14 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.915 0.388 . . . . 0.0 110.14 -179.926 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.5 pt -156.81 40.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.01 179.425 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 tp -150.49 -26.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.254 -179.683 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -83.5 6.71 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.837 179.484 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.45 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -170.79 -28.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.952 -179.978 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.83 -47.64 38.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.161 -0.542 . . . . 0.0 111.987 179.96 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.08 36.72 25.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.722 0.296 . . . . 0.0 110.583 179.958 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.59 -5.26 27.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.418 179.853 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -51.63 -35.51 42.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.619 179.981 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.48 21.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.702 179.967 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.21 179.979 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.525 ' C ' ' N ' ' A' ' 6' ' ' LEU . 13.8 mtp180 . . . . . 1 N--CA 1.318 -7.044 0 CA-C-O 121.315 0.578 . . . . 0.0 110.583 . . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -43.81 -18.12 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.682 -179.975 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.525 ' N ' ' C ' ' A' ' 4' ' ' ARG . 63.3 mt -120.6 -9.14 9.44 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.184 179.236 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.1 mt-10 -116.43 32.33 6.19 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.096 0.474 . . . . 0.0 109.749 179.626 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -49.03 92.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.534 179.76 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 7' ' ' GLU . 16.4 pt -71.59 -32.58 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 -179.891 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.35 6.58 1.56 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.029 -179.978 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.535 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 78.6 tttt -68.83 -7.45 34.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 110.217 179.976 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 74.89 -21.54 0.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.607 -179.85 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 42.64 52.64 5.39 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.627 -179.816 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.8 t80 70.91 44.61 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.993 0.425 . . . . 0.0 109.978 -179.124 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.8 mt 61.22 74.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.46 -179.99 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.7 mm -136.0 -71.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.693 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 tp -72.46 -23.52 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.136 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.16 -54.99 3.63 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.383 179.253 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -40.65 41.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.78 179.688 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.15 59.27 4.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.833 0.349 . . . . 0.0 110.245 -179.951 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 21' ' ' LEU . 10.1 mp -48.32 117.3 1.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.338 -179.827 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t0 55.16 51.93 12.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.986 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.1 m170 53.28 35.01 19.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.689 179.927 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.331 179.906 . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 59.4 mtt85 . . . . . 1 N--CA 1.325 -6.717 0 CA-C-O 122.499 1.142 . . . . 0.0 111.999 . . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -40.8 -21.1 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.387 -179.934 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.9 mt -108.44 -24.92 11.22 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.676 179.365 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.1 mm-40 -89.89 33.8 0.85 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-O 120.928 0.394 . . . . 0.0 110.34 179.876 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -146.63 70.47 1.21 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.128 179.961 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 9' ' ' ILE . 13.8 tt -61.04 120.79 7.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 179.963 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.87 -31.5 67.13 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.893 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.469 ' C ' ' H ' ' A' ' 13' ' ' GLY . 93.5 mttt -69.46 95.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 110.159 179.62 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.16 -8.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.39 -179.993 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 67.43 0.41 11.39 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.479 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.451 ' O ' HG23 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -80.86 -68.26 0.7 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.949 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 14' ' ' PHE . 19.6 pt -158.25 42.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.771 179.42 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 16' ' ' ILE . 1.5 mp -85.66 -49.79 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.142 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.513 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -75.41 18.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.747 179.891 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -152.69 -58.1 0.01 OUTLIER Glycine 0 C--N 1.334 0.455 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 -179.938 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.43 -33.0 65.09 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.895 -179.994 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.99 -66.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 110.521 179.951 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.81 73.07 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.166 0.508 . . . . 0.0 109.899 179.898 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -160.87 32.51 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.306 179.984 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 50.5 t-80 55.48 39.51 31.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.285 -179.816 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.091 -179.76 . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 6' ' ' LEU . 66.8 mtp180 . . . . . 1 N--CA 1.325 -6.71 0 CA-C-O 122.58 1.181 . . . . 0.0 112.059 . . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -42.91 -18.44 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.887 -1.96 . . . . 0.0 110.214 179.85 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.4 tp -114.8 -20.24 10.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.422 179.469 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 45.0 mm-40 -89.99 19.16 5.09 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.556 -179.998 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -78.68 56.32 1.83 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.183 179.952 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.61 83.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.658 -179.774 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.5 -25.11 75.03 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.119 -0.562 . . . . 0.0 111.716 179.625 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -78.39 107.92 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.776 0.322 . . . . 0.0 110.245 179.814 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.91 55.43 1.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.835 179.754 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 53.11 47.64 60.27 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.371 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 t80 61.0 45.55 9.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.029 0.443 . . . . 0.0 110.008 -179.392 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 mt 60.99 70.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.583 -179.803 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -135.8 -64.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.5 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -70.74 -26.76 28.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.352 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.07 -56.2 2.77 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.409 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.37 82.62 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 179.666 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.61 47.8 12.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.726 0.298 . . . . 0.0 110.675 179.829 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.2 tp -72.85 -34.6 66.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.022 179.854 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.45 44.14 0.59 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.568 179.998 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 42.3 m80 51.6 17.32 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.564 179.994 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.1 tp . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.262 -179.93 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 66.1 mtp180 . . . . . 1 N--CA 1.324 -6.77 0 CA-C-O 122.624 1.202 . . . . 0.0 111.966 . . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -44.39 -20.02 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 112.984 -1.917 . . . . 0.0 109.908 179.675 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.447 ' N ' ' C ' ' A' ' 4' ' ' ARG . 42.6 tp -105.34 -22.84 12.96 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.431 179.791 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.8 tt0 -48.26 -36.2 13.56 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.7 mtt85 -77.06 -63.89 1.26 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.559 179.839 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.4 tt -170.42 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.447 -179.998 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 77.84 -50.39 3.3 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -179.796 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -81.25 96.58 7.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.696 0.284 . . . . 0.0 110.261 179.761 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.9 47.61 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.771 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.7 54.39 33.33 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.676 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 55.2 49.1 17.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.497 -179.698 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.6 mt 60.58 70.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.67 179.921 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.6 mm -136.35 -68.31 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.609 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -68.49 -22.99 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.654 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.24 -59.89 1.8 Allowed Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.486 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.52 -31.63 79.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.715 179.774 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.13 57.91 5.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 110.407 179.959 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.0 mt -56.75 90.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.386 179.954 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 24' ' ' LEU . 8.2 m-20 54.33 -135.1 1.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.354 -179.93 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -76.41 21.3 0.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.789 0.328 . . . . 0.0 110.744 179.885 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' A' ' 22' ' ' ASP . 15.9 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.145 -179.997 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 6' ' ' LEU . 93.9 mtt180 . . . . . 1 N--CA 1.324 -6.735 0 CA-C-O 122.441 1.115 . . . . 0.0 112.044 . . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -39.84 -20.61 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 112.919 -1.946 . . . . 0.0 110.66 -179.802 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.5 tp -117.55 -19.15 9.54 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.501 179.406 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.0 mt-10 -89.5 24.56 2.23 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.777 0.322 . . . . 0.0 110.53 -179.978 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -76.36 -63.69 1.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.721 -179.984 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 9' ' ' ILE . 14.2 tt -49.66 109.77 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.196 0.522 . . . . 0.0 110.558 -179.8 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.74 -27.58 64.71 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.933 -179.754 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 3.8 mptp? -54.96 111.2 0.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.714 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.12 3.53 3.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.96 0.41 . . . . 0.0 110.308 -179.61 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.38 38.48 0.63 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.796 179.586 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -168.38 -19.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 110.663 179.87 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 pt -151.17 48.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.123 0.487 . . . . 0.0 109.991 179.562 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.8 tp -146.4 -35.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.09 -179.892 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -83.51 4.8 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.813 179.423 . . . . . . . . 3 3 . 1 . 051 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.473 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -164.39 -33.88 0.02 OUTLIER Glycine 0 C--N 1.33 0.248 0 N-CA-C 111.779 -0.529 . . . . 0.0 111.779 -179.856 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.13 -42.96 97.35 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.148 -0.549 . . . . 0.0 111.806 179.967 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.46 -51.36 60.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.724 0.297 . . . . 0.0 110.45 -179.955 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 tp 55.76 100.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.276 -179.953 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -164.72 -36.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.597 -179.954 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -170.32 1.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.71 -179.922 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.674 ' C ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.196 -179.857 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 84.0 mtm180 . . . . . 1 N--CA 1.324 -6.763 0 CA-C-O 122.529 1.157 . . . . 0.0 111.923 . . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -42.08 -19.27 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.943 -1.935 . . . . 0.0 110.366 179.889 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.7 mt -114.12 -19.51 11.33 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.953 179.799 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.7 mm-40 -86.19 -16.23 38.44 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.721 -179.658 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -80.47 103.94 10.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.419 179.783 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.3 pt -65.31 -31.19 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.593 -179.854 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.21 28.35 4.3 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.04 179.966 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 21.8 ttpp -79.09 -19.26 51.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.545 0.212 . . . . 0.0 110.769 -179.692 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 78.5 -21.42 0.33 Allowed 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.164 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.11 36.43 0.87 Allowed Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -179.831 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.4 t80 73.69 48.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.647 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 12' ' ' ALA . 33.6 mt 64.6 70.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.517 -179.714 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.3 mm -134.66 -76.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.846 179.752 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.609 ' C ' HD12 ' A' ' 17' ' ' ILE . 2.7 pp -63.36 -6.53 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.143 -179.86 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.568 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -106.09 -65.8 0.65 Allowed Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.982 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.2 -19.95 74.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.683 179.668 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.447 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 63.05 9.75 4.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.629 0.252 . . . . 0.0 110.835 179.681 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 52.47 12.38 0.23 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.088 0.47 . . . . 0.0 109.783 -179.965 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' N ' ' C ' ' A' ' 20' ' ' ALA . 25.1 t70 -70.19 -102.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.274 179.975 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.478 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 57.5 t-80 -67.41 2.08 1.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 110.103 179.582 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' H ' ' C ' ' A' ' 22' ' ' ASP . 1.4 tt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.129 -179.923 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.8 mtt180 . . . . . 1 N--CA 1.325 -6.704 0 CA-C-O 122.383 1.087 . . . . 0.0 112.047 . . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -40.99 -18.93 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.639 -179.954 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.8 tp -123.47 -13.27 7.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.632 179.492 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.0 tt0 -82.93 -8.62 59.55 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.556 -179.806 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -50.11 115.49 1.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.466 179.774 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 11' ' ' LYS . 17.6 tt -70.68 -23.17 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.608 -179.837 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -47.13 87.43 0.01 OUTLIER Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.344 -179.887 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 9' ' ' ILE . 9.6 mtpm? -149.55 4.76 0.6 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.768 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 53.17 56.39 7.53 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.285 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -41.1 88.17 0.01 OUTLIER Glycine 0 C--N 1.335 0.523 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.019 -179.847 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 12' ' ' ALA . 89.6 m-85 53.26 48.19 22.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.815 0.34 . . . . 0.0 110.091 -179.108 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.7 mt 62.13 80.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.626 -179.835 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.0 tp -146.57 -35.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.249 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 mm -98.96 -37.24 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.007 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.02 -57.81 5.06 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.226 179.358 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.86 86.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.671 179.545 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.04 40.58 17.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.7 179.814 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 23' ' ' HIS . 22.8 mt -68.71 -25.98 65.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.579 -179.957 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.42 34.0 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.942 -179.74 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.487 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 12.0 t-80 54.85 27.87 9.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.574 179.31 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.238 179.527 . . . . . . . . 0 0 . 1 . 054 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' GLU . 74.4 mtm180 . . . . . 1 N--CA 1.323 -6.813 0 CA-C-O 122.477 1.132 . . . . 0.0 111.835 . . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -42.17 -19.73 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.095 -1.866 . . . . 0.0 110.262 179.862 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.498 ' N ' ' C ' ' A' ' 4' ' ' ARG . 31.0 mt -108.82 -24.2 11.39 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.531 179.568 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 4' ' ' ARG . 27.6 tt0 -89.5 -5.41 57.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.057 0.456 . . . . 0.0 110.008 179.905 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -67.57 -51.27 52.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.644 179.987 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 10' ' ' GLY . 10.5 tt -167.32 -44.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.666 -179.9 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.517 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 75.9 -39.85 1.38 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.159 179.981 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 13' ' ' GLY . 86.4 mttt -79.77 81.14 6.08 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.768 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.38 15.34 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.8 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 65.45 19.25 66.49 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.616 -179.623 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.418 ' C ' ' H ' ' A' ' 16' ' ' ILE . 65.4 m-85 -147.18 -52.82 0.21 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.767 0.317 . . . . 0.0 110.207 179.879 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.3 pt -80.18 32.54 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 121.045 0.45 . . . . 0.0 110.53 179.815 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 17' ' ' ILE . 4.2 tp -148.97 -44.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.429 -179.787 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.568 ' C ' HD12 ' A' ' 17' ' ' ILE . 2.2 pp -71.3 1.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.294 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.539 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -163.89 -40.69 0.02 OUTLIER Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.946 -179.899 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -73.27 -29.14 64.75 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.92 179.989 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.18 8.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.653 0.263 . . . . 0.0 110.908 179.978 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 23' ' ' HIS . 8.3 tp 49.66 -115.26 0.79 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.299 179.933 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 57.05 -79.72 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.746 0.308 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 21' ' ' LEU . 14.8 p-80 -156.78 -1.66 0.12 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.623 -179.969 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.399 179.756 . . . . . . . . 0 0 . 1 . 055 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.593 ' O ' ' N ' ' A' ' 7' ' ' GLU . 20.8 mtp180 . . . . . 1 N--CA 1.315 -7.175 0 CA-C-O 121.399 0.619 . . . . 0.0 110.646 . . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -40.79 -23.71 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.112 -179.397 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 6' ' ' LEU . 10.5 mp -97.67 -26.04 14.9 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.444 179.558 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.3 tp10 -119.53 35.4 4.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.075 0.464 . . . . 0.0 109.906 179.9 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.523 ' NH2' ' CZ ' ' A' ' 4' ' ' ARG . 6.8 tpm_? -80.6 88.56 5.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.216 179.994 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.4 tt -53.8 -45.06 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.479 -179.921 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.541 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 71.01 -70.56 0.77 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.276 179.747 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 13' ' ' GLY . 51.6 mttp -51.79 108.15 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 110.605 -179.738 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.523 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -76.35 37.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.351 179.683 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 70.04 72.52 0.86 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.98 -179.832 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 51.4 t80 52.36 28.62 5.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.766 0.317 . . . . 0.0 110.459 179.979 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.5 mt 61.19 62.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.651 0.739 . . . . 0.0 109.77 -179.737 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -130.92 -50.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.046 -179.674 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.585 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.4 mp -66.29 -45.56 89.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.989 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -81.49 -41.08 10.27 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.721 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -58.86 -39.73 94.29 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.969 179.477 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.38 37.74 0.13 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.814 0.34 . . . . 0.0 110.744 -179.778 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 19' ' ' GLY . 16.7 tp -70.67 110.53 5.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.132 179.819 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.1 t0 55.76 39.18 30.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.559 -179.908 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 60.5 t60 52.09 50.03 19.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.519 179.983 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.945 179.955 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 7' ' ' GLU . 28.0 mtt180 . . . . . 1 N--CA 1.316 -7.164 0 CA-C-O 121.409 0.623 . . . . 0.0 110.846 . . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -44.1 -21.17 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.78 -179.647 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.492 ' N ' ' C ' ' A' ' 4' ' ' ARG . 26.7 mt -97.34 -23.86 15.92 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.536 179.663 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.3 tt0 -66.67 -18.5 65.41 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.234 179.869 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -81.9 47.68 1.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.261 179.734 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -50.0 120.86 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 110.48 -179.685 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.38 39.82 0.46 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.718 -179.842 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -50.64 -33.4 22.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.612 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.96 -15.93 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.383 179.932 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' O ' ' CG ' ' A' ' 14' ' ' PHE . . . 69.33 31.1 71.33 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.616 -179.788 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.404 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 67.0 m-85 -155.91 -10.3 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.703 0.287 . . . . 0.0 110.269 179.983 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.0 pt -153.98 42.37 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.096 0.474 . . . . 0.0 110.476 179.644 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.501 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.4 tp -147.94 -43.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.792 179.782 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.501 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.4 tp -77.44 -37.98 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.696 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.57 -39.79 6.58 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.166 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.02 -38.24 95.75 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 179.682 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.0 -73.42 0.05 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.42 ' C ' HD23 ' A' ' 21' ' ' LEU . 2.1 tt 63.59 87.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 109.984 179.797 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 30.0 p-10 -168.78 -120.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.023 -179.75 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -67.92 -12.56 60.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.0 0.429 . . . . 0.0 109.879 179.451 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.6 mt . . . . . 0 C--O 1.232 0.181 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.331 179.858 . . . . . . . . 0 0 . 1 . 057 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' GLU . 38.1 mtt85 . . . . . 1 N--CA 1.326 -6.673 0 CA-C-O 122.634 1.207 . . . . 0.0 112.085 . . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -43.09 -19.81 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.223 179.858 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 mt -108.11 -21.51 12.77 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.93 179.932 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.4 tp10 -72.55 -9.41 58.55 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.116 -179.828 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -54.9 122.35 10.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.505 -179.983 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.608 ' C ' HD12 ' A' ' 9' ' ' ILE . 2.5 pp -69.36 -2.42 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.725 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.568 ' N ' HD12 ' A' ' 9' ' ' ILE . . . -75.91 71.61 1.91 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.227 -179.898 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -51.82 -31.17 26.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.022 0.439 . . . . 0.0 109.892 179.523 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.99 -2.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.336 179.931 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.17 32.29 12.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.838 -179.924 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -145.84 -10.35 0.52 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 110.232 -179.969 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 pt -156.94 36.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.018 179.4 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.0 tp -150.67 -21.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.943 -179.79 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.3 pp -88.81 4.41 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.836 179.347 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.506 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -166.93 -36.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.82 -179.944 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.19 -5.1 75.43 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.901 179.852 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -67.54 -56.52 9.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 0.0 110.47 -179.94 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 23' ' ' HIS . 5.0 tp 64.27 -0.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.447 179.965 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 20' ' ' ALA . 34.6 t70 -77.6 30.81 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.628 -179.94 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.427 ' H ' ' C ' ' A' ' 21' ' ' LEU . 66.3 m80 51.45 65.69 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.465 179.966 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.144 -179.973 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 7' ' ' GLU . 19.8 mtt180 . . . . . 1 N--CA 1.315 -7.212 0 CA-C-O 121.609 0.718 . . . . 0.0 110.455 . . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -40.97 -22.59 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.296 -179.616 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.529 ' O ' HD23 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -97.47 -26.64 14.76 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.364 179.873 . . . . . . . . 3 3 . 1 . 058 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.9 tp10 -67.21 -32.01 72.78 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.176 179.748 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -53.12 -70.13 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 -179.973 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 10' ' ' GLY . 14.2 tt -66.12 -39.97 85.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.355 -179.888 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 46.26 60.19 4.75 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.315 179.847 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -170.89 74.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.772 0.32 . . . . 0.0 110.473 179.925 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.95 65.12 5.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.007 179.855 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 49.02 53.09 19.93 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -179.576 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 60.68 38.67 18.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.898 0.38 . . . . 0.0 110.258 -179.519 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 mt 60.92 69.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.374 -179.862 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.592 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.9 tp -139.2 -50.51 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.91 179.688 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.592 ' N ' HG23 ' A' ' 16' ' ' ILE . 4.1 tp -79.27 -27.39 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.73 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.0 -50.89 3.54 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 178.97 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.39 -42.23 99.72 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.075 179.635 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.89 -52.23 58.32 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.447 -179.945 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.424 ' C ' ' H ' ' A' ' 23' ' ' HIS . 12.2 tp -60.57 -34.03 73.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.362 179.993 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -76.86 35.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.621 -179.872 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 21' ' ' LEU . 16.9 m80 49.97 44.95 25.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.543 179.892 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.347 -179.872 . . . . . . . . 0 0 . 1 . 059 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 46.3 mtt85 . . . . . 1 N--CA 1.324 -6.755 0 CA-C-O 122.434 1.112 . . . . 0.0 111.97 . . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 71.6 t-105 -41.14 -20.32 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.111 -1.859 . . . . 0.0 110.394 -179.874 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.6 tp -111.27 -23.21 10.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.315 179.528 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 14.9 mm-40 -92.77 -1.65 56.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.838 0.351 . . . . 0.0 110.534 179.998 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.407 ' CG ' ' H ' ' A' ' 9' ' ' ILE . 14.8 tpp180 -82.5 -133.46 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.291 -179.912 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 11' ' ' LYS . 18.8 tt -167.94 -21.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.482 -179.986 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.24 86.8 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.008 -179.948 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 9' ' ' ILE . 63.1 mttm -153.32 0.9 0.26 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.992 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 54.81 62.07 2.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.54 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -42.38 90.8 0.01 OUTLIER Glycine 0 C--N 1.333 0.382 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 -179.92 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.5 ' N ' ' O ' ' A' ' 12' ' ' ALA . 78.1 m-85 55.35 47.04 22.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.926 0.394 . . . . 0.0 110.089 -179.326 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 60.61 77.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.513 -179.966 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.582 HG23 ' N ' ' A' ' 17' ' ' ILE . 6.2 tp -142.91 -56.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.709 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.582 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.2 mp -77.81 -33.2 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.637 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.95 -48.67 9.62 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 178.361 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.76 -45.99 91.08 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.76 179.161 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.8 -72.63 0.05 OUTLIER 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.414 -179.934 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.6 tp 52.43 94.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.287 179.981 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -157.92 -28.44 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.326 179.99 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -168.0 -27.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 -179.958 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.0 mp . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.208 179.926 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 7' ' ' GLU . 2.9 mtp85 . . . . . 1 N--CA 1.311 -7.381 0 CA-C-O 121.629 0.728 . . . . 0.0 109.984 . . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.42 ' CZ2' ' NH2' ' A' ' 8' ' ' ARG . 74.2 t-105 -42.77 -23.17 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.795 179.996 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.475 ' N ' ' C ' ' A' ' 4' ' ' ARG . 28.8 mt -92.85 -27.68 16.98 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.748 179.902 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.573 ' N ' ' O ' ' A' ' 4' ' ' ARG . 71.5 mt-10 -79.78 10.87 3.62 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.606 179.965 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.42 ' NH2' ' CZ2' ' A' ' 5' ' ' TRP . 54.8 ttp180 -77.92 85.52 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.555 -179.978 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 10' ' ' GLY . 16.7 tt -73.86 -42.82 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.383 179.913 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.5 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 60.73 53.05 48.54 Favored Glycine 0 N--CA 1.453 -0.204 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.365 179.744 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -171.13 67.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 0.0 110.644 179.771 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.532 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -80.79 45.07 0.78 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.439 179.944 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.87 67.38 2.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.131 -0.556 . . . . 0.0 111.895 -179.977 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 52.6 t80 52.37 31.19 9.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.766 0.317 . . . . 0.0 110.555 -179.988 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 61.7 64.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.547 0.689 . . . . 0.0 110.263 -179.819 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.2 mm -131.8 -48.96 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.651 179.912 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.4 mp -69.55 -47.29 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.633 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.532 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -76.78 -42.3 21.32 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 178.978 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.43 -48.31 86.6 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.866 179.537 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.88 -47.45 71.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.732 0.301 . . . . 0.0 110.503 -179.863 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.4 36.53 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.893 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -81.17 -86.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.631 -179.712 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 32.4 p-80 -73.8 -27.0 60.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.626 -179.933 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.9 tt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.121 179.999 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 6' ' ' LEU . 93.9 mtt180 . . . . . 1 N--CA 1.325 -6.698 0 CA-C-O 122.462 1.125 . . . . 0.0 111.965 . . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.44 ' CE3' HD21 ' A' ' 6' ' ' LEU . 19.4 t90 -42.71 -18.46 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.291 -179.95 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.8 mt -118.01 -16.89 9.8 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.632 179.31 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 19.4 mm-40 -88.65 -1.14 57.91 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 120.887 0.375 . . . . 0.0 110.402 179.971 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 55.81 106.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 179.859 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 9' ' ' ILE . 4.4 tp -114.2 87.68 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 121.526 0.679 . . . . 0.0 110.024 179.946 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.9 -1.82 60.04 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.781 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 pttm 33.86 35.68 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.4 -0.4 . . . . 0.0 111.93 179.889 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.469 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -81.72 32.94 0.36 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.039 179.483 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.23 60.46 3.07 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.769 -179.755 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.492 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 66.9 t80 55.53 33.77 21.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.954 0.406 . . . . 0.0 110.191 -179.786 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.2 mm 61.85 66.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.509 0.671 . . . . 0.0 110.15 -179.802 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 mm -133.77 -51.09 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.715 179.624 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.5 mp -68.18 -46.28 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.577 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.469 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -77.26 -48.11 8.52 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.429 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.38 -43.77 98.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.606 179.573 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.77 9.19 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.737 0.303 . . . . 0.0 110.92 179.761 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 21' ' ' LEU . 8.0 mp 53.85 -97.78 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.807 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 72.1 m-20 50.24 -87.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.676 179.79 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 21' ' ' LEU . 75.4 m80 -156.44 11.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.509 179.922 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 N--CA 1.465 0.279 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.355 179.958 . . . . . . . . 0 0 . 1 . 062 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 7' ' ' GLU . 79.0 mtt180 . . . . . 1 N--CA 1.325 -6.698 0 CA-C-O 122.511 1.148 . . . . 0.0 112.048 . . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 85.1 t90 -39.62 -21.63 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.521 179.936 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 10.8 tp -107.83 -26.99 10.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.455 179.347 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' ARG . 90.3 mt-10 -100.44 22.33 11.84 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.806 0.336 . . . . 0.0 110.29 179.79 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -53.29 -57.17 11.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.654 -179.809 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.456 ' C ' ' H ' ' A' ' 11' ' ' LYS . 14.0 pt -71.29 -35.2 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.666 -179.862 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.7 -19.19 1.21 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.07 -179.953 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 9' ' ' ILE . 41.9 mtmt -73.99 95.16 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.567 -179.978 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.426 ' HB3' ' H ' ' A' ' 15' ' ' ILE . . . -58.96 -6.46 0.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.315 179.829 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 60.53 15.73 41.04 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.772 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -164.67 -39.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.942 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' H ' ' HB3' ' A' ' 12' ' ' ALA . 13.5 mt -111.24 57.48 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.709 179.38 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.1 tp -151.78 -45.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.485 -0.78 . . . . 0.0 108.911 -179.988 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.526 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.1 pp -91.17 4.98 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.749 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.509 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -136.14 -57.03 0.06 OUTLIER Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.631 -179.761 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.5 -46.07 94.53 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.702 179.895 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.99 44.98 28.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 110.691 179.922 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.7 mm? -63.15 103.09 0.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.926 179.766 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 35.3 t70 56.26 56.17 6.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 -179.849 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 19.8 p-80 40.82 39.5 0.81 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.349 -179.935 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.9 tp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.256 179.826 . . . . . . . . 0 0 . 1 . 063 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 6' ' ' LEU . 95.7 mtt180 . . . . . 1 N--CA 1.324 -6.746 0 CA-C-O 122.507 1.146 . . . . 0.0 112.066 . . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -40.26 -19.85 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.66 -179.985 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.5 mt -120.37 -15.46 8.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.013 179.499 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.6 mm-40 -87.95 -7.04 57.68 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.645 -179.91 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -68.92 88.93 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.254 179.774 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.4 pt -60.22 -34.71 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.962 -179.627 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.38 17.51 1.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.696 -179.671 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -70.25 -5.16 25.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.888 -0.156 . . . . 0.0 110.827 -179.779 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.99 52.02 9.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.64 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.509 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -43.49 87.45 0.01 OUTLIER Glycine 0 C--N 1.335 0.498 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.868 -179.337 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 12' ' ' ALA . 89.4 m-85 52.74 41.75 31.6 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.074 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 mm 61.16 77.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.183 -179.416 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.659 HG23 ' H ' ' A' ' 17' ' ' ILE . 6.6 tp -140.37 -59.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.883 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.659 ' H ' HG23 ' A' ' 16' ' ' ILE . 3.7 tp -74.98 -31.02 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.011 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.02 -48.13 5.27 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 179.011 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.7 -44.84 96.92 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.037 -0.602 . . . . 0.0 111.706 179.612 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.44 -65.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.402 179.875 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.7 79.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.866 179.953 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -159.77 33.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.483 -179.791 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.42 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 33.8 t-80 55.18 22.91 4.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.659 179.948 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 tp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.209 179.972 . . . . . . . . 0 0 . 1 . 064 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' GLU . 3.6 mmt180 . . . . . 1 N--CA 1.318 -7.044 0 CA-C-O 121.329 0.585 . . . . 0.0 110.428 . . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -44.19 -18.67 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.961 -179.63 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.497 ' N ' ' C ' ' A' ' 4' ' ' ARG . 9.3 mp -109.74 -19.28 13.22 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.067 179.235 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 4' ' ' ARG . 15.1 mp0 -112.27 12.88 20.36 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 120.71 0.29 . . . . 0.0 110.328 -179.89 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 4' ' ' ARG . 61.0 ttp180 -52.32 123.67 11.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.378 179.795 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 tp -54.79 92.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.344 0.593 . . . . 0.0 110.16 -179.883 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.12 -30.83 10.44 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.787 -179.974 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -60.37 104.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.07 179.851 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.88 -4.01 4.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.691 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.71 34.19 5.16 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.139 179.722 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 15' ' ' ILE . 30.4 t80 -170.2 -17.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' PHE . 8.9 pt -155.55 55.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.13 0.491 . . . . 0.0 110.361 179.787 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.4 tp -144.16 -42.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.061 179.792 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.522 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -71.87 4.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.901 179.676 . . . . . . . . 3 3 . 1 . 064 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.471 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -175.89 -22.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.033 179.999 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.47 -31.84 79.97 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.991 179.993 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.38 -59.35 2.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.766 0.317 . . . . 0.0 110.567 -179.978 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tp 54.98 37.62 29.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.351 -179.943 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.61 -33.28 58.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.602 179.992 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -164.66 6.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.437 -179.98 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.161 179.989 . . . . . . . . 0 0 . 1 . 065 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 6' ' ' LEU . 48.5 mtp180 . . . . . 1 N--CA 1.324 -6.752 0 CA-C-O 122.513 1.149 . . . . 0.0 111.988 . . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -42.78 -17.59 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 112.828 -1.987 . . . . 0.0 110.393 179.904 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.4 mt -121.28 -14.38 8.33 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.933 179.621 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.2 tt0 -82.64 0.05 44.9 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.181 -179.974 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -50.26 163.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 180.0 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.6 pt -54.0 -43.03 57.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.458 -179.922 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.83 -48.59 2.35 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.771 179.39 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HZ2' HG12 ' A' ' 17' ' ' ILE . 9.5 mtpm? -75.44 -75.52 0.17 Allowed 'General case' 0 C--N 1.331 -0.217 0 O-C-N 122.741 -0.27 . . . . 0.0 110.817 -179.572 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 66.81 30.7 7.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.525 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -36.54 -39.82 0.39 Allowed Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.782 179.537 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.487 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 74.0 t80 179.78 54.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.296 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 pt 38.95 53.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.005 -177.816 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -113.83 -47.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.075 -178.847 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.516 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -78.31 6.5 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.176 . . . . . . . . 3 3 . 1 . 065 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.44 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -141.97 -50.99 0.04 OUTLIER Glycine 0 C--N 1.333 0.406 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.935 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.33 -44.72 84.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.712 179.618 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.48 10.41 4.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.8 0.333 . . . . 0.0 110.41 179.913 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' HIS . 19.5 tp 53.35 101.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.092 -179.995 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 56.75 -79.8 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 21' ' ' LEU . 34.0 t-80 -162.25 29.16 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 110.396 179.901 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.442 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.203 179.977 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' GLU . 22.0 mtt180 . . . . . 1 N--CA 1.319 -7.02 0 CA-C-O 121.317 0.58 . . . . 0.0 110.966 . . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.565 ' CE3' HD21 ' A' ' 6' ' ' LEU . 33.9 t90 -43.99 -18.3 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.723 -179.981 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.565 HD21 ' CE3' ' A' ' 5' ' ' TRP . 44.0 mt -113.25 -15.9 12.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.646 179.091 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.5 mt-10 -116.03 15.08 16.16 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.772 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 ttm180 -76.85 126.28 30.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.474 179.885 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 tp -56.28 108.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.253 0.549 . . . . 0.0 109.962 179.852 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.54 38.96 0.48 Allowed Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.865 -179.871 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.14 -26.74 63.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.38 . . . . 0.0 110.316 179.846 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.451 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -158.96 31.36 0.21 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.158 179.9 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.62 53.76 11.67 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.967 -179.945 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 61.03 33.43 19.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.725 0.297 . . . . 0.0 110.323 -179.979 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 mt 63.24 64.96 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.576 0.703 . . . . 0.0 110.226 -179.74 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -133.01 -50.41 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.776 179.755 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.631 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.5 mp -70.46 -43.6 77.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.733 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.451 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -76.25 -48.17 9.9 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.092 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -63.49 -52.28 47.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.636 179.45 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.436 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 58.25 4.5 0.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.717 0.294 . . . . 0.0 110.931 179.749 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 21' ' ' LEU . 8.2 mp 50.66 13.47 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.357 179.883 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' N ' ' C ' ' A' ' 20' ' ' ALA . 72.8 m-20 -75.69 37.01 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.615 -179.936 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.434 ' H ' ' C ' ' A' ' 21' ' ' LEU . 6.4 t60 49.91 37.71 14.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 110.555 179.985 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.9 tp . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.101 -179.903 . . . . . . . . 0 0 . 1 . 067 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 5.5 mtp85 . . . . . 1 N--CA 1.317 -7.112 0 CA-C-O 121.475 0.655 . . . . 0.0 110.629 . . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -43.55 -17.91 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.933 -179.84 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -118.34 -12.82 9.85 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.104 179.133 . . . . . . . . 3 3 . 1 . 067 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 45.2 mm-40 -122.18 29.41 7.03 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-O 120.784 0.326 . . . . 0.0 110.319 179.877 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.6 ttp85 -72.42 89.01 1.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.387 179.908 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 tp -55.64 101.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.167 0.508 . . . . 0.0 110.288 -179.98 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.0 -35.33 12.77 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.921 -179.888 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.466 ' C ' ' H ' ' A' ' 13' ' ' GLY . 66.2 mttm -69.39 82.75 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 0.0 110.469 -179.849 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.455 ' O ' ' CD2' ' A' ' 14' ' ' PHE . . . -55.73 -7.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.032 179.46 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 62.72 52.2 50.29 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.971 -179.967 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.455 ' CD2' ' O ' ' A' ' 12' ' ' ALA . 65.4 m-85 -156.53 -61.88 0.1 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.698 0.285 . . . . 0.0 110.668 179.813 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 14' ' ' PHE . 14.9 pt -155.76 57.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.305 0.574 . . . . 0.0 110.457 -179.906 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.4 -69.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.235 179.665 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -73.62 -35.68 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.349 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.71 -47.04 10.34 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 179.46 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -74.22 -44.55 28.37 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.108 -0.567 . . . . 0.0 111.872 179.714 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.88 6.3 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.668 0.27 . . . . 0.0 110.918 179.844 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.1 mt 45.86 70.96 0.32 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -158.99 53.85 0.41 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.435 179.901 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.479 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 12.7 t60 52.2 23.89 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.396 -179.913 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.377 179.959 . . . . . . . . 0 0 . 1 . 068 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 56.5 mtt85 . . . . . 1 N--CA 1.325 -6.712 0 CA-C-O 122.588 1.185 . . . . 0.0 111.92 . . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -40.98 -20.78 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 112.995 -1.911 . . . . 0.0 110.594 179.988 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.3 tp -108.06 -22.96 12.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.725 179.956 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.2 tp10 -46.26 -43.79 15.89 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.892 -179.755 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -62.31 179.58 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.409 179.863 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.5 tt -49.49 -35.48 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.745 -179.923 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.51 64.1 3.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.9 179.979 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -168.44 74.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 110.479 -179.877 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -74.7 70.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.265 179.903 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.33 62.25 5.25 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.771 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 55.74 32.72 19.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.786 0.326 . . . . 0.0 110.523 -179.755 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 mm 60.6 66.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.405 0.622 . . . . 0.0 110.101 -179.902 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -133.41 -46.04 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.883 179.935 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.1 mm -75.34 -46.98 36.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.975 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.433 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -76.25 -50.41 7.55 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.454 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.22 -36.78 93.25 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.95 179.749 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 51.6 37.17 19.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.757 0.313 . . . . 0.0 110.62 179.99 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.0 mt -54.84 -12.76 0.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.407 179.916 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -57.79 -76.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.356 179.951 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -84.42 -27.01 27.88 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.583 -179.998 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.9 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.435 -179.803 . . . . . . . . 0 0 . 1 . 069 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' GLU . 41.7 mtp180 . . . . . 1 N--CA 1.323 -6.782 0 CA-C-O 122.677 1.227 . . . . 0.0 111.984 . . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -41.0 -21.71 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.934 -1.939 . . . . 0.0 110.493 179.834 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' ARG . 47.9 tp -104.4 -25.04 12.98 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.712 -179.838 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.1 tm-20 -51.14 -35.28 34.9 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.351 -179.899 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -48.84 128.77 16.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.609 -180.0 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 10' ' ' GLY . 13.6 tt -66.19 -51.77 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.547 -179.814 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.603 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 42.04 76.64 0.1 OUTLIER Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.484 -0.389 . . . . 0.0 112.801 179.522 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -148.16 -9.61 0.38 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.565 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 55.63 62.18 2.53 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.38 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.3 86.84 0.01 OUTLIER Glycine 0 C--N 1.333 0.372 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.025 -179.598 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 12' ' ' ALA . 28.7 t80 64.98 44.35 3.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.814 0.34 . . . . 0.0 110.526 -179.618 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.2 mm 60.43 76.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.54 179.448 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 mm -135.86 -55.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.914 179.129 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 mm -69.9 -49.28 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.619 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.51 -43.75 35.92 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 178.833 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.09 -48.62 85.02 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.571 179.292 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.75 -14.6 0.96 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.0 110.224 179.745 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' HIS . 8.0 tp 58.3 112.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.192 179.966 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 57.5 -78.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.546 -179.728 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' LEU . 2.3 t60 -168.62 24.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.392 179.827 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.464 0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.461 179.902 . . . . . . . . 0 0 . 1 . 070 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 51.2 mtt85 . . . . . 1 N--CA 1.325 -6.677 0 CA-C-O 122.565 1.174 . . . . 0.0 112.051 . . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -44.66 -15.62 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.918 -1.946 . . . . 0.0 110.305 179.673 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 0.7 OUTLIER -129.9 -6.94 4.48 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.452 179.782 . . . . . . . . 3 3 . 1 . 070 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -84.2 -25.86 29.19 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.313 179.926 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -49.18 156.23 0.58 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.628 179.698 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' ILE . 6.3 tp -168.5 126.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.196 179.829 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.61 20.81 0.05 OUTLIER Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.726 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -73.44 3.4 6.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.229 -0.188 . . . . 0.0 110.904 -179.768 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.33 36.92 28.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.81 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -34.24 88.86 0.01 OUTLIER Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.926 -179.561 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 12' ' ' ALA . 59.2 t80 56.9 57.4 4.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.063 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.1 pt 35.0 79.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.342 -179.012 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.601 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.2 tp -135.61 -51.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.076 179.665 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.601 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.5 tp -89.06 -36.12 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.003 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.62 -32.07 16.75 Favored Glycine 0 C--N 1.331 0.293 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 178.833 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.28 -47.17 13.41 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.505 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.72 -28.43 14.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.929 0.395 . . . . 0.0 110.265 179.658 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.5 tp 55.39 70.8 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.676 179.816 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 52.11 46.29 26.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.791 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 50.19 52.34 14.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.679 179.81 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.293 179.984 . . . . . . . . 0 0 . 1 . 071 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 7' ' ' GLU . 54.7 mtt85 . . . . . 1 N--CA 1.325 -6.7 0 CA-C-O 122.528 1.156 . . . . 0.0 112.075 . . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -41.39 -25.83 0.05 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.107 -1.861 . . . . 0.0 109.822 179.907 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 6' ' ' LEU . 2.7 mm? -93.57 -30.46 14.97 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.336 179.682 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.0 tt0 -87.86 -5.4 58.61 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.959 0.409 . . . . 0.0 110.259 -179.799 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -66.68 -24.74 66.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.438 179.864 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.9 pt -50.33 -31.87 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.69 -179.853 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.07 66.05 3.05 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.682 -179.814 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.523 ' NZ ' ' CD1' ' A' ' 14' ' ' PHE . 20.9 tptp -158.29 83.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.874 0.369 . . . . 0.0 110.135 -179.881 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.32 63.25 4.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.353 -179.831 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.443 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 47.4 58.07 6.84 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -179.74 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.523 ' CD1' ' NZ ' ' A' ' 11' ' ' LYS . 43.5 m-85 59.2 38.01 23.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.563 0.22 . . . . 0.0 110.458 -179.512 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt 59.62 69.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.85 0.357 . . . . 0.0 110.196 -179.93 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.565 HG23 ' N ' ' A' ' 17' ' ' ILE . 8.5 tp -139.08 -48.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.121 179.811 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.565 ' N ' HG23 ' A' ' 16' ' ' ILE . 4.3 tp -80.7 -26.86 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.946 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.52 -57.63 1.95 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.145 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.01 84.58 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.499 179.246 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 54.7 15.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.613 0.244 . . . . 0.0 110.875 179.657 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.7 mt -66.21 4.17 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.758 0.313 . . . . 0.0 110.583 179.855 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 20' ' ' ALA . 30.0 t0 -66.93 -24.73 66.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.82 -179.825 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.414 ' H ' ' H ' ' A' ' 24' ' ' LEU . 54.5 t60 -169.39 -8.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.174 -179.767 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.414 ' H ' ' H ' ' A' ' 23' ' ' HIS . 49.2 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.236 -179.865 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 7' ' ' GLU . 54.2 mtp180 . . . . . 1 N--CA 1.325 -6.695 0 CA-C-O 122.506 1.146 . . . . 0.0 112.033 . . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 27.3 t-105 -41.08 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.544 -179.906 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.8 tp -113.17 -22.13 10.66 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.36 179.457 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.9 mt-10 -101.95 13.01 35.99 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.655 0.264 . . . . 0.0 110.54 -179.994 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -75.03 -74.57 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.769 -179.93 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 11' ' ' LYS . 15.7 tt -75.37 -25.02 17.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.752 -179.707 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . -52.45 -8.28 0.5 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.265 -179.821 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 9' ' ' ILE . 24.3 mtpp -76.96 22.95 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.861 -179.818 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 15' ' ' ILE . . . 57.29 40.24 27.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.218 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -34.47 89.01 0.01 OUTLIER Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.449 -179.508 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 12' ' ' ALA . 35.0 t80 66.65 53.78 0.89 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.748 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 12' ' ' ALA . 9.7 pt 37.86 82.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.759 -179.493 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.0 mm -132.93 -60.29 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.846 178.844 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.617 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.6 mp -69.43 -55.47 15.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.779 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.64 -37.19 52.65 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.024 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.09 -51.46 55.03 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 179.569 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.5 -68.75 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.844 0.354 . . . . 0.0 110.314 179.898 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.0 tp 49.91 95.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.62 179.821 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -168.01 -31.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.53 179.996 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -171.49 -16.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.52 179.958 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.1 mp . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.195 179.958 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 49.2 mtp180 . . . . . 1 N--CA 1.325 -6.718 0 CA-C-O 122.518 1.151 . . . . 0.0 111.968 . . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -42.43 -18.82 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.93 -1.941 . . . . 0.0 110.446 179.959 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.6 mt -113.86 -18.64 11.74 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.908 179.884 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.9 tt0 -50.01 -20.44 0.95 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.651 -179.736 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -56.61 144.56 31.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.563 -179.872 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 10' ' ' GLY . 18.2 tt -68.42 -37.14 77.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.521 -179.946 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 80.23 -32.64 2.27 Favored Glycine 0 C--N 1.331 0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.071 179.843 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -76.82 23.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.335 179.984 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 48.44 67.05 0.91 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.288 -179.517 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -40.48 86.41 0.01 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.52 -179.54 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 12' ' ' ALA . 17.6 m-85 63.14 53.29 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.683 0.278 . . . . 0.0 110.964 -179.699 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 mt 62.54 76.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.335 -0.059 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.591 179.217 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.5 mm -134.39 -64.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.872 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.7 mm -78.19 -32.87 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.35 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.513 ' H ' ' CB ' ' A' ' 12' ' ' ALA . . . -68.74 -53.74 18.43 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.519 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.35 -47.95 15.69 Favored Glycine 0 C--N 1.332 0.314 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.111 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.88 27.4 1.13 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.723 0.296 . . . . 0.0 110.917 179.783 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.4 tp -62.96 96.47 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.197 179.963 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 23.5 m-20 55.35 47.08 22.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.517 -179.834 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.501 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 50.0 p-80 41.2 52.62 3.52 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.17 -179.935 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.441 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.133 179.951 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 80.8 mtt180 . . . . . 1 N--CA 1.323 -6.78 0 CA-C-O 122.544 1.164 . . . . 0.0 111.911 . . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.466 ' CE3' HD21 ' A' ' 6' ' ' LEU . 28.5 t90 -41.9 -19.78 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.32 179.908 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.1 mt -108.71 -25.3 10.91 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.32 179.373 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.7 mt-10 -93.27 26.52 2.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -62.44 -144.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.444 -179.997 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.401 ' C ' ' N ' ' A' ' 11' ' ' LYS . 23.2 pt -50.14 -24.33 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.461 179.93 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.1 18.26 0.43 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.049 -179.965 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 9' ' ' ILE . 25.4 mmtp -133.73 44.84 2.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.728 0.299 . . . . 0.0 110.302 -179.892 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.483 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -79.72 52.91 1.52 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.569 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 68.69 30.64 72.81 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.348 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 70.57 69.38 0.2 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.47 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.1 pt 35.34 60.52 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.673 -179.72 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -138.48 -47.36 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.547 179.036 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.521 ' N ' HG23 ' A' ' 16' ' ' ILE . 38.0 mm -73.82 -53.21 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.817 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.483 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -75.76 -29.43 59.36 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.425 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -72.06 -37.59 60.04 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.786 -0.526 . . . . 0.0 111.786 179.441 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.77 35.28 0.15 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.843 0.354 . . . . 0.0 110.395 179.796 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.45 ' H ' ' C ' ' A' ' 19' ' ' GLY . 21.5 tp -55.44 119.32 5.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.184 -179.961 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 52.02 24.76 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.501 179.966 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 51.52 46.66 26.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.454 -179.953 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.203 -179.994 . . . . . . . . 0 0 . 1 . 075 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 7' ' ' GLU . 68.0 mtp180 . . . . . 1 N--CA 1.324 -6.765 0 CA-C-O 122.586 1.184 . . . . 0.0 112.032 . . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -42.55 -24.57 0.06 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.649 -179.966 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.505 ' N ' HD12 ' A' ' 6' ' ' LEU . 10.4 mp -98.0 -27.94 14.01 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.196 179.389 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 4' ' ' ARG . 17.7 tt0 -87.85 38.43 0.84 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.036 0.446 . . . . 0.0 110.238 -179.873 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -64.15 -31.99 73.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 179.988 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -167.74 -32.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.381 179.935 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.05 87.23 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.238 179.701 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 39.5 tttm -168.72 -17.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.236 179.645 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 71.72 -11.4 0.74 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.59 179.95 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 35.85 55.0 1.12 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 179.932 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 t80 68.32 40.31 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.568 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 12' ' ' ALA . 18.1 mt 63.65 79.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.749 -179.711 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 12' ' ' ALA . 4.4 tp -148.21 -19.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.186 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.41 ' H ' ' H ' ' A' ' 16' ' ' ILE . 29.0 mm -114.25 -38.21 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.598 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.96 -53.98 5.05 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.245 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.55 -28.99 37.36 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 179.627 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 49.84 19.53 0.45 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.88 0.372 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.3 mt 57.7 6.23 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.475 -179.886 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 20' ' ' ALA . 88.9 m-20 -80.83 19.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.471 179.957 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.7 m80 54.0 44.05 29.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.478 -179.845 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.132 -179.955 . . . . . . . . 0 0 . 1 . 076 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 6' ' ' LEU . 78.9 mtp180 . . . . . 1 N--CA 1.325 -6.703 0 CA-C-O 122.552 1.168 . . . . 0.0 111.981 . . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.565 ' CE3' HD21 ' A' ' 6' ' ' LEU . 27.8 t90 -42.62 -18.53 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 112.93 -1.941 . . . . 0.0 110.371 179.847 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.565 HD21 ' CE3' ' A' ' 5' ' ' TRP . 34.4 mt -114.62 -18.01 11.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.96 179.597 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.3 tt0 -47.22 -34.02 6.01 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.705 -179.816 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 50.59 85.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 179.935 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.632 ' N ' HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -46.58 -21.37 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.918 . . . . . . . . 3 3 . 1 . 076 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 34.61 28.37 0.01 OUTLIER Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.483 179.209 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 9' ' ' ILE . 21.0 tptp -51.5 -30.73 21.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.084 179.726 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.6 -42.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.152 179.897 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.79 -44.87 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.785 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 64.2 t80 -173.93 33.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.615 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.2 mt 64.88 58.63 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 121.811 0.815 . . . . 0.0 109.461 -178.765 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.3 mm -119.49 -56.08 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.328 -179.784 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 35.1 mm -73.98 -50.31 29.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.771 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.85 -49.98 72.64 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.034 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.76 -53.33 31.71 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.227 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.63 35.79 12.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.559 0.219 . . . . 0.0 110.895 179.607 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.2 mt -73.83 84.64 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.197 179.816 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 51.38 59.15 4.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.472 -179.91 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 33.9 m170 53.55 55.81 8.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.542 -179.863 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.452 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.075 -179.897 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 6' ' ' LEU . 44.7 mtt85 . . . . . 1 N--CA 1.324 -6.748 0 CA-C-O 122.406 1.098 . . . . 0.0 111.954 . . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 42.3 t-105 -41.14 -19.98 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.443 -179.972 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 8.1 tp -115.79 -20.28 10.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.294 179.323 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 52.3 mt-10 -91.72 21.33 4.84 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.744 0.307 . . . . 0.0 110.636 179.977 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -50.81 -32.79 21.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.513 179.896 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 pt -47.66 119.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.411 0.624 . . . . 0.0 110.638 -179.625 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.03 -6.95 61.46 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.899 -179.87 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 13' ' ' GLY . 9.5 mtmp? -60.69 98.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.0 110.475 179.976 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -54.89 -8.28 0.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.296 179.625 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 61.05 4.36 4.47 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.641 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.46 ' O ' HG23 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -82.8 -70.98 0.51 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.973 . . . . . . . . 3 3 . 1 . 077 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 14' ' ' PHE . 12.8 pt -158.85 46.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.139 0.495 . . . . 0.0 110.145 179.1 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -80.37 -67.82 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.99 179.374 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.523 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -81.07 1.31 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.035 179.743 . . . . . . . . 3 3 . 1 . 077 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -101.53 -67.8 0.81 Allowed Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.796 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.435 ' C ' ' N ' ' A' ' 21' ' ' LEU . . . -81.46 -37.96 15.97 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.632 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.95 11.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.741 179.898 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.435 ' N ' ' C ' ' A' ' 19' ' ' GLY . 33.3 mt 48.58 77.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.751 179.821 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 8.9 p-10 -174.82 23.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.102 179.735 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.406 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 76.0 t60 57.12 32.26 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.652 -179.859 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.421 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.08 179.933 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 68.2 mtt85 . . . . . 1 N--CA 1.325 -6.716 0 CA-C-O 122.489 1.138 . . . . 0.0 111.994 . . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -42.08 -18.88 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.992 -1.913 . . . . 0.0 110.43 -179.988 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.2 mp -112.82 -21.72 11.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.536 179.215 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.1 tt0 -91.4 -5.68 54.04 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.06 0.457 . . . . 0.0 110.317 -179.832 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -71.95 148.59 45.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.62 179.859 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 tp -52.71 97.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.206 0.526 . . . . 0.0 110.129 179.878 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.99 30.2 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.793 -179.809 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -49.69 -18.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.69 -179.961 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.57 -10.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.158 -179.851 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.11 57.96 0.13 Allowed Glycine 0 C--N 1.333 0.404 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.636 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.4 t80 69.31 22.77 6.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.802 0.334 . . . . 0.0 110.31 -179.428 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 mt 62.18 65.27 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.583 0.706 . . . . 0.0 110.308 179.956 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 mm -132.72 -49.71 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.627 179.766 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.647 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.6 mp -71.53 -45.94 65.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.673 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.78 -46.33 24.29 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 178.969 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.431 ' C ' ' N ' ' A' ' 21' ' ' LEU . . . -67.31 -56.57 11.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.924 179.537 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.48 15.44 0.14 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.877 0.37 . . . . 0.0 110.606 -179.968 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 23' ' ' HIS . 6.7 tp -83.76 -13.52 53.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.287 -179.856 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -75.0 36.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.714 179.886 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.445 ' H ' ' C ' ' A' ' 21' ' ' LEU . 50.3 t-80 52.56 28.47 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.556 179.963 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.057 179.989 . . . . . . . . 0 0 . 1 . 079 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 85.4 mtt180 . . . . . 1 N--CA 1.325 -6.719 0 CA-C-O 122.479 1.133 . . . . 0.0 111.999 . . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 27.5 t90 -41.37 -19.66 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.425 -179.966 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.0 mt -114.77 -21.16 10.32 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.273 179.032 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 tt0 -92.21 31.93 1.23 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.978 0.418 . . . . 0.0 109.942 179.905 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -51.44 -63.9 0.98 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.753 -179.739 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 9' ' ' ILE . 2.9 tp -51.13 100.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.19 0.519 . . . . 0.0 110.261 -179.762 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.73 -43.52 7.71 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.111 -179.801 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 13' ' ' GLY . 60.8 mttp -57.5 106.91 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.233 -179.971 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.76 0.94 4.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.661 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 42.06 35.29 1.64 Allowed Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.306 179.858 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' HG23 ' A' ' 15' ' ' ILE . 61.4 t80 -168.35 -13.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.957 -179.888 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 14' ' ' PHE . 11.9 pt -157.78 52.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.061 0.458 . . . . 0.0 110.245 179.371 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.6 tp -143.82 -43.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.215 179.994 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.5 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -62.22 -2.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.082 179.396 . . . . . . . . 3 3 . 1 . 079 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . 178.2 -10.49 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.966 -179.925 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 18' ' ' GLY . . . -66.44 -35.4 90.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.141 -179.979 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -12.6 61.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.739 0.304 . . . . 0.0 110.698 -179.815 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.43 ' C ' HD23 ' A' ' 21' ' ' LEU . 2.4 tt 60.3 109.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.149 -179.977 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 57.52 23.84 9.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.756 179.93 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 1.1 t60 50.79 37.59 17.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.648 179.807 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.166 179.922 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.49 ' O ' ' N ' ' A' ' 6' ' ' LEU . 27.8 mtp85 . . . . . 1 N--CA 1.322 -6.831 0 CA-C-O 122.667 1.223 . . . . 0.0 111.983 . . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.503 ' CE3' HD21 ' A' ' 6' ' ' LEU . 20.1 t90 -43.54 -18.18 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 112.885 -1.962 . . . . 0.0 110.232 179.894 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.503 HD21 ' CE3' ' A' ' 5' ' ' TRP . 37.0 mt -116.83 -14.86 10.72 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.075 179.861 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.3 tp10 -63.36 -23.27 67.34 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.201 -179.931 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.9 ttt85 -47.14 107.72 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.709 179.881 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -50.2 98.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.17 0.509 . . . . 0.0 110.484 -179.791 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.69 -17.85 13.99 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.874 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 13' ' ' GLY . 57.7 mttm -64.18 100.46 0.34 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 110.478 -179.987 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.91 -4.93 0.82 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.047 179.742 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 57.08 8.81 3.48 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.646 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -87.17 -61.47 1.72 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.885 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 pt -155.18 40.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.167 0.508 . . . . 0.0 110.283 179.506 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 16' ' ' ILE . 1.5 mp -89.73 -45.41 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.435 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.515 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -75.19 17.81 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.363 179.522 . . . . . . . . 3 3 . 1 . 080 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -157.37 -39.6 0.02 OUTLIER Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.466 -179.756 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.89 -3.48 70.52 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.306 -0.473 . . . . 0.0 112.415 -179.582 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.05 45.62 0.54 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.533 -179.96 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -135.87 6.66 3.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.152 179.959 . . . . . . . . 3 3 . 1 . 080 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' N ' HD12 ' A' ' 21' ' ' LEU . 63.1 m-20 -76.61 -23.93 53.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.326 179.822 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -166.68 -39.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.499 -179.993 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.185 -179.898 . . . . . . . . 0 0 . 1 . 081 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 7' ' ' GLU . 91.2 mtt180 . . . . . 1 N--CA 1.324 -6.73 0 CA-C-O 122.572 1.177 . . . . 0.0 112.115 . . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -39.13 -23.84 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.713 -179.942 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.7 tp -101.82 -25.95 13.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.068 -179.535 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.2 tp10 -58.81 -35.23 72.52 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.277 -179.808 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -69.11 177.01 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.671 -179.822 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.3 tp -174.05 131.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.938 179.906 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.88 -23.05 0.19 Allowed Glycine 0 C--N 1.333 0.417 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -179.773 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -61.96 110.32 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.028 179.712 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.72 2.7 7.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.799 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 39.38 31.95 0.23 Allowed Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.327 -179.962 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.433 ' H ' ' H ' ' A' ' 15' ' ' ILE . 66.6 t80 -162.72 -10.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.79 0.328 . . . . 0.0 110.571 -179.794 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.433 ' H ' ' H ' ' A' ' 14' ' ' PHE . 2.8 tt -161.58 54.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.753 0.787 . . . . 0.0 109.926 179.824 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.4 tp -149.0 -39.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.462 -179.757 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.457 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.1 pp -92.04 16.71 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 179.614 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.38 -57.51 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 179.888 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.69 -38.77 37.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.1 -0.571 . . . . 0.0 111.995 -179.676 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.84 -70.56 0.3 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.86 0.362 . . . . 0.0 110.376 179.99 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 23' ' ' HIS . 2.1 tt -170.89 96.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.988 -179.996 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.494 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 32.4 t70 55.09 -84.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.519 -179.815 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.494 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 94.0 m-70 -157.77 36.3 0.26 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.57 179.948 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.16 179.959 . . . . . . . . 0 0 . 1 . 082 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 7' ' ' GLU . 29.1 mmt180 . . . . . 1 N--CA 1.324 -6.739 0 CA-C-O 122.569 1.176 . . . . 0.0 111.861 . . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -42.85 -22.57 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.98 179.76 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 4' ' ' ARG . 41.8 tp -100.0 -25.92 14.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.487 179.901 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.9 tt0 -50.58 -31.3 15.42 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.313 179.869 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.0 ttt85 57.85 64.2 1.6 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.548 -179.942 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -55.86 111.35 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.174 0.511 . . . . 0.0 109.954 179.937 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.93 35.11 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.691 -179.687 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -50.1 -41.42 48.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.779 -179.86 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.88 -39.28 1.23 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.014 -179.872 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.2 60.95 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.651 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 23.6 t80 69.0 23.61 6.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.76 0.314 . . . . 0.0 110.184 -179.074 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.2 mt 62.14 71.71 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.591 0.71 . . . . 0.0 110.448 -179.986 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.5 mm -132.82 -51.97 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.699 179.603 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.2 mm -82.87 -41.31 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.569 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.22 -50.77 42.91 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.086 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -73.84 -50.44 11.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.941 179.504 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.75 1.04 0.27 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.557 0.218 . . . . 0.0 110.985 -179.961 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.3 mm? 52.42 96.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.831 0.348 . . . . 0.0 110.218 179.852 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -171.79 -54.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.297 179.793 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -171.39 -10.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.406 179.965 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 N--CA 1.463 0.225 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.394 179.979 . . . . . . . . 0 0 . 1 . 083 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 6' ' ' LEU . 77.8 mtm180 . . . . . 1 N--CA 1.323 -6.808 0 CA-C-O 122.492 1.139 . . . . 0.0 111.956 . . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 57.3 t90 -41.43 -19.89 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.225 179.766 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.1 tp -119.72 -17.65 8.53 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.883 179.254 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.2 tt0 -91.96 22.95 3.95 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 120.978 0.418 . . . . 0.0 110.03 179.85 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -52.6 132.56 35.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.614 -179.819 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 9' ' ' ILE . 15.7 tt -72.15 120.92 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.05 0.453 . . . . 0.0 110.129 179.749 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.08 -26.7 57.52 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.03 -179.692 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -66.79 103.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.381 -179.973 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.39 -2.75 4.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.727 179.511 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.64 29.44 4.12 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.728 -179.742 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.428 ' O ' HG23 ' A' ' 15' ' ' ILE . 36.7 t80 -162.45 -15.42 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.166 -0.214 . . . . 0.0 110.922 -179.587 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 14' ' ' PHE . 9.9 pt -156.68 54.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 110.353 179.541 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.481 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.3 tp -143.21 -42.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.039 179.733 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.501 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -65.49 -3.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.95 179.289 . . . . . . . . 3 3 . 1 . 083 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.79 -24.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.839 -179.869 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.4 4.43 55.57 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.306 -0.473 . . . . 0.0 111.925 179.994 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.3 -20.21 57.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.323 . . . . 0.0 110.716 -179.88 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.6 mt 56.42 15.41 1.99 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.503 -179.798 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.33 -60.7 2.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.603 179.951 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 57.9 t-80 -170.15 1.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.569 179.989 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.4 mm? . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.114 179.976 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 6' ' ' LEU . 87.8 mtt180 . . . . . 1 N--CA 1.323 -6.78 0 CA-C-O 122.559 1.171 . . . . 0.0 112.083 . . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -41.82 -18.96 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.928 -1.942 . . . . 0.0 110.541 -179.974 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.6 tp -114.68 -19.29 11.14 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.716 179.941 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.0 tt0 -85.84 -14.56 44.63 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.736 -179.716 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 10' ' ' GLY . 26.6 ttp85 -74.27 -81.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.904 -179.981 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.488 HG23 ' O ' ' A' ' 9' ' ' ILE . 5.8 tp -62.9 79.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.722 0.773 . . . . 0.0 110.004 -179.803 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -82.75 -18.99 64.47 Favored Glycine 0 CA--C 1.517 0.17 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.976 -179.515 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.431 ' HA ' HG21 ' A' ' 16' ' ' ILE . 34.0 mtmm -75.59 100.47 4.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.781 0.324 . . . . 0.0 110.763 -179.828 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.14 -1.34 4.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.103 179.641 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.4 47.51 43.55 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.214 179.985 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -169.23 -40.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.768 179.855 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.6 pt -154.34 61.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.899 0.381 . . . . 0.0 110.571 179.977 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.431 HG21 ' HA ' ' A' ' 11' ' ' LYS . 17.6 mm -149.42 -48.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.572 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.85 9.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.924 179.781 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -172.82 -38.99 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.875 179.951 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -54.7 -35.73 58.13 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.021 179.94 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.17 7.13 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.525 -179.975 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.4 tp 51.17 23.82 1.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.235 -179.972 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -73.09 -53.99 9.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.611 -179.954 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.412 ' H ' ' H ' ' A' ' 24' ' ' LEU . 12.2 p-80 -166.62 -9.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.745 -179.944 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.412 ' H ' ' H ' ' A' ' 23' ' ' HIS . 11.1 tp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.324 179.908 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.9 mtm180 . . . . . 1 N--CA 1.324 -6.764 0 CA-C-O 122.493 1.14 . . . . 0.0 112.023 . . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.526 ' CE3' HD21 ' A' ' 6' ' ' LEU . 29.7 t90 -40.96 -21.1 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.014 -1.903 . . . . 0.0 110.325 -179.915 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.526 HD21 ' CE3' ' A' ' 5' ' ' TRP . 26.1 mt -108.49 -25.1 11.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.44 179.247 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.0 mp0 -93.98 2.8 56.02 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.141 179.789 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 4' ' ' ARG . 60.9 ttt180 -54.28 -71.38 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.408 179.966 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 9' ' ' ILE . 4.8 tp -171.27 87.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.351 0.596 . . . . 0.0 110.18 179.789 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.01 -53.15 3.8 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.999 -179.78 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 13' ' ' GLY . 57.2 mttp -57.06 101.24 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.794 0.331 . . . . 0.0 110.635 -179.89 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -63.84 -1.3 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.015 179.514 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 55.8 7.55 1.66 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.767 -179.873 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 12' ' ' ALA . 50.5 t80 -127.1 -19.68 4.31 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.542 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 17' ' ' ILE . 4.5 mt -147.14 -135.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.715 179.359 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.456 ' H ' HG22 ' A' ' 15' ' ' ILE . 21.2 mm 52.76 -82.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 121.276 -0.17 . . . . 0.0 110.872 179.323 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 15' ' ' ILE . 3.7 tp -73.74 -38.28 50.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.675 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.51 -50.14 45.74 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.482 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.98 -47.64 7.51 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.779 -0.529 . . . . 0.0 111.779 179.627 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.86 47.88 15.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.935 179.881 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.3 mt -68.33 -19.28 64.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.547 -179.979 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -53.04 -92.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.584 -179.977 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.472 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 2.0 t60 -80.51 11.08 3.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.785 -179.81 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.211 -179.985 . . . . . . . . 0 0 . 1 . 086 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.576 ' O ' ' N ' ' A' ' 7' ' ' GLU . 55.4 mtp85 . . . . . 1 N--CA 1.323 -6.807 0 CA-C-O 122.542 1.163 . . . . 0.0 112.016 . . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -40.89 -24.84 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.02 -1.9 . . . . 0.0 109.843 179.763 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.5 mm? -96.69 -31.24 12.79 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.947 179.218 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 4' ' ' ARG . 52.5 mm-40 -90.68 43.36 1.14 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.782 0.325 . . . . 0.0 110.28 179.723 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -145.85 22.9 1.41 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.392 -179.79 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 pt -51.48 121.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.232 0.539 . . . . 0.0 110.327 -179.98 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.44 -18.28 79.93 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.865 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -80.05 109.2 14.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.764 0.316 . . . . 0.0 110.366 179.974 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.45 10.45 7.16 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.507 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.84 37.53 7.29 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.97 -179.768 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -159.24 -68.67 0.08 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.773 0.32 . . . . 0.0 110.171 -179.902 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.573 ' O ' HG23 ' A' ' 15' ' ' ILE . 9.5 tt -93.69 44.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.784 0.802 . . . . 0.0 109.899 179.721 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.1 tp -145.11 -43.8 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.326 -179.896 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.491 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.1 pp -88.49 13.85 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.422 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.86 -48.54 0.01 OUTLIER Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.773 -179.823 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.67 -15.12 66.06 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.05 -179.986 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.72 -28.32 61.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.619 -179.887 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 21' ' ' LEU . 8.8 mp -55.92 116.39 2.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.145 179.951 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.87 25.93 4.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.979 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 8.5 t60 53.08 52.17 14.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.527 -179.982 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.157 179.999 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 62.5 mtp180 . . . . . 1 N--CA 1.324 -6.761 0 CA-C-O 122.518 1.151 . . . . 0.0 111.998 . . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -42.82 -18.88 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.915 -1.948 . . . . 0.0 110.16 179.731 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.5 mt -113.49 -20.19 11.38 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.764 179.547 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.0 tt0 -83.23 24.33 0.81 Allowed 'General case' 0 C--N 1.342 0.269 0 CA-C-O 121.138 0.494 . . . . 0.0 110.047 179.924 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -66.09 -96.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.908 -179.789 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.2 pt -75.08 -35.39 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.03 -179.525 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.41 17.05 0.37 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.9 -179.714 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 46.5 tttm -75.71 -4.95 43.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.834 0.35 . . . . 0.0 110.53 -179.745 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 71.76 8.73 6.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.284 -179.943 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 40.51 48.96 3.9 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 179.979 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 t80 78.13 49.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.831 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.2 mt 61.46 75.55 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.765 179.895 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 12' ' ' ALA . 7.5 mm -130.92 -57.59 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.652 179.703 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.608 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.3 mp -69.17 -52.5 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.524 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.11 -48.04 68.24 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 178.621 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.55 -56.98 17.3 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.666 179.091 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.0 -67.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.77 0.319 . . . . 0.0 110.496 -179.944 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.5 tt 62.18 86.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.122 0.487 . . . . 0.0 110.142 -179.837 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -170.65 51.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.282 -179.957 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 74.8 t60 56.24 25.39 9.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.264 -179.829 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.051 -179.906 . . . . . . . . 0 0 . 1 . 088 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' LEU . 94.7 mtt180 . . . . . 1 N--CA 1.323 -6.777 0 CA-C-O 122.496 1.141 . . . . 0.0 111.911 . . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 56.6 t-105 -41.96 -18.55 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.453 179.946 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.4 mp -117.7 -17.09 9.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.839 179.358 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' ARG . 14.2 tp10 -81.66 -6.02 58.63 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.049 0.452 . . . . 0.0 110.093 -179.955 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -56.09 -20.87 19.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.742 -179.916 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.7 mm -70.28 73.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -179.989 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.84 -9.37 87.15 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 179.644 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 58.5 mmtt -75.05 8.46 2.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 110.688 -179.859 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 72.66 -11.71 0.82 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.55 179.91 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 39.9 54.33 3.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.471 -0.395 . . . . 0.0 112.218 179.976 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CG ' ' C ' ' A' ' 13' ' ' GLY . 3.9 m-85 74.81 45.34 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.782 0.325 . . . . 0.0 110.16 -179.272 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.8 mt 61.4 79.4 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.427 0.632 . . . . 0.0 111.179 179.807 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -135.74 -61.81 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.95 179.434 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.654 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.6 mp -71.84 -49.03 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.508 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.35 -56.36 22.32 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.452 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.58 -48.64 61.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.968 179.657 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.17 37.34 14.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.761 0.315 . . . . 0.0 110.545 -179.955 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.0 mt -70.49 109.69 4.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.55 179.988 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.29 32.29 18.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.706 179.903 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.8 m170 50.72 48.94 21.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 -179.975 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.0 tt . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.107 -179.89 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 6' ' ' LEU . 95.9 mtt180 . . . . . 1 N--CA 1.326 -6.626 0 CA-C-O 122.464 1.126 . . . . 0.0 112.066 . . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.568 ' CE3' HD21 ' A' ' 6' ' ' LEU . 29.0 t90 -41.0 -19.98 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.55 -179.963 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.568 HD21 ' CE3' ' A' ' 5' ' ' TRP . 45.8 mt -115.03 -20.58 10.43 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.51 179.197 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.4 mm-40 -91.63 17.13 9.25 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.959 0.409 . . . . 0.0 110.162 179.668 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -57.45 -50.06 74.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.913 -179.893 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 10' ' ' GLY . 13.6 tt -52.81 -44.37 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.643 -179.663 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 77.82 -50.67 3.33 Favored Glycine 0 C--N 1.331 0.266 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 -179.954 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 13' ' ' GLY . 94.2 mttt -66.54 100.45 0.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.318 179.836 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.15 5.9 2.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.063 179.933 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 43.53 48.51 7.17 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.042 -179.86 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -162.5 -31.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.586 0.231 . . . . 0.0 110.885 -179.702 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 15' ' ' ILE . 16.4 tt -166.98 61.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 110.724 179.922 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 18' ' ' GLY . 22.1 mm -145.45 -61.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.864 179.584 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.478 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -69.32 3.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.035 179.479 . . . . . . . . 3 3 . 1 . 089 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -135.91 -55.05 0.06 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 179.889 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -74.38 -56.44 5.12 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.519 -0.633 . . . . 0.0 111.519 179.486 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.447 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 61.74 -1.93 0.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.599 0.238 . . . . 0.0 111.329 179.566 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 21' ' ' LEU . 8.2 mp 51.42 12.12 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.733 0.301 . . . . 0.0 110.256 179.938 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' N ' ' C ' ' A' ' 20' ' ' ALA . 14.6 t0 -68.27 -55.72 11.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.617 -179.904 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.407 ' H ' ' H ' ' A' ' 24' ' ' LEU . 7.7 t60 -167.62 -17.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.567 -179.992 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.407 ' H ' ' H ' ' A' ' 23' ' ' HIS . 16.5 mt . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.501 179.876 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 6' ' ' LEU . 1.7 mtm180 . . . . . 1 N--CA 1.32 -6.926 0 CA-C-O 121.354 0.597 . . . . 0.0 110.077 . . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -42.2 -18.55 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.363 -179.566 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.2 tp -114.47 -17.54 11.71 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.628 179.467 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.3 mt-10 -107.55 15.32 24.89 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 120.819 0.343 . . . . 0.0 110.264 179.958 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -53.64 163.08 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.534 179.921 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.44 ' C ' ' H ' ' A' ' 11' ' ' LYS . 11.1 pt -76.19 -36.69 31.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.426 179.921 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.25 -5.44 1.43 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.195 179.958 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 9' ' ' ILE . 67.0 mmtt -87.73 105.38 17.34 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.672 -179.922 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.468 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -78.59 46.71 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.235 179.676 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.68 67.18 2.03 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.768 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 53.8 t80 55.2 26.93 8.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.016 -179.731 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 mt 62.14 62.32 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.679 0.752 . . . . 0.0 109.639 -179.453 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.8 mm -129.38 -46.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.025 -179.817 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.5 mp -70.96 -46.94 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.809 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.468 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -78.41 -39.2 23.03 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 178.652 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.49 -52.75 50.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.081 -0.581 . . . . 0.0 111.73 179.369 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.42 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . -62.73 -58.18 8.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.332 179.8 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 tp 53.35 12.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.236 179.891 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 20' ' ' ALA . 77.9 m-20 -66.36 -107.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.335 -179.994 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -68.64 -30.18 68.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 110.429 179.938 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.438 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.429 179.896 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.9 mtm180 . . . . . 1 N--CA 1.325 -6.705 0 CA-C-O 122.654 1.216 . . . . 0.0 112.09 . . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -41.46 -24.66 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.957 -1.929 . . . . 0.0 109.912 179.796 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' N ' ' C ' ' A' ' 4' ' ' ARG . 17.2 mt -96.55 -27.82 14.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.75 179.853 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.6 tt0 -51.31 -22.73 3.02 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.38 179.934 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 59.46 64.87 1.25 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.648 -179.861 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.3 pt -80.01 -31.97 13.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.347 179.807 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.78 15.75 0.56 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.123 -0.561 . . . . 0.0 111.942 -179.98 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -77.0 -45.8 26.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.697 0.284 . . . . 0.0 110.777 -179.868 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 16' ' ' ILE . . . 56.54 10.36 0.68 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.155 -179.918 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 41.38 53.54 4.14 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.839 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 t80 73.89 48.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -178.996 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mt 63.1 76.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.034 179.924 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.6 mm -131.06 -67.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.401 179.497 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 47.1 mm -78.8 -31.61 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.584 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.77 -51.71 23.54 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.678 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.36 -47.61 6.81 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.254 -0.498 . . . . 0.0 111.903 179.296 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.63 43.48 16.42 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.792 0.329 . . . . 0.0 110.759 -179.981 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.5 mt -75.16 116.31 15.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.675 -179.801 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 47.36 36.02 4.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.98 179.829 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.2 m80 52.72 62.57 2.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.578 -179.957 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.219 179.99 . . . . . . . . 0 0 . 1 . 092 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 7' ' ' GLU . 35.1 mtt180 . . . . . 1 N--CA 1.312 -7.355 0 CA-C-O 121.519 0.676 . . . . 0.0 110.459 . . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -43.8 -22.83 0.06 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.669 -179.687 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 6' ' ' LEU . 8.2 mp -90.74 -28.38 18.32 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.865 179.289 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.7 tt0 -78.42 -21.32 49.4 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.275 179.715 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 10' ' ' GLY . 1.2 tpm_? -68.41 -58.93 3.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.9 -179.457 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -48.81 92.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.398 0.618 . . . . 0.0 110.318 -179.794 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 156.84 38.16 0.02 OUTLIER Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.593 -179.677 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -46.65 -29.54 1.91 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.825 0.345 . . . . 0.0 110.46 179.834 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.407 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -164.84 -3.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.492 -179.921 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 52.82 27.79 29.54 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.742 -179.842 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -144.9 -11.91 0.57 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.901 0.382 . . . . 0.0 110.065 179.951 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.2 pt -155.44 42.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.904 179.448 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.1 tp -152.91 -27.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.004 -179.778 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.41 ' C ' HD12 ' A' ' 17' ' ' ILE . 1.1 pp -81.5 9.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.679 179.516 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.86 -28.36 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.839 -179.901 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.51 -43.88 67.23 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.854 179.979 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.18 -39.91 74.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 110.415 179.882 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 23' ' ' HIS . 2.3 tt 65.49 -76.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.015 -179.863 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 42.73 -90.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 111.092 179.799 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' LEU . 59.1 t-80 -122.96 -14.78 7.54 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.225 179.759 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 21' ' ' LEU . 24.5 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.392 179.958 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.8 mtt180 . . . . . 1 N--CA 1.323 -6.797 0 CA-C-O 122.502 1.144 . . . . 0.0 111.95 . . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -41.38 -19.47 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.041 -1.89 . . . . 0.0 110.486 -179.957 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 mt -114.4 -20.39 10.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.659 179.377 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.8 mt-10 -89.82 -8.32 52.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.671 0.272 . . . . 0.0 110.763 -179.872 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -69.88 -91.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.208 179.831 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 9' ' ' ILE . 2.9 tp -60.15 91.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 0.0 110.108 -179.97 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.05 29.85 11.61 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.896 -179.79 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -149.62 62.01 1.01 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.719 0.295 . . . . 0.0 110.372 -179.964 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.53 52.08 1.58 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.39 179.853 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.86 60.14 8.56 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.847 -179.844 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.492 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 57.9 t80 57.09 32.98 22.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.883 0.373 . . . . 0.0 110.653 -179.818 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 mt 61.26 61.78 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.599 0.714 . . . . 0.0 109.892 -179.818 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mm -129.96 -51.21 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.75 -179.838 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.9 mm -69.14 -41.41 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.473 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.421 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . -82.21 -38.07 13.8 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.166 179.193 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.05 -37.22 73.16 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.452 179.855 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.34 -64.64 1.09 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.663 0.268 . . . . 0.0 111.357 -179.26 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' HIS . 23.6 mt 53.76 -99.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.175 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 50.18 -87.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.746 179.758 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' LEU . 79.6 m80 -153.96 13.17 0.45 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.494 -179.88 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.455 179.885 . . . . . . . . 0 0 . 1 . 094 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 32.5 mtt180 . . . . . 1 N--CA 1.313 -7.295 0 CA-C-O 121.693 0.758 . . . . 0.0 110.297 . . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.501 ' CE3' HD21 ' A' ' 6' ' ' LEU . 28.6 t90 -43.63 -20.46 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.73 179.973 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.502 ' N ' ' C ' ' A' ' 4' ' ' ARG . 19.3 mt -102.89 -21.2 14.03 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.908 179.864 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.8 tm-20 -67.49 -25.76 66.03 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.124 179.878 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -63.44 163.47 10.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.894 -179.963 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.482 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.5 tt -162.42 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.964 179.915 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.482 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 76.7 -46.33 2.3 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.117 179.778 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 13' ' ' GLY . 54.7 mtpt -77.55 93.73 4.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.745 0.307 . . . . 0.0 110.857 -179.926 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.46 -4.84 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.973 0.415 . . . . 0.0 109.98 179.517 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 52.94 51.52 45.19 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.011 179.928 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 15' ' ' ILE . 34.0 t80 -168.83 -45.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.214 179.814 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' PHE . 7.9 pt -155.3 58.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.241 0.544 . . . . 0.0 110.718 -179.912 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.7 mm -140.11 -65.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.621 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 18' ' ' GLY . 4.2 tp -70.5 -39.37 76.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.498 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.414 ' N ' HG23 ' A' ' 17' ' ' ILE . . . -82.07 -42.81 8.52 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.7 179.601 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.95 -38.04 64.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.106 -0.568 . . . . 0.0 111.898 179.868 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 53.13 15.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.814 0.34 . . . . 0.0 110.583 179.892 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 21' ' ' LEU . 7.6 mp 54.01 9.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.276 -179.963 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 20' ' ' ALA . 28.9 t70 -78.31 -103.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.329 179.921 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.436 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -73.22 9.69 1.19 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 110.377 179.815 . . . . . . . . 3 3 . 1 . 094 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 22' ' ' ASP . 17.8 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.353 -179.936 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.2 mtt-85 . . . . . 1 N--CA 1.325 -6.725 0 CA-C-O 122.551 1.167 . . . . 0.0 112.067 . . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -41.15 -20.32 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.394 179.859 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.4 tt -109.24 -25.33 10.66 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.359 179.279 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.4 mt-10 -99.43 25.43 7.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.388 179.875 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -50.77 140.55 14.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.639 -179.87 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.473 HG23 ' N ' ' A' ' 10' ' ' GLY . 14.3 tt -72.62 -40.45 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.368 179.867 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.473 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 78.04 -56.07 3.94 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.048 179.914 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 13' ' ' GLY . 52.0 mtpt -60.98 101.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 110.518 -179.911 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.34 1.93 2.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.926 179.711 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 46.0 38.41 8.22 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.181 -179.996 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -166.81 -26.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 pt -154.45 59.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.914 0.388 . . . . 0.0 110.981 179.863 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.431 ' C ' ' H ' ' A' ' 18' ' ' GLY . 13.6 mm -150.67 -50.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.327 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.78 10.61 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.041 179.798 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -173.35 -20.46 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.216 -0.516 . . . . 0.0 111.971 179.902 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.73 -28.57 46.35 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.095 -179.899 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -66.58 -76.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.737 0.303 . . . . 0.0 110.85 -179.795 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.1 mt 59.88 3.92 0.53 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.579 -179.639 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 24' ' ' LEU . 56.4 p-10 -76.72 -133.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.196 179.711 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.575 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 1.2 m-70 -76.41 35.77 0.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 110.428 179.682 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 22' ' ' ASP . 15.5 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.179 -179.797 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 7' ' ' GLU . 7.0 mtm105 . . . . . 1 N--CA 1.319 -7.004 0 CA-C-O 121.511 0.672 . . . . 0.0 110.624 . . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -39.82 -23.29 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.258 -179.294 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.527 ' N ' HD12 ' A' ' 6' ' ' LEU . 10.0 mp -97.3 -27.45 14.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.242 179.15 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.1 mp0 -117.87 34.23 5.26 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.715 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 4' ' ' ARG . 56.6 ttm-85 -67.38 126.59 29.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.559 -179.989 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.8 pt -73.26 -30.76 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.56 56.4 20.22 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.898 -179.86 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -164.75 78.67 0.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.811 0.339 . . . . 0.0 110.553 -179.903 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.37 46.48 0.63 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.609 179.976 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.91 59.69 7.27 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.964 179.989 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 52.2 t80 57.34 35.03 25.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.621 0.248 . . . . 0.0 110.759 179.91 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt 62.19 71.94 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.482 0.658 . . . . 0.0 110.421 179.769 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.476 ' O ' ' N ' ' A' ' 20' ' ' ALA . 14.4 mt -146.75 -57.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.525 179.674 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.5 mp -58.9 -29.64 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.344 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.43 -45.83 2.9 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.147 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.55 -64.36 2.39 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.05 179.336 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 57.54 27.54 14.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.628 0.251 . . . . 0.0 110.628 -179.842 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.8 mt 53.43 -124.05 2.22 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.026 -179.747 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -82.87 63.96 7.24 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 179.692 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 50.3 t-80 56.49 19.02 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.141 -179.54 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.8 tp . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.424 -179.915 . . . . . . . . 0 0 . 1 . 097 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.0 mtm180 . . . . . 1 N--CA 1.325 -6.725 0 CA-C-O 122.46 1.124 . . . . 0.0 112.032 . . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -39.56 -21.7 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.798 -179.733 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.8 mt -107.83 -24.44 11.67 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.84 179.646 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 15.0 mp0 -86.87 29.38 0.81 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.63 0.252 . . . . 0.0 110.51 -179.894 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -87.74 -33.18 18.79 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.686 179.838 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 11' ' ' LYS . 3.6 tp -166.91 -3.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.157 0.503 . . . . 0.0 109.908 -179.568 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.446 ' H ' ' H ' ' A' ' 9' ' ' ILE . . . -36.17 -27.4 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.839 179.708 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 9' ' ' ILE . 63.2 mttp -54.64 107.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.381 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -67.65 3.9 1.26 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.6 -179.592 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 46.51 14.03 0.1 OUTLIER Glycine 0 C--N 1.329 0.183 0 C-N-CA 121.312 -0.47 . . . . 0.0 112.25 -179.945 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.46 ' N ' ' O ' ' A' ' 12' ' ' ALA . 73.6 t80 -138.29 -4.4 1.68 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.577 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 17' ' ' ILE . 3.3 mt -146.13 -137.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.038 179.604 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.504 ' C ' ' H ' ' A' ' 18' ' ' GLY . 47.5 mm 41.54 -87.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.333 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.581 HD12 ' C ' ' A' ' 17' ' ' ILE . 2.4 pp -55.11 -1.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.416 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.568 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -132.59 -70.97 0.09 OUTLIER Glycine 0 C--N 1.338 0.655 0 N-CA-C 112.326 -0.31 . . . . 0.0 112.326 -179.855 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -51.82 -25.27 15.34 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.693 -179.382 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.89 -11.84 0.1 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.612 179.999 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 23' ' ' HIS . 27.2 tp -44.52 123.86 3.84 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.479 179.841 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 56.02 -81.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.611 -179.541 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 21' ' ' LEU . 23.2 t-80 -163.79 43.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.676 179.97 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 30.8 mt . . . . . 0 N--CA 1.469 0.513 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.262 179.852 . . . . . . . . 0 0 . 1 . 098 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 7' ' ' GLU . 69.4 mtm180 . . . . . 1 N--CA 1.325 -6.725 0 CA-C-O 122.463 1.125 . . . . 0.0 112.007 . . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -39.59 -21.86 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.521 -179.944 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.5 tp -107.74 -26.24 10.9 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.724 179.615 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.9 tt0 -89.28 -3.01 58.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.103 0.477 . . . . 0.0 109.934 179.88 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -83.55 152.48 24.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.469 179.902 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.5 pt -55.72 -9.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.567 -179.979 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.22 31.32 4.52 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.145 179.96 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -151.4 70.37 0.96 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.972 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.03 48.98 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.567 -179.888 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.02 40.28 20.16 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.865 -179.976 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 t80 70.49 54.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.92 0.391 . . . . 0.0 110.493 -179.776 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 mm 62.05 75.57 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.157 179.703 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.9 mm -137.14 -51.65 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.686 179.244 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 mm -74.48 -49.86 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.042 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.01 -51.55 18.09 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.367 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -63.7 -43.02 98.45 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.796 179.62 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 70.11 -13.79 0.41 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.581 0.229 . . . . 0.0 110.957 179.943 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.473 ' H ' ' C ' ' A' ' 19' ' ' GLY . 4.8 tp 61.13 2.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.0 110.446 179.98 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 24' ' ' LEU . 74.7 m-20 -74.29 84.93 1.92 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.45 179.975 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 27.7 m170 56.73 5.92 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 -179.858 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 22' ' ' ASP . 37.6 mt . . . . . 0 N--CA 1.469 0.519 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.052 179.69 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' GLU . 70.7 mtp180 . . . . . 1 N--CA 1.325 -6.703 0 CA-C-O 122.66 1.219 . . . . 0.0 112.08 . . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -42.25 -20.36 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.121 179.68 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.8 tp -107.54 -25.12 11.52 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.363 179.618 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' ARG . 78.0 mt-10 -90.17 35.32 0.86 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -146.39 -37.2 0.24 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.25 -179.996 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.401 ' CG1' ' H ' ' A' ' 10' ' ' GLY . 3.3 pt -149.38 -105.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 65.22 -132.47 36.08 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.966 179.95 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 tttp 73.11 -35.56 0.33 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.611 0.243 . . . . 0.0 110.824 179.979 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.523 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -163.91 13.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.931 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.14 66.02 2.66 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.419 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 68.5 t80 57.83 32.33 21.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.075 -179.15 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 mt 62.03 63.69 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.584 0.707 . . . . 0.0 110.083 -179.73 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mm -130.19 -52.64 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.414 -179.827 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.57 -44.78 79.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.625 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -74.35 -48.08 15.3 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.873 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -59.79 -43.59 97.77 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.619 179.29 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 69.05 -14.91 0.28 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.509 0.195 . . . . 0.0 111.383 179.815 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.5 mm? 47.27 75.11 0.13 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.755 0.312 . . . . 0.0 110.429 179.934 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -171.17 -109.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.315 179.879 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -60.02 -28.17 67.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.834 0.349 . . . . 0.0 110.105 179.719 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.569 179.774 . . . . . . . . 0 0 . 1 . 100 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.498 ' C ' ' N ' ' A' ' 6' ' ' LEU . 82.2 mtm180 . . . . . 1 N--CA 1.325 -6.723 0 CA-C-O 122.555 1.169 . . . . 0.0 112.069 . . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -44.0 -17.03 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.321 179.922 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.498 ' N ' ' C ' ' A' ' 4' ' ' ARG . 30.0 mt -130.71 -4.78 4.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.857 179.561 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -84.71 -11.07 56.6 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.074 179.829 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 61.08 131.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.627 179.701 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.7 pt -61.3 -23.85 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.447 179.879 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.04 60.01 8.66 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.872 -179.909 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -169.65 57.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 110.421 -179.931 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.15 64.49 2.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.406 179.98 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 55.19 55.7 26.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.802 -179.857 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 58.59 36.51 25.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.474 -179.832 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 mt 61.18 62.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.405 -179.957 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 13' ' ' GLY . 4.1 tp -131.19 -44.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.447 179.672 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.469 ' N ' HG23 ' A' ' 16' ' ' ILE . 35.8 mm -77.22 -44.89 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.5 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.58 -43.05 38.09 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 178.448 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.78 -43.4 99.0 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.091 -0.575 . . . . 0.0 111.696 179.233 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.88 -55.54 6.06 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.396 179.895 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.1 tp 51.47 96.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 179.832 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 50.79 29.85 4.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.866 179.782 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 52.35 51.71 15.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.661 179.876 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 tp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.158 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 111.956 -0.457 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -67.92 -129.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.141 -0.223 . . . . 0.0 110.515 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.429 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 49.23 71.0 0.67 Allowed Glycine 1 CA--C 1.385 -8.078 0 CA-C-O 126.193 3.107 . . . . 0.0 112.851 -178.51 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.9 mtp85 157.93 -11.46 0.0 OUTLIER 'General case' 1 N--CA 1.315 -7.197 1 CA-C-N 100.791 -7.704 . . . . 0.0 110.364 160.684 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -43.38 -21.1 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.79 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' C ' ' A' ' 4' ' ' ARG . 22.3 mt -99.74 -23.04 15.13 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.885 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.4 tt0 -66.35 -15.55 63.35 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.208 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -63.18 94.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.314 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.0 tt -58.02 -38.45 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.44 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 76.71 -44.48 2.03 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.096 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 13' ' ' GLY . 47.1 tttp -86.28 77.21 9.57 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.77 0.319 . . . . 0.0 110.427 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.463 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -76.29 37.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.231 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 67.74 61.2 5.15 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 59.9 t80 57.08 36.54 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.931 0.396 . . . . 0.0 110.297 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.5 mm 59.36 66.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.391 0.615 . . . . 0.0 110.219 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -132.24 -51.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.006 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 mm -65.9 -43.94 92.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -85.47 -36.69 10.39 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.97 -33.25 86.74 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.28 -0.486 . . . . 0.0 111.889 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.52 -22.51 61.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.763 0.316 . . . . 0.0 110.638 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -76.62 -15.26 59.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.541 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -50.86 -42.13 58.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.582 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -169.68 -13.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.722 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.1 mp . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.047 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -76.71 40.25 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.419 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.486 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -49.06 -57.53 8.76 Favored Glycine 1 CA--C 1.356 -9.862 0 CA-C-O 123.593 1.663 . . . . 0.0 115.736 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 7' ' ' GLU . 43.2 mtm180 -60.15 -10.98 5.06 Favored 'General case' 1 N--CA 1.325 -6.696 1 CA-C-N 105.443 -5.379 . . . . 0.0 112.055 -157.469 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.486 ' N ' ' C ' ' A' ' 3' ' ' GLY . 44.2 t-105 -42.78 -18.84 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.194 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.502 ' N ' ' C ' ' A' ' 4' ' ' ARG . 42.4 tp -113.76 -21.44 10.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.122 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 4' ' ' ARG . 13.6 tp10 -110.99 46.73 1.04 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.981 0.42 . . . . 0.0 109.87 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.438 ' C ' ' H ' ' A' ' 10' ' ' GLY . 36.9 ttt-85 -63.64 126.59 28.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.569 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' LYS . 4.1 tp -54.05 -10.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . -37.08 -26.52 0.01 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.569 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 9' ' ' ILE . 14.4 pttp -70.46 99.75 1.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.82 -3.17 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.747 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 47.21 49.31 19.26 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.066 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.408 ' O ' HG23 ' A' ' 15' ' ' ILE . 20.2 t80 -160.97 -47.46 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.608 0.242 . . . . 0.0 110.471 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 14' ' ' PHE . 14.8 pt -156.02 55.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.15 0.5 . . . . 0.0 110.598 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 18' ' ' GLY . 3.8 mm -141.28 -48.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -69.36 5.76 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.462 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -175.54 -19.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.809 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -67.3 -57.28 9.52 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.142 -0.551 . . . . 0.0 111.875 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.1 7.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.333 . . . . 0.0 110.596 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 23' ' ' HIS . 12.9 mt 53.92 14.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.47 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -75.99 36.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.787 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.43 ' H ' ' C ' ' A' ' 21' ' ' LEU . 49.7 t-80 54.52 21.4 3.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.564 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 tp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.24 -179.886 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 84.5 mttt 57.75 -147.03 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.677 0.275 . . . . 0.0 110.586 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 52.74 68.71 1.47 Allowed Glycine 1 CA--C 1.381 -8.308 0 CA-C-O 125.48 2.711 . . . . 0.0 113.402 -178.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.535 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER 163.55 -11.94 0.0 OUTLIER 'General case' 1 N--CA 1.319 -7.021 1 CA-C-N 101.338 -7.431 . . . . 0.0 110.428 159.4 . . . . . . . . 5 4 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 17.8 m0 -44.08 -19.09 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.541 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.9 mt -110.66 -17.98 13.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.617 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.5 mt-10 -110.17 13.21 23.19 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.93 0.395 . . . . 0.0 110.096 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 4' ' ' ARG . 56.9 ttt-85 -52.56 102.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.575 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 tp -56.54 109.16 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.098 0.475 . . . . 0.0 110.154 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.82 -38.28 4.45 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.982 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -65.97 103.97 1.03 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.894 0.378 . . . . 0.0 110.624 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.63 1.67 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.003 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.32 53.68 15.07 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.133 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' O ' HG23 ' A' ' 15' ' ' ILE . 20.7 t80 -163.08 -48.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.682 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 14' ' ' PHE . 8.3 pt -155.74 59.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.337 0.589 . . . . 0.0 110.867 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.5 mm -135.23 -72.37 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.51 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -71.85 -38.94 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.04 -45.62 11.47 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.71 -42.54 38.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.918 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.97 37.37 28.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.775 0.321 . . . . 0.0 110.46 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 23' ' ' HIS . 21.4 mt -75.81 114.95 15.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.636 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 58.55 -76.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.326 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 21' ' ' LEU . 69.1 m-70 -38.55 -32.74 0.08 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.026 0.441 . . . . 0.0 110.868 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.7 tp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.98 178.986 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -149.4 50.71 0.95 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.739 0.304 . . . . 0.0 110.363 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.483 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -55.7 -58.18 15.25 Favored Glycine 1 CA--C 1.355 -9.941 0 CA-C-O 123.599 1.666 . . . . 0.0 115.178 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 7' ' ' GLU . 58.6 mtp180 -59.87 -11.5 5.6 Favored 'General case' 1 N--CA 1.324 -6.749 1 CA-C-N 105.417 -5.392 . . . . 0.0 111.931 -157.599 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.483 ' N ' ' C ' ' A' ' 3' ' ' GLY . 37.1 t-105 -43.2 -18.97 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.916 -1.947 . . . . 0.0 109.999 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' C ' ' A' ' 4' ' ' ARG . 2.2 pp -111.3 -22.49 11.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.639 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.6 tt0 -88.35 1.05 55.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.032 0.444 . . . . 0.0 110.219 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -58.98 140.45 55.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.621 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 9' ' ' ILE . 5.9 tp -75.74 113.68 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.943 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.1 14.18 6.28 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -91.27 105.86 18.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.7 0.286 . . . . 0.0 110.431 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.46 62.2 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 50.52 53.51 24.58 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.7 t80 60.46 38.06 19.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.07 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.2 mt 61.18 70.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.358 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.59 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -140.28 -50.65 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.89 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.59 ' N ' HG23 ' A' ' 16' ' ' ILE . 4.2 tp -76.58 -29.46 18.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.76 -50.75 3.63 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.65 -42.2 94.11 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.652 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.26 52.81 1.16 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 110.489 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 tt -156.92 61.91 0.52 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -160.33 -34.85 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.656 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -164.94 -24.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.904 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 0.0 110.262 179.946 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -78.86 48.28 0.82 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.019 0.438 . . . . 0.0 110.288 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.483 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -49.09 -54.29 15.5 Favored Glycine 1 CA--C 1.358 -9.73 0 CA-C-O 123.689 1.716 . . . . 0.0 115.793 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -59.36 -11.31 4.07 Favored 'General case' 1 N--CA 1.328 -6.555 1 CA-C-N 105.249 -5.475 . . . . 0.0 112.191 -157.055 . . . . . . . . 5 4 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.483 ' N ' ' C ' ' A' ' 3' ' ' GLY . 27.3 t90 -41.24 -20.11 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 112.846 -1.979 . . . . 0.0 110.412 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.7 mt -115.84 -20.05 10.19 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.347 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.7 tt0 -96.2 30.47 2.47 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.999 0.428 . . . . 0.0 110.208 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.17 146.77 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.472 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 tp -165.16 96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.188 0.518 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.55 24.79 3.02 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.156 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -151.41 72.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.769 0.319 . . . . 0.0 110.375 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.9 45.35 0.9 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.056 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.5 33.76 54.37 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 18.9 t80 71.1 54.32 0.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.691 0.282 . . . . 0.0 110.56 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 mt 63.93 68.09 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.415 0.626 . . . . 0.0 110.94 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.0 mm -135.04 -51.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.662 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.5 mm -70.92 -42.01 77.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.68 -51.57 7.09 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -64.95 -36.3 92.92 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.815 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.08 7.17 0.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.646 0.26 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.7 mt 45.31 78.42 0.06 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.726 0.298 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -168.49 39.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.496 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 57.47 36.97 27.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.498 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.456 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.17 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp 50.71 178.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.821 0.343 . . . . 0.0 110.588 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.499 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 116.77 -58.88 0.47 Allowed Glycine 1 CA--C 1.356 -9.891 0 CA-C-O 123.722 1.735 . . . . 0.0 114.934 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 7' ' ' GLU . 89.5 mtt180 -60.66 -10.12 4.84 Favored 'General case' 1 N--CA 1.325 -6.72 1 CA-C-N 105.296 -5.452 . . . . 0.0 111.9 -157.667 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.499 ' N ' ' C ' ' A' ' 3' ' ' GLY . 70.0 t-105 -41.09 -20.49 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.327 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.2 tp -108.51 -26.15 10.57 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.173 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' ARG . 27.2 mp0 -99.83 8.73 43.95 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.84 0.352 . . . . 0.0 110.398 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.9 ttp180 -52.11 118.47 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.463 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.0 pt -61.92 -29.26 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.62 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.44 52.69 27.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.608 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -161.69 80.71 0.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.478 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.415 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -83.97 52.35 2.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.335 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.27 49.1 32.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.855 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.6 t80 61.15 48.73 6.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.897 0.38 . . . . 0.0 110.379 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 mt 61.22 70.87 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.732 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -135.03 -67.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -69.86 -25.07 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.415 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -83.05 -58.75 2.28 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.494 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.41 -32.46 68.16 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.936 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.73 34.97 10.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.773 0.321 . . . . 0.0 110.68 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.483 ' N ' HD23 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -65.89 1.64 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.952 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -58.75 -30.15 67.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.392 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.441 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 4.0 t60 -171.47 23.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.159 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.077 -179.792 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 111.969 -0.453 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.9 tttt 59.74 13.32 3.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.004 0.431 . . . . 0.0 110.118 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -49.89 -57.7 9.47 Favored Glycine 1 CA--C 1.357 -9.793 0 CA-C-O 123.715 1.73 . . . . 0.0 115.514 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' LEU . 38.0 mtm-85 -60.33 -10.87 5.26 Favored 'General case' 1 N--CA 1.325 -6.68 1 CA-C-N 105.33 -5.435 . . . . 0.0 111.941 -157.453 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.492 ' N ' ' C ' ' A' ' 3' ' ' GLY . 41.9 t-105 -41.36 -19.51 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 112.938 -1.937 . . . . 0.0 110.433 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.1 tp -114.57 -20.62 10.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.593 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 66.2 mm-40 -87.02 20.48 2.65 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 110.452 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -53.47 -21.11 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.111 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 11' ' ' LYS . 3.6 tp -165.09 -41.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.837 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 53.84 -82.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.263 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 9' ' ' ILE . 55.8 mttm -51.06 101.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.823 0.344 . . . . 0.0 110.795 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.85 3.27 3.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 45.3 40.43 7.83 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.45 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 15' ' ' ILE . 23.3 t80 -167.51 -20.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.314 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 14' ' ' PHE . 21.8 pt -155.85 50.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 120.925 0.393 . . . . 0.0 111.275 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.419 ' C ' ' H ' ' A' ' 18' ' ' GLY . 2.8 mm -143.77 -51.04 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.4 ' C ' HD12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -71.65 8.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.299 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -167.48 -31.69 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.001 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.79 -30.99 60.41 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.135 -0.555 . . . . 0.0 111.856 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.43 -68.23 0.39 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.735 0.302 . . . . 0.0 110.477 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 tp 52.79 49.44 20.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.448 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -167.23 88.25 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.528 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.6 m80 53.76 25.91 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.466 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.163 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.4 mtmm -61.79 -141.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.524 0.202 . . . . 0.0 110.498 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.533 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 53.92 69.02 1.36 Allowed Glycine 1 CA--C 1.379 -8.435 0 CA-C-O 125.403 2.668 . . . . 0.0 113.572 -179.09 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.8 OUTLIER 164.83 -11.24 0.0 OUTLIER 'General case' 1 N--CA 1.32 -6.943 1 CA-C-N 101.503 -7.348 . . . . 0.0 110.414 159.15 . . . . . . . . 5 4 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -43.48 -19.09 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.937 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.5 ' N ' ' C ' ' A' ' 4' ' ' ARG . 43.3 tp -108.28 -20.78 13.02 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.284 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.6 mm-40 -109.34 13.8 24.03 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.5 ttt85 -79.64 -69.09 0.61 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.574 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.1 pt -68.31 -33.65 61.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.4 55.82 23.42 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.944 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -168.26 67.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.481 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.529 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -68.71 76.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.364 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.629 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 46.93 62.68 3.63 Favored Glycine 0 CA--C 1.517 0.218 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.929 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 55.24 34.77 23.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.913 0.387 . . . . 0.0 109.96 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.0 mm 59.8 69.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.541 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 13' ' ' GLY . 9.8 tp -137.51 -34.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.1 mm -92.43 -41.1 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.529 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -77.68 -45.63 10.62 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.63 -37.78 57.65 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.663 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.81 52.21 11.66 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.714 0.293 . . . . 0.0 110.961 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.12 114.12 2.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.034 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 53.73 15.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.454 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.424 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 3.4 t60 54.39 25.83 6.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.465 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.201 179.971 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -78.15 57.61 1.86 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.782 0.325 . . . . 0.0 110.544 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.493 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -51.57 -58.05 10.89 Favored Glycine 1 CA--C 1.355 -9.964 0 CA-C-O 123.617 1.676 . . . . 0.0 115.37 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 7' ' ' GLU . 78.0 mtm180 -61.18 -9.67 5.24 Favored 'General case' 1 N--CA 1.323 -6.786 1 CA-C-N 105.438 -5.381 . . . . 0.0 111.966 -157.543 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' N ' ' C ' ' A' ' 3' ' ' GLY . 24.9 t90 -42.12 -24.56 0.05 OUTLIER 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.718 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.9 mm? -96.42 -30.21 13.49 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.938 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 4' ' ' ARG . 60.3 mt-10 -112.46 49.8 0.9 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.79 0.328 . . . . 0.0 110.545 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -60.32 148.44 36.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.431 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 11' ' ' LYS . 15.7 pt -152.93 -31.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.399 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.26 -17.13 1.94 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.949 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 9' ' ' ILE . 55.0 mttp -69.55 105.88 2.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.687 0.279 . . . . 0.0 110.539 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.454 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -70.65 0.51 6.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.58 -0.77 1.94 Allowed Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.845 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' A' ' 12' ' ' ALA . 62.1 t80 -101.58 -31.78 10.68 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.559 ' O ' ' N ' ' A' ' 17' ' ' ILE . 5.2 pt -153.31 -112.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.225 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 mm 47.61 -81.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 111.355 0.132 . . . . 0.0 111.355 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 15' ' ' ILE . 3.7 tp -69.69 -42.25 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.077 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 17' ' ' ILE . . . -77.63 -42.53 17.25 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.033 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.46 -41.1 31.09 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.087 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.03 53.74 12.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 0.0 110.719 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 21' ' ' LEU . 8.4 mp -60.6 89.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.168 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 50.01 46.24 24.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.69 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.442 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 20.9 t-80 53.57 52.01 14.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.555 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.186 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 80.4 mttt 52.22 174.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.509 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.463 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 127.62 -57.32 0.71 Allowed Glycine 1 CA--C 1.355 -9.915 0 CA-C-O 123.775 1.764 . . . . 0.0 115.134 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 7' ' ' GLU . 51.5 mtm180 -60.67 -10.12 4.84 Favored 'General case' 1 N--CA 1.323 -6.78 1 CA-C-N 105.308 -5.446 . . . . 0.0 111.996 -157.522 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.463 ' N ' ' C ' ' A' ' 3' ' ' GLY . 42.7 t-105 -41.28 -21.34 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.043 -1.889 . . . . 0.0 110.272 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 57.6 tp -105.79 -26.89 11.58 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.219 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.3 mt-10 -90.75 8.88 32.39 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.951 0.405 . . . . 0.0 110.166 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -63.33 82.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.576 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.544 HG23 ' N ' ' A' ' 10' ' ' GLY . 16.4 tt -65.99 -45.25 91.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.356 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.544 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 41.78 45.29 4.65 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.361 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -164.56 71.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.33 . . . . 0.0 110.542 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.27 70.95 1.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.374 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.53 64.51 4.0 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.829 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 50.5 t80 57.53 28.39 15.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.772 0.32 . . . . 0.0 110.476 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.2 mt 62.43 64.71 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.646 0.736 . . . . 0.0 110.161 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -132.54 -49.47 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.786 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.617 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.5 mp -69.72 -44.84 78.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.74 -43.82 11.21 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.72 -43.33 99.22 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.987 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.46 40.66 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.665 0.269 . . . . 0.0 110.703 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.6 tp -52.95 96.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.229 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 53.02 52.55 13.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.432 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.465 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 16.4 t-160 53.8 47.2 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.334 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.005 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -74.63 -99.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.724 0.297 . . . . 0.0 110.528 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.493 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 90.05 -61.46 3.34 Favored Glycine 1 CA--C 1.356 -9.866 0 CA-C-O 123.681 1.712 . . . . 0.0 115.455 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 93.3 mtt180 -60.17 -11.05 5.25 Favored 'General case' 1 N--CA 1.325 -6.722 1 CA-C-N 105.392 -5.404 . . . . 0.0 112.039 -157.663 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' N ' ' C ' ' A' ' 3' ' ' GLY . 23.1 t90 -42.96 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 112.791 -2.004 . . . . 0.0 110.455 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 37.7 mt -117.13 -16.31 10.44 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.87 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.4 tt0 -48.52 -26.87 2.38 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.661 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -50.01 148.66 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.634 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 10' ' ' GLY . 16.0 tt -167.63 -40.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.494 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 76.81 -58.64 3.47 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.187 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.0 mttt -52.85 102.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.707 0.289 . . . . 0.0 110.507 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.28 -1.13 2.13 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 44.81 36.05 4.65 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.197 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 15' ' ' ILE . 58.9 t80 -168.97 -17.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.284 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' PHE . 15.0 pt -155.71 50.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.718 0.294 . . . . 0.0 111.057 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 mm -144.31 -47.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.419 ' C ' HD12 ' A' ' 17' ' ' ILE . 1.1 pp -85.29 24.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.186 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.62 -45.84 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.092 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.32 -40.23 98.34 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.039 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -78.49 50.71 0.98 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.839 0.352 . . . . 0.0 110.541 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 pp -59.22 -4.88 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.715 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 2.2 m-20 -52.23 -39.62 60.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.452 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.06 10.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.433 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.826 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -77.16 22.75 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.794 0.331 . . . . 0.0 110.645 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.495 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -52.55 -57.68 13.24 Favored Glycine 1 CA--C 1.356 -9.887 0 CA-C-O 123.835 1.797 . . . . 0.0 115.293 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 6' ' ' LEU . 73.4 mtt-85 -60.05 -11.53 6.12 Favored 'General case' 1 N--CA 1.324 -6.747 1 CA-C-N 105.225 -5.487 . . . . 0.0 112.047 -157.51 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.495 ' N ' ' C ' ' A' ' 3' ' ' GLY . 65.6 t-105 -43.07 -18.61 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.854 -1.975 . . . . 0.0 110.337 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 4' ' ' ARG . 19.6 mt -114.32 -18.04 11.66 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.802 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.6 tt0 -48.02 -20.87 0.37 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.76 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 54.35 61.45 3.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.62 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 9' ' ' ILE . 3.2 tp -54.47 113.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.078 0.466 . . . . 0.0 110.126 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.51 34.18 1.28 Allowed Glycine 0 C--N 1.332 0.354 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -150.98 38.51 0.66 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.161 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.498 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -79.68 56.79 2.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.52 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.9 67.13 2.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.979 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 54.44 30.55 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.781 0.324 . . . . 0.0 110.706 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 mt 62.14 65.28 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.552 0.692 . . . . 0.0 110.281 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.2 mm -133.34 -51.65 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.691 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.3 mm -66.59 -42.89 90.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.498 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -81.74 -42.17 9.22 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.23 95.69 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.031 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.47 -30.87 0.61 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.667 0.27 . . . . 0.0 111.179 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 21' ' ' LEU . 8.0 mp -74.44 -47.81 31.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.316 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -50.55 -72.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.608 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -169.98 63.91 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.384 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.303 -179.887 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -75.62 66.41 1.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 0.0 110.573 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.495 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -54.63 -57.91 15.61 Favored Glycine 1 CA--C 1.357 -9.799 0 CA-C-O 123.715 1.731 . . . . 0.0 115.384 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 6' ' ' LEU . 47.5 mtt85 -60.07 -11.31 5.65 Favored 'General case' 1 N--CA 1.325 -6.675 1 CA-C-N 105.203 -5.498 . . . . 0.0 111.997 -157.439 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.495 ' N ' ' C ' ' A' ' 3' ' ' GLY . 66.4 t-105 -43.36 -18.31 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.249 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 4' ' ' ARG . 24.4 mt -115.82 -16.45 11.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.812 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.3 tt0 -45.43 -28.08 0.82 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -71.69 -137.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.307 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.2 pt -59.77 -113.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.437 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.26 39.59 82.0 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -57.13 -31.95 65.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.669 0.271 . . . . 0.0 110.541 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.72 -25.53 0.27 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.058 0.456 . . . . 0.0 110.442 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' C ' ' CG ' ' A' ' 14' ' ' PHE . . . 150.97 54.99 0.01 OUTLIER Glycine 0 CA--C 1.509 -0.31 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.442 ' CG ' ' C ' ' A' ' 13' ' ' GLY . 3.4 m-85 75.63 17.46 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.2 mt 61.55 60.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.558 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.1 tp -128.0 -48.69 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.558 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.9 tp -66.25 -36.25 76.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.38 -44.65 4.59 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.27 -33.0 51.93 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.662 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.72 -46.81 41.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.75 0.309 . . . . 0.0 110.863 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' C ' ' H ' ' A' ' 23' ' ' HIS . 40.9 mt 52.49 20.04 1.35 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 0.0 110.278 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 24' ' ' LEU . 66.2 m-20 -76.08 38.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.375 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.426 ' H ' ' C ' ' A' ' 21' ' ' LEU . 32.3 m80 57.67 6.52 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.252 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.279 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 80.3 mttt 50.75 -169.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 110.596 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.473 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 116.99 -59.45 0.46 Allowed Glycine 1 CA--C 1.357 -9.789 0 CA-C-O 123.768 1.76 . . . . 0.0 115.266 179.847 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 6' ' ' LEU . 79.1 mtm180 -60.26 -11.06 5.43 Favored 'General case' 1 N--CA 1.324 -6.739 1 CA-C-N 105.322 -5.439 . . . . 0.0 112.094 -157.585 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.473 ' N ' ' C ' ' A' ' 3' ' ' GLY . 74.6 t-105 -41.16 -19.18 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 112.79 -2.005 . . . . 0.0 110.61 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.4 mt -121.99 -14.06 8.09 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.748 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 4' ' ' ARG . 37.1 mt-10 -88.95 -11.18 45.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 110.307 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.9 tpm_? -83.13 106.45 14.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.255 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.496 HG23 ' O ' ' A' ' 9' ' ' ILE . 14.6 tt -63.19 111.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.078 0.466 . . . . 0.0 110.224 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.7 -19.18 79.3 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.147 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.1 mttt -69.96 99.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.713 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.426 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -62.47 -2.65 1.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.161 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 59.18 5.15 2.99 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -85.51 -71.48 0.53 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 14' ' ' PHE . 17.5 pt -158.14 53.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.402 0.62 . . . . 0.0 110.217 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.61 -63.95 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.79 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -70.35 -35.01 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.31 -49.66 7.25 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.412 ' C ' ' N ' ' A' ' 21' ' ' LEU . . . -66.51 -46.35 77.81 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.73 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.4 15.09 0.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.765 0.317 . . . . 0.0 110.7 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.412 ' N ' ' C ' ' A' ' 19' ' ' GLY . 13.9 mt 55.26 11.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.592 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.41 49.07 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.506 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 51.82 20.97 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.542 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.221 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 50.21 -134.82 1.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.759 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.43 ' O ' ' CB ' ' A' ' 4' ' ' ARG . . . 48.6 70.42 0.77 Allowed Glycine 1 CA--C 1.386 -7.995 0 CA-C-O 126.438 3.243 . . . . 0.0 112.38 -178.051 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 11.2 mtp180 154.73 -12.08 0.0 OUTLIER 'General case' 1 N--CA 1.312 -7.365 1 CA-C-N 100.527 -7.836 . . . . 0.0 110.301 161.265 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -44.24 -19.73 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.743 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.496 ' N ' ' C ' ' A' ' 4' ' ' ARG . 20.2 mt -103.77 -21.18 13.72 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.711 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 35.5 tp10 -68.39 -25.98 65.32 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.337 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.43 ' C ' ' H ' ' A' ' 10' ' ' GLY . 19.9 ttm180 68.09 163.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.003 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.2 pt -53.49 -9.09 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.779 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . 54.42 59.78 9.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.769 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -167.32 73.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.309 . . . . 0.0 110.405 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.494 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -87.63 53.64 2.85 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.058 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 64.35 33.25 86.73 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 67.0 72.81 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.637 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.3 pt 35.25 56.5 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.989 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 13' ' ' GLY . 4.2 tp -135.63 -43.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.579 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.401 ' N ' HG23 ' A' ' 16' ' ' ILE . 40.8 mm -81.33 -45.42 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.494 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -81.99 -24.78 54.39 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.2 -37.32 21.84 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.25 -72.89 0.08 Allowed 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.667 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.7 mt 58.62 24.73 12.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.471 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.21 -103.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.471 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -71.24 -4.76 27.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 110.649 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.412 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.1 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 111.989 -0.445 . . . . 0.0 111.989 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -77.28 31.67 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.701 0.286 . . . . 0.0 110.655 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.47 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -51.88 -57.25 13.1 Favored Glycine 1 CA--C 1.355 -9.934 0 CA-C-O 123.821 1.789 . . . . 0.0 115.235 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' GLU . 61.2 mtm180 -60.76 -10.39 5.38 Favored 'General case' 1 N--CA 1.324 -6.775 1 CA-C-N 105.232 -5.484 . . . . 0.0 111.946 -157.462 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.47 ' N ' ' C ' ' A' ' 3' ' ' GLY . 85.0 t90 -41.3 -20.03 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 112.981 -1.918 . . . . 0.0 110.415 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.8 tp -110.38 -24.58 10.55 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.334 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' ARG . 55.2 mm-40 -96.81 33.91 1.79 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.768 0.318 . . . . 0.0 110.249 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -64.47 -74.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.715 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.594 ' C ' HD12 ' A' ' 9' ' ' ILE . 2.4 pp -68.64 -2.87 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.788 0.328 . . . . 0.0 110.66 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.57 ' N ' HD12 ' A' ' 9' ' ' ILE . . . -86.93 70.38 2.92 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 112.068 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -50.27 -32.53 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.107 0.48 . . . . 0.0 109.893 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -163.88 -0.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.124 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 46.3 32.84 5.38 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.931 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -149.87 -11.79 0.28 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.906 0.384 . . . . 0.0 110.007 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.8 pt -154.88 40.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.078 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.4 tp -151.36 -25.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.0 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -81.51 4.93 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.497 179.147 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.486 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -177.79 -13.76 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.953 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.94 -10.16 86.42 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.051 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.67 53.96 1.81 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.727 0.298 . . . . 0.0 110.573 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.1 mt -56.97 110.38 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.367 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.456 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 3.1 m-20 52.88 21.54 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.615 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.466 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 19.6 t60 53.75 46.52 25.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.582 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.33 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -59.32 159.77 7.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.85 0.357 . . . . 0.0 110.382 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.482 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 107.34 -56.53 0.48 Allowed Glycine 1 CA--C 1.354 -9.973 0 CA-C-O 123.836 1.798 . . . . 0.0 114.688 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.0 mtm180 -61.03 -9.49 4.47 Favored 'General case' 1 N--CA 1.324 -6.772 1 CA-C-N 105.169 -5.516 . . . . 0.0 112.006 -157.595 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.482 ' N ' ' C ' ' A' ' 3' ' ' GLY . 96.3 m95 -42.53 -24.25 0.05 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.058 -1.883 . . . . 0.0 109.838 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 6' ' ' LEU . 10.3 mp -95.82 -28.03 14.93 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.406 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 4' ' ' ARG . 38.3 tt0 -48.42 -29.07 3.67 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.686 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 7' ' ' GLU . 11.8 tpp180 60.36 129.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.68 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.2 tt -54.29 -37.95 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.404 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 55.04 59.05 11.04 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.0 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -169.15 68.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.792 0.329 . . . . 0.0 110.512 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.78 67.78 1.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.486 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 56.16 41.88 86.86 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.99 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.6 43.0 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 0.0 109.826 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.2 mt 54.95 61.64 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.372 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.4 mm -129.81 -42.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.009 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.7 mm -87.79 -37.3 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.0 -49.07 10.13 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -75.09 -37.4 43.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.811 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.67 5.58 0.35 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 0.0 110.586 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' A' ' 19' ' ' GLY . 9.0 tp 46.62 63.16 2.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.748 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -158.67 47.44 0.33 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.548 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 1.7 t60 51.98 20.78 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.474 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.7 tp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.257 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -59.65 -158.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.583 0.23 . . . . 0.0 110.489 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 54.23 71.21 0.74 Allowed Glycine 1 CA--C 1.375 -8.667 0 CA-C-O 125.555 2.753 . . . . 0.0 113.228 -178.822 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.587 ' O ' ' N ' ' A' ' 7' ' ' GLU . 6.7 mtt-85 164.79 -10.89 0.0 OUTLIER 'General case' 1 N--CA 1.321 -6.882 1 CA-C-N 101.807 -7.197 . . . . 0.0 111.303 159.423 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -42.68 -19.62 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.643 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.9 tp -107.66 -21.54 12.84 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.987 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.587 ' N ' ' O ' ' A' ' 4' ' ' ARG . 94.8 mt-10 -115.73 30.32 7.42 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 ptt85 -50.3 143.64 8.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.968 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.412 ' C ' ' H ' ' A' ' 11' ' ' LYS . 14.8 pt -64.93 -23.92 34.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.357 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.86 7.18 1.52 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.354 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' H ' ' C ' ' A' ' 9' ' ' ILE . 56.3 mttp -144.84 75.66 1.46 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.953 0.406 . . . . 0.0 110.226 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.542 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -76.86 62.92 2.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.647 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.62 68.92 1.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.091 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 61.8 t80 55.29 27.98 10.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.591 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.2 mt 61.51 63.55 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.652 0.739 . . . . 0.0 110.035 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 mm -131.65 -48.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.762 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.631 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.5 mp -69.79 -46.1 75.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.542 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -78.28 -43.29 13.33 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.78 -44.59 96.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.676 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.54 82.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.372 . . . . 0.0 110.405 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp 55.43 57.81 5.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.393 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.0 t70 58.0 45.82 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.683 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 49.64 52.37 14.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.7 tp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.211 179.94 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -146.2 179.08 7.74 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.777 0.322 . . . . 0.0 110.234 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.499 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 137.45 -57.46 0.66 Allowed Glycine 1 CA--C 1.357 -9.791 0 CA-C-O 123.665 1.703 . . . . 0.0 115.404 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 6' ' ' LEU . 75.3 mtt85 -59.92 -11.48 5.67 Favored 'General case' 1 N--CA 1.325 -6.684 1 CA-C-N 105.24 -5.48 . . . . 0.0 112.161 -157.379 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.499 ' N ' ' C ' ' A' ' 3' ' ' GLY . 23.5 t90 -42.37 -16.86 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.63 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.1 tp -125.22 -12.19 6.89 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.984 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -76.11 -25.91 55.89 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.812 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -75.88 -135.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.29 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.6 pt -143.68 127.9 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.258 0.552 . . . . 0.0 110.117 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.0 -11.42 78.86 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.942 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -60.19 110.94 1.34 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.94 4.6 6.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 39.25 38.48 0.88 Allowed Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.634 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -168.05 -15.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.693 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 pt -152.71 46.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.192 0.52 . . . . 0.0 110.228 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -145.73 -41.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.256 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.539 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.8 pp -69.02 2.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.222 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.539 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -172.26 -30.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.873 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.89 -37.06 52.13 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.864 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -26.07 59.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.754 0.311 . . . . 0.0 110.508 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.5 tp 57.25 63.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.38 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER 52.31 46.54 26.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.555 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 52.03 60.67 3.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.495 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.15 -180.0 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt 56.3 -150.08 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.667 0.27 . . . . 0.0 110.692 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.434 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 52.43 70.38 0.92 Allowed Glycine 1 CA--C 1.381 -8.31 0 CA-C-O 126.122 3.068 . . . . 0.0 112.749 -178.41 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 7' ' ' GLU . 16.1 mtp180 159.35 -11.0 0.0 OUTLIER 'General case' 1 N--CA 1.316 -7.163 1 CA-C-N 100.983 -7.609 . . . . 0.0 110.523 160.309 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -43.7 -21.48 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.682 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 4' ' ' ARG . 16.7 mt -96.83 -24.54 15.85 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.677 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.7 tm-20 -68.0 -28.84 67.77 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.267 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -58.21 128.89 39.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.467 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 pt -75.32 115.39 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.401 0.62 . . . . 0.0 110.239 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.56 -2.1 79.15 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.775 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 13' ' ' GLY . 59.6 mttp -75.4 98.33 3.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.701 0.286 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.403 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -77.68 37.39 0.23 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.478 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 73.34 63.11 2.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.916 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 63.8 t80 56.1 32.56 20.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.814 0.34 . . . . 0.0 110.773 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.0 mt 61.01 63.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.588 0.708 . . . . 0.0 109.948 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.0 mm -132.43 -51.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.93 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.8 mm -68.94 -41.18 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.403 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -80.07 -48.77 6.31 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -66.82 -31.95 79.75 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.037 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.27 1.64 0.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.775 0.321 . . . . 0.0 110.568 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.1 tp 61.02 5.42 1.0 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.37 -97.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.211 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -88.97 -36.86 15.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.885 0.374 . . . . 0.0 110.361 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.508 -179.94 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 111.901 -0.479 . . . . 0.0 111.901 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -146.56 -129.64 0.07 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 4' ' ' ARG . . . 49.84 69.83 0.96 Allowed Glycine 1 CA--C 1.383 -8.194 0 CA-C-O 126.072 3.04 . . . . 0.0 113.072 -178.658 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 7' ' ' GLU . 12.1 mtt85 160.56 -11.8 0.0 OUTLIER 'General case' 1 N--CA 1.317 -7.076 1 CA-C-N 101.116 -7.542 . . . . 0.0 110.563 159.995 . . . . . . . . 4 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.52 ' CE3' HD21 ' A' ' 6' ' ' LEU . 26.3 t90 -43.83 -18.4 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.519 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.52 HD21 ' CE3' ' A' ' 5' ' ' TRP . 30.2 mt -114.43 -16.04 11.99 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.728 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 4' ' ' ARG . 90.6 mt-10 -118.5 31.1 6.84 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -51.97 -18.41 1.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.97 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.437 ' C ' ' H ' ' A' ' 11' ' ' LYS . 18.3 pt -154.45 -24.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.603 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.68 -35.07 1.01 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.874 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 9' ' ' ILE . 58.0 mttp -54.38 108.27 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.07 2.84 3.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.036 0.446 . . . . 0.0 110.09 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.23 34.73 0.65 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.535 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -166.26 -17.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.2 pt -152.23 50.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.139 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.451 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.4 tp -145.73 -39.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.078 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -78.63 4.64 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.214 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.475 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -159.13 -30.86 0.02 OUTLIER Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.69 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.65 -35.95 47.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.592 179.7 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.39 47.22 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.729 0.3 . . . . 0.0 110.822 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 21' ' ' LEU . 9.8 mp -60.37 114.55 2.99 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.7 t0 58.22 -78.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.696 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' LEU . 55.3 t-80 -166.81 30.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.534 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.448 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.6 tt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.153 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -62.94 -130.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.131 -0.227 . . . . 0.0 110.457 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 44.96 70.97 0.53 Allowed Glycine 1 CA--C 1.387 -7.952 0 CA-C-O 126.496 3.275 . . . . 0.0 112.907 -178.168 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.5 ' C ' ' N ' ' A' ' 6' ' ' LEU . 12.7 mtt180 155.27 -12.67 0.0 OUTLIER 'General case' 1 N--CA 1.312 -7.329 1 CA-C-N 100.431 -7.885 . . . . 0.0 110.058 161.221 . . . . . . . . 4 3 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CE3' HD21 ' A' ' 6' ' ' LEU . 23.0 t90 -45.34 -17.37 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.947 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.5 ' N ' ' C ' ' A' ' 4' ' ' ARG . 32.1 mt -114.09 -12.51 12.55 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.997 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 4' ' ' ARG . 12.3 tm-20 -64.26 -22.35 66.92 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.778 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -43.4 96.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.18 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 11' ' ' LYS . 16.4 pt -64.49 -17.96 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.417 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.09 -37.14 1.09 Allowed Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 9' ' ' ILE . 9.1 mtpm? -71.85 107.23 4.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.802 0.334 . . . . 0.0 110.297 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.562 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -77.84 45.71 0.53 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.646 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.32 66.79 2.28 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.188 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 58.1 t80 54.44 30.9 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.748 0.309 . . . . 0.0 110.663 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mt 61.98 65.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.626 0.727 . . . . 0.0 110.271 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -132.29 -48.28 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.934 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.5 mp -70.83 -45.75 71.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.562 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -77.92 -42.74 15.69 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 178.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.99 -47.42 90.82 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.652 179.238 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -60.86 -48.89 79.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.789 0.328 . . . . 0.0 110.244 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tp 62.07 1.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.34 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 20' ' ' ALA . 70.0 m-20 -85.79 37.61 0.71 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.366 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.475 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 0.7 OUTLIER 54.18 24.42 4.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.527 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.9 tt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.127 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -60.93 -171.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.532 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.475 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 106.39 -59.42 0.4 Allowed Glycine 1 CA--C 1.355 -9.913 0 CA-C-O 123.713 1.729 . . . . 0.0 115.159 -179.954 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.5 mtm180 -60.67 -10.31 5.12 Favored 'General case' 1 N--CA 1.325 -6.72 1 CA-C-N 105.37 -5.415 . . . . 0.0 111.973 -157.659 . . . . . . . . 4 3 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.475 ' N ' ' C ' ' A' ' 3' ' ' GLY . 67.3 t-105 -40.89 -21.21 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.317 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 8.1 tp -106.8 -26.43 11.27 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.455 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' ARG . 50.5 tt0 -90.1 -0.34 57.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.23 0.538 . . . . 0.0 109.736 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.6 ptt85 -45.93 147.89 0.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 mt -79.9 -64.61 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.109 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 79.02 -13.8 17.5 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.936 179.308 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.548 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 2.4 ttmp? -70.31 7.14 1.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.263 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 75.72 -20.68 0.34 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.344 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 35.21 65.77 0.4 Allowed Glycine 0 C--N 1.339 0.708 0 N-CA-C 112.254 -0.338 . . . . 0.0 112.254 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 56.04 36.67 27.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -178.553 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' ALA . 11.9 mm 64.24 80.49 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.765 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.624 HG23 ' N ' ' A' ' 17' ' ' ILE . 8.7 tp -145.84 -54.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.194 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.624 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.7 tp -74.77 -33.8 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.807 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.15 -47.69 4.88 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 178.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.14 96.76 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.08 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.21 -64.86 0.68 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.759 0.314 . . . . 0.0 110.543 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.9 tp 55.4 74.59 0.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.569 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -165.3 41.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.558 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.466 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 3.5 m80 53.31 48.92 20.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.488 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.6 tp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.319 -179.966 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -55.34 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.799 0.333 . . . . 0.0 110.553 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.505 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 96.4 -59.16 1.34 Allowed Glycine 1 CA--C 1.354 -9.972 0 CA-C-O 123.824 1.791 . . . . 0.0 114.842 -179.742 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.8 mmt180 -60.19 -10.88 5.02 Favored 'General case' 1 N--CA 1.324 -6.753 1 CA-C-N 105.187 -5.506 . . . . 0.0 111.943 -157.659 . . . . . . . . 4 3 . 1 . 024 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.529 ' CE3' HD21 ' A' ' 6' ' ' LEU . 31.3 t90 -41.05 -20.24 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.298 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.529 HD21 ' CE3' ' A' ' 5' ' ' TRP . 27.8 mt -109.69 -24.86 10.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.562 179.264 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 4' ' ' ARG . 22.2 tt0 -101.71 14.08 33.02 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.993 0.425 . . . . 0.0 110.026 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.7 ttp85 -72.06 -50.15 30.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 11' ' ' LYS . 21.0 pt -62.34 -23.54 32.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.705 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.45 -32.11 1.17 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.249 -0.5 . . . . 0.0 111.898 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 9' ' ' ILE . 93.7 mttt -73.66 108.99 6.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.161 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.03 8.51 4.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.209 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 43.99 30.71 1.81 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.101 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -155.68 -76.71 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.653 0.263 . . . . 0.0 110.34 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.565 ' O ' HG23 ' A' ' 15' ' ' ILE . 17.1 tt -90.41 47.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.951 0.881 . . . . 0.0 110.087 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.511 HG23 ' N ' ' A' ' 17' ' ' ILE . 3.9 tp -142.33 -44.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.378 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.511 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.1 tp -82.55 -39.47 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.109 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.58 -45.54 4.89 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -58.26 -36.22 81.92 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.909 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.13 39.63 0.19 Allowed 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.69 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.402 ' H ' ' C ' ' A' ' 19' ' ' GLY . 21.2 tp -68.05 -51.98 40.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.117 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -54.42 -45.47 73.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.609 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.418 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -48.48 -36.86 15.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.32 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.648 179.547 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 111.949 -0.461 . . . . 0.0 111.949 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -76.96 172.79 12.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.867 0.365 . . . . 0.0 110.54 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.503 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 122.01 -58.77 0.59 Allowed Glycine 1 CA--C 1.357 -9.831 0 CA-C-O 123.812 1.785 . . . . 0.0 115.159 -179.944 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 6' ' ' LEU . 73.1 mtp180 -60.24 -11.2 5.77 Favored 'General case' 1 N--CA 1.324 -6.774 1 CA-C-N 105.142 -5.529 . . . . 0.0 112.182 -157.524 . . . . . . . . 4 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.503 ' N ' ' C ' ' A' ' 3' ' ' GLY . 77.0 t-105 -40.67 -20.51 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 112.828 -1.987 . . . . 0.0 110.797 -179.744 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.7 tp -112.06 -19.29 12.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.088 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.3 tp10 -60.81 -27.87 68.36 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.31 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -57.78 153.37 13.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.599 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 pt -155.89 8.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.121 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.24 29.53 5.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.288 -0.482 . . . . 0.0 111.94 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -161.75 55.35 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.954 0.407 . . . . 0.0 110.382 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.14 -0.45 31.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.932 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.42 54.31 0.23 Allowed Glycine 0 C--N 1.332 0.316 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 41.1 t80 63.22 29.09 15.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.755 0.312 . . . . 0.0 110.341 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.6 mt 61.25 60.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.632 0.729 . . . . 0.0 109.353 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.6 mm -126.44 -47.96 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.249 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.596 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.4 mp -66.7 -38.91 82.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.828 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.86 -40.26 6.3 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 178.394 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.14 79.56 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.983 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.7 -39.45 73.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.72 0.295 . . . . 0.0 110.691 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.2 mt 51.25 71.45 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.485 -179.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.464 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 1.9 m-20 50.98 37.67 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.507 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.8 m80 53.7 61.4 3.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.684 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 tp . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.308 179.975 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -60.88 155.23 20.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.343 . . . . 0.0 110.428 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.463 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 116.97 -57.09 0.52 Allowed Glycine 1 CA--C 1.355 -9.954 0 CA-C-O 123.948 1.86 . . . . 0.0 114.687 -179.58 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 87.4 mtm180 -60.35 -10.92 5.36 Favored 'General case' 1 N--CA 1.323 -6.784 1 CA-C-N 104.946 -5.627 . . . . 0.0 112.001 -157.573 . . . . . . . . 4 3 . 1 . 026 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.463 ' N ' ' C ' ' A' ' 3' ' ' GLY . 81.6 m95 -43.22 -18.26 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 113.002 -1.908 . . . . 0.0 110.178 179.72 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.2 tt -114.17 -19.5 11.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.711 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.4 tp10 -82.0 16.99 1.69 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.394 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -70.3 178.35 2.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.619 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 9' ' ' ILE . 16.6 tt -170.82 130.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.453 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.99 17.2 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.837 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.58 -2.76 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.269 -0.172 . . . . 0.0 110.788 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 58.94 62.94 1.75 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.34 85.97 0.01 OUTLIER Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.469 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 12' ' ' ALA . 29.4 t80 64.14 38.27 8.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.966 0.413 . . . . 0.0 110.043 -179.085 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.4 mm 61.41 73.7 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.095 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -133.72 -53.39 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.081 179.341 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.6 mp -70.44 -51.32 38.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.787 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.09 -42.44 51.29 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 178.926 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.46 -45.42 96.43 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.024 179.413 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.72 -16.2 62.76 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.813 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.8 mt 51.87 79.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.289 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.8 p30 42.45 32.58 0.36 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.157 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 15.3 m80 58.96 61.76 2.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.583 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 -179.931 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -78.4 50.14 0.91 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.79 0.329 . . . . 0.0 110.591 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.479 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -59.69 -58.14 15.84 Favored Glycine 1 CA--C 1.355 -9.925 0 CA-C-O 123.76 1.755 . . . . 0.0 115.302 179.854 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 6' ' ' LEU . 52.0 mtm-85 -59.97 -11.61 6.1 Favored 'General case' 1 N--CA 1.324 -6.754 1 CA-C-N 105.233 -5.483 . . . . 0.0 112.004 -157.549 . . . . . . . . 4 3 . 1 . 027 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.479 ' N ' ' C ' ' A' ' 3' ' ' GLY . 68.0 t-105 -41.92 -19.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.149 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 24.0 mt -118.66 -16.29 9.42 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.581 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.7 tt0 -87.96 -6.03 58.22 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 120.92 0.39 . . . . 0.0 110.181 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 62.12 -131.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.247 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 9' ' ' ILE . 14.8 tt -163.43 123.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 110.371 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.89 27.9 4.23 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.191 -179.625 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -101.12 100.84 11.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.774 0.321 . . . . 0.0 110.309 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.55 57.64 3.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.004 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.54 49.25 53.22 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.495 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 48.1 t80 59.05 45.06 15.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 110.533 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 mt 62.42 68.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.167 0.508 . . . . 0.0 110.628 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -134.04 -65.79 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 tp -71.19 -21.89 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.867 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.3 -45.16 5.09 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.613 179.717 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.67 -39.6 34.02 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.398 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.58 -75.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.638 0.256 . . . . 0.0 111.327 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.6 mt 59.76 14.03 3.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.146 -179.228 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 19.1 m-20 -74.33 -83.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.652 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.462 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 96.9 m-70 -156.52 56.28 0.56 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.469 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.127 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -76.92 63.33 2.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.501 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.49 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -53.5 -56.31 20.55 Favored Glycine 1 CA--C 1.357 -9.805 0 CA-C-O 123.715 1.73 . . . . 0.0 115.419 179.897 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.0 mtt180 -60.16 -10.92 5.02 Favored 'General case' 1 N--CA 1.325 -6.688 1 CA-C-N 105.318 -5.441 . . . . 0.0 112.082 -157.35 . . . . . . . . 4 3 . 1 . 028 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.49 ' N ' ' C ' ' A' ' 3' ' ' GLY . 66.9 t-105 -41.81 -19.28 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 112.892 -1.958 . . . . 0.0 110.358 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 mt -117.04 -18.36 10.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.549 179.301 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 4' ' ' ARG . 57.5 mm-40 -89.68 18.58 5.37 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.843 0.354 . . . . 0.0 110.411 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -55.25 -173.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 pt -150.09 124.28 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.967 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.44 -3.32 31.95 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.898 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -77.01 96.28 4.36 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.489 ' O ' ' CD1' ' A' ' 14' ' ' PHE . . . -57.87 -9.87 1.48 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 109.998 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.47 34.61 81.81 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.029 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 12' ' ' ALA . 61.4 m-85 -142.8 -53.21 0.39 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.795 -0.238 . . . . 0.0 110.404 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 pt -153.97 61.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.081 0.467 . . . . 0.0 110.589 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.4 mm -136.2 -39.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.416 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.429 ' C ' HD12 ' A' ' 17' ' ' ILE . 1.2 pp -96.87 14.59 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.32 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.17 -48.28 0.02 OUTLIER Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.135 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.05 -43.47 93.23 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.895 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -62.98 -53.22 57.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.796 0.331 . . . . 0.0 110.427 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tp 63.13 1.38 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.389 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 20' ' ' ALA . 30.7 t70 -78.3 56.76 1.76 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.625 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 54.6 t-80 55.59 17.98 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.602 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.1 tp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.215 -179.967 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -71.12 -141.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.473 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.537 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 52.91 68.17 1.75 Allowed Glycine 1 CA--C 1.38 -8.402 0 CA-C-O 125.135 2.52 . . . . 0.0 113.786 -179.157 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 1.2 mtm-85 166.65 -11.83 0.0 OUTLIER 'General case' 1 N--CA 1.319 -6.987 1 CA-C-N 101.53 -7.335 . . . . 0.0 110.041 158.771 . . . . . . . . 4 3 . 1 . 029 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -43.4 -18.74 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.141 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.1 mt -111.32 -18.0 13.02 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.744 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.7 mp0 -105.56 29.24 6.7 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 120.886 0.374 . . . . 0.0 110.112 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 10' ' ' GLY . 85.6 mtm180 -47.72 -71.5 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.768 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 pt -57.88 -6.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.453 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . 50.51 51.06 33.81 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.928 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -166.97 74.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.409 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.27 62.89 3.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.203 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.69 49.66 16.01 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 -179.682 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.4 t80 63.88 48.66 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 110.121 -179.539 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mm 51.45 65.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.401 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.4 mm -132.7 -62.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.373 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 tp -67.67 -31.02 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.271 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.16 -48.87 4.67 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.82 -44.17 97.28 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.12 -71.82 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.18 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.9 tp 52.62 80.24 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.57 179.707 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -158.86 -69.53 0.09 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.442 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -165.62 37.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.593 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.452 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.9 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.096 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.8 mttm 52.61 -163.71 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.726 0.298 . . . . 0.0 110.463 179.955 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.505 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 92.23 -59.1 2.71 Favored Glycine 1 CA--C 1.357 -9.8 0 CA-C-O 123.626 1.681 . . . . 0.0 115.222 179.955 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 7' ' ' GLU . 94.6 mtt180 -60.24 -10.77 4.96 Favored 'General case' 1 N--CA 1.324 -6.732 1 CA-C-N 105.395 -5.403 . . . . 0.0 111.996 -157.551 . . . . . . . . 4 3 . 1 . 030 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.505 ' N ' ' C ' ' A' ' 3' ' ' GLY . 83.7 m95 -42.0 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.435 179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.0 mt -110.13 -21.08 12.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.912 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 38.4 tt0 -47.54 -19.85 0.21 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.911 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -52.02 -71.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.493 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.668 HG23 ' H ' ' A' ' 10' ' ' GLY . 14.6 tt -70.1 -59.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.332 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.668 ' H ' HG23 ' A' ' 9' ' ' ILE . . . 44.3 38.61 5.13 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.431 179.089 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 61.5 mttp -96.15 -1.05 49.23 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 76.06 -30.28 0.19 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.156 -179.276 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.8 68.33 0.48 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 63.24 58.74 1.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.599 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 pt 38.77 81.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.998 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.3 mm -134.17 -41.45 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.471 178.648 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.92 -73.31 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.687 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.25 -44.0 98.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.719 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -77.47 -47.12 9.19 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 121.302 -0.475 . . . . 0.0 111.95 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.5 8.02 0.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 110.477 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.434 ' H ' ' C ' ' A' ' 19' ' ' GLY . 12.7 tp 52.82 75.81 0.22 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.399 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.1 p30 -168.3 49.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.1 t60 52.39 20.41 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.43 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.242 -179.995 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -77.35 27.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.727 0.299 . . . . 0.0 110.638 179.993 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.47 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -51.65 -58.88 9.29 Favored Glycine 1 CA--C 1.356 -9.899 0 CA-C-O 123.737 1.743 . . . . 0.0 115.283 179.859 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 52.7 mtp85 -60.52 -10.58 5.23 Favored 'General case' 1 N--CA 1.324 -6.745 1 CA-C-N 105.276 -5.462 . . . . 0.0 112.026 -157.633 . . . . . . . . 4 3 . 1 . 031 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.47 ' N ' ' C ' ' A' ' 3' ' ' GLY . 45.2 t-105 -41.95 -18.03 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.642 -179.881 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.6 tp -128.47 -8.42 5.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.625 179.622 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.8 tt0 -87.93 -7.68 56.8 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 110.174 179.819 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -54.33 -83.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.523 179.886 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 11' ' ' LYS . 22.5 pt -78.31 16.48 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.812 0.339 . . . . 0.0 110.541 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.21 90.43 0.01 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.234 -179.821 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' ILE . 9.8 mtmp? -154.34 -2.42 0.18 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.69 57.09 5.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.198 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.486 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -43.1 88.38 0.01 OUTLIER Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.834 -179.648 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 12' ' ' ALA . 98.0 m-85 53.54 44.63 29.59 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.15 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.4 mt 61.9 76.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.643 -179.84 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 13' ' ' GLY . 7.4 tp -142.73 -28.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.346 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 mm -104.26 -39.89 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.378 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.52 -59.88 4.28 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.413 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.414 ' C ' ' N ' ' A' ' 21' ' ' LEU . . . -72.41 -36.64 59.18 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.554 179.542 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.9 16.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.663 0.268 . . . . 0.0 111.053 179.734 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.437 ' C ' ' N ' ' A' ' 23' ' ' HIS . 23.7 mt 54.08 -123.7 2.14 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.048 -179.735 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 t0 46.05 17.6 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.761 0.315 . . . . 0.0 110.876 179.801 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.437 ' N ' ' C ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER 51.78 41.69 29.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.339 -179.862 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.7 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.256 -179.923 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt 51.33 20.67 0.99 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.75 0.309 . . . . 0.0 110.452 -179.989 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.513 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -49.97 -57.51 9.81 Favored Glycine 1 CA--C 1.356 -9.863 0 CA-C-O 123.74 1.745 . . . . 0.0 115.332 179.861 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' GLU . 58.8 mtm180 -60.58 -10.32 4.99 Favored 'General case' 1 N--CA 1.325 -6.714 1 CA-C-N 105.23 -5.485 . . . . 0.0 111.949 -157.604 . . . . . . . . 4 3 . 1 . 032 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.513 ' N ' ' C ' ' A' ' 3' ' ' GLY . 27.6 t90 -42.19 -18.93 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.294 179.932 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.5 mt -112.21 -23.09 10.61 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.379 179.077 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 82.3 mt-10 -97.24 14.26 26.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.85 0.357 . . . . 0.0 110.328 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -62.86 -37.2 85.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.709 -179.857 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 11' ' ' LYS . 4.1 tp -170.04 -11.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.96 0.409 . . . . 0.0 109.915 -179.799 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 9' ' ' ILE . . . -37.4 -25.98 0.02 OUTLIER Glycine 0 C--N 1.335 0.482 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.634 179.615 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 9' ' ' ILE . 85.9 mttt -71.2 103.29 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.31 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.7 2.87 0.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.64 -179.813 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.75 45.42 3.61 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.557 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -163.47 -41.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.663 0.268 . . . . 0.0 110.65 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 pt -154.26 60.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.105 0.479 . . . . 0.0 110.442 179.998 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 mm -147.58 -30.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.4 mm -112.39 -49.45 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.447 179.206 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.51 -41.99 49.71 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.344 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.09 -38.25 7.41 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 179.52 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.6 67.46 1.0 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.332 . . . . 0.0 110.499 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 23' ' ' HIS . 9.7 tp -49.61 120.83 4.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.514 179.889 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 52.58 -85.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.694 179.864 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -156.91 45.07 0.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.36 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.26 -179.841 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.229 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -69.89 -141.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.999 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.414 ' O ' ' NE ' ' A' ' 4' ' ' ARG . . . 44.51 70.2 0.62 Allowed Glycine 1 CA--C 1.383 -8.181 0 CA-C-O 125.784 2.88 . . . . 0.0 113.57 -179.051 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 7' ' ' GLU . 10.3 mtm180 163.24 -11.83 0.0 OUTLIER 'General case' 1 N--CA 1.319 -7.0 1 CA-C-N 101.468 -7.366 . . . . 0.0 110.658 159.621 . . . . . . . . 4 3 . 1 . 033 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -43.53 -18.63 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.312 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.533 ' N ' ' C ' ' A' ' 4' ' ' ARG . 36.3 mt -115.2 -14.9 11.7 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.937 178.919 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.1 mt-10 -118.2 25.95 9.97 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.413 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -66.93 152.22 46.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.565 -179.903 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.511 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.0 tt -68.93 -42.99 82.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.363 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.511 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 44.69 -129.71 7.59 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.232 -179.987 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 90.4 mttt 49.79 18.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.302 . . . . 0.0 110.532 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 71.9 -13.6 0.57 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.775 -179.918 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.97 56.59 2.14 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 112.211 -0.355 . . . . 0.0 112.211 179.99 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 67.43 46.99 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.07 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.2 mm 62.68 77.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.891 -179.945 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' ALA . 7.6 mm -131.77 -73.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.4 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -74.47 -29.77 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.418 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.85 -53.12 8.4 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.18 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -77.15 -45.21 11.85 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.526 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.59 10.72 0.24 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.768 0.318 . . . . 0.0 110.537 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 21' ' ' LEU . 8.6 mp 53.85 -111.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.016 -179.97 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 t70 54.91 -82.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.708 0.289 . . . . 0.0 110.757 179.924 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' LEU . 15.4 t60 -160.67 4.31 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.425 179.922 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.538 179.894 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -71.53 -154.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.191 -0.204 . . . . 0.0 110.531 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 58.11 71.77 0.7 Allowed Glycine 1 CA--C 1.381 -8.327 0 CA-C-O 126.129 3.071 . . . . 0.0 112.207 -178.176 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 7' ' ' GLU . 10.1 mtp180 158.31 -11.44 0.0 OUTLIER 'General case' 1 N--CA 1.314 -7.235 1 CA-C-N 100.894 -7.653 . . . . 0.0 110.593 160.655 . . . . . . . . 4 3 . 1 . 034 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -44.37 -21.62 0.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.387 -179.773 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.476 ' N ' ' C ' ' A' ' 4' ' ' ARG . 17.1 mt -99.81 -21.26 15.82 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.634 179.713 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.3 tp10 -68.83 -28.19 66.52 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.467 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -66.15 155.73 36.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.575 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.52 HG23 ' O ' ' A' ' 9' ' ' ILE . 16.8 tt -165.87 121.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.478 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.26 -25.34 19.41 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 13' ' ' GLY . 45.9 mttp -83.3 87.66 6.95 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.947 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.07 17.58 1.21 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.586 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 57.61 22.3 45.65 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.452 -179.531 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.421 ' C ' ' H ' ' A' ' 16' ' ' ILE . 45.5 t80 -146.06 -55.29 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.8 pt -80.37 31.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 179.71 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.538 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.6 tp -148.54 -46.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.924 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.538 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.5 tp -79.26 -32.33 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.188 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.78 -47.75 3.86 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 178.655 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.42 -38.39 86.72 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.408 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -75.01 -68.64 0.53 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.845 0.355 . . . . 0.0 110.285 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.432 ' C ' ' H ' ' A' ' 23' ' ' HIS . 0.7 OUTLIER 59.03 5.96 0.6 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.052 179.879 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 20' ' ' ALA . 8.4 m-20 -77.58 23.0 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.531 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.432 ' H ' ' C ' ' A' ' 21' ' ' LEU . 37.8 m-70 52.86 35.67 19.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.427 179.964 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.251 -179.988 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.019 -0.433 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 51.72 -158.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -179.997 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 55.43 70.3 1.0 Allowed Glycine 1 CA--C 1.381 -8.302 0 CA-C-O 126.392 3.218 . . . . 0.0 112.251 -178.002 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.602 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.9 mtt-85 157.33 -10.03 0.0 OUTLIER 'General case' 1 N--CA 1.314 -7.254 1 CA-C-N 100.612 -7.794 . . . . 0.0 110.175 160.903 . . . . . . . . 4 3 . 1 . 035 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -41.28 -24.21 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.957 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.4 mm? -92.33 -29.3 16.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.209 179.459 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.7 tt0 -71.3 -19.02 62.38 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.126 179.715 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.44 131.78 51.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.525 179.947 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.8 pt -64.16 -34.51 69.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.529 -179.901 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.51 47.02 92.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.074 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -154.18 73.19 0.91 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.782 0.325 . . . . 0.0 110.254 179.988 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.514 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -80.01 49.65 1.11 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.612 179.908 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.73 65.71 2.91 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.166 179.897 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 54.77 31.63 15.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.701 0.286 . . . . 0.0 110.923 179.785 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 61.26 64.08 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.578 0.704 . . . . 0.0 110.277 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 mm -133.01 -47.28 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.717 179.923 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.5 mp -72.13 -46.18 59.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.858 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.514 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -75.92 -48.7 9.6 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.082 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.53 -42.45 99.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.857 179.618 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 59.95 3.39 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.743 0.306 . . . . 0.0 110.784 -179.958 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.2 mt 49.71 13.41 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.736 179.91 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' N ' ' C ' ' A' ' 20' ' ' ALA . 47.6 t0 -62.83 -73.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.565 179.984 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -169.62 20.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.548 179.942 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 24' ' ' LEU . 10.1 mp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.079 179.908 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.254 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -168.43 160.33 11.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.397 -179.981 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.494 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 144.33 -56.05 0.55 Allowed Glycine 1 CA--C 1.353 -10.073 0 CA-C-O 123.965 1.87 . . . . 0.0 114.571 -179.491 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 7' ' ' GLU . 65.5 mtt-85 -60.48 -10.73 5.37 Favored 'General case' 1 N--CA 1.321 -6.897 1 CA-C-N 104.923 -5.639 . . . . 0.0 111.949 -157.671 . . . . . . . . 4 3 . 1 . 036 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.494 ' N ' ' C ' ' A' ' 3' ' ' GLY . 69.9 t-105 -43.03 -19.04 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.151 179.876 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.497 ' N ' ' C ' ' A' ' 4' ' ' ARG . 20.6 mt -111.89 -19.66 12.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.75 179.788 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.2 tt0 -49.04 -24.58 1.62 Allowed 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.71 -179.844 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 56.5 99.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.231 -179.913 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 pt -62.59 113.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.411 0.624 . . . . 0.0 110.279 -179.845 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.82 8.25 8.03 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.648 179.854 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.457 ' HA ' HG21 ' A' ' 16' ' ' ILE . 57.5 mttp -67.28 108.37 2.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.694 0.283 . . . . 0.0 110.64 -179.924 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.91 4.76 5.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.064 0.459 . . . . 0.0 109.783 179.536 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 14' ' ' PHE . . . 59.99 22.89 58.55 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.998 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 63.9 m-85 -158.6 -100.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.738 0.304 . . . . 0.0 111.166 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.8 pt -78.05 60.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.988 0.423 . . . . 0.0 111.739 -178.834 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.457 HG21 ' HA ' ' A' ' 11' ' ' LYS . 16.7 mm -149.26 -44.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.036 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.03 -50.07 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.805 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.56 -43.61 67.79 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.059 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.1 -42.62 7.96 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 179.386 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.35 50.38 18.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.767 0.318 . . . . 0.0 110.649 179.861 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.3 mt -75.19 -26.76 59.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.416 179.931 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 24' ' ' LEU . 16.3 m-20 -77.2 -67.77 0.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.42 1.4 0.79 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.709 -179.798 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 22' ' ' ASP . 1.6 tt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.351 179.992 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 111.994 -0.443 . . . . 0.0 111.994 . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -77.14 38.34 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 0.0 110.568 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.475 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -49.69 -58.06 8.83 Favored Glycine 1 CA--C 1.356 -9.884 0 CA-C-O 123.656 1.698 . . . . 0.0 115.299 179.806 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 7' ' ' GLU . 88.0 mtt180 -60.6 -10.98 5.91 Favored 'General case' 1 N--CA 1.324 -6.76 1 CA-C-N 105.317 -5.441 . . . . 0.0 111.855 -157.626 . . . . . . . . 4 3 . 1 . 037 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.475 ' N ' ' C ' ' A' ' 3' ' ' GLY . 26.6 t90 -42.7 -21.34 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.836 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.483 ' N ' ' C ' ' A' ' 4' ' ' ARG . 11.0 mp -105.27 -26.32 12.07 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.995 179.151 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 4' ' ' ARG . 22.4 mm-40 -93.34 37.65 1.05 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.694 0.283 . . . . 0.0 110.607 -179.855 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -69.9 172.36 7.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.446 179.988 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 tp -170.4 124.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.192 179.849 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.36 25.26 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.769 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -69.62 -5.81 27.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 55.54 60.72 3.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.015 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.66 87.59 0.01 OUTLIER Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -179.657 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 12' ' ' ALA . 98.8 m-85 54.01 42.05 31.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -178.621 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.5 mt 62.66 83.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.465 -179.576 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.633 HG23 ' H ' ' A' ' 17' ' ' ILE . 5.2 tp -143.66 -58.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.398 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.633 ' H ' HG23 ' A' ' 16' ' ' ILE . 3.7 tp -86.15 -26.34 6.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.505 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.18 -55.29 4.42 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 178.871 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.16 -43.28 40.19 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.632 179.299 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.34 38.76 30.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.694 0.283 . . . . 0.0 110.778 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.1 mt -99.8 -20.07 16.39 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.481 179.839 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -50.09 -50.9 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -165.28 -20.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.46 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.6 mp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.169 179.923 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -149.63 -179.48 7.14 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.786 0.326 . . . . 0.0 110.155 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.5 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 97.21 -58.33 1.18 Allowed Glycine 1 CA--C 1.357 -9.842 0 CA-C-O 123.639 1.688 . . . . 0.0 115.454 179.924 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 7' ' ' GLU . 71.1 mtm180 -60.47 -10.51 5.06 Favored 'General case' 1 N--CA 1.325 -6.71 1 CA-C-N 105.445 -5.378 . . . . 0.0 112.057 -157.454 . . . . . . . . 4 3 . 1 . 038 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.5 ' N ' ' C ' ' A' ' 3' ' ' GLY . 58.3 m95 -41.19 -20.05 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 112.924 -1.944 . . . . 0.0 110.334 179.834 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.0 tp -112.93 -22.62 10.53 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.342 179.351 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.2 mm-40 -102.06 38.77 1.59 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.657 0.265 . . . . 0.0 110.563 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -51.47 139.23 20.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.383 179.981 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.554 HG23 ' H ' ' A' ' 10' ' ' GLY . 2.7 tp -52.64 -56.08 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.406 -179.797 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.554 ' H ' HG23 ' A' ' 9' ' ' ILE . . . 74.49 -38.92 1.04 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.073 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -78.12 105.42 9.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.745 0.307 . . . . 0.0 110.389 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.85 9.17 3.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.192 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.13 34.43 12.25 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.114 179.878 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -161.96 -73.85 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.826 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 pt -81.48 38.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.207 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 17' ' ' ILE . 4.0 tp -146.23 -42.72 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.087 -179.656 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.56 ' C ' HD12 ' A' ' 17' ' ' ILE . 2.2 pp -77.04 0.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.043 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.55 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -158.15 -42.64 0.02 OUTLIER Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.686 -179.808 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -61.23 -36.34 92.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.69 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.438 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 56.29 6.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.748 0.308 . . . . 0.0 110.704 179.918 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.436 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.0 tp 49.97 14.09 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.411 179.99 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.438 ' N ' ' C ' ' A' ' 20' ' ' ALA . 18.3 t70 -71.73 -40.96 69.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.441 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.466 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -165.78 12.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.343 179.9 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.226 -179.988 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -57.45 171.95 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.36 . . . . 0.0 110.62 -179.998 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 91.88 -58.77 2.87 Favored Glycine 1 CA--C 1.355 -9.908 0 CA-C-O 123.778 1.766 . . . . 0.0 115.174 -179.855 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 7' ' ' GLU . 94.8 mtt180 -60.43 -10.59 5.09 Favored 'General case' 1 N--CA 1.326 -6.634 1 CA-C-N 105.266 -5.467 . . . . 0.0 111.966 -157.524 . . . . . . . . 4 3 . 1 . 039 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.492 ' N ' ' C ' ' A' ' 3' ' ' GLY . 56.3 m95 -42.11 -20.12 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.964 -1.925 . . . . 0.0 110.38 179.83 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.3 mt -110.18 -20.48 12.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.995 179.93 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.6 tt0 -46.99 -22.02 0.28 Allowed 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.823 -179.917 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 -79.61 -44.05 21.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 9' ' ' ILE . 26.4 mm -70.28 -6.88 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 -179.64 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.37 -25.57 6.18 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.739 -0.744 . . . . 0.0 111.35 179.542 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 13' ' ' GLY . 98.0 mttt -116.68 76.45 1.03 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.228 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.92 84.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.381 -179.535 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . 47.18 54.65 9.62 Favored Glycine 0 C--N 1.33 0.209 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -179.593 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.1 t80 57.68 39.91 26.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.885 0.374 . . . . 0.0 110.285 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 mt 60.85 67.59 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.482 -179.979 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.524 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.2 tp -137.89 -47.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.387 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.524 ' N ' HG23 ' A' ' 16' ' ' ILE . 28.9 mm -77.63 -36.68 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.297 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.12 -50.68 6.64 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 178.884 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . -67.61 -36.86 88.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.568 179.342 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 73.17 -35.68 0.33 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.635 0.255 . . . . 0.0 111.06 179.865 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.4 mm? 53.35 10.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.953 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 20' ' ' ALA . 15.8 t0 -79.56 -37.42 36.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.623 -179.913 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -167.6 -22.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.806 -179.942 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.418 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.145 -179.958 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.79 176.98 4.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 110.619 -179.989 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.488 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 127.72 -57.82 0.7 Allowed Glycine 1 CA--C 1.355 -9.964 0 CA-C-O 123.83 1.794 . . . . 0.0 114.86 -179.737 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 7' ' ' GLU . 58.0 mtm180 -61.12 -9.41 4.62 Favored 'General case' 1 N--CA 1.323 -6.802 1 CA-C-N 105.22 -5.49 . . . . 0.0 112.001 -157.688 . . . . . . . . 4 3 . 1 . 040 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.488 ' N ' ' C ' ' A' ' 3' ' ' GLY . 95.5 m95 -38.48 -26.56 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.118 -1.856 . . . . 0.0 110.354 -179.913 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.4 mm? -94.18 -33.54 13.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.077 179.334 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.5 mt-10 -96.1 14.14 24.87 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.708 0.289 . . . . 0.0 110.437 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 4' ' ' ARG . 0.6 OUTLIER -70.04 -68.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.322 -179.795 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.5 pt -98.59 -33.34 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.63 179.894 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.01 59.89 6.52 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.841 -179.724 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -162.75 83.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.34 . . . . 0.0 110.241 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.474 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -79.33 57.03 2.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 -179.825 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 57.31 64.47 4.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.057 179.993 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 47.0 t80 54.89 33.27 19.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.797 0.332 . . . . 0.0 110.467 179.918 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 mt 59.52 64.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.575 0.702 . . . . 0.0 110.113 -179.831 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -132.18 -51.87 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.847 -179.941 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 mm -68.87 -44.37 81.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.764 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -77.99 -44.36 12.13 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.936 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.19 -43.3 99.57 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.892 179.543 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.08 -22.24 49.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.838 0.351 . . . . 0.0 110.495 -179.898 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.3 tp -56.55 -19.12 14.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.413 179.994 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 79.4 m-20 -51.04 -51.99 47.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.666 179.903 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.488 ' ND1' ' O ' ' A' ' 22' ' ' ASP . 77.1 m-70 -153.89 39.62 0.48 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.246 179.956 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.134 -179.932 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -169.37 157.96 7.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.0 110.322 179.987 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.495 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 118.76 -56.03 0.58 Allowed Glycine 1 CA--C 1.354 -9.97 0 CA-C-O 123.849 1.805 . . . . 0.0 114.652 -179.568 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 7' ' ' GLU . 83.8 mtm180 -60.99 -9.08 3.75 Favored 'General case' 1 N--CA 1.323 -6.81 1 CA-C-N 105.093 -5.553 . . . . 0.0 112.072 -157.644 . . . . . . . . 4 3 . 1 . 041 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.495 ' N ' ' C ' ' A' ' 3' ' ' GLY . 97.8 m95 -38.4 -23.99 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.569 -179.901 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.0 tp -102.43 -29.89 11.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.412 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.4 mm-40 -97.38 43.99 1.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -50.97 -39.09 54.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 -179.851 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.447 ' C ' ' H ' ' A' ' 11' ' ' LYS . 11.2 pt -155.83 -35.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.428 179.903 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.34 -12.99 1.64 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.225 179.886 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 9' ' ' ILE . 31.9 mtmm -89.76 105.49 17.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.749 0.309 . . . . 0.0 110.201 179.903 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.02 61.2 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.806 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.461 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 46.62 50.91 13.4 Favored Glycine 0 C--N 1.331 0.27 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -179.236 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.9 t80 60.24 63.54 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.713 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.5 pt 35.26 62.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.346 -179.342 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.56 HG23 ' N ' ' A' ' 17' ' ' ILE . 4.5 tp -129.15 -48.71 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.56 ' N ' HG23 ' A' ' 16' ' ' ILE . 4.1 tp -82.31 -33.77 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.518 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.86 -35.64 6.72 Favored Glycine 0 C--N 1.331 0.262 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.23 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.66 -37.83 61.56 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.016 179.805 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.54 -68.16 0.45 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.824 0.345 . . . . 0.0 110.5 179.993 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.21 85.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.132 -179.97 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.9 t0 51.19 35.62 13.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.7 179.967 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.431 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 7.0 t60 53.24 46.21 26.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.565 179.871 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.438 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.127 179.922 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.008 -0.437 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -170.11 65.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.765 0.317 . . . . 0.0 110.409 -179.954 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.487 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -50.68 -57.84 10.11 Favored Glycine 1 CA--C 1.356 -9.9 0 CA-C-O 123.729 1.739 . . . . 0.0 115.218 179.843 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 7' ' ' GLU . 80.0 mtm180 -60.7 -10.34 5.22 Favored 'General case' 1 N--CA 1.323 -6.806 1 CA-C-N 105.27 -5.465 . . . . 0.0 111.921 -157.619 . . . . . . . . 4 3 . 1 . 042 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.487 ' N ' ' C ' ' A' ' 3' ' ' GLY . 27.3 t90 -42.3 -20.22 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.065 -1.88 . . . . 0.0 110.218 179.81 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 4' ' ' ARG . 24.0 mt -107.05 -24.98 11.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.375 179.446 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' ARG . 11.8 mp0 -89.24 -3.78 58.42 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.645 0.26 . . . . 0.0 110.318 -179.981 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -73.66 -29.72 62.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.52 -179.943 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 9' ' ' ILE . 13.2 tt -48.67 99.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.227 0.537 . . . . 0.0 110.653 -179.805 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.14 -14.45 82.27 Favored Glycine 0 C--N 1.329 0.18 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.978 -179.927 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -73.95 97.98 2.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.815 0.34 . . . . 0.0 110.464 -179.983 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.8 -3.27 1.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.803 -179.906 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.7 14.2 42.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.703 -179.888 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -163.79 -46.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.929 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.6 mm -99.77 52.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.339 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.546 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -149.74 -45.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.208 -179.827 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.546 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -79.77 5.37 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.765 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.478 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -152.14 -44.11 0.02 OUTLIER Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.648 -179.916 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.41 -35.38 61.07 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.948 179.843 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.74 -29.47 59.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 0.0 110.507 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.3 mt -81.98 -27.14 33.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.633 -179.944 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -50.56 -59.91 3.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.603 179.983 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.4 ' H ' ' H ' ' A' ' 24' ' ' LEU . 11.4 t-80 -170.03 -4.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.539 179.935 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' H ' ' H ' ' A' ' 23' ' ' HIS . 17.2 mt . . . . . 0 N--CA 1.468 0.45 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.393 179.923 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 111.896 -0.481 . . . . 0.0 111.896 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.0 mttm 51.72 -166.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.771 0.32 . . . . 0.0 110.482 179.991 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.498 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 128.42 -58.02 0.71 Allowed Glycine 1 CA--C 1.356 -9.883 0 CA-C-O 123.718 1.732 . . . . 0.0 115.129 -179.924 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 7' ' ' GLU . 52.3 mtm-85 -60.6 -10.31 5.0 Favored 'General case' 1 N--CA 1.324 -6.75 1 CA-C-N 105.265 -5.467 . . . . 0.0 112.048 -157.534 . . . . . . . . 4 3 . 1 . 043 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.498 ' N ' ' C ' ' A' ' 3' ' ' GLY . 65.4 t-105 -41.07 -25.06 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.999 -1.91 . . . . 0.0 109.989 179.914 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.451 ' N ' ' C ' ' A' ' 4' ' ' ARG . 3.3 mm? -96.75 -29.0 14.02 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.424 179.508 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 4' ' ' ARG . 2.3 mp0 -86.39 -8.22 57.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.656 -179.498 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -80.26 -114.86 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.491 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.449 ' C ' ' H ' ' A' ' 11' ' ' LYS . 6.9 mm -83.09 -74.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.762 0.315 . . . . 0.0 110.171 179.742 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.85 -33.15 0.88 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.21 179.982 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 13' ' ' GLY . 40.8 mtmt -117.12 74.97 0.94 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.871 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.33 77.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.191 179.977 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 51.62 54.6 23.94 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.544 -179.532 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 60.38 35.74 20.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.33 -179.644 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.3 mt 60.48 62.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.442 -179.988 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 13' ' ' GLY . 4.4 tp -132.28 -41.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.552 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.42 ' N ' HG23 ' A' ' 16' ' ' ILE . 40.4 mm -81.27 -43.55 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.541 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.5 -47.83 26.21 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 178.834 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.0 -37.62 87.83 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.703 179.301 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.42 51.18 11.93 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.88 0.371 . . . . 0.0 110.753 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.5 103.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.552 -179.914 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t70 54.53 44.16 29.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.616 -179.997 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.3 m80 51.56 31.84 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 179.923 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.358 179.971 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -149.98 -179.24 7.0 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 110.31 179.971 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.51 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 96.57 -58.88 1.31 Allowed Glycine 1 CA--C 1.354 -9.974 0 CA-C-O 123.675 1.708 . . . . 0.0 115.161 -179.886 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' GLU . 71.7 mtm-85 -60.55 -10.46 5.12 Favored 'General case' 1 N--CA 1.325 -6.7 1 CA-C-N 105.365 -5.418 . . . . 0.0 111.933 -157.684 . . . . . . . . 4 3 . 1 . 044 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.51 ' N ' ' C ' ' A' ' 3' ' ' GLY . 76.2 m95 -41.85 -19.8 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.224 179.896 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.6 tp -112.11 -23.01 10.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.226 179.371 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.5 mt-10 -94.61 20.92 7.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.844 0.354 . . . . 0.0 110.463 179.946 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.411 ' O ' HG23 ' A' ' 9' ' ' ILE . 43.4 ttt85 -68.77 122.09 17.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.555 -179.965 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.414 ' H ' ' H ' ' A' ' 10' ' ' GLY . 20.8 pt -157.01 -9.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.309 -179.891 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 9' ' ' ILE . . . 53.93 38.57 60.47 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.973 -179.97 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 13' ' ' GLY . 67.5 mttm -148.71 77.27 1.38 Allowed 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.989 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.438 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -76.91 33.53 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.591 179.978 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 52.32 48.48 53.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.896 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.8 t80 67.78 50.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.692 0.282 . . . . 0.0 110.946 179.894 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.5 mm 60.66 73.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.333 0.587 . . . . 0.0 111.334 179.301 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.3 mm -136.05 -51.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.001 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.6 mp -70.45 -54.05 20.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.859 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.438 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -70.62 -50.98 22.65 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.475 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.76 -45.8 95.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.865 179.684 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.63 -0.65 0.52 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.636 0.255 . . . . 0.0 110.896 -179.927 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 19' ' ' GLY . 16.0 mt 47.26 73.76 0.18 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 110.712 179.787 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.9 p-10 -170.68 35.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.621 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 51.36 42.59 29.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.535 179.973 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.452 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.195 -179.985 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -75.76 -173.68 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.854 0.359 . . . . 0.0 110.629 -179.932 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 131.6 -58.31 0.71 Allowed Glycine 1 CA--C 1.356 -9.848 0 CA-C-O 123.769 1.76 . . . . 0.0 115.01 -179.91 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 6' ' ' LEU . 97.5 mtt180 -60.5 -10.64 5.26 Favored 'General case' 1 N--CA 1.323 -6.777 1 CA-C-N 105.203 -5.499 . . . . 0.0 111.978 -157.612 . . . . . . . . 4 3 . 1 . 045 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.492 ' N ' ' C ' ' A' ' 3' ' ' GLY . 74.6 t-105 -41.67 -18.99 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.004 -1.907 . . . . 0.0 110.455 -179.912 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.3 mp -117.34 -17.91 10.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.646 179.374 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 4' ' ' ARG . 68.4 mm-40 -90.71 -9.99 44.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.719 0.295 . . . . 0.0 110.752 -179.844 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -83.45 68.45 9.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.521 -179.983 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.22 81.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.548 -179.872 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.33 -32.42 14.39 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.201 -0.523 . . . . 0.0 111.874 179.856 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -59.43 106.53 0.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.32 . . . . 0.0 110.298 179.881 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.91 1.45 3.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.037 -179.954 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 43.23 38.15 3.56 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.463 179.859 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 15' ' ' ILE . 31.2 t80 -169.42 -15.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.053 179.988 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 14' ' ' PHE . 19.0 pt -157.06 49.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.826 0.346 . . . . 0.0 111.06 179.826 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.417 ' C ' ' H ' ' A' ' 18' ' ' GLY . 1.5 mm -143.78 -50.25 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.559 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.4 ' C ' HD12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -75.9 15.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.222 179.876 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -171.99 -31.87 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.157 -0.544 . . . . 0.0 111.855 -179.963 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.31 -23.86 69.87 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 -180.0 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.66 -50.32 58.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 0.0 110.575 -179.902 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.7 mt 56.09 56.49 5.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.116 -179.93 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -157.87 68.63 0.51 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.567 -179.943 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.466 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 49.5 t-80 51.82 39.61 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.608 179.856 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.2 tp . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.211 179.953 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -169.59 -146.29 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.977 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.455 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 56.73 72.58 0.56 Allowed Glycine 1 CA--C 1.383 -8.17 0 CA-C-O 126.319 3.177 . . . . 0.0 112.192 -178.07 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER 156.18 -10.46 0.0 OUTLIER 'General case' 1 N--CA 1.312 -7.367 1 CA-C-N 100.548 -7.826 . . . . 0.0 109.951 161.25 . . . . . . . . 5 4 . 1 . 046 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.6 t90 -42.4 -23.5 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.896 -179.943 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' N ' ' C ' ' A' ' 4' ' ' ARG . 5.0 mp -92.87 -27.63 17.0 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.61 179.765 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.5 mt-10 -79.21 -14.61 58.95 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.737 -179.928 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -70.17 -179.91 2.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 0.0 110.594 -179.881 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 tp -60.05 105.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.262 0.553 . . . . 0.0 110.409 -179.712 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.77 42.76 0.02 OUTLIER Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.831 179.995 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -50.29 -31.36 14.1 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.604 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.403 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -162.67 -9.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.622 -179.876 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 58.57 33.35 71.62 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.7 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -154.32 -9.79 0.14 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.915 0.388 . . . . 0.0 110.14 -179.926 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.5 pt -156.81 40.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.01 179.425 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 tp -150.49 -26.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.254 -179.683 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -83.5 6.71 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.837 179.484 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.45 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -170.79 -28.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.952 -179.978 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.83 -47.64 38.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.161 -0.542 . . . . 0.0 111.987 179.96 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.08 36.72 25.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.722 0.296 . . . . 0.0 110.583 179.958 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.59 -5.26 27.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.418 179.853 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -51.63 -35.51 42.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.619 179.981 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.48 21.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.702 179.967 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.21 179.979 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.214 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 81.6 mttt 52.07 -143.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.56 179.988 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.424 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 51.4 69.53 1.11 Allowed Glycine 1 CA--C 1.381 -8.298 0 CA-C-O 125.826 2.903 . . . . 0.0 113.095 -178.758 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.525 ' C ' ' N ' ' A' ' 6' ' ' LEU . 13.8 mtp180 162.38 -13.06 0.0 OUTLIER 'General case' 1 N--CA 1.318 -7.044 1 CA-C-N 101.345 -7.427 . . . . 0.0 110.583 159.656 . . . . . . . . 4 3 . 1 . 047 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -43.81 -18.12 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.682 -179.975 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.525 ' N ' ' C ' ' A' ' 4' ' ' ARG . 63.3 mt -120.6 -9.14 9.44 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.184 179.236 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.1 mt-10 -116.43 32.33 6.19 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.096 0.474 . . . . 0.0 109.749 179.626 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -49.03 92.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.534 179.76 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 7' ' ' GLU . 16.4 pt -71.59 -32.58 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 -179.891 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.35 6.58 1.56 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.029 -179.978 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.535 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 78.6 tttt -68.83 -7.45 34.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 110.217 179.976 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 74.89 -21.54 0.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.607 -179.85 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 42.64 52.64 5.39 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.627 -179.816 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.8 t80 70.91 44.61 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.993 0.425 . . . . 0.0 109.978 -179.124 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.8 mt 61.22 74.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.46 -179.99 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.7 mm -136.0 -71.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.693 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 tp -72.46 -23.52 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.136 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.16 -54.99 3.63 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.383 179.253 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -40.65 41.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.78 179.688 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.15 59.27 4.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.833 0.349 . . . . 0.0 110.245 -179.951 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 21' ' ' LEU . 10.1 mp -48.32 117.3 1.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.338 -179.827 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t0 55.16 51.93 12.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.986 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.1 m170 53.28 35.01 19.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.689 179.927 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.331 179.906 . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -62.92 178.29 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.534 179.905 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.457 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 119.6 -58.75 0.54 Allowed Glycine 1 CA--C 1.356 -9.891 0 CA-C-O 123.758 1.754 . . . . 0.0 115.23 179.99 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 59.4 mtt85 -60.59 -10.32 4.99 Favored 'General case' 1 N--CA 1.325 -6.717 1 CA-C-N 105.272 -5.464 . . . . 0.0 111.999 -157.609 . . . . . . . . 4 3 . 1 . 048 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.457 ' N ' ' C ' ' A' ' 3' ' ' GLY . 67.7 t-105 -40.8 -21.1 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.387 -179.934 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.9 mt -108.44 -24.92 11.22 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.676 179.365 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.1 mm-40 -89.89 33.8 0.85 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-O 120.928 0.394 . . . . 0.0 110.34 179.876 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -146.63 70.47 1.21 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.128 179.961 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 9' ' ' ILE . 13.8 tt -61.04 120.79 7.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 179.963 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.87 -31.5 67.13 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.893 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.469 ' C ' ' H ' ' A' ' 13' ' ' GLY . 93.5 mttt -69.46 95.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 110.159 179.62 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.16 -8.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.39 -179.993 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 67.43 0.41 11.39 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.479 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.451 ' O ' HG23 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -80.86 -68.26 0.7 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.949 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 14' ' ' PHE . 19.6 pt -158.25 42.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.771 179.42 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 16' ' ' ILE . 1.5 mp -85.66 -49.79 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.142 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.513 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -75.41 18.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.747 179.891 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -152.69 -58.1 0.01 OUTLIER Glycine 0 C--N 1.334 0.455 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 -179.938 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.43 -33.0 65.09 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.895 -179.994 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.99 -66.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 110.521 179.951 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.81 73.07 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.166 0.508 . . . . 0.0 109.899 179.898 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -160.87 32.51 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.306 179.984 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 50.5 t-80 55.48 39.51 31.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.285 -179.816 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.091 -179.76 . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.491 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -50.33 -179.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.768 0.318 . . . . 0.0 110.744 -179.886 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.485 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 110.29 -59.2 0.36 Allowed Glycine 1 CA--C 1.356 -9.869 0 CA-C-O 123.628 1.682 . . . . 0.0 115.232 179.875 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 6' ' ' LEU . 66.8 mtp180 -60.2 -11.24 5.77 Favored 'General case' 1 N--CA 1.325 -6.71 1 CA-C-N 105.435 -5.382 . . . . 0.0 112.059 -157.467 . . . . . . . . 4 3 . 1 . 049 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.485 ' N ' ' C ' ' A' ' 3' ' ' GLY . 50.0 t90 -42.91 -18.44 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.887 -1.96 . . . . 0.0 110.214 179.85 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.4 tp -114.8 -20.24 10.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.422 179.469 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 45.0 mm-40 -89.99 19.16 5.09 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.556 -179.998 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -78.68 56.32 1.83 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.183 179.952 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.61 83.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.658 -179.774 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.5 -25.11 75.03 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.119 -0.562 . . . . 0.0 111.716 179.625 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -78.39 107.92 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.776 0.322 . . . . 0.0 110.245 179.814 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.91 55.43 1.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.835 179.754 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 53.11 47.64 60.27 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.371 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 t80 61.0 45.55 9.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.029 0.443 . . . . 0.0 110.008 -179.392 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 mt 60.99 70.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.583 -179.803 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -135.8 -64.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.5 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -70.74 -26.76 28.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.352 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.07 -56.2 2.77 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.409 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.37 82.62 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 179.666 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.61 47.8 12.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.726 0.298 . . . . 0.0 110.675 179.829 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.2 tp -72.85 -34.6 66.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.022 179.854 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.45 44.14 0.59 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.568 179.998 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 42.3 m80 51.6 17.32 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.564 179.994 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.1 tp . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.262 -179.93 . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.56 -146.94 0.22 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.794 0.331 . . . . 0.0 110.241 179.987 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.469 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 102.33 -58.88 0.58 Allowed Glycine 1 CA--C 1.355 -9.947 0 CA-C-O 123.693 1.718 . . . . 0.0 115.013 -179.801 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 66.1 mtp180 -60.57 -10.68 5.45 Favored 'General case' 1 N--CA 1.324 -6.77 1 CA-C-N 105.38 -5.41 . . . . 0.0 111.966 -157.592 . . . . . . . . 4 3 . 1 . 050 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.469 ' N ' ' C ' ' A' ' 3' ' ' GLY . 33.2 t90 -44.39 -20.02 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 112.984 -1.917 . . . . 0.0 109.908 179.675 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.447 ' N ' ' C ' ' A' ' 4' ' ' ARG . 42.6 tp -105.34 -22.84 12.96 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.431 179.791 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.8 tt0 -48.26 -36.2 13.56 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.7 mtt85 -77.06 -63.89 1.26 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.559 179.839 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.4 tt -170.42 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.447 -179.998 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 77.84 -50.39 3.3 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -179.796 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -81.25 96.58 7.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.696 0.284 . . . . 0.0 110.261 179.761 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.9 47.61 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.771 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.7 54.39 33.33 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.676 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 55.2 49.1 17.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.497 -179.698 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.6 mt 60.58 70.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.67 179.921 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.6 mm -136.35 -68.31 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.609 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -68.49 -22.99 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.654 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.24 -59.89 1.8 Allowed Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.486 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.52 -31.63 79.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.715 179.774 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.13 57.91 5.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 110.407 179.959 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.0 mt -56.75 90.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.386 179.954 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 24' ' ' LEU . 8.2 m-20 54.33 -135.1 1.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.354 -179.93 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -76.41 21.3 0.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.789 0.328 . . . . 0.0 110.744 179.885 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' A' ' 22' ' ' ASP . 15.9 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.145 -179.997 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 111.954 -0.459 . . . . 0.0 111.954 . . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.49 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -76.8 35.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 110.18 -179.963 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.489 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -53.77 -57.92 14.33 Favored Glycine 1 CA--C 1.356 -9.9 0 CA-C-O 123.782 1.768 . . . . 0.0 115.094 179.796 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 6' ' ' LEU . 93.9 mtt180 -60.73 -10.26 5.14 Favored 'General case' 1 N--CA 1.324 -6.735 1 CA-C-N 105.178 -5.511 . . . . 0.0 112.044 -157.609 . . . . . . . . 4 3 . 1 . 051 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.489 ' N ' ' C ' ' A' ' 3' ' ' GLY . 48.6 t-105 -39.84 -20.61 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 112.919 -1.946 . . . . 0.0 110.66 -179.802 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.5 tp -117.55 -19.15 9.54 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.501 179.406 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.0 mt-10 -89.5 24.56 2.23 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.777 0.322 . . . . 0.0 110.53 -179.978 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -76.36 -63.69 1.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.721 -179.984 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 9' ' ' ILE . 14.2 tt -49.66 109.77 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.196 0.522 . . . . 0.0 110.558 -179.8 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.74 -27.58 64.71 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.933 -179.754 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 3.8 mptp? -54.96 111.2 0.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.714 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.12 3.53 3.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.96 0.41 . . . . 0.0 110.308 -179.61 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.38 38.48 0.63 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.796 179.586 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -168.38 -19.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 110.663 179.87 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 pt -151.17 48.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.123 0.487 . . . . 0.0 109.991 179.562 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.8 tp -146.4 -35.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.09 -179.892 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -83.51 4.8 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.813 179.423 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.473 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -164.39 -33.88 0.02 OUTLIER Glycine 0 C--N 1.33 0.248 0 N-CA-C 111.779 -0.529 . . . . 0.0 111.779 -179.856 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.13 -42.96 97.35 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.148 -0.549 . . . . 0.0 111.806 179.967 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.46 -51.36 60.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.724 0.297 . . . . 0.0 110.45 -179.955 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 tp 55.76 100.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.276 -179.953 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -164.72 -36.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.597 -179.954 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -170.32 1.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.71 -179.922 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.674 ' C ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.196 -179.857 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 052 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -149.79 178.64 8.7 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.865 0.364 . . . . 0.0 110.383 179.941 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.487 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 132.06 -58.8 0.7 Allowed Glycine 1 CA--C 1.354 -9.995 0 CA-C-O 123.797 1.776 . . . . 0.0 114.912 -179.784 . . . . . . . . 3 3 . 1 . 052 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 84.0 mtm180 -60.32 -11.22 5.96 Favored 'General case' 1 N--CA 1.324 -6.763 1 CA-C-N 105.247 -5.476 . . . . 0.0 111.923 -157.61 . . . . . . . . 4 3 . 1 . 052 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.487 ' N ' ' C ' ' A' ' 3' ' ' GLY . 67.0 m95 -42.08 -19.27 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.943 -1.935 . . . . 0.0 110.366 179.889 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.7 mt -114.12 -19.51 11.33 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.953 179.799 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.7 mm-40 -86.19 -16.23 38.44 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.721 -179.658 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -80.47 103.94 10.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.419 179.783 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.3 pt -65.31 -31.19 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.593 -179.854 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.21 28.35 4.3 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.04 179.966 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 21.8 ttpp -79.09 -19.26 51.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.545 0.212 . . . . 0.0 110.769 -179.692 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 78.5 -21.42 0.33 Allowed 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.164 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.11 36.43 0.87 Allowed Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -179.831 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.4 t80 73.69 48.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.647 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 12' ' ' ALA . 33.6 mt 64.6 70.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.517 -179.714 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.3 mm -134.66 -76.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.846 179.752 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.609 ' C ' HD12 ' A' ' 17' ' ' ILE . 2.7 pp -63.36 -6.53 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.143 -179.86 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.568 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -106.09 -65.8 0.65 Allowed Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.982 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.2 -19.95 74.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.683 179.668 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.447 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 63.05 9.75 4.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.629 0.252 . . . . 0.0 110.835 179.681 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 52.47 12.38 0.23 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.088 0.47 . . . . 0.0 109.783 -179.965 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' N ' ' C ' ' A' ' 20' ' ' ALA . 25.1 t70 -70.19 -102.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.274 179.975 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.478 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 57.5 t-80 -67.41 2.08 1.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 110.103 179.582 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' H ' ' C ' ' A' ' 22' ' ' ASP . 1.4 tt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.129 -179.923 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 . . . . . . . . . 0 0 . 1 . 053 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -78.79 68.24 4.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 110.571 -179.878 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.468 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -57.82 -57.75 18.2 Favored Glycine 1 CA--C 1.355 -9.908 0 CA-C-O 123.751 1.75 . . . . 0.0 115.286 179.894 . . . . . . . . 3 3 . 1 . 053 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.8 mtt180 -60.21 -10.89 5.06 Favored 'General case' 1 N--CA 1.325 -6.704 1 CA-C-N 105.263 -5.469 . . . . 0.0 112.047 -157.48 . . . . . . . . 4 3 . 1 . 053 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.468 ' N ' ' C ' ' A' ' 3' ' ' GLY . 43.4 t90 -40.99 -18.93 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.639 -179.954 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.8 tp -123.47 -13.27 7.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.632 179.492 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.0 tt0 -82.93 -8.62 59.55 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.556 -179.806 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -50.11 115.49 1.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.466 179.774 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 11' ' ' LYS . 17.6 tt -70.68 -23.17 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.608 -179.837 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -47.13 87.43 0.01 OUTLIER Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.344 -179.887 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 9' ' ' ILE . 9.6 mtpm? -149.55 4.76 0.6 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.768 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 53.17 56.39 7.53 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.285 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -41.1 88.17 0.01 OUTLIER Glycine 0 C--N 1.335 0.523 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.019 -179.847 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 12' ' ' ALA . 89.6 m-85 53.26 48.19 22.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.815 0.34 . . . . 0.0 110.091 -179.108 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.7 mt 62.13 80.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.626 -179.835 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.0 tp -146.57 -35.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.249 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 mm -98.96 -37.24 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.007 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.02 -57.81 5.06 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.226 179.358 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.86 86.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.671 179.545 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.04 40.58 17.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.7 179.814 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 23' ' ' HIS . 22.8 mt -68.71 -25.98 65.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.579 -179.957 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.42 34.0 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.942 -179.74 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.487 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 12.0 t-80 54.85 27.87 9.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.574 179.31 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.238 179.527 . . . . . . . . 0 0 . 1 . 054 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 054 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -145.55 -159.74 1.05 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 110.489 -179.974 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.51 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 129.74 -59.86 0.68 Allowed Glycine 1 CA--C 1.354 -10.012 0 CA-C-O 123.794 1.775 . . . . 0.0 114.932 -179.938 . . . . . . . . 3 3 . 1 . 054 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' GLU . 74.4 mtm180 -60.7 -10.49 5.4 Favored 'General case' 1 N--CA 1.323 -6.813 1 CA-C-N 105.273 -5.464 . . . . 0.0 111.835 -157.727 . . . . . . . . 4 3 . 1 . 054 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.51 ' N ' ' C ' ' A' ' 3' ' ' GLY . 19.4 t90 -42.17 -19.73 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.095 -1.866 . . . . 0.0 110.262 179.862 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.498 ' N ' ' C ' ' A' ' 4' ' ' ARG . 31.0 mt -108.82 -24.2 11.39 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.531 179.568 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 4' ' ' ARG . 27.6 tt0 -89.5 -5.41 57.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.057 0.456 . . . . 0.0 110.008 179.905 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -67.57 -51.27 52.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.644 179.987 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 10' ' ' GLY . 10.5 tt -167.32 -44.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.666 -179.9 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 75.9 -39.85 1.38 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.159 179.981 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 13' ' ' GLY . 86.4 mttt -79.77 81.14 6.08 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.768 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.38 15.34 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.8 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 65.45 19.25 66.49 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.616 -179.623 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.418 ' C ' ' H ' ' A' ' 16' ' ' ILE . 65.4 m-85 -147.18 -52.82 0.21 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.767 0.317 . . . . 0.0 110.207 179.879 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.3 pt -80.18 32.54 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 121.045 0.45 . . . . 0.0 110.53 179.815 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 17' ' ' ILE . 4.2 tp -148.97 -44.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.429 -179.787 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.568 ' C ' HD12 ' A' ' 17' ' ' ILE . 2.2 pp -71.3 1.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.294 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.539 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -163.89 -40.69 0.02 OUTLIER Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.946 -179.899 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -73.27 -29.14 64.75 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.92 179.989 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.18 8.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.653 0.263 . . . . 0.0 110.908 179.978 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 23' ' ' HIS . 8.3 tp 49.66 -115.26 0.79 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.299 179.933 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 57.05 -79.72 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.746 0.308 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 21' ' ' LEU . 14.8 p-80 -156.78 -1.66 0.12 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.623 -179.969 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.399 179.756 . . . . . . . . 0 0 . 1 . 055 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 055 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.2 mttp 50.86 -142.57 0.68 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.575 0.226 . . . . 0.0 110.745 179.958 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 51.64 69.66 1.09 Allowed Glycine 1 CA--C 1.383 -8.211 0 CA-C-O 126.312 3.173 . . . . 0.0 112.576 -178.117 . . . . . . . . 3 3 . 1 . 055 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.593 ' O ' ' N ' ' A' ' 7' ' ' GLU . 20.8 mtp180 157.15 -10.87 0.0 OUTLIER 'General case' 1 N--CA 1.315 -7.175 1 CA-C-N 100.771 -7.714 . . . . 0.0 110.646 160.469 . . . . . . . . 4 3 . 1 . 055 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -40.79 -23.71 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.112 -179.397 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 6' ' ' LEU . 10.5 mp -97.67 -26.04 14.9 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.444 179.558 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.3 tp10 -119.53 35.4 4.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.075 0.464 . . . . 0.0 109.906 179.9 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.523 ' NH2' ' CZ ' ' A' ' 4' ' ' ARG . 6.8 tpm_? -80.6 88.56 5.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.216 179.994 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.4 tt -53.8 -45.06 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.479 -179.921 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.541 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 71.01 -70.56 0.77 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.276 179.747 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 13' ' ' GLY . 51.6 mttp -51.79 108.15 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 110.605 -179.738 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.523 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -76.35 37.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.351 179.683 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 70.04 72.52 0.86 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.98 -179.832 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 51.4 t80 52.36 28.62 5.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.766 0.317 . . . . 0.0 110.459 179.979 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.5 mt 61.19 62.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.651 0.739 . . . . 0.0 109.77 -179.737 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -130.92 -50.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.046 -179.674 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.585 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.4 mp -66.29 -45.56 89.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.989 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -81.49 -41.08 10.27 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.721 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -58.86 -39.73 94.29 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.969 179.477 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.38 37.74 0.13 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.814 0.34 . . . . 0.0 110.744 -179.778 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 19' ' ' GLY . 16.7 tp -70.67 110.53 5.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.132 179.819 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.1 t0 55.76 39.18 30.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.559 -179.908 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 60.5 t60 52.09 50.03 19.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.519 179.983 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.945 179.955 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 056 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.48 -145.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -179.994 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 43.62 69.44 0.67 Allowed Glycine 1 CA--C 1.383 -8.158 0 CA-C-O 126.088 3.049 . . . . 0.0 113.029 -178.359 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 7' ' ' GLU . 28.0 mtt180 157.89 -11.72 0.0 OUTLIER 'General case' 1 N--CA 1.316 -7.164 1 CA-C-N 100.9 -7.65 . . . . 0.0 110.846 160.507 . . . . . . . . 4 3 . 1 . 056 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -44.1 -21.17 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.78 -179.647 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.492 ' N ' ' C ' ' A' ' 4' ' ' ARG . 26.7 mt -97.34 -23.86 15.92 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.536 179.663 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.3 tt0 -66.67 -18.5 65.41 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.234 179.869 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -81.9 47.68 1.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.261 179.734 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -50.0 120.86 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 110.48 -179.685 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.38 39.82 0.46 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.718 -179.842 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -50.64 -33.4 22.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.612 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.96 -15.93 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.383 179.932 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' O ' ' CG ' ' A' ' 14' ' ' PHE . . . 69.33 31.1 71.33 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.616 -179.788 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.404 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 67.0 m-85 -155.91 -10.3 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.703 0.287 . . . . 0.0 110.269 179.983 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.0 pt -153.98 42.37 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.096 0.474 . . . . 0.0 110.476 179.644 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.501 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.4 tp -147.94 -43.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.792 179.782 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.501 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.4 tp -77.44 -37.98 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.696 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.57 -39.79 6.58 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.166 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.02 -38.24 95.75 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 179.682 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.0 -73.42 0.05 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.42 ' C ' HD23 ' A' ' 21' ' ' LEU . 2.1 tt 63.59 87.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 109.984 179.797 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 30.0 p-10 -168.78 -120.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.023 -179.75 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -67.92 -12.56 60.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.0 0.429 . . . . 0.0 109.879 179.451 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.6 mt . . . . . 0 C--O 1.232 0.181 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.331 179.858 . . . . . . . . 0 0 . 1 . 057 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 057 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -69.9 -173.77 0.68 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.85 0.357 . . . . 0.0 110.539 179.978 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.472 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 115.69 -59.18 0.44 Allowed Glycine 1 CA--C 1.356 -9.877 0 CA-C-O 123.875 1.82 . . . . 0.0 115.129 -179.964 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' GLU . 38.1 mtt85 -60.14 -11.35 5.9 Favored 'General case' 1 N--CA 1.326 -6.673 1 CA-C-N 105.214 -5.493 . . . . 0.0 112.085 -157.531 . . . . . . . . 4 3 . 1 . 057 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.472 ' N ' ' C ' ' A' ' 3' ' ' GLY . 68.9 t-105 -43.09 -19.81 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.223 179.858 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 mt -108.11 -21.51 12.77 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.93 179.932 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.4 tp10 -72.55 -9.41 58.55 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.116 -179.828 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -54.9 122.35 10.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.505 -179.983 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.608 ' C ' HD12 ' A' ' 9' ' ' ILE . 2.5 pp -69.36 -2.42 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.725 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.568 ' N ' HD12 ' A' ' 9' ' ' ILE . . . -75.91 71.61 1.91 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.227 -179.898 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -51.82 -31.17 26.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.022 0.439 . . . . 0.0 109.892 179.523 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.99 -2.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.336 179.931 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.17 32.29 12.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.838 -179.924 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -145.84 -10.35 0.52 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 110.232 -179.969 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 pt -156.94 36.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.018 179.4 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.0 tp -150.67 -21.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.943 -179.79 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.3 pp -88.81 4.41 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.836 179.347 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.506 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -166.93 -36.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.82 -179.944 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.19 -5.1 75.43 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.901 179.852 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -67.54 -56.52 9.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 0.0 110.47 -179.94 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 23' ' ' HIS . 5.0 tp 64.27 -0.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.447 179.965 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 20' ' ' ALA . 34.6 t70 -77.6 30.81 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.628 -179.94 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.427 ' H ' ' C ' ' A' ' 21' ' ' LEU . 66.3 m80 51.45 65.69 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.465 179.966 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.144 -179.973 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 058 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -165.18 -138.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.933 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.436 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 43.31 70.53 0.52 Allowed Glycine 1 CA--C 1.385 -8.087 0 CA-C-O 126.22 3.122 . . . . 0.0 113.138 -178.588 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 7' ' ' GLU . 19.8 mtt180 157.47 -10.54 0.0 OUTLIER 'General case' 1 N--CA 1.315 -7.212 1 CA-C-N 100.835 -7.682 . . . . 0.0 110.455 160.671 . . . . . . . . 4 3 . 1 . 058 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -40.97 -22.59 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.296 -179.616 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.529 ' O ' HD23 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -97.47 -26.64 14.76 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.364 179.873 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.9 tp10 -67.21 -32.01 72.78 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.176 179.748 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -53.12 -70.13 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 -179.973 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 10' ' ' GLY . 14.2 tt -66.12 -39.97 85.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.355 -179.888 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 46.26 60.19 4.75 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.315 179.847 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -170.89 74.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.772 0.32 . . . . 0.0 110.473 179.925 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.95 65.12 5.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.007 179.855 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 49.02 53.09 19.93 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -179.576 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 60.68 38.67 18.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.898 0.38 . . . . 0.0 110.258 -179.519 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 mt 60.92 69.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.374 -179.862 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.592 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.9 tp -139.2 -50.51 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.91 179.688 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.592 ' N ' HG23 ' A' ' 16' ' ' ILE . 4.1 tp -79.27 -27.39 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.73 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.0 -50.89 3.54 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 178.97 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.39 -42.23 99.72 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.075 179.635 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.89 -52.23 58.32 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.447 -179.945 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.424 ' C ' ' H ' ' A' ' 23' ' ' HIS . 12.2 tp -60.57 -34.03 73.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.362 179.993 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -76.86 35.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.621 -179.872 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 21' ' ' LEU . 16.9 m80 49.97 44.95 25.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.543 179.892 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.347 -179.872 . . . . . . . . 0 0 . 1 . 059 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.027 -0.429 . . . . 0.0 112.027 . . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -78.54 28.12 0.2 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.762 0.315 . . . . 0.0 110.631 -179.967 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.49 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -51.16 -57.89 10.6 Favored Glycine 1 CA--C 1.356 -9.881 0 CA-C-O 123.629 1.683 . . . . 0.0 115.403 179.997 . . . . . . . . 3 3 . 1 . 059 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 46.3 mtt85 -60.67 -10.31 5.12 Favored 'General case' 1 N--CA 1.324 -6.755 1 CA-C-N 105.362 -5.419 . . . . 0.0 111.97 -157.555 . . . . . . . . 4 3 . 1 . 059 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.49 ' N ' ' C ' ' A' ' 3' ' ' GLY . 71.6 t-105 -41.14 -20.32 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.111 -1.859 . . . . 0.0 110.394 -179.874 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.6 tp -111.27 -23.21 10.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.315 179.528 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 14.9 mm-40 -92.77 -1.65 56.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.838 0.351 . . . . 0.0 110.534 179.998 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.407 ' CG ' ' H ' ' A' ' 9' ' ' ILE . 14.8 tpp180 -82.5 -133.46 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.291 -179.912 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 11' ' ' LYS . 18.8 tt -167.94 -21.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.482 -179.986 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.24 86.8 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.008 -179.948 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 9' ' ' ILE . 63.1 mttm -153.32 0.9 0.26 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.992 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 54.81 62.07 2.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.54 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -42.38 90.8 0.01 OUTLIER Glycine 0 C--N 1.333 0.382 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 -179.92 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.5 ' N ' ' O ' ' A' ' 12' ' ' ALA . 78.1 m-85 55.35 47.04 22.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.926 0.394 . . . . 0.0 110.089 -179.326 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 60.61 77.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.513 -179.966 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.582 HG23 ' N ' ' A' ' 17' ' ' ILE . 6.2 tp -142.91 -56.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.709 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.582 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.2 mp -77.81 -33.2 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.637 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.95 -48.67 9.62 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 178.361 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.76 -45.99 91.08 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.76 179.161 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.8 -72.63 0.05 OUTLIER 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.414 -179.934 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.6 tp 52.43 94.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.287 179.981 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -157.92 -28.44 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.326 179.99 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -168.0 -27.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 -179.958 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.0 mp . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.208 179.926 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 060 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -165.22 -153.35 0.19 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 121.066 -0.254 . . . . 0.0 110.555 179.969 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 57.33 71.68 0.71 Allowed Glycine 1 CA--C 1.384 -8.126 0 CA-C-O 126.549 3.305 . . . . 0.0 111.835 -177.705 . . . . . . . . 3 3 . 1 . 060 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 7' ' ' GLU . 2.9 mtp85 154.91 -10.77 0.0 OUTLIER 'General case' 1 N--CA 1.311 -7.381 1 CA-C-N 100.354 -7.923 . . . . 0.0 109.984 161.484 . . . . . . . . 4 3 . 1 . 060 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.42 ' CZ2' ' NH2' ' A' ' 8' ' ' ARG . 74.2 t-105 -42.77 -23.17 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.795 179.996 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.475 ' N ' ' C ' ' A' ' 4' ' ' ARG . 28.8 mt -92.85 -27.68 16.98 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.748 179.902 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.573 ' N ' ' O ' ' A' ' 4' ' ' ARG . 71.5 mt-10 -79.78 10.87 3.62 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.606 179.965 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.42 ' NH2' ' CZ2' ' A' ' 5' ' ' TRP . 54.8 ttp180 -77.92 85.52 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.555 -179.978 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 10' ' ' GLY . 16.7 tt -73.86 -42.82 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.383 179.913 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.5 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 60.73 53.05 48.54 Favored Glycine 0 N--CA 1.453 -0.204 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.365 179.744 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -171.13 67.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 0.0 110.644 179.771 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.532 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -80.79 45.07 0.78 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.439 179.944 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.87 67.38 2.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.131 -0.556 . . . . 0.0 111.895 -179.977 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 52.6 t80 52.37 31.19 9.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.766 0.317 . . . . 0.0 110.555 -179.988 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 61.7 64.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.547 0.689 . . . . 0.0 110.263 -179.819 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.2 mm -131.8 -48.96 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.651 179.912 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.4 mp -69.55 -47.29 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.633 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.532 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -76.78 -42.3 21.32 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 178.978 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.43 -48.31 86.6 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.866 179.537 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.88 -47.45 71.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.732 0.301 . . . . 0.0 110.503 -179.863 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.4 36.53 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.893 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -81.17 -86.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.631 -179.712 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 32.4 p-80 -73.8 -27.0 60.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.626 -179.933 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.9 tt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.121 179.999 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 061 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.407 ' CB ' ' NZ ' ' A' ' 2' ' ' LYS . 9.0 mtmp? -79.61 53.0 1.5 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.786 0.327 . . . . 0.0 110.705 179.965 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -55.06 -58.4 13.9 Favored Glycine 1 CA--C 1.356 -9.874 0 CA-C-O 123.701 1.723 . . . . 0.0 115.417 -179.97 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 6' ' ' LEU . 93.9 mtt180 -60.25 -11.48 6.48 Favored 'General case' 1 N--CA 1.325 -6.698 1 CA-C-N 105.318 -5.441 . . . . 0.0 111.965 -157.439 . . . . . . . . 4 3 . 1 . 061 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.492 ' N ' ' C ' ' A' ' 3' ' ' GLY . 19.4 t90 -42.71 -18.46 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.291 -179.95 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.8 mt -118.01 -16.89 9.8 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.632 179.31 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 19.4 mm-40 -88.65 -1.14 57.91 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 120.887 0.375 . . . . 0.0 110.402 179.971 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 55.81 106.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 179.859 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 9' ' ' ILE . 4.4 tp -114.2 87.68 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 121.526 0.679 . . . . 0.0 110.024 179.946 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.9 -1.82 60.04 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.781 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 pttm 33.86 35.68 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.4 -0.4 . . . . 0.0 111.93 179.889 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.469 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -81.72 32.94 0.36 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.039 179.483 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.23 60.46 3.07 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.769 -179.755 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.492 ' O ' ' CD2' ' A' ' 14' ' ' PHE . 66.9 t80 55.53 33.77 21.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.954 0.406 . . . . 0.0 110.191 -179.786 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.2 mm 61.85 66.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.509 0.671 . . . . 0.0 110.15 -179.802 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 mm -133.77 -51.09 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.715 179.624 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.5 mp -68.18 -46.28 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.577 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.469 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -77.26 -48.11 8.52 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.429 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.38 -43.77 98.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.606 179.573 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.77 9.19 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.737 0.303 . . . . 0.0 110.92 179.761 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 21' ' ' LEU . 8.0 mp 53.85 -97.78 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.807 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 72.1 m-20 50.24 -87.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.676 179.79 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 21' ' ' LEU . 75.4 m80 -156.44 11.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.509 179.922 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 N--CA 1.465 0.279 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.355 179.958 . . . . . . . . 0 0 . 1 . 062 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 062 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -56.91 -106.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.559 0.219 . . . . 0.0 110.413 -179.959 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.491 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 93.4 -59.84 2.23 Favored Glycine 1 CA--C 1.355 -9.934 0 CA-C-O 123.677 1.71 . . . . 0.0 115.371 179.937 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 7' ' ' GLU . 79.0 mtt180 -60.52 -10.37 4.95 Favored 'General case' 1 N--CA 1.325 -6.698 1 CA-C-N 105.434 -5.383 . . . . 0.0 112.048 -157.588 . . . . . . . . 4 3 . 1 . 062 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.491 ' N ' ' C ' ' A' ' 3' ' ' GLY . 85.1 t90 -39.62 -21.63 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.521 179.936 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 10.8 tp -107.83 -26.99 10.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.455 179.347 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' ARG . 90.3 mt-10 -100.44 22.33 11.84 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.806 0.336 . . . . 0.0 110.29 179.79 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -53.29 -57.17 11.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.654 -179.809 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.456 ' C ' ' H ' ' A' ' 11' ' ' LYS . 14.0 pt -71.29 -35.2 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.666 -179.862 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.7 -19.19 1.21 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.07 -179.953 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 9' ' ' ILE . 41.9 mtmt -73.99 95.16 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.567 -179.978 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.426 ' HB3' ' H ' ' A' ' 15' ' ' ILE . . . -58.96 -6.46 0.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.315 179.829 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 60.53 15.73 41.04 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.772 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -164.67 -39.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.942 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' H ' ' HB3' ' A' ' 12' ' ' ALA . 13.5 mt -111.24 57.48 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.709 179.38 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.1 tp -151.78 -45.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.485 -0.78 . . . . 0.0 108.911 -179.988 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.526 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.1 pp -91.17 4.98 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.749 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.509 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -136.14 -57.03 0.06 OUTLIER Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.631 -179.761 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.5 -46.07 94.53 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.702 179.895 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.99 44.98 28.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 110.691 179.922 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.7 mm? -63.15 103.09 0.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.926 179.766 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 35.3 t70 56.26 56.17 6.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 -179.849 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 19.8 p-80 40.82 39.5 0.81 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.349 -179.935 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.9 tp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.256 179.826 . . . . . . . . 0 0 . 1 . 063 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 063 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.21 -172.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.826 0.346 . . . . 0.0 110.509 -179.968 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.507 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 127.09 -58.81 0.69 Allowed Glycine 1 CA--C 1.357 -9.794 0 CA-C-O 123.778 1.766 . . . . 0.0 115.111 -179.984 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 6' ' ' LEU . 95.7 mtt180 -60.33 -10.74 5.1 Favored 'General case' 1 N--CA 1.324 -6.746 1 CA-C-N 105.222 -5.489 . . . . 0.0 112.066 -157.591 . . . . . . . . 4 3 . 1 . 063 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.507 ' N ' ' C ' ' A' ' 3' ' ' GLY . 77.4 t-105 -40.26 -19.85 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.66 -179.985 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.5 mt -120.37 -15.46 8.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.013 179.499 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.6 mm-40 -87.95 -7.04 57.68 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.645 -179.91 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -68.92 88.93 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.254 179.774 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.4 pt -60.22 -34.71 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.962 -179.627 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.38 17.51 1.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.696 -179.671 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -70.25 -5.16 25.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.888 -0.156 . . . . 0.0 110.827 -179.779 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.99 52.02 9.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.64 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.509 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -43.49 87.45 0.01 OUTLIER Glycine 0 C--N 1.335 0.498 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.868 -179.337 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 12' ' ' ALA . 89.4 m-85 52.74 41.75 31.6 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.074 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 mm 61.16 77.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.183 -179.416 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.659 HG23 ' H ' ' A' ' 17' ' ' ILE . 6.6 tp -140.37 -59.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.883 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.659 ' H ' HG23 ' A' ' 16' ' ' ILE . 3.7 tp -74.98 -31.02 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.011 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.02 -48.13 5.27 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 179.011 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.7 -44.84 96.92 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.037 -0.602 . . . . 0.0 111.706 179.612 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.44 -65.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.402 179.875 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.7 79.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.866 179.953 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -159.77 33.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.483 -179.791 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.42 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 33.8 t-80 55.18 22.91 4.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.659 179.948 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 tp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.209 179.972 . . . . . . . . 0 0 . 1 . 064 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 064 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -168.88 -135.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.938 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 42.01 68.91 0.63 Allowed Glycine 1 CA--C 1.382 -8.26 0 CA-C-O 125.453 2.696 . . . . 0.0 114.003 -179.095 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.546 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 3.6 mmt180 163.14 -12.13 0.0 OUTLIER 'General case' 1 N--CA 1.318 -7.044 1 CA-C-N 101.362 -7.419 . . . . 0.0 110.428 159.443 . . . . . . . . 4 3 . 1 . 064 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -44.19 -18.67 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.961 -179.63 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.497 ' N ' ' C ' ' A' ' 4' ' ' ARG . 9.3 mp -109.74 -19.28 13.22 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.067 179.235 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 4' ' ' ARG . 15.1 mp0 -112.27 12.88 20.36 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 120.71 0.29 . . . . 0.0 110.328 -179.89 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 4' ' ' ARG . 61.0 ttp180 -52.32 123.67 11.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.378 179.795 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 tp -54.79 92.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.344 0.593 . . . . 0.0 110.16 -179.883 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.12 -30.83 10.44 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.787 -179.974 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -60.37 104.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.07 179.851 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.88 -4.01 4.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.691 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.71 34.19 5.16 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.139 179.722 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 15' ' ' ILE . 30.4 t80 -170.2 -17.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' PHE . 8.9 pt -155.55 55.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.13 0.491 . . . . 0.0 110.361 179.787 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.4 tp -144.16 -42.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.061 179.792 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.522 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -71.87 4.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.901 179.676 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.471 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -175.89 -22.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.033 179.999 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.47 -31.84 79.97 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.991 179.993 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.38 -59.35 2.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.766 0.317 . . . . 0.0 110.567 -179.978 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tp 54.98 37.62 29.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.351 -179.943 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.61 -33.28 58.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.602 179.992 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -164.66 6.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.437 -179.98 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.161 179.989 . . . . . . . . 0 0 . 1 . 065 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 065 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -73.86 -171.07 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.545 -179.956 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.504 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 106.23 -60.23 0.38 Allowed Glycine 1 CA--C 1.356 -9.851 0 CA-C-O 123.678 1.71 . . . . 0.0 115.141 -179.95 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 6' ' ' LEU . 48.5 mtp180 -60.18 -11.23 5.7 Favored 'General case' 1 N--CA 1.324 -6.752 1 CA-C-N 105.358 -5.421 . . . . 0.0 111.988 -157.588 . . . . . . . . 4 3 . 1 . 065 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.504 ' N ' ' C ' ' A' ' 3' ' ' GLY . 30.7 t-105 -42.78 -17.59 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 112.828 -1.987 . . . . 0.0 110.393 179.904 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.4 mt -121.28 -14.38 8.33 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.933 179.621 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.2 tt0 -82.64 0.05 44.9 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.181 -179.974 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -50.26 163.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 180.0 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.6 pt -54.0 -43.03 57.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.458 -179.922 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.83 -48.59 2.35 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.771 179.39 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HZ2' HG12 ' A' ' 17' ' ' ILE . 9.5 mtpm? -75.44 -75.52 0.17 Allowed 'General case' 0 C--N 1.331 -0.217 0 O-C-N 122.741 -0.27 . . . . 0.0 110.817 -179.572 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 66.81 30.7 7.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.525 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -36.54 -39.82 0.39 Allowed Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.782 179.537 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.487 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 74.0 t80 179.78 54.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.296 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 pt 38.95 53.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.005 -177.816 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -113.83 -47.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.075 -178.847 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.516 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -78.31 6.5 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.176 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.44 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -141.97 -50.99 0.04 OUTLIER Glycine 0 C--N 1.333 0.406 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.935 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.33 -44.72 84.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.712 179.618 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.48 10.41 4.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.8 0.333 . . . . 0.0 110.41 179.913 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' HIS . 19.5 tp 53.35 101.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.092 -179.995 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 56.75 -79.8 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 21' ' ' LEU . 34.0 t-80 -162.25 29.16 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 110.396 179.901 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.442 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.203 179.977 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.211 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 . . . . . . . . . 0 0 . 1 . 066 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -70.14 -147.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.627 0.251 . . . . 0.0 110.643 179.991 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.421 ' O ' ' CB ' ' A' ' 4' ' ' ARG . . . 52.38 69.77 1.09 Allowed Glycine 1 CA--C 1.38 -8.364 0 CA-C-O 126.039 3.022 . . . . 0.0 112.913 -178.421 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' GLU . 22.0 mtt180 160.79 -12.3 0.0 OUTLIER 'General case' 1 N--CA 1.319 -7.02 1 CA-C-N 101.192 -7.504 . . . . 0.0 110.966 159.966 . . . . . . . . 4 3 . 1 . 066 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.565 ' CE3' HD21 ' A' ' 6' ' ' LEU . 33.9 t90 -43.99 -18.3 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.723 -179.981 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.565 HD21 ' CE3' ' A' ' 5' ' ' TRP . 44.0 mt -113.25 -15.9 12.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.646 179.091 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.5 mt-10 -116.03 15.08 16.16 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.772 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 ttm180 -76.85 126.28 30.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.474 179.885 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 tp -56.28 108.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.253 0.549 . . . . 0.0 109.962 179.852 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.54 38.96 0.48 Allowed Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.865 -179.871 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.14 -26.74 63.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.38 . . . . 0.0 110.316 179.846 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.451 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -158.96 31.36 0.21 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.158 179.9 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.62 53.76 11.67 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.967 -179.945 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 61.03 33.43 19.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.725 0.297 . . . . 0.0 110.323 -179.979 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 mt 63.24 64.96 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.576 0.703 . . . . 0.0 110.226 -179.74 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -133.01 -50.41 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.776 179.755 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.631 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.5 mp -70.46 -43.6 77.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.733 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.451 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -76.25 -48.17 9.9 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.092 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -63.49 -52.28 47.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.636 179.45 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.436 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 58.25 4.5 0.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.717 0.294 . . . . 0.0 110.931 179.749 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 21' ' ' LEU . 8.2 mp 50.66 13.47 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.357 179.883 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' N ' ' C ' ' A' ' 20' ' ' ALA . 72.8 m-20 -75.69 37.01 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.615 -179.936 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.434 ' H ' ' C ' ' A' ' 21' ' ' LEU . 6.4 t60 49.91 37.71 14.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 110.555 179.985 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.9 tp . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.101 -179.903 . . . . . . . . 0 0 . 1 . 067 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 067 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -67.26 -120.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.709 -179.884 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.421 ' O ' ' CB ' ' A' ' 4' ' ' ARG . . . 48.12 69.07 1.02 Allowed Glycine 1 CA--C 1.383 -8.199 0 CA-C-O 126.167 3.093 . . . . 0.0 112.993 -178.4 . . . . . . . . 3 3 . 1 . 067 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 5.5 mtp85 159.21 -11.81 0.0 OUTLIER 'General case' 1 N--CA 1.317 -7.112 1 CA-C-N 101.014 -7.593 . . . . 0.0 110.629 160.194 . . . . . . . . 4 3 . 1 . 067 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -43.55 -17.91 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.933 -179.84 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -118.34 -12.82 9.85 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.104 179.133 . . . . . . . . 3 3 . 1 . 067 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 45.2 mm-40 -122.18 29.41 7.03 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-O 120.784 0.326 . . . . 0.0 110.319 179.877 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.6 ttp85 -72.42 89.01 1.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.387 179.908 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 tp -55.64 101.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.167 0.508 . . . . 0.0 110.288 -179.98 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.0 -35.33 12.77 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.921 -179.888 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.466 ' C ' ' H ' ' A' ' 13' ' ' GLY . 66.2 mttm -69.39 82.75 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 0.0 110.469 -179.849 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.455 ' O ' ' CD2' ' A' ' 14' ' ' PHE . . . -55.73 -7.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.032 179.46 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 62.72 52.2 50.29 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.971 -179.967 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.455 ' CD2' ' O ' ' A' ' 12' ' ' ALA . 65.4 m-85 -156.53 -61.88 0.1 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.698 0.285 . . . . 0.0 110.668 179.813 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 14' ' ' PHE . 14.9 pt -155.76 57.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.305 0.574 . . . . 0.0 110.457 -179.906 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.4 -69.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.235 179.665 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -73.62 -35.68 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.349 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.71 -47.04 10.34 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 179.46 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -74.22 -44.55 28.37 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.108 -0.567 . . . . 0.0 111.872 179.714 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.88 6.3 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.668 0.27 . . . . 0.0 110.918 179.844 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.1 mt 45.86 70.96 0.32 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -158.99 53.85 0.41 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.435 179.901 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.479 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 12.7 t60 52.2 23.89 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.396 -179.913 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.377 179.959 . . . . . . . . 0 0 . 1 . 068 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 068 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -70.26 155.88 40.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.732 0.301 . . . . 0.0 110.355 179.997 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.481 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 129.0 -56.62 0.74 Allowed Glycine 1 CA--C 1.354 -9.97 0 CA-C-O 123.899 1.833 . . . . 0.0 114.846 -179.543 . . . . . . . . 3 3 . 1 . 068 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 56.5 mtt85 -60.81 -9.57 4.28 Favored 'General case' 1 N--CA 1.325 -6.712 1 CA-C-N 105.044 -5.578 . . . . 0.0 111.92 -157.606 . . . . . . . . 4 3 . 1 . 068 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.481 ' N ' ' C ' ' A' ' 3' ' ' GLY . 36.5 t90 -40.98 -20.78 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 112.995 -1.911 . . . . 0.0 110.594 179.988 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.3 tp -108.06 -22.96 12.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.725 179.956 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.2 tp10 -46.26 -43.79 15.89 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.892 -179.755 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -62.31 179.58 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.409 179.863 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.5 tt -49.49 -35.48 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.745 -179.923 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.51 64.1 3.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.9 179.979 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -168.44 74.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 110.479 -179.877 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -74.7 70.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.265 179.903 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.33 62.25 5.25 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.771 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 55.74 32.72 19.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.786 0.326 . . . . 0.0 110.523 -179.755 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 mm 60.6 66.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.405 0.622 . . . . 0.0 110.101 -179.902 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -133.41 -46.04 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.883 179.935 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.1 mm -75.34 -46.98 36.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.975 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.433 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -76.25 -50.41 7.55 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.454 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.22 -36.78 93.25 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.95 179.749 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 51.6 37.17 19.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.757 0.313 . . . . 0.0 110.62 179.99 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.0 mt -54.84 -12.76 0.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.407 179.916 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -57.79 -76.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.356 179.951 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -84.42 -27.01 27.88 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.583 -179.998 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.9 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.435 -179.803 . . . . . . . . 0 0 . 1 . 069 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 069 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -63.3 -177.0 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.574 -179.956 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.493 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 115.2 -59.5 0.42 Allowed Glycine 1 CA--C 1.355 -9.94 0 CA-C-O 123.833 1.796 . . . . 0.0 114.92 -179.838 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' GLU . 41.7 mtp180 -60.73 -10.14 4.97 Favored 'General case' 1 N--CA 1.323 -6.782 1 CA-C-N 105.222 -5.489 . . . . 0.0 111.984 -157.739 . . . . . . . . 4 3 . 1 . 069 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' N ' ' C ' ' A' ' 3' ' ' GLY . 30.4 t90 -41.0 -21.71 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.934 -1.939 . . . . 0.0 110.493 179.834 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' ARG . 47.9 tp -104.4 -25.04 12.98 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.712 -179.838 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.1 tm-20 -51.14 -35.28 34.9 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.351 -179.899 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -48.84 128.77 16.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.609 -180.0 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 10' ' ' GLY . 13.6 tt -66.19 -51.77 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.547 -179.814 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.603 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 42.04 76.64 0.1 OUTLIER Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.484 -0.389 . . . . 0.0 112.801 179.522 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -148.16 -9.61 0.38 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.565 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 55.63 62.18 2.53 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.38 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.3 86.84 0.01 OUTLIER Glycine 0 C--N 1.333 0.372 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.025 -179.598 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 12' ' ' ALA . 28.7 t80 64.98 44.35 3.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.814 0.34 . . . . 0.0 110.526 -179.618 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.2 mm 60.43 76.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.54 179.448 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 mm -135.86 -55.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.914 179.129 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 mm -69.9 -49.28 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.619 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.51 -43.75 35.92 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 178.833 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.09 -48.62 85.02 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.571 179.292 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.75 -14.6 0.96 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.0 110.224 179.745 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' HIS . 8.0 tp 58.3 112.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.192 179.966 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 57.5 -78.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.546 -179.728 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' LEU . 2.3 t60 -168.62 24.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.392 179.827 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.464 0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.461 179.902 . . . . . . . . 0 0 . 1 . 070 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 070 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -69.12 -168.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.508 -179.981 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.478 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 91.9 -59.41 2.82 Favored Glycine 1 CA--C 1.357 -9.799 0 CA-C-O 123.572 1.651 . . . . 0.0 115.495 179.778 . . . . . . . . 3 3 . 1 . 070 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 51.2 mtt85 -59.81 -11.93 6.34 Favored 'General case' 1 N--CA 1.325 -6.677 1 CA-C-N 105.569 -5.315 . . . . 0.0 112.051 -157.375 . . . . . . . . 4 3 . 1 . 070 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.478 ' N ' ' C ' ' A' ' 3' ' ' GLY . 99.0 m95 -44.66 -15.62 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.918 -1.946 . . . . 0.0 110.305 179.673 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 0.7 OUTLIER -129.9 -6.94 4.48 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.452 179.782 . . . . . . . . 3 3 . 1 . 070 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -84.2 -25.86 29.19 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.313 179.926 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -49.18 156.23 0.58 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.628 179.698 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' ILE . 6.3 tp -168.5 126.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.196 179.829 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.61 20.81 0.05 OUTLIER Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.726 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -73.44 3.4 6.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.229 -0.188 . . . . 0.0 110.904 -179.768 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.33 36.92 28.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.81 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -34.24 88.86 0.01 OUTLIER Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.926 -179.561 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 12' ' ' ALA . 59.2 t80 56.9 57.4 4.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.063 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.1 pt 35.0 79.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.342 -179.012 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.601 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.2 tp -135.61 -51.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.076 179.665 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.601 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.5 tp -89.06 -36.12 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.003 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.62 -32.07 16.75 Favored Glycine 0 C--N 1.331 0.293 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 178.833 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.28 -47.17 13.41 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.505 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.72 -28.43 14.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.929 0.395 . . . . 0.0 110.265 179.658 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.5 tp 55.39 70.8 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.676 179.816 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 52.11 46.29 26.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.791 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 50.19 52.34 14.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.679 179.81 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.293 179.984 . . . . . . . . 0 0 . 1 . 071 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 071 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -59.81 -177.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 0.0 110.393 179.958 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.496 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 133.04 -57.07 0.72 Allowed Glycine 1 CA--C 1.356 -9.863 0 CA-C-O 123.653 1.696 . . . . 0.0 115.217 -179.838 . . . . . . . . 3 3 . 1 . 071 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 7' ' ' GLU . 54.7 mtt85 -60.72 -10.0 4.76 Favored 'General case' 1 N--CA 1.325 -6.7 1 CA-C-N 105.273 -5.464 . . . . 0.0 112.075 -157.552 . . . . . . . . 4 3 . 1 . 071 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.496 ' N ' ' C ' ' A' ' 3' ' ' GLY . 64.9 t-105 -41.39 -25.83 0.05 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.107 -1.861 . . . . 0.0 109.822 179.907 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 6' ' ' LEU . 2.7 mm? -93.57 -30.46 14.97 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.336 179.682 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.0 tt0 -87.86 -5.4 58.61 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.959 0.409 . . . . 0.0 110.259 -179.799 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -66.68 -24.74 66.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.438 179.864 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.9 pt -50.33 -31.87 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.69 -179.853 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.07 66.05 3.05 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.682 -179.814 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.523 ' NZ ' ' CD1' ' A' ' 14' ' ' PHE . 20.9 tptp -158.29 83.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.874 0.369 . . . . 0.0 110.135 -179.881 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.32 63.25 4.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.353 -179.831 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.443 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 47.4 58.07 6.84 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -179.74 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.523 ' CD1' ' NZ ' ' A' ' 11' ' ' LYS . 43.5 m-85 59.2 38.01 23.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.563 0.22 . . . . 0.0 110.458 -179.512 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt 59.62 69.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.85 0.357 . . . . 0.0 110.196 -179.93 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.565 HG23 ' N ' ' A' ' 17' ' ' ILE . 8.5 tp -139.08 -48.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.121 179.811 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.565 ' N ' HG23 ' A' ' 16' ' ' ILE . 4.3 tp -80.7 -26.86 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.946 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.52 -57.63 1.95 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.145 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.01 84.58 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.499 179.246 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 54.7 15.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.613 0.244 . . . . 0.0 110.875 179.657 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.7 mt -66.21 4.17 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.758 0.313 . . . . 0.0 110.583 179.855 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 20' ' ' ALA . 30.0 t0 -66.93 -24.73 66.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.82 -179.825 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.414 ' H ' ' H ' ' A' ' 24' ' ' LEU . 54.5 t60 -169.39 -8.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.174 -179.767 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.414 ' H ' ' H ' ' A' ' 23' ' ' HIS . 49.2 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.236 -179.865 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 072 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -64.6 175.98 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 110.536 179.945 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.493 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 129.01 -57.3 0.72 Allowed Glycine 1 CA--C 1.355 -9.939 0 CA-C-O 123.752 1.751 . . . . 0.0 115.005 -179.77 . . . . . . . . 3 3 . 1 . 072 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 7' ' ' GLU . 54.2 mtp180 -60.75 -9.99 4.79 Favored 'General case' 1 N--CA 1.325 -6.695 1 CA-C-N 105.168 -5.516 . . . . 0.0 112.033 -157.54 . . . . . . . . 4 3 . 1 . 072 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' N ' ' C ' ' A' ' 3' ' ' GLY . 27.3 t-105 -41.08 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.544 -179.906 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.8 tp -113.17 -22.13 10.66 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.36 179.457 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.9 mt-10 -101.95 13.01 35.99 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.655 0.264 . . . . 0.0 110.54 -179.994 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -75.03 -74.57 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.769 -179.93 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 11' ' ' LYS . 15.7 tt -75.37 -25.02 17.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.752 -179.707 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . -52.45 -8.28 0.5 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.265 -179.821 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 9' ' ' ILE . 24.3 mtpp -76.96 22.95 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.861 -179.818 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 15' ' ' ILE . . . 57.29 40.24 27.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.218 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -34.47 89.01 0.01 OUTLIER Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.449 -179.508 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 12' ' ' ALA . 35.0 t80 66.65 53.78 0.89 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.748 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 12' ' ' ALA . 9.7 pt 37.86 82.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.759 -179.493 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.0 mm -132.93 -60.29 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.846 178.844 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.617 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.6 mp -69.43 -55.47 15.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.779 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.64 -37.19 52.65 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.024 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.09 -51.46 55.03 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 179.569 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.5 -68.75 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.844 0.354 . . . . 0.0 110.314 179.898 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.0 tp 49.91 95.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.62 179.821 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -168.01 -31.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.53 179.996 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -171.49 -16.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.52 179.958 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.1 mp . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.195 179.958 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 073 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -59.91 179.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 110.577 -179.996 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.476 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 100.85 -59.72 0.66 Allowed Glycine 1 CA--C 1.356 -9.855 0 CA-C-O 123.735 1.742 . . . . 0.0 115.238 179.999 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 49.2 mtp180 -60.32 -11.03 5.49 Favored 'General case' 1 N--CA 1.325 -6.718 1 CA-C-N 105.307 -5.447 . . . . 0.0 111.968 -157.494 . . . . . . . . 4 3 . 1 . 073 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.476 ' N ' ' C ' ' A' ' 3' ' ' GLY . 78.1 m95 -42.43 -18.82 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.93 -1.941 . . . . 0.0 110.446 179.959 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.6 mt -113.86 -18.64 11.74 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.908 179.884 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.9 tt0 -50.01 -20.44 0.95 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.651 -179.736 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -56.61 144.56 31.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.563 -179.872 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 10' ' ' GLY . 18.2 tt -68.42 -37.14 77.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.521 -179.946 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 80.23 -32.64 2.27 Favored Glycine 0 C--N 1.331 0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.071 179.843 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -76.82 23.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.335 179.984 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 48.44 67.05 0.91 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.288 -179.517 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -40.48 86.41 0.01 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.52 -179.54 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 12' ' ' ALA . 17.6 m-85 63.14 53.29 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.683 0.278 . . . . 0.0 110.964 -179.699 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 mt 62.54 76.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.335 -0.059 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.591 179.217 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.5 mm -134.39 -64.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.872 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.7 mm -78.19 -32.87 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.35 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.513 ' H ' ' CB ' ' A' ' 12' ' ' ALA . . . -68.74 -53.74 18.43 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.519 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.35 -47.95 15.69 Favored Glycine 0 C--N 1.332 0.314 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.111 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.88 27.4 1.13 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.723 0.296 . . . . 0.0 110.917 179.783 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.4 tp -62.96 96.47 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.197 179.963 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 23.5 m-20 55.35 47.08 22.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.517 -179.834 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.501 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 50.0 p-80 41.2 52.62 3.52 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.17 -179.935 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.441 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.133 179.951 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.056 -0.417 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 074 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -82.09 40.59 0.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.667 0.27 . . . . 0.0 110.638 -179.93 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.463 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -51.06 -58.86 8.86 Favored Glycine 1 CA--C 1.355 -9.944 0 CA-C-O 123.724 1.736 . . . . 0.0 115.14 179.977 . . . . . . . . 3 3 . 1 . 074 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 80.8 mtt180 -60.87 -10.31 5.44 Favored 'General case' 1 N--CA 1.323 -6.78 1 CA-C-N 105.29 -5.455 . . . . 0.0 111.911 -157.706 . . . . . . . . 4 3 . 1 . 074 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.466 ' CE3' HD21 ' A' ' 6' ' ' LEU . 28.5 t90 -41.9 -19.78 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.32 179.908 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.1 mt -108.71 -25.3 10.91 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.32 179.373 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.7 mt-10 -93.27 26.52 2.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -62.44 -144.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.444 -179.997 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.401 ' C ' ' N ' ' A' ' 11' ' ' LYS . 23.2 pt -50.14 -24.33 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.461 179.93 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.1 18.26 0.43 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.049 -179.965 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 9' ' ' ILE . 25.4 mmtp -133.73 44.84 2.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.728 0.299 . . . . 0.0 110.302 -179.892 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.483 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -79.72 52.91 1.52 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.569 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 68.69 30.64 72.81 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.348 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 70.57 69.38 0.2 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.47 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.1 pt 35.34 60.52 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.673 -179.72 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -138.48 -47.36 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.547 179.036 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.521 ' N ' HG23 ' A' ' 16' ' ' ILE . 38.0 mm -73.82 -53.21 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.817 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.483 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -75.76 -29.43 59.36 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.425 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -72.06 -37.59 60.04 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.786 -0.526 . . . . 0.0 111.786 179.441 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.77 35.28 0.15 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.843 0.354 . . . . 0.0 110.395 179.796 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.45 ' H ' ' C ' ' A' ' 19' ' ' GLY . 21.5 tp -55.44 119.32 5.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.184 -179.961 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 52.02 24.76 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.501 179.966 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 51.52 46.66 26.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.454 -179.953 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.203 -179.994 . . . . . . . . 0 0 . 1 . 075 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 . . . . . . . . . 0 0 . 1 . 075 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -62.76 -176.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.848 0.356 . . . . 0.0 110.591 -179.915 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.501 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 130.98 -59.11 0.7 Allowed Glycine 1 CA--C 1.355 -9.945 0 CA-C-O 123.86 1.811 . . . . 0.0 115.058 -179.923 . . . . . . . . 3 3 . 1 . 075 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 7' ' ' GLU . 68.0 mtp180 -60.69 -10.48 5.38 Favored 'General case' 1 N--CA 1.324 -6.765 1 CA-C-N 105.117 -5.542 . . . . 0.0 112.032 -157.751 . . . . . . . . 4 3 . 1 . 075 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.501 ' N ' ' C ' ' A' ' 3' ' ' GLY . 11.7 t-105 -42.55 -24.57 0.06 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.649 -179.966 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.505 ' N ' HD12 ' A' ' 6' ' ' LEU . 10.4 mp -98.0 -27.94 14.01 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.196 179.389 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 4' ' ' ARG . 17.7 tt0 -87.85 38.43 0.84 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.036 0.446 . . . . 0.0 110.238 -179.873 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -64.15 -31.99 73.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 179.988 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -167.74 -32.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.381 179.935 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.05 87.23 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.238 179.701 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 39.5 tttm -168.72 -17.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.236 179.645 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 71.72 -11.4 0.74 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.59 179.95 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 35.85 55.0 1.12 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 179.932 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 t80 68.32 40.31 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.568 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 12' ' ' ALA . 18.1 mt 63.65 79.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.749 -179.711 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 12' ' ' ALA . 4.4 tp -148.21 -19.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.186 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.41 ' H ' ' H ' ' A' ' 16' ' ' ILE . 29.0 mm -114.25 -38.21 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.598 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.96 -53.98 5.05 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.245 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.55 -28.99 37.36 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 179.627 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 49.84 19.53 0.45 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.88 0.372 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.3 mt 57.7 6.23 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.475 -179.886 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 20' ' ' ALA . 88.9 m-20 -80.83 19.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.471 179.957 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.7 m80 54.0 44.05 29.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.478 -179.845 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.132 -179.955 . . . . . . . . 0 0 . 1 . 076 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 076 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -169.7 169.47 8.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.31 . . . . 0.0 110.464 179.947 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.483 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 131.1 -57.44 0.72 Allowed Glycine 1 CA--C 1.355 -9.928 0 CA-C-O 123.825 1.792 . . . . 0.0 115.044 -179.7 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 6' ' ' LEU . 78.9 mtp180 -60.31 -10.62 4.93 Favored 'General case' 1 N--CA 1.325 -6.703 1 CA-C-N 105.145 -5.528 . . . . 0.0 111.981 -157.582 . . . . . . . . 4 3 . 1 . 076 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.565 ' CE3' HD21 ' A' ' 6' ' ' LEU . 27.8 t90 -42.62 -18.53 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 112.93 -1.941 . . . . 0.0 110.371 179.847 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.565 HD21 ' CE3' ' A' ' 5' ' ' TRP . 34.4 mt -114.62 -18.01 11.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.96 179.597 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.3 tt0 -47.22 -34.02 6.01 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.705 -179.816 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 50.59 85.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 179.935 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.632 ' N ' HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -46.58 -21.37 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.918 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 34.61 28.37 0.01 OUTLIER Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.483 179.209 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 9' ' ' ILE . 21.0 tptp -51.5 -30.73 21.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.084 179.726 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.6 -42.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.152 179.897 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.79 -44.87 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.785 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 64.2 t80 -173.93 33.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.615 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.2 mt 64.88 58.63 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 121.811 0.815 . . . . 0.0 109.461 -178.765 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.3 mm -119.49 -56.08 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.328 -179.784 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 35.1 mm -73.98 -50.31 29.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.771 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.85 -49.98 72.64 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.034 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.76 -53.33 31.71 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.227 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.63 35.79 12.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.559 0.219 . . . . 0.0 110.895 179.607 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.2 mt -73.83 84.64 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.197 179.816 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 51.38 59.15 4.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.472 -179.91 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 33.9 m170 53.55 55.81 8.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.542 -179.863 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.452 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.075 -179.897 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 077 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -60.71 -171.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 110.633 179.955 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.501 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 124.83 -59.36 0.64 Allowed Glycine 1 CA--C 1.355 -9.945 0 CA-C-O 123.781 1.767 . . . . 0.0 115.208 180.0 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 6' ' ' LEU . 44.7 mtt85 -60.66 -10.39 5.22 Favored 'General case' 1 N--CA 1.324 -6.748 1 CA-C-N 105.259 -5.471 . . . . 0.0 111.954 -157.665 . . . . . . . . 4 3 . 1 . 077 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.501 ' N ' ' C ' ' A' ' 3' ' ' GLY . 42.3 t-105 -41.14 -19.98 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.443 -179.972 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 8.1 tp -115.79 -20.28 10.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.294 179.323 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 52.3 mt-10 -91.72 21.33 4.84 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.744 0.307 . . . . 0.0 110.636 179.977 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -50.81 -32.79 21.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.513 179.896 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 pt -47.66 119.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.411 0.624 . . . . 0.0 110.638 -179.625 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.03 -6.95 61.46 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.899 -179.87 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 13' ' ' GLY . 9.5 mtmp? -60.69 98.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.0 110.475 179.976 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -54.89 -8.28 0.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.296 179.625 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 61.05 4.36 4.47 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.641 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.46 ' O ' HG23 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -82.8 -70.98 0.51 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.973 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 14' ' ' PHE . 12.8 pt -158.85 46.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.139 0.495 . . . . 0.0 110.145 179.1 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -80.37 -67.82 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.99 179.374 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.523 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -81.07 1.31 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.035 179.743 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -101.53 -67.8 0.81 Allowed Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.796 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.435 ' C ' ' N ' ' A' ' 21' ' ' LEU . . . -81.46 -37.96 15.97 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.632 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.95 11.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.741 179.898 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.435 ' N ' ' C ' ' A' ' 19' ' ' GLY . 33.3 mt 48.58 77.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.751 179.821 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 8.9 p-10 -174.82 23.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.102 179.735 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.406 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 76.0 t60 57.12 32.26 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.652 -179.859 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.421 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.08 179.933 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 078 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -53.47 -173.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.756 0.313 . . . . 0.0 110.652 179.972 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.511 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 110.25 -59.34 0.36 Allowed Glycine 1 CA--C 1.356 -9.905 0 CA-C-O 123.724 1.736 . . . . 0.0 115.268 -179.942 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 68.2 mtt85 -60.41 -10.84 5.38 Favored 'General case' 1 N--CA 1.325 -6.716 1 CA-C-N 105.316 -5.442 . . . . 0.0 111.994 -157.605 . . . . . . . . 4 3 . 1 . 078 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.511 ' N ' ' C ' ' A' ' 3' ' ' GLY . 76.9 t-105 -42.08 -18.88 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.992 -1.913 . . . . 0.0 110.43 -179.988 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.2 mp -112.82 -21.72 11.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.536 179.215 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.1 tt0 -91.4 -5.68 54.04 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.06 0.457 . . . . 0.0 110.317 -179.832 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -71.95 148.59 45.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.62 179.859 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 tp -52.71 97.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.206 0.526 . . . . 0.0 110.129 179.878 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.99 30.2 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.793 -179.809 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -49.69 -18.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.69 -179.961 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.57 -10.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.158 -179.851 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.11 57.96 0.13 Allowed Glycine 0 C--N 1.333 0.404 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.636 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.4 t80 69.31 22.77 6.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.802 0.334 . . . . 0.0 110.31 -179.428 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 mt 62.18 65.27 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.583 0.706 . . . . 0.0 110.308 179.956 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 mm -132.72 -49.71 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.627 179.766 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.647 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.6 mp -71.53 -45.94 65.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.673 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.78 -46.33 24.29 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 178.969 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.431 ' C ' ' N ' ' A' ' 21' ' ' LEU . . . -67.31 -56.57 11.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.924 179.537 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.48 15.44 0.14 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.877 0.37 . . . . 0.0 110.606 -179.968 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 23' ' ' HIS . 6.7 tp -83.76 -13.52 53.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.287 -179.856 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -75.0 36.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.714 179.886 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.445 ' H ' ' C ' ' A' ' 21' ' ' LEU . 50.3 t-80 52.56 28.47 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.556 179.963 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.057 179.989 . . . . . . . . 0 0 . 1 . 079 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 079 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -164.49 -178.94 5.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.77 0.319 . . . . 0.0 110.472 -179.966 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.478 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 119.09 -58.3 0.54 Allowed Glycine 1 CA--C 1.355 -9.956 0 CA-C-O 123.74 1.744 . . . . 0.0 115.198 -179.935 . . . . . . . . 3 3 . 1 . 079 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 85.4 mtt180 -60.74 -10.17 5.02 Favored 'General case' 1 N--CA 1.325 -6.719 1 CA-C-N 105.303 -5.449 . . . . 0.0 111.999 -157.552 . . . . . . . . 4 3 . 1 . 079 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.478 ' N ' ' C ' ' A' ' 3' ' ' GLY . 27.5 t90 -41.37 -19.66 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.425 -179.966 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.0 mt -114.77 -21.16 10.32 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.273 179.032 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 tt0 -92.21 31.93 1.23 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.978 0.418 . . . . 0.0 109.942 179.905 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -51.44 -63.9 0.98 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.753 -179.739 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 9' ' ' ILE . 2.9 tp -51.13 100.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.19 0.519 . . . . 0.0 110.261 -179.762 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.73 -43.52 7.71 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.111 -179.801 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 13' ' ' GLY . 60.8 mttp -57.5 106.91 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.233 -179.971 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.76 0.94 4.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.661 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 42.06 35.29 1.64 Allowed Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.306 179.858 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' HG23 ' A' ' 15' ' ' ILE . 61.4 t80 -168.35 -13.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.957 -179.888 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 14' ' ' PHE . 11.9 pt -157.78 52.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.061 0.458 . . . . 0.0 110.245 179.371 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.6 tp -143.82 -43.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.215 179.994 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.5 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -62.22 -2.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.082 179.396 . . . . . . . . 3 3 . 1 . 079 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . 178.2 -10.49 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.966 -179.925 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 18' ' ' GLY . . . -66.44 -35.4 90.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.141 -179.979 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -12.6 61.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.739 0.304 . . . . 0.0 110.698 -179.815 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.43 ' C ' HD23 ' A' ' 21' ' ' LEU . 2.4 tt 60.3 109.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.149 -179.977 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 57.52 23.84 9.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.756 179.93 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 1.1 t60 50.79 37.59 17.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.648 179.807 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.166 179.922 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 080 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -68.75 74.97 0.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.445 179.953 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.478 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -52.23 -57.66 12.75 Favored Glycine 1 CA--C 1.356 -9.85 0 CA-C-O 123.775 1.764 . . . . 0.0 114.981 179.728 . . . . . . . . 3 3 . 1 . 080 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.49 ' O ' ' N ' ' A' ' 6' ' ' LEU . 27.8 mtp85 -59.94 -12.05 7.0 Favored 'General case' 1 N--CA 1.322 -6.831 1 CA-C-N 105.118 -5.541 . . . . 0.0 111.983 -157.543 . . . . . . . . 4 3 . 1 . 080 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.503 ' CE3' HD21 ' A' ' 6' ' ' LEU . 20.1 t90 -43.54 -18.18 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 112.885 -1.962 . . . . 0.0 110.232 179.894 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.503 HD21 ' CE3' ' A' ' 5' ' ' TRP . 37.0 mt -116.83 -14.86 10.72 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.075 179.861 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.3 tp10 -63.36 -23.27 67.34 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.201 -179.931 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.9 ttt85 -47.14 107.72 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.709 179.881 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -50.2 98.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.17 0.509 . . . . 0.0 110.484 -179.791 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.69 -17.85 13.99 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.874 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 13' ' ' GLY . 57.7 mttm -64.18 100.46 0.34 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 110.478 -179.987 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.91 -4.93 0.82 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.047 179.742 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 57.08 8.81 3.48 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.646 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -87.17 -61.47 1.72 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.885 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 pt -155.18 40.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.167 0.508 . . . . 0.0 110.283 179.506 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 16' ' ' ILE . 1.5 mp -89.73 -45.41 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.435 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.515 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -75.19 17.81 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.363 179.522 . . . . . . . . 3 3 . 1 . 080 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -157.37 -39.6 0.02 OUTLIER Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.466 -179.756 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.89 -3.48 70.52 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.306 -0.473 . . . . 0.0 112.415 -179.582 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.05 45.62 0.54 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.533 -179.96 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -135.87 6.66 3.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.152 179.959 . . . . . . . . 3 3 . 1 . 080 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' N ' HD12 ' A' ' 21' ' ' LEU . 63.1 m-20 -76.61 -23.93 53.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.326 179.822 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -166.68 -39.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.499 -179.993 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.185 -179.898 . . . . . . . . 0 0 . 1 . 081 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.223 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 081 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.7 mttp 53.03 60.59 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 110.649 179.962 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.483 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -59.49 -57.38 19.92 Favored Glycine 1 CA--C 1.357 -9.812 0 CA-C-O 123.715 1.731 . . . . 0.0 115.298 179.849 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 7' ' ' GLU . 91.2 mtt180 -60.61 -10.1 4.74 Favored 'General case' 1 N--CA 1.324 -6.73 1 CA-C-N 105.184 -5.508 . . . . 0.0 112.115 -157.439 . . . . . . . . 4 3 . 1 . 081 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.483 ' N ' ' C ' ' A' ' 3' ' ' GLY . 76.2 t-105 -39.13 -23.84 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.713 -179.942 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.7 tp -101.82 -25.95 13.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.068 -179.535 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.2 tp10 -58.81 -35.23 72.52 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.277 -179.808 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -69.11 177.01 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.671 -179.822 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.3 tp -174.05 131.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.938 179.906 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.88 -23.05 0.19 Allowed Glycine 0 C--N 1.333 0.417 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -179.773 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -61.96 110.32 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.028 179.712 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.72 2.7 7.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.799 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 39.38 31.95 0.23 Allowed Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.327 -179.962 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.433 ' H ' ' H ' ' A' ' 15' ' ' ILE . 66.6 t80 -162.72 -10.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.79 0.328 . . . . 0.0 110.571 -179.794 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.433 ' H ' ' H ' ' A' ' 14' ' ' PHE . 2.8 tt -161.58 54.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.753 0.787 . . . . 0.0 109.926 179.824 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.4 tp -149.0 -39.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.462 -179.757 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.457 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.1 pp -92.04 16.71 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 179.614 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.38 -57.51 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 179.888 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.69 -38.77 37.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.1 -0.571 . . . . 0.0 111.995 -179.676 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.84 -70.56 0.3 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.86 0.362 . . . . 0.0 110.376 179.99 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 23' ' ' HIS . 2.1 tt -170.89 96.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.988 -179.996 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.494 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 32.4 t70 55.09 -84.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.519 -179.815 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.494 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 94.0 m-70 -157.77 36.3 0.26 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.57 179.948 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.16 179.959 . . . . . . . . 0 0 . 1 . 082 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 082 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -167.19 47.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.8 0.334 . . . . 0.0 110.504 179.996 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.469 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -50.23 -58.43 8.84 Favored Glycine 1 CA--C 1.355 -9.933 0 CA-C-O 123.604 1.669 . . . . 0.0 115.515 179.936 . . . . . . . . 3 3 . 1 . 082 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 7' ' ' GLU . 29.1 mmt180 -60.57 -10.32 4.97 Favored 'General case' 1 N--CA 1.324 -6.739 1 CA-C-N 105.404 -5.398 . . . . 0.0 111.861 -157.607 . . . . . . . . 4 3 . 1 . 082 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.469 ' N ' ' C ' ' A' ' 3' ' ' GLY . 89.2 t90 -42.85 -22.57 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.98 179.76 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 4' ' ' ARG . 41.8 tp -100.0 -25.92 14.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.487 179.901 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.9 tt0 -50.58 -31.3 15.42 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.313 179.869 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.0 ttt85 57.85 64.2 1.6 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.548 -179.942 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -55.86 111.35 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.174 0.511 . . . . 0.0 109.954 179.937 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.93 35.11 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.691 -179.687 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -50.1 -41.42 48.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.779 -179.86 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.88 -39.28 1.23 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.014 -179.872 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.2 60.95 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.651 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 23.6 t80 69.0 23.61 6.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.76 0.314 . . . . 0.0 110.184 -179.074 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.2 mt 62.14 71.71 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.591 0.71 . . . . 0.0 110.448 -179.986 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.5 mm -132.82 -51.97 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.699 179.603 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.2 mm -82.87 -41.31 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.569 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.22 -50.77 42.91 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.086 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -73.84 -50.44 11.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.941 179.504 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.75 1.04 0.27 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.557 0.218 . . . . 0.0 110.985 -179.961 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.3 mm? 52.42 96.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.831 0.348 . . . . 0.0 110.218 179.852 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -171.79 -54.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.297 179.793 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -171.39 -10.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.406 179.965 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 N--CA 1.463 0.225 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.394 179.979 . . . . . . . . 0 0 . 1 . 083 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 083 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -72.3 -163.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 0.0 110.583 -179.923 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.511 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 131.19 -57.87 0.72 Allowed Glycine 1 CA--C 1.356 -9.879 0 CA-C-O 123.78 1.766 . . . . 0.0 114.864 -179.74 . . . . . . . . 3 3 . 1 . 083 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 6' ' ' LEU . 77.8 mtm180 -60.52 -10.54 5.19 Favored 'General case' 1 N--CA 1.323 -6.808 1 CA-C-N 105.202 -5.499 . . . . 0.0 111.956 -157.632 . . . . . . . . 4 3 . 1 . 083 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.511 ' N ' ' C ' ' A' ' 3' ' ' GLY . 57.3 t90 -41.43 -19.89 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.225 179.766 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.1 tp -119.72 -17.65 8.53 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.883 179.254 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.2 tt0 -91.96 22.95 3.95 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 120.978 0.418 . . . . 0.0 110.03 179.85 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -52.6 132.56 35.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.614 -179.819 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 9' ' ' ILE . 15.7 tt -72.15 120.92 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.05 0.453 . . . . 0.0 110.129 179.749 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.08 -26.7 57.52 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.03 -179.692 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -66.79 103.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.381 -179.973 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.39 -2.75 4.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.727 179.511 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.64 29.44 4.12 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.728 -179.742 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.428 ' O ' HG23 ' A' ' 15' ' ' ILE . 36.7 t80 -162.45 -15.42 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.166 -0.214 . . . . 0.0 110.922 -179.587 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 14' ' ' PHE . 9.9 pt -156.68 54.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 110.353 179.541 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.481 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.3 tp -143.21 -42.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.039 179.733 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.501 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -65.49 -3.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.95 179.289 . . . . . . . . 3 3 . 1 . 083 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.79 -24.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.839 -179.869 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.4 4.43 55.57 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.306 -0.473 . . . . 0.0 111.925 179.994 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.3 -20.21 57.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.323 . . . . 0.0 110.716 -179.88 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.6 mt 56.42 15.41 1.99 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.503 -179.798 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.33 -60.7 2.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.603 179.951 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 57.9 t-80 -170.15 1.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.569 179.989 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.4 mm? . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.114 179.976 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 084 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -69.45 78.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.804 0.335 . . . . 0.0 110.603 -179.965 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.493 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -49.0 -57.07 9.14 Favored Glycine 1 CA--C 1.357 -9.839 0 CA-C-O 123.838 1.799 . . . . 0.0 115.109 179.662 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 6' ' ' LEU . 87.8 mtt180 -60.38 -10.95 5.46 Favored 'General case' 1 N--CA 1.323 -6.78 1 CA-C-N 105.126 -5.537 . . . . 0.0 112.083 -157.623 . . . . . . . . 4 3 . 1 . 084 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' N ' ' C ' ' A' ' 3' ' ' GLY . 29.5 t90 -41.82 -18.96 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.928 -1.942 . . . . 0.0 110.541 -179.974 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.6 tp -114.68 -19.29 11.14 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.716 179.941 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.0 tt0 -85.84 -14.56 44.63 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.736 -179.716 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 10' ' ' GLY . 26.6 ttp85 -74.27 -81.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.904 -179.981 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.488 HG23 ' O ' ' A' ' 9' ' ' ILE . 5.8 tp -62.9 79.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.722 0.773 . . . . 0.0 110.004 -179.803 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -82.75 -18.99 64.47 Favored Glycine 0 CA--C 1.517 0.17 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.976 -179.515 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.431 ' HA ' HG21 ' A' ' 16' ' ' ILE . 34.0 mtmm -75.59 100.47 4.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.781 0.324 . . . . 0.0 110.763 -179.828 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.14 -1.34 4.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.103 179.641 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.4 47.51 43.55 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.214 179.985 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -169.23 -40.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.768 179.855 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.6 pt -154.34 61.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.899 0.381 . . . . 0.0 110.571 179.977 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.431 HG21 ' HA ' ' A' ' 11' ' ' LYS . 17.6 mm -149.42 -48.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.572 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.85 9.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.924 179.781 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -172.82 -38.99 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.875 179.951 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -54.7 -35.73 58.13 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.021 179.94 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.17 7.13 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.525 -179.975 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.4 tp 51.17 23.82 1.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.235 -179.972 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -73.09 -53.99 9.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.611 -179.954 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.412 ' H ' ' H ' ' A' ' 24' ' ' LEU . 12.2 p-80 -166.62 -9.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.745 -179.944 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.412 ' H ' ' H ' ' A' ' 23' ' ' HIS . 11.1 tp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.324 179.908 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.233 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 085 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -167.44 -129.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.989 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.464 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 96.43 -59.17 1.34 Allowed Glycine 1 CA--C 1.356 -9.869 0 CA-C-O 123.619 1.677 . . . . 0.0 115.259 -179.944 . . . . . . . . 3 3 . 1 . 085 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.9 mtm180 -60.7 -10.42 5.3 Favored 'General case' 1 N--CA 1.324 -6.764 1 CA-C-N 105.449 -5.375 . . . . 0.0 112.023 -157.576 . . . . . . . . 4 3 . 1 . 085 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.526 ' CE3' HD21 ' A' ' 6' ' ' LEU . 29.7 t90 -40.96 -21.1 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.014 -1.903 . . . . 0.0 110.325 -179.915 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.526 HD21 ' CE3' ' A' ' 5' ' ' TRP . 26.1 mt -108.49 -25.1 11.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.44 179.247 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.0 mp0 -93.98 2.8 56.02 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.141 179.789 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 4' ' ' ARG . 60.9 ttt180 -54.28 -71.38 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.408 179.966 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 9' ' ' ILE . 4.8 tp -171.27 87.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.351 0.596 . . . . 0.0 110.18 179.789 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.01 -53.15 3.8 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.999 -179.78 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 13' ' ' GLY . 57.2 mttp -57.06 101.24 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.794 0.331 . . . . 0.0 110.635 -179.89 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -63.84 -1.3 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.015 179.514 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 55.8 7.55 1.66 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.767 -179.873 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 12' ' ' ALA . 50.5 t80 -127.1 -19.68 4.31 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.542 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 17' ' ' ILE . 4.5 mt -147.14 -135.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.715 179.359 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.456 ' H ' HG22 ' A' ' 15' ' ' ILE . 21.2 mm 52.76 -82.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 121.276 -0.17 . . . . 0.0 110.872 179.323 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 15' ' ' ILE . 3.7 tp -73.74 -38.28 50.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.675 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.51 -50.14 45.74 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.482 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.98 -47.64 7.51 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.779 -0.529 . . . . 0.0 111.779 179.627 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.86 47.88 15.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.935 179.881 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.3 mt -68.33 -19.28 64.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.547 -179.979 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -53.04 -92.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.584 -179.977 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.472 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 2.0 t60 -80.51 11.08 3.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.785 -179.81 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.211 -179.985 . . . . . . . . 0 0 . 1 . 086 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 086 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.42 ' NZ ' ' CB ' ' A' ' 2' ' ' LYS . 0.3 OUTLIER -166.51 34.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.699 0.285 . . . . 0.0 110.567 -179.924 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.512 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -50.87 -58.49 9.29 Favored Glycine 1 CA--C 1.355 -9.918 0 CA-C-O 123.647 1.693 . . . . 0.0 115.313 179.996 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.576 ' O ' ' N ' ' A' ' 7' ' ' GLU . 55.4 mtp85 -60.94 -9.78 4.75 Favored 'General case' 1 N--CA 1.323 -6.807 1 CA-C-N 105.388 -5.406 . . . . 0.0 112.016 -157.612 . . . . . . . . 4 3 . 1 . 086 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.512 ' N ' ' C ' ' A' ' 3' ' ' GLY . 23.2 t90 -40.89 -24.84 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.02 -1.9 . . . . 0.0 109.843 179.763 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.5 mm? -96.69 -31.24 12.79 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.947 179.218 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 4' ' ' ARG . 52.5 mm-40 -90.68 43.36 1.14 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.782 0.325 . . . . 0.0 110.28 179.723 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -145.85 22.9 1.41 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.392 -179.79 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 pt -51.48 121.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.232 0.539 . . . . 0.0 110.327 -179.98 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.44 -18.28 79.93 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.865 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -80.05 109.2 14.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.764 0.316 . . . . 0.0 110.366 179.974 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.45 10.45 7.16 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.507 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.84 37.53 7.29 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.97 -179.768 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -159.24 -68.67 0.08 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.773 0.32 . . . . 0.0 110.171 -179.902 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.573 ' O ' HG23 ' A' ' 15' ' ' ILE . 9.5 tt -93.69 44.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.784 0.802 . . . . 0.0 109.899 179.721 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.1 tp -145.11 -43.8 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.326 -179.896 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.491 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.1 pp -88.49 13.85 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.422 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.86 -48.54 0.01 OUTLIER Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.773 -179.823 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.67 -15.12 66.06 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.05 -179.986 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.72 -28.32 61.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.619 -179.887 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 21' ' ' LEU . 8.8 mp -55.92 116.39 2.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.145 179.951 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.87 25.93 4.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.979 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 8.5 t60 53.08 52.17 14.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.527 -179.982 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.157 179.999 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.244 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 087 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -167.69 176.7 6.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.792 0.33 . . . . 0.0 110.629 179.958 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.502 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 122.59 -59.13 0.59 Allowed Glycine 1 CA--C 1.355 -9.937 0 CA-C-O 123.72 1.733 . . . . 0.0 115.164 179.993 . . . . . . . . 3 3 . 1 . 087 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 62.5 mtp180 -59.99 -11.65 6.25 Favored 'General case' 1 N--CA 1.324 -6.761 1 CA-C-N 105.371 -5.415 . . . . 0.0 111.998 -157.513 . . . . . . . . 4 3 . 1 . 087 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.502 ' N ' ' C ' ' A' ' 3' ' ' GLY . 97.5 m95 -42.82 -18.88 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.915 -1.948 . . . . 0.0 110.16 179.731 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.5 mt -113.49 -20.19 11.38 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.764 179.547 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.0 tt0 -83.23 24.33 0.81 Allowed 'General case' 0 C--N 1.342 0.269 0 CA-C-O 121.138 0.494 . . . . 0.0 110.047 179.924 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -66.09 -96.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.908 -179.789 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.2 pt -75.08 -35.39 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.03 -179.525 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.41 17.05 0.37 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.9 -179.714 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 46.5 tttm -75.71 -4.95 43.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.834 0.35 . . . . 0.0 110.53 -179.745 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 71.76 8.73 6.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.284 -179.943 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 40.51 48.96 3.9 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 179.979 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 t80 78.13 49.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.831 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.2 mt 61.46 75.55 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.765 179.895 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 12' ' ' ALA . 7.5 mm -130.92 -57.59 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.652 179.703 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.608 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.3 mp -69.17 -52.5 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.524 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.11 -48.04 68.24 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 178.621 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.55 -56.98 17.3 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.666 179.091 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.0 -67.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.77 0.319 . . . . 0.0 110.496 -179.944 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.5 tt 62.18 86.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.122 0.487 . . . . 0.0 110.142 -179.837 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -170.65 51.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.282 -179.957 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 74.8 t60 56.24 25.39 9.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.264 -179.829 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.051 -179.906 . . . . . . . . 0 0 . 1 . 088 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 088 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -58.13 156.75 9.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.868 0.366 . . . . 0.0 110.44 179.946 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.469 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 141.38 -56.23 0.6 Allowed Glycine 1 CA--C 1.354 -9.979 0 CA-C-O 123.918 1.843 . . . . 0.0 114.796 -179.464 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' LEU . 94.7 mtt180 -60.36 -10.81 5.24 Favored 'General case' 1 N--CA 1.323 -6.777 1 CA-C-N 105.023 -5.589 . . . . 0.0 111.911 -157.569 . . . . . . . . 4 3 . 1 . 088 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.469 ' N ' ' C ' ' A' ' 3' ' ' GLY . 56.6 t-105 -41.96 -18.55 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.453 179.946 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.4 mp -117.7 -17.09 9.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.839 179.358 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' ARG . 14.2 tp10 -81.66 -6.02 58.63 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.049 0.452 . . . . 0.0 110.093 -179.955 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -56.09 -20.87 19.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.742 -179.916 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.7 mm -70.28 73.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -179.989 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.84 -9.37 87.15 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 179.644 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 58.5 mmtt -75.05 8.46 2.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 110.688 -179.859 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 72.66 -11.71 0.82 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.55 179.91 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 39.9 54.33 3.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.471 -0.395 . . . . 0.0 112.218 179.976 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CG ' ' C ' ' A' ' 13' ' ' GLY . 3.9 m-85 74.81 45.34 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.782 0.325 . . . . 0.0 110.16 -179.272 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.8 mt 61.4 79.4 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.427 0.632 . . . . 0.0 111.179 179.807 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -135.74 -61.81 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.95 179.434 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.654 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.6 mp -71.84 -49.03 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.508 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.35 -56.36 22.32 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.452 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.58 -48.64 61.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.968 179.657 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.17 37.34 14.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.761 0.315 . . . . 0.0 110.545 -179.955 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.0 mt -70.49 109.69 4.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.55 179.988 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.29 32.29 18.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.706 179.903 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.8 m170 50.72 48.94 21.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 -179.975 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.0 tt . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.107 -179.89 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 . . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.74 36.0 0.16 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.791 0.329 . . . . 0.0 110.553 179.864 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.493 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -52.95 -57.3 15.02 Favored Glycine 1 CA--C 1.357 -9.809 0 CA-C-O 123.608 1.671 . . . . 0.0 115.658 -179.93 . . . . . . . . 3 3 . 1 . 089 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 6' ' ' LEU . 95.9 mtt180 -60.33 -10.46 4.76 Favored 'General case' 1 N--CA 1.326 -6.626 1 CA-C-N 105.42 -5.39 . . . . 0.0 112.066 -157.384 . . . . . . . . 4 3 . 1 . 089 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.568 ' CE3' HD21 ' A' ' 6' ' ' LEU . 29.0 t90 -41.0 -19.98 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.55 -179.963 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.568 HD21 ' CE3' ' A' ' 5' ' ' TRP . 45.8 mt -115.03 -20.58 10.43 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.51 179.197 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.4 mm-40 -91.63 17.13 9.25 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.959 0.409 . . . . 0.0 110.162 179.668 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -57.45 -50.06 74.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.913 -179.893 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 10' ' ' GLY . 13.6 tt -52.81 -44.37 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.643 -179.663 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 77.82 -50.67 3.33 Favored Glycine 0 C--N 1.331 0.266 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 -179.954 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 13' ' ' GLY . 94.2 mttt -66.54 100.45 0.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.318 179.836 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.15 5.9 2.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.063 179.933 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 43.53 48.51 7.17 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.042 -179.86 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -162.5 -31.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.586 0.231 . . . . 0.0 110.885 -179.702 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 15' ' ' ILE . 16.4 tt -166.98 61.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 110.724 179.922 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 18' ' ' GLY . 22.1 mm -145.45 -61.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.864 179.584 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.478 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -69.32 3.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.035 179.479 . . . . . . . . 3 3 . 1 . 089 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -135.91 -55.05 0.06 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 179.889 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -74.38 -56.44 5.12 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.519 -0.633 . . . . 0.0 111.519 179.486 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.447 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 61.74 -1.93 0.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.599 0.238 . . . . 0.0 111.329 179.566 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 21' ' ' LEU . 8.2 mp 51.42 12.12 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.733 0.301 . . . . 0.0 110.256 179.938 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' N ' ' C ' ' A' ' 20' ' ' ALA . 14.6 t0 -68.27 -55.72 11.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.617 -179.904 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.407 ' H ' ' H ' ' A' ' 24' ' ' LEU . 7.7 t60 -167.62 -17.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.567 -179.992 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.407 ' H ' ' H ' ' A' ' 23' ' ' HIS . 16.5 mt . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.501 179.876 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 090 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -63.0 -144.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.592 0.234 . . . . 0.0 110.55 179.976 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 52.23 68.36 1.61 Allowed Glycine 1 CA--C 1.381 -8.311 0 CA-C-O 125.48 2.711 . . . . 0.0 113.437 -178.959 . . . . . . . . 3 3 . 1 . 090 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 1.7 mtm180 163.65 -10.94 0.0 OUTLIER 'General case' 1 N--CA 1.32 -6.926 1 CA-C-N 101.252 -7.474 . . . . 0.0 110.077 159.266 . . . . . . . . 4 3 . 1 . 090 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -42.2 -18.55 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.363 -179.566 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.2 tp -114.47 -17.54 11.71 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.628 179.467 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.3 mt-10 -107.55 15.32 24.89 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 120.819 0.343 . . . . 0.0 110.264 179.958 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -53.64 163.08 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.534 179.921 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.44 ' C ' ' H ' ' A' ' 11' ' ' LYS . 11.1 pt -76.19 -36.69 31.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.426 179.921 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.25 -5.44 1.43 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.195 179.958 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 9' ' ' ILE . 67.0 mmtt -87.73 105.38 17.34 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.672 -179.922 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.468 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -78.59 46.71 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.235 179.676 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.68 67.18 2.03 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.768 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 53.8 t80 55.2 26.93 8.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.016 -179.731 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 mt 62.14 62.32 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.679 0.752 . . . . 0.0 109.639 -179.453 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.8 mm -129.38 -46.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.025 -179.817 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.5 mp -70.96 -46.94 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.809 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.468 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -78.41 -39.2 23.03 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 178.652 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.49 -52.75 50.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.081 -0.581 . . . . 0.0 111.73 179.369 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.42 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . -62.73 -58.18 8.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.332 179.8 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 tp 53.35 12.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.236 179.891 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 20' ' ' ALA . 77.9 m-20 -66.36 -107.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.335 -179.994 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -68.64 -30.18 68.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 110.429 179.938 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.438 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.429 179.896 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 091 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm 50.23 -177.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.796 0.331 . . . . 0.0 110.624 -179.977 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.493 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 102.28 -59.24 0.57 Allowed Glycine 1 CA--C 1.356 -9.877 0 CA-C-O 123.747 1.748 . . . . 0.0 115.243 -179.961 . . . . . . . . 3 3 . 1 . 091 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.9 mtm180 -60.7 -9.86 4.54 Favored 'General case' 1 N--CA 1.325 -6.705 1 CA-C-N 105.38 -5.41 . . . . 0.0 112.09 -157.676 . . . . . . . . 4 3 . 1 . 091 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' N ' ' C ' ' A' ' 3' ' ' GLY . 38.2 m0 -41.46 -24.66 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.957 -1.929 . . . . 0.0 109.912 179.796 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' N ' ' C ' ' A' ' 4' ' ' ARG . 17.2 mt -96.55 -27.82 14.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.75 179.853 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.6 tt0 -51.31 -22.73 3.02 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.38 179.934 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 59.46 64.87 1.25 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.648 -179.861 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.3 pt -80.01 -31.97 13.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.347 179.807 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.78 15.75 0.56 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.123 -0.561 . . . . 0.0 111.942 -179.98 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -77.0 -45.8 26.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.697 0.284 . . . . 0.0 110.777 -179.868 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 16' ' ' ILE . . . 56.54 10.36 0.68 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.155 -179.918 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 41.38 53.54 4.14 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.839 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 t80 73.89 48.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -178.996 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mt 63.1 76.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.034 179.924 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.6 mm -131.06 -67.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.401 179.497 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 47.1 mm -78.8 -31.61 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.584 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.77 -51.71 23.54 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.678 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.36 -47.61 6.81 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.254 -0.498 . . . . 0.0 111.903 179.296 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.63 43.48 16.42 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.792 0.329 . . . . 0.0 110.759 -179.981 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.5 mt -75.16 116.31 15.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.675 -179.801 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 47.36 36.02 4.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.98 179.829 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.2 m80 52.72 62.57 2.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.578 -179.957 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.219 179.99 . . . . . . . . 0 0 . 1 . 092 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 092 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 77.7 mttt 58.99 -135.94 0.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.166 -0.214 . . . . 0.0 110.697 -179.94 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.435 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 48.96 70.54 0.76 Allowed Glycine 1 CA--C 1.385 -8.091 0 CA-C-O 126.475 3.264 . . . . 0.0 112.52 -178.056 . . . . . . . . 3 3 . 1 . 092 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 7' ' ' GLU . 35.1 mtt180 155.03 -10.59 0.0 OUTLIER 'General case' 1 N--CA 1.312 -7.355 1 CA-C-N 100.472 -7.864 . . . . 0.0 110.459 161.152 . . . . . . . . 4 3 . 1 . 092 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -43.8 -22.83 0.06 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.669 -179.687 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 6' ' ' LEU . 8.2 mp -90.74 -28.38 18.32 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.865 179.289 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.7 tt0 -78.42 -21.32 49.4 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.275 179.715 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 10' ' ' GLY . 1.2 tpm_? -68.41 -58.93 3.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.9 -179.457 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -48.81 92.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.398 0.618 . . . . 0.0 110.318 -179.794 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 156.84 38.16 0.02 OUTLIER Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.593 -179.677 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -46.65 -29.54 1.91 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.825 0.345 . . . . 0.0 110.46 179.834 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.407 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -164.84 -3.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.492 -179.921 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 52.82 27.79 29.54 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.742 -179.842 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -144.9 -11.91 0.57 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.901 0.382 . . . . 0.0 110.065 179.951 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.2 pt -155.44 42.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.904 179.448 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.1 tp -152.91 -27.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.004 -179.778 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.41 ' C ' HD12 ' A' ' 17' ' ' ILE . 1.1 pp -81.5 9.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.679 179.516 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.86 -28.36 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.839 -179.901 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.51 -43.88 67.23 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.854 179.979 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.18 -39.91 74.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 110.415 179.882 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 23' ' ' HIS . 2.3 tt 65.49 -76.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.015 -179.863 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 42.73 -90.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 111.092 179.799 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' LEU . 59.1 t-80 -122.96 -14.78 7.54 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.225 179.759 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 21' ' ' LEU . 24.5 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.392 179.958 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 093 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -52.03 157.57 1.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 0.0 110.392 179.985 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.482 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 133.91 -55.79 0.74 Allowed Glycine 1 CA--C 1.355 -9.967 0 CA-C-O 123.922 1.846 . . . . 0.0 114.818 -179.543 . . . . . . . . 3 3 . 1 . 093 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.8 mtt180 -60.77 -10.04 4.89 Favored 'General case' 1 N--CA 1.323 -6.797 1 CA-C-N 104.974 -5.613 . . . . 0.0 111.95 -157.563 . . . . . . . . 4 3 . 1 . 093 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.482 ' N ' ' C ' ' A' ' 3' ' ' GLY . 98.2 m95 -41.38 -19.47 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.041 -1.89 . . . . 0.0 110.486 -179.957 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 mt -114.4 -20.39 10.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.659 179.377 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.8 mt-10 -89.82 -8.32 52.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.671 0.272 . . . . 0.0 110.763 -179.872 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -69.88 -91.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.208 179.831 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 9' ' ' ILE . 2.9 tp -60.15 91.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 0.0 110.108 -179.97 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.05 29.85 11.61 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.896 -179.79 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -149.62 62.01 1.01 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.719 0.295 . . . . 0.0 110.372 -179.964 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.53 52.08 1.58 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.39 179.853 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.86 60.14 8.56 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.847 -179.844 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.492 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 57.9 t80 57.09 32.98 22.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.883 0.373 . . . . 0.0 110.653 -179.818 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 mt 61.26 61.78 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.599 0.714 . . . . 0.0 109.892 -179.818 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mm -129.96 -51.21 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.75 -179.838 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.9 mm -69.14 -41.41 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.473 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.421 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . -82.21 -38.07 13.8 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.166 179.193 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.05 -37.22 73.16 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.452 179.855 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.34 -64.64 1.09 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.663 0.268 . . . . 0.0 111.357 -179.26 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' HIS . 23.6 mt 53.76 -99.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.175 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 50.18 -87.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.746 179.758 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' LEU . 79.6 m80 -153.96 13.17 0.45 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.494 -179.88 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.455 179.885 . . . . . . . . 0 0 . 1 . 094 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 094 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -145.54 -141.39 0.12 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.604 0.24 . . . . 0.0 110.508 179.968 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.436 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 50.87 70.84 0.75 Allowed Glycine 1 CA--C 1.384 -8.129 0 CA-C-O 126.377 3.21 . . . . 0.0 112.493 -178.199 . . . . . . . . 3 3 . 1 . 094 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 32.5 mtt180 156.47 -11.66 0.0 OUTLIER 'General case' 1 N--CA 1.313 -7.295 1 CA-C-N 100.656 -7.772 . . . . 0.0 110.297 161.025 . . . . . . . . 4 3 . 1 . 094 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.501 ' CE3' HD21 ' A' ' 6' ' ' LEU . 28.6 t90 -43.63 -20.46 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.73 179.973 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.502 ' N ' ' C ' ' A' ' 4' ' ' ARG . 19.3 mt -102.89 -21.2 14.03 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.908 179.864 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.8 tm-20 -67.49 -25.76 66.03 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.124 179.878 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -63.44 163.47 10.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.894 -179.963 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.482 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.5 tt -162.42 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.964 179.915 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.482 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 76.7 -46.33 2.3 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.117 179.778 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 13' ' ' GLY . 54.7 mtpt -77.55 93.73 4.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.745 0.307 . . . . 0.0 110.857 -179.926 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.46 -4.84 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.973 0.415 . . . . 0.0 109.98 179.517 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 52.94 51.52 45.19 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.011 179.928 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 15' ' ' ILE . 34.0 t80 -168.83 -45.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.214 179.814 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' PHE . 7.9 pt -155.3 58.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.241 0.544 . . . . 0.0 110.718 -179.912 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.7 mm -140.11 -65.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.621 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 18' ' ' GLY . 4.2 tp -70.5 -39.37 76.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.498 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.414 ' N ' HG23 ' A' ' 17' ' ' ILE . . . -82.07 -42.81 8.52 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.7 179.601 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.95 -38.04 64.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.106 -0.568 . . . . 0.0 111.898 179.868 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 53.13 15.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.814 0.34 . . . . 0.0 110.583 179.892 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 21' ' ' LEU . 7.6 mp 54.01 9.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.276 -179.963 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 20' ' ' ALA . 28.9 t70 -78.31 -103.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.329 179.921 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.436 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -73.22 9.69 1.19 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 110.377 179.815 . . . . . . . . 3 3 . 1 . 094 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 22' ' ' ASP . 17.8 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.353 -179.936 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 . . . . . . . . . 0 0 . 1 . 095 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? 56.28 -124.19 1.89 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.982 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.499 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 101.16 -58.12 0.68 Allowed Glycine 1 CA--C 1.355 -9.928 0 CA-C-O 123.685 1.714 . . . . 0.0 115.259 179.941 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.2 mtt-85 -60.66 -10.02 4.71 Favored 'General case' 1 N--CA 1.325 -6.725 1 CA-C-N 105.397 -5.402 . . . . 0.0 112.067 -157.537 . . . . . . . . 4 3 . 1 . 095 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.499 ' N ' ' C ' ' A' ' 3' ' ' GLY . 85.9 t90 -41.15 -20.32 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.394 179.859 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.4 tt -109.24 -25.33 10.66 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.359 179.279 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.4 mt-10 -99.43 25.43 7.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.388 179.875 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -50.77 140.55 14.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.639 -179.87 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.473 HG23 ' N ' ' A' ' 10' ' ' GLY . 14.3 tt -72.62 -40.45 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.368 179.867 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.473 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 78.04 -56.07 3.94 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.048 179.914 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 13' ' ' GLY . 52.0 mtpt -60.98 101.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 110.518 -179.911 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.34 1.93 2.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.926 179.711 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 46.0 38.41 8.22 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.181 -179.996 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -166.81 -26.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 pt -154.45 59.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.914 0.388 . . . . 0.0 110.981 179.863 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.431 ' C ' ' H ' ' A' ' 18' ' ' GLY . 13.6 mm -150.67 -50.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.327 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.78 10.61 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.041 179.798 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -173.35 -20.46 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.216 -0.516 . . . . 0.0 111.971 179.902 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.73 -28.57 46.35 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.095 -179.899 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -66.58 -76.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.737 0.303 . . . . 0.0 110.85 -179.795 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.1 mt 59.88 3.92 0.53 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.579 -179.639 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 24' ' ' LEU . 56.4 p-10 -76.72 -133.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.196 179.711 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.575 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 1.2 m-70 -76.41 35.77 0.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 110.428 179.682 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 22' ' ' ASP . 15.5 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.179 -179.797 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.064 -0.414 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 096 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -69.09 -134.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.515 179.866 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.494 ' O ' ' NE ' ' A' ' 4' ' ' ARG . . . 52.38 70.44 0.9 Allowed Glycine 1 CA--C 1.382 -8.251 0 CA-C-O 125.956 2.976 . . . . 0.0 112.955 -178.679 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 7' ' ' GLU . 7.0 mtm105 160.25 -10.04 0.0 OUTLIER 'General case' 1 N--CA 1.319 -7.004 1 CA-C-N 101.131 -7.535 . . . . 0.0 110.624 160.132 . . . . . . . . 4 3 . 1 . 096 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -39.82 -23.29 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.258 -179.294 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.527 ' N ' HD12 ' A' ' 6' ' ' LEU . 10.0 mp -97.3 -27.45 14.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.242 179.15 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.1 mp0 -117.87 34.23 5.26 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.715 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 4' ' ' ARG . 56.6 ttm-85 -67.38 126.59 29.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.559 -179.989 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.8 pt -73.26 -30.76 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.56 56.4 20.22 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.898 -179.86 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -164.75 78.67 0.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.811 0.339 . . . . 0.0 110.553 -179.903 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.37 46.48 0.63 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.609 179.976 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.91 59.69 7.27 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.964 179.989 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 52.2 t80 57.34 35.03 25.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.621 0.248 . . . . 0.0 110.759 179.91 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt 62.19 71.94 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.482 0.658 . . . . 0.0 110.421 179.769 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.476 ' O ' ' N ' ' A' ' 20' ' ' ALA . 14.4 mt -146.75 -57.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.525 179.674 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.5 mp -58.9 -29.64 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.344 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.43 -45.83 2.9 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.147 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.55 -64.36 2.39 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.05 179.336 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 57.54 27.54 14.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.628 0.251 . . . . 0.0 110.628 -179.842 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.8 mt 53.43 -124.05 2.22 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.026 -179.747 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -82.87 63.96 7.24 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 179.692 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 50.3 t-80 56.49 19.02 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.141 -179.54 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.8 tp . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.424 -179.915 . . . . . . . . 0 0 . 1 . 097 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 097 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt 53.02 -100.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.725 0.298 . . . . 0.0 110.589 -179.988 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.46 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 95.89 -60.62 1.42 Allowed Glycine 1 CA--C 1.356 -9.895 0 CA-C-O 123.74 1.744 . . . . 0.0 115.279 -179.954 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.0 mtm180 -60.68 -10.39 5.24 Favored 'General case' 1 N--CA 1.325 -6.725 1 CA-C-N 105.297 -5.452 . . . . 0.0 112.032 -157.572 . . . . . . . . 4 3 . 1 . 097 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.46 ' N ' ' C ' ' A' ' 3' ' ' GLY . 27.3 t90 -39.56 -21.7 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.798 -179.733 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.8 mt -107.83 -24.44 11.67 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.84 179.646 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 15.0 mp0 -86.87 29.38 0.81 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.63 0.252 . . . . 0.0 110.51 -179.894 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -87.74 -33.18 18.79 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.686 179.838 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 11' ' ' LYS . 3.6 tp -166.91 -3.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.157 0.503 . . . . 0.0 109.908 -179.568 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.446 ' H ' ' H ' ' A' ' 9' ' ' ILE . . . -36.17 -27.4 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.839 179.708 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 9' ' ' ILE . 63.2 mttp -54.64 107.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.381 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -67.65 3.9 1.26 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.6 -179.592 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 46.51 14.03 0.1 OUTLIER Glycine 0 C--N 1.329 0.183 0 C-N-CA 121.312 -0.47 . . . . 0.0 112.25 -179.945 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.46 ' N ' ' O ' ' A' ' 12' ' ' ALA . 73.6 t80 -138.29 -4.4 1.68 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.577 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 17' ' ' ILE . 3.3 mt -146.13 -137.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.038 179.604 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.504 ' C ' ' H ' ' A' ' 18' ' ' GLY . 47.5 mm 41.54 -87.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.333 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.581 HD12 ' C ' ' A' ' 17' ' ' ILE . 2.4 pp -55.11 -1.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.416 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.568 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -132.59 -70.97 0.09 OUTLIER Glycine 0 C--N 1.338 0.655 0 N-CA-C 112.326 -0.31 . . . . 0.0 112.326 -179.855 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -51.82 -25.27 15.34 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.693 -179.382 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.89 -11.84 0.1 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.612 179.999 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 23' ' ' HIS . 27.2 tp -44.52 123.86 3.84 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.479 179.841 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 56.02 -81.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.611 -179.541 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 21' ' ' LEU . 23.2 t-80 -163.79 43.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.676 179.97 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 30.8 mt . . . . . 0 N--CA 1.469 0.513 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.262 179.852 . . . . . . . . 0 0 . 1 . 098 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 . . . . . . . . . 0 0 . 1 . 098 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -65.77 -169.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.831 0.348 . . . . 0.0 110.547 -179.981 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.509 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 97.84 -59.15 1.05 Allowed Glycine 1 CA--C 1.357 -9.823 0 CA-C-O 123.627 1.682 . . . . 0.0 115.332 -179.981 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 7' ' ' GLU . 69.4 mtm180 -60.59 -10.24 4.89 Favored 'General case' 1 N--CA 1.325 -6.725 1 CA-C-N 105.399 -5.401 . . . . 0.0 112.007 -157.484 . . . . . . . . 4 3 . 1 . 098 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.509 ' N ' ' C ' ' A' ' 3' ' ' GLY . 57.6 t-105 -39.59 -21.86 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.521 -179.944 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.5 tp -107.74 -26.24 10.9 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.724 179.615 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.9 tt0 -89.28 -3.01 58.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.103 0.477 . . . . 0.0 109.934 179.88 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -83.55 152.48 24.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.469 179.902 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.5 pt -55.72 -9.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.567 -179.979 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.22 31.32 4.52 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.145 179.96 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -151.4 70.37 0.96 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.972 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.03 48.98 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.567 -179.888 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.02 40.28 20.16 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.865 -179.976 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 t80 70.49 54.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.92 0.391 . . . . 0.0 110.493 -179.776 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 mm 62.05 75.57 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.157 179.703 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.9 mm -137.14 -51.65 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.686 179.244 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 mm -74.48 -49.86 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.042 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.01 -51.55 18.09 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.367 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -63.7 -43.02 98.45 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.796 179.62 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 70.11 -13.79 0.41 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.581 0.229 . . . . 0.0 110.957 179.943 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.473 ' H ' ' C ' ' A' ' 19' ' ' GLY . 4.8 tp 61.13 2.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.0 110.446 179.98 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 24' ' ' LEU . 74.7 m-20 -74.29 84.93 1.92 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.45 179.975 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 27.7 m170 56.73 5.92 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 -179.858 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 22' ' ' ASP . 37.6 mt . . . . . 0 N--CA 1.469 0.519 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.052 179.69 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 099 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -55.58 170.37 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.321 . . . . 0.0 110.461 179.959 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.493 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 104.14 -57.75 0.52 Allowed Glycine 1 CA--C 1.355 -9.911 0 CA-C-O 123.768 1.76 . . . . 0.0 115.203 -179.917 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' GLU . 70.7 mtp180 -60.22 -10.94 5.13 Favored 'General case' 1 N--CA 1.325 -6.703 1 CA-C-N 105.323 -5.438 . . . . 0.0 112.08 -157.486 . . . . . . . . 4 3 . 1 . 099 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' N ' ' C ' ' A' ' 3' ' ' GLY . 5.3 m-90 -42.25 -20.36 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.121 179.68 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.8 tp -107.54 -25.12 11.52 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.363 179.618 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' ARG . 78.0 mt-10 -90.17 35.32 0.86 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -146.39 -37.2 0.24 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.25 -179.996 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.401 ' CG1' ' H ' ' A' ' 10' ' ' GLY . 3.3 pt -149.38 -105.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 65.22 -132.47 36.08 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.966 179.95 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 tttp 73.11 -35.56 0.33 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.611 0.243 . . . . 0.0 110.824 179.979 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.523 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -163.91 13.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.931 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.14 66.02 2.66 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.419 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 68.5 t80 57.83 32.33 21.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.075 -179.15 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 mt 62.03 63.69 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.584 0.707 . . . . 0.0 110.083 -179.73 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mm -130.19 -52.64 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.414 -179.827 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.57 -44.78 79.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.625 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -74.35 -48.08 15.3 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.873 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -59.79 -43.59 97.77 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.619 179.29 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 69.05 -14.91 0.28 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.509 0.195 . . . . 0.0 111.383 179.815 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.5 mm? 47.27 75.11 0.13 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.755 0.312 . . . . 0.0 110.429 179.934 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -171.17 -109.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.315 179.879 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -60.02 -28.17 67.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.834 0.349 . . . . 0.0 110.105 179.719 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.569 179.774 . . . . . . . . 0 0 . 1 . 100 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 . . . . . . . . . 0 0 . 1 . 100 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm 51.79 -151.59 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.5 -179.97 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.465 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 107.38 -61.22 0.32 Allowed Glycine 1 CA--C 1.356 -9.866 0 CA-C-O 123.651 1.695 . . . . 0.0 115.423 179.753 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.498 ' C ' ' N ' ' A' ' 6' ' ' LEU . 82.2 mtm180 -59.96 -12.26 7.52 Favored 'General case' 1 N--CA 1.325 -6.723 1 CA-C-N 105.462 -5.369 . . . . 0.0 112.069 -157.481 . . . . . . . . 4 3 . 1 . 100 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.465 ' N ' ' C ' ' A' ' 3' ' ' GLY . 72.6 t-105 -44.0 -17.03 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.321 179.922 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.498 ' N ' ' C ' ' A' ' 4' ' ' ARG . 30.0 mt -130.71 -4.78 4.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.857 179.561 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -84.71 -11.07 56.6 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.074 179.829 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 61.08 131.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.627 179.701 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.7 pt -61.3 -23.85 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.447 179.879 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.04 60.01 8.66 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.872 -179.909 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -169.65 57.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 110.421 -179.931 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.15 64.49 2.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.406 179.98 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 55.19 55.7 26.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.802 -179.857 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 58.59 36.51 25.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.474 -179.832 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 mt 61.18 62.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.405 -179.957 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 13' ' ' GLY . 4.1 tp -131.19 -44.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.447 179.672 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.469 ' N ' HG23 ' A' ' 16' ' ' ILE . 35.8 mm -77.22 -44.89 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.5 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.58 -43.05 38.09 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 178.448 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.78 -43.4 99.0 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.091 -0.575 . . . . 0.0 111.696 179.233 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.88 -55.54 6.06 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.396 179.895 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.1 tp 51.47 96.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 179.832 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 50.79 29.85 4.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.866 179.782 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 52.35 51.71 15.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.661 179.876 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 tp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.158 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.9 mtp85 . . . . . 1 N--CA 1.315 -7.197 0 CA-C-O 121.596 0.712 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -43.38 -21.1 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.79 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' C ' ' A' ' 4' ' ' ARG . 22.3 mt -99.74 -23.04 15.13 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.885 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.4 tt0 -66.35 -15.55 63.35 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.208 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -63.18 94.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.314 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.0 tt -58.02 -38.45 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.44 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 76.71 -44.48 2.03 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.096 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 13' ' ' GLY . 47.1 tttp -86.28 77.21 9.57 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.77 0.319 . . . . 0.0 110.427 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.463 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -76.29 37.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.231 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 67.74 61.2 5.15 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 59.9 t80 57.08 36.54 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.931 0.396 . . . . 0.0 110.297 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.5 mm 59.36 66.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.391 0.615 . . . . 0.0 110.219 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -132.24 -51.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.006 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 mm -65.9 -43.94 92.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -85.47 -36.69 10.39 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.97 -33.25 86.74 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.28 -0.486 . . . . 0.0 111.889 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.52 -22.51 61.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.763 0.316 . . . . 0.0 110.638 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -76.62 -15.26 59.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.541 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -50.86 -42.13 58.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.582 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -169.68 -13.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.722 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.1 mp . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.047 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 7' ' ' GLU . 43.2 mtm180 . . . . . 1 N--CA 1.325 -6.696 0 CA-C-O 122.572 1.177 . . . . 0.0 112.055 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 44.2 t-105 -42.78 -18.84 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.194 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.502 ' N ' ' C ' ' A' ' 4' ' ' ARG . 42.4 tp -113.76 -21.44 10.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.122 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 4' ' ' ARG . 13.6 tp10 -110.99 46.73 1.04 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.981 0.42 . . . . 0.0 109.87 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.438 ' C ' ' H ' ' A' ' 10' ' ' GLY . 36.9 ttt-85 -63.64 126.59 28.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.569 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' LYS . 4.1 tp -54.05 -10.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . -37.08 -26.52 0.01 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.569 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 9' ' ' ILE . 14.4 pttp -70.46 99.75 1.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.82 -3.17 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.747 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 47.21 49.31 19.26 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.066 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.408 ' O ' HG23 ' A' ' 15' ' ' ILE . 20.2 t80 -160.97 -47.46 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.608 0.242 . . . . 0.0 110.471 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 14' ' ' PHE . 14.8 pt -156.02 55.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.15 0.5 . . . . 0.0 110.598 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 18' ' ' GLY . 3.8 mm -141.28 -48.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -69.36 5.76 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.462 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -175.54 -19.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.809 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -67.3 -57.28 9.52 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.142 -0.551 . . . . 0.0 111.875 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.1 7.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.333 . . . . 0.0 110.596 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 23' ' ' HIS . 12.9 mt 53.92 14.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.47 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -75.99 36.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.787 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.43 ' H ' ' C ' ' A' ' 21' ' ' LEU . 49.7 t-80 54.52 21.4 3.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.564 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 tp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.24 -179.886 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER . . . . . 1 N--CA 1.319 -7.021 0 CA-C-O 121.413 0.625 . . . . 0.0 110.428 . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 17.8 m0 -44.08 -19.09 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.541 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.9 mt -110.66 -17.98 13.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.617 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.5 mt-10 -110.17 13.21 23.19 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.93 0.395 . . . . 0.0 110.096 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 4' ' ' ARG . 56.9 ttt-85 -52.56 102.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.575 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 tp -56.54 109.16 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.098 0.475 . . . . 0.0 110.154 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.82 -38.28 4.45 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.982 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -65.97 103.97 1.03 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.894 0.378 . . . . 0.0 110.624 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.63 1.67 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.003 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.32 53.68 15.07 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.133 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' O ' HG23 ' A' ' 15' ' ' ILE . 20.7 t80 -163.08 -48.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.682 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 14' ' ' PHE . 8.3 pt -155.74 59.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.337 0.589 . . . . 0.0 110.867 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.5 mm -135.23 -72.37 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.51 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -71.85 -38.94 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.04 -45.62 11.47 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.71 -42.54 38.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.918 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.97 37.37 28.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.775 0.321 . . . . 0.0 110.46 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 23' ' ' HIS . 21.4 mt -75.81 114.95 15.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.636 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 58.55 -76.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.326 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 21' ' ' LEU . 69.1 m-70 -38.55 -32.74 0.08 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.026 0.441 . . . . 0.0 110.868 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.7 tp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.98 178.986 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 7' ' ' GLU . 58.6 mtp180 . . . . . 1 N--CA 1.324 -6.749 0 CA-C-O 122.563 1.173 . . . . 0.0 111.931 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -43.2 -18.97 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.916 -1.947 . . . . 0.0 109.999 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' C ' ' A' ' 4' ' ' ARG . 2.2 pp -111.3 -22.49 11.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.639 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.6 tt0 -88.35 1.05 55.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.032 0.444 . . . . 0.0 110.219 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -58.98 140.45 55.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.621 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 9' ' ' ILE . 5.9 tp -75.74 113.68 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.943 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.1 14.18 6.28 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -91.27 105.86 18.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.7 0.286 . . . . 0.0 110.431 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.46 62.2 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 50.52 53.51 24.58 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.7 t80 60.46 38.06 19.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.07 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.2 mt 61.18 70.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.358 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.59 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -140.28 -50.65 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.89 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.59 ' N ' HG23 ' A' ' 16' ' ' ILE . 4.2 tp -76.58 -29.46 18.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.76 -50.75 3.63 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.65 -42.2 94.11 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.652 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.26 52.81 1.16 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 110.489 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 tt -156.92 61.91 0.52 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -160.33 -34.85 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.656 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -164.94 -24.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 0.0 110.262 179.946 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER . . . . . 1 N--CA 1.328 -6.555 0 CA-C-O 122.534 1.159 . . . . 0.0 112.191 . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.437 ' CE3' HD21 ' A' ' 6' ' ' LEU . 27.3 t90 -41.24 -20.11 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 112.846 -1.979 . . . . 0.0 110.412 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.7 mt -115.84 -20.05 10.19 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.347 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.7 tt0 -96.2 30.47 2.47 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.999 0.428 . . . . 0.0 110.208 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.17 146.77 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.472 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 tp -165.16 96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.188 0.518 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.55 24.79 3.02 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.156 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -151.41 72.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.769 0.319 . . . . 0.0 110.375 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.9 45.35 0.9 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.056 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.5 33.76 54.37 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 18.9 t80 71.1 54.32 0.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.691 0.282 . . . . 0.0 110.56 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 mt 63.93 68.09 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.415 0.626 . . . . 0.0 110.94 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.0 mm -135.04 -51.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.662 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.5 mm -70.92 -42.01 77.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.68 -51.57 7.09 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -64.95 -36.3 92.92 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.815 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.08 7.17 0.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.646 0.26 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.7 mt 45.31 78.42 0.06 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.726 0.298 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -168.49 39.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.496 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 57.47 36.97 27.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.498 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.456 HD23 ' C ' ' A' ' 24' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.17 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 7' ' ' GLU . 89.5 mtt180 . . . . . 1 N--CA 1.325 -6.72 0 CA-C-O 122.47 1.128 . . . . 0.0 111.9 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -41.09 -20.49 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.327 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.2 tp -108.51 -26.15 10.57 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.173 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' ARG . 27.2 mp0 -99.83 8.73 43.95 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.84 0.352 . . . . 0.0 110.398 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.9 ttp180 -52.11 118.47 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.463 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.0 pt -61.92 -29.26 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.62 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.44 52.69 27.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.608 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -161.69 80.71 0.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.478 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.415 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -83.97 52.35 2.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.335 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.27 49.1 32.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.855 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.6 t80 61.15 48.73 6.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.897 0.38 . . . . 0.0 110.379 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 mt 61.22 70.87 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.732 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -135.03 -67.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -69.86 -25.07 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.415 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -83.05 -58.75 2.28 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.494 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.41 -32.46 68.16 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.936 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.73 34.97 10.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.773 0.321 . . . . 0.0 110.68 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.483 ' N ' HD23 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -65.89 1.64 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.952 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -58.75 -30.15 67.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.392 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.441 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 4.0 t60 -171.47 23.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.159 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.077 -179.792 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' LEU . 38.0 mtm-85 . . . . . 1 N--CA 1.325 -6.68 0 CA-C-O 122.447 1.118 . . . . 0.0 111.941 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.404 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 41.9 t-105 -41.36 -19.51 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 112.938 -1.937 . . . . 0.0 110.433 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.1 tp -114.57 -20.62 10.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.593 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 66.2 mm-40 -87.02 20.48 2.65 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 110.452 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -53.47 -21.11 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.111 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 11' ' ' LYS . 3.6 tp -165.09 -41.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.837 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 53.84 -82.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.263 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 9' ' ' ILE . 55.8 mttm -51.06 101.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.823 0.344 . . . . 0.0 110.795 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.85 3.27 3.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 45.3 40.43 7.83 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.45 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 15' ' ' ILE . 23.3 t80 -167.51 -20.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.314 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 14' ' ' PHE . 21.8 pt -155.85 50.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 120.925 0.393 . . . . 0.0 111.275 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.419 ' C ' ' H ' ' A' ' 18' ' ' GLY . 2.8 mm -143.77 -51.04 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.4 ' C ' HD12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -71.65 8.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.299 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -167.48 -31.69 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.001 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.79 -30.99 60.41 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.135 -0.555 . . . . 0.0 111.856 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.43 -68.23 0.39 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.735 0.302 . . . . 0.0 110.477 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 tp 52.79 49.44 20.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.448 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -167.23 88.25 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.528 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.6 m80 53.76 25.91 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.466 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.163 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.8 OUTLIER . . . . . 1 N--CA 1.32 -6.943 0 CA-C-O 121.466 0.651 . . . . 0.0 110.414 . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -43.48 -19.09 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.937 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.5 ' N ' ' C ' ' A' ' 4' ' ' ARG . 43.3 tp -108.28 -20.78 13.02 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.284 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.6 mm-40 -109.34 13.8 24.03 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.5 ttt85 -79.64 -69.09 0.61 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.574 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.1 pt -68.31 -33.65 61.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.4 55.82 23.42 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.944 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -168.26 67.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.481 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.529 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -68.71 76.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.364 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.629 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 46.93 62.68 3.63 Favored Glycine 0 CA--C 1.517 0.218 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.929 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 55.24 34.77 23.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.913 0.387 . . . . 0.0 109.96 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.0 mm 59.8 69.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.541 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 13' ' ' GLY . 9.8 tp -137.51 -34.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.1 mm -92.43 -41.1 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.529 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -77.68 -45.63 10.62 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.63 -37.78 57.65 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.663 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.81 52.21 11.66 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.714 0.293 . . . . 0.0 110.961 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.12 114.12 2.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.034 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 53.73 15.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.454 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 3.4 t60 54.39 25.83 6.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.465 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.201 179.971 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 7' ' ' GLU . 78.0 mtm180 . . . . . 1 N--CA 1.323 -6.786 0 CA-C-O 122.525 1.155 . . . . 0.0 111.966 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -42.12 -24.56 0.05 OUTLIER 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.718 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.9 mm? -96.42 -30.21 13.49 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.938 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 4' ' ' ARG . 60.3 mt-10 -112.46 49.8 0.9 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.79 0.328 . . . . 0.0 110.545 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -60.32 148.44 36.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.431 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 11' ' ' LYS . 15.7 pt -152.93 -31.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.399 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.26 -17.13 1.94 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.949 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 9' ' ' ILE . 55.0 mttp -69.55 105.88 2.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.687 0.279 . . . . 0.0 110.539 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.454 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -70.65 0.51 6.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.58 -0.77 1.94 Allowed Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.845 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' A' ' 12' ' ' ALA . 62.1 t80 -101.58 -31.78 10.68 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.559 ' O ' ' N ' ' A' ' 17' ' ' ILE . 5.2 pt -153.31 -112.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.225 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 mm 47.61 -81.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 111.355 0.132 . . . . 0.0 111.355 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 15' ' ' ILE . 3.7 tp -69.69 -42.25 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.077 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 17' ' ' ILE . . . -77.63 -42.53 17.25 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.033 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.46 -41.1 31.09 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.087 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.03 53.74 12.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 0.0 110.719 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 21' ' ' LEU . 8.4 mp -60.6 89.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.168 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 50.01 46.24 24.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.69 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 20.9 t-80 53.57 52.01 14.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.555 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.186 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 7' ' ' GLU . 51.5 mtm180 . . . . . 1 N--CA 1.323 -6.78 0 CA-C-O 122.466 1.127 . . . . 0.0 111.996 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -41.28 -21.34 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.043 -1.889 . . . . 0.0 110.272 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 57.6 tp -105.79 -26.89 11.58 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.219 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.3 mt-10 -90.75 8.88 32.39 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.951 0.405 . . . . 0.0 110.166 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -63.33 82.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.576 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.544 HG23 ' N ' ' A' ' 10' ' ' GLY . 16.4 tt -65.99 -45.25 91.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.356 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.544 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 41.78 45.29 4.65 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.361 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -164.56 71.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.33 . . . . 0.0 110.542 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.27 70.95 1.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.374 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.53 64.51 4.0 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.829 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 50.5 t80 57.53 28.39 15.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.772 0.32 . . . . 0.0 110.476 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.2 mt 62.43 64.71 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.646 0.736 . . . . 0.0 110.161 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -132.54 -49.47 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.786 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -69.72 -44.84 78.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.74 -43.82 11.21 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.72 -43.33 99.22 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.987 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.46 40.66 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.665 0.269 . . . . 0.0 110.703 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.6 tp -52.95 96.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.229 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 53.02 52.55 13.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.432 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.465 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 16.4 t-160 53.8 47.2 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.334 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.005 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 93.3 mtt180 . . . . . 1 N--CA 1.325 -6.722 0 CA-C-O 122.593 1.187 . . . . 0.0 112.039 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CE3' HD21 ' A' ' 6' ' ' LEU . 23.1 t90 -42.96 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 112.791 -2.004 . . . . 0.0 110.455 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 37.7 mt -117.13 -16.31 10.44 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.87 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.4 tt0 -48.52 -26.87 2.38 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.661 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -50.01 148.66 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.634 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 10' ' ' GLY . 16.0 tt -167.63 -40.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.494 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 76.81 -58.64 3.47 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.187 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.0 mttt -52.85 102.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.707 0.289 . . . . 0.0 110.507 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.28 -1.13 2.13 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 44.81 36.05 4.65 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.197 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 15' ' ' ILE . 58.9 t80 -168.97 -17.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.284 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' PHE . 15.0 pt -155.71 50.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.718 0.294 . . . . 0.0 111.057 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 mm -144.31 -47.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.419 HD12 ' C ' ' A' ' 17' ' ' ILE . 1.1 pp -85.29 24.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.186 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.62 -45.84 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.092 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.32 -40.23 98.34 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.039 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -78.49 50.71 0.98 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.839 0.352 . . . . 0.0 110.541 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 pp -59.22 -4.88 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.715 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 2.2 m-20 -52.23 -39.62 60.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.452 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.408 ' CD2' ' N ' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -168.06 10.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.433 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.826 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 6' ' ' LEU . 73.4 mtt-85 . . . . . 1 N--CA 1.324 -6.747 0 CA-C-O 122.656 1.217 . . . . 0.0 112.047 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -43.07 -18.61 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.854 -1.975 . . . . 0.0 110.337 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 4' ' ' ARG . 19.6 mt -114.32 -18.04 11.66 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.802 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.6 tt0 -48.02 -20.87 0.37 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.76 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 54.35 61.45 3.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.62 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 9' ' ' ILE . 3.2 tp -54.47 113.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.078 0.466 . . . . 0.0 110.126 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.51 34.18 1.28 Allowed Glycine 0 C--N 1.332 0.354 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -150.98 38.51 0.66 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.161 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.498 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -79.68 56.79 2.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.52 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.9 67.13 2.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.979 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 54.44 30.55 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.781 0.324 . . . . 0.0 110.706 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 mt 62.14 65.28 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.552 0.692 . . . . 0.0 110.281 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.2 mm -133.34 -51.65 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.691 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.3 mm -66.59 -42.89 90.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.498 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -81.74 -42.17 9.22 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.23 95.69 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.031 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.47 -30.87 0.61 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.667 0.27 . . . . 0.0 111.179 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 21' ' ' LEU . 8.0 mp -74.44 -47.81 31.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.316 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -50.55 -72.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.608 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -169.98 63.91 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.384 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.303 -179.887 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 6' ' ' LEU . 47.5 mtt85 . . . . . 1 N--CA 1.325 -6.675 0 CA-C-O 122.567 1.175 . . . . 0.0 111.997 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 66.4 t-105 -43.36 -18.31 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.249 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 4' ' ' ARG . 24.4 mt -115.82 -16.45 11.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.812 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.3 tt0 -45.43 -28.08 0.82 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -71.69 -137.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.307 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.2 pt -59.77 -113.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.437 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.26 39.59 82.0 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -57.13 -31.95 65.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.669 0.271 . . . . 0.0 110.541 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.72 -25.53 0.27 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.058 0.456 . . . . 0.0 110.442 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' C ' ' CG ' ' A' ' 14' ' ' PHE . . . 150.97 54.99 0.01 OUTLIER Glycine 0 CA--C 1.509 -0.31 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.442 ' CG ' ' C ' ' A' ' 13' ' ' GLY . 3.4 m-85 75.63 17.46 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.2 mt 61.55 60.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.558 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.1 tp -128.0 -48.69 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.558 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.9 tp -66.25 -36.25 76.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.38 -44.65 4.59 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.27 -33.0 51.93 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.662 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.72 -46.81 41.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.75 0.309 . . . . 0.0 110.863 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' C ' ' H ' ' A' ' 23' ' ' HIS . 40.9 mt 52.49 20.04 1.35 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 0.0 110.278 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 24' ' ' LEU . 66.2 m-20 -76.08 38.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.375 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.426 ' H ' ' C ' ' A' ' 21' ' ' LEU . 32.3 m80 57.67 6.52 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.252 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.279 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 6' ' ' LEU . 79.1 mtm180 . . . . . 1 N--CA 1.324 -6.739 0 CA-C-O 122.492 1.139 . . . . 0.0 112.094 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -41.16 -19.18 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 112.79 -2.005 . . . . 0.0 110.61 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.4 mt -121.99 -14.06 8.09 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.748 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 4' ' ' ARG . 37.1 mt-10 -88.95 -11.18 45.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 110.307 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.9 tpm_? -83.13 106.45 14.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.255 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.496 ' O ' HG23 ' A' ' 9' ' ' ILE . 14.6 tt -63.19 111.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.078 0.466 . . . . 0.0 110.224 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.7 -19.18 79.3 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.147 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.1 mttt -69.96 99.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.713 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.426 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -62.47 -2.65 1.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.161 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 59.18 5.15 2.99 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -85.51 -71.48 0.53 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 14' ' ' PHE . 17.5 pt -158.14 53.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.402 0.62 . . . . 0.0 110.217 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.61 -63.95 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.79 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -70.35 -35.01 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.31 -49.66 7.25 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.412 ' C ' ' N ' ' A' ' 21' ' ' LEU . . . -66.51 -46.35 77.81 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.73 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.4 15.09 0.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.765 0.317 . . . . 0.0 110.7 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.412 ' N ' ' C ' ' A' ' 19' ' ' GLY . 13.9 mt 55.26 11.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.592 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.41 49.07 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.506 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 51.82 20.97 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.542 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.221 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 11.2 mtp180 . . . . . 1 N--CA 1.312 -7.365 0 CA-C-O 121.556 0.693 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -44.24 -19.73 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.743 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.496 ' N ' ' C ' ' A' ' 4' ' ' ARG . 20.2 mt -103.77 -21.18 13.72 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.711 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 35.5 tp10 -68.39 -25.98 65.32 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.337 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.43 ' C ' ' H ' ' A' ' 10' ' ' GLY . 19.9 ttm180 68.09 163.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.003 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.2 pt -53.49 -9.09 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.779 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . 54.42 59.78 9.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.769 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -167.32 73.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.309 . . . . 0.0 110.405 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.494 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -87.63 53.64 2.85 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.058 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.435 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 64.35 33.25 86.73 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 67.0 72.81 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.637 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.3 pt 35.25 56.5 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.989 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 13' ' ' GLY . 4.2 tp -135.63 -43.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.579 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.401 ' N ' HG23 ' A' ' 16' ' ' ILE . 40.8 mm -81.33 -45.42 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.494 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -81.99 -24.78 54.39 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.2 -37.32 21.84 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.25 -72.89 0.08 Allowed 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.667 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.7 mt 58.62 24.73 12.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.471 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.21 -103.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.471 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -71.24 -4.76 27.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 110.649 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.412 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.1 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' GLU . 61.2 mtm180 . . . . . 1 N--CA 1.324 -6.775 0 CA-C-O 122.47 1.128 . . . . 0.0 111.946 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -41.3 -20.03 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 112.981 -1.918 . . . . 0.0 110.415 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.8 tp -110.38 -24.58 10.55 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.334 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' ARG . 55.2 mm-40 -96.81 33.91 1.79 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.768 0.318 . . . . 0.0 110.249 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -64.47 -74.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.715 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.594 HD12 ' C ' ' A' ' 9' ' ' ILE . 2.4 pp -68.64 -2.87 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.788 0.328 . . . . 0.0 110.66 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.57 ' N ' HD12 ' A' ' 9' ' ' ILE . . . -86.93 70.38 2.92 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 112.068 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -50.27 -32.53 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.107 0.48 . . . . 0.0 109.893 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -163.88 -0.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.124 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 46.3 32.84 5.38 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.931 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -149.87 -11.79 0.28 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.906 0.384 . . . . 0.0 110.007 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.8 pt -154.88 40.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.078 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.4 tp -151.36 -25.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.0 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -81.51 4.93 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.497 179.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.486 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -177.79 -13.76 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.953 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.94 -10.16 86.42 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.051 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.67 53.96 1.81 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.727 0.298 . . . . 0.0 110.573 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.1 mt -56.97 110.38 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.367 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 3.1 m-20 52.88 21.54 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.615 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.466 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 19.6 t60 53.75 46.52 25.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.582 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.33 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.0 mtm180 . . . . . 1 N--CA 1.324 -6.772 0 CA-C-O 122.626 1.203 . . . . 0.0 112.006 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -42.53 -24.25 0.05 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.058 -1.883 . . . . 0.0 109.838 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 6' ' ' LEU . 10.3 mp -95.82 -28.03 14.93 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.406 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 4' ' ' ARG . 38.3 tt0 -48.42 -29.07 3.67 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.686 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 7' ' ' GLU . 11.8 tpp180 60.36 129.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.68 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.2 tt -54.29 -37.95 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.404 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 55.04 59.05 11.04 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.0 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -169.15 68.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.792 0.329 . . . . 0.0 110.512 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.78 67.78 1.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.486 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 56.16 41.88 86.86 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.99 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.6 43.0 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 0.0 109.826 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.2 mt 54.95 61.64 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.372 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.4 mm -129.81 -42.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.009 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.7 mm -87.79 -37.3 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.0 -49.07 10.13 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -75.09 -37.4 43.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.811 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.67 5.58 0.35 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 0.0 110.586 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' A' ' 19' ' ' GLY . 9.0 tp 46.62 63.16 2.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.748 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -158.67 47.44 0.33 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.548 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.467 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 1.7 t60 51.98 20.78 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.474 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.7 tp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.257 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.587 ' O ' ' N ' ' A' ' 7' ' ' GLU . 6.7 mtt-85 . . . . . 1 N--CA 1.321 -6.882 0 CA-C-O 121.308 0.575 . . . . 0.0 111.303 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -42.68 -19.62 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.643 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.9 tp -107.66 -21.54 12.84 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.987 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.587 ' N ' ' O ' ' A' ' 4' ' ' ARG . 94.8 mt-10 -115.73 30.32 7.42 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 ptt85 -50.3 143.64 8.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.968 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.412 ' C ' ' H ' ' A' ' 11' ' ' LYS . 14.8 pt -64.93 -23.92 34.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.357 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.86 7.18 1.52 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.354 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' H ' ' C ' ' A' ' 9' ' ' ILE . 56.3 mttp -144.84 75.66 1.46 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.953 0.406 . . . . 0.0 110.226 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.542 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -76.86 62.92 2.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.647 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.62 68.92 1.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.091 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 61.8 t80 55.29 27.98 10.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.591 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.2 mt 61.51 63.55 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.652 0.739 . . . . 0.0 110.035 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 mm -131.65 -48.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.762 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.631 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -69.79 -46.1 75.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.542 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -78.28 -43.29 13.33 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.78 -44.59 96.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.676 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.54 82.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.372 . . . . 0.0 110.405 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp 55.43 57.81 5.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.393 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.0 t70 58.0 45.82 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.683 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 49.64 52.37 14.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.7 tp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.211 179.94 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 6' ' ' LEU . 75.3 mtt85 . . . . . 1 N--CA 1.325 -6.684 0 CA-C-O 122.526 1.155 . . . . 0.0 112.161 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 23.5 t90 -42.37 -16.86 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.63 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.1 tp -125.22 -12.19 6.89 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.984 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -76.11 -25.91 55.89 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.812 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -75.88 -135.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.29 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.6 pt -143.68 127.9 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.258 0.552 . . . . 0.0 110.117 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.0 -11.42 78.86 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.942 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -60.19 110.94 1.34 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.94 4.6 6.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 39.25 38.48 0.88 Allowed Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.634 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -168.05 -15.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.693 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 pt -152.71 46.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.192 0.52 . . . . 0.0 110.228 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -145.73 -41.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.256 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.539 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.8 pp -69.02 2.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.222 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.539 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -172.26 -30.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.873 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.89 -37.06 52.13 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.864 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -26.07 59.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.754 0.311 . . . . 0.0 110.508 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.5 tp 57.25 63.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.38 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER 52.31 46.54 26.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.555 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 52.03 60.67 3.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.495 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.15 -180.0 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 7' ' ' GLU . 16.1 mtp180 . . . . . 1 N--CA 1.316 -7.163 0 CA-C-O 121.492 0.663 . . . . 0.0 110.523 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -43.7 -21.48 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.682 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 4' ' ' ARG . 16.7 mt -96.83 -24.54 15.85 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.677 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.7 tm-20 -68.0 -28.84 67.77 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.267 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -58.21 128.89 39.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.467 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 pt -75.32 115.39 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.401 0.62 . . . . 0.0 110.239 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.56 -2.1 79.15 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.775 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 13' ' ' GLY . 59.6 mttp -75.4 98.33 3.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.701 0.286 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.403 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -77.68 37.39 0.23 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.478 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 73.34 63.11 2.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.916 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 63.8 t80 56.1 32.56 20.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.814 0.34 . . . . 0.0 110.773 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.0 mt 61.01 63.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.588 0.708 . . . . 0.0 109.948 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.0 mm -132.43 -51.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.93 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.8 mm -68.94 -41.18 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.403 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -80.07 -48.77 6.31 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -66.82 -31.95 79.75 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.037 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.27 1.64 0.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.775 0.321 . . . . 0.0 110.568 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.1 tp 61.02 5.42 1.0 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.37 -97.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.211 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -88.97 -36.86 15.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.885 0.374 . . . . 0.0 110.361 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.508 -179.94 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 7' ' ' GLU . 12.1 mtt85 . . . . . 1 N--CA 1.317 -7.076 0 CA-C-O 121.538 0.685 . . . . 0.0 110.563 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.52 ' CE3' HD21 ' A' ' 6' ' ' LEU . 26.3 t90 -43.83 -18.4 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.519 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.52 HD21 ' CE3' ' A' ' 5' ' ' TRP . 30.2 mt -114.43 -16.04 11.99 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.728 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 4' ' ' ARG . 90.6 mt-10 -118.5 31.1 6.84 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -51.97 -18.41 1.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.97 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.437 ' C ' ' H ' ' A' ' 11' ' ' LYS . 18.3 pt -154.45 -24.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.603 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.68 -35.07 1.01 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.874 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 9' ' ' ILE . 58.0 mttp -54.38 108.27 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.07 2.84 3.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.036 0.446 . . . . 0.0 110.09 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.23 34.73 0.65 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.535 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -166.26 -17.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.2 pt -152.23 50.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.139 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.451 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.4 tp -145.73 -39.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.078 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -78.63 4.64 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.214 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.475 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -159.13 -30.86 0.02 OUTLIER Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.69 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.65 -35.95 47.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.592 179.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.39 47.22 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.729 0.3 . . . . 0.0 110.822 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 21' ' ' LEU . 9.8 mp -60.37 114.55 2.99 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.7 t0 58.22 -78.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.696 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' LEU . 55.3 t-80 -166.81 30.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.534 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.448 HD23 ' C ' ' A' ' 24' ' ' LEU . 2.6 tt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.153 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.5 ' C ' ' N ' ' A' ' 6' ' ' LEU . 12.7 mtt180 . . . . . 1 N--CA 1.312 -7.329 0 CA-C-O 121.549 0.69 . . . . 0.0 110.058 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CE3' HD21 ' A' ' 6' ' ' LEU . 23.0 t90 -45.34 -17.37 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.947 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.5 ' N ' ' C ' ' A' ' 4' ' ' ARG . 32.1 mt -114.09 -12.51 12.55 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.997 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 4' ' ' ARG . 12.3 tm-20 -64.26 -22.35 66.92 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.778 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -43.4 96.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.18 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 11' ' ' LYS . 16.4 pt -64.49 -17.96 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.417 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.09 -37.14 1.09 Allowed Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 9' ' ' ILE . 9.1 mtpm? -71.85 107.23 4.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.802 0.334 . . . . 0.0 110.297 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.562 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -77.84 45.71 0.53 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.646 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.32 66.79 2.28 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.188 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 58.1 t80 54.44 30.9 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.748 0.309 . . . . 0.0 110.663 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mt 61.98 65.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.626 0.727 . . . . 0.0 110.271 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -132.29 -48.28 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.934 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -70.83 -45.75 71.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.562 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -77.92 -42.74 15.69 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 178.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.99 -47.42 90.82 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.652 179.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -60.86 -48.89 79.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.789 0.328 . . . . 0.0 110.244 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tp 62.07 1.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.34 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 20' ' ' ALA . 70.0 m-20 -85.79 37.61 0.71 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.366 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 23' ' ' HIS . 0.7 OUTLIER 54.18 24.42 4.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.527 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.9 tt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.127 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.5 mtm180 . . . . . 1 N--CA 1.325 -6.72 0 CA-C-O 122.564 1.173 . . . . 0.0 111.973 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -40.89 -21.21 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.317 179.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 8.1 tp -106.8 -26.43 11.27 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.455 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' ARG . 50.5 tt0 -90.1 -0.34 57.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.23 0.538 . . . . 0.0 109.736 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.6 ptt85 -45.93 147.89 0.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 mt -79.9 -64.61 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.109 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 79.02 -13.8 17.5 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.936 179.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.548 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 2.4 ttmp? -70.31 7.14 1.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.263 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 75.72 -20.68 0.34 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.344 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 35.21 65.77 0.4 Allowed Glycine 0 C--N 1.339 0.708 0 N-CA-C 112.254 -0.338 . . . . 0.0 112.254 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 56.04 36.67 27.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -178.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' ALA . 11.9 mm 64.24 80.49 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.765 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.624 HG23 ' N ' ' A' ' 17' ' ' ILE . 8.7 tp -145.84 -54.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.194 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.624 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.7 tp -74.77 -33.8 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.15 -47.69 4.88 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 178.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.14 96.76 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.08 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.21 -64.86 0.68 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.759 0.314 . . . . 0.0 110.543 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.9 tp 55.4 74.59 0.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.569 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -165.3 41.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.558 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.466 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 3.5 m80 53.31 48.92 20.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.488 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.6 tp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.319 -179.966 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.8 mmt180 . . . . . 1 N--CA 1.324 -6.753 0 CA-C-O 122.51 1.148 . . . . 0.0 111.943 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.529 ' CE3' HD21 ' A' ' 6' ' ' LEU . 31.3 t90 -41.05 -20.24 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.298 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.529 HD21 ' CE3' ' A' ' 5' ' ' TRP . 27.8 mt -109.69 -24.86 10.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.562 179.264 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 4' ' ' ARG . 22.2 tt0 -101.71 14.08 33.02 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.993 0.425 . . . . 0.0 110.026 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.7 ttp85 -72.06 -50.15 30.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 11' ' ' LYS . 21.0 pt -62.34 -23.54 32.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.705 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.45 -32.11 1.17 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.249 -0.5 . . . . 0.0 111.898 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 9' ' ' ILE . 93.7 mttt -73.66 108.99 6.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.161 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.03 8.51 4.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.209 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 43.99 30.71 1.81 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.101 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -155.68 -76.71 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.653 0.263 . . . . 0.0 110.34 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 15' ' ' ILE . 17.1 tt -90.41 47.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.951 0.881 . . . . 0.0 110.087 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.511 HG23 ' N ' ' A' ' 17' ' ' ILE . 3.9 tp -142.33 -44.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.378 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.511 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.1 tp -82.55 -39.47 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.109 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.58 -45.54 4.89 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -58.26 -36.22 81.92 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.909 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.13 39.63 0.19 Allowed 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.69 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.402 ' H ' ' C ' ' A' ' 19' ' ' GLY . 21.2 tp -68.05 -51.98 40.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.117 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -54.42 -45.47 73.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.609 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.418 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -48.48 -36.86 15.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.32 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.648 179.547 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 6' ' ' LEU . 73.1 mtp180 . . . . . 1 N--CA 1.324 -6.774 0 CA-C-O 122.597 1.189 . . . . 0.0 112.182 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -40.67 -20.51 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 112.828 -1.987 . . . . 0.0 110.797 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.7 tp -112.06 -19.29 12.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.088 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.3 tp10 -60.81 -27.87 68.36 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.31 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -57.78 153.37 13.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.599 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 pt -155.89 8.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.121 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.24 29.53 5.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.288 -0.482 . . . . 0.0 111.94 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -161.75 55.35 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.954 0.407 . . . . 0.0 110.382 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.14 -0.45 31.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.932 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.42 54.31 0.23 Allowed Glycine 0 C--N 1.332 0.316 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 41.1 t80 63.22 29.09 15.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.755 0.312 . . . . 0.0 110.341 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.6 mt 61.25 60.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.632 0.729 . . . . 0.0 109.353 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.6 mm -126.44 -47.96 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.249 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.596 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.4 mp -66.7 -38.91 82.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.86 -40.26 6.3 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 178.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.14 79.56 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.983 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.7 -39.45 73.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.72 0.295 . . . . 0.0 110.691 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.2 mt 51.25 71.45 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.485 -179.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.464 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 1.9 m-20 50.98 37.67 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.507 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.8 m80 53.7 61.4 3.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.684 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 tp . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.308 179.975 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 87.4 mtm180 . . . . . 1 N--CA 1.323 -6.784 0 CA-C-O 122.564 1.173 . . . . 0.0 112.001 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -43.22 -18.26 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 113.002 -1.908 . . . . 0.0 110.178 179.72 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.2 tt -114.17 -19.5 11.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.711 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.4 tp10 -82.0 16.99 1.69 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.394 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -70.3 178.35 2.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.619 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 9' ' ' ILE . 16.6 tt -170.82 130.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.453 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.99 17.2 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.837 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.58 -2.76 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.269 -0.172 . . . . 0.0 110.788 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 58.94 62.94 1.75 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.34 85.97 0.01 OUTLIER Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.469 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 12' ' ' ALA . 29.4 t80 64.14 38.27 8.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.966 0.413 . . . . 0.0 110.043 -179.085 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.4 mm 61.41 73.7 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.095 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -133.72 -53.39 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.081 179.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.666 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -70.44 -51.32 38.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.787 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.09 -42.44 51.29 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 178.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.46 -45.42 96.43 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.024 179.413 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.72 -16.2 62.76 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.813 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.8 mt 51.87 79.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.289 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.8 p30 42.45 32.58 0.36 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.157 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 15.3 m80 58.96 61.76 2.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.583 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 -179.931 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 6' ' ' LEU . 52.0 mtm-85 . . . . . 1 N--CA 1.324 -6.754 0 CA-C-O 122.488 1.137 . . . . 0.0 112.004 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -41.92 -19.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.149 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 24.0 mt -118.66 -16.29 9.42 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.581 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.7 tt0 -87.96 -6.03 58.22 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 120.92 0.39 . . . . 0.0 110.181 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 62.12 -131.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.247 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.504 ' O ' HG23 ' A' ' 9' ' ' ILE . 14.8 tt -163.43 123.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 110.371 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.89 27.9 4.23 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.191 -179.625 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -101.12 100.84 11.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.774 0.321 . . . . 0.0 110.309 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.55 57.64 3.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.004 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.54 49.25 53.22 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.495 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 48.1 t80 59.05 45.06 15.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 110.533 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 mt 62.42 68.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.167 0.508 . . . . 0.0 110.628 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -134.04 -65.79 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 tp -71.19 -21.89 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.3 -45.16 5.09 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.613 179.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.67 -39.6 34.02 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.398 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.58 -75.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.638 0.256 . . . . 0.0 111.327 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.6 mt 59.76 14.03 3.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.146 -179.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 19.1 m-20 -74.33 -83.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.652 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.462 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 96.9 m-70 -156.52 56.28 0.56 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.469 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.127 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.0 mtt180 . . . . . 1 N--CA 1.325 -6.688 0 CA-C-O 122.472 1.13 . . . . 0.0 112.082 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 66.9 t-105 -41.81 -19.28 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 112.892 -1.958 . . . . 0.0 110.358 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 mt -117.04 -18.36 10.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.549 179.301 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 4' ' ' ARG . 57.5 mm-40 -89.68 18.58 5.37 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.843 0.354 . . . . 0.0 110.411 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -55.25 -173.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 pt -150.09 124.28 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.967 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.44 -3.32 31.95 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.898 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -77.01 96.28 4.36 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.489 ' O ' ' CD1' ' A' ' 14' ' ' PHE . . . -57.87 -9.87 1.48 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 109.998 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.47 34.61 81.81 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.029 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 12' ' ' ALA . 61.4 m-85 -142.8 -53.21 0.39 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.795 -0.238 . . . . 0.0 110.404 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 pt -153.97 61.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.081 0.467 . . . . 0.0 110.589 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.4 mm -136.2 -39.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.416 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.429 HD12 ' C ' ' A' ' 17' ' ' ILE . 1.2 pp -96.87 14.59 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.32 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.17 -48.28 0.02 OUTLIER Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.135 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.05 -43.47 93.23 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.895 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -62.98 -53.22 57.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.796 0.331 . . . . 0.0 110.427 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tp 63.13 1.38 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.389 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 20' ' ' ALA . 30.7 t70 -78.3 56.76 1.76 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.625 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.434 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 54.6 t-80 55.59 17.98 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.602 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.1 tp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.215 -179.967 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 7' ' ' GLU . 1.2 mtm-85 . . . . . 1 N--CA 1.319 -6.987 0 CA-C-O 121.503 0.668 . . . . 0.0 110.041 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -43.4 -18.74 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.141 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.1 mt -111.32 -18.0 13.02 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.744 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.7 mp0 -105.56 29.24 6.7 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 120.886 0.374 . . . . 0.0 110.112 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 10' ' ' GLY . 85.6 mtm180 -47.72 -71.5 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.768 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 pt -57.88 -6.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.453 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . 50.51 51.06 33.81 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.928 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -166.97 74.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.409 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.27 62.89 3.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.203 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.69 49.66 16.01 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 -179.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.4 t80 63.88 48.66 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 110.121 -179.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mm 51.45 65.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.401 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.4 mm -132.7 -62.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.373 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 tp -67.67 -31.02 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.16 -48.87 4.67 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.82 -44.17 97.28 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.12 -71.82 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.18 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.9 tp 52.62 80.24 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.57 179.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -158.86 -69.53 0.09 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.442 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -165.62 37.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.593 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.9 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.096 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 7' ' ' GLU . 94.6 mtt180 . . . . . 1 N--CA 1.324 -6.732 0 CA-C-O 122.594 1.188 . . . . 0.0 111.996 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -42.0 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.435 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.0 mt -110.13 -21.08 12.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.912 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 38.4 tt0 -47.54 -19.85 0.21 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.911 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -52.02 -71.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.493 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.668 HG23 ' H ' ' A' ' 10' ' ' GLY . 14.6 tt -70.1 -59.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.332 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.668 ' H ' HG23 ' A' ' 9' ' ' ILE . . . 44.3 38.61 5.13 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.431 179.089 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 61.5 mttp -96.15 -1.05 49.23 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 76.06 -30.28 0.19 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.156 -179.276 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.8 68.33 0.48 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 63.24 58.74 1.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 pt 38.77 81.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.998 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.3 mm -134.17 -41.45 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.471 178.648 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.92 -73.31 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.687 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.25 -44.0 98.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.719 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -77.47 -47.12 9.19 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 121.302 -0.475 . . . . 0.0 111.95 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.5 8.02 0.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 110.477 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.434 ' H ' ' C ' ' A' ' 19' ' ' GLY . 12.7 tp 52.82 75.81 0.22 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.399 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.1 p30 -168.3 49.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.1 t60 52.39 20.41 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.43 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.242 -179.995 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 52.7 mtp85 . . . . . 1 N--CA 1.324 -6.745 0 CA-C-O 122.56 1.172 . . . . 0.0 112.026 . . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.414 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 45.2 t-105 -41.95 -18.03 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.642 -179.881 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.6 tp -128.47 -8.42 5.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.625 179.622 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.8 tt0 -87.93 -7.68 56.8 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 110.174 179.819 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -54.33 -83.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.523 179.886 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 11' ' ' LYS . 22.5 pt -78.31 16.48 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.812 0.339 . . . . 0.0 110.541 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.21 90.43 0.01 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.234 -179.821 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' ILE . 9.8 mtmp? -154.34 -2.42 0.18 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.69 57.09 5.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.198 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.486 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -43.1 88.38 0.01 OUTLIER Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.834 -179.648 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 12' ' ' ALA . 98.0 m-85 53.54 44.63 29.59 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.15 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.4 mt 61.9 76.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.643 -179.84 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 13' ' ' GLY . 7.4 tp -142.73 -28.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.346 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 mm -104.26 -39.89 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.378 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.52 -59.88 4.28 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.413 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.414 ' C ' ' N ' ' A' ' 21' ' ' LEU . . . -72.41 -36.64 59.18 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.554 179.542 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.9 16.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.663 0.268 . . . . 0.0 111.053 179.734 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.437 ' C ' ' N ' ' A' ' 23' ' ' HIS . 23.7 mt 54.08 -123.7 2.14 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.048 -179.735 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 t0 46.05 17.6 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.761 0.315 . . . . 0.0 110.876 179.801 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.437 ' N ' ' C ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER 51.78 41.69 29.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.339 -179.862 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.7 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.256 -179.923 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' GLU . 58.8 mtm180 . . . . . 1 N--CA 1.325 -6.714 0 CA-C-O 122.436 1.113 . . . . 0.0 111.949 . . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.459 ' CE3' HD21 ' A' ' 6' ' ' LEU . 27.6 t90 -42.19 -18.93 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.294 179.932 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.5 mt -112.21 -23.09 10.61 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.379 179.077 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 82.3 mt-10 -97.24 14.26 26.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.85 0.357 . . . . 0.0 110.328 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -62.86 -37.2 85.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.709 -179.857 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 11' ' ' LYS . 4.1 tp -170.04 -11.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.96 0.409 . . . . 0.0 109.915 -179.799 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 9' ' ' ILE . . . -37.4 -25.98 0.02 OUTLIER Glycine 0 C--N 1.335 0.482 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.634 179.615 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 9' ' ' ILE . 85.9 mttt -71.2 103.29 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.31 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.7 2.87 0.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.64 -179.813 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.75 45.42 3.61 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.557 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -163.47 -41.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.663 0.268 . . . . 0.0 110.65 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 pt -154.26 60.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.105 0.479 . . . . 0.0 110.442 179.998 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 mm -147.58 -30.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.4 mm -112.39 -49.45 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.447 179.206 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.51 -41.99 49.71 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.344 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.09 -38.25 7.41 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 179.52 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.6 67.46 1.0 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.332 . . . . 0.0 110.499 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 23' ' ' HIS . 9.7 tp -49.61 120.83 4.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.514 179.889 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 52.58 -85.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.694 179.864 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -156.91 45.07 0.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.36 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.26 -179.841 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 7' ' ' GLU . 10.3 mtm180 . . . . . 1 N--CA 1.319 -7.0 0 CA-C-O 121.389 0.614 . . . . 0.0 110.658 . . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -43.53 -18.63 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.312 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.533 ' N ' ' C ' ' A' ' 4' ' ' ARG . 36.3 mt -115.2 -14.9 11.7 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.937 178.919 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.1 mt-10 -118.2 25.95 9.97 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.413 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -66.93 152.22 46.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.565 -179.903 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.511 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.0 tt -68.93 -42.99 82.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.363 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.511 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 44.69 -129.71 7.59 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.232 -179.987 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 90.4 mttt 49.79 18.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.302 . . . . 0.0 110.532 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 71.9 -13.6 0.57 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.775 -179.918 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.97 56.59 2.14 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 112.211 -0.355 . . . . 0.0 112.211 179.99 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 67.43 46.99 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.07 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.2 mm 62.68 77.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.891 -179.945 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' ALA . 7.6 mm -131.77 -73.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.4 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -74.47 -29.77 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.418 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.85 -53.12 8.4 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.18 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -77.15 -45.21 11.85 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.526 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.59 10.72 0.24 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.768 0.318 . . . . 0.0 110.537 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 21' ' ' LEU . 8.6 mp 53.85 -111.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.016 -179.97 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 t70 54.91 -82.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.708 0.289 . . . . 0.0 110.757 179.924 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' LEU . 15.4 t60 -160.67 4.31 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.425 179.922 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.538 179.894 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 7' ' ' GLU . 10.1 mtp180 . . . . . 1 N--CA 1.314 -7.235 0 CA-C-O 121.557 0.694 . . . . 0.0 110.593 . . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -44.37 -21.62 0.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.387 -179.773 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.476 ' N ' ' C ' ' A' ' 4' ' ' ARG . 17.1 mt -99.81 -21.26 15.82 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.634 179.713 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.3 tp10 -68.83 -28.19 66.52 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.467 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -66.15 155.73 36.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.575 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.52 ' O ' HG23 ' A' ' 9' ' ' ILE . 16.8 tt -165.87 121.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.478 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.26 -25.34 19.41 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 13' ' ' GLY . 45.9 mttp -83.3 87.66 6.95 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.947 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.07 17.58 1.21 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.586 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 57.61 22.3 45.65 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.452 -179.531 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.421 ' C ' ' H ' ' A' ' 16' ' ' ILE . 45.5 t80 -146.06 -55.29 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.8 pt -80.37 31.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 179.71 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.538 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.6 tp -148.54 -46.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.924 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.538 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.5 tp -79.26 -32.33 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.188 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.78 -47.75 3.86 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 178.655 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.42 -38.39 86.72 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.408 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -75.01 -68.64 0.53 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.845 0.355 . . . . 0.0 110.285 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.432 ' C ' ' H ' ' A' ' 23' ' ' HIS . 0.7 OUTLIER 59.03 5.96 0.6 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.052 179.879 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 20' ' ' ALA . 8.4 m-20 -77.58 23.0 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.531 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.432 ' H ' ' C ' ' A' ' 21' ' ' LEU . 37.8 m-70 52.86 35.67 19.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.427 179.964 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.251 -179.988 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.602 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.9 mtt-85 . . . . . 1 N--CA 1.314 -7.254 0 CA-C-O 121.586 0.707 . . . . 0.0 110.175 . . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -41.28 -24.21 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.957 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.4 mm? -92.33 -29.3 16.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.209 179.459 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.7 tt0 -71.3 -19.02 62.38 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.126 179.715 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.44 131.78 51.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.525 179.947 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.8 pt -64.16 -34.51 69.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.529 -179.901 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.51 47.02 92.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.074 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -154.18 73.19 0.91 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.782 0.325 . . . . 0.0 110.254 179.988 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.514 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -80.01 49.65 1.11 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.612 179.908 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.73 65.71 2.91 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.166 179.897 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 54.77 31.63 15.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.701 0.286 . . . . 0.0 110.923 179.785 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 61.26 64.08 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.578 0.704 . . . . 0.0 110.277 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 mm -133.01 -47.28 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.717 179.923 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.655 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -72.13 -46.18 59.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.858 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.514 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -75.92 -48.7 9.6 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.082 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.53 -42.45 99.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.857 179.618 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 59.95 3.39 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.743 0.306 . . . . 0.0 110.784 -179.958 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.2 mt 49.71 13.41 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.736 179.91 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.439 ' N ' ' C ' ' A' ' 20' ' ' ALA . 47.6 t0 -62.83 -73.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.565 179.984 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -169.62 20.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.548 179.942 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 24' ' ' LEU . 10.1 mp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.079 179.908 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 7' ' ' GLU . 65.5 mtt-85 . . . . . 1 N--CA 1.321 -6.897 0 CA-C-O 122.633 1.206 . . . . 0.0 111.949 . . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -43.03 -19.04 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.151 179.876 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.497 ' N ' ' C ' ' A' ' 4' ' ' ARG . 20.6 mt -111.89 -19.66 12.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.75 179.788 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.2 tt0 -49.04 -24.58 1.62 Allowed 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.71 -179.844 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 56.5 99.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.231 -179.913 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 pt -62.59 113.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.411 0.624 . . . . 0.0 110.279 -179.845 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.82 8.25 8.03 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.648 179.854 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.457 ' HA ' HG21 ' A' ' 16' ' ' ILE . 57.5 mttp -67.28 108.37 2.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.694 0.283 . . . . 0.0 110.64 -179.924 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.91 4.76 5.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.064 0.459 . . . . 0.0 109.783 179.536 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 14' ' ' PHE . . . 59.99 22.89 58.55 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.998 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 63.9 m-85 -158.6 -100.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.738 0.304 . . . . 0.0 111.166 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.8 pt -78.05 60.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.988 0.423 . . . . 0.0 111.739 -178.834 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.457 HG21 ' HA ' ' A' ' 11' ' ' LYS . 16.7 mm -149.26 -44.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.036 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.03 -50.07 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.805 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.56 -43.61 67.79 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.059 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.1 -42.62 7.96 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 179.386 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.35 50.38 18.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.767 0.318 . . . . 0.0 110.649 179.861 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.3 mt -75.19 -26.76 59.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.416 179.931 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 24' ' ' LEU . 16.3 m-20 -77.2 -67.77 0.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.42 1.4 0.79 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.709 -179.798 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 22' ' ' ASP . 1.6 tt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.351 179.992 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 7' ' ' GLU . 88.0 mtt180 . . . . . 1 N--CA 1.324 -6.76 0 CA-C-O 122.536 1.16 . . . . 0.0 111.855 . . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -42.7 -21.34 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.836 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.483 ' N ' ' C ' ' A' ' 4' ' ' ARG . 11.0 mp -105.27 -26.32 12.07 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.995 179.151 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 4' ' ' ARG . 22.4 mm-40 -93.34 37.65 1.05 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.694 0.283 . . . . 0.0 110.607 -179.855 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -69.9 172.36 7.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.446 179.988 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 tp -170.4 124.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.192 179.849 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.36 25.26 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.769 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -69.62 -5.81 27.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 55.54 60.72 3.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.015 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.66 87.59 0.01 OUTLIER Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -179.657 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 12' ' ' ALA . 98.8 m-85 54.01 42.05 31.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -178.621 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.5 mt 62.66 83.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.465 -179.576 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.633 HG23 ' H ' ' A' ' 17' ' ' ILE . 5.2 tp -143.66 -58.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.398 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.633 ' H ' HG23 ' A' ' 16' ' ' ILE . 3.7 tp -86.15 -26.34 6.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.505 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.18 -55.29 4.42 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 178.871 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.16 -43.28 40.19 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.632 179.299 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.34 38.76 30.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.694 0.283 . . . . 0.0 110.778 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.1 mt -99.8 -20.07 16.39 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.481 179.839 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -50.09 -50.9 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -165.28 -20.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.46 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.6 mp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.169 179.923 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 7' ' ' GLU . 71.1 mtm180 . . . . . 1 N--CA 1.325 -6.71 0 CA-C-O 122.467 1.127 . . . . 0.0 112.057 . . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -41.19 -20.05 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 112.924 -1.944 . . . . 0.0 110.334 179.834 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.0 tp -112.93 -22.62 10.53 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.342 179.351 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.2 mm-40 -102.06 38.77 1.59 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.657 0.265 . . . . 0.0 110.563 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -51.47 139.23 20.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.383 179.981 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.554 HG23 ' H ' ' A' ' 10' ' ' GLY . 2.7 tp -52.64 -56.08 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.406 -179.797 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.554 ' H ' HG23 ' A' ' 9' ' ' ILE . . . 74.49 -38.92 1.04 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.073 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -78.12 105.42 9.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.745 0.307 . . . . 0.0 110.389 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.85 9.17 3.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.192 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.13 34.43 12.25 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.114 179.878 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -161.96 -73.85 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.826 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 pt -81.48 38.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.207 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 17' ' ' ILE . 4.0 tp -146.23 -42.72 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.087 -179.656 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.56 HD12 ' C ' ' A' ' 17' ' ' ILE . 2.2 pp -77.04 0.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.043 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.55 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -158.15 -42.64 0.02 OUTLIER Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.686 -179.808 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -61.23 -36.34 92.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.69 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.438 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 56.29 6.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.748 0.308 . . . . 0.0 110.704 179.918 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.436 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.0 tp 49.97 14.09 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.411 179.99 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.438 ' N ' ' C ' ' A' ' 20' ' ' ALA . 18.3 t70 -71.73 -40.96 69.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.441 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.466 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -165.78 12.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.343 179.9 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.226 -179.988 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 7' ' ' GLU . 94.8 mtt180 . . . . . 1 N--CA 1.326 -6.634 0 CA-C-O 122.672 1.225 . . . . 0.0 111.966 . . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -42.11 -20.12 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.964 -1.925 . . . . 0.0 110.38 179.83 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.3 mt -110.18 -20.48 12.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.995 179.93 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.6 tt0 -46.99 -22.02 0.28 Allowed 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.823 -179.917 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 -79.61 -44.05 21.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 9' ' ' ILE . 26.4 mm -70.28 -6.88 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 -179.64 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.37 -25.57 6.18 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.739 -0.744 . . . . 0.0 111.35 179.542 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 13' ' ' GLY . 98.0 mttt -116.68 76.45 1.03 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.228 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.92 84.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.381 -179.535 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . 47.18 54.65 9.62 Favored Glycine 0 C--N 1.33 0.209 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -179.593 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.1 t80 57.68 39.91 26.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.885 0.374 . . . . 0.0 110.285 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 mt 60.85 67.59 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.482 -179.979 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.524 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.2 tp -137.89 -47.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.387 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.524 ' N ' HG23 ' A' ' 16' ' ' ILE . 28.9 mm -77.63 -36.68 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.297 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.12 -50.68 6.64 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 178.884 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . -67.61 -36.86 88.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.568 179.342 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 73.17 -35.68 0.33 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.635 0.255 . . . . 0.0 111.06 179.865 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.4 mm? 53.35 10.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.953 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 20' ' ' ALA . 15.8 t0 -79.56 -37.42 36.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.623 -179.913 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -167.6 -22.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.806 -179.942 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.145 -179.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 7' ' ' GLU . 58.0 mtm180 . . . . . 1 N--CA 1.323 -6.802 0 CA-C-O 122.391 1.091 . . . . 0.0 112.001 . . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -38.48 -26.56 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.118 -1.856 . . . . 0.0 110.354 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.4 mm? -94.18 -33.54 13.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.077 179.334 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.5 mt-10 -96.1 14.14 24.87 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.708 0.289 . . . . 0.0 110.437 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 4' ' ' ARG . 0.6 OUTLIER -70.04 -68.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.322 -179.795 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.5 pt -98.59 -33.34 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.63 179.894 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.01 59.89 6.52 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.841 -179.724 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -162.75 83.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.34 . . . . 0.0 110.241 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.474 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -79.33 57.03 2.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 -179.825 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 57.31 64.47 4.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.057 179.993 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 47.0 t80 54.89 33.27 19.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.797 0.332 . . . . 0.0 110.467 179.918 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 mt 59.52 64.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.575 0.702 . . . . 0.0 110.113 -179.831 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -132.18 -51.87 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.847 -179.941 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 mm -68.87 -44.37 81.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.764 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.474 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -77.99 -44.36 12.13 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.936 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.19 -43.3 99.57 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.892 179.543 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.08 -22.24 49.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.838 0.351 . . . . 0.0 110.495 -179.898 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.3 tp -56.55 -19.12 14.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.413 179.994 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 79.4 m-20 -51.04 -51.99 47.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.666 179.903 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.488 ' ND1' ' O ' ' A' ' 22' ' ' ASP . 77.1 m-70 -153.89 39.62 0.48 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.246 179.956 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.134 -179.932 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 7' ' ' GLU . 83.8 mtm180 . . . . . 1 N--CA 1.323 -6.81 0 CA-C-O 122.379 1.085 . . . . 0.0 112.072 . . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -38.4 -23.99 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.569 -179.901 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.0 tp -102.43 -29.89 11.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.412 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.4 mm-40 -97.38 43.99 1.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -50.97 -39.09 54.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 -179.851 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.447 ' C ' ' H ' ' A' ' 11' ' ' LYS . 11.2 pt -155.83 -35.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.428 179.903 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.34 -12.99 1.64 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.225 179.886 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 9' ' ' ILE . 31.9 mtmm -89.76 105.49 17.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.749 0.309 . . . . 0.0 110.201 179.903 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.02 61.2 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.806 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.461 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 46.62 50.91 13.4 Favored Glycine 0 C--N 1.331 0.27 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -179.236 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.9 t80 60.24 63.54 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.713 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.5 pt 35.26 62.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.346 -179.342 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.56 HG23 ' N ' ' A' ' 17' ' ' ILE . 4.5 tp -129.15 -48.71 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.56 ' N ' HG23 ' A' ' 16' ' ' ILE . 4.1 tp -82.31 -33.77 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.518 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.86 -35.64 6.72 Favored Glycine 0 C--N 1.331 0.262 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.23 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.66 -37.83 61.56 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.016 179.805 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.54 -68.16 0.45 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.824 0.345 . . . . 0.0 110.5 179.993 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.21 85.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.132 -179.97 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.9 t0 51.19 35.62 13.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.7 179.967 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.431 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 7.0 t60 53.24 46.21 26.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.565 179.871 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.127 179.922 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 7' ' ' GLU . 80.0 mtm180 . . . . . 1 N--CA 1.323 -6.806 0 CA-C-O 122.574 1.178 . . . . 0.0 111.921 . . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -42.3 -20.22 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.065 -1.88 . . . . 0.0 110.218 179.81 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 4' ' ' ARG . 24.0 mt -107.05 -24.98 11.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.375 179.446 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' ARG . 11.8 mp0 -89.24 -3.78 58.42 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.645 0.26 . . . . 0.0 110.318 -179.981 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -73.66 -29.72 62.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.52 -179.943 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 9' ' ' ILE . 13.2 tt -48.67 99.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.227 0.537 . . . . 0.0 110.653 -179.805 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.14 -14.45 82.27 Favored Glycine 0 C--N 1.329 0.18 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.978 -179.927 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -73.95 97.98 2.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.815 0.34 . . . . 0.0 110.464 -179.983 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.8 -3.27 1.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.803 -179.906 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.7 14.2 42.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.703 -179.888 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -163.79 -46.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.929 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.6 mm -99.77 52.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.339 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.546 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -149.74 -45.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.208 -179.827 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.546 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -79.77 5.37 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.765 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.478 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -152.14 -44.11 0.02 OUTLIER Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.648 -179.916 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.41 -35.38 61.07 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.948 179.843 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.74 -29.47 59.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 0.0 110.507 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.3 mt -81.98 -27.14 33.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.633 -179.944 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -50.56 -59.91 3.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.603 179.983 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.4 ' H ' ' H ' ' A' ' 24' ' ' LEU . 11.4 t-80 -170.03 -4.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.539 179.935 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' H ' ' H ' ' A' ' 23' ' ' HIS . 17.2 mt . . . . . 0 N--CA 1.468 0.45 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.393 179.923 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 7' ' ' GLU . 52.3 mtm-85 . . . . . 1 N--CA 1.324 -6.75 0 CA-C-O 122.54 1.162 . . . . 0.0 112.048 . . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -41.07 -25.06 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.999 -1.91 . . . . 0.0 109.989 179.914 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.451 ' N ' ' C ' ' A' ' 4' ' ' ARG . 3.3 mm? -96.75 -29.0 14.02 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.424 179.508 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 4' ' ' ARG . 2.3 mp0 -86.39 -8.22 57.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.656 -179.498 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -80.26 -114.86 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.491 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.449 ' C ' ' H ' ' A' ' 11' ' ' LYS . 6.9 mm -83.09 -74.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.762 0.315 . . . . 0.0 110.171 179.742 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.85 -33.15 0.88 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.21 179.982 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 13' ' ' GLY . 40.8 mtmt -117.12 74.97 0.94 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.871 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.33 77.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.191 179.977 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 51.62 54.6 23.94 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.544 -179.532 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 60.38 35.74 20.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.33 -179.644 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.3 mt 60.48 62.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.442 -179.988 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 13' ' ' GLY . 4.4 tp -132.28 -41.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.552 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.42 ' N ' HG23 ' A' ' 16' ' ' ILE . 40.4 mm -81.27 -43.55 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.541 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.5 -47.83 26.21 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 178.834 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.0 -37.62 87.83 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.703 179.301 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.42 51.18 11.93 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.88 0.371 . . . . 0.0 110.753 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.5 103.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.552 -179.914 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t70 54.53 44.16 29.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.616 -179.997 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.3 m80 51.56 31.84 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 179.923 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.358 179.971 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' GLU . 71.7 mtm-85 . . . . . 1 N--CA 1.325 -6.7 0 CA-C-O 122.478 1.132 . . . . 0.0 111.933 . . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -41.85 -19.8 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.224 179.896 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.6 tp -112.11 -23.01 10.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.226 179.371 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.5 mt-10 -94.61 20.92 7.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.844 0.354 . . . . 0.0 110.463 179.946 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.411 ' O ' HG23 ' A' ' 9' ' ' ILE . 43.4 ttt85 -68.77 122.09 17.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.555 -179.965 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.414 ' H ' ' H ' ' A' ' 10' ' ' GLY . 20.8 pt -157.01 -9.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.309 -179.891 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 9' ' ' ILE . . . 53.93 38.57 60.47 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.973 -179.97 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 13' ' ' GLY . 67.5 mttm -148.71 77.27 1.38 Allowed 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.989 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.438 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -76.91 33.53 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.591 179.978 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 52.32 48.48 53.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.896 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.8 t80 67.78 50.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.692 0.282 . . . . 0.0 110.946 179.894 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.5 mm 60.66 73.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.333 0.587 . . . . 0.0 111.334 179.301 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.3 mm -136.05 -51.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.001 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.642 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -70.45 -54.05 20.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.859 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.438 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -70.62 -50.98 22.65 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.475 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.76 -45.8 95.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.865 179.684 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.63 -0.65 0.52 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.636 0.255 . . . . 0.0 110.896 -179.927 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 19' ' ' GLY . 16.0 mt 47.26 73.76 0.18 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 110.712 179.787 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.9 p-10 -170.68 35.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.621 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 51.36 42.59 29.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.535 179.973 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 24' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.195 -179.985 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 6' ' ' LEU . 97.5 mtt180 . . . . . 1 N--CA 1.323 -6.777 0 CA-C-O 122.426 1.108 . . . . 0.0 111.978 . . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -41.67 -18.99 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.004 -1.907 . . . . 0.0 110.455 -179.912 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.3 mp -117.34 -17.91 10.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.646 179.374 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 4' ' ' ARG . 68.4 mm-40 -90.71 -9.99 44.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.719 0.295 . . . . 0.0 110.752 -179.844 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -83.45 68.45 9.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.521 -179.983 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.22 81.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.548 -179.872 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.33 -32.42 14.39 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.201 -0.523 . . . . 0.0 111.874 179.856 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -59.43 106.53 0.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.32 . . . . 0.0 110.298 179.881 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.91 1.45 3.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.037 -179.954 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 43.23 38.15 3.56 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.463 179.859 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 15' ' ' ILE . 31.2 t80 -169.42 -15.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.053 179.988 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 14' ' ' PHE . 19.0 pt -157.06 49.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.826 0.346 . . . . 0.0 111.06 179.826 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.417 ' C ' ' H ' ' A' ' 18' ' ' GLY . 1.5 mm -143.78 -50.25 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.559 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.4 ' C ' HD12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -75.9 15.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.222 179.876 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -171.99 -31.87 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.157 -0.544 . . . . 0.0 111.855 -179.963 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.31 -23.86 69.87 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 -180.0 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.66 -50.32 58.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 0.0 110.575 -179.902 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.7 mt 56.09 56.49 5.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.116 -179.93 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -157.87 68.63 0.51 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.567 -179.943 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.466 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 49.5 t-80 51.82 39.61 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.608 179.856 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.2 tp . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.211 179.953 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER . . . . . 1 N--CA 1.312 -7.367 0 CA-C-O 121.546 0.688 . . . . 0.0 109.951 . . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.6 t90 -42.4 -23.5 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.896 -179.943 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' N ' ' C ' ' A' ' 4' ' ' ARG . 5.0 mp -92.87 -27.63 17.0 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.61 179.765 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.5 mt-10 -79.21 -14.61 58.95 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.737 -179.928 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -70.17 -179.91 2.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 0.0 110.594 -179.881 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 tp -60.05 105.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.262 0.553 . . . . 0.0 110.409 -179.712 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.77 42.76 0.02 OUTLIER Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.831 179.995 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -50.29 -31.36 14.1 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.604 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.403 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -162.67 -9.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.622 -179.876 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 58.57 33.35 71.62 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.7 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -154.32 -9.79 0.14 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.915 0.388 . . . . 0.0 110.14 -179.926 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.5 pt -156.81 40.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.01 179.425 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 tp -150.49 -26.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.254 -179.683 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -83.5 6.71 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.837 179.484 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.45 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -170.79 -28.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.952 -179.978 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.83 -47.64 38.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.161 -0.542 . . . . 0.0 111.987 179.96 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.08 36.72 25.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.722 0.296 . . . . 0.0 110.583 179.958 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.59 -5.26 27.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.418 179.853 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -51.63 -35.51 42.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.619 179.981 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -168.48 21.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.702 179.967 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.21 179.979 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.525 ' C ' ' N ' ' A' ' 6' ' ' LEU . 13.8 mtp180 . . . . . 1 N--CA 1.318 -7.044 0 CA-C-O 121.315 0.578 . . . . 0.0 110.583 . . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -43.81 -18.12 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.682 -179.975 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.525 ' N ' ' C ' ' A' ' 4' ' ' ARG . 63.3 mt -120.6 -9.14 9.44 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.184 179.236 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.1 mt-10 -116.43 32.33 6.19 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.096 0.474 . . . . 0.0 109.749 179.626 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -49.03 92.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.534 179.76 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 7' ' ' GLU . 16.4 pt -71.59 -32.58 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 -179.891 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.35 6.58 1.56 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.029 -179.978 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.535 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 78.6 tttt -68.83 -7.45 34.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 110.217 179.976 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 74.89 -21.54 0.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.607 -179.85 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 42.64 52.64 5.39 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.627 -179.816 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.8 t80 70.91 44.61 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.993 0.425 . . . . 0.0 109.978 -179.124 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.8 mt 61.22 74.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.46 -179.99 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.7 mm -136.0 -71.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.693 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 tp -72.46 -23.52 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.136 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.16 -54.99 3.63 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.383 179.253 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -40.65 41.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.78 179.688 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.15 59.27 4.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.833 0.349 . . . . 0.0 110.245 -179.951 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 21' ' ' LEU . 10.1 mp -48.32 117.3 1.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.338 -179.827 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t0 55.16 51.93 12.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.986 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.1 m170 53.28 35.01 19.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.689 179.927 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.331 179.906 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 59.4 mtt85 . . . . . 1 N--CA 1.325 -6.717 0 CA-C-O 122.499 1.142 . . . . 0.0 111.999 . . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -40.8 -21.1 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.387 -179.934 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.9 mt -108.44 -24.92 11.22 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.676 179.365 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.1 mm-40 -89.89 33.8 0.85 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-O 120.928 0.394 . . . . 0.0 110.34 179.876 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -146.63 70.47 1.21 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.128 179.961 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 9' ' ' ILE . 13.8 tt -61.04 120.79 7.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 179.963 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.87 -31.5 67.13 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.893 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.469 ' C ' ' H ' ' A' ' 13' ' ' GLY . 93.5 mttt -69.46 95.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 110.159 179.62 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.16 -8.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.39 -179.993 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 67.43 0.41 11.39 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.479 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.451 ' O ' HG23 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -80.86 -68.26 0.7 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.949 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 14' ' ' PHE . 19.6 pt -158.25 42.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.771 179.42 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 16' ' ' ILE . 1.5 mp -85.66 -49.79 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.142 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.513 ' CD1' ' H ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -75.41 18.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.747 179.891 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -152.69 -58.1 0.01 OUTLIER Glycine 0 C--N 1.334 0.455 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 -179.938 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.43 -33.0 65.09 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.895 -179.994 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.99 -66.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 110.521 179.951 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.81 73.07 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.166 0.508 . . . . 0.0 109.899 179.898 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -160.87 32.51 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.306 179.984 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 50.5 t-80 55.48 39.51 31.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.285 -179.816 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.091 -179.76 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 6' ' ' LEU . 66.8 mtp180 . . . . . 1 N--CA 1.325 -6.71 0 CA-C-O 122.58 1.181 . . . . 0.0 112.059 . . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -42.91 -18.44 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.887 -1.96 . . . . 0.0 110.214 179.85 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.4 tp -114.8 -20.24 10.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.422 179.469 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 45.0 mm-40 -89.99 19.16 5.09 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.556 -179.998 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -78.68 56.32 1.83 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.183 179.952 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.61 83.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.658 -179.774 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.5 -25.11 75.03 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.119 -0.562 . . . . 0.0 111.716 179.625 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -78.39 107.92 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.776 0.322 . . . . 0.0 110.245 179.814 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.91 55.43 1.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.835 179.754 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 53.11 47.64 60.27 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.371 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 t80 61.0 45.55 9.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.029 0.443 . . . . 0.0 110.008 -179.392 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 mt 60.99 70.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.583 -179.803 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -135.8 -64.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.5 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -70.74 -26.76 28.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.352 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.07 -56.2 2.77 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.409 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.37 82.62 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 179.666 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.61 47.8 12.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.726 0.298 . . . . 0.0 110.675 179.829 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.2 tp -72.85 -34.6 66.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.022 179.854 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.45 44.14 0.59 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.568 179.998 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 42.3 m80 51.6 17.32 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.564 179.994 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.1 tp . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.262 -179.93 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 66.1 mtp180 . . . . . 1 N--CA 1.324 -6.77 0 CA-C-O 122.624 1.202 . . . . 0.0 111.966 . . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -44.39 -20.02 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 112.984 -1.917 . . . . 0.0 109.908 179.675 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.447 ' N ' ' C ' ' A' ' 4' ' ' ARG . 42.6 tp -105.34 -22.84 12.96 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.431 179.791 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.8 tt0 -48.26 -36.2 13.56 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.7 mtt85 -77.06 -63.89 1.26 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.559 179.839 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.4 tt -170.42 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.447 -179.998 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 77.84 -50.39 3.3 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -179.796 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -81.25 96.58 7.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.696 0.284 . . . . 0.0 110.261 179.761 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.9 47.61 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.771 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.7 54.39 33.33 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.676 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 55.2 49.1 17.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.497 -179.698 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.6 mt 60.58 70.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.67 179.921 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.6 mm -136.35 -68.31 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.609 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -68.49 -22.99 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.654 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.24 -59.89 1.8 Allowed Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.486 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.52 -31.63 79.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.715 179.774 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.13 57.91 5.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 110.407 179.959 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.0 mt -56.75 90.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.386 179.954 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 24' ' ' LEU . 8.2 m-20 54.33 -135.1 1.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.354 -179.93 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -76.41 21.3 0.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.789 0.328 . . . . 0.0 110.744 179.885 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' A' ' 22' ' ' ASP . 15.9 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.145 -179.997 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 6' ' ' LEU . 93.9 mtt180 . . . . . 1 N--CA 1.324 -6.735 0 CA-C-O 122.441 1.115 . . . . 0.0 112.044 . . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -39.84 -20.61 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 112.919 -1.946 . . . . 0.0 110.66 -179.802 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.5 tp -117.55 -19.15 9.54 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.501 179.406 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.0 mt-10 -89.5 24.56 2.23 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.777 0.322 . . . . 0.0 110.53 -179.978 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -76.36 -63.69 1.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.721 -179.984 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 9' ' ' ILE . 14.2 tt -49.66 109.77 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.196 0.522 . . . . 0.0 110.558 -179.8 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.74 -27.58 64.71 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.933 -179.754 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.437 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 3.8 mptp? -54.96 111.2 0.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.714 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.12 3.53 3.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.96 0.41 . . . . 0.0 110.308 -179.61 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.38 38.48 0.63 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.796 179.586 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -168.38 -19.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 110.663 179.87 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 pt -151.17 48.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.123 0.487 . . . . 0.0 109.991 179.562 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.8 tp -146.4 -35.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.09 -179.892 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -83.51 4.8 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.813 179.423 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.473 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -164.39 -33.88 0.02 OUTLIER Glycine 0 C--N 1.33 0.248 0 N-CA-C 111.779 -0.529 . . . . 0.0 111.779 -179.856 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.13 -42.96 97.35 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.148 -0.549 . . . . 0.0 111.806 179.967 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.46 -51.36 60.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.724 0.297 . . . . 0.0 110.45 -179.955 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 tp 55.76 100.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.276 -179.953 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -164.72 -36.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.597 -179.954 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -170.32 1.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.71 -179.922 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.674 HD22 ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.196 -179.857 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 84.0 mtm180 . . . . . 1 N--CA 1.324 -6.763 0 CA-C-O 122.529 1.157 . . . . 0.0 111.923 . . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -42.08 -19.27 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.943 -1.935 . . . . 0.0 110.366 179.889 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.7 mt -114.12 -19.51 11.33 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.953 179.799 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.7 mm-40 -86.19 -16.23 38.44 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.721 -179.658 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -80.47 103.94 10.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.419 179.783 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.3 pt -65.31 -31.19 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.593 -179.854 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.21 28.35 4.3 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.04 179.966 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 21.8 ttpp -79.09 -19.26 51.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.545 0.212 . . . . 0.0 110.769 -179.692 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 78.5 -21.42 0.33 Allowed 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.164 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.11 36.43 0.87 Allowed Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -179.831 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.4 t80 73.69 48.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.647 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 12' ' ' ALA . 33.6 mt 64.6 70.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.517 -179.714 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.3 mm -134.66 -76.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.846 179.752 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.609 HD12 ' C ' ' A' ' 17' ' ' ILE . 2.7 pp -63.36 -6.53 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.143 -179.86 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.568 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -106.09 -65.8 0.65 Allowed Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.982 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.2 -19.95 74.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.683 179.668 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.447 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 63.05 9.75 4.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.629 0.252 . . . . 0.0 110.835 179.681 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 52.47 12.38 0.23 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.088 0.47 . . . . 0.0 109.783 -179.965 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' N ' ' C ' ' A' ' 20' ' ' ALA . 25.1 t70 -70.19 -102.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.274 179.975 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 23' ' ' HIS . 57.5 t-80 -67.41 2.08 1.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 110.103 179.582 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' H ' ' C ' ' A' ' 22' ' ' ASP . 1.4 tt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.129 -179.923 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.8 mtt180 . . . . . 1 N--CA 1.325 -6.704 0 CA-C-O 122.383 1.087 . . . . 0.0 112.047 . . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -40.99 -18.93 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.639 -179.954 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.8 tp -123.47 -13.27 7.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.632 179.492 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.0 tt0 -82.93 -8.62 59.55 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.556 -179.806 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -50.11 115.49 1.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.466 179.774 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 11' ' ' LYS . 17.6 tt -70.68 -23.17 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.608 -179.837 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -47.13 87.43 0.01 OUTLIER Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.344 -179.887 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 9' ' ' ILE . 9.6 mtpm? -149.55 4.76 0.6 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.768 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 53.17 56.39 7.53 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.285 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -41.1 88.17 0.01 OUTLIER Glycine 0 C--N 1.335 0.523 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.019 -179.847 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 12' ' ' ALA . 89.6 m-85 53.26 48.19 22.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.815 0.34 . . . . 0.0 110.091 -179.108 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.7 mt 62.13 80.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.626 -179.835 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.0 tp -146.57 -35.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.249 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 mm -98.96 -37.24 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.007 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.02 -57.81 5.06 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.226 179.358 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.86 86.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.671 179.545 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.04 40.58 17.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.7 179.814 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 23' ' ' HIS . 22.8 mt -68.71 -25.98 65.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.579 -179.957 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.42 34.0 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.942 -179.74 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 12.0 t-80 54.85 27.87 9.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.574 179.31 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.238 179.527 . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' GLU . 74.4 mtm180 . . . . . 1 N--CA 1.323 -6.813 0 CA-C-O 122.477 1.132 . . . . 0.0 111.835 . . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -42.17 -19.73 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.095 -1.866 . . . . 0.0 110.262 179.862 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.498 ' N ' ' C ' ' A' ' 4' ' ' ARG . 31.0 mt -108.82 -24.2 11.39 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.531 179.568 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 4' ' ' ARG . 27.6 tt0 -89.5 -5.41 57.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.057 0.456 . . . . 0.0 110.008 179.905 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -67.57 -51.27 52.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.644 179.987 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 10' ' ' GLY . 10.5 tt -167.32 -44.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.666 -179.9 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.517 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 75.9 -39.85 1.38 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.159 179.981 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 13' ' ' GLY . 86.4 mttt -79.77 81.14 6.08 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.768 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.38 15.34 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.8 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 65.45 19.25 66.49 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.616 -179.623 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.418 ' C ' ' H ' ' A' ' 16' ' ' ILE . 65.4 m-85 -147.18 -52.82 0.21 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.767 0.317 . . . . 0.0 110.207 179.879 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.3 pt -80.18 32.54 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 121.045 0.45 . . . . 0.0 110.53 179.815 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 17' ' ' ILE . 4.2 tp -148.97 -44.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.429 -179.787 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.568 HD12 ' C ' ' A' ' 17' ' ' ILE . 2.2 pp -71.3 1.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.294 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.539 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -163.89 -40.69 0.02 OUTLIER Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.946 -179.899 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -73.27 -29.14 64.75 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.92 179.989 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.18 8.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.653 0.263 . . . . 0.0 110.908 179.978 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 23' ' ' HIS . 8.3 tp 49.66 -115.26 0.79 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.299 179.933 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 57.05 -79.72 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.746 0.308 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 21' ' ' LEU . 14.8 p-80 -156.78 -1.66 0.12 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.623 -179.969 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.399 179.756 . . . . . . . . 0 0 . 1 . 055 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.593 ' O ' ' N ' ' A' ' 7' ' ' GLU . 20.8 mtp180 . . . . . 1 N--CA 1.315 -7.175 0 CA-C-O 121.399 0.619 . . . . 0.0 110.646 . . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -40.79 -23.71 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.112 -179.397 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 6' ' ' LEU . 10.5 mp -97.67 -26.04 14.9 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.444 179.558 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.3 tp10 -119.53 35.4 4.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.075 0.464 . . . . 0.0 109.906 179.9 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.523 ' NH2' ' CZ ' ' A' ' 4' ' ' ARG . 6.8 tpm_? -80.6 88.56 5.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.216 179.994 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.4 tt -53.8 -45.06 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.479 -179.921 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.541 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 71.01 -70.56 0.77 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.276 179.747 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 13' ' ' GLY . 51.6 mttp -51.79 108.15 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 110.605 -179.738 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.523 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -76.35 37.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.351 179.683 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 70.04 72.52 0.86 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.98 -179.832 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 51.4 t80 52.36 28.62 5.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.766 0.317 . . . . 0.0 110.459 179.979 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.5 mt 61.19 62.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.651 0.739 . . . . 0.0 109.77 -179.737 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -130.92 -50.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.046 -179.674 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.585 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.4 mp -66.29 -45.56 89.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.989 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -81.49 -41.08 10.27 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.721 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -58.86 -39.73 94.29 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.969 179.477 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.38 37.74 0.13 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.814 0.34 . . . . 0.0 110.744 -179.778 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 19' ' ' GLY . 16.7 tp -70.67 110.53 5.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.132 179.819 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.1 t0 55.76 39.18 30.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.559 -179.908 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 60.5 t60 52.09 50.03 19.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.519 179.983 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.945 179.955 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 7' ' ' GLU . 28.0 mtt180 . . . . . 1 N--CA 1.316 -7.164 0 CA-C-O 121.409 0.623 . . . . 0.0 110.846 . . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -44.1 -21.17 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.78 -179.647 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.492 ' N ' ' C ' ' A' ' 4' ' ' ARG . 26.7 mt -97.34 -23.86 15.92 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.536 179.663 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.3 tt0 -66.67 -18.5 65.41 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.234 179.869 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -81.9 47.68 1.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.261 179.734 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -50.0 120.86 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 110.48 -179.685 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.38 39.82 0.46 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.718 -179.842 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -50.64 -33.4 22.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.612 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.96 -15.93 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.383 179.932 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' O ' ' CG ' ' A' ' 14' ' ' PHE . . . 69.33 31.1 71.33 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.616 -179.788 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.404 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 67.0 m-85 -155.91 -10.3 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.703 0.287 . . . . 0.0 110.269 179.983 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.0 pt -153.98 42.37 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.096 0.474 . . . . 0.0 110.476 179.644 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.501 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.4 tp -147.94 -43.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.792 179.782 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.501 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.4 tp -77.44 -37.98 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.696 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.57 -39.79 6.58 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.166 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.02 -38.24 95.75 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 179.682 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.0 -73.42 0.05 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.42 HD23 ' C ' ' A' ' 21' ' ' LEU . 2.1 tt 63.59 87.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 109.984 179.797 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 30.0 p-10 -168.78 -120.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.023 -179.75 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -67.92 -12.56 60.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.0 0.429 . . . . 0.0 109.879 179.451 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.6 mt . . . . . 0 C--O 1.232 0.181 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.331 179.858 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' GLU . 38.1 mtt85 . . . . . 1 N--CA 1.326 -6.673 0 CA-C-O 122.634 1.207 . . . . 0.0 112.085 . . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -43.09 -19.81 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.223 179.858 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 mt -108.11 -21.51 12.77 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.93 179.932 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.4 tp10 -72.55 -9.41 58.55 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.116 -179.828 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -54.9 122.35 10.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.505 -179.983 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.608 HD12 ' C ' ' A' ' 9' ' ' ILE . 2.5 pp -69.36 -2.42 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.725 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.568 ' N ' HD12 ' A' ' 9' ' ' ILE . . . -75.91 71.61 1.91 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.227 -179.898 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -51.82 -31.17 26.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.022 0.439 . . . . 0.0 109.892 179.523 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.99 -2.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.336 179.931 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.17 32.29 12.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.838 -179.924 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -145.84 -10.35 0.52 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 110.232 -179.969 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 pt -156.94 36.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.018 179.4 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.0 tp -150.67 -21.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.943 -179.79 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.3 pp -88.81 4.41 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.836 179.347 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.506 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -166.93 -36.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.82 -179.944 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.19 -5.1 75.43 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.901 179.852 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -67.54 -56.52 9.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 0.0 110.47 -179.94 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 23' ' ' HIS . 5.0 tp 64.27 -0.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.447 179.965 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 20' ' ' ALA . 34.6 t70 -77.6 30.81 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.628 -179.94 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.427 ' H ' ' C ' ' A' ' 21' ' ' LEU . 66.3 m80 51.45 65.69 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.465 179.966 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.46 HD23 ' C ' ' A' ' 24' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.144 -179.973 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 7' ' ' GLU . 19.8 mtt180 . . . . . 1 N--CA 1.315 -7.212 0 CA-C-O 121.609 0.718 . . . . 0.0 110.455 . . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -40.97 -22.59 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.296 -179.616 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -97.47 -26.64 14.76 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.364 179.873 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.9 tp10 -67.21 -32.01 72.78 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.176 179.748 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -53.12 -70.13 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 -179.973 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 10' ' ' GLY . 14.2 tt -66.12 -39.97 85.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.355 -179.888 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 46.26 60.19 4.75 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.315 179.847 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -170.89 74.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.772 0.32 . . . . 0.0 110.473 179.925 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.95 65.12 5.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.007 179.855 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 49.02 53.09 19.93 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -179.576 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 60.68 38.67 18.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.898 0.38 . . . . 0.0 110.258 -179.519 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 mt 60.92 69.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.374 -179.862 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.592 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.9 tp -139.2 -50.51 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.91 179.688 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.592 ' N ' HG23 ' A' ' 16' ' ' ILE . 4.1 tp -79.27 -27.39 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.73 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.0 -50.89 3.54 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 178.97 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.39 -42.23 99.72 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.075 179.635 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.89 -52.23 58.32 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.447 -179.945 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.424 ' C ' ' H ' ' A' ' 23' ' ' HIS . 12.2 tp -60.57 -34.03 73.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.362 179.993 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -76.86 35.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.621 -179.872 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 21' ' ' LEU . 16.9 m80 49.97 44.95 25.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.543 179.892 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.347 -179.872 . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 46.3 mtt85 . . . . . 1 N--CA 1.324 -6.755 0 CA-C-O 122.434 1.112 . . . . 0.0 111.97 . . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 71.6 t-105 -41.14 -20.32 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.111 -1.859 . . . . 0.0 110.394 -179.874 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.6 tp -111.27 -23.21 10.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.315 179.528 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 14.9 mm-40 -92.77 -1.65 56.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.838 0.351 . . . . 0.0 110.534 179.998 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.407 ' CG ' ' H ' ' A' ' 9' ' ' ILE . 14.8 tpp180 -82.5 -133.46 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.291 -179.912 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 11' ' ' LYS . 18.8 tt -167.94 -21.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.482 -179.986 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.24 86.8 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.008 -179.948 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 9' ' ' ILE . 63.1 mttm -153.32 0.9 0.26 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.992 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 54.81 62.07 2.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.54 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -42.38 90.8 0.01 OUTLIER Glycine 0 C--N 1.333 0.382 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 -179.92 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.5 ' N ' ' O ' ' A' ' 12' ' ' ALA . 78.1 m-85 55.35 47.04 22.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.926 0.394 . . . . 0.0 110.089 -179.326 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 60.61 77.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.513 -179.966 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.582 HG23 ' N ' ' A' ' 17' ' ' ILE . 6.2 tp -142.91 -56.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.709 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.582 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.2 mp -77.81 -33.2 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.637 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.95 -48.67 9.62 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 178.361 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.76 -45.99 91.08 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.76 179.161 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.8 -72.63 0.05 OUTLIER 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.414 -179.934 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.6 tp 52.43 94.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.287 179.981 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -157.92 -28.44 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.326 179.99 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -168.0 -27.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 -179.958 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.0 mp . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.208 179.926 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 7' ' ' GLU . 2.9 mtp85 . . . . . 1 N--CA 1.311 -7.381 0 CA-C-O 121.629 0.728 . . . . 0.0 109.984 . . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.42 ' CZ2' ' NH2' ' A' ' 8' ' ' ARG . 74.2 t-105 -42.77 -23.17 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.795 179.996 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.475 ' N ' ' C ' ' A' ' 4' ' ' ARG . 28.8 mt -92.85 -27.68 16.98 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.748 179.902 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.573 ' N ' ' O ' ' A' ' 4' ' ' ARG . 71.5 mt-10 -79.78 10.87 3.62 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.606 179.965 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.42 ' NH2' ' CZ2' ' A' ' 5' ' ' TRP . 54.8 ttp180 -77.92 85.52 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.555 -179.978 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 10' ' ' GLY . 16.7 tt -73.86 -42.82 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.383 179.913 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.5 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 60.73 53.05 48.54 Favored Glycine 0 N--CA 1.453 -0.204 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.365 179.744 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -171.13 67.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 0.0 110.644 179.771 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.532 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -80.79 45.07 0.78 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.439 179.944 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.87 67.38 2.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.131 -0.556 . . . . 0.0 111.895 -179.977 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 52.6 t80 52.37 31.19 9.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.766 0.317 . . . . 0.0 110.555 -179.988 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 61.7 64.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.547 0.689 . . . . 0.0 110.263 -179.819 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.2 mm -131.8 -48.96 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.651 179.912 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.4 mp -69.55 -47.29 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.633 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.532 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -76.78 -42.3 21.32 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 178.978 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.43 -48.31 86.6 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.866 179.537 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.88 -47.45 71.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.732 0.301 . . . . 0.0 110.503 -179.863 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.4 36.53 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.893 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -81.17 -86.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.631 -179.712 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.481 ' CD2' ' H ' ' A' ' 23' ' ' HIS . 12.1 p80 -73.8 -27.0 60.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.626 -179.933 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.44 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.9 tt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.121 179.999 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 6' ' ' LEU . 93.9 mtt180 . . . . . 1 N--CA 1.325 -6.698 0 CA-C-O 122.462 1.125 . . . . 0.0 111.965 . . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.44 ' CE3' HD21 ' A' ' 6' ' ' LEU . 19.4 t90 -42.71 -18.46 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.291 -179.95 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.8 mt -118.01 -16.89 9.8 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.632 179.31 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 19.4 mm-40 -88.65 -1.14 57.91 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 120.887 0.375 . . . . 0.0 110.402 179.971 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 55.81 106.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 179.859 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 9' ' ' ILE . 4.4 tp -114.2 87.68 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 121.526 0.679 . . . . 0.0 110.024 179.946 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.9 -1.82 60.04 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.781 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 pttm 33.86 35.68 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.4 -0.4 . . . . 0.0 111.93 179.889 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.469 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -81.72 32.94 0.36 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.039 179.483 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.23 60.46 3.07 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.769 -179.755 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.492 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 66.9 t80 55.53 33.77 21.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.954 0.406 . . . . 0.0 110.191 -179.786 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.2 mm 61.85 66.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.509 0.671 . . . . 0.0 110.15 -179.802 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 mm -133.77 -51.09 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.715 179.624 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -68.18 -46.28 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.577 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.469 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -77.26 -48.11 8.52 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.429 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.38 -43.77 98.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.606 179.573 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.77 9.19 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.737 0.303 . . . . 0.0 110.92 179.761 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 21' ' ' LEU . 8.0 mp 53.85 -97.78 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.807 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 72.1 m-20 50.24 -87.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.676 179.79 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 21' ' ' LEU . 75.4 m80 -156.44 11.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.509 179.922 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 N--CA 1.465 0.279 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.355 179.958 . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 7' ' ' GLU . 79.0 mtt180 . . . . . 1 N--CA 1.325 -6.698 0 CA-C-O 122.511 1.148 . . . . 0.0 112.048 . . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 85.1 t90 -39.62 -21.63 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.521 179.936 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 10.8 tp -107.83 -26.99 10.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.455 179.347 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' ARG . 90.3 mt-10 -100.44 22.33 11.84 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.806 0.336 . . . . 0.0 110.29 179.79 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -53.29 -57.17 11.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.654 -179.809 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.456 ' C ' ' H ' ' A' ' 11' ' ' LYS . 14.0 pt -71.29 -35.2 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.666 -179.862 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.7 -19.19 1.21 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.07 -179.953 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 9' ' ' ILE . 41.9 mtmt -73.99 95.16 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.567 -179.978 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.426 ' HB3' ' H ' ' A' ' 15' ' ' ILE . . . -58.96 -6.46 0.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.315 179.829 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 60.53 15.73 41.04 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.772 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -164.67 -39.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.942 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' H ' ' HB3' ' A' ' 12' ' ' ALA . 13.5 mt -111.24 57.48 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.709 179.38 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.1 tp -151.78 -45.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.485 -0.78 . . . . 0.0 108.911 -179.988 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.526 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.1 pp -91.17 4.98 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.749 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.509 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -136.14 -57.03 0.06 OUTLIER Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.631 -179.761 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.5 -46.07 94.53 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.702 179.895 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.99 44.98 28.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 110.691 179.922 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.7 mm? -63.15 103.09 0.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.926 179.766 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 35.3 t70 56.26 56.17 6.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 -179.849 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 19.8 p-80 40.82 39.5 0.81 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.349 -179.935 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.9 tp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.256 179.826 . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 6' ' ' LEU . 95.7 mtt180 . . . . . 1 N--CA 1.324 -6.746 0 CA-C-O 122.507 1.146 . . . . 0.0 112.066 . . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -40.26 -19.85 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.66 -179.985 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.5 mt -120.37 -15.46 8.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.013 179.499 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.6 mm-40 -87.95 -7.04 57.68 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.645 -179.91 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -68.92 88.93 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.254 179.774 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.4 pt -60.22 -34.71 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.962 -179.627 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.38 17.51 1.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.696 -179.671 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -70.25 -5.16 25.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.888 -0.156 . . . . 0.0 110.827 -179.779 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.99 52.02 9.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.64 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.509 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -43.49 87.45 0.01 OUTLIER Glycine 0 C--N 1.335 0.498 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.868 -179.337 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 12' ' ' ALA . 89.4 m-85 52.74 41.75 31.6 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.074 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 mm 61.16 77.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.183 -179.416 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.659 HG23 ' H ' ' A' ' 17' ' ' ILE . 6.6 tp -140.37 -59.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.883 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.659 ' H ' HG23 ' A' ' 16' ' ' ILE . 3.7 tp -74.98 -31.02 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.011 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.02 -48.13 5.27 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 179.011 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.7 -44.84 96.92 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.037 -0.602 . . . . 0.0 111.706 179.612 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.44 -65.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.402 179.875 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.7 79.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.866 179.953 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -159.77 33.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.483 -179.791 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.42 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 33.8 t-80 55.18 22.91 4.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.659 179.948 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 tp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.209 179.972 . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' GLU . 3.6 mmt180 . . . . . 1 N--CA 1.318 -7.044 0 CA-C-O 121.329 0.585 . . . . 0.0 110.428 . . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -44.19 -18.67 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.961 -179.63 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.497 ' N ' ' C ' ' A' ' 4' ' ' ARG . 9.3 mp -109.74 -19.28 13.22 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.067 179.235 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 4' ' ' ARG . 15.1 mp0 -112.27 12.88 20.36 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 120.71 0.29 . . . . 0.0 110.328 -179.89 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 4' ' ' ARG . 61.0 ttp180 -52.32 123.67 11.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.378 179.795 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 tp -54.79 92.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.344 0.593 . . . . 0.0 110.16 -179.883 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.12 -30.83 10.44 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.787 -179.974 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -60.37 104.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.07 179.851 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.88 -4.01 4.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.691 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.71 34.19 5.16 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.139 179.722 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 15' ' ' ILE . 30.4 t80 -170.2 -17.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' PHE . 8.9 pt -155.55 55.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.13 0.491 . . . . 0.0 110.361 179.787 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.4 tp -144.16 -42.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.061 179.792 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.522 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -71.87 4.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.901 179.676 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.471 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -175.89 -22.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.033 179.999 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.47 -31.84 79.97 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.991 179.993 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.38 -59.35 2.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.766 0.317 . . . . 0.0 110.567 -179.978 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tp 54.98 37.62 29.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.351 -179.943 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.61 -33.28 58.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.602 179.992 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -164.66 6.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.437 -179.98 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.161 179.989 . . . . . . . . 0 0 . 1 . 065 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 6' ' ' LEU . 48.5 mtp180 . . . . . 1 N--CA 1.324 -6.752 0 CA-C-O 122.513 1.149 . . . . 0.0 111.988 . . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -42.78 -17.59 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 112.828 -1.987 . . . . 0.0 110.393 179.904 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.4 mt -121.28 -14.38 8.33 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.933 179.621 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.2 tt0 -82.64 0.05 44.9 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.181 -179.974 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -50.26 163.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 180.0 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.6 pt -54.0 -43.03 57.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.458 -179.922 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.83 -48.59 2.35 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.771 179.39 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HZ2' HG12 ' A' ' 17' ' ' ILE . 9.5 mtpm? -75.44 -75.52 0.17 Allowed 'General case' 0 C--N 1.331 -0.217 0 O-C-N 122.741 -0.27 . . . . 0.0 110.817 -179.572 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 66.81 30.7 7.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.525 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -36.54 -39.82 0.39 Allowed Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.782 179.537 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.487 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 74.0 t80 179.78 54.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.296 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 pt 38.95 53.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.005 -177.816 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -113.83 -47.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.075 -178.847 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.516 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -78.31 6.5 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.176 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.44 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -141.97 -50.99 0.04 OUTLIER Glycine 0 C--N 1.333 0.406 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.935 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.33 -44.72 84.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.712 179.618 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.48 10.41 4.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.8 0.333 . . . . 0.0 110.41 179.913 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' HIS . 19.5 tp 53.35 101.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.092 -179.995 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 56.75 -79.8 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 21' ' ' LEU . 34.0 t-80 -162.25 29.16 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 110.396 179.901 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.442 HD23 ' C ' ' A' ' 24' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.203 179.977 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' GLU . 22.0 mtt180 . . . . . 1 N--CA 1.319 -7.02 0 CA-C-O 121.317 0.58 . . . . 0.0 110.966 . . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.565 ' CE3' HD21 ' A' ' 6' ' ' LEU . 33.9 t90 -43.99 -18.3 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.723 -179.981 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.565 HD21 ' CE3' ' A' ' 5' ' ' TRP . 44.0 mt -113.25 -15.9 12.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.646 179.091 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.5 mt-10 -116.03 15.08 16.16 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.772 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 ttm180 -76.85 126.28 30.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.474 179.885 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 tp -56.28 108.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.253 0.549 . . . . 0.0 109.962 179.852 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.54 38.96 0.48 Allowed Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.865 -179.871 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.14 -26.74 63.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.38 . . . . 0.0 110.316 179.846 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.451 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -158.96 31.36 0.21 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.158 179.9 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.62 53.76 11.67 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.967 -179.945 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 61.03 33.43 19.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.725 0.297 . . . . 0.0 110.323 -179.979 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 mt 63.24 64.96 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.576 0.703 . . . . 0.0 110.226 -179.74 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -133.01 -50.41 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.776 179.755 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.631 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -70.46 -43.6 77.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.733 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.451 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -76.25 -48.17 9.9 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.092 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -63.49 -52.28 47.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.636 179.45 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.436 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 58.25 4.5 0.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.717 0.294 . . . . 0.0 110.931 179.749 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 21' ' ' LEU . 8.2 mp 50.66 13.47 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.357 179.883 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' N ' ' C ' ' A' ' 20' ' ' ALA . 72.8 m-20 -75.69 37.01 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.615 -179.936 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.434 ' H ' ' C ' ' A' ' 21' ' ' LEU . 6.4 t60 49.91 37.71 14.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 110.555 179.985 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.9 tp . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.101 -179.903 . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 5.5 mtp85 . . . . . 1 N--CA 1.317 -7.112 0 CA-C-O 121.475 0.655 . . . . 0.0 110.629 . . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -43.55 -17.91 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.933 -179.84 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -118.34 -12.82 9.85 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.104 179.133 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 45.2 mm-40 -122.18 29.41 7.03 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-O 120.784 0.326 . . . . 0.0 110.319 179.877 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.6 ttp85 -72.42 89.01 1.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.387 179.908 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 tp -55.64 101.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.167 0.508 . . . . 0.0 110.288 -179.98 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.0 -35.33 12.77 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.921 -179.888 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.466 ' C ' ' H ' ' A' ' 13' ' ' GLY . 66.2 mttm -69.39 82.75 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 0.0 110.469 -179.849 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.455 ' O ' ' CD2' ' A' ' 14' ' ' PHE . . . -55.73 -7.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.032 179.46 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 62.72 52.2 50.29 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.971 -179.967 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.455 ' CD2' ' O ' ' A' ' 12' ' ' ALA . 65.4 m-85 -156.53 -61.88 0.1 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.698 0.285 . . . . 0.0 110.668 179.813 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 14' ' ' PHE . 14.9 pt -155.76 57.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.305 0.574 . . . . 0.0 110.457 -179.906 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.4 -69.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.235 179.665 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -73.62 -35.68 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.349 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.71 -47.04 10.34 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 179.46 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -74.22 -44.55 28.37 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.108 -0.567 . . . . 0.0 111.872 179.714 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.88 6.3 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.668 0.27 . . . . 0.0 110.918 179.844 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.1 mt 45.86 70.96 0.32 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -158.99 53.85 0.41 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.435 179.901 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.479 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 12.7 t60 52.2 23.89 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.396 -179.913 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.377 179.959 . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 56.5 mtt85 . . . . . 1 N--CA 1.325 -6.712 0 CA-C-O 122.588 1.185 . . . . 0.0 111.92 . . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -40.98 -20.78 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 112.995 -1.911 . . . . 0.0 110.594 179.988 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.3 tp -108.06 -22.96 12.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.725 179.956 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.2 tp10 -46.26 -43.79 15.89 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.892 -179.755 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -62.31 179.58 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.409 179.863 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.5 tt -49.49 -35.48 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.745 -179.923 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.51 64.1 3.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.9 179.979 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -168.44 74.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 110.479 -179.877 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -74.7 70.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.265 179.903 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.33 62.25 5.25 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.771 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 55.74 32.72 19.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.786 0.326 . . . . 0.0 110.523 -179.755 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 mm 60.6 66.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.405 0.622 . . . . 0.0 110.101 -179.902 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -133.41 -46.04 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.883 179.935 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.1 mm -75.34 -46.98 36.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.975 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.433 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -76.25 -50.41 7.55 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.454 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.22 -36.78 93.25 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.95 179.749 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 51.6 37.17 19.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.757 0.313 . . . . 0.0 110.62 179.99 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.0 mt -54.84 -12.76 0.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.407 179.916 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -57.79 -76.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.356 179.951 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -84.42 -27.01 27.88 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.583 -179.998 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.9 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.435 -179.803 . . . . . . . . 0 0 . 1 . 069 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' GLU . 41.7 mtp180 . . . . . 1 N--CA 1.323 -6.782 0 CA-C-O 122.677 1.227 . . . . 0.0 111.984 . . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -41.0 -21.71 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.934 -1.939 . . . . 0.0 110.493 179.834 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' ARG . 47.9 tp -104.4 -25.04 12.98 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.712 -179.838 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.1 tm-20 -51.14 -35.28 34.9 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.351 -179.899 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -48.84 128.77 16.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.609 -180.0 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 10' ' ' GLY . 13.6 tt -66.19 -51.77 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.547 -179.814 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.603 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 42.04 76.64 0.1 OUTLIER Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.484 -0.389 . . . . 0.0 112.801 179.522 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -148.16 -9.61 0.38 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.565 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 55.63 62.18 2.53 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.38 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.3 86.84 0.01 OUTLIER Glycine 0 C--N 1.333 0.372 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.025 -179.598 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 12' ' ' ALA . 28.7 t80 64.98 44.35 3.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.814 0.34 . . . . 0.0 110.526 -179.618 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.2 mm 60.43 76.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.54 179.448 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 mm -135.86 -55.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.914 179.129 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 mm -69.9 -49.28 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.619 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.51 -43.75 35.92 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 178.833 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.09 -48.62 85.02 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.571 179.292 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.75 -14.6 0.96 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.0 110.224 179.745 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' HIS . 8.0 tp 58.3 112.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.192 179.966 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 57.5 -78.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.546 -179.728 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' LEU . 2.3 t60 -168.62 24.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.392 179.827 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.464 0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.461 179.902 . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 51.2 mtt85 . . . . . 1 N--CA 1.325 -6.677 0 CA-C-O 122.565 1.174 . . . . 0.0 112.051 . . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -44.66 -15.62 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.918 -1.946 . . . . 0.0 110.305 179.673 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 0.7 OUTLIER -129.9 -6.94 4.48 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.452 179.782 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -84.2 -25.86 29.19 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.313 179.926 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -49.18 156.23 0.58 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.628 179.698 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 9' ' ' ILE . 6.3 tp -168.5 126.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.196 179.829 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.61 20.81 0.05 OUTLIER Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.726 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -73.44 3.4 6.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.229 -0.188 . . . . 0.0 110.904 -179.768 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.33 36.92 28.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.81 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -34.24 88.86 0.01 OUTLIER Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.926 -179.561 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 12' ' ' ALA . 59.2 t80 56.9 57.4 4.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.063 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.1 pt 35.0 79.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.342 -179.012 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.601 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.2 tp -135.61 -51.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.076 179.665 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.601 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.5 tp -89.06 -36.12 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.003 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.62 -32.07 16.75 Favored Glycine 0 C--N 1.331 0.293 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 178.833 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.28 -47.17 13.41 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.505 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.72 -28.43 14.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.929 0.395 . . . . 0.0 110.265 179.658 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.5 tp 55.39 70.8 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.676 179.816 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 52.11 46.29 26.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.791 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 50.19 52.34 14.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.679 179.81 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.293 179.984 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 7' ' ' GLU . 54.7 mtt85 . . . . . 1 N--CA 1.325 -6.7 0 CA-C-O 122.528 1.156 . . . . 0.0 112.075 . . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -41.39 -25.83 0.05 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.107 -1.861 . . . . 0.0 109.822 179.907 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 6' ' ' LEU . 2.7 mm? -93.57 -30.46 14.97 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.336 179.682 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.0 tt0 -87.86 -5.4 58.61 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.959 0.409 . . . . 0.0 110.259 -179.799 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -66.68 -24.74 66.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.438 179.864 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.9 pt -50.33 -31.87 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.69 -179.853 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.07 66.05 3.05 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.682 -179.814 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.523 ' NZ ' ' CD1' ' A' ' 14' ' ' PHE . 20.9 tptp -158.29 83.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.874 0.369 . . . . 0.0 110.135 -179.881 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.32 63.25 4.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.353 -179.831 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.443 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 47.4 58.07 6.84 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -179.74 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.523 ' CD1' ' NZ ' ' A' ' 11' ' ' LYS . 43.5 m-85 59.2 38.01 23.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.563 0.22 . . . . 0.0 110.458 -179.512 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt 59.62 69.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.85 0.357 . . . . 0.0 110.196 -179.93 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.565 HG23 ' N ' ' A' ' 17' ' ' ILE . 8.5 tp -139.08 -48.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.121 179.811 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.565 ' N ' HG23 ' A' ' 16' ' ' ILE . 4.3 tp -80.7 -26.86 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.946 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.52 -57.63 1.95 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.145 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.01 84.58 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.499 179.246 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 54.7 15.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.613 0.244 . . . . 0.0 110.875 179.657 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.7 mt -66.21 4.17 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.758 0.313 . . . . 0.0 110.583 179.855 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 20' ' ' ALA . 30.0 t0 -66.93 -24.73 66.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.82 -179.825 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.414 ' H ' ' H ' ' A' ' 24' ' ' LEU . 54.5 t60 -169.39 -8.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.174 -179.767 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.414 ' H ' ' H ' ' A' ' 23' ' ' HIS . 49.2 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.236 -179.865 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 7' ' ' GLU . 54.2 mtp180 . . . . . 1 N--CA 1.325 -6.695 0 CA-C-O 122.506 1.146 . . . . 0.0 112.033 . . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 27.3 t-105 -41.08 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.544 -179.906 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.8 tp -113.17 -22.13 10.66 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.36 179.457 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.9 mt-10 -101.95 13.01 35.99 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.655 0.264 . . . . 0.0 110.54 -179.994 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -75.03 -74.57 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.769 -179.93 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 11' ' ' LYS . 15.7 tt -75.37 -25.02 17.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.752 -179.707 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . -52.45 -8.28 0.5 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.265 -179.821 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 9' ' ' ILE . 24.3 mtpp -76.96 22.95 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.861 -179.818 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 15' ' ' ILE . . . 57.29 40.24 27.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.218 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -34.47 89.01 0.01 OUTLIER Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.449 -179.508 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 12' ' ' ALA . 35.0 t80 66.65 53.78 0.89 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.748 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 12' ' ' ALA . 9.7 pt 37.86 82.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.759 -179.493 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.0 mm -132.93 -60.29 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.846 178.844 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -69.43 -55.47 15.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.779 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.64 -37.19 52.65 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.024 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.09 -51.46 55.03 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 179.569 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.5 -68.75 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.844 0.354 . . . . 0.0 110.314 179.898 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.0 tp 49.91 95.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.62 179.821 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -168.01 -31.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.53 179.996 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -171.49 -16.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.52 179.958 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.1 mp . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.195 179.958 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 49.2 mtp180 . . . . . 1 N--CA 1.325 -6.718 0 CA-C-O 122.518 1.151 . . . . 0.0 111.968 . . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -42.43 -18.82 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.93 -1.941 . . . . 0.0 110.446 179.959 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.6 mt -113.86 -18.64 11.74 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.908 179.884 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.9 tt0 -50.01 -20.44 0.95 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.651 -179.736 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -56.61 144.56 31.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.563 -179.872 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 10' ' ' GLY . 18.2 tt -68.42 -37.14 77.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.521 -179.946 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 80.23 -32.64 2.27 Favored Glycine 0 C--N 1.331 0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.071 179.843 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -76.82 23.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.335 179.984 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 48.44 67.05 0.91 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.288 -179.517 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -40.48 86.41 0.01 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.52 -179.54 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 12' ' ' ALA . 17.6 m-85 63.14 53.29 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.683 0.278 . . . . 0.0 110.964 -179.699 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 mt 62.54 76.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.335 -0.059 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.591 179.217 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.5 mm -134.39 -64.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.872 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.7 mm -78.19 -32.87 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.35 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.513 ' H ' ' CB ' ' A' ' 12' ' ' ALA . . . -68.74 -53.74 18.43 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.519 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.35 -47.95 15.69 Favored Glycine 0 C--N 1.332 0.314 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.111 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.88 27.4 1.13 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.723 0.296 . . . . 0.0 110.917 179.783 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.4 tp -62.96 96.47 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.197 179.963 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 23.5 m-20 55.35 47.08 22.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.517 -179.834 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.501 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 50.0 p-80 41.2 52.62 3.52 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.17 -179.935 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.133 179.951 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 80.8 mtt180 . . . . . 1 N--CA 1.323 -6.78 0 CA-C-O 122.544 1.164 . . . . 0.0 111.911 . . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.466 ' CE3' HD21 ' A' ' 6' ' ' LEU . 28.5 t90 -41.9 -19.78 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.32 179.908 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.1 mt -108.71 -25.3 10.91 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.32 179.373 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.7 mt-10 -93.27 26.52 2.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -62.44 -144.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.444 -179.997 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.401 ' C ' ' N ' ' A' ' 11' ' ' LYS . 23.2 pt -50.14 -24.33 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.461 179.93 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.1 18.26 0.43 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.049 -179.965 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 9' ' ' ILE . 25.4 mmtp -133.73 44.84 2.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.728 0.299 . . . . 0.0 110.302 -179.892 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.483 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -79.72 52.91 1.52 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.569 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 68.69 30.64 72.81 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.348 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 70.57 69.38 0.2 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.47 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.1 pt 35.34 60.52 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.673 -179.72 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -138.48 -47.36 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.547 179.036 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.521 ' N ' HG23 ' A' ' 16' ' ' ILE . 38.0 mm -73.82 -53.21 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.817 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.483 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -75.76 -29.43 59.36 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.425 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -72.06 -37.59 60.04 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.786 -0.526 . . . . 0.0 111.786 179.441 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.77 35.28 0.15 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.843 0.354 . . . . 0.0 110.395 179.796 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.45 ' H ' ' C ' ' A' ' 19' ' ' GLY . 21.5 tp -55.44 119.32 5.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.184 -179.961 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 52.02 24.76 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.501 179.966 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 51.52 46.66 26.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.454 -179.953 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.203 -179.994 . . . . . . . . 0 0 . 1 . 075 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 7' ' ' GLU . 68.0 mtp180 . . . . . 1 N--CA 1.324 -6.765 0 CA-C-O 122.586 1.184 . . . . 0.0 112.032 . . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -42.55 -24.57 0.06 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.649 -179.966 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.505 HD12 ' N ' ' A' ' 6' ' ' LEU . 10.4 mp -98.0 -27.94 14.01 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.196 179.389 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 4' ' ' ARG . 17.7 tt0 -87.85 38.43 0.84 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.036 0.446 . . . . 0.0 110.238 -179.873 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -64.15 -31.99 73.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 179.988 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -167.74 -32.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.381 179.935 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.05 87.23 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.238 179.701 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 39.5 tttm -168.72 -17.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.236 179.645 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 71.72 -11.4 0.74 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.59 179.95 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 35.85 55.0 1.12 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 179.932 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 t80 68.32 40.31 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.568 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 12' ' ' ALA . 18.1 mt 63.65 79.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.749 -179.711 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 12' ' ' ALA . 4.4 tp -148.21 -19.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.186 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.41 ' H ' ' H ' ' A' ' 16' ' ' ILE . 29.0 mm -114.25 -38.21 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.598 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.96 -53.98 5.05 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.245 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.55 -28.99 37.36 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 179.627 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 49.84 19.53 0.45 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.88 0.372 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.3 mt 57.7 6.23 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.475 -179.886 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 20' ' ' ALA . 88.9 m-20 -80.83 19.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.471 179.957 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.7 m80 54.0 44.05 29.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.478 -179.845 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.132 -179.955 . . . . . . . . 0 0 . 1 . 076 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 6' ' ' LEU . 78.9 mtp180 . . . . . 1 N--CA 1.325 -6.703 0 CA-C-O 122.552 1.168 . . . . 0.0 111.981 . . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.565 ' CE3' HD21 ' A' ' 6' ' ' LEU . 27.8 t90 -42.62 -18.53 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 112.93 -1.941 . . . . 0.0 110.371 179.847 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.565 HD21 ' CE3' ' A' ' 5' ' ' TRP . 34.4 mt -114.62 -18.01 11.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.96 179.597 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.3 tt0 -47.22 -34.02 6.01 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.705 -179.816 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 50.59 85.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 179.935 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.632 ' N ' HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -46.58 -21.37 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.918 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 34.61 28.37 0.01 OUTLIER Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.483 179.209 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 9' ' ' ILE . 21.0 tptp -51.5 -30.73 21.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.084 179.726 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.6 -42.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.152 179.897 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.79 -44.87 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.785 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 64.2 t80 -173.93 33.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.615 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.2 mt 64.88 58.63 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 121.811 0.815 . . . . 0.0 109.461 -178.765 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.3 mm -119.49 -56.08 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.328 -179.784 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 35.1 mm -73.98 -50.31 29.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.771 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.85 -49.98 72.64 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.034 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.76 -53.33 31.71 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.227 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.63 35.79 12.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.559 0.219 . . . . 0.0 110.895 179.607 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.2 mt -73.83 84.64 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.197 179.816 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 51.38 59.15 4.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.472 -179.91 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 33.9 m170 53.55 55.81 8.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.542 -179.863 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 24' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.075 -179.897 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 6' ' ' LEU . 44.7 mtt85 . . . . . 1 N--CA 1.324 -6.748 0 CA-C-O 122.406 1.098 . . . . 0.0 111.954 . . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 42.3 t-105 -41.14 -19.98 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.443 -179.972 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 8.1 tp -115.79 -20.28 10.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.294 179.323 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 52.3 mt-10 -91.72 21.33 4.84 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.744 0.307 . . . . 0.0 110.636 179.977 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -50.81 -32.79 21.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.513 179.896 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 pt -47.66 119.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.411 0.624 . . . . 0.0 110.638 -179.625 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.03 -6.95 61.46 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.899 -179.87 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 13' ' ' GLY . 9.5 mtmp? -60.69 98.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.0 110.475 179.976 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -54.89 -8.28 0.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.296 179.625 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 61.05 4.36 4.47 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.641 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.46 ' O ' HG23 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -82.8 -70.98 0.51 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.973 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 14' ' ' PHE . 12.8 pt -158.85 46.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.139 0.495 . . . . 0.0 110.145 179.1 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -80.37 -67.82 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.99 179.374 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.523 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -81.07 1.31 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.035 179.743 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -101.53 -67.8 0.81 Allowed Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.796 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.435 ' C ' ' N ' ' A' ' 21' ' ' LEU . . . -81.46 -37.96 15.97 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.632 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.95 11.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.741 179.898 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.435 ' N ' ' C ' ' A' ' 19' ' ' GLY . 33.3 mt 48.58 77.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.751 179.821 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 8.9 p-10 -174.82 23.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.102 179.735 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.406 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 76.0 t60 57.12 32.26 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.652 -179.859 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.08 179.933 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 68.2 mtt85 . . . . . 1 N--CA 1.325 -6.716 0 CA-C-O 122.489 1.138 . . . . 0.0 111.994 . . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -42.08 -18.88 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.992 -1.913 . . . . 0.0 110.43 -179.988 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.2 mp -112.82 -21.72 11.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.536 179.215 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.1 tt0 -91.4 -5.68 54.04 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.06 0.457 . . . . 0.0 110.317 -179.832 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -71.95 148.59 45.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.62 179.859 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 tp -52.71 97.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.206 0.526 . . . . 0.0 110.129 179.878 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.99 30.2 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.793 -179.809 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -49.69 -18.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.69 -179.961 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.57 -10.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.158 -179.851 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.11 57.96 0.13 Allowed Glycine 0 C--N 1.333 0.404 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.636 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.4 t80 69.31 22.77 6.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.802 0.334 . . . . 0.0 110.31 -179.428 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 mt 62.18 65.27 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.583 0.706 . . . . 0.0 110.308 179.956 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 mm -132.72 -49.71 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.627 179.766 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.647 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -71.53 -45.94 65.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.673 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.78 -46.33 24.29 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 178.969 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.431 ' C ' ' N ' ' A' ' 21' ' ' LEU . . . -67.31 -56.57 11.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.924 179.537 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.48 15.44 0.14 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.877 0.37 . . . . 0.0 110.606 -179.968 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 23' ' ' HIS . 6.7 tp -83.76 -13.52 53.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.287 -179.856 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -75.0 36.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.714 179.886 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.472 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 61.8 t60 52.56 28.47 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.556 179.963 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.057 179.989 . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 85.4 mtt180 . . . . . 1 N--CA 1.325 -6.719 0 CA-C-O 122.479 1.133 . . . . 0.0 111.999 . . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 27.5 t90 -41.37 -19.66 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.425 -179.966 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.0 mt -114.77 -21.16 10.32 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.273 179.032 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 tt0 -92.21 31.93 1.23 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.978 0.418 . . . . 0.0 109.942 179.905 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -51.44 -63.9 0.98 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.753 -179.739 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.409 ' O ' HG23 ' A' ' 9' ' ' ILE . 2.9 tp -51.13 100.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.19 0.519 . . . . 0.0 110.261 -179.762 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.73 -43.52 7.71 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.111 -179.801 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 13' ' ' GLY . 60.8 mttp -57.5 106.91 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.233 -179.971 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.76 0.94 4.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.661 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 42.06 35.29 1.64 Allowed Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.306 179.858 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' HG23 ' A' ' 15' ' ' ILE . 61.4 t80 -168.35 -13.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.957 -179.888 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 14' ' ' PHE . 11.9 pt -157.78 52.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.061 0.458 . . . . 0.0 110.245 179.371 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.6 tp -143.82 -43.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.215 179.994 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.5 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -62.22 -2.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.082 179.396 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . 178.2 -10.49 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.966 -179.925 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 18' ' ' GLY . . . -66.44 -35.4 90.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.141 -179.979 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -12.6 61.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.739 0.304 . . . . 0.0 110.698 -179.815 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 21' ' ' LEU . 2.4 tt 60.3 109.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.149 -179.977 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 57.52 23.84 9.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.756 179.93 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.467 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 21.2 t-160 50.79 37.59 17.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.648 179.807 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.411 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.166 179.922 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.49 ' O ' ' N ' ' A' ' 6' ' ' LEU . 27.8 mtp85 . . . . . 1 N--CA 1.322 -6.831 0 CA-C-O 122.667 1.223 . . . . 0.0 111.983 . . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.503 ' CE3' HD21 ' A' ' 6' ' ' LEU . 20.1 t90 -43.54 -18.18 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 112.885 -1.962 . . . . 0.0 110.232 179.894 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.503 HD21 ' CE3' ' A' ' 5' ' ' TRP . 37.0 mt -116.83 -14.86 10.72 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.075 179.861 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.3 tp10 -63.36 -23.27 67.34 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.201 -179.931 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.9 ttt85 -47.14 107.72 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.709 179.881 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -50.2 98.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.17 0.509 . . . . 0.0 110.484 -179.791 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.69 -17.85 13.99 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.874 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 13' ' ' GLY . 57.7 mttm -64.18 100.46 0.34 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 110.478 -179.987 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.91 -4.93 0.82 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.047 179.742 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 57.08 8.81 3.48 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.646 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -87.17 -61.47 1.72 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.885 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 pt -155.18 40.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.167 0.508 . . . . 0.0 110.283 179.506 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 16' ' ' ILE . 1.5 mp -89.73 -45.41 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.435 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.515 ' CD1' ' H ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -75.19 17.81 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.363 179.522 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -157.37 -39.6 0.02 OUTLIER Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.466 -179.756 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.89 -3.48 70.52 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.306 -0.473 . . . . 0.0 112.415 -179.582 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.05 45.62 0.54 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.533 -179.96 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -135.87 6.66 3.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.152 179.959 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' N ' HD12 ' A' ' 21' ' ' LEU . 63.1 m-20 -76.61 -23.93 53.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.326 179.822 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -166.68 -39.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.499 -179.993 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.185 -179.898 . . . . . . . . 0 0 . 1 . 081 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 7' ' ' GLU . 91.2 mtt180 . . . . . 1 N--CA 1.324 -6.73 0 CA-C-O 122.572 1.177 . . . . 0.0 112.115 . . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -39.13 -23.84 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.713 -179.942 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.7 tp -101.82 -25.95 13.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.068 -179.535 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.2 tp10 -58.81 -35.23 72.52 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.277 -179.808 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -69.11 177.01 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.671 -179.822 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.3 tp -174.05 131.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.938 179.906 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.88 -23.05 0.19 Allowed Glycine 0 C--N 1.333 0.417 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -179.773 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -61.96 110.32 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.028 179.712 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.72 2.7 7.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.799 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 39.38 31.95 0.23 Allowed Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.327 -179.962 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.433 ' H ' ' H ' ' A' ' 15' ' ' ILE . 66.6 t80 -162.72 -10.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.79 0.328 . . . . 0.0 110.571 -179.794 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.433 ' H ' ' H ' ' A' ' 14' ' ' PHE . 2.8 tt -161.58 54.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.753 0.787 . . . . 0.0 109.926 179.824 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.4 tp -149.0 -39.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.462 -179.757 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.457 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.1 pp -92.04 16.71 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 179.614 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.38 -57.51 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 179.888 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.69 -38.77 37.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.1 -0.571 . . . . 0.0 111.995 -179.676 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.84 -70.56 0.3 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.86 0.362 . . . . 0.0 110.376 179.99 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 23' ' ' HIS . 2.1 tt -170.89 96.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.988 -179.996 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.494 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 32.4 t70 55.09 -84.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.519 -179.815 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.494 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 94.0 m-70 -157.77 36.3 0.26 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.57 179.948 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.16 179.959 . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 7' ' ' GLU . 29.1 mmt180 . . . . . 1 N--CA 1.324 -6.739 0 CA-C-O 122.569 1.176 . . . . 0.0 111.861 . . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -42.85 -22.57 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.98 179.76 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 4' ' ' ARG . 41.8 tp -100.0 -25.92 14.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.487 179.901 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.9 tt0 -50.58 -31.3 15.42 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.313 179.869 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.0 ttt85 57.85 64.2 1.6 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.548 -179.942 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -55.86 111.35 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.174 0.511 . . . . 0.0 109.954 179.937 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.93 35.11 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.691 -179.687 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -50.1 -41.42 48.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.779 -179.86 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.88 -39.28 1.23 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.014 -179.872 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.2 60.95 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.651 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 23.6 t80 69.0 23.61 6.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.76 0.314 . . . . 0.0 110.184 -179.074 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.2 mt 62.14 71.71 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.591 0.71 . . . . 0.0 110.448 -179.986 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.5 mm -132.82 -51.97 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.699 179.603 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.2 mm -82.87 -41.31 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.569 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.22 -50.77 42.91 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.086 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -73.84 -50.44 11.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.941 179.504 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.75 1.04 0.27 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.557 0.218 . . . . 0.0 110.985 -179.961 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.3 mm? 52.42 96.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.831 0.348 . . . . 0.0 110.218 179.852 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -171.79 -54.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.297 179.793 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -171.39 -10.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.406 179.965 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 N--CA 1.463 0.225 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.394 179.979 . . . . . . . . 0 0 . 1 . 083 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 6' ' ' LEU . 77.8 mtm180 . . . . . 1 N--CA 1.323 -6.808 0 CA-C-O 122.492 1.139 . . . . 0.0 111.956 . . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 57.3 t90 -41.43 -19.89 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.225 179.766 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.1 tp -119.72 -17.65 8.53 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.883 179.254 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.2 tt0 -91.96 22.95 3.95 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 120.978 0.418 . . . . 0.0 110.03 179.85 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -52.6 132.56 35.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.614 -179.819 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 9' ' ' ILE . 15.7 tt -72.15 120.92 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.05 0.453 . . . . 0.0 110.129 179.749 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.08 -26.7 57.52 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.03 -179.692 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -66.79 103.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.381 -179.973 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.39 -2.75 4.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.727 179.511 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.64 29.44 4.12 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.728 -179.742 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.428 ' O ' HG23 ' A' ' 15' ' ' ILE . 36.7 t80 -162.45 -15.42 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.166 -0.214 . . . . 0.0 110.922 -179.587 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 14' ' ' PHE . 9.9 pt -156.68 54.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 110.353 179.541 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.481 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.3 tp -143.21 -42.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.039 179.733 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.501 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -65.49 -3.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.95 179.289 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.79 -24.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.839 -179.869 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.4 4.43 55.57 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.306 -0.473 . . . . 0.0 111.925 179.994 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.3 -20.21 57.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.323 . . . . 0.0 110.716 -179.88 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.6 mt 56.42 15.41 1.99 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.503 -179.798 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.33 -60.7 2.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.603 179.951 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 76.4 t60 -170.15 1.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.569 179.989 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 2.4 mm? . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.114 179.976 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 6' ' ' LEU . 87.8 mtt180 . . . . . 1 N--CA 1.323 -6.78 0 CA-C-O 122.559 1.171 . . . . 0.0 112.083 . . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -41.82 -18.96 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.928 -1.942 . . . . 0.0 110.541 -179.974 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.6 tp -114.68 -19.29 11.14 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.716 179.941 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.0 tt0 -85.84 -14.56 44.63 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.736 -179.716 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 10' ' ' GLY . 26.6 ttp85 -74.27 -81.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.904 -179.981 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 9' ' ' ILE . 5.8 tp -62.9 79.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.722 0.773 . . . . 0.0 110.004 -179.803 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -82.75 -18.99 64.47 Favored Glycine 0 CA--C 1.517 0.17 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.976 -179.515 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.431 ' HA ' HG21 ' A' ' 16' ' ' ILE . 34.0 mtmm -75.59 100.47 4.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.781 0.324 . . . . 0.0 110.763 -179.828 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.14 -1.34 4.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.103 179.641 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.4 47.51 43.55 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.214 179.985 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -169.23 -40.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.768 179.855 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.6 pt -154.34 61.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.899 0.381 . . . . 0.0 110.571 179.977 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.431 HG21 ' HA ' ' A' ' 11' ' ' LYS . 17.6 mm -149.42 -48.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.572 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.85 9.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.924 179.781 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -172.82 -38.99 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.875 179.951 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -54.7 -35.73 58.13 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.021 179.94 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.17 7.13 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.525 -179.975 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.4 tp 51.17 23.82 1.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.235 -179.972 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -73.09 -53.99 9.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.611 -179.954 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.412 ' H ' ' H ' ' A' ' 24' ' ' LEU . 12.2 p-80 -166.62 -9.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.745 -179.944 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.412 ' H ' ' H ' ' A' ' 23' ' ' HIS . 11.1 tp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.324 179.908 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.9 mtm180 . . . . . 1 N--CA 1.324 -6.764 0 CA-C-O 122.493 1.14 . . . . 0.0 112.023 . . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.526 ' CE3' HD21 ' A' ' 6' ' ' LEU . 29.7 t90 -40.96 -21.1 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.014 -1.903 . . . . 0.0 110.325 -179.915 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.526 HD21 ' CE3' ' A' ' 5' ' ' TRP . 26.1 mt -108.49 -25.1 11.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.44 179.247 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.0 mp0 -93.98 2.8 56.02 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.141 179.789 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 4' ' ' ARG . 60.9 ttt180 -54.28 -71.38 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.408 179.966 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 9' ' ' ILE . 4.8 tp -171.27 87.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.351 0.596 . . . . 0.0 110.18 179.789 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.01 -53.15 3.8 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.999 -179.78 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 13' ' ' GLY . 57.2 mttp -57.06 101.24 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.794 0.331 . . . . 0.0 110.635 -179.89 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -63.84 -1.3 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.015 179.514 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 55.8 7.55 1.66 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.767 -179.873 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 12' ' ' ALA . 50.5 t80 -127.1 -19.68 4.31 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.542 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 17' ' ' ILE . 4.5 mt -147.14 -135.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.715 179.359 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.456 ' H ' HG22 ' A' ' 15' ' ' ILE . 21.2 mm 52.76 -82.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 121.276 -0.17 . . . . 0.0 110.872 179.323 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 15' ' ' ILE . 3.7 tp -73.74 -38.28 50.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.675 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.51 -50.14 45.74 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.482 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.98 -47.64 7.51 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.779 -0.529 . . . . 0.0 111.779 179.627 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.86 47.88 15.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.935 179.881 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.3 mt -68.33 -19.28 64.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.547 -179.979 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -53.04 -92.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.584 -179.977 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.472 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 2.0 t60 -80.51 11.08 3.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.785 -179.81 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.211 -179.985 . . . . . . . . 0 0 . 1 . 086 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.576 ' O ' ' N ' ' A' ' 7' ' ' GLU . 55.4 mtp85 . . . . . 1 N--CA 1.323 -6.807 0 CA-C-O 122.542 1.163 . . . . 0.0 112.016 . . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -40.89 -24.84 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.02 -1.9 . . . . 0.0 109.843 179.763 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.5 mm? -96.69 -31.24 12.79 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.947 179.218 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 4' ' ' ARG . 52.5 mm-40 -90.68 43.36 1.14 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.782 0.325 . . . . 0.0 110.28 179.723 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -145.85 22.9 1.41 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.392 -179.79 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 pt -51.48 121.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.232 0.539 . . . . 0.0 110.327 -179.98 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.44 -18.28 79.93 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.865 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -80.05 109.2 14.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.764 0.316 . . . . 0.0 110.366 179.974 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.45 10.45 7.16 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.507 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.84 37.53 7.29 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.97 -179.768 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -159.24 -68.67 0.08 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.773 0.32 . . . . 0.0 110.171 -179.902 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 15' ' ' ILE . 9.5 tt -93.69 44.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.784 0.802 . . . . 0.0 109.899 179.721 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.1 tp -145.11 -43.8 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.326 -179.896 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.491 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.1 pp -88.49 13.85 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.422 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.86 -48.54 0.01 OUTLIER Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.773 -179.823 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.67 -15.12 66.06 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.05 -179.986 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.72 -28.32 61.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.619 -179.887 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 21' ' ' LEU . 8.8 mp -55.92 116.39 2.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.145 179.951 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.87 25.93 4.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.979 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 8.5 t60 53.08 52.17 14.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.527 -179.982 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.157 179.999 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 62.5 mtp180 . . . . . 1 N--CA 1.324 -6.761 0 CA-C-O 122.518 1.151 . . . . 0.0 111.998 . . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -42.82 -18.88 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.915 -1.948 . . . . 0.0 110.16 179.731 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.5 mt -113.49 -20.19 11.38 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.764 179.547 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.0 tt0 -83.23 24.33 0.81 Allowed 'General case' 0 C--N 1.342 0.269 0 CA-C-O 121.138 0.494 . . . . 0.0 110.047 179.924 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -66.09 -96.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.908 -179.789 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.2 pt -75.08 -35.39 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.03 -179.525 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.41 17.05 0.37 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.9 -179.714 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 46.5 tttm -75.71 -4.95 43.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.834 0.35 . . . . 0.0 110.53 -179.745 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 71.76 8.73 6.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.284 -179.943 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 40.51 48.96 3.9 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 179.979 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 t80 78.13 49.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.831 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.2 mt 61.46 75.55 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.765 179.895 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 12' ' ' ALA . 7.5 mm -130.92 -57.59 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.652 179.703 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.608 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.3 mp -69.17 -52.5 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.524 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.11 -48.04 68.24 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 178.621 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.55 -56.98 17.3 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.666 179.091 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.0 -67.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.77 0.319 . . . . 0.0 110.496 -179.944 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.5 tt 62.18 86.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.122 0.487 . . . . 0.0 110.142 -179.837 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -170.65 51.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.282 -179.957 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 74.8 t60 56.24 25.39 9.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.264 -179.829 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.051 -179.906 . . . . . . . . 0 0 . 1 . 088 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' LEU . 94.7 mtt180 . . . . . 1 N--CA 1.323 -6.777 0 CA-C-O 122.496 1.141 . . . . 0.0 111.911 . . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 56.6 t-105 -41.96 -18.55 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.453 179.946 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.4 mp -117.7 -17.09 9.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.839 179.358 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' ARG . 14.2 tp10 -81.66 -6.02 58.63 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.049 0.452 . . . . 0.0 110.093 -179.955 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -56.09 -20.87 19.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.742 -179.916 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.7 mm -70.28 73.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -179.989 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.84 -9.37 87.15 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 179.644 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 58.5 mmtt -75.05 8.46 2.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 110.688 -179.859 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 72.66 -11.71 0.82 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.55 179.91 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 39.9 54.33 3.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.471 -0.395 . . . . 0.0 112.218 179.976 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CG ' ' C ' ' A' ' 13' ' ' GLY . 3.9 m-85 74.81 45.34 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.782 0.325 . . . . 0.0 110.16 -179.272 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.8 mt 61.4 79.4 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.427 0.632 . . . . 0.0 111.179 179.807 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -135.74 -61.81 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.95 179.434 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.654 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -71.84 -49.03 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.508 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.35 -56.36 22.32 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.452 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.58 -48.64 61.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.968 179.657 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.17 37.34 14.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.761 0.315 . . . . 0.0 110.545 -179.955 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.0 mt -70.49 109.69 4.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.55 179.988 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.29 32.29 18.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.706 179.903 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.8 m170 50.72 48.94 21.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 -179.975 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 24' ' ' LEU . 2.0 tt . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.107 -179.89 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 6' ' ' LEU . 95.9 mtt180 . . . . . 1 N--CA 1.326 -6.626 0 CA-C-O 122.464 1.126 . . . . 0.0 112.066 . . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.568 ' CE3' HD21 ' A' ' 6' ' ' LEU . 29.0 t90 -41.0 -19.98 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.55 -179.963 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.568 HD21 ' CE3' ' A' ' 5' ' ' TRP . 45.8 mt -115.03 -20.58 10.43 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.51 179.197 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.4 mm-40 -91.63 17.13 9.25 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.959 0.409 . . . . 0.0 110.162 179.668 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -57.45 -50.06 74.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.913 -179.893 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 10' ' ' GLY . 13.6 tt -52.81 -44.37 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.643 -179.663 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 77.82 -50.67 3.33 Favored Glycine 0 C--N 1.331 0.266 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 -179.954 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 13' ' ' GLY . 94.2 mttt -66.54 100.45 0.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.318 179.836 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.15 5.9 2.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.063 179.933 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 43.53 48.51 7.17 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.042 -179.86 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -162.5 -31.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.586 0.231 . . . . 0.0 110.885 -179.702 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 15' ' ' ILE . 16.4 tt -166.98 61.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 110.724 179.922 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 18' ' ' GLY . 22.1 mm -145.45 -61.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.864 179.584 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.478 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -69.32 3.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.035 179.479 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -135.91 -55.05 0.06 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 179.889 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -74.38 -56.44 5.12 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.519 -0.633 . . . . 0.0 111.519 179.486 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.447 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 61.74 -1.93 0.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.599 0.238 . . . . 0.0 111.329 179.566 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 21' ' ' LEU . 8.2 mp 51.42 12.12 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.733 0.301 . . . . 0.0 110.256 179.938 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' N ' ' C ' ' A' ' 20' ' ' ALA . 14.6 t0 -68.27 -55.72 11.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.617 -179.904 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.407 ' H ' ' H ' ' A' ' 24' ' ' LEU . 7.7 t60 -167.62 -17.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.567 -179.992 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.407 ' H ' ' H ' ' A' ' 23' ' ' HIS . 16.5 mt . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.501 179.876 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 6' ' ' LEU . 1.7 mtm180 . . . . . 1 N--CA 1.32 -6.926 0 CA-C-O 121.354 0.597 . . . . 0.0 110.077 . . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -42.2 -18.55 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.363 -179.566 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.2 tp -114.47 -17.54 11.71 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.628 179.467 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.3 mt-10 -107.55 15.32 24.89 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 120.819 0.343 . . . . 0.0 110.264 179.958 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -53.64 163.08 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.534 179.921 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.44 ' C ' ' H ' ' A' ' 11' ' ' LYS . 11.1 pt -76.19 -36.69 31.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.426 179.921 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.25 -5.44 1.43 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.195 179.958 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 9' ' ' ILE . 67.0 mmtt -87.73 105.38 17.34 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.672 -179.922 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.468 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -78.59 46.71 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.235 179.676 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.68 67.18 2.03 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.768 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 53.8 t80 55.2 26.93 8.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.016 -179.731 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 mt 62.14 62.32 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.679 0.752 . . . . 0.0 109.639 -179.453 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.8 mm -129.38 -46.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.025 -179.817 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -70.96 -46.94 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.809 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.468 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -78.41 -39.2 23.03 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 178.652 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.49 -52.75 50.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.081 -0.581 . . . . 0.0 111.73 179.369 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.42 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . -62.73 -58.18 8.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.332 179.8 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 tp 53.35 12.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.236 179.891 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 20' ' ' ALA . 77.9 m-20 -66.36 -107.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.335 -179.994 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -68.64 -30.18 68.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 110.429 179.938 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 24' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.429 179.896 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.9 mtm180 . . . . . 1 N--CA 1.325 -6.705 0 CA-C-O 122.654 1.216 . . . . 0.0 112.09 . . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -41.46 -24.66 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.957 -1.929 . . . . 0.0 109.912 179.796 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' N ' ' C ' ' A' ' 4' ' ' ARG . 17.2 mt -96.55 -27.82 14.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.75 179.853 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.6 tt0 -51.31 -22.73 3.02 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.38 179.934 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 59.46 64.87 1.25 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.648 -179.861 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.3 pt -80.01 -31.97 13.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.347 179.807 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.78 15.75 0.56 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.123 -0.561 . . . . 0.0 111.942 -179.98 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -77.0 -45.8 26.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.697 0.284 . . . . 0.0 110.777 -179.868 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 16' ' ' ILE . . . 56.54 10.36 0.68 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.155 -179.918 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 41.38 53.54 4.14 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.839 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 t80 73.89 48.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -178.996 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mt 63.1 76.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.034 179.924 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.6 mm -131.06 -67.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.401 179.497 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 47.1 mm -78.8 -31.61 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.584 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.77 -51.71 23.54 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.678 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.36 -47.61 6.81 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.254 -0.498 . . . . 0.0 111.903 179.296 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.63 43.48 16.42 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.792 0.329 . . . . 0.0 110.759 -179.981 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.5 mt -75.16 116.31 15.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.675 -179.801 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 47.36 36.02 4.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.98 179.829 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.2 m80 52.72 62.57 2.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.578 -179.957 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.219 179.99 . . . . . . . . 0 0 . 1 . 092 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 7' ' ' GLU . 35.1 mtt180 . . . . . 1 N--CA 1.312 -7.355 0 CA-C-O 121.519 0.676 . . . . 0.0 110.459 . . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -43.8 -22.83 0.06 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.669 -179.687 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 6' ' ' LEU . 8.2 mp -90.74 -28.38 18.32 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.865 179.289 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.7 tt0 -78.42 -21.32 49.4 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.275 179.715 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 10' ' ' GLY . 1.2 tpm_? -68.41 -58.93 3.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.9 -179.457 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -48.81 92.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.398 0.618 . . . . 0.0 110.318 -179.794 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 156.84 38.16 0.02 OUTLIER Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.593 -179.677 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -46.65 -29.54 1.91 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.825 0.345 . . . . 0.0 110.46 179.834 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.407 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -164.84 -3.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.492 -179.921 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 52.82 27.79 29.54 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.742 -179.842 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -144.9 -11.91 0.57 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.901 0.382 . . . . 0.0 110.065 179.951 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.2 pt -155.44 42.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.904 179.448 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.1 tp -152.91 -27.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.004 -179.778 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.41 HD12 ' C ' ' A' ' 17' ' ' ILE . 1.1 pp -81.5 9.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.679 179.516 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.86 -28.36 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.839 -179.901 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.51 -43.88 67.23 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.854 179.979 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.18 -39.91 74.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 110.415 179.882 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 23' ' ' HIS . 2.3 tt 65.49 -76.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.015 -179.863 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 42.73 -90.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 111.092 179.799 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' LEU . 59.1 t-80 -122.96 -14.78 7.54 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.225 179.759 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 21' ' ' LEU . 24.5 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.392 179.958 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.8 mtt180 . . . . . 1 N--CA 1.323 -6.797 0 CA-C-O 122.502 1.144 . . . . 0.0 111.95 . . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -41.38 -19.47 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.041 -1.89 . . . . 0.0 110.486 -179.957 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 mt -114.4 -20.39 10.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.659 179.377 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.8 mt-10 -89.82 -8.32 52.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.671 0.272 . . . . 0.0 110.763 -179.872 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -69.88 -91.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.208 179.831 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 9' ' ' ILE . 2.9 tp -60.15 91.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 0.0 110.108 -179.97 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.05 29.85 11.61 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.896 -179.79 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -149.62 62.01 1.01 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.719 0.295 . . . . 0.0 110.372 -179.964 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.53 52.08 1.58 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.39 179.853 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.86 60.14 8.56 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.847 -179.844 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.492 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 57.9 t80 57.09 32.98 22.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.883 0.373 . . . . 0.0 110.653 -179.818 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 mt 61.26 61.78 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.599 0.714 . . . . 0.0 109.892 -179.818 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mm -129.96 -51.21 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.75 -179.838 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.9 mm -69.14 -41.41 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.473 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.421 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . -82.21 -38.07 13.8 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.166 179.193 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.05 -37.22 73.16 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.452 179.855 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.34 -64.64 1.09 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.663 0.268 . . . . 0.0 111.357 -179.26 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' HIS . 23.6 mt 53.76 -99.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.175 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 80.4 m-20 50.18 -87.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.746 179.758 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' LEU . 78.7 m-70 -153.96 13.17 0.45 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.494 -179.88 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.455 179.885 . . . . . . . . 0 0 . 1 . 094 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 32.5 mtt180 . . . . . 1 N--CA 1.313 -7.295 0 CA-C-O 121.693 0.758 . . . . 0.0 110.297 . . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.501 ' CE3' HD21 ' A' ' 6' ' ' LEU . 28.6 t90 -43.63 -20.46 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.73 179.973 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.502 ' N ' ' C ' ' A' ' 4' ' ' ARG . 19.3 mt -102.89 -21.2 14.03 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.908 179.864 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.8 tm-20 -67.49 -25.76 66.03 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.124 179.878 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -63.44 163.47 10.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.894 -179.963 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.482 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.5 tt -162.42 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.964 179.915 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.482 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 76.7 -46.33 2.3 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.117 179.778 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 13' ' ' GLY . 54.7 mtpt -77.55 93.73 4.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.745 0.307 . . . . 0.0 110.857 -179.926 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.46 -4.84 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.973 0.415 . . . . 0.0 109.98 179.517 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 52.94 51.52 45.19 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.011 179.928 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 15' ' ' ILE . 34.0 t80 -168.83 -45.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.214 179.814 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' PHE . 7.9 pt -155.3 58.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.241 0.544 . . . . 0.0 110.718 -179.912 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.7 mm -140.11 -65.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.621 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 18' ' ' GLY . 4.2 tp -70.5 -39.37 76.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.498 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.414 ' N ' HG23 ' A' ' 17' ' ' ILE . . . -82.07 -42.81 8.52 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.7 179.601 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.95 -38.04 64.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.106 -0.568 . . . . 0.0 111.898 179.868 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 53.13 15.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.814 0.34 . . . . 0.0 110.583 179.892 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 21' ' ' LEU . 7.6 mp 54.01 9.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.276 -179.963 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 20' ' ' ALA . 28.9 t70 -78.31 -103.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.329 179.921 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.436 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -73.22 9.69 1.19 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 110.377 179.815 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 22' ' ' ASP . 17.8 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.353 -179.936 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.2 mtt-85 . . . . . 1 N--CA 1.325 -6.725 0 CA-C-O 122.551 1.167 . . . . 0.0 112.067 . . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -41.15 -20.32 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.394 179.859 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.4 tt -109.24 -25.33 10.66 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.359 179.279 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.4 mt-10 -99.43 25.43 7.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.388 179.875 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -50.77 140.55 14.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.639 -179.87 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.473 HG23 ' N ' ' A' ' 10' ' ' GLY . 14.3 tt -72.62 -40.45 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.368 179.867 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.473 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 78.04 -56.07 3.94 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.048 179.914 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 13' ' ' GLY . 52.0 mtpt -60.98 101.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 110.518 -179.911 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.34 1.93 2.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.926 179.711 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 46.0 38.41 8.22 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.181 -179.996 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -166.81 -26.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 pt -154.45 59.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.914 0.388 . . . . 0.0 110.981 179.863 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.431 ' C ' ' H ' ' A' ' 18' ' ' GLY . 13.6 mm -150.67 -50.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.327 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.78 10.61 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.041 179.798 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -173.35 -20.46 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.216 -0.516 . . . . 0.0 111.971 179.902 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.73 -28.57 46.35 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.095 -179.899 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -66.58 -76.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.737 0.303 . . . . 0.0 110.85 -179.795 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.1 mt 59.88 3.92 0.53 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.579 -179.639 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 24' ' ' LEU . 56.4 p-10 -76.72 -133.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.196 179.711 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 1.2 m-70 -76.41 35.77 0.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 110.428 179.682 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 22' ' ' ASP . 15.5 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.179 -179.797 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 7' ' ' GLU . 7.0 mtm105 . . . . . 1 N--CA 1.319 -7.004 0 CA-C-O 121.511 0.672 . . . . 0.0 110.624 . . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -39.82 -23.29 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.258 -179.294 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 6' ' ' LEU . 10.0 mp -97.3 -27.45 14.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.242 179.15 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.1 mp0 -117.87 34.23 5.26 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.715 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 4' ' ' ARG . 56.6 ttm-85 -67.38 126.59 29.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.559 -179.989 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.8 pt -73.26 -30.76 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.56 56.4 20.22 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.898 -179.86 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -164.75 78.67 0.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.811 0.339 . . . . 0.0 110.553 -179.903 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.37 46.48 0.63 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.609 179.976 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.91 59.69 7.27 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.964 179.989 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.425 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 52.2 t80 57.34 35.03 25.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.621 0.248 . . . . 0.0 110.759 179.91 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt 62.19 71.94 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.482 0.658 . . . . 0.0 110.421 179.769 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.476 ' O ' ' N ' ' A' ' 20' ' ' ALA . 14.4 mt -146.75 -57.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.525 179.674 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.55 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -58.9 -29.64 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.344 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.43 -45.83 2.9 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.147 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.55 -64.36 2.39 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.05 179.336 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 57.54 27.54 14.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.628 0.251 . . . . 0.0 110.628 -179.842 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.8 mt 53.43 -124.05 2.22 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.026 -179.747 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -82.87 63.96 7.24 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 179.692 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.403 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 50.3 t-80 56.49 19.02 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.141 -179.54 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.8 tp . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.424 -179.915 . . . . . . . . 0 0 . 1 . 097 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.0 mtm180 . . . . . 1 N--CA 1.325 -6.725 0 CA-C-O 122.46 1.124 . . . . 0.0 112.032 . . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -39.56 -21.7 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.798 -179.733 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.8 mt -107.83 -24.44 11.67 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.84 179.646 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 15.0 mp0 -86.87 29.38 0.81 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.63 0.252 . . . . 0.0 110.51 -179.894 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -87.74 -33.18 18.79 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.686 179.838 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 11' ' ' LYS . 3.6 tp -166.91 -3.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.157 0.503 . . . . 0.0 109.908 -179.568 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.446 ' H ' ' H ' ' A' ' 9' ' ' ILE . . . -36.17 -27.4 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.839 179.708 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 9' ' ' ILE . 63.2 mttp -54.64 107.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.381 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -67.65 3.9 1.26 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.6 -179.592 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 46.51 14.03 0.1 OUTLIER Glycine 0 C--N 1.329 0.183 0 C-N-CA 121.312 -0.47 . . . . 0.0 112.25 -179.945 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.46 ' N ' ' O ' ' A' ' 12' ' ' ALA . 73.6 t80 -138.29 -4.4 1.68 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.577 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 17' ' ' ILE . 3.3 mt -146.13 -137.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.038 179.604 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.504 ' C ' ' H ' ' A' ' 18' ' ' GLY . 47.5 mm 41.54 -87.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.333 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.581 ' C ' HD12 ' A' ' 17' ' ' ILE . 2.4 pp -55.11 -1.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.416 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.568 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -132.59 -70.97 0.09 OUTLIER Glycine 0 C--N 1.338 0.655 0 N-CA-C 112.326 -0.31 . . . . 0.0 112.326 -179.855 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -51.82 -25.27 15.34 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.693 -179.382 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.89 -11.84 0.1 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.612 179.999 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 23' ' ' HIS . 27.2 tp -44.52 123.86 3.84 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.479 179.841 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 56.02 -81.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.611 -179.541 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 21' ' ' LEU . 23.2 t-80 -163.79 43.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.676 179.97 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 30.8 mt . . . . . 0 N--CA 1.469 0.513 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.262 179.852 . . . . . . . . 0 0 . 1 . 098 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 7' ' ' GLU . 69.4 mtm180 . . . . . 1 N--CA 1.325 -6.725 0 CA-C-O 122.463 1.125 . . . . 0.0 112.007 . . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -39.59 -21.86 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.521 -179.944 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.5 tp -107.74 -26.24 10.9 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.724 179.615 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.9 tt0 -89.28 -3.01 58.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.103 0.477 . . . . 0.0 109.934 179.88 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -83.55 152.48 24.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.469 179.902 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.5 pt -55.72 -9.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.567 -179.979 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.22 31.32 4.52 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.145 179.96 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -151.4 70.37 0.96 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.972 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.03 48.98 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.567 -179.888 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.02 40.28 20.16 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.865 -179.976 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 t80 70.49 54.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.92 0.391 . . . . 0.0 110.493 -179.776 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 mm 62.05 75.57 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.157 179.703 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.9 mm -137.14 -51.65 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.686 179.244 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 mm -74.48 -49.86 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.042 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.01 -51.55 18.09 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.367 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -63.7 -43.02 98.45 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.796 179.62 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 70.11 -13.79 0.41 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.581 0.229 . . . . 0.0 110.957 179.943 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.473 ' H ' ' C ' ' A' ' 19' ' ' GLY . 4.8 tp 61.13 2.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.0 110.446 179.98 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 24' ' ' LEU . 74.7 m-20 -74.29 84.93 1.92 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.45 179.975 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 27.7 m170 56.73 5.92 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 -179.858 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 22' ' ' ASP . 37.6 mt . . . . . 0 N--CA 1.469 0.519 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.052 179.69 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' GLU . 70.7 mtp180 . . . . . 1 N--CA 1.325 -6.703 0 CA-C-O 122.66 1.219 . . . . 0.0 112.08 . . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -42.25 -20.36 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.121 179.68 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.8 tp -107.54 -25.12 11.52 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.363 179.618 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' ARG . 78.0 mt-10 -90.17 35.32 0.86 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -146.39 -37.2 0.24 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.25 -179.996 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.401 ' CG1' ' H ' ' A' ' 10' ' ' GLY . 3.3 pt -149.38 -105.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 65.22 -132.47 36.08 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.966 179.95 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 tttp 73.11 -35.56 0.33 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.611 0.243 . . . . 0.0 110.824 179.979 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.523 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -163.91 13.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.931 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.14 66.02 2.66 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.419 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 68.5 t80 57.83 32.33 21.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.075 -179.15 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 mt 62.03 63.69 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.584 0.707 . . . . 0.0 110.083 -179.73 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mm -130.19 -52.64 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.414 -179.827 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.57 -44.78 79.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.625 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -74.35 -48.08 15.3 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.873 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -59.79 -43.59 97.77 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.619 179.29 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 69.05 -14.91 0.28 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.509 0.195 . . . . 0.0 111.383 179.815 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.5 mm? 47.27 75.11 0.13 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.755 0.312 . . . . 0.0 110.429 179.934 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -171.17 -109.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.315 179.879 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -60.02 -28.17 67.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.834 0.349 . . . . 0.0 110.105 179.719 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.569 179.774 . . . . . . . . 0 0 . 1 . 100 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.498 ' C ' ' N ' ' A' ' 6' ' ' LEU . 82.2 mtm180 . . . . . 1 N--CA 1.325 -6.723 0 CA-C-O 122.555 1.169 . . . . 0.0 112.069 . . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -44.0 -17.03 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.321 179.922 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.498 ' N ' ' C ' ' A' ' 4' ' ' ARG . 30.0 mt -130.71 -4.78 4.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.857 179.561 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -84.71 -11.07 56.6 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.074 179.829 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 61.08 131.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.627 179.701 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.7 pt -61.3 -23.85 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.447 179.879 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.04 60.01 8.66 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.872 -179.909 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -169.65 57.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 110.421 -179.931 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.15 64.49 2.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.406 179.98 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 55.19 55.7 26.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.802 -179.857 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 58.59 36.51 25.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.474 -179.832 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 mt 61.18 62.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.405 -179.957 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 13' ' ' GLY . 4.1 tp -131.19 -44.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.447 179.672 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.469 ' N ' HG23 ' A' ' 16' ' ' ILE . 35.8 mm -77.22 -44.89 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.5 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.58 -43.05 38.09 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 178.448 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.78 -43.4 99.0 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.091 -0.575 . . . . 0.0 111.696 179.233 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.88 -55.54 6.06 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.396 179.895 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.1 tp 51.47 96.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 179.832 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 50.79 29.85 4.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.866 179.782 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 52.35 51.71 15.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.661 179.876 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 tp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.158 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 111.956 -0.457 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -67.92 -129.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.141 -0.223 . . . . 0.0 110.515 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.429 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 49.23 71.0 0.67 Allowed Glycine 1 CA--C 1.385 -8.078 0 CA-C-O 126.193 3.107 . . . . 0.0 112.851 -178.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.9 mtp85 157.93 -11.46 0.0 OUTLIER 'General case' 1 N--CA 1.315 -7.197 1 CA-C-N 100.791 -7.704 . . . . 0.0 110.364 160.684 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -43.38 -21.1 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.79 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' C ' ' A' ' 4' ' ' ARG . 22.3 mt -99.74 -23.04 15.13 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.885 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.4 tt0 -66.35 -15.55 63.35 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.208 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -63.18 94.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.314 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.0 tt -58.02 -38.45 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.44 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 76.71 -44.48 2.03 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.096 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 13' ' ' GLY . 47.1 tttp -86.28 77.21 9.57 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.77 0.319 . . . . 0.0 110.427 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.463 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -76.29 37.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.231 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 67.74 61.2 5.15 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 59.9 t80 57.08 36.54 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.931 0.396 . . . . 0.0 110.297 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.5 mm 59.36 66.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.391 0.615 . . . . 0.0 110.219 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -132.24 -51.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.006 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 mm -65.9 -43.94 92.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -85.47 -36.69 10.39 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.97 -33.25 86.74 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.28 -0.486 . . . . 0.0 111.889 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.52 -22.51 61.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.763 0.316 . . . . 0.0 110.638 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -76.62 -15.26 59.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.541 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -50.86 -42.13 58.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.582 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -169.68 -13.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.722 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.1 mp . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.047 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -76.71 40.25 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.419 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.486 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -49.06 -57.53 8.76 Favored Glycine 1 CA--C 1.356 -9.862 0 CA-C-O 123.593 1.663 . . . . 0.0 115.736 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 7' ' ' GLU . 43.2 mtm180 -60.15 -10.98 5.06 Favored 'General case' 1 N--CA 1.325 -6.696 1 CA-C-N 105.443 -5.379 . . . . 0.0 112.055 -157.469 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.486 ' N ' ' C ' ' A' ' 3' ' ' GLY . 44.2 t-105 -42.78 -18.84 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.194 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.502 ' N ' ' C ' ' A' ' 4' ' ' ARG . 42.4 tp -113.76 -21.44 10.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.122 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 4' ' ' ARG . 13.6 tp10 -110.99 46.73 1.04 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.981 0.42 . . . . 0.0 109.87 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.438 ' C ' ' H ' ' A' ' 10' ' ' GLY . 36.9 ttt-85 -63.64 126.59 28.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.569 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' LYS . 4.1 tp -54.05 -10.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . -37.08 -26.52 0.01 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.569 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 9' ' ' ILE . 14.4 pttp -70.46 99.75 1.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.82 -3.17 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.747 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 47.21 49.31 19.26 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.066 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.408 ' O ' HG23 ' A' ' 15' ' ' ILE . 20.2 t80 -160.97 -47.46 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.608 0.242 . . . . 0.0 110.471 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 14' ' ' PHE . 14.8 pt -156.02 55.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.15 0.5 . . . . 0.0 110.598 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 18' ' ' GLY . 3.8 mm -141.28 -48.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -69.36 5.76 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.462 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -175.54 -19.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.809 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -67.3 -57.28 9.52 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.142 -0.551 . . . . 0.0 111.875 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.1 7.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.333 . . . . 0.0 110.596 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 23' ' ' HIS . 12.9 mt 53.92 14.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.47 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -75.99 36.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.787 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.43 ' H ' ' C ' ' A' ' 21' ' ' LEU . 49.7 t-80 54.52 21.4 3.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.564 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 tp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.24 -179.886 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 84.5 mttt 57.75 -147.03 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.677 0.275 . . . . 0.0 110.586 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 52.74 68.71 1.47 Allowed Glycine 1 CA--C 1.381 -8.308 0 CA-C-O 125.48 2.711 . . . . 0.0 113.402 -178.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.535 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER 163.55 -11.94 0.0 OUTLIER 'General case' 1 N--CA 1.319 -7.021 1 CA-C-N 101.338 -7.431 . . . . 0.0 110.428 159.4 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 17.8 m0 -44.08 -19.09 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.541 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.9 mt -110.66 -17.98 13.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.617 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.5 mt-10 -110.17 13.21 23.19 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.93 0.395 . . . . 0.0 110.096 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 4' ' ' ARG . 56.9 ttt-85 -52.56 102.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.575 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 tp -56.54 109.16 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.098 0.475 . . . . 0.0 110.154 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.82 -38.28 4.45 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.982 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -65.97 103.97 1.03 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.894 0.378 . . . . 0.0 110.624 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.63 1.67 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.003 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.32 53.68 15.07 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.133 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' O ' HG23 ' A' ' 15' ' ' ILE . 20.7 t80 -163.08 -48.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.682 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 14' ' ' PHE . 8.3 pt -155.74 59.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.337 0.589 . . . . 0.0 110.867 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.5 mm -135.23 -72.37 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.51 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -71.85 -38.94 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.04 -45.62 11.47 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.71 -42.54 38.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.918 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.97 37.37 28.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.775 0.321 . . . . 0.0 110.46 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 23' ' ' HIS . 21.4 mt -75.81 114.95 15.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.636 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 58.55 -76.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.326 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 21' ' ' LEU . 69.1 m-70 -38.55 -32.74 0.08 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.026 0.441 . . . . 0.0 110.868 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.7 tp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.98 178.986 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -149.4 50.71 0.95 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.739 0.304 . . . . 0.0 110.363 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.483 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -55.7 -58.18 15.25 Favored Glycine 1 CA--C 1.355 -9.941 0 CA-C-O 123.599 1.666 . . . . 0.0 115.178 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 7' ' ' GLU . 58.6 mtp180 -59.87 -11.5 5.6 Favored 'General case' 1 N--CA 1.324 -6.749 1 CA-C-N 105.417 -5.392 . . . . 0.0 111.931 -157.599 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.483 ' N ' ' C ' ' A' ' 3' ' ' GLY . 37.1 t-105 -43.2 -18.97 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.916 -1.947 . . . . 0.0 109.999 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' C ' ' A' ' 4' ' ' ARG . 2.2 pp -111.3 -22.49 11.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.639 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.6 tt0 -88.35 1.05 55.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.032 0.444 . . . . 0.0 110.219 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -58.98 140.45 55.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.621 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 9' ' ' ILE . 5.9 tp -75.74 113.68 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.943 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.1 14.18 6.28 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -91.27 105.86 18.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.7 0.286 . . . . 0.0 110.431 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.46 62.2 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 50.52 53.51 24.58 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.7 t80 60.46 38.06 19.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.07 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.2 mt 61.18 70.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.358 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.59 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -140.28 -50.65 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.89 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.59 ' N ' HG23 ' A' ' 16' ' ' ILE . 4.2 tp -76.58 -29.46 18.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.76 -50.75 3.63 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.65 -42.2 94.11 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.652 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.26 52.81 1.16 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 110.489 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 tt -156.92 61.91 0.52 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -160.33 -34.85 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.656 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -164.94 -24.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 0.0 110.262 179.946 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -78.86 48.28 0.82 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.019 0.438 . . . . 0.0 110.288 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.483 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -49.09 -54.29 15.5 Favored Glycine 1 CA--C 1.358 -9.73 0 CA-C-O 123.689 1.716 . . . . 0.0 115.793 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -59.36 -11.31 4.07 Favored 'General case' 1 N--CA 1.328 -6.555 1 CA-C-N 105.249 -5.475 . . . . 0.0 112.191 -157.055 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.483 ' N ' ' C ' ' A' ' 3' ' ' GLY . 27.3 t90 -41.24 -20.11 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 112.846 -1.979 . . . . 0.0 110.412 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.7 mt -115.84 -20.05 10.19 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.347 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.7 tt0 -96.2 30.47 2.47 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.999 0.428 . . . . 0.0 110.208 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.17 146.77 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.472 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 tp -165.16 96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.188 0.518 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.55 24.79 3.02 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.156 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -151.41 72.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.769 0.319 . . . . 0.0 110.375 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.9 45.35 0.9 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.056 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.5 33.76 54.37 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 18.9 t80 71.1 54.32 0.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.691 0.282 . . . . 0.0 110.56 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 mt 63.93 68.09 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.415 0.626 . . . . 0.0 110.94 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.0 mm -135.04 -51.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.662 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.5 mm -70.92 -42.01 77.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.68 -51.57 7.09 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -64.95 -36.3 92.92 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.815 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.08 7.17 0.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.646 0.26 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.7 mt 45.31 78.42 0.06 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.726 0.298 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -168.49 39.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.496 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 57.47 36.97 27.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.498 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.456 HD23 ' C ' ' A' ' 24' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.17 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp 50.71 178.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.821 0.343 . . . . 0.0 110.588 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.499 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 116.77 -58.88 0.47 Allowed Glycine 1 CA--C 1.356 -9.891 0 CA-C-O 123.722 1.735 . . . . 0.0 114.934 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 7' ' ' GLU . 89.5 mtt180 -60.66 -10.12 4.84 Favored 'General case' 1 N--CA 1.325 -6.72 1 CA-C-N 105.296 -5.452 . . . . 0.0 111.9 -157.667 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.499 ' N ' ' C ' ' A' ' 3' ' ' GLY . 70.0 t-105 -41.09 -20.49 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.327 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.2 tp -108.51 -26.15 10.57 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.173 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' ARG . 27.2 mp0 -99.83 8.73 43.95 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.84 0.352 . . . . 0.0 110.398 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.9 ttp180 -52.11 118.47 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.463 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.0 pt -61.92 -29.26 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.62 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.44 52.69 27.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.608 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -161.69 80.71 0.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.478 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.415 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -83.97 52.35 2.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.335 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.27 49.1 32.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.855 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.6 t80 61.15 48.73 6.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.897 0.38 . . . . 0.0 110.379 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 mt 61.22 70.87 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.732 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -135.03 -67.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -69.86 -25.07 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.415 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -83.05 -58.75 2.28 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.494 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.41 -32.46 68.16 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.936 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.73 34.97 10.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.773 0.321 . . . . 0.0 110.68 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.483 ' N ' HD23 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -65.89 1.64 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.952 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -58.75 -30.15 67.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.392 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.441 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 4.0 t60 -171.47 23.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.159 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.077 -179.792 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 111.969 -0.453 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.9 tttt 59.74 13.32 3.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.004 0.431 . . . . 0.0 110.118 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -49.89 -57.7 9.47 Favored Glycine 1 CA--C 1.357 -9.793 0 CA-C-O 123.715 1.73 . . . . 0.0 115.514 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' LEU . 38.0 mtm-85 -60.33 -10.87 5.26 Favored 'General case' 1 N--CA 1.325 -6.68 1 CA-C-N 105.33 -5.435 . . . . 0.0 111.941 -157.453 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.492 ' N ' ' C ' ' A' ' 3' ' ' GLY . 41.9 t-105 -41.36 -19.51 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 112.938 -1.937 . . . . 0.0 110.433 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.1 tp -114.57 -20.62 10.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.593 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 66.2 mm-40 -87.02 20.48 2.65 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 110.452 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -53.47 -21.11 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.111 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 11' ' ' LYS . 3.6 tp -165.09 -41.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.837 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 53.84 -82.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.263 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 9' ' ' ILE . 55.8 mttm -51.06 101.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.823 0.344 . . . . 0.0 110.795 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.85 3.27 3.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 45.3 40.43 7.83 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.45 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 15' ' ' ILE . 23.3 t80 -167.51 -20.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.314 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 14' ' ' PHE . 21.8 pt -155.85 50.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 120.925 0.393 . . . . 0.0 111.275 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.419 ' C ' ' H ' ' A' ' 18' ' ' GLY . 2.8 mm -143.77 -51.04 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.4 ' C ' HD12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -71.65 8.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.299 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -167.48 -31.69 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.001 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.79 -30.99 60.41 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.135 -0.555 . . . . 0.0 111.856 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.43 -68.23 0.39 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.735 0.302 . . . . 0.0 110.477 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 tp 52.79 49.44 20.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.448 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -167.23 88.25 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.528 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.6 m80 53.76 25.91 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.466 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.163 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.4 mtmm -61.79 -141.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.524 0.202 . . . . 0.0 110.498 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.533 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 53.92 69.02 1.36 Allowed Glycine 1 CA--C 1.379 -8.435 0 CA-C-O 125.403 2.668 . . . . 0.0 113.572 -179.09 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.8 OUTLIER 164.83 -11.24 0.0 OUTLIER 'General case' 1 N--CA 1.32 -6.943 1 CA-C-N 101.503 -7.348 . . . . 0.0 110.414 159.15 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -43.48 -19.09 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.937 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.5 ' N ' ' C ' ' A' ' 4' ' ' ARG . 43.3 tp -108.28 -20.78 13.02 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.284 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.6 mm-40 -109.34 13.8 24.03 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.5 ttt85 -79.64 -69.09 0.61 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.574 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.1 pt -68.31 -33.65 61.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.4 55.82 23.42 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.944 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -168.26 67.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.481 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.529 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -68.71 76.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.364 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.629 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 46.93 62.68 3.63 Favored Glycine 0 CA--C 1.517 0.218 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.929 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 55.24 34.77 23.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.913 0.387 . . . . 0.0 109.96 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.0 mm 59.8 69.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.541 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 13' ' ' GLY . 9.8 tp -137.51 -34.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.1 mm -92.43 -41.1 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.529 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -77.68 -45.63 10.62 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.63 -37.78 57.65 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.663 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.81 52.21 11.66 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.714 0.293 . . . . 0.0 110.961 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.12 114.12 2.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.034 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 53.73 15.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.454 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 3.4 t60 54.39 25.83 6.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.465 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.201 179.971 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -78.15 57.61 1.86 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.782 0.325 . . . . 0.0 110.544 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.493 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -51.57 -58.05 10.89 Favored Glycine 1 CA--C 1.355 -9.964 0 CA-C-O 123.617 1.676 . . . . 0.0 115.37 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 7' ' ' GLU . 78.0 mtm180 -61.18 -9.67 5.24 Favored 'General case' 1 N--CA 1.323 -6.786 1 CA-C-N 105.438 -5.381 . . . . 0.0 111.966 -157.543 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' N ' ' C ' ' A' ' 3' ' ' GLY . 24.9 t90 -42.12 -24.56 0.05 OUTLIER 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.718 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.9 mm? -96.42 -30.21 13.49 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.938 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 4' ' ' ARG . 60.3 mt-10 -112.46 49.8 0.9 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.79 0.328 . . . . 0.0 110.545 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -60.32 148.44 36.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.431 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 11' ' ' LYS . 15.7 pt -152.93 -31.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.399 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.26 -17.13 1.94 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.949 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 9' ' ' ILE . 55.0 mttp -69.55 105.88 2.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.687 0.279 . . . . 0.0 110.539 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.454 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -70.65 0.51 6.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.58 -0.77 1.94 Allowed Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.845 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' A' ' 12' ' ' ALA . 62.1 t80 -101.58 -31.78 10.68 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.559 ' O ' ' N ' ' A' ' 17' ' ' ILE . 5.2 pt -153.31 -112.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.225 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 mm 47.61 -81.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 111.355 0.132 . . . . 0.0 111.355 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 15' ' ' ILE . 3.7 tp -69.69 -42.25 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.077 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 17' ' ' ILE . . . -77.63 -42.53 17.25 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.033 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.46 -41.1 31.09 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.087 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.03 53.74 12.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 0.0 110.719 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 21' ' ' LEU . 8.4 mp -60.6 89.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.168 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 50.01 46.24 24.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.69 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 20.9 t-80 53.57 52.01 14.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.555 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.186 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 80.4 mttt 52.22 174.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.509 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.463 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 127.62 -57.32 0.71 Allowed Glycine 1 CA--C 1.355 -9.915 0 CA-C-O 123.775 1.764 . . . . 0.0 115.134 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 7' ' ' GLU . 51.5 mtm180 -60.67 -10.12 4.84 Favored 'General case' 1 N--CA 1.323 -6.78 1 CA-C-N 105.308 -5.446 . . . . 0.0 111.996 -157.522 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.463 ' N ' ' C ' ' A' ' 3' ' ' GLY . 42.7 t-105 -41.28 -21.34 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.043 -1.889 . . . . 0.0 110.272 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 57.6 tp -105.79 -26.89 11.58 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.219 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.3 mt-10 -90.75 8.88 32.39 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.951 0.405 . . . . 0.0 110.166 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -63.33 82.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.576 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.544 HG23 ' N ' ' A' ' 10' ' ' GLY . 16.4 tt -65.99 -45.25 91.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.356 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.544 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 41.78 45.29 4.65 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.361 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -164.56 71.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.33 . . . . 0.0 110.542 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.27 70.95 1.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.374 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.53 64.51 4.0 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.829 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 50.5 t80 57.53 28.39 15.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.772 0.32 . . . . 0.0 110.476 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.2 mt 62.43 64.71 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.646 0.736 . . . . 0.0 110.161 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -132.54 -49.47 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.786 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -69.72 -44.84 78.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.74 -43.82 11.21 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.72 -43.33 99.22 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.987 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.46 40.66 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.665 0.269 . . . . 0.0 110.703 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.6 tp -52.95 96.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.229 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 53.02 52.55 13.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.432 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.465 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 16.4 t-160 53.8 47.2 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.334 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.005 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -74.63 -99.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.724 0.297 . . . . 0.0 110.528 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.493 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 90.05 -61.46 3.34 Favored Glycine 1 CA--C 1.356 -9.866 0 CA-C-O 123.681 1.712 . . . . 0.0 115.455 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 93.3 mtt180 -60.17 -11.05 5.25 Favored 'General case' 1 N--CA 1.325 -6.722 1 CA-C-N 105.392 -5.404 . . . . 0.0 112.039 -157.663 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' N ' ' C ' ' A' ' 3' ' ' GLY . 23.1 t90 -42.96 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 112.791 -2.004 . . . . 0.0 110.455 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 37.7 mt -117.13 -16.31 10.44 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.87 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.4 tt0 -48.52 -26.87 2.38 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.661 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -50.01 148.66 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.634 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 10' ' ' GLY . 16.0 tt -167.63 -40.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.494 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 76.81 -58.64 3.47 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.187 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.0 mttt -52.85 102.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.707 0.289 . . . . 0.0 110.507 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.28 -1.13 2.13 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 44.81 36.05 4.65 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.197 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 15' ' ' ILE . 58.9 t80 -168.97 -17.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.284 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' PHE . 15.0 pt -155.71 50.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.718 0.294 . . . . 0.0 111.057 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 mm -144.31 -47.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.419 HD12 ' C ' ' A' ' 17' ' ' ILE . 1.1 pp -85.29 24.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.186 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.62 -45.84 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.092 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.32 -40.23 98.34 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.039 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -78.49 50.71 0.98 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.839 0.352 . . . . 0.0 110.541 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 pp -59.22 -4.88 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.715 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 2.2 m-20 -52.23 -39.62 60.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.452 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.408 ' CD2' ' N ' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -168.06 10.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.433 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.826 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -77.16 22.75 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.794 0.331 . . . . 0.0 110.645 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.495 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -52.55 -57.68 13.24 Favored Glycine 1 CA--C 1.356 -9.887 0 CA-C-O 123.835 1.797 . . . . 0.0 115.293 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 6' ' ' LEU . 73.4 mtt-85 -60.05 -11.53 6.12 Favored 'General case' 1 N--CA 1.324 -6.747 1 CA-C-N 105.225 -5.487 . . . . 0.0 112.047 -157.51 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.495 ' N ' ' C ' ' A' ' 3' ' ' GLY . 65.6 t-105 -43.07 -18.61 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.854 -1.975 . . . . 0.0 110.337 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 4' ' ' ARG . 19.6 mt -114.32 -18.04 11.66 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.802 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.6 tt0 -48.02 -20.87 0.37 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.76 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 54.35 61.45 3.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.62 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 9' ' ' ILE . 3.2 tp -54.47 113.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.078 0.466 . . . . 0.0 110.126 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.51 34.18 1.28 Allowed Glycine 0 C--N 1.332 0.354 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -150.98 38.51 0.66 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.161 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.498 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -79.68 56.79 2.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.52 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.9 67.13 2.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.979 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 54.44 30.55 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.781 0.324 . . . . 0.0 110.706 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 mt 62.14 65.28 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.552 0.692 . . . . 0.0 110.281 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.2 mm -133.34 -51.65 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.691 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.3 mm -66.59 -42.89 90.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.498 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -81.74 -42.17 9.22 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.23 95.69 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.031 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.47 -30.87 0.61 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.667 0.27 . . . . 0.0 111.179 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 21' ' ' LEU . 8.0 mp -74.44 -47.81 31.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.316 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -50.55 -72.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.608 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -169.98 63.91 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.384 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.303 -179.887 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -75.62 66.41 1.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 0.0 110.573 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.495 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -54.63 -57.91 15.61 Favored Glycine 1 CA--C 1.357 -9.799 0 CA-C-O 123.715 1.731 . . . . 0.0 115.384 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 6' ' ' LEU . 47.5 mtt85 -60.07 -11.31 5.65 Favored 'General case' 1 N--CA 1.325 -6.675 1 CA-C-N 105.203 -5.498 . . . . 0.0 111.997 -157.439 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.495 ' N ' ' C ' ' A' ' 3' ' ' GLY . 66.4 t-105 -43.36 -18.31 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.249 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 4' ' ' ARG . 24.4 mt -115.82 -16.45 11.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.812 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.3 tt0 -45.43 -28.08 0.82 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -71.69 -137.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.307 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.2 pt -59.77 -113.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.437 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.26 39.59 82.0 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -57.13 -31.95 65.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.669 0.271 . . . . 0.0 110.541 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.72 -25.53 0.27 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.058 0.456 . . . . 0.0 110.442 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' C ' ' CG ' ' A' ' 14' ' ' PHE . . . 150.97 54.99 0.01 OUTLIER Glycine 0 CA--C 1.509 -0.31 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.442 ' CG ' ' C ' ' A' ' 13' ' ' GLY . 3.4 m-85 75.63 17.46 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.2 mt 61.55 60.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.558 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.1 tp -128.0 -48.69 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.558 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.9 tp -66.25 -36.25 76.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.38 -44.65 4.59 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.27 -33.0 51.93 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.662 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.72 -46.81 41.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.75 0.309 . . . . 0.0 110.863 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' C ' ' H ' ' A' ' 23' ' ' HIS . 40.9 mt 52.49 20.04 1.35 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 0.0 110.278 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 24' ' ' LEU . 66.2 m-20 -76.08 38.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.375 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.426 ' H ' ' C ' ' A' ' 21' ' ' LEU . 32.3 m80 57.67 6.52 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.252 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.279 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 80.3 mttt 50.75 -169.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 110.596 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.473 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 116.99 -59.45 0.46 Allowed Glycine 1 CA--C 1.357 -9.789 0 CA-C-O 123.768 1.76 . . . . 0.0 115.266 179.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 6' ' ' LEU . 79.1 mtm180 -60.26 -11.06 5.43 Favored 'General case' 1 N--CA 1.324 -6.739 1 CA-C-N 105.322 -5.439 . . . . 0.0 112.094 -157.585 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.473 ' N ' ' C ' ' A' ' 3' ' ' GLY . 74.6 t-105 -41.16 -19.18 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 112.79 -2.005 . . . . 0.0 110.61 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.4 mt -121.99 -14.06 8.09 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.748 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 4' ' ' ARG . 37.1 mt-10 -88.95 -11.18 45.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 110.307 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.9 tpm_? -83.13 106.45 14.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.255 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.496 ' O ' HG23 ' A' ' 9' ' ' ILE . 14.6 tt -63.19 111.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.078 0.466 . . . . 0.0 110.224 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.7 -19.18 79.3 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.147 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.1 mttt -69.96 99.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.713 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.426 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -62.47 -2.65 1.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.161 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 59.18 5.15 2.99 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -85.51 -71.48 0.53 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 14' ' ' PHE . 17.5 pt -158.14 53.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.402 0.62 . . . . 0.0 110.217 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.61 -63.95 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.79 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -70.35 -35.01 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.31 -49.66 7.25 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.412 ' C ' ' N ' ' A' ' 21' ' ' LEU . . . -66.51 -46.35 77.81 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.73 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.4 15.09 0.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.765 0.317 . . . . 0.0 110.7 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.412 ' N ' ' C ' ' A' ' 19' ' ' GLY . 13.9 mt 55.26 11.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.592 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.41 49.07 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.506 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 51.82 20.97 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.542 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.221 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 50.21 -134.82 1.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.759 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.43 ' O ' ' CB ' ' A' ' 4' ' ' ARG . . . 48.6 70.42 0.77 Allowed Glycine 1 CA--C 1.386 -7.995 0 CA-C-O 126.438 3.243 . . . . 0.0 112.38 -178.051 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 11.2 mtp180 154.73 -12.08 0.0 OUTLIER 'General case' 1 N--CA 1.312 -7.365 1 CA-C-N 100.527 -7.836 . . . . 0.0 110.301 161.265 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -44.24 -19.73 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.743 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.496 ' N ' ' C ' ' A' ' 4' ' ' ARG . 20.2 mt -103.77 -21.18 13.72 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.711 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 35.5 tp10 -68.39 -25.98 65.32 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.337 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.43 ' C ' ' H ' ' A' ' 10' ' ' GLY . 19.9 ttm180 68.09 163.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.003 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.2 pt -53.49 -9.09 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.779 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . 54.42 59.78 9.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.769 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -167.32 73.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.309 . . . . 0.0 110.405 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.494 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -87.63 53.64 2.85 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.058 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 64.35 33.25 86.73 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 67.0 72.81 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.637 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.3 pt 35.25 56.5 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.989 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 13' ' ' GLY . 4.2 tp -135.63 -43.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.579 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.401 ' N ' HG23 ' A' ' 16' ' ' ILE . 40.8 mm -81.33 -45.42 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.494 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -81.99 -24.78 54.39 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.2 -37.32 21.84 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.25 -72.89 0.08 Allowed 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.667 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.7 mt 58.62 24.73 12.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.471 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.21 -103.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.471 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -71.24 -4.76 27.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 110.649 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.412 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.1 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 111.989 -0.445 . . . . 0.0 111.989 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -77.28 31.67 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.701 0.286 . . . . 0.0 110.655 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.47 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -51.88 -57.25 13.1 Favored Glycine 1 CA--C 1.355 -9.934 0 CA-C-O 123.821 1.789 . . . . 0.0 115.235 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' GLU . 61.2 mtm180 -60.76 -10.39 5.38 Favored 'General case' 1 N--CA 1.324 -6.775 1 CA-C-N 105.232 -5.484 . . . . 0.0 111.946 -157.462 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.47 ' N ' ' C ' ' A' ' 3' ' ' GLY . 85.0 t90 -41.3 -20.03 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 112.981 -1.918 . . . . 0.0 110.415 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.8 tp -110.38 -24.58 10.55 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.334 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' ARG . 55.2 mm-40 -96.81 33.91 1.79 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.768 0.318 . . . . 0.0 110.249 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -64.47 -74.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.715 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.594 HD12 ' C ' ' A' ' 9' ' ' ILE . 2.4 pp -68.64 -2.87 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.788 0.328 . . . . 0.0 110.66 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.57 ' N ' HD12 ' A' ' 9' ' ' ILE . . . -86.93 70.38 2.92 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 112.068 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -50.27 -32.53 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.107 0.48 . . . . 0.0 109.893 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -163.88 -0.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.124 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 46.3 32.84 5.38 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.931 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -149.87 -11.79 0.28 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.906 0.384 . . . . 0.0 110.007 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.8 pt -154.88 40.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.078 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.4 tp -151.36 -25.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.0 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -81.51 4.93 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.497 179.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.486 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -177.79 -13.76 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.953 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.94 -10.16 86.42 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.051 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.67 53.96 1.81 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.727 0.298 . . . . 0.0 110.573 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.1 mt -56.97 110.38 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.367 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.456 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 3.1 m-20 52.88 21.54 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.615 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.466 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 19.6 t60 53.75 46.52 25.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.582 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.33 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -59.32 159.77 7.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.85 0.357 . . . . 0.0 110.382 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.482 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 107.34 -56.53 0.48 Allowed Glycine 1 CA--C 1.354 -9.973 0 CA-C-O 123.836 1.798 . . . . 0.0 114.688 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.0 mtm180 -61.03 -9.49 4.47 Favored 'General case' 1 N--CA 1.324 -6.772 1 CA-C-N 105.169 -5.516 . . . . 0.0 112.006 -157.595 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.482 ' N ' ' C ' ' A' ' 3' ' ' GLY . 96.3 m95 -42.53 -24.25 0.05 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.058 -1.883 . . . . 0.0 109.838 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 6' ' ' LEU . 10.3 mp -95.82 -28.03 14.93 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.406 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 4' ' ' ARG . 38.3 tt0 -48.42 -29.07 3.67 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.686 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 7' ' ' GLU . 11.8 tpp180 60.36 129.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.68 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.2 tt -54.29 -37.95 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.404 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 55.04 59.05 11.04 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.0 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -169.15 68.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.792 0.329 . . . . 0.0 110.512 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.78 67.78 1.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.486 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 56.16 41.88 86.86 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.99 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.6 43.0 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 0.0 109.826 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.2 mt 54.95 61.64 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.372 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.4 mm -129.81 -42.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.009 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.7 mm -87.79 -37.3 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.0 -49.07 10.13 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -75.09 -37.4 43.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.811 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.67 5.58 0.35 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 0.0 110.586 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' A' ' 19' ' ' GLY . 9.0 tp 46.62 63.16 2.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.748 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -158.67 47.44 0.33 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.548 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.467 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 1.7 t60 51.98 20.78 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.474 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.7 tp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.257 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -59.65 -158.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.583 0.23 . . . . 0.0 110.489 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 54.23 71.21 0.74 Allowed Glycine 1 CA--C 1.375 -8.667 0 CA-C-O 125.555 2.753 . . . . 0.0 113.228 -178.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.587 ' O ' ' N ' ' A' ' 7' ' ' GLU . 6.7 mtt-85 164.79 -10.89 0.0 OUTLIER 'General case' 1 N--CA 1.321 -6.882 1 CA-C-N 101.807 -7.197 . . . . 0.0 111.303 159.423 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -42.68 -19.62 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.643 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.9 tp -107.66 -21.54 12.84 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.987 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.587 ' N ' ' O ' ' A' ' 4' ' ' ARG . 94.8 mt-10 -115.73 30.32 7.42 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 ptt85 -50.3 143.64 8.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.968 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.412 ' C ' ' H ' ' A' ' 11' ' ' LYS . 14.8 pt -64.93 -23.92 34.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.357 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.86 7.18 1.52 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.354 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' H ' ' C ' ' A' ' 9' ' ' ILE . 56.3 mttp -144.84 75.66 1.46 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.953 0.406 . . . . 0.0 110.226 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.542 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -76.86 62.92 2.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.647 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.62 68.92 1.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.091 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 61.8 t80 55.29 27.98 10.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.591 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.2 mt 61.51 63.55 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.652 0.739 . . . . 0.0 110.035 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 mm -131.65 -48.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.762 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.631 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -69.79 -46.1 75.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.542 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -78.28 -43.29 13.33 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.78 -44.59 96.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.676 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.54 82.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.372 . . . . 0.0 110.405 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp 55.43 57.81 5.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.393 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.0 t70 58.0 45.82 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.683 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 49.64 52.37 14.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.7 tp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.211 179.94 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -146.2 179.08 7.74 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.777 0.322 . . . . 0.0 110.234 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.499 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 137.45 -57.46 0.66 Allowed Glycine 1 CA--C 1.357 -9.791 0 CA-C-O 123.665 1.703 . . . . 0.0 115.404 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 6' ' ' LEU . 75.3 mtt85 -59.92 -11.48 5.67 Favored 'General case' 1 N--CA 1.325 -6.684 1 CA-C-N 105.24 -5.48 . . . . 0.0 112.161 -157.379 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.499 ' N ' ' C ' ' A' ' 3' ' ' GLY . 23.5 t90 -42.37 -16.86 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.63 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.1 tp -125.22 -12.19 6.89 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.984 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -76.11 -25.91 55.89 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.812 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -75.88 -135.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.29 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.6 pt -143.68 127.9 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.258 0.552 . . . . 0.0 110.117 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.0 -11.42 78.86 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.942 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -60.19 110.94 1.34 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.94 4.6 6.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 39.25 38.48 0.88 Allowed Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.634 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -168.05 -15.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.693 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 pt -152.71 46.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.192 0.52 . . . . 0.0 110.228 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -145.73 -41.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.256 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.539 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.8 pp -69.02 2.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.222 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.539 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -172.26 -30.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.873 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.89 -37.06 52.13 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.864 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -26.07 59.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.754 0.311 . . . . 0.0 110.508 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.5 tp 57.25 63.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.38 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER 52.31 46.54 26.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.555 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 52.03 60.67 3.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.495 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.15 -180.0 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt 56.3 -150.08 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.667 0.27 . . . . 0.0 110.692 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.434 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 52.43 70.38 0.92 Allowed Glycine 1 CA--C 1.381 -8.31 0 CA-C-O 126.122 3.068 . . . . 0.0 112.749 -178.41 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 7' ' ' GLU . 16.1 mtp180 159.35 -11.0 0.0 OUTLIER 'General case' 1 N--CA 1.316 -7.163 1 CA-C-N 100.983 -7.609 . . . . 0.0 110.523 160.309 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -43.7 -21.48 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.682 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 4' ' ' ARG . 16.7 mt -96.83 -24.54 15.85 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.677 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.7 tm-20 -68.0 -28.84 67.77 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.267 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -58.21 128.89 39.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.467 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 pt -75.32 115.39 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.401 0.62 . . . . 0.0 110.239 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.56 -2.1 79.15 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.775 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 13' ' ' GLY . 59.6 mttp -75.4 98.33 3.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.701 0.286 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.403 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -77.68 37.39 0.23 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.478 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 73.34 63.11 2.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.916 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 63.8 t80 56.1 32.56 20.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.814 0.34 . . . . 0.0 110.773 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.0 mt 61.01 63.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.588 0.708 . . . . 0.0 109.948 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.0 mm -132.43 -51.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.93 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.8 mm -68.94 -41.18 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.403 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -80.07 -48.77 6.31 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -66.82 -31.95 79.75 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.037 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.27 1.64 0.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.775 0.321 . . . . 0.0 110.568 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.1 tp 61.02 5.42 1.0 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.37 -97.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.211 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -88.97 -36.86 15.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.885 0.374 . . . . 0.0 110.361 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.508 -179.94 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 111.901 -0.479 . . . . 0.0 111.901 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -146.56 -129.64 0.07 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 4' ' ' ARG . . . 49.84 69.83 0.96 Allowed Glycine 1 CA--C 1.383 -8.194 0 CA-C-O 126.072 3.04 . . . . 0.0 113.072 -178.658 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 7' ' ' GLU . 12.1 mtt85 160.56 -11.8 0.0 OUTLIER 'General case' 1 N--CA 1.317 -7.076 1 CA-C-N 101.116 -7.542 . . . . 0.0 110.563 159.995 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.52 ' CE3' HD21 ' A' ' 6' ' ' LEU . 26.3 t90 -43.83 -18.4 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.519 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.52 HD21 ' CE3' ' A' ' 5' ' ' TRP . 30.2 mt -114.43 -16.04 11.99 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.728 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 4' ' ' ARG . 90.6 mt-10 -118.5 31.1 6.84 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -51.97 -18.41 1.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.97 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.437 ' C ' ' H ' ' A' ' 11' ' ' LYS . 18.3 pt -154.45 -24.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.603 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.68 -35.07 1.01 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.874 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 9' ' ' ILE . 58.0 mttp -54.38 108.27 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.07 2.84 3.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.036 0.446 . . . . 0.0 110.09 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.23 34.73 0.65 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.535 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -166.26 -17.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.2 pt -152.23 50.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.139 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.451 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.4 tp -145.73 -39.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.078 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -78.63 4.64 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.214 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.475 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -159.13 -30.86 0.02 OUTLIER Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.69 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.65 -35.95 47.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.592 179.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.39 47.22 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.729 0.3 . . . . 0.0 110.822 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 21' ' ' LEU . 9.8 mp -60.37 114.55 2.99 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.7 t0 58.22 -78.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.696 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' LEU . 55.3 t-80 -166.81 30.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.534 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.448 HD23 ' C ' ' A' ' 24' ' ' LEU . 2.6 tt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.153 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -62.94 -130.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.131 -0.227 . . . . 0.0 110.457 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 44.96 70.97 0.53 Allowed Glycine 1 CA--C 1.387 -7.952 0 CA-C-O 126.496 3.275 . . . . 0.0 112.907 -178.168 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.5 ' C ' ' N ' ' A' ' 6' ' ' LEU . 12.7 mtt180 155.27 -12.67 0.0 OUTLIER 'General case' 1 N--CA 1.312 -7.329 1 CA-C-N 100.431 -7.885 . . . . 0.0 110.058 161.221 . . . . . . . . 4 3 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CE3' HD21 ' A' ' 6' ' ' LEU . 23.0 t90 -45.34 -17.37 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.947 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.5 ' N ' ' C ' ' A' ' 4' ' ' ARG . 32.1 mt -114.09 -12.51 12.55 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.997 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 4' ' ' ARG . 12.3 tm-20 -64.26 -22.35 66.92 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.778 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -43.4 96.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.18 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 11' ' ' LYS . 16.4 pt -64.49 -17.96 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.417 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.09 -37.14 1.09 Allowed Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 9' ' ' ILE . 9.1 mtpm? -71.85 107.23 4.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.802 0.334 . . . . 0.0 110.297 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.562 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -77.84 45.71 0.53 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.646 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.32 66.79 2.28 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.188 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 58.1 t80 54.44 30.9 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.748 0.309 . . . . 0.0 110.663 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mt 61.98 65.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.626 0.727 . . . . 0.0 110.271 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -132.29 -48.28 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.934 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -70.83 -45.75 71.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.562 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -77.92 -42.74 15.69 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 178.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.99 -47.42 90.82 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.652 179.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -60.86 -48.89 79.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.789 0.328 . . . . 0.0 110.244 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tp 62.07 1.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.34 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 20' ' ' ALA . 70.0 m-20 -85.79 37.61 0.71 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.366 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 23' ' ' HIS . 0.7 OUTLIER 54.18 24.42 4.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.527 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.9 tt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.127 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -60.93 -171.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.532 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.475 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 106.39 -59.42 0.4 Allowed Glycine 1 CA--C 1.355 -9.913 0 CA-C-O 123.713 1.729 . . . . 0.0 115.159 -179.954 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.5 mtm180 -60.67 -10.31 5.12 Favored 'General case' 1 N--CA 1.325 -6.72 1 CA-C-N 105.37 -5.415 . . . . 0.0 111.973 -157.659 . . . . . . . . 4 3 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.475 ' N ' ' C ' ' A' ' 3' ' ' GLY . 67.3 t-105 -40.89 -21.21 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.317 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 8.1 tp -106.8 -26.43 11.27 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.455 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' ARG . 50.5 tt0 -90.1 -0.34 57.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.23 0.538 . . . . 0.0 109.736 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.6 ptt85 -45.93 147.89 0.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 mt -79.9 -64.61 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.109 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 79.02 -13.8 17.5 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.936 179.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.548 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 2.4 ttmp? -70.31 7.14 1.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.263 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 75.72 -20.68 0.34 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.344 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 35.21 65.77 0.4 Allowed Glycine 0 C--N 1.339 0.708 0 N-CA-C 112.254 -0.338 . . . . 0.0 112.254 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 56.04 36.67 27.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -178.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' ALA . 11.9 mm 64.24 80.49 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.765 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.624 HG23 ' N ' ' A' ' 17' ' ' ILE . 8.7 tp -145.84 -54.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.194 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.624 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.7 tp -74.77 -33.8 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.15 -47.69 4.88 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 178.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.14 96.76 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.08 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.21 -64.86 0.68 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.759 0.314 . . . . 0.0 110.543 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.9 tp 55.4 74.59 0.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.569 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -165.3 41.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.558 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.466 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 3.5 m80 53.31 48.92 20.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.488 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.6 tp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.319 -179.966 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -55.34 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.799 0.333 . . . . 0.0 110.553 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.505 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 96.4 -59.16 1.34 Allowed Glycine 1 CA--C 1.354 -9.972 0 CA-C-O 123.824 1.791 . . . . 0.0 114.842 -179.742 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.8 mmt180 -60.19 -10.88 5.02 Favored 'General case' 1 N--CA 1.324 -6.753 1 CA-C-N 105.187 -5.506 . . . . 0.0 111.943 -157.659 . . . . . . . . 4 3 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.529 ' CE3' HD21 ' A' ' 6' ' ' LEU . 31.3 t90 -41.05 -20.24 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.298 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.529 HD21 ' CE3' ' A' ' 5' ' ' TRP . 27.8 mt -109.69 -24.86 10.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.562 179.264 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 4' ' ' ARG . 22.2 tt0 -101.71 14.08 33.02 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.993 0.425 . . . . 0.0 110.026 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.7 ttp85 -72.06 -50.15 30.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 11' ' ' LYS . 21.0 pt -62.34 -23.54 32.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.705 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.45 -32.11 1.17 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.249 -0.5 . . . . 0.0 111.898 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 9' ' ' ILE . 93.7 mttt -73.66 108.99 6.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.161 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.03 8.51 4.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.209 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 43.99 30.71 1.81 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.101 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -155.68 -76.71 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.653 0.263 . . . . 0.0 110.34 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 15' ' ' ILE . 17.1 tt -90.41 47.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.951 0.881 . . . . 0.0 110.087 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.511 HG23 ' N ' ' A' ' 17' ' ' ILE . 3.9 tp -142.33 -44.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.378 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.511 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.1 tp -82.55 -39.47 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.109 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.58 -45.54 4.89 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -58.26 -36.22 81.92 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.909 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.13 39.63 0.19 Allowed 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.69 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.402 ' H ' ' C ' ' A' ' 19' ' ' GLY . 21.2 tp -68.05 -51.98 40.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.117 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -54.42 -45.47 73.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.609 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.418 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -48.48 -36.86 15.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.32 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.648 179.547 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 111.949 -0.461 . . . . 0.0 111.949 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -76.96 172.79 12.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.867 0.365 . . . . 0.0 110.54 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.503 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 122.01 -58.77 0.59 Allowed Glycine 1 CA--C 1.357 -9.831 0 CA-C-O 123.812 1.785 . . . . 0.0 115.159 -179.944 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 6' ' ' LEU . 73.1 mtp180 -60.24 -11.2 5.77 Favored 'General case' 1 N--CA 1.324 -6.774 1 CA-C-N 105.142 -5.529 . . . . 0.0 112.182 -157.524 . . . . . . . . 4 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.503 ' N ' ' C ' ' A' ' 3' ' ' GLY . 77.0 t-105 -40.67 -20.51 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 112.828 -1.987 . . . . 0.0 110.797 -179.744 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.7 tp -112.06 -19.29 12.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.088 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.3 tp10 -60.81 -27.87 68.36 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.31 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -57.78 153.37 13.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.599 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 pt -155.89 8.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.121 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.24 29.53 5.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.288 -0.482 . . . . 0.0 111.94 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -161.75 55.35 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.954 0.407 . . . . 0.0 110.382 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.14 -0.45 31.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.932 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.42 54.31 0.23 Allowed Glycine 0 C--N 1.332 0.316 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 41.1 t80 63.22 29.09 15.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.755 0.312 . . . . 0.0 110.341 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.6 mt 61.25 60.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.632 0.729 . . . . 0.0 109.353 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.6 mm -126.44 -47.96 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.249 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.596 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.4 mp -66.7 -38.91 82.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.86 -40.26 6.3 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 178.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.14 79.56 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.983 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.7 -39.45 73.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.72 0.295 . . . . 0.0 110.691 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.2 mt 51.25 71.45 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.485 -179.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.464 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 1.9 m-20 50.98 37.67 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.507 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.8 m80 53.7 61.4 3.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.684 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 tp . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.308 179.975 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -60.88 155.23 20.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.343 . . . . 0.0 110.428 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.463 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 116.97 -57.09 0.52 Allowed Glycine 1 CA--C 1.355 -9.954 0 CA-C-O 123.948 1.86 . . . . 0.0 114.687 -179.58 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 87.4 mtm180 -60.35 -10.92 5.36 Favored 'General case' 1 N--CA 1.323 -6.784 1 CA-C-N 104.946 -5.627 . . . . 0.0 112.001 -157.573 . . . . . . . . 4 3 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.463 ' N ' ' C ' ' A' ' 3' ' ' GLY . 81.6 m95 -43.22 -18.26 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 113.002 -1.908 . . . . 0.0 110.178 179.72 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.2 tt -114.17 -19.5 11.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.711 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.4 tp10 -82.0 16.99 1.69 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.394 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -70.3 178.35 2.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.619 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 9' ' ' ILE . 16.6 tt -170.82 130.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.453 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.99 17.2 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.837 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.58 -2.76 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.269 -0.172 . . . . 0.0 110.788 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 58.94 62.94 1.75 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.34 85.97 0.01 OUTLIER Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.469 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 12' ' ' ALA . 29.4 t80 64.14 38.27 8.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.966 0.413 . . . . 0.0 110.043 -179.085 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.4 mm 61.41 73.7 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.095 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -133.72 -53.39 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.081 179.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.666 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -70.44 -51.32 38.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.787 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.09 -42.44 51.29 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 178.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.46 -45.42 96.43 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.024 179.413 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.72 -16.2 62.76 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.813 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.8 mt 51.87 79.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.289 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.8 p30 42.45 32.58 0.36 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.157 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 15.3 m80 58.96 61.76 2.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.583 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 -179.931 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -78.4 50.14 0.91 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.79 0.329 . . . . 0.0 110.591 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.479 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -59.69 -58.14 15.84 Favored Glycine 1 CA--C 1.355 -9.925 0 CA-C-O 123.76 1.755 . . . . 0.0 115.302 179.854 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 6' ' ' LEU . 52.0 mtm-85 -59.97 -11.61 6.1 Favored 'General case' 1 N--CA 1.324 -6.754 1 CA-C-N 105.233 -5.483 . . . . 0.0 112.004 -157.549 . . . . . . . . 4 3 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.479 ' N ' ' C ' ' A' ' 3' ' ' GLY . 68.0 t-105 -41.92 -19.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.149 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 24.0 mt -118.66 -16.29 9.42 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.581 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.7 tt0 -87.96 -6.03 58.22 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 120.92 0.39 . . . . 0.0 110.181 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 62.12 -131.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.247 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.504 ' O ' HG23 ' A' ' 9' ' ' ILE . 14.8 tt -163.43 123.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 110.371 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.89 27.9 4.23 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.191 -179.625 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -101.12 100.84 11.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.774 0.321 . . . . 0.0 110.309 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.55 57.64 3.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.004 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.54 49.25 53.22 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.495 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 48.1 t80 59.05 45.06 15.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 110.533 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 mt 62.42 68.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.167 0.508 . . . . 0.0 110.628 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -134.04 -65.79 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 tp -71.19 -21.89 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.3 -45.16 5.09 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.613 179.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.67 -39.6 34.02 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.398 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.58 -75.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.638 0.256 . . . . 0.0 111.327 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.6 mt 59.76 14.03 3.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.146 -179.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 19.1 m-20 -74.33 -83.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.652 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.462 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 96.9 m-70 -156.52 56.28 0.56 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.469 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.127 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -76.92 63.33 2.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.501 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.49 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -53.5 -56.31 20.55 Favored Glycine 1 CA--C 1.357 -9.805 0 CA-C-O 123.715 1.73 . . . . 0.0 115.419 179.897 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.0 mtt180 -60.16 -10.92 5.02 Favored 'General case' 1 N--CA 1.325 -6.688 1 CA-C-N 105.318 -5.441 . . . . 0.0 112.082 -157.35 . . . . . . . . 4 3 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.49 ' N ' ' C ' ' A' ' 3' ' ' GLY . 66.9 t-105 -41.81 -19.28 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 112.892 -1.958 . . . . 0.0 110.358 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 mt -117.04 -18.36 10.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.549 179.301 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 4' ' ' ARG . 57.5 mm-40 -89.68 18.58 5.37 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.843 0.354 . . . . 0.0 110.411 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -55.25 -173.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 pt -150.09 124.28 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.967 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.44 -3.32 31.95 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.898 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -77.01 96.28 4.36 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.489 ' O ' ' CD1' ' A' ' 14' ' ' PHE . . . -57.87 -9.87 1.48 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 109.998 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.47 34.61 81.81 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.029 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 12' ' ' ALA . 61.4 m-85 -142.8 -53.21 0.39 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.795 -0.238 . . . . 0.0 110.404 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 pt -153.97 61.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.081 0.467 . . . . 0.0 110.589 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.4 mm -136.2 -39.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.416 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.429 HD12 ' C ' ' A' ' 17' ' ' ILE . 1.2 pp -96.87 14.59 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.32 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.17 -48.28 0.02 OUTLIER Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.135 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.05 -43.47 93.23 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.895 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -62.98 -53.22 57.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.796 0.331 . . . . 0.0 110.427 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tp 63.13 1.38 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.389 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 20' ' ' ALA . 30.7 t70 -78.3 56.76 1.76 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.625 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.434 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 54.6 t-80 55.59 17.98 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.602 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.1 tp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.215 -179.967 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -71.12 -141.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.473 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.537 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 52.91 68.17 1.75 Allowed Glycine 1 CA--C 1.38 -8.402 0 CA-C-O 125.135 2.52 . . . . 0.0 113.786 -179.157 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 1.2 mtm-85 166.65 -11.83 0.0 OUTLIER 'General case' 1 N--CA 1.319 -6.987 1 CA-C-N 101.53 -7.335 . . . . 0.0 110.041 158.771 . . . . . . . . 4 3 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -43.4 -18.74 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.141 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.1 mt -111.32 -18.0 13.02 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.744 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.7 mp0 -105.56 29.24 6.7 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 120.886 0.374 . . . . 0.0 110.112 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 10' ' ' GLY . 85.6 mtm180 -47.72 -71.5 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.768 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 pt -57.88 -6.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.453 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 8' ' ' ARG . . . 50.51 51.06 33.81 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.928 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -166.97 74.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.409 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.27 62.89 3.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.203 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.69 49.66 16.01 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 -179.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.4 t80 63.88 48.66 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 110.121 -179.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mm 51.45 65.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.401 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.4 mm -132.7 -62.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.373 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 tp -67.67 -31.02 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.16 -48.87 4.67 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.82 -44.17 97.28 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.12 -71.82 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.18 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.9 tp 52.62 80.24 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.57 179.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -158.86 -69.53 0.09 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.442 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -165.62 37.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.593 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.9 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.096 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.8 mttm 52.61 -163.71 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.726 0.298 . . . . 0.0 110.463 179.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.505 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 92.23 -59.1 2.71 Favored Glycine 1 CA--C 1.357 -9.8 0 CA-C-O 123.626 1.681 . . . . 0.0 115.222 179.955 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 7' ' ' GLU . 94.6 mtt180 -60.24 -10.77 4.96 Favored 'General case' 1 N--CA 1.324 -6.732 1 CA-C-N 105.395 -5.403 . . . . 0.0 111.996 -157.551 . . . . . . . . 4 3 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.505 ' N ' ' C ' ' A' ' 3' ' ' GLY . 83.7 m95 -42.0 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.435 179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.0 mt -110.13 -21.08 12.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.912 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 38.4 tt0 -47.54 -19.85 0.21 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.911 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -52.02 -71.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.493 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.668 HG23 ' H ' ' A' ' 10' ' ' GLY . 14.6 tt -70.1 -59.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.332 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.668 ' H ' HG23 ' A' ' 9' ' ' ILE . . . 44.3 38.61 5.13 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.431 179.089 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 61.5 mttp -96.15 -1.05 49.23 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 76.06 -30.28 0.19 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.156 -179.276 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.8 68.33 0.48 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 63.24 58.74 1.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 pt 38.77 81.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.998 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.3 mm -134.17 -41.45 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.471 178.648 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.92 -73.31 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.687 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.25 -44.0 98.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.719 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -77.47 -47.12 9.19 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 121.302 -0.475 . . . . 0.0 111.95 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.5 8.02 0.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 110.477 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.434 ' H ' ' C ' ' A' ' 19' ' ' GLY . 12.7 tp 52.82 75.81 0.22 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.399 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.1 p30 -168.3 49.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.1 t60 52.39 20.41 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.43 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.242 -179.995 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -77.35 27.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.727 0.299 . . . . 0.0 110.638 179.993 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.47 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -51.65 -58.88 9.29 Favored Glycine 1 CA--C 1.356 -9.899 0 CA-C-O 123.737 1.743 . . . . 0.0 115.283 179.859 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 52.7 mtp85 -60.52 -10.58 5.23 Favored 'General case' 1 N--CA 1.324 -6.745 1 CA-C-N 105.276 -5.462 . . . . 0.0 112.026 -157.633 . . . . . . . . 4 3 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.47 ' N ' ' C ' ' A' ' 3' ' ' GLY . 45.2 t-105 -41.95 -18.03 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.642 -179.881 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.6 tp -128.47 -8.42 5.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.625 179.622 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.8 tt0 -87.93 -7.68 56.8 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 110.174 179.819 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -54.33 -83.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.523 179.886 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 11' ' ' LYS . 22.5 pt -78.31 16.48 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.812 0.339 . . . . 0.0 110.541 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.21 90.43 0.01 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.234 -179.821 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' ILE . 9.8 mtmp? -154.34 -2.42 0.18 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.69 57.09 5.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.198 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.486 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -43.1 88.38 0.01 OUTLIER Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.834 -179.648 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 12' ' ' ALA . 98.0 m-85 53.54 44.63 29.59 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.15 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.4 mt 61.9 76.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.643 -179.84 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 13' ' ' GLY . 7.4 tp -142.73 -28.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.346 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 mm -104.26 -39.89 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.378 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.52 -59.88 4.28 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.413 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.414 ' C ' ' N ' ' A' ' 21' ' ' LEU . . . -72.41 -36.64 59.18 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.554 179.542 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.9 16.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.663 0.268 . . . . 0.0 111.053 179.734 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.437 ' C ' ' N ' ' A' ' 23' ' ' HIS . 23.7 mt 54.08 -123.7 2.14 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.048 -179.735 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 t0 46.05 17.6 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.761 0.315 . . . . 0.0 110.876 179.801 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.437 ' N ' ' C ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER 51.78 41.69 29.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.339 -179.862 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.7 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.256 -179.923 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt 51.33 20.67 0.99 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.75 0.309 . . . . 0.0 110.452 -179.989 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.513 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -49.97 -57.51 9.81 Favored Glycine 1 CA--C 1.356 -9.863 0 CA-C-O 123.74 1.745 . . . . 0.0 115.332 179.861 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' GLU . 58.8 mtm180 -60.58 -10.32 4.99 Favored 'General case' 1 N--CA 1.325 -6.714 1 CA-C-N 105.23 -5.485 . . . . 0.0 111.949 -157.604 . . . . . . . . 4 3 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.513 ' N ' ' C ' ' A' ' 3' ' ' GLY . 27.6 t90 -42.19 -18.93 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.294 179.932 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.5 mt -112.21 -23.09 10.61 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.379 179.077 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 82.3 mt-10 -97.24 14.26 26.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.85 0.357 . . . . 0.0 110.328 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -62.86 -37.2 85.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.709 -179.857 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 11' ' ' LYS . 4.1 tp -170.04 -11.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.96 0.409 . . . . 0.0 109.915 -179.799 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 9' ' ' ILE . . . -37.4 -25.98 0.02 OUTLIER Glycine 0 C--N 1.335 0.482 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.634 179.615 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 9' ' ' ILE . 85.9 mttt -71.2 103.29 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.31 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.7 2.87 0.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.64 -179.813 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.75 45.42 3.61 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.557 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -163.47 -41.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.663 0.268 . . . . 0.0 110.65 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 pt -154.26 60.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.105 0.479 . . . . 0.0 110.442 179.998 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 mm -147.58 -30.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.4 mm -112.39 -49.45 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.447 179.206 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.51 -41.99 49.71 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.344 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.09 -38.25 7.41 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 179.52 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.6 67.46 1.0 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.332 . . . . 0.0 110.499 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 23' ' ' HIS . 9.7 tp -49.61 120.83 4.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.514 179.889 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 52.58 -85.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.694 179.864 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -156.91 45.07 0.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.36 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.26 -179.841 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.229 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -69.89 -141.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.999 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.414 ' O ' ' NE ' ' A' ' 4' ' ' ARG . . . 44.51 70.2 0.62 Allowed Glycine 1 CA--C 1.383 -8.181 0 CA-C-O 125.784 2.88 . . . . 0.0 113.57 -179.051 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 7' ' ' GLU . 10.3 mtm180 163.24 -11.83 0.0 OUTLIER 'General case' 1 N--CA 1.319 -7.0 1 CA-C-N 101.468 -7.366 . . . . 0.0 110.658 159.621 . . . . . . . . 4 3 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -43.53 -18.63 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.312 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.533 ' N ' ' C ' ' A' ' 4' ' ' ARG . 36.3 mt -115.2 -14.9 11.7 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.937 178.919 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.1 mt-10 -118.2 25.95 9.97 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.413 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -66.93 152.22 46.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.565 -179.903 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.511 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.0 tt -68.93 -42.99 82.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.363 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.511 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 44.69 -129.71 7.59 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.232 -179.987 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 90.4 mttt 49.79 18.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.302 . . . . 0.0 110.532 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 71.9 -13.6 0.57 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.775 -179.918 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.97 56.59 2.14 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 112.211 -0.355 . . . . 0.0 112.211 179.99 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 67.43 46.99 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.07 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.2 mm 62.68 77.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.891 -179.945 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' ALA . 7.6 mm -131.77 -73.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.4 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -74.47 -29.77 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.418 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.85 -53.12 8.4 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.18 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -77.15 -45.21 11.85 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.526 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.59 10.72 0.24 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.768 0.318 . . . . 0.0 110.537 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 21' ' ' LEU . 8.6 mp 53.85 -111.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.016 -179.97 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 t70 54.91 -82.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.708 0.289 . . . . 0.0 110.757 179.924 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' LEU . 15.4 t60 -160.67 4.31 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.425 179.922 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.538 179.894 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -71.53 -154.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.191 -0.204 . . . . 0.0 110.531 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 58.11 71.77 0.7 Allowed Glycine 1 CA--C 1.381 -8.327 0 CA-C-O 126.129 3.071 . . . . 0.0 112.207 -178.176 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 7' ' ' GLU . 10.1 mtp180 158.31 -11.44 0.0 OUTLIER 'General case' 1 N--CA 1.314 -7.235 1 CA-C-N 100.894 -7.653 . . . . 0.0 110.593 160.655 . . . . . . . . 4 3 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -44.37 -21.62 0.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.387 -179.773 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.476 ' N ' ' C ' ' A' ' 4' ' ' ARG . 17.1 mt -99.81 -21.26 15.82 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.634 179.713 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.3 tp10 -68.83 -28.19 66.52 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.467 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -66.15 155.73 36.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.575 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.52 ' O ' HG23 ' A' ' 9' ' ' ILE . 16.8 tt -165.87 121.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.478 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.26 -25.34 19.41 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 13' ' ' GLY . 45.9 mttp -83.3 87.66 6.95 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.947 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.07 17.58 1.21 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.586 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 57.61 22.3 45.65 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.452 -179.531 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.421 ' C ' ' H ' ' A' ' 16' ' ' ILE . 45.5 t80 -146.06 -55.29 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.8 pt -80.37 31.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 179.71 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.538 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.6 tp -148.54 -46.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.924 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.538 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.5 tp -79.26 -32.33 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.188 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.78 -47.75 3.86 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 178.655 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.42 -38.39 86.72 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.408 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -75.01 -68.64 0.53 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.845 0.355 . . . . 0.0 110.285 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.432 ' C ' ' H ' ' A' ' 23' ' ' HIS . 0.7 OUTLIER 59.03 5.96 0.6 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.052 179.879 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 20' ' ' ALA . 8.4 m-20 -77.58 23.0 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.531 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.432 ' H ' ' C ' ' A' ' 21' ' ' LEU . 37.8 m-70 52.86 35.67 19.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.427 179.964 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.251 -179.988 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.019 -0.433 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 51.72 -158.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -179.997 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 55.43 70.3 1.0 Allowed Glycine 1 CA--C 1.381 -8.302 0 CA-C-O 126.392 3.218 . . . . 0.0 112.251 -178.002 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.602 ' O ' ' N ' ' A' ' 7' ' ' GLU . 14.9 mtt-85 157.33 -10.03 0.0 OUTLIER 'General case' 1 N--CA 1.314 -7.254 1 CA-C-N 100.612 -7.794 . . . . 0.0 110.175 160.903 . . . . . . . . 4 3 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -41.28 -24.21 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.957 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.4 mm? -92.33 -29.3 16.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.209 179.459 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.7 tt0 -71.3 -19.02 62.38 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.126 179.715 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.44 131.78 51.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.525 179.947 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.8 pt -64.16 -34.51 69.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.529 -179.901 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.51 47.02 92.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.074 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -154.18 73.19 0.91 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.782 0.325 . . . . 0.0 110.254 179.988 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.514 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -80.01 49.65 1.11 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.612 179.908 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.73 65.71 2.91 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.166 179.897 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 54.77 31.63 15.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.701 0.286 . . . . 0.0 110.923 179.785 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 61.26 64.08 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.578 0.704 . . . . 0.0 110.277 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 mm -133.01 -47.28 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.717 179.923 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.655 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -72.13 -46.18 59.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.858 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.514 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -75.92 -48.7 9.6 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.082 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.53 -42.45 99.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.857 179.618 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 59.95 3.39 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.743 0.306 . . . . 0.0 110.784 -179.958 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.2 mt 49.71 13.41 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.736 179.91 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' N ' ' C ' ' A' ' 20' ' ' ALA . 47.6 t0 -62.83 -73.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.565 179.984 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -169.62 20.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.548 179.942 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 24' ' ' LEU . 10.1 mp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.079 179.908 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.254 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -168.43 160.33 11.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.397 -179.981 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.494 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 144.33 -56.05 0.55 Allowed Glycine 1 CA--C 1.353 -10.073 0 CA-C-O 123.965 1.87 . . . . 0.0 114.571 -179.491 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 7' ' ' GLU . 65.5 mtt-85 -60.48 -10.73 5.37 Favored 'General case' 1 N--CA 1.321 -6.897 1 CA-C-N 104.923 -5.639 . . . . 0.0 111.949 -157.671 . . . . . . . . 4 3 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.494 ' N ' ' C ' ' A' ' 3' ' ' GLY . 69.9 t-105 -43.03 -19.04 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.151 179.876 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.497 ' N ' ' C ' ' A' ' 4' ' ' ARG . 20.6 mt -111.89 -19.66 12.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.75 179.788 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.2 tt0 -49.04 -24.58 1.62 Allowed 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.71 -179.844 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 56.5 99.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.231 -179.913 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 pt -62.59 113.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.411 0.624 . . . . 0.0 110.279 -179.845 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.82 8.25 8.03 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.648 179.854 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.457 ' HA ' HG21 ' A' ' 16' ' ' ILE . 57.5 mttp -67.28 108.37 2.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.694 0.283 . . . . 0.0 110.64 -179.924 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.91 4.76 5.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.064 0.459 . . . . 0.0 109.783 179.536 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 14' ' ' PHE . . . 59.99 22.89 58.55 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.998 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 63.9 m-85 -158.6 -100.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.738 0.304 . . . . 0.0 111.166 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.8 pt -78.05 60.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.988 0.423 . . . . 0.0 111.739 -178.834 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.457 HG21 ' HA ' ' A' ' 11' ' ' LYS . 16.7 mm -149.26 -44.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.036 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.03 -50.07 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.805 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.56 -43.61 67.79 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.059 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.1 -42.62 7.96 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 179.386 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.35 50.38 18.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.767 0.318 . . . . 0.0 110.649 179.861 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.3 mt -75.19 -26.76 59.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.416 179.931 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 24' ' ' LEU . 16.3 m-20 -77.2 -67.77 0.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.42 1.4 0.79 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.709 -179.798 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 22' ' ' ASP . 1.6 tt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.351 179.992 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 111.994 -0.443 . . . . 0.0 111.994 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -77.14 38.34 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 0.0 110.568 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.475 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -49.69 -58.06 8.83 Favored Glycine 1 CA--C 1.356 -9.884 0 CA-C-O 123.656 1.698 . . . . 0.0 115.299 179.806 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 7' ' ' GLU . 88.0 mtt180 -60.6 -10.98 5.91 Favored 'General case' 1 N--CA 1.324 -6.76 1 CA-C-N 105.317 -5.441 . . . . 0.0 111.855 -157.626 . . . . . . . . 4 3 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.475 ' N ' ' C ' ' A' ' 3' ' ' GLY . 26.6 t90 -42.7 -21.34 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.836 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.483 ' N ' ' C ' ' A' ' 4' ' ' ARG . 11.0 mp -105.27 -26.32 12.07 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.995 179.151 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 4' ' ' ARG . 22.4 mm-40 -93.34 37.65 1.05 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.694 0.283 . . . . 0.0 110.607 -179.855 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -69.9 172.36 7.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.446 179.988 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 tp -170.4 124.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.192 179.849 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.36 25.26 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.769 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -69.62 -5.81 27.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 55.54 60.72 3.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.015 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.66 87.59 0.01 OUTLIER Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -179.657 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 12' ' ' ALA . 98.8 m-85 54.01 42.05 31.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -178.621 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.5 mt 62.66 83.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.465 -179.576 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.633 HG23 ' H ' ' A' ' 17' ' ' ILE . 5.2 tp -143.66 -58.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.398 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.633 ' H ' HG23 ' A' ' 16' ' ' ILE . 3.7 tp -86.15 -26.34 6.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.505 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.18 -55.29 4.42 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 178.871 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.16 -43.28 40.19 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.632 179.299 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.34 38.76 30.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.694 0.283 . . . . 0.0 110.778 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.1 mt -99.8 -20.07 16.39 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.481 179.839 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -50.09 -50.9 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -165.28 -20.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.46 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.6 mp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.169 179.923 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -149.63 -179.48 7.14 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.786 0.326 . . . . 0.0 110.155 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.5 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 97.21 -58.33 1.18 Allowed Glycine 1 CA--C 1.357 -9.842 0 CA-C-O 123.639 1.688 . . . . 0.0 115.454 179.924 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 7' ' ' GLU . 71.1 mtm180 -60.47 -10.51 5.06 Favored 'General case' 1 N--CA 1.325 -6.71 1 CA-C-N 105.445 -5.378 . . . . 0.0 112.057 -157.454 . . . . . . . . 4 3 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.5 ' N ' ' C ' ' A' ' 3' ' ' GLY . 58.3 m95 -41.19 -20.05 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 112.924 -1.944 . . . . 0.0 110.334 179.834 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.0 tp -112.93 -22.62 10.53 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.342 179.351 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.2 mm-40 -102.06 38.77 1.59 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.657 0.265 . . . . 0.0 110.563 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -51.47 139.23 20.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.383 179.981 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.554 HG23 ' H ' ' A' ' 10' ' ' GLY . 2.7 tp -52.64 -56.08 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.406 -179.797 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.554 ' H ' HG23 ' A' ' 9' ' ' ILE . . . 74.49 -38.92 1.04 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.073 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -78.12 105.42 9.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.745 0.307 . . . . 0.0 110.389 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.85 9.17 3.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.192 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.13 34.43 12.25 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.114 179.878 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -161.96 -73.85 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.826 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 pt -81.48 38.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.207 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 17' ' ' ILE . 4.0 tp -146.23 -42.72 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.087 -179.656 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.56 HD12 ' C ' ' A' ' 17' ' ' ILE . 2.2 pp -77.04 0.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.043 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.55 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -158.15 -42.64 0.02 OUTLIER Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.686 -179.808 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -61.23 -36.34 92.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.69 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.438 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 56.29 6.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.748 0.308 . . . . 0.0 110.704 179.918 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.436 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.0 tp 49.97 14.09 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.411 179.99 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.438 ' N ' ' C ' ' A' ' 20' ' ' ALA . 18.3 t70 -71.73 -40.96 69.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.441 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.466 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -165.78 12.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.343 179.9 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.226 -179.988 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -57.45 171.95 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.36 . . . . 0.0 110.62 -179.998 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 91.88 -58.77 2.87 Favored Glycine 1 CA--C 1.355 -9.908 0 CA-C-O 123.778 1.766 . . . . 0.0 115.174 -179.855 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 7' ' ' GLU . 94.8 mtt180 -60.43 -10.59 5.09 Favored 'General case' 1 N--CA 1.326 -6.634 1 CA-C-N 105.266 -5.467 . . . . 0.0 111.966 -157.524 . . . . . . . . 4 3 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.492 ' N ' ' C ' ' A' ' 3' ' ' GLY . 56.3 m95 -42.11 -20.12 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.964 -1.925 . . . . 0.0 110.38 179.83 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.3 mt -110.18 -20.48 12.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.995 179.93 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 40.6 tt0 -46.99 -22.02 0.28 Allowed 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.823 -179.917 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 -79.61 -44.05 21.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 9' ' ' ILE . 26.4 mm -70.28 -6.88 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 -179.64 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.37 -25.57 6.18 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.739 -0.744 . . . . 0.0 111.35 179.542 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 13' ' ' GLY . 98.0 mttt -116.68 76.45 1.03 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.228 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.92 84.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.381 -179.535 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . 47.18 54.65 9.62 Favored Glycine 0 C--N 1.33 0.209 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -179.593 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.1 t80 57.68 39.91 26.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.885 0.374 . . . . 0.0 110.285 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 mt 60.85 67.59 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.482 -179.979 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.524 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.2 tp -137.89 -47.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.387 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.524 ' N ' HG23 ' A' ' 16' ' ' ILE . 28.9 mm -77.63 -36.68 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.297 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.12 -50.68 6.64 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 178.884 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . -67.61 -36.86 88.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.568 179.342 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 73.17 -35.68 0.33 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.635 0.255 . . . . 0.0 111.06 179.865 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.4 mm? 53.35 10.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.953 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 20' ' ' ALA . 15.8 t0 -79.56 -37.42 36.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.623 -179.913 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -167.6 -22.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.806 -179.942 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.145 -179.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.79 176.98 4.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 110.619 -179.989 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.488 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 127.72 -57.82 0.7 Allowed Glycine 1 CA--C 1.355 -9.964 0 CA-C-O 123.83 1.794 . . . . 0.0 114.86 -179.737 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 7' ' ' GLU . 58.0 mtm180 -61.12 -9.41 4.62 Favored 'General case' 1 N--CA 1.323 -6.802 1 CA-C-N 105.22 -5.49 . . . . 0.0 112.001 -157.688 . . . . . . . . 4 3 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.488 ' N ' ' C ' ' A' ' 3' ' ' GLY . 95.5 m95 -38.48 -26.56 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.118 -1.856 . . . . 0.0 110.354 -179.913 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.4 mm? -94.18 -33.54 13.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.077 179.334 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.5 mt-10 -96.1 14.14 24.87 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.708 0.289 . . . . 0.0 110.437 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 4' ' ' ARG . 0.6 OUTLIER -70.04 -68.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.322 -179.795 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.5 pt -98.59 -33.34 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.63 179.894 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.01 59.89 6.52 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.841 -179.724 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -162.75 83.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.34 . . . . 0.0 110.241 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.474 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -79.33 57.03 2.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 -179.825 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 57.31 64.47 4.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.057 179.993 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 47.0 t80 54.89 33.27 19.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.797 0.332 . . . . 0.0 110.467 179.918 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 mt 59.52 64.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.575 0.702 . . . . 0.0 110.113 -179.831 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -132.18 -51.87 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.847 -179.941 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 mm -68.87 -44.37 81.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.764 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -77.99 -44.36 12.13 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.936 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.19 -43.3 99.57 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.892 179.543 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.08 -22.24 49.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.838 0.351 . . . . 0.0 110.495 -179.898 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.3 tp -56.55 -19.12 14.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.413 179.994 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 79.4 m-20 -51.04 -51.99 47.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.666 179.903 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.488 ' ND1' ' O ' ' A' ' 22' ' ' ASP . 77.1 m-70 -153.89 39.62 0.48 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.246 179.956 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.134 -179.932 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -169.37 157.96 7.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.0 110.322 179.987 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.495 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 118.76 -56.03 0.58 Allowed Glycine 1 CA--C 1.354 -9.97 0 CA-C-O 123.849 1.805 . . . . 0.0 114.652 -179.568 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 7' ' ' GLU . 83.8 mtm180 -60.99 -9.08 3.75 Favored 'General case' 1 N--CA 1.323 -6.81 1 CA-C-N 105.093 -5.553 . . . . 0.0 112.072 -157.644 . . . . . . . . 4 3 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.495 ' N ' ' C ' ' A' ' 3' ' ' GLY . 97.8 m95 -38.4 -23.99 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.569 -179.901 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.0 tp -102.43 -29.89 11.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.412 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.4 mm-40 -97.38 43.99 1.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -50.97 -39.09 54.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 -179.851 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.447 ' C ' ' H ' ' A' ' 11' ' ' LYS . 11.2 pt -155.83 -35.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.428 179.903 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.34 -12.99 1.64 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.225 179.886 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 9' ' ' ILE . 31.9 mtmm -89.76 105.49 17.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.749 0.309 . . . . 0.0 110.201 179.903 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.02 61.2 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.806 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.461 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 46.62 50.91 13.4 Favored Glycine 0 C--N 1.331 0.27 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -179.236 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.9 t80 60.24 63.54 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.713 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.5 pt 35.26 62.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.346 -179.342 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.56 HG23 ' N ' ' A' ' 17' ' ' ILE . 4.5 tp -129.15 -48.71 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.56 ' N ' HG23 ' A' ' 16' ' ' ILE . 4.1 tp -82.31 -33.77 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.518 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.86 -35.64 6.72 Favored Glycine 0 C--N 1.331 0.262 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.23 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.66 -37.83 61.56 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.016 179.805 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.54 -68.16 0.45 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.824 0.345 . . . . 0.0 110.5 179.993 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.21 85.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.132 -179.97 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.9 t0 51.19 35.62 13.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.7 179.967 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.431 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 7.0 t60 53.24 46.21 26.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.565 179.871 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.127 179.922 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.008 -0.437 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -170.11 65.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.765 0.317 . . . . 0.0 110.409 -179.954 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.487 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -50.68 -57.84 10.11 Favored Glycine 1 CA--C 1.356 -9.9 0 CA-C-O 123.729 1.739 . . . . 0.0 115.218 179.843 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 7' ' ' GLU . 80.0 mtm180 -60.7 -10.34 5.22 Favored 'General case' 1 N--CA 1.323 -6.806 1 CA-C-N 105.27 -5.465 . . . . 0.0 111.921 -157.619 . . . . . . . . 4 3 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.487 ' N ' ' C ' ' A' ' 3' ' ' GLY . 27.3 t90 -42.3 -20.22 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.065 -1.88 . . . . 0.0 110.218 179.81 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 4' ' ' ARG . 24.0 mt -107.05 -24.98 11.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.375 179.446 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' ARG . 11.8 mp0 -89.24 -3.78 58.42 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.645 0.26 . . . . 0.0 110.318 -179.981 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -73.66 -29.72 62.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.52 -179.943 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 9' ' ' ILE . 13.2 tt -48.67 99.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.227 0.537 . . . . 0.0 110.653 -179.805 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.14 -14.45 82.27 Favored Glycine 0 C--N 1.329 0.18 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.978 -179.927 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -73.95 97.98 2.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.815 0.34 . . . . 0.0 110.464 -179.983 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.8 -3.27 1.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.803 -179.906 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.7 14.2 42.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.703 -179.888 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -163.79 -46.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.929 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.6 mm -99.77 52.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.339 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.546 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -149.74 -45.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.208 -179.827 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.546 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -79.77 5.37 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.765 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.478 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -152.14 -44.11 0.02 OUTLIER Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.648 -179.916 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.41 -35.38 61.07 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.948 179.843 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.74 -29.47 59.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 0.0 110.507 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.3 mt -81.98 -27.14 33.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.633 -179.944 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -50.56 -59.91 3.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.603 179.983 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.4 ' H ' ' H ' ' A' ' 24' ' ' LEU . 11.4 t-80 -170.03 -4.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.539 179.935 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' H ' ' H ' ' A' ' 23' ' ' HIS . 17.2 mt . . . . . 0 N--CA 1.468 0.45 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.393 179.923 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 111.896 -0.481 . . . . 0.0 111.896 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.0 mttm 51.72 -166.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.771 0.32 . . . . 0.0 110.482 179.991 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.498 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 128.42 -58.02 0.71 Allowed Glycine 1 CA--C 1.356 -9.883 0 CA-C-O 123.718 1.732 . . . . 0.0 115.129 -179.924 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 7' ' ' GLU . 52.3 mtm-85 -60.6 -10.31 5.0 Favored 'General case' 1 N--CA 1.324 -6.75 1 CA-C-N 105.265 -5.467 . . . . 0.0 112.048 -157.534 . . . . . . . . 4 3 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.498 ' N ' ' C ' ' A' ' 3' ' ' GLY . 65.4 t-105 -41.07 -25.06 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.999 -1.91 . . . . 0.0 109.989 179.914 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.451 ' N ' ' C ' ' A' ' 4' ' ' ARG . 3.3 mm? -96.75 -29.0 14.02 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.424 179.508 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 4' ' ' ARG . 2.3 mp0 -86.39 -8.22 57.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.656 -179.498 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -80.26 -114.86 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.491 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.449 ' C ' ' H ' ' A' ' 11' ' ' LYS . 6.9 mm -83.09 -74.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.762 0.315 . . . . 0.0 110.171 179.742 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.85 -33.15 0.88 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.21 179.982 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 13' ' ' GLY . 40.8 mtmt -117.12 74.97 0.94 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.871 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.33 77.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.191 179.977 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 51.62 54.6 23.94 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.544 -179.532 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 60.38 35.74 20.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.33 -179.644 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.3 mt 60.48 62.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.442 -179.988 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 13' ' ' GLY . 4.4 tp -132.28 -41.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.552 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.42 ' N ' HG23 ' A' ' 16' ' ' ILE . 40.4 mm -81.27 -43.55 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.541 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.5 -47.83 26.21 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 178.834 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.0 -37.62 87.83 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.703 179.301 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.42 51.18 11.93 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.88 0.371 . . . . 0.0 110.753 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.5 103.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.552 -179.914 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t70 54.53 44.16 29.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.616 -179.997 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.3 m80 51.56 31.84 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 179.923 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.358 179.971 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -149.98 -179.24 7.0 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 110.31 179.971 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.51 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 96.57 -58.88 1.31 Allowed Glycine 1 CA--C 1.354 -9.974 0 CA-C-O 123.675 1.708 . . . . 0.0 115.161 -179.886 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' GLU . 71.7 mtm-85 -60.55 -10.46 5.12 Favored 'General case' 1 N--CA 1.325 -6.7 1 CA-C-N 105.365 -5.418 . . . . 0.0 111.933 -157.684 . . . . . . . . 4 3 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.51 ' N ' ' C ' ' A' ' 3' ' ' GLY . 76.2 m95 -41.85 -19.8 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.224 179.896 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.6 tp -112.11 -23.01 10.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.226 179.371 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.5 mt-10 -94.61 20.92 7.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.844 0.354 . . . . 0.0 110.463 179.946 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.411 ' O ' HG23 ' A' ' 9' ' ' ILE . 43.4 ttt85 -68.77 122.09 17.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.555 -179.965 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.414 ' H ' ' H ' ' A' ' 10' ' ' GLY . 20.8 pt -157.01 -9.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.309 -179.891 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 9' ' ' ILE . . . 53.93 38.57 60.47 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.973 -179.97 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 13' ' ' GLY . 67.5 mttm -148.71 77.27 1.38 Allowed 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.989 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.438 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -76.91 33.53 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.591 179.978 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 52.32 48.48 53.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.896 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.8 t80 67.78 50.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.692 0.282 . . . . 0.0 110.946 179.894 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.5 mm 60.66 73.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.333 0.587 . . . . 0.0 111.334 179.301 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.3 mm -136.05 -51.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.001 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.642 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -70.45 -54.05 20.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.859 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.438 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -70.62 -50.98 22.65 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.475 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.76 -45.8 95.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.865 179.684 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.63 -0.65 0.52 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.636 0.255 . . . . 0.0 110.896 -179.927 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 19' ' ' GLY . 16.0 mt 47.26 73.76 0.18 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 110.712 179.787 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.9 p-10 -170.68 35.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.621 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 51.36 42.59 29.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.535 179.973 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 24' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.195 -179.985 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -75.76 -173.68 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.854 0.359 . . . . 0.0 110.629 -179.932 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 131.6 -58.31 0.71 Allowed Glycine 1 CA--C 1.356 -9.848 0 CA-C-O 123.769 1.76 . . . . 0.0 115.01 -179.91 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 6' ' ' LEU . 97.5 mtt180 -60.5 -10.64 5.26 Favored 'General case' 1 N--CA 1.323 -6.777 1 CA-C-N 105.203 -5.499 . . . . 0.0 111.978 -157.612 . . . . . . . . 4 3 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.492 ' N ' ' C ' ' A' ' 3' ' ' GLY . 74.6 t-105 -41.67 -18.99 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.004 -1.907 . . . . 0.0 110.455 -179.912 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.3 mp -117.34 -17.91 10.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.646 179.374 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 4' ' ' ARG . 68.4 mm-40 -90.71 -9.99 44.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.719 0.295 . . . . 0.0 110.752 -179.844 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -83.45 68.45 9.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.521 -179.983 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.22 81.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.548 -179.872 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.33 -32.42 14.39 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.201 -0.523 . . . . 0.0 111.874 179.856 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -59.43 106.53 0.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.32 . . . . 0.0 110.298 179.881 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.91 1.45 3.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.037 -179.954 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 43.23 38.15 3.56 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.463 179.859 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 15' ' ' ILE . 31.2 t80 -169.42 -15.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.053 179.988 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 14' ' ' PHE . 19.0 pt -157.06 49.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.826 0.346 . . . . 0.0 111.06 179.826 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.417 ' C ' ' H ' ' A' ' 18' ' ' GLY . 1.5 mm -143.78 -50.25 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.559 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.4 ' C ' HD12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -75.9 15.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.222 179.876 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -171.99 -31.87 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.157 -0.544 . . . . 0.0 111.855 -179.963 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.31 -23.86 69.87 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 -180.0 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.66 -50.32 58.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 0.0 110.575 -179.902 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.7 mt 56.09 56.49 5.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.116 -179.93 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -157.87 68.63 0.51 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.567 -179.943 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.466 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 49.5 t-80 51.82 39.61 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.608 179.856 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.2 tp . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.211 179.953 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -169.59 -146.29 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.977 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.455 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 56.73 72.58 0.56 Allowed Glycine 1 CA--C 1.383 -8.17 0 CA-C-O 126.319 3.177 . . . . 0.0 112.192 -178.07 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER 156.18 -10.46 0.0 OUTLIER 'General case' 1 N--CA 1.312 -7.367 1 CA-C-N 100.548 -7.826 . . . . 0.0 109.951 161.25 . . . . . . . . 5 4 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.6 t90 -42.4 -23.5 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.896 -179.943 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' N ' ' C ' ' A' ' 4' ' ' ARG . 5.0 mp -92.87 -27.63 17.0 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.61 179.765 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.5 mt-10 -79.21 -14.61 58.95 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.737 -179.928 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -70.17 -179.91 2.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 0.0 110.594 -179.881 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 tp -60.05 105.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.262 0.553 . . . . 0.0 110.409 -179.712 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.77 42.76 0.02 OUTLIER Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.831 179.995 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -50.29 -31.36 14.1 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.604 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.403 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -162.67 -9.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.622 -179.876 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 58.57 33.35 71.62 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.7 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -154.32 -9.79 0.14 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.915 0.388 . . . . 0.0 110.14 -179.926 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.5 pt -156.81 40.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.01 179.425 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 tp -150.49 -26.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.254 -179.683 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -83.5 6.71 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.837 179.484 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.45 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -170.79 -28.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.952 -179.978 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.83 -47.64 38.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.161 -0.542 . . . . 0.0 111.987 179.96 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.08 36.72 25.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.722 0.296 . . . . 0.0 110.583 179.958 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.59 -5.26 27.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.418 179.853 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -51.63 -35.51 42.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.619 179.981 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -168.48 21.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.702 179.967 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.21 179.979 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.214 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 81.6 mttt 52.07 -143.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.56 179.988 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.424 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 51.4 69.53 1.11 Allowed Glycine 1 CA--C 1.381 -8.298 0 CA-C-O 125.826 2.903 . . . . 0.0 113.095 -178.758 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.525 ' C ' ' N ' ' A' ' 6' ' ' LEU . 13.8 mtp180 162.38 -13.06 0.0 OUTLIER 'General case' 1 N--CA 1.318 -7.044 1 CA-C-N 101.345 -7.427 . . . . 0.0 110.583 159.656 . . . . . . . . 4 3 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -43.81 -18.12 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.682 -179.975 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.525 ' N ' ' C ' ' A' ' 4' ' ' ARG . 63.3 mt -120.6 -9.14 9.44 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.184 179.236 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.1 mt-10 -116.43 32.33 6.19 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.096 0.474 . . . . 0.0 109.749 179.626 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -49.03 92.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.534 179.76 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 7' ' ' GLU . 16.4 pt -71.59 -32.58 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 -179.891 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.35 6.58 1.56 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.029 -179.978 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.535 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 78.6 tttt -68.83 -7.45 34.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 110.217 179.976 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 74.89 -21.54 0.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.607 -179.85 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 42.64 52.64 5.39 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.627 -179.816 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.8 t80 70.91 44.61 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.993 0.425 . . . . 0.0 109.978 -179.124 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.8 mt 61.22 74.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.46 -179.99 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.7 mm -136.0 -71.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.693 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 tp -72.46 -23.52 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.136 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.16 -54.99 3.63 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.383 179.253 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -40.65 41.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.78 179.688 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.15 59.27 4.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.833 0.349 . . . . 0.0 110.245 -179.951 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 21' ' ' LEU . 10.1 mp -48.32 117.3 1.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.338 -179.827 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t0 55.16 51.93 12.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.986 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.1 m170 53.28 35.01 19.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.689 179.927 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.331 179.906 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -62.92 178.29 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.534 179.905 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.457 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 119.6 -58.75 0.54 Allowed Glycine 1 CA--C 1.356 -9.891 0 CA-C-O 123.758 1.754 . . . . 0.0 115.23 179.99 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 59.4 mtt85 -60.59 -10.32 4.99 Favored 'General case' 1 N--CA 1.325 -6.717 1 CA-C-N 105.272 -5.464 . . . . 0.0 111.999 -157.609 . . . . . . . . 4 3 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.457 ' N ' ' C ' ' A' ' 3' ' ' GLY . 67.7 t-105 -40.8 -21.1 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.387 -179.934 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.9 mt -108.44 -24.92 11.22 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.676 179.365 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.1 mm-40 -89.89 33.8 0.85 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-O 120.928 0.394 . . . . 0.0 110.34 179.876 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -146.63 70.47 1.21 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.128 179.961 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 9' ' ' ILE . 13.8 tt -61.04 120.79 7.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 179.963 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.87 -31.5 67.13 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.893 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.469 ' C ' ' H ' ' A' ' 13' ' ' GLY . 93.5 mttt -69.46 95.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 110.159 179.62 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.16 -8.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.39 -179.993 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 67.43 0.41 11.39 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.479 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.451 ' O ' HG23 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -80.86 -68.26 0.7 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.949 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 14' ' ' PHE . 19.6 pt -158.25 42.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.771 179.42 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 16' ' ' ILE . 1.5 mp -85.66 -49.79 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.142 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.513 ' CD1' ' H ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -75.41 18.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.747 179.891 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -152.69 -58.1 0.01 OUTLIER Glycine 0 C--N 1.334 0.455 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 -179.938 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.43 -33.0 65.09 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.895 -179.994 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.99 -66.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 110.521 179.951 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.81 73.07 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.166 0.508 . . . . 0.0 109.899 179.898 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -160.87 32.51 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.306 179.984 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 50.5 t-80 55.48 39.51 31.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.285 -179.816 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.091 -179.76 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.491 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -50.33 -179.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.768 0.318 . . . . 0.0 110.744 -179.886 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.485 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 110.29 -59.2 0.36 Allowed Glycine 1 CA--C 1.356 -9.869 0 CA-C-O 123.628 1.682 . . . . 0.0 115.232 179.875 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 6' ' ' LEU . 66.8 mtp180 -60.2 -11.24 5.77 Favored 'General case' 1 N--CA 1.325 -6.71 1 CA-C-N 105.435 -5.382 . . . . 0.0 112.059 -157.467 . . . . . . . . 4 3 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.485 ' N ' ' C ' ' A' ' 3' ' ' GLY . 50.0 t90 -42.91 -18.44 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.887 -1.96 . . . . 0.0 110.214 179.85 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.4 tp -114.8 -20.24 10.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.422 179.469 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 45.0 mm-40 -89.99 19.16 5.09 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.556 -179.998 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -78.68 56.32 1.83 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.183 179.952 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.61 83.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.658 -179.774 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.5 -25.11 75.03 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.119 -0.562 . . . . 0.0 111.716 179.625 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -78.39 107.92 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.776 0.322 . . . . 0.0 110.245 179.814 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.91 55.43 1.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.835 179.754 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 53.11 47.64 60.27 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.371 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 t80 61.0 45.55 9.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.029 0.443 . . . . 0.0 110.008 -179.392 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 mt 60.99 70.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.583 -179.803 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.5 mm -135.8 -64.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.5 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -70.74 -26.76 28.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.352 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.07 -56.2 2.77 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.409 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.37 82.62 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 179.666 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.61 47.8 12.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.726 0.298 . . . . 0.0 110.675 179.829 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.2 tp -72.85 -34.6 66.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.022 179.854 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.45 44.14 0.59 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.568 179.998 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 42.3 m80 51.6 17.32 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.564 179.994 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.1 tp . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.262 -179.93 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.56 -146.94 0.22 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.794 0.331 . . . . 0.0 110.241 179.987 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.469 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 102.33 -58.88 0.58 Allowed Glycine 1 CA--C 1.355 -9.947 0 CA-C-O 123.693 1.718 . . . . 0.0 115.013 -179.801 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 66.1 mtp180 -60.57 -10.68 5.45 Favored 'General case' 1 N--CA 1.324 -6.77 1 CA-C-N 105.38 -5.41 . . . . 0.0 111.966 -157.592 . . . . . . . . 4 3 . 1 . 050 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.469 ' N ' ' C ' ' A' ' 3' ' ' GLY . 33.2 t90 -44.39 -20.02 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 112.984 -1.917 . . . . 0.0 109.908 179.675 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.447 ' N ' ' C ' ' A' ' 4' ' ' ARG . 42.6 tp -105.34 -22.84 12.96 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.431 179.791 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 36.8 tt0 -48.26 -36.2 13.56 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.7 mtt85 -77.06 -63.89 1.26 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.559 179.839 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.4 tt -170.42 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.447 -179.998 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 77.84 -50.39 3.3 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -179.796 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -81.25 96.58 7.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.696 0.284 . . . . 0.0 110.261 179.761 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.9 47.61 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.771 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.7 54.39 33.33 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.676 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 55.2 49.1 17.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.497 -179.698 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.6 mt 60.58 70.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.67 179.921 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.6 mm -136.35 -68.31 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.609 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 tp -68.49 -22.99 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.654 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.24 -59.89 1.8 Allowed Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.486 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.52 -31.63 79.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.715 179.774 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.13 57.91 5.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 110.407 179.959 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.0 mt -56.75 90.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.386 179.954 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 24' ' ' LEU . 8.2 m-20 54.33 -135.1 1.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.354 -179.93 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -76.41 21.3 0.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.789 0.328 . . . . 0.0 110.744 179.885 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' A' ' 22' ' ' ASP . 15.9 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.145 -179.997 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 111.954 -0.459 . . . . 0.0 111.954 . . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.49 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -76.8 35.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 110.18 -179.963 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.489 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -53.77 -57.92 14.33 Favored Glycine 1 CA--C 1.356 -9.9 0 CA-C-O 123.782 1.768 . . . . 0.0 115.094 179.796 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 6' ' ' LEU . 93.9 mtt180 -60.73 -10.26 5.14 Favored 'General case' 1 N--CA 1.324 -6.735 1 CA-C-N 105.178 -5.511 . . . . 0.0 112.044 -157.609 . . . . . . . . 4 3 . 1 . 051 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.489 ' N ' ' C ' ' A' ' 3' ' ' GLY . 48.6 t-105 -39.84 -20.61 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 112.919 -1.946 . . . . 0.0 110.66 -179.802 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.5 tp -117.55 -19.15 9.54 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.501 179.406 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.0 mt-10 -89.5 24.56 2.23 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.777 0.322 . . . . 0.0 110.53 -179.978 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -76.36 -63.69 1.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.721 -179.984 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 9' ' ' ILE . 14.2 tt -49.66 109.77 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.196 0.522 . . . . 0.0 110.558 -179.8 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.74 -27.58 64.71 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.933 -179.754 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.437 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 3.8 mptp? -54.96 111.2 0.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.714 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.12 3.53 3.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.96 0.41 . . . . 0.0 110.308 -179.61 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 38.38 38.48 0.63 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.796 179.586 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -168.38 -19.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 110.663 179.87 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 pt -151.17 48.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.123 0.487 . . . . 0.0 109.991 179.562 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.8 tp -146.4 -35.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.09 -179.892 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -83.51 4.8 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.813 179.423 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.473 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -164.39 -33.88 0.02 OUTLIER Glycine 0 C--N 1.33 0.248 0 N-CA-C 111.779 -0.529 . . . . 0.0 111.779 -179.856 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.13 -42.96 97.35 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.148 -0.549 . . . . 0.0 111.806 179.967 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.46 -51.36 60.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.724 0.297 . . . . 0.0 110.45 -179.955 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 tp 55.76 100.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.276 -179.953 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -164.72 -36.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.597 -179.954 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -170.32 1.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.71 -179.922 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.674 HD22 ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.196 -179.857 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -149.79 178.64 8.7 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.865 0.364 . . . . 0.0 110.383 179.941 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.487 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 132.06 -58.8 0.7 Allowed Glycine 1 CA--C 1.354 -9.995 0 CA-C-O 123.797 1.776 . . . . 0.0 114.912 -179.784 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 84.0 mtm180 -60.32 -11.22 5.96 Favored 'General case' 1 N--CA 1.324 -6.763 1 CA-C-N 105.247 -5.476 . . . . 0.0 111.923 -157.61 . . . . . . . . 4 3 . 1 . 052 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.487 ' N ' ' C ' ' A' ' 3' ' ' GLY . 67.0 m95 -42.08 -19.27 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.943 -1.935 . . . . 0.0 110.366 179.889 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.7 mt -114.12 -19.51 11.33 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.953 179.799 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.7 mm-40 -86.19 -16.23 38.44 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.721 -179.658 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -80.47 103.94 10.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.419 179.783 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.3 pt -65.31 -31.19 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.593 -179.854 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.21 28.35 4.3 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.04 179.966 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 21.8 ttpp -79.09 -19.26 51.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.545 0.212 . . . . 0.0 110.769 -179.692 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 78.5 -21.42 0.33 Allowed 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.164 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 40.11 36.43 0.87 Allowed Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -179.831 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.4 t80 73.69 48.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.647 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 12' ' ' ALA . 33.6 mt 64.6 70.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.517 -179.714 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.3 mm -134.66 -76.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.846 179.752 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.609 HD12 ' C ' ' A' ' 17' ' ' ILE . 2.7 pp -63.36 -6.53 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.143 -179.86 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.568 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -106.09 -65.8 0.65 Allowed Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.982 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.2 -19.95 74.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.683 179.668 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.447 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 63.05 9.75 4.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.629 0.252 . . . . 0.0 110.835 179.681 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 52.47 12.38 0.23 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.088 0.47 . . . . 0.0 109.783 -179.965 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' N ' ' C ' ' A' ' 20' ' ' ALA . 25.1 t70 -70.19 -102.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.274 179.975 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 23' ' ' HIS . 57.5 t-80 -67.41 2.08 1.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 110.103 179.582 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' H ' ' C ' ' A' ' 22' ' ' ASP . 1.4 tt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.129 -179.923 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -78.79 68.24 4.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 110.571 -179.878 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.468 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -57.82 -57.75 18.2 Favored Glycine 1 CA--C 1.355 -9.908 0 CA-C-O 123.751 1.75 . . . . 0.0 115.286 179.894 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.8 mtt180 -60.21 -10.89 5.06 Favored 'General case' 1 N--CA 1.325 -6.704 1 CA-C-N 105.263 -5.469 . . . . 0.0 112.047 -157.48 . . . . . . . . 4 3 . 1 . 053 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.468 ' N ' ' C ' ' A' ' 3' ' ' GLY . 43.4 t90 -40.99 -18.93 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.639 -179.954 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.8 tp -123.47 -13.27 7.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.632 179.492 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.0 tt0 -82.93 -8.62 59.55 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.556 -179.806 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -50.11 115.49 1.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.466 179.774 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 11' ' ' LYS . 17.6 tt -70.68 -23.17 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.608 -179.837 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -47.13 87.43 0.01 OUTLIER Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.344 -179.887 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 9' ' ' ILE . 9.6 mtpm? -149.55 4.76 0.6 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.768 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 53.17 56.39 7.53 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.285 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -41.1 88.17 0.01 OUTLIER Glycine 0 C--N 1.335 0.523 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.019 -179.847 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 12' ' ' ALA . 89.6 m-85 53.26 48.19 22.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.815 0.34 . . . . 0.0 110.091 -179.108 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.7 mt 62.13 80.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.626 -179.835 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.0 tp -146.57 -35.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.249 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 mm -98.96 -37.24 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.007 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.02 -57.81 5.06 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.226 179.358 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.86 86.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.671 179.545 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.04 40.58 17.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.7 179.814 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 23' ' ' HIS . 22.8 mt -68.71 -25.98 65.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.579 -179.957 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.42 34.0 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.942 -179.74 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 12.0 t-80 54.85 27.87 9.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.574 179.31 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.238 179.527 . . . . . . . . 0 0 . 1 . 054 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -145.55 -159.74 1.05 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 110.489 -179.974 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.51 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 129.74 -59.86 0.68 Allowed Glycine 1 CA--C 1.354 -10.012 0 CA-C-O 123.794 1.775 . . . . 0.0 114.932 -179.938 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' GLU . 74.4 mtm180 -60.7 -10.49 5.4 Favored 'General case' 1 N--CA 1.323 -6.813 1 CA-C-N 105.273 -5.464 . . . . 0.0 111.835 -157.727 . . . . . . . . 4 3 . 1 . 054 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.51 ' N ' ' C ' ' A' ' 3' ' ' GLY . 19.4 t90 -42.17 -19.73 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.095 -1.866 . . . . 0.0 110.262 179.862 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.498 ' N ' ' C ' ' A' ' 4' ' ' ARG . 31.0 mt -108.82 -24.2 11.39 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.531 179.568 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 4' ' ' ARG . 27.6 tt0 -89.5 -5.41 57.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.057 0.456 . . . . 0.0 110.008 179.905 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -67.57 -51.27 52.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.644 179.987 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 10' ' ' GLY . 10.5 tt -167.32 -44.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.666 -179.9 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 75.9 -39.85 1.38 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.159 179.981 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 13' ' ' GLY . 86.4 mttt -79.77 81.14 6.08 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.768 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.38 15.34 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.8 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 65.45 19.25 66.49 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.616 -179.623 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.418 ' C ' ' H ' ' A' ' 16' ' ' ILE . 65.4 m-85 -147.18 -52.82 0.21 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.767 0.317 . . . . 0.0 110.207 179.879 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.3 pt -80.18 32.54 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 121.045 0.45 . . . . 0.0 110.53 179.815 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 17' ' ' ILE . 4.2 tp -148.97 -44.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.429 -179.787 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.568 HD12 ' C ' ' A' ' 17' ' ' ILE . 2.2 pp -71.3 1.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.294 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.539 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -163.89 -40.69 0.02 OUTLIER Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.946 -179.899 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -73.27 -29.14 64.75 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.92 179.989 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.18 8.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.653 0.263 . . . . 0.0 110.908 179.978 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 23' ' ' HIS . 8.3 tp 49.66 -115.26 0.79 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.299 179.933 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 57.05 -79.72 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.746 0.308 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 21' ' ' LEU . 14.8 p-80 -156.78 -1.66 0.12 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.623 -179.969 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.399 179.756 . . . . . . . . 0 0 . 1 . 055 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.2 mttp 50.86 -142.57 0.68 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.575 0.226 . . . . 0.0 110.745 179.958 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 51.64 69.66 1.09 Allowed Glycine 1 CA--C 1.383 -8.211 0 CA-C-O 126.312 3.173 . . . . 0.0 112.576 -178.117 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.593 ' O ' ' N ' ' A' ' 7' ' ' GLU . 20.8 mtp180 157.15 -10.87 0.0 OUTLIER 'General case' 1 N--CA 1.315 -7.175 1 CA-C-N 100.771 -7.714 . . . . 0.0 110.646 160.469 . . . . . . . . 4 3 . 1 . 055 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -40.79 -23.71 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.112 -179.397 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 6' ' ' LEU . 10.5 mp -97.67 -26.04 14.9 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.444 179.558 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.3 tp10 -119.53 35.4 4.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.075 0.464 . . . . 0.0 109.906 179.9 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.523 ' NH2' ' CZ ' ' A' ' 4' ' ' ARG . 6.8 tpm_? -80.6 88.56 5.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.216 179.994 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.4 tt -53.8 -45.06 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.479 -179.921 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.541 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 71.01 -70.56 0.77 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.276 179.747 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 13' ' ' GLY . 51.6 mttp -51.79 108.15 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 110.605 -179.738 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.523 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -76.35 37.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.351 179.683 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 70.04 72.52 0.86 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.98 -179.832 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.494 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 51.4 t80 52.36 28.62 5.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.766 0.317 . . . . 0.0 110.459 179.979 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.5 mt 61.19 62.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.651 0.739 . . . . 0.0 109.77 -179.737 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mm -130.92 -50.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.046 -179.674 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.585 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.4 mp -66.29 -45.56 89.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.989 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -81.49 -41.08 10.27 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.721 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -58.86 -39.73 94.29 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.969 179.477 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.38 37.74 0.13 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.814 0.34 . . . . 0.0 110.744 -179.778 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 19' ' ' GLY . 16.7 tp -70.67 110.53 5.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.132 179.819 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.1 t0 55.76 39.18 30.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.559 -179.908 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 60.5 t60 52.09 50.03 19.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.519 179.983 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.945 179.955 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 056 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.48 -145.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -179.994 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 43.62 69.44 0.67 Allowed Glycine 1 CA--C 1.383 -8.158 0 CA-C-O 126.088 3.049 . . . . 0.0 113.029 -178.359 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 7' ' ' GLU . 28.0 mtt180 157.89 -11.72 0.0 OUTLIER 'General case' 1 N--CA 1.316 -7.164 1 CA-C-N 100.9 -7.65 . . . . 0.0 110.846 160.507 . . . . . . . . 4 3 . 1 . 056 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -44.1 -21.17 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.78 -179.647 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.492 ' N ' ' C ' ' A' ' 4' ' ' ARG . 26.7 mt -97.34 -23.86 15.92 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.536 179.663 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.3 tt0 -66.67 -18.5 65.41 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.234 179.869 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -81.9 47.68 1.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.261 179.734 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -50.0 120.86 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 110.48 -179.685 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.38 39.82 0.46 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.718 -179.842 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -50.64 -33.4 22.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.612 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.96 -15.93 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.383 179.932 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' O ' ' CG ' ' A' ' 14' ' ' PHE . . . 69.33 31.1 71.33 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.616 -179.788 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.404 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 67.0 m-85 -155.91 -10.3 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.703 0.287 . . . . 0.0 110.269 179.983 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.0 pt -153.98 42.37 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.096 0.474 . . . . 0.0 110.476 179.644 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.501 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.4 tp -147.94 -43.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.792 179.782 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.501 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.4 tp -77.44 -37.98 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.696 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.57 -39.79 6.58 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.166 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.02 -38.24 95.75 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 179.682 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.0 -73.42 0.05 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.42 HD23 ' C ' ' A' ' 21' ' ' LEU . 2.1 tt 63.59 87.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 109.984 179.797 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 30.0 p-10 -168.78 -120.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.023 -179.75 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -67.92 -12.56 60.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.0 0.429 . . . . 0.0 109.879 179.451 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.6 mt . . . . . 0 C--O 1.232 0.181 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.331 179.858 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 057 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -69.9 -173.77 0.68 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.85 0.357 . . . . 0.0 110.539 179.978 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.472 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 115.69 -59.18 0.44 Allowed Glycine 1 CA--C 1.356 -9.877 0 CA-C-O 123.875 1.82 . . . . 0.0 115.129 -179.964 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' GLU . 38.1 mtt85 -60.14 -11.35 5.9 Favored 'General case' 1 N--CA 1.326 -6.673 1 CA-C-N 105.214 -5.493 . . . . 0.0 112.085 -157.531 . . . . . . . . 4 3 . 1 . 057 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.472 ' N ' ' C ' ' A' ' 3' ' ' GLY . 68.9 t-105 -43.09 -19.81 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.223 179.858 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 mt -108.11 -21.51 12.77 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.93 179.932 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.4 tp10 -72.55 -9.41 58.55 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.116 -179.828 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -54.9 122.35 10.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.505 -179.983 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.608 HD12 ' C ' ' A' ' 9' ' ' ILE . 2.5 pp -69.36 -2.42 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.725 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.568 ' N ' HD12 ' A' ' 9' ' ' ILE . . . -75.91 71.61 1.91 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.227 -179.898 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -51.82 -31.17 26.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.022 0.439 . . . . 0.0 109.892 179.523 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.99 -2.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.336 179.931 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.17 32.29 12.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.838 -179.924 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -145.84 -10.35 0.52 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 110.232 -179.969 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 pt -156.94 36.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.018 179.4 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.0 tp -150.67 -21.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.943 -179.79 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.3 pp -88.81 4.41 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.836 179.347 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.506 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -166.93 -36.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.82 -179.944 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.19 -5.1 75.43 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.901 179.852 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -67.54 -56.52 9.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 0.0 110.47 -179.94 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 23' ' ' HIS . 5.0 tp 64.27 -0.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.447 179.965 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 20' ' ' ALA . 34.6 t70 -77.6 30.81 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.628 -179.94 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.427 ' H ' ' C ' ' A' ' 21' ' ' LEU . 66.3 m80 51.45 65.69 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.465 179.966 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.46 HD23 ' C ' ' A' ' 24' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.144 -179.973 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -165.18 -138.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.933 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.436 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 43.31 70.53 0.52 Allowed Glycine 1 CA--C 1.385 -8.087 0 CA-C-O 126.22 3.122 . . . . 0.0 113.138 -178.588 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 7' ' ' GLU . 19.8 mtt180 157.47 -10.54 0.0 OUTLIER 'General case' 1 N--CA 1.315 -7.212 1 CA-C-N 100.835 -7.682 . . . . 0.0 110.455 160.671 . . . . . . . . 4 3 . 1 . 058 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -40.97 -22.59 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.296 -179.616 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -97.47 -26.64 14.76 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.364 179.873 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.9 tp10 -67.21 -32.01 72.78 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.176 179.748 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -53.12 -70.13 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 -179.973 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 10' ' ' GLY . 14.2 tt -66.12 -39.97 85.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.355 -179.888 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 46.26 60.19 4.75 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.315 179.847 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -170.89 74.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.772 0.32 . . . . 0.0 110.473 179.925 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.95 65.12 5.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.007 179.855 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 49.02 53.09 19.93 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -179.576 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 60.68 38.67 18.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.898 0.38 . . . . 0.0 110.258 -179.519 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 mt 60.92 69.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.374 -179.862 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.592 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.9 tp -139.2 -50.51 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.91 179.688 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.592 ' N ' HG23 ' A' ' 16' ' ' ILE . 4.1 tp -79.27 -27.39 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.73 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.0 -50.89 3.54 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 178.97 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.39 -42.23 99.72 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.075 179.635 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.89 -52.23 58.32 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.447 -179.945 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.424 ' C ' ' H ' ' A' ' 23' ' ' HIS . 12.2 tp -60.57 -34.03 73.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.362 179.993 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -76.86 35.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.621 -179.872 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 21' ' ' LEU . 16.9 m80 49.97 44.95 25.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.543 179.892 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.347 -179.872 . . . . . . . . 0 0 . 1 . 059 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.027 -0.429 . . . . 0.0 112.027 . . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -78.54 28.12 0.2 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.762 0.315 . . . . 0.0 110.631 -179.967 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.49 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -51.16 -57.89 10.6 Favored Glycine 1 CA--C 1.356 -9.881 0 CA-C-O 123.629 1.683 . . . . 0.0 115.403 179.997 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 46.3 mtt85 -60.67 -10.31 5.12 Favored 'General case' 1 N--CA 1.324 -6.755 1 CA-C-N 105.362 -5.419 . . . . 0.0 111.97 -157.555 . . . . . . . . 4 3 . 1 . 059 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.49 ' N ' ' C ' ' A' ' 3' ' ' GLY . 71.6 t-105 -41.14 -20.32 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.111 -1.859 . . . . 0.0 110.394 -179.874 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.6 tp -111.27 -23.21 10.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.315 179.528 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 14.9 mm-40 -92.77 -1.65 56.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.838 0.351 . . . . 0.0 110.534 179.998 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.407 ' CG ' ' H ' ' A' ' 9' ' ' ILE . 14.8 tpp180 -82.5 -133.46 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.291 -179.912 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 11' ' ' LYS . 18.8 tt -167.94 -21.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.482 -179.986 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.24 86.8 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.008 -179.948 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 9' ' ' ILE . 63.1 mttm -153.32 0.9 0.26 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.992 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 54.81 62.07 2.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.54 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -42.38 90.8 0.01 OUTLIER Glycine 0 C--N 1.333 0.382 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 -179.92 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.5 ' N ' ' O ' ' A' ' 12' ' ' ALA . 78.1 m-85 55.35 47.04 22.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.926 0.394 . . . . 0.0 110.089 -179.326 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 60.61 77.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.513 -179.966 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.582 HG23 ' N ' ' A' ' 17' ' ' ILE . 6.2 tp -142.91 -56.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.709 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.582 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.2 mp -77.81 -33.2 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.637 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.95 -48.67 9.62 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 178.361 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.76 -45.99 91.08 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.76 179.161 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.8 -72.63 0.05 OUTLIER 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.414 -179.934 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.6 tp 52.43 94.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.287 179.981 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -157.92 -28.44 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.326 179.99 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -168.0 -27.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 -179.958 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.0 mp . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.208 179.926 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 060 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -165.22 -153.35 0.19 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 121.066 -0.254 . . . . 0.0 110.555 179.969 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 57.33 71.68 0.71 Allowed Glycine 1 CA--C 1.384 -8.126 0 CA-C-O 126.549 3.305 . . . . 0.0 111.835 -177.705 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 7' ' ' GLU . 2.9 mtp85 154.91 -10.77 0.0 OUTLIER 'General case' 1 N--CA 1.311 -7.381 1 CA-C-N 100.354 -7.923 . . . . 0.0 109.984 161.484 . . . . . . . . 4 3 . 1 . 060 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.42 ' CZ2' ' NH2' ' A' ' 8' ' ' ARG . 74.2 t-105 -42.77 -23.17 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.795 179.996 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.475 ' N ' ' C ' ' A' ' 4' ' ' ARG . 28.8 mt -92.85 -27.68 16.98 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.748 179.902 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.573 ' N ' ' O ' ' A' ' 4' ' ' ARG . 71.5 mt-10 -79.78 10.87 3.62 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.606 179.965 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.42 ' NH2' ' CZ2' ' A' ' 5' ' ' TRP . 54.8 ttp180 -77.92 85.52 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.555 -179.978 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 10' ' ' GLY . 16.7 tt -73.86 -42.82 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.383 179.913 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.5 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 60.73 53.05 48.54 Favored Glycine 0 N--CA 1.453 -0.204 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.365 179.744 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -171.13 67.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 0.0 110.644 179.771 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.532 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -80.79 45.07 0.78 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.439 179.944 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.87 67.38 2.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.131 -0.556 . . . . 0.0 111.895 -179.977 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 52.6 t80 52.37 31.19 9.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.766 0.317 . . . . 0.0 110.555 -179.988 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mt 61.7 64.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.547 0.689 . . . . 0.0 110.263 -179.819 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.2 mm -131.8 -48.96 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.651 179.912 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.4 mp -69.55 -47.29 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.633 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.532 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -76.78 -42.3 21.32 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 178.978 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.43 -48.31 86.6 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.866 179.537 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.88 -47.45 71.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.732 0.301 . . . . 0.0 110.503 -179.863 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.4 36.53 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.893 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -81.17 -86.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.631 -179.712 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.481 ' CD2' ' H ' ' A' ' 23' ' ' HIS . 12.1 p80 -73.8 -27.0 60.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.626 -179.933 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.44 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.9 tt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.121 179.999 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 061 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.407 ' CB ' ' NZ ' ' A' ' 2' ' ' LYS . 9.0 mtmp? -79.61 53.0 1.5 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.786 0.327 . . . . 0.0 110.705 179.965 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -55.06 -58.4 13.9 Favored Glycine 1 CA--C 1.356 -9.874 0 CA-C-O 123.701 1.723 . . . . 0.0 115.417 -179.97 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 6' ' ' LEU . 93.9 mtt180 -60.25 -11.48 6.48 Favored 'General case' 1 N--CA 1.325 -6.698 1 CA-C-N 105.318 -5.441 . . . . 0.0 111.965 -157.439 . . . . . . . . 4 3 . 1 . 061 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.492 ' N ' ' C ' ' A' ' 3' ' ' GLY . 19.4 t90 -42.71 -18.46 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.291 -179.95 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.8 mt -118.01 -16.89 9.8 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.632 179.31 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' ARG . 19.4 mm-40 -88.65 -1.14 57.91 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 120.887 0.375 . . . . 0.0 110.402 179.971 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 55.81 106.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 179.859 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 9' ' ' ILE . 4.4 tp -114.2 87.68 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 121.526 0.679 . . . . 0.0 110.024 179.946 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.9 -1.82 60.04 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.781 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 pttm 33.86 35.68 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.4 -0.4 . . . . 0.0 111.93 179.889 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.469 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -81.72 32.94 0.36 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.039 179.483 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.23 60.46 3.07 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.769 -179.755 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.492 ' O ' ' CD2' ' A' ' 14' ' ' PHE . 66.9 t80 55.53 33.77 21.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.954 0.406 . . . . 0.0 110.191 -179.786 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.2 mm 61.85 66.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.509 0.671 . . . . 0.0 110.15 -179.802 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 mm -133.77 -51.09 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.715 179.624 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -68.18 -46.28 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.577 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.469 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -77.26 -48.11 8.52 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.429 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -60.38 -43.77 98.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.606 179.573 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 53.77 9.19 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.737 0.303 . . . . 0.0 110.92 179.761 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 21' ' ' LEU . 8.0 mp 53.85 -97.78 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.807 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 72.1 m-20 50.24 -87.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.676 179.79 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 21' ' ' LEU . 75.4 m80 -156.44 11.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.509 179.922 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 N--CA 1.465 0.279 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.355 179.958 . . . . . . . . 0 0 . 1 . 062 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -56.91 -106.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.559 0.219 . . . . 0.0 110.413 -179.959 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.491 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 93.4 -59.84 2.23 Favored Glycine 1 CA--C 1.355 -9.934 0 CA-C-O 123.677 1.71 . . . . 0.0 115.371 179.937 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 7' ' ' GLU . 79.0 mtt180 -60.52 -10.37 4.95 Favored 'General case' 1 N--CA 1.325 -6.698 1 CA-C-N 105.434 -5.383 . . . . 0.0 112.048 -157.588 . . . . . . . . 4 3 . 1 . 062 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.491 ' N ' ' C ' ' A' ' 3' ' ' GLY . 85.1 t90 -39.62 -21.63 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.521 179.936 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 10.8 tp -107.83 -26.99 10.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.455 179.347 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' ARG . 90.3 mt-10 -100.44 22.33 11.84 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.806 0.336 . . . . 0.0 110.29 179.79 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -53.29 -57.17 11.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.654 -179.809 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.456 ' C ' ' H ' ' A' ' 11' ' ' LYS . 14.0 pt -71.29 -35.2 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.666 -179.862 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.7 -19.19 1.21 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.07 -179.953 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 9' ' ' ILE . 41.9 mtmt -73.99 95.16 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.567 -179.978 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.426 ' HB3' ' H ' ' A' ' 15' ' ' ILE . . . -58.96 -6.46 0.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.315 179.829 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 60.53 15.73 41.04 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.772 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -164.67 -39.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.942 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' H ' ' HB3' ' A' ' 12' ' ' ALA . 13.5 mt -111.24 57.48 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.709 179.38 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.1 tp -151.78 -45.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.485 -0.78 . . . . 0.0 108.911 -179.988 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.526 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.1 pp -91.17 4.98 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.749 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.509 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -136.14 -57.03 0.06 OUTLIER Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.631 -179.761 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.5 -46.07 94.53 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.702 179.895 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.99 44.98 28.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 110.691 179.922 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.7 mm? -63.15 103.09 0.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.926 179.766 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 35.3 t70 56.26 56.17 6.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 -179.849 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 19.8 p-80 40.82 39.5 0.81 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.349 -179.935 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.9 tp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.256 179.826 . . . . . . . . 0 0 . 1 . 063 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.21 -172.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.826 0.346 . . . . 0.0 110.509 -179.968 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.507 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 127.09 -58.81 0.69 Allowed Glycine 1 CA--C 1.357 -9.794 0 CA-C-O 123.778 1.766 . . . . 0.0 115.111 -179.984 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 6' ' ' LEU . 95.7 mtt180 -60.33 -10.74 5.1 Favored 'General case' 1 N--CA 1.324 -6.746 1 CA-C-N 105.222 -5.489 . . . . 0.0 112.066 -157.591 . . . . . . . . 4 3 . 1 . 063 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.507 ' N ' ' C ' ' A' ' 3' ' ' GLY . 77.4 t-105 -40.26 -19.85 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.66 -179.985 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.5 mt -120.37 -15.46 8.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.013 179.499 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.6 mm-40 -87.95 -7.04 57.68 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.645 -179.91 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -68.92 88.93 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.254 179.774 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.4 pt -60.22 -34.71 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.962 -179.627 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.38 17.51 1.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.696 -179.671 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -70.25 -5.16 25.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.888 -0.156 . . . . 0.0 110.827 -179.779 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.99 52.02 9.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.64 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.509 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -43.49 87.45 0.01 OUTLIER Glycine 0 C--N 1.335 0.498 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.868 -179.337 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 12' ' ' ALA . 89.4 m-85 52.74 41.75 31.6 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.074 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 mm 61.16 77.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.183 -179.416 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.659 HG23 ' H ' ' A' ' 17' ' ' ILE . 6.6 tp -140.37 -59.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.883 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.659 ' H ' HG23 ' A' ' 16' ' ' ILE . 3.7 tp -74.98 -31.02 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.011 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.02 -48.13 5.27 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 179.011 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.7 -44.84 96.92 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.037 -0.602 . . . . 0.0 111.706 179.612 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.44 -65.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.402 179.875 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.7 79.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.866 179.953 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -159.77 33.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.483 -179.791 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.42 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 33.8 t-80 55.18 22.91 4.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.659 179.948 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 tp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.209 179.972 . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -168.88 -135.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.938 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 42.01 68.91 0.63 Allowed Glycine 1 CA--C 1.382 -8.26 0 CA-C-O 125.453 2.696 . . . . 0.0 114.003 -179.095 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.546 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 3.6 mmt180 163.14 -12.13 0.0 OUTLIER 'General case' 1 N--CA 1.318 -7.044 1 CA-C-N 101.362 -7.419 . . . . 0.0 110.428 159.443 . . . . . . . . 4 3 . 1 . 064 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -44.19 -18.67 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.961 -179.63 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.497 ' N ' ' C ' ' A' ' 4' ' ' ARG . 9.3 mp -109.74 -19.28 13.22 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.067 179.235 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 4' ' ' ARG . 15.1 mp0 -112.27 12.88 20.36 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 120.71 0.29 . . . . 0.0 110.328 -179.89 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 4' ' ' ARG . 61.0 ttp180 -52.32 123.67 11.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.378 179.795 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 tp -54.79 92.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.344 0.593 . . . . 0.0 110.16 -179.883 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.12 -30.83 10.44 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.787 -179.974 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -60.37 104.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.07 179.851 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.88 -4.01 4.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.691 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.71 34.19 5.16 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.139 179.722 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 15' ' ' ILE . 30.4 t80 -170.2 -17.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' PHE . 8.9 pt -155.55 55.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.13 0.491 . . . . 0.0 110.361 179.787 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.4 tp -144.16 -42.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.061 179.792 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.522 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -71.87 4.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.901 179.676 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.471 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -175.89 -22.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.033 179.999 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.47 -31.84 79.97 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.991 179.993 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.38 -59.35 2.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.766 0.317 . . . . 0.0 110.567 -179.978 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tp 54.98 37.62 29.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.351 -179.943 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.61 -33.28 58.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.602 179.992 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -164.66 6.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.437 -179.98 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.161 179.989 . . . . . . . . 0 0 . 1 . 065 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 065 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -73.86 -171.07 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.545 -179.956 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.504 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 106.23 -60.23 0.38 Allowed Glycine 1 CA--C 1.356 -9.851 0 CA-C-O 123.678 1.71 . . . . 0.0 115.141 -179.95 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 6' ' ' LEU . 48.5 mtp180 -60.18 -11.23 5.7 Favored 'General case' 1 N--CA 1.324 -6.752 1 CA-C-N 105.358 -5.421 . . . . 0.0 111.988 -157.588 . . . . . . . . 4 3 . 1 . 065 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.504 ' N ' ' C ' ' A' ' 3' ' ' GLY . 30.7 t-105 -42.78 -17.59 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 112.828 -1.987 . . . . 0.0 110.393 179.904 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.4 mt -121.28 -14.38 8.33 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.933 179.621 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 4' ' ' ARG . 49.2 tt0 -82.64 0.05 44.9 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.181 -179.974 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -50.26 163.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 180.0 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.6 pt -54.0 -43.03 57.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.458 -179.922 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.83 -48.59 2.35 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.771 179.39 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HZ2' HG12 ' A' ' 17' ' ' ILE . 9.5 mtpm? -75.44 -75.52 0.17 Allowed 'General case' 0 C--N 1.331 -0.217 0 O-C-N 122.741 -0.27 . . . . 0.0 110.817 -179.572 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 66.81 30.7 7.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.525 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -36.54 -39.82 0.39 Allowed Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.782 179.537 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.487 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 74.0 t80 179.78 54.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.296 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 pt 38.95 53.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.005 -177.816 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -113.83 -47.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.075 -178.847 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.516 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -78.31 6.5 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.176 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.44 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -141.97 -50.99 0.04 OUTLIER Glycine 0 C--N 1.333 0.406 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.935 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.33 -44.72 84.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.712 179.618 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.48 10.41 4.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.8 0.333 . . . . 0.0 110.41 179.913 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' HIS . 19.5 tp 53.35 101.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.092 -179.995 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 56.75 -79.8 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 21' ' ' LEU . 34.0 t-80 -162.25 29.16 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 110.396 179.901 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.442 HD23 ' C ' ' A' ' 24' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.203 179.977 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.211 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -70.14 -147.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.627 0.251 . . . . 0.0 110.643 179.991 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.421 ' O ' ' CB ' ' A' ' 4' ' ' ARG . . . 52.38 69.77 1.09 Allowed Glycine 1 CA--C 1.38 -8.364 0 CA-C-O 126.039 3.022 . . . . 0.0 112.913 -178.421 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' GLU . 22.0 mtt180 160.79 -12.3 0.0 OUTLIER 'General case' 1 N--CA 1.319 -7.02 1 CA-C-N 101.192 -7.504 . . . . 0.0 110.966 159.966 . . . . . . . . 4 3 . 1 . 066 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.565 ' CE3' HD21 ' A' ' 6' ' ' LEU . 33.9 t90 -43.99 -18.3 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.723 -179.981 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.565 HD21 ' CE3' ' A' ' 5' ' ' TRP . 44.0 mt -113.25 -15.9 12.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.646 179.091 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.5 mt-10 -116.03 15.08 16.16 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.772 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.1 ttm180 -76.85 126.28 30.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.474 179.885 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 tp -56.28 108.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.253 0.549 . . . . 0.0 109.962 179.852 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.54 38.96 0.48 Allowed Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.865 -179.871 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.14 -26.74 63.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.38 . . . . 0.0 110.316 179.846 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.451 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -158.96 31.36 0.21 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.158 179.9 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.62 53.76 11.67 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.967 -179.945 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 61.03 33.43 19.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.725 0.297 . . . . 0.0 110.323 -179.979 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 mt 63.24 64.96 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.576 0.703 . . . . 0.0 110.226 -179.74 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -133.01 -50.41 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.776 179.755 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.631 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -70.46 -43.6 77.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.733 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.451 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -76.25 -48.17 9.9 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.092 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -63.49 -52.28 47.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.636 179.45 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.436 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 58.25 4.5 0.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.717 0.294 . . . . 0.0 110.931 179.749 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 21' ' ' LEU . 8.2 mp 50.66 13.47 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.357 179.883 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' N ' ' C ' ' A' ' 20' ' ' ALA . 72.8 m-20 -75.69 37.01 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.615 -179.936 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.434 ' H ' ' C ' ' A' ' 21' ' ' LEU . 6.4 t60 49.91 37.71 14.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 110.555 179.985 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.9 tp . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.101 -179.903 . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -67.26 -120.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.709 -179.884 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.421 ' O ' ' CB ' ' A' ' 4' ' ' ARG . . . 48.12 69.07 1.02 Allowed Glycine 1 CA--C 1.383 -8.199 0 CA-C-O 126.167 3.093 . . . . 0.0 112.993 -178.4 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 5.5 mtp85 159.21 -11.81 0.0 OUTLIER 'General case' 1 N--CA 1.317 -7.112 1 CA-C-N 101.014 -7.593 . . . . 0.0 110.629 160.194 . . . . . . . . 4 3 . 1 . 067 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -43.55 -17.91 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.933 -179.84 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -118.34 -12.82 9.85 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.104 179.133 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 45.2 mm-40 -122.18 29.41 7.03 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-O 120.784 0.326 . . . . 0.0 110.319 179.877 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.6 ttp85 -72.42 89.01 1.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.387 179.908 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 tp -55.64 101.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.167 0.508 . . . . 0.0 110.288 -179.98 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.0 -35.33 12.77 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.921 -179.888 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.466 ' C ' ' H ' ' A' ' 13' ' ' GLY . 66.2 mttm -69.39 82.75 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 0.0 110.469 -179.849 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.455 ' O ' ' CD2' ' A' ' 14' ' ' PHE . . . -55.73 -7.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.032 179.46 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 62.72 52.2 50.29 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.971 -179.967 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.455 ' CD2' ' O ' ' A' ' 12' ' ' ALA . 65.4 m-85 -156.53 -61.88 0.1 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.698 0.285 . . . . 0.0 110.668 179.813 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 14' ' ' PHE . 14.9 pt -155.76 57.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.305 0.574 . . . . 0.0 110.457 -179.906 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.4 -69.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.235 179.665 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 tp -73.62 -35.68 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.349 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.71 -47.04 10.34 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 179.46 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -74.22 -44.55 28.37 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.108 -0.567 . . . . 0.0 111.872 179.714 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.88 6.3 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.668 0.27 . . . . 0.0 110.918 179.844 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 19' ' ' GLY . 15.1 mt 45.86 70.96 0.32 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -158.99 53.85 0.41 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.435 179.901 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.479 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 12.7 t60 52.2 23.89 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.396 -179.913 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.377 179.959 . . . . . . . . 0 0 . 1 . 068 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -70.26 155.88 40.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.732 0.301 . . . . 0.0 110.355 179.997 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.481 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 129.0 -56.62 0.74 Allowed Glycine 1 CA--C 1.354 -9.97 0 CA-C-O 123.899 1.833 . . . . 0.0 114.846 -179.543 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLU . 56.5 mtt85 -60.81 -9.57 4.28 Favored 'General case' 1 N--CA 1.325 -6.712 1 CA-C-N 105.044 -5.578 . . . . 0.0 111.92 -157.606 . . . . . . . . 4 3 . 1 . 068 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.481 ' N ' ' C ' ' A' ' 3' ' ' GLY . 36.5 t90 -40.98 -20.78 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 112.995 -1.911 . . . . 0.0 110.594 179.988 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 4' ' ' ARG . 44.3 tp -108.06 -22.96 12.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.725 179.956 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.2 tp10 -46.26 -43.79 15.89 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.892 -179.755 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -62.31 179.58 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.409 179.863 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.5 tt -49.49 -35.48 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.745 -179.923 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.51 64.1 3.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.9 179.979 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -168.44 74.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 110.479 -179.877 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -74.7 70.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.265 179.903 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.33 62.25 5.25 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.771 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 55.74 32.72 19.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.786 0.326 . . . . 0.0 110.523 -179.755 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 mm 60.6 66.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.405 0.622 . . . . 0.0 110.101 -179.902 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -133.41 -46.04 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.883 179.935 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.1 mm -75.34 -46.98 36.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.975 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.433 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -76.25 -50.41 7.55 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.454 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.22 -36.78 93.25 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.95 179.749 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 51.6 37.17 19.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.757 0.313 . . . . 0.0 110.62 179.99 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.0 mt -54.84 -12.76 0.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.407 179.916 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -57.79 -76.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.356 179.951 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -84.42 -27.01 27.88 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.583 -179.998 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.9 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.435 -179.803 . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -63.3 -177.0 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.574 -179.956 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.493 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 115.2 -59.5 0.42 Allowed Glycine 1 CA--C 1.355 -9.94 0 CA-C-O 123.833 1.796 . . . . 0.0 114.92 -179.838 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' GLU . 41.7 mtp180 -60.73 -10.14 4.97 Favored 'General case' 1 N--CA 1.323 -6.782 1 CA-C-N 105.222 -5.489 . . . . 0.0 111.984 -157.739 . . . . . . . . 4 3 . 1 . 069 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' N ' ' C ' ' A' ' 3' ' ' GLY . 30.4 t90 -41.0 -21.71 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.934 -1.939 . . . . 0.0 110.493 179.834 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' ARG . 47.9 tp -104.4 -25.04 12.98 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.712 -179.838 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.1 tm-20 -51.14 -35.28 34.9 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.351 -179.899 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -48.84 128.77 16.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.609 -180.0 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 10' ' ' GLY . 13.6 tt -66.19 -51.77 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.547 -179.814 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.603 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 42.04 76.64 0.1 OUTLIER Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.484 -0.389 . . . . 0.0 112.801 179.522 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -148.16 -9.61 0.38 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.565 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 55.63 62.18 2.53 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.38 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.3 86.84 0.01 OUTLIER Glycine 0 C--N 1.333 0.372 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.025 -179.598 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 12' ' ' ALA . 28.7 t80 64.98 44.35 3.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.814 0.34 . . . . 0.0 110.526 -179.618 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.2 mm 60.43 76.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.54 179.448 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 mm -135.86 -55.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.914 179.129 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 mm -69.9 -49.28 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.619 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.51 -43.75 35.92 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 178.833 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.09 -48.62 85.02 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.571 179.292 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.75 -14.6 0.96 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.0 110.224 179.745 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' HIS . 8.0 tp 58.3 112.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.192 179.966 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 57.5 -78.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.546 -179.728 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' LEU . 2.3 t60 -168.62 24.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.392 179.827 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.464 0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.461 179.902 . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -69.12 -168.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.508 -179.981 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.478 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 91.9 -59.41 2.82 Favored Glycine 1 CA--C 1.357 -9.799 0 CA-C-O 123.572 1.651 . . . . 0.0 115.495 179.778 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 51.2 mtt85 -59.81 -11.93 6.34 Favored 'General case' 1 N--CA 1.325 -6.677 1 CA-C-N 105.569 -5.315 . . . . 0.0 112.051 -157.375 . . . . . . . . 4 3 . 1 . 070 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.478 ' N ' ' C ' ' A' ' 3' ' ' GLY . 99.0 m95 -44.66 -15.62 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.918 -1.946 . . . . 0.0 110.305 179.673 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 0.7 OUTLIER -129.9 -6.94 4.48 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.452 179.782 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -84.2 -25.86 29.19 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.313 179.926 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -49.18 156.23 0.58 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.628 179.698 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 9' ' ' ILE . 6.3 tp -168.5 126.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.196 179.829 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.61 20.81 0.05 OUTLIER Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.726 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -73.44 3.4 6.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.229 -0.188 . . . . 0.0 110.904 -179.768 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 56.33 36.92 28.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.81 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -34.24 88.86 0.01 OUTLIER Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.926 -179.561 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 12' ' ' ALA . 59.2 t80 56.9 57.4 4.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.063 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.1 pt 35.0 79.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.342 -179.012 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.601 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.2 tp -135.61 -51.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.076 179.665 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.601 ' N ' HG23 ' A' ' 16' ' ' ILE . 3.5 tp -89.06 -36.12 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.003 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.62 -32.07 16.75 Favored Glycine 0 C--N 1.331 0.293 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 178.833 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.28 -47.17 13.41 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.505 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.72 -28.43 14.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.929 0.395 . . . . 0.0 110.265 179.658 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.5 tp 55.39 70.8 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.676 179.816 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 52.11 46.29 26.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.791 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 50.19 52.34 14.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.679 179.81 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.293 179.984 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -59.81 -177.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 0.0 110.393 179.958 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.496 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 133.04 -57.07 0.72 Allowed Glycine 1 CA--C 1.356 -9.863 0 CA-C-O 123.653 1.696 . . . . 0.0 115.217 -179.838 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 7' ' ' GLU . 54.7 mtt85 -60.72 -10.0 4.76 Favored 'General case' 1 N--CA 1.325 -6.7 1 CA-C-N 105.273 -5.464 . . . . 0.0 112.075 -157.552 . . . . . . . . 4 3 . 1 . 071 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.496 ' N ' ' C ' ' A' ' 3' ' ' GLY . 64.9 t-105 -41.39 -25.83 0.05 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.107 -1.861 . . . . 0.0 109.822 179.907 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 6' ' ' LEU . 2.7 mm? -93.57 -30.46 14.97 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.336 179.682 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.0 tt0 -87.86 -5.4 58.61 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.959 0.409 . . . . 0.0 110.259 -179.799 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -66.68 -24.74 66.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.438 179.864 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.9 pt -50.33 -31.87 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.69 -179.853 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.07 66.05 3.05 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.682 -179.814 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.523 ' NZ ' ' CD1' ' A' ' 14' ' ' PHE . 20.9 tptp -158.29 83.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.874 0.369 . . . . 0.0 110.135 -179.881 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.32 63.25 4.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.353 -179.831 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.443 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 47.4 58.07 6.84 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -179.74 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.523 ' CD1' ' NZ ' ' A' ' 11' ' ' LYS . 43.5 m-85 59.2 38.01 23.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.563 0.22 . . . . 0.0 110.458 -179.512 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt 59.62 69.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.85 0.357 . . . . 0.0 110.196 -179.93 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.565 HG23 ' N ' ' A' ' 17' ' ' ILE . 8.5 tp -139.08 -48.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.121 179.811 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.565 ' N ' HG23 ' A' ' 16' ' ' ILE . 4.3 tp -80.7 -26.86 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.946 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.52 -57.63 1.95 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.145 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.01 84.58 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.499 179.246 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 54.7 15.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.613 0.244 . . . . 0.0 110.875 179.657 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.7 mt -66.21 4.17 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.758 0.313 . . . . 0.0 110.583 179.855 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 20' ' ' ALA . 30.0 t0 -66.93 -24.73 66.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.82 -179.825 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.414 ' H ' ' H ' ' A' ' 24' ' ' LEU . 54.5 t60 -169.39 -8.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.174 -179.767 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.414 ' H ' ' H ' ' A' ' 23' ' ' HIS . 49.2 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.236 -179.865 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -64.6 175.98 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 110.536 179.945 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.493 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 129.01 -57.3 0.72 Allowed Glycine 1 CA--C 1.355 -9.939 0 CA-C-O 123.752 1.751 . . . . 0.0 115.005 -179.77 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 7' ' ' GLU . 54.2 mtp180 -60.75 -9.99 4.79 Favored 'General case' 1 N--CA 1.325 -6.695 1 CA-C-N 105.168 -5.516 . . . . 0.0 112.033 -157.54 . . . . . . . . 4 3 . 1 . 072 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' N ' ' C ' ' A' ' 3' ' ' GLY . 27.3 t-105 -41.08 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.544 -179.906 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.8 tp -113.17 -22.13 10.66 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.36 179.457 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 4' ' ' ARG . 59.9 mt-10 -101.95 13.01 35.99 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.655 0.264 . . . . 0.0 110.54 -179.994 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -75.03 -74.57 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.769 -179.93 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 11' ' ' LYS . 15.7 tt -75.37 -25.02 17.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.752 -179.707 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . -52.45 -8.28 0.5 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.265 -179.821 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 9' ' ' ILE . 24.3 mtpp -76.96 22.95 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.861 -179.818 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 15' ' ' ILE . . . 57.29 40.24 27.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.218 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -34.47 89.01 0.01 OUTLIER Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.449 -179.508 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 12' ' ' ALA . 35.0 t80 66.65 53.78 0.89 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.748 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 12' ' ' ALA . 9.7 pt 37.86 82.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.759 -179.493 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.0 mm -132.93 -60.29 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.846 178.844 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -69.43 -55.47 15.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.779 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.64 -37.19 52.65 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.024 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.09 -51.46 55.03 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 179.569 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.5 -68.75 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.844 0.354 . . . . 0.0 110.314 179.898 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.0 tp 49.91 95.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.62 179.821 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -168.01 -31.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.53 179.996 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -171.49 -16.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.52 179.958 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.1 mp . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.195 179.958 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 073 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -59.91 179.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 110.577 -179.996 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.476 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 100.85 -59.72 0.66 Allowed Glycine 1 CA--C 1.356 -9.855 0 CA-C-O 123.735 1.742 . . . . 0.0 115.238 179.999 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 49.2 mtp180 -60.32 -11.03 5.49 Favored 'General case' 1 N--CA 1.325 -6.718 1 CA-C-N 105.307 -5.447 . . . . 0.0 111.968 -157.494 . . . . . . . . 4 3 . 1 . 073 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.476 ' N ' ' C ' ' A' ' 3' ' ' GLY . 78.1 m95 -42.43 -18.82 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.93 -1.941 . . . . 0.0 110.446 179.959 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.6 mt -113.86 -18.64 11.74 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.908 179.884 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.9 tt0 -50.01 -20.44 0.95 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.651 -179.736 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -56.61 144.56 31.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.563 -179.872 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 10' ' ' GLY . 18.2 tt -68.42 -37.14 77.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.521 -179.946 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 80.23 -32.64 2.27 Favored Glycine 0 C--N 1.331 0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.071 179.843 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -76.82 23.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.335 179.984 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . 48.44 67.05 0.91 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.288 -179.517 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -40.48 86.41 0.01 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.52 -179.54 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 12' ' ' ALA . 17.6 m-85 63.14 53.29 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.683 0.278 . . . . 0.0 110.964 -179.699 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 mt 62.54 76.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.335 -0.059 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.591 179.217 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.5 mm -134.39 -64.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.872 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.7 mm -78.19 -32.87 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.35 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.513 ' H ' ' CB ' ' A' ' 12' ' ' ALA . . . -68.74 -53.74 18.43 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.519 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.35 -47.95 15.69 Favored Glycine 0 C--N 1.332 0.314 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.111 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.88 27.4 1.13 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.723 0.296 . . . . 0.0 110.917 179.783 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.4 tp -62.96 96.47 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.197 179.963 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 23.5 m-20 55.35 47.08 22.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.517 -179.834 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.501 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 50.0 p-80 41.2 52.62 3.52 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.17 -179.935 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.133 179.951 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.056 -0.417 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -82.09 40.59 0.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.667 0.27 . . . . 0.0 110.638 -179.93 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.463 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -51.06 -58.86 8.86 Favored Glycine 1 CA--C 1.355 -9.944 0 CA-C-O 123.724 1.736 . . . . 0.0 115.14 179.977 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 80.8 mtt180 -60.87 -10.31 5.44 Favored 'General case' 1 N--CA 1.323 -6.78 1 CA-C-N 105.29 -5.455 . . . . 0.0 111.911 -157.706 . . . . . . . . 4 3 . 1 . 074 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.466 ' CE3' HD21 ' A' ' 6' ' ' LEU . 28.5 t90 -41.9 -19.78 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.32 179.908 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.1 mt -108.71 -25.3 10.91 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.32 179.373 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 46.7 mt-10 -93.27 26.52 2.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -62.44 -144.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.444 -179.997 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.401 ' C ' ' N ' ' A' ' 11' ' ' LYS . 23.2 pt -50.14 -24.33 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.461 179.93 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.1 18.26 0.43 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.049 -179.965 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 9' ' ' ILE . 25.4 mmtp -133.73 44.84 2.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.728 0.299 . . . . 0.0 110.302 -179.892 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.483 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -79.72 52.91 1.52 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.569 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 68.69 30.64 72.81 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.348 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 70.57 69.38 0.2 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.47 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.1 pt 35.34 60.52 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.673 -179.72 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.0 tp -138.48 -47.36 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.547 179.036 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.521 ' N ' HG23 ' A' ' 16' ' ' ILE . 38.0 mm -73.82 -53.21 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.817 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.483 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -75.76 -29.43 59.36 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.425 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -72.06 -37.59 60.04 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.786 -0.526 . . . . 0.0 111.786 179.441 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.77 35.28 0.15 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.843 0.354 . . . . 0.0 110.395 179.796 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.45 ' H ' ' C ' ' A' ' 19' ' ' GLY . 21.5 tp -55.44 119.32 5.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.184 -179.961 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 52.02 24.76 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.501 179.966 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 51.52 46.66 26.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.454 -179.953 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.203 -179.994 . . . . . . . . 0 0 . 1 . 075 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -62.76 -176.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.848 0.356 . . . . 0.0 110.591 -179.915 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.501 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 130.98 -59.11 0.7 Allowed Glycine 1 CA--C 1.355 -9.945 0 CA-C-O 123.86 1.811 . . . . 0.0 115.058 -179.923 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 7' ' ' GLU . 68.0 mtp180 -60.69 -10.48 5.38 Favored 'General case' 1 N--CA 1.324 -6.765 1 CA-C-N 105.117 -5.542 . . . . 0.0 112.032 -157.751 . . . . . . . . 4 3 . 1 . 075 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.501 ' N ' ' C ' ' A' ' 3' ' ' GLY . 11.7 t-105 -42.55 -24.57 0.06 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.649 -179.966 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.505 HD12 ' N ' ' A' ' 6' ' ' LEU . 10.4 mp -98.0 -27.94 14.01 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.196 179.389 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 4' ' ' ARG . 17.7 tt0 -87.85 38.43 0.84 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.036 0.446 . . . . 0.0 110.238 -179.873 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -64.15 -31.99 73.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 179.988 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -167.74 -32.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.381 179.935 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.05 87.23 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.238 179.701 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 39.5 tttm -168.72 -17.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.236 179.645 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 71.72 -11.4 0.74 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.59 179.95 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 35.85 55.0 1.12 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 179.932 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 t80 68.32 40.31 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.568 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 12' ' ' ALA . 18.1 mt 63.65 79.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.749 -179.711 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 12' ' ' ALA . 4.4 tp -148.21 -19.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.186 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.41 ' H ' ' H ' ' A' ' 16' ' ' ILE . 29.0 mm -114.25 -38.21 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.598 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.96 -53.98 5.05 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.245 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.55 -28.99 37.36 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 179.627 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 49.84 19.53 0.45 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.88 0.372 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.3 mt 57.7 6.23 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.475 -179.886 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 20' ' ' ALA . 88.9 m-20 -80.83 19.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.471 179.957 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.7 m80 54.0 44.05 29.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.478 -179.845 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.132 -179.955 . . . . . . . . 0 0 . 1 . 076 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -169.7 169.47 8.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.31 . . . . 0.0 110.464 179.947 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.483 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 131.1 -57.44 0.72 Allowed Glycine 1 CA--C 1.355 -9.928 0 CA-C-O 123.825 1.792 . . . . 0.0 115.044 -179.7 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 6' ' ' LEU . 78.9 mtp180 -60.31 -10.62 4.93 Favored 'General case' 1 N--CA 1.325 -6.703 1 CA-C-N 105.145 -5.528 . . . . 0.0 111.981 -157.582 . . . . . . . . 4 3 . 1 . 076 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.565 ' CE3' HD21 ' A' ' 6' ' ' LEU . 27.8 t90 -42.62 -18.53 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 112.93 -1.941 . . . . 0.0 110.371 179.847 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.565 HD21 ' CE3' ' A' ' 5' ' ' TRP . 34.4 mt -114.62 -18.01 11.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.96 179.597 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 4' ' ' ARG . 31.3 tt0 -47.22 -34.02 6.01 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.705 -179.816 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 50.59 85.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 179.935 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.632 ' N ' HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -46.58 -21.37 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.918 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 34.61 28.37 0.01 OUTLIER Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.483 179.209 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 9' ' ' ILE . 21.0 tptp -51.5 -30.73 21.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.084 179.726 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.6 -42.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.152 179.897 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.79 -44.87 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.785 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 64.2 t80 -173.93 33.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.615 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.2 mt 64.88 58.63 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 121.811 0.815 . . . . 0.0 109.461 -178.765 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.3 mm -119.49 -56.08 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.328 -179.784 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 35.1 mm -73.98 -50.31 29.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.771 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.85 -49.98 72.64 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.034 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.76 -53.33 31.71 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.227 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.63 35.79 12.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.559 0.219 . . . . 0.0 110.895 179.607 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.2 mt -73.83 84.64 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.197 179.816 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 51.38 59.15 4.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.472 -179.91 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 33.9 m170 53.55 55.81 8.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.542 -179.863 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 24' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.075 -179.897 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -60.71 -171.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 110.633 179.955 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.501 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 124.83 -59.36 0.64 Allowed Glycine 1 CA--C 1.355 -9.945 0 CA-C-O 123.781 1.767 . . . . 0.0 115.208 180.0 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 6' ' ' LEU . 44.7 mtt85 -60.66 -10.39 5.22 Favored 'General case' 1 N--CA 1.324 -6.748 1 CA-C-N 105.259 -5.471 . . . . 0.0 111.954 -157.665 . . . . . . . . 4 3 . 1 . 077 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.501 ' N ' ' C ' ' A' ' 3' ' ' GLY . 42.3 t-105 -41.14 -19.98 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.443 -179.972 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 8.1 tp -115.79 -20.28 10.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.294 179.323 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 52.3 mt-10 -91.72 21.33 4.84 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.744 0.307 . . . . 0.0 110.636 179.977 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -50.81 -32.79 21.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.513 179.896 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 pt -47.66 119.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.411 0.624 . . . . 0.0 110.638 -179.625 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.03 -6.95 61.46 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.899 -179.87 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 13' ' ' GLY . 9.5 mtmp? -60.69 98.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.0 110.475 179.976 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -54.89 -8.28 0.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.296 179.625 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 61.05 4.36 4.47 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.641 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.46 ' O ' HG23 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -82.8 -70.98 0.51 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.973 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 14' ' ' PHE . 12.8 pt -158.85 46.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.139 0.495 . . . . 0.0 110.145 179.1 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -80.37 -67.82 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.99 179.374 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.523 HD12 ' N ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -81.07 1.31 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.035 179.743 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -101.53 -67.8 0.81 Allowed Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.796 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.435 ' C ' ' N ' ' A' ' 21' ' ' LEU . . . -81.46 -37.96 15.97 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.632 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.95 11.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.741 179.898 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.435 ' N ' ' C ' ' A' ' 19' ' ' GLY . 33.3 mt 48.58 77.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.751 179.821 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 8.9 p-10 -174.82 23.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.102 179.735 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.406 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 76.0 t60 57.12 32.26 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.652 -179.859 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.08 179.933 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 078 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -53.47 -173.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.756 0.313 . . . . 0.0 110.652 179.972 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.511 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 110.25 -59.34 0.36 Allowed Glycine 1 CA--C 1.356 -9.905 0 CA-C-O 123.724 1.736 . . . . 0.0 115.268 -179.942 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 6' ' ' LEU . 68.2 mtt85 -60.41 -10.84 5.38 Favored 'General case' 1 N--CA 1.325 -6.716 1 CA-C-N 105.316 -5.442 . . . . 0.0 111.994 -157.605 . . . . . . . . 4 3 . 1 . 078 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.511 ' N ' ' C ' ' A' ' 3' ' ' GLY . 76.9 t-105 -42.08 -18.88 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.992 -1.913 . . . . 0.0 110.43 -179.988 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' ARG . 5.2 mp -112.82 -21.72 11.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.536 179.215 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.1 tt0 -91.4 -5.68 54.04 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.06 0.457 . . . . 0.0 110.317 -179.832 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -71.95 148.59 45.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.62 179.859 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 tp -52.71 97.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.206 0.526 . . . . 0.0 110.129 179.878 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.99 30.2 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.793 -179.809 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -49.69 -18.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.69 -179.961 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.57 -10.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.158 -179.851 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.11 57.96 0.13 Allowed Glycine 0 C--N 1.333 0.404 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.636 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.4 t80 69.31 22.77 6.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.802 0.334 . . . . 0.0 110.31 -179.428 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 mt 62.18 65.27 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.583 0.706 . . . . 0.0 110.308 179.956 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 mm -132.72 -49.71 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.627 179.766 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.647 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -71.53 -45.94 65.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.673 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.78 -46.33 24.29 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 178.969 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.431 ' C ' ' N ' ' A' ' 21' ' ' LEU . . . -67.31 -56.57 11.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.924 179.537 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.48 15.44 0.14 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.877 0.37 . . . . 0.0 110.606 -179.968 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 23' ' ' HIS . 6.7 tp -83.76 -13.52 53.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.287 -179.856 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -75.0 36.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.714 179.886 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.472 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 61.8 t60 52.56 28.47 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.556 179.963 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.057 179.989 . . . . . . . . 0 0 . 1 . 079 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -164.49 -178.94 5.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.77 0.319 . . . . 0.0 110.472 -179.966 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.478 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 119.09 -58.3 0.54 Allowed Glycine 1 CA--C 1.355 -9.956 0 CA-C-O 123.74 1.744 . . . . 0.0 115.198 -179.935 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLU . 85.4 mtt180 -60.74 -10.17 5.02 Favored 'General case' 1 N--CA 1.325 -6.719 1 CA-C-N 105.303 -5.449 . . . . 0.0 111.999 -157.552 . . . . . . . . 4 3 . 1 . 079 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.478 ' N ' ' C ' ' A' ' 3' ' ' GLY . 27.5 t90 -41.37 -19.66 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.425 -179.966 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 4' ' ' ARG . 34.0 mt -114.77 -21.16 10.32 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.273 179.032 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 tt0 -92.21 31.93 1.23 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.978 0.418 . . . . 0.0 109.942 179.905 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -51.44 -63.9 0.98 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.753 -179.739 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.409 ' O ' HG23 ' A' ' 9' ' ' ILE . 2.9 tp -51.13 100.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.19 0.519 . . . . 0.0 110.261 -179.762 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.73 -43.52 7.71 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.111 -179.801 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 13' ' ' GLY . 60.8 mttp -57.5 106.91 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.233 -179.971 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.76 0.94 4.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.661 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 42.06 35.29 1.64 Allowed Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.306 179.858 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' HG23 ' A' ' 15' ' ' ILE . 61.4 t80 -168.35 -13.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.957 -179.888 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 14' ' ' PHE . 11.9 pt -157.78 52.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.061 0.458 . . . . 0.0 110.245 179.371 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.6 tp -143.82 -43.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.215 179.994 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.5 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -62.22 -2.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.082 179.396 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . 178.2 -10.49 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.966 -179.925 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 18' ' ' GLY . . . -66.44 -35.4 90.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.141 -179.979 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -12.6 61.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.739 0.304 . . . . 0.0 110.698 -179.815 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 21' ' ' LEU . 2.4 tt 60.3 109.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.149 -179.977 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 57.52 23.84 9.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.756 179.93 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.467 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 21.2 t-160 50.79 37.59 17.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.648 179.807 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.411 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.166 179.922 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 080 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -68.75 74.97 0.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.445 179.953 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.478 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -52.23 -57.66 12.75 Favored Glycine 1 CA--C 1.356 -9.85 0 CA-C-O 123.775 1.764 . . . . 0.0 114.981 179.728 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.49 ' O ' ' N ' ' A' ' 6' ' ' LEU . 27.8 mtp85 -59.94 -12.05 7.0 Favored 'General case' 1 N--CA 1.322 -6.831 1 CA-C-N 105.118 -5.541 . . . . 0.0 111.983 -157.543 . . . . . . . . 4 3 . 1 . 080 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.503 ' CE3' HD21 ' A' ' 6' ' ' LEU . 20.1 t90 -43.54 -18.18 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 112.885 -1.962 . . . . 0.0 110.232 179.894 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.503 HD21 ' CE3' ' A' ' 5' ' ' TRP . 37.0 mt -116.83 -14.86 10.72 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.075 179.861 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.3 tp10 -63.36 -23.27 67.34 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.201 -179.931 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.9 ttt85 -47.14 107.72 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.709 179.881 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -50.2 98.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.17 0.509 . . . . 0.0 110.484 -179.791 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.69 -17.85 13.99 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.874 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 13' ' ' GLY . 57.7 mttm -64.18 100.46 0.34 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 110.478 -179.987 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.91 -4.93 0.82 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.047 179.742 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 57.08 8.81 3.48 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.646 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -87.17 -61.47 1.72 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.885 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 pt -155.18 40.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.167 0.508 . . . . 0.0 110.283 179.506 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 16' ' ' ILE . 1.5 mp -89.73 -45.41 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.435 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.515 ' CD1' ' H ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -75.19 17.81 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.363 179.522 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -157.37 -39.6 0.02 OUTLIER Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.466 -179.756 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.89 -3.48 70.52 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.306 -0.473 . . . . 0.0 112.415 -179.582 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.05 45.62 0.54 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.533 -179.96 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -135.87 6.66 3.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.152 179.959 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' N ' HD12 ' A' ' 21' ' ' LEU . 63.1 m-20 -76.61 -23.93 53.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.326 179.822 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -166.68 -39.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.499 -179.993 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.185 -179.898 . . . . . . . . 0 0 . 1 . 081 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.223 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.7 mttp 53.03 60.59 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 110.649 179.962 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.483 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -59.49 -57.38 19.92 Favored Glycine 1 CA--C 1.357 -9.812 0 CA-C-O 123.715 1.731 . . . . 0.0 115.298 179.849 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 7' ' ' GLU . 91.2 mtt180 -60.61 -10.1 4.74 Favored 'General case' 1 N--CA 1.324 -6.73 1 CA-C-N 105.184 -5.508 . . . . 0.0 112.115 -157.439 . . . . . . . . 4 3 . 1 . 081 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.483 ' N ' ' C ' ' A' ' 3' ' ' GLY . 76.2 t-105 -39.13 -23.84 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.713 -179.942 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.7 tp -101.82 -25.95 13.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.068 -179.535 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 4' ' ' ARG . 28.2 tp10 -58.81 -35.23 72.52 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.277 -179.808 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -69.11 177.01 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.671 -179.822 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.3 tp -174.05 131.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.938 179.906 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.88 -23.05 0.19 Allowed Glycine 0 C--N 1.333 0.417 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -179.773 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -61.96 110.32 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.028 179.712 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.72 2.7 7.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.799 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 39.38 31.95 0.23 Allowed Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.327 -179.962 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.433 ' H ' ' H ' ' A' ' 15' ' ' ILE . 66.6 t80 -162.72 -10.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.79 0.328 . . . . 0.0 110.571 -179.794 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.433 ' H ' ' H ' ' A' ' 14' ' ' PHE . 2.8 tt -161.58 54.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.753 0.787 . . . . 0.0 109.926 179.824 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.4 tp -149.0 -39.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.462 -179.757 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.457 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.1 pp -92.04 16.71 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 179.614 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.38 -57.51 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 179.888 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.69 -38.77 37.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.1 -0.571 . . . . 0.0 111.995 -179.676 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.84 -70.56 0.3 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.86 0.362 . . . . 0.0 110.376 179.99 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 23' ' ' HIS . 2.1 tt -170.89 96.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.988 -179.996 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.494 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 32.4 t70 55.09 -84.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.519 -179.815 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.494 ' CG ' ' O ' ' A' ' 22' ' ' ASP . 94.0 m-70 -157.77 36.3 0.26 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.57 179.948 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.16 179.959 . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -167.19 47.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.8 0.334 . . . . 0.0 110.504 179.996 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.469 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -50.23 -58.43 8.84 Favored Glycine 1 CA--C 1.355 -9.933 0 CA-C-O 123.604 1.669 . . . . 0.0 115.515 179.936 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 7' ' ' GLU . 29.1 mmt180 -60.57 -10.32 4.97 Favored 'General case' 1 N--CA 1.324 -6.739 1 CA-C-N 105.404 -5.398 . . . . 0.0 111.861 -157.607 . . . . . . . . 4 3 . 1 . 082 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.469 ' N ' ' C ' ' A' ' 3' ' ' GLY . 89.2 t90 -42.85 -22.57 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.98 179.76 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 4' ' ' ARG . 41.8 tp -100.0 -25.92 14.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.487 179.901 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 4' ' ' ARG . 26.9 tt0 -50.58 -31.3 15.42 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.313 179.869 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.0 ttt85 57.85 64.2 1.6 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.548 -179.942 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -55.86 111.35 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.174 0.511 . . . . 0.0 109.954 179.937 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.93 35.11 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.691 -179.687 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -50.1 -41.42 48.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.779 -179.86 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.88 -39.28 1.23 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.014 -179.872 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.2 60.95 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.651 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 23.6 t80 69.0 23.61 6.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.76 0.314 . . . . 0.0 110.184 -179.074 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.2 mt 62.14 71.71 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.591 0.71 . . . . 0.0 110.448 -179.986 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.5 mm -132.82 -51.97 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.699 179.603 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.2 mm -82.87 -41.31 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.569 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.22 -50.77 42.91 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.086 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -73.84 -50.44 11.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.941 179.504 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.75 1.04 0.27 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.557 0.218 . . . . 0.0 110.985 -179.961 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.3 mm? 52.42 96.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.831 0.348 . . . . 0.0 110.218 179.852 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -171.79 -54.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.297 179.793 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -171.39 -10.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.406 179.965 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 N--CA 1.463 0.225 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.394 179.979 . . . . . . . . 0 0 . 1 . 083 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -72.3 -163.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 0.0 110.583 -179.923 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.511 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 131.19 -57.87 0.72 Allowed Glycine 1 CA--C 1.356 -9.879 0 CA-C-O 123.78 1.766 . . . . 0.0 114.864 -179.74 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 6' ' ' LEU . 77.8 mtm180 -60.52 -10.54 5.19 Favored 'General case' 1 N--CA 1.323 -6.808 1 CA-C-N 105.202 -5.499 . . . . 0.0 111.956 -157.632 . . . . . . . . 4 3 . 1 . 083 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.511 ' N ' ' C ' ' A' ' 3' ' ' GLY . 57.3 t90 -41.43 -19.89 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.225 179.766 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.1 tp -119.72 -17.65 8.53 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.883 179.254 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ARG . 18.2 tt0 -91.96 22.95 3.95 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 120.978 0.418 . . . . 0.0 110.03 179.85 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -52.6 132.56 35.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.614 -179.819 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 9' ' ' ILE . 15.7 tt -72.15 120.92 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.05 0.453 . . . . 0.0 110.129 179.749 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.08 -26.7 57.52 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.03 -179.692 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -66.79 103.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.381 -179.973 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.39 -2.75 4.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.727 179.511 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.64 29.44 4.12 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.728 -179.742 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.428 ' O ' HG23 ' A' ' 15' ' ' ILE . 36.7 t80 -162.45 -15.42 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.166 -0.214 . . . . 0.0 110.922 -179.587 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 14' ' ' PHE . 9.9 pt -156.68 54.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 110.353 179.541 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.481 HG23 ' N ' ' A' ' 17' ' ' ILE . 9.3 tp -143.21 -42.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.039 179.733 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.501 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -65.49 -3.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.95 179.289 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.79 -24.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.839 -179.869 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.4 4.43 55.57 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.306 -0.473 . . . . 0.0 111.925 179.994 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.3 -20.21 57.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.323 . . . . 0.0 110.716 -179.88 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.6 mt 56.42 15.41 1.99 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.503 -179.798 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.33 -60.7 2.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.603 179.951 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 76.4 t60 -170.15 1.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.569 179.989 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 2.4 mm? . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.114 179.976 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -69.45 78.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.804 0.335 . . . . 0.0 110.603 -179.965 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.493 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -49.0 -57.07 9.14 Favored Glycine 1 CA--C 1.357 -9.839 0 CA-C-O 123.838 1.799 . . . . 0.0 115.109 179.662 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 6' ' ' LEU . 87.8 mtt180 -60.38 -10.95 5.46 Favored 'General case' 1 N--CA 1.323 -6.78 1 CA-C-N 105.126 -5.537 . . . . 0.0 112.083 -157.623 . . . . . . . . 4 3 . 1 . 084 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' N ' ' C ' ' A' ' 3' ' ' GLY . 29.5 t90 -41.82 -18.96 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.928 -1.942 . . . . 0.0 110.541 -179.974 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ARG . 43.6 tp -114.68 -19.29 11.14 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.716 179.941 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.0 tt0 -85.84 -14.56 44.63 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.736 -179.716 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 10' ' ' GLY . 26.6 ttp85 -74.27 -81.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.904 -179.981 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 9' ' ' ILE . 5.8 tp -62.9 79.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.722 0.773 . . . . 0.0 110.004 -179.803 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -82.75 -18.99 64.47 Favored Glycine 0 CA--C 1.517 0.17 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.976 -179.515 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.431 ' HA ' HG21 ' A' ' 16' ' ' ILE . 34.0 mtmm -75.59 100.47 4.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.781 0.324 . . . . 0.0 110.763 -179.828 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.14 -1.34 4.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.103 179.641 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.4 47.51 43.55 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.214 179.985 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -169.23 -40.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.768 179.855 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.6 pt -154.34 61.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.899 0.381 . . . . 0.0 110.571 179.977 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.431 HG21 ' HA ' ' A' ' 11' ' ' LYS . 17.6 mm -149.42 -48.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.572 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.85 9.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.924 179.781 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -172.82 -38.99 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.875 179.951 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -54.7 -35.73 58.13 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.021 179.94 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.17 7.13 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.525 -179.975 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 19' ' ' GLY . 5.4 tp 51.17 23.82 1.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.235 -179.972 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -73.09 -53.99 9.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.611 -179.954 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.412 ' H ' ' H ' ' A' ' 24' ' ' LEU . 12.2 p-80 -166.62 -9.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.745 -179.944 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.412 ' H ' ' H ' ' A' ' 23' ' ' HIS . 11.1 tp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.324 179.908 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.233 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -167.44 -129.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.989 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.464 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 96.43 -59.17 1.34 Allowed Glycine 1 CA--C 1.356 -9.869 0 CA-C-O 123.619 1.677 . . . . 0.0 115.259 -179.944 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.9 mtm180 -60.7 -10.42 5.3 Favored 'General case' 1 N--CA 1.324 -6.764 1 CA-C-N 105.449 -5.375 . . . . 0.0 112.023 -157.576 . . . . . . . . 4 3 . 1 . 085 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.526 ' CE3' HD21 ' A' ' 6' ' ' LEU . 29.7 t90 -40.96 -21.1 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.014 -1.903 . . . . 0.0 110.325 -179.915 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.526 HD21 ' CE3' ' A' ' 5' ' ' TRP . 26.1 mt -108.49 -25.1 11.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.44 179.247 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' ARG . 20.0 mp0 -93.98 2.8 56.02 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.141 179.789 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 4' ' ' ARG . 60.9 ttt180 -54.28 -71.38 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.408 179.966 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 9' ' ' ILE . 4.8 tp -171.27 87.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.351 0.596 . . . . 0.0 110.18 179.789 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.01 -53.15 3.8 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.999 -179.78 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 13' ' ' GLY . 57.2 mttp -57.06 101.24 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.794 0.331 . . . . 0.0 110.635 -179.89 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 14' ' ' PHE . . . -63.84 -1.3 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.015 179.514 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 55.8 7.55 1.66 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.767 -179.873 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 12' ' ' ALA . 50.5 t80 -127.1 -19.68 4.31 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.542 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 17' ' ' ILE . 4.5 mt -147.14 -135.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.715 179.359 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.456 ' H ' HG22 ' A' ' 15' ' ' ILE . 21.2 mm 52.76 -82.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 121.276 -0.17 . . . . 0.0 110.872 179.323 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 15' ' ' ILE . 3.7 tp -73.74 -38.28 50.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.675 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.51 -50.14 45.74 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.482 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.98 -47.64 7.51 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.779 -0.529 . . . . 0.0 111.779 179.627 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.86 47.88 15.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.935 179.881 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.3 mt -68.33 -19.28 64.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.547 -179.979 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -53.04 -92.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.584 -179.977 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.472 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 2.0 t60 -80.51 11.08 3.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.785 -179.81 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.211 -179.985 . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.42 ' NZ ' ' CB ' ' A' ' 2' ' ' LYS . 0.3 OUTLIER -166.51 34.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.699 0.285 . . . . 0.0 110.567 -179.924 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.512 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -50.87 -58.49 9.29 Favored Glycine 1 CA--C 1.355 -9.918 0 CA-C-O 123.647 1.693 . . . . 0.0 115.313 179.996 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.576 ' O ' ' N ' ' A' ' 7' ' ' GLU . 55.4 mtp85 -60.94 -9.78 4.75 Favored 'General case' 1 N--CA 1.323 -6.807 1 CA-C-N 105.388 -5.406 . . . . 0.0 112.016 -157.612 . . . . . . . . 4 3 . 1 . 086 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.512 ' N ' ' C ' ' A' ' 3' ' ' GLY . 23.2 t90 -40.89 -24.84 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.02 -1.9 . . . . 0.0 109.843 179.763 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 6' ' ' LEU . 2.5 mm? -96.69 -31.24 12.79 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.947 179.218 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 4' ' ' ARG . 52.5 mm-40 -90.68 43.36 1.14 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.782 0.325 . . . . 0.0 110.28 179.723 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -145.85 22.9 1.41 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.392 -179.79 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 pt -51.48 121.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.232 0.539 . . . . 0.0 110.327 -179.98 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.44 -18.28 79.93 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.865 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -80.05 109.2 14.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.764 0.316 . . . . 0.0 110.366 179.974 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.45 10.45 7.16 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.507 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.84 37.53 7.29 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.97 -179.768 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -159.24 -68.67 0.08 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.773 0.32 . . . . 0.0 110.171 -179.902 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 15' ' ' ILE . 9.5 tt -93.69 44.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.784 0.802 . . . . 0.0 109.899 179.721 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 17' ' ' ILE . 10.1 tp -145.11 -43.8 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.326 -179.896 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.491 ' N ' HG23 ' A' ' 16' ' ' ILE . 1.1 pp -88.49 13.85 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.422 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.86 -48.54 0.01 OUTLIER Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.773 -179.823 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.67 -15.12 66.06 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.05 -179.986 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.72 -28.32 61.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.619 -179.887 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 21' ' ' LEU . 8.8 mp -55.92 116.39 2.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.145 179.951 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.87 25.93 4.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.979 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 8.5 t60 53.08 52.17 14.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.527 -179.982 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 24' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.157 179.999 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.244 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -167.69 176.7 6.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.792 0.33 . . . . 0.0 110.629 179.958 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.502 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 122.59 -59.13 0.59 Allowed Glycine 1 CA--C 1.355 -9.937 0 CA-C-O 123.72 1.733 . . . . 0.0 115.164 179.993 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LEU . 62.5 mtp180 -59.99 -11.65 6.25 Favored 'General case' 1 N--CA 1.324 -6.761 1 CA-C-N 105.371 -5.415 . . . . 0.0 111.998 -157.513 . . . . . . . . 4 3 . 1 . 087 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.502 ' N ' ' C ' ' A' ' 3' ' ' GLY . 97.5 m95 -42.82 -18.88 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.915 -1.948 . . . . 0.0 110.16 179.731 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ARG . 21.5 mt -113.49 -20.19 11.38 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.764 179.547 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.0 tt0 -83.23 24.33 0.81 Allowed 'General case' 0 C--N 1.342 0.269 0 CA-C-O 121.138 0.494 . . . . 0.0 110.047 179.924 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -66.09 -96.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.908 -179.789 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.2 pt -75.08 -35.39 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.03 -179.525 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.41 17.05 0.37 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.9 -179.714 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 46.5 tttm -75.71 -4.95 43.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.834 0.35 . . . . 0.0 110.53 -179.745 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 71.76 8.73 6.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.284 -179.943 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 40.51 48.96 3.9 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 179.979 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 t80 78.13 49.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.831 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.2 mt 61.46 75.55 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.765 179.895 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 12' ' ' ALA . 7.5 mm -130.92 -57.59 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.652 179.703 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.608 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.3 mp -69.17 -52.5 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.524 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.11 -48.04 68.24 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 178.621 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.55 -56.98 17.3 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.666 179.091 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.0 -67.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.77 0.319 . . . . 0.0 110.496 -179.944 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.5 tt 62.18 86.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.122 0.487 . . . . 0.0 110.142 -179.837 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -170.65 51.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.282 -179.957 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 74.8 t60 56.24 25.39 9.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.264 -179.829 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.051 -179.906 . . . . . . . . 0 0 . 1 . 088 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -58.13 156.75 9.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.868 0.366 . . . . 0.0 110.44 179.946 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.469 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 141.38 -56.23 0.6 Allowed Glycine 1 CA--C 1.354 -9.979 0 CA-C-O 123.918 1.843 . . . . 0.0 114.796 -179.464 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' LEU . 94.7 mtt180 -60.36 -10.81 5.24 Favored 'General case' 1 N--CA 1.323 -6.777 1 CA-C-N 105.023 -5.589 . . . . 0.0 111.911 -157.569 . . . . . . . . 4 3 . 1 . 088 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.469 ' N ' ' C ' ' A' ' 3' ' ' GLY . 56.6 t-105 -41.96 -18.55 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.453 179.946 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' ARG . 4.4 mp -117.7 -17.09 9.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.839 179.358 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' ARG . 14.2 tp10 -81.66 -6.02 58.63 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.049 0.452 . . . . 0.0 110.093 -179.955 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -56.09 -20.87 19.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.742 -179.916 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.7 mm -70.28 73.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -179.989 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.84 -9.37 87.15 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 179.644 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 58.5 mmtt -75.05 8.46 2.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 110.688 -179.859 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 11' ' ' LYS . . . 72.66 -11.71 0.82 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.55 179.91 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 39.9 54.33 3.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.471 -0.395 . . . . 0.0 112.218 179.976 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CG ' ' C ' ' A' ' 13' ' ' GLY . 3.9 m-85 74.81 45.34 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.782 0.325 . . . . 0.0 110.16 -179.272 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.8 mt 61.4 79.4 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.427 0.632 . . . . 0.0 111.179 179.807 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mm -135.74 -61.81 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.95 179.434 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.654 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.6 mp -71.84 -49.03 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.508 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.35 -56.36 22.32 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.452 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.58 -48.64 61.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.968 179.657 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.17 37.34 14.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.761 0.315 . . . . 0.0 110.545 -179.955 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.0 mt -70.49 109.69 4.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.55 179.988 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.29 32.29 18.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.706 179.903 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.8 m170 50.72 48.94 21.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 -179.975 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 24' ' ' LEU . 2.0 tt . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.107 -179.89 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 . . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.74 36.0 0.16 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.791 0.329 . . . . 0.0 110.553 179.864 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.493 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . -52.95 -57.3 15.02 Favored Glycine 1 CA--C 1.357 -9.809 0 CA-C-O 123.608 1.671 . . . . 0.0 115.658 -179.93 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 6' ' ' LEU . 95.9 mtt180 -60.33 -10.46 4.76 Favored 'General case' 1 N--CA 1.326 -6.626 1 CA-C-N 105.42 -5.39 . . . . 0.0 112.066 -157.384 . . . . . . . . 4 3 . 1 . 089 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.568 ' CE3' HD21 ' A' ' 6' ' ' LEU . 29.0 t90 -41.0 -19.98 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.55 -179.963 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.568 HD21 ' CE3' ' A' ' 5' ' ' TRP . 45.8 mt -115.03 -20.58 10.43 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.51 179.197 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.4 mm-40 -91.63 17.13 9.25 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.959 0.409 . . . . 0.0 110.162 179.668 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -57.45 -50.06 74.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.913 -179.893 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 10' ' ' GLY . 13.6 tt -52.81 -44.37 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.643 -179.663 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 77.82 -50.67 3.33 Favored Glycine 0 C--N 1.331 0.266 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 -179.954 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 13' ' ' GLY . 94.2 mttt -66.54 100.45 0.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.318 179.836 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.15 5.9 2.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.063 179.933 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 43.53 48.51 7.17 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.042 -179.86 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -162.5 -31.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.586 0.231 . . . . 0.0 110.885 -179.702 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 15' ' ' ILE . 16.4 tt -166.98 61.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 110.724 179.922 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 18' ' ' GLY . 22.1 mm -145.45 -61.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.864 179.584 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.478 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -69.32 3.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.035 179.479 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -135.91 -55.05 0.06 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 179.889 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -74.38 -56.44 5.12 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.519 -0.633 . . . . 0.0 111.519 179.486 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.447 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . 61.74 -1.93 0.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.599 0.238 . . . . 0.0 111.329 179.566 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 21' ' ' LEU . 8.2 mp 51.42 12.12 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.733 0.301 . . . . 0.0 110.256 179.938 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' N ' ' C ' ' A' ' 20' ' ' ALA . 14.6 t0 -68.27 -55.72 11.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.617 -179.904 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.407 ' H ' ' H ' ' A' ' 24' ' ' LEU . 7.7 t60 -167.62 -17.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.567 -179.992 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.407 ' H ' ' H ' ' A' ' 23' ' ' HIS . 16.5 mt . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.501 179.876 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -63.0 -144.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.592 0.234 . . . . 0.0 110.55 179.976 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 52.23 68.36 1.61 Allowed Glycine 1 CA--C 1.381 -8.311 0 CA-C-O 125.48 2.711 . . . . 0.0 113.437 -178.959 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 1.7 mtm180 163.65 -10.94 0.0 OUTLIER 'General case' 1 N--CA 1.32 -6.926 1 CA-C-N 101.252 -7.474 . . . . 0.0 110.077 159.266 . . . . . . . . 4 3 . 1 . 090 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -42.2 -18.55 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.363 -179.566 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.2 tp -114.47 -17.54 11.71 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.628 179.467 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 39.3 mt-10 -107.55 15.32 24.89 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 120.819 0.343 . . . . 0.0 110.264 179.958 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -53.64 163.08 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.534 179.921 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.44 ' C ' ' H ' ' A' ' 11' ' ' LYS . 11.1 pt -76.19 -36.69 31.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.426 179.921 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.25 -5.44 1.43 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.195 179.958 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 9' ' ' ILE . 67.0 mmtt -87.73 105.38 17.34 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.672 -179.922 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.468 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -78.59 46.71 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.235 179.676 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.68 67.18 2.03 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.768 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 53.8 t80 55.2 26.93 8.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.016 -179.731 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 mt 62.14 62.32 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.679 0.752 . . . . 0.0 109.639 -179.453 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.8 mm -129.38 -46.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.025 -179.817 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -70.96 -46.94 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.809 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.468 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -78.41 -39.2 23.03 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 178.652 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.49 -52.75 50.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.081 -0.581 . . . . 0.0 111.73 179.369 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.42 ' C ' ' N ' ' A' ' 22' ' ' ASP . . . -62.73 -58.18 8.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.332 179.8 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 tp 53.35 12.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.236 179.891 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 20' ' ' ALA . 77.9 m-20 -66.36 -107.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.335 -179.994 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -68.64 -30.18 68.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 110.429 179.938 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 24' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.429 179.896 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm 50.23 -177.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.796 0.331 . . . . 0.0 110.624 -179.977 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.493 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 102.28 -59.24 0.57 Allowed Glycine 1 CA--C 1.356 -9.877 0 CA-C-O 123.747 1.748 . . . . 0.0 115.243 -179.961 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.9 mtm180 -60.7 -9.86 4.54 Favored 'General case' 1 N--CA 1.325 -6.705 1 CA-C-N 105.38 -5.41 . . . . 0.0 112.09 -157.676 . . . . . . . . 4 3 . 1 . 091 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' N ' ' C ' ' A' ' 3' ' ' GLY . 38.2 m0 -41.46 -24.66 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.957 -1.929 . . . . 0.0 109.912 179.796 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' N ' ' C ' ' A' ' 4' ' ' ARG . 17.2 mt -96.55 -27.82 14.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.75 179.853 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.6 tt0 -51.31 -22.73 3.02 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.38 179.934 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 59.46 64.87 1.25 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.648 -179.861 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.3 pt -80.01 -31.97 13.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.347 179.807 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.78 15.75 0.56 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.123 -0.561 . . . . 0.0 111.942 -179.98 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -77.0 -45.8 26.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.697 0.284 . . . . 0.0 110.777 -179.868 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 16' ' ' ILE . . . 56.54 10.36 0.68 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.155 -179.918 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 41.38 53.54 4.14 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.839 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 t80 73.89 48.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -178.996 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mt 63.1 76.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.034 179.924 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ALA . 8.6 mm -131.06 -67.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.401 179.497 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 47.1 mm -78.8 -31.61 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.584 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.77 -51.71 23.54 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.678 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.36 -47.61 6.81 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.254 -0.498 . . . . 0.0 111.903 179.296 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 47.63 43.48 16.42 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.792 0.329 . . . . 0.0 110.759 -179.981 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.5 mt -75.16 116.31 15.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.675 -179.801 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 47.36 36.02 4.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.98 179.829 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.2 m80 52.72 62.57 2.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.578 -179.957 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.219 179.99 . . . . . . . . 0 0 . 1 . 092 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 77.7 mttt 58.99 -135.94 0.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.166 -0.214 . . . . 0.0 110.697 -179.94 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.435 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 48.96 70.54 0.76 Allowed Glycine 1 CA--C 1.385 -8.091 0 CA-C-O 126.475 3.264 . . . . 0.0 112.52 -178.056 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 7' ' ' GLU . 35.1 mtt180 155.03 -10.59 0.0 OUTLIER 'General case' 1 N--CA 1.312 -7.355 1 CA-C-N 100.472 -7.864 . . . . 0.0 110.459 161.152 . . . . . . . . 4 3 . 1 . 092 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -43.8 -22.83 0.06 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.669 -179.687 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 6' ' ' LEU . 8.2 mp -90.74 -28.38 18.32 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.865 179.289 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 4' ' ' ARG . 41.7 tt0 -78.42 -21.32 49.4 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.275 179.715 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 10' ' ' GLY . 1.2 tpm_? -68.41 -58.93 3.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.9 -179.457 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 tp -48.81 92.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.398 0.618 . . . . 0.0 110.318 -179.794 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 156.84 38.16 0.02 OUTLIER Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.593 -179.677 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -46.65 -29.54 1.91 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.825 0.345 . . . . 0.0 110.46 179.834 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.407 ' H ' ' H ' ' A' ' 13' ' ' GLY . . . -164.84 -3.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.492 -179.921 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . 52.82 27.79 29.54 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.742 -179.842 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -144.9 -11.91 0.57 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.901 0.382 . . . . 0.0 110.065 179.951 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.2 pt -155.44 42.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.904 179.448 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.1 tp -152.91 -27.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.004 -179.778 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.41 HD12 ' C ' ' A' ' 17' ' ' ILE . 1.1 pp -81.5 9.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.679 179.516 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.86 -28.36 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.839 -179.901 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.51 -43.88 67.23 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.854 179.979 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.18 -39.91 74.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 110.415 179.882 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 23' ' ' HIS . 2.3 tt 65.49 -76.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.015 -179.863 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 42.73 -90.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 111.092 179.799 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' LEU . 59.1 t-80 -122.96 -14.78 7.54 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.225 179.759 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 21' ' ' LEU . 24.5 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.392 179.958 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 093 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -52.03 157.57 1.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 0.0 110.392 179.985 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.482 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 133.91 -55.79 0.74 Allowed Glycine 1 CA--C 1.355 -9.967 0 CA-C-O 123.922 1.846 . . . . 0.0 114.818 -179.543 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 6' ' ' LEU . 96.8 mtt180 -60.77 -10.04 4.89 Favored 'General case' 1 N--CA 1.323 -6.797 1 CA-C-N 104.974 -5.613 . . . . 0.0 111.95 -157.563 . . . . . . . . 4 3 . 1 . 093 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.482 ' N ' ' C ' ' A' ' 3' ' ' GLY . 98.2 m95 -41.38 -19.47 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.041 -1.89 . . . . 0.0 110.486 -179.957 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 4' ' ' ARG . 23.2 mt -114.4 -20.39 10.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.659 179.377 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 4' ' ' ARG . 30.8 mt-10 -89.82 -8.32 52.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.671 0.272 . . . . 0.0 110.763 -179.872 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -69.88 -91.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.208 179.831 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 9' ' ' ILE . 2.9 tp -60.15 91.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 0.0 110.108 -179.97 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.05 29.85 11.61 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.896 -179.79 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -149.62 62.01 1.01 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.719 0.295 . . . . 0.0 110.372 -179.964 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.53 52.08 1.58 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.39 179.853 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.86 60.14 8.56 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.847 -179.844 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.492 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 57.9 t80 57.09 32.98 22.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.883 0.373 . . . . 0.0 110.653 -179.818 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 mt 61.26 61.78 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.599 0.714 . . . . 0.0 109.892 -179.818 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mm -129.96 -51.21 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.75 -179.838 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.9 mm -69.14 -41.41 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.473 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.421 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . -82.21 -38.07 13.8 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.166 179.193 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.05 -37.22 73.16 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.452 179.855 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.34 -64.64 1.09 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.663 0.268 . . . . 0.0 111.357 -179.26 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' HIS . 23.6 mt 53.76 -99.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.175 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 80.4 m-20 50.18 -87.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.746 179.758 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' LEU . 78.7 m-70 -153.96 13.17 0.45 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.494 -179.88 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.455 179.885 . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -145.54 -141.39 0.12 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.604 0.24 . . . . 0.0 110.508 179.968 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.436 ' O ' ' CG ' ' A' ' 4' ' ' ARG . . . 50.87 70.84 0.75 Allowed Glycine 1 CA--C 1.384 -8.129 0 CA-C-O 126.377 3.21 . . . . 0.0 112.493 -178.199 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 7' ' ' GLU . 32.5 mtt180 156.47 -11.66 0.0 OUTLIER 'General case' 1 N--CA 1.313 -7.295 1 CA-C-N 100.656 -7.772 . . . . 0.0 110.297 161.025 . . . . . . . . 4 3 . 1 . 094 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.501 ' CE3' HD21 ' A' ' 6' ' ' LEU . 28.6 t90 -43.63 -20.46 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.73 179.973 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.502 ' N ' ' C ' ' A' ' 4' ' ' ARG . 19.3 mt -102.89 -21.2 14.03 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.908 179.864 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' ARG . 6.8 tm-20 -67.49 -25.76 66.03 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.124 179.878 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -63.44 163.47 10.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.894 -179.963 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.482 HG23 ' N ' ' A' ' 10' ' ' GLY . 17.5 tt -162.42 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.964 179.915 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.482 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 76.7 -46.33 2.3 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.117 179.778 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 13' ' ' GLY . 54.7 mtpt -77.55 93.73 4.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.745 0.307 . . . . 0.0 110.857 -179.926 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.46 -4.84 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.973 0.415 . . . . 0.0 109.98 179.517 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 52.94 51.52 45.19 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.011 179.928 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 15' ' ' ILE . 34.0 t80 -168.83 -45.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.214 179.814 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' PHE . 7.9 pt -155.3 58.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.241 0.544 . . . . 0.0 110.718 -179.912 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.7 mm -140.11 -65.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.621 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 18' ' ' GLY . 4.2 tp -70.5 -39.37 76.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.498 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.414 ' N ' HG23 ' A' ' 17' ' ' ILE . . . -82.07 -42.81 8.52 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.7 179.601 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.95 -38.04 64.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.106 -0.568 . . . . 0.0 111.898 179.868 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . 53.13 15.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.814 0.34 . . . . 0.0 110.583 179.892 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 21' ' ' LEU . 7.6 mp 54.01 9.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.276 -179.963 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 20' ' ' ALA . 28.9 t70 -78.31 -103.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.329 179.921 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.436 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -73.22 9.69 1.19 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 110.377 179.815 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 22' ' ' ASP . 17.8 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.353 -179.936 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? 56.28 -124.19 1.89 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.982 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.499 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 101.16 -58.12 0.68 Allowed Glycine 1 CA--C 1.355 -9.928 0 CA-C-O 123.685 1.714 . . . . 0.0 115.259 179.941 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 50.2 mtt-85 -60.66 -10.02 4.71 Favored 'General case' 1 N--CA 1.325 -6.725 1 CA-C-N 105.397 -5.402 . . . . 0.0 112.067 -157.537 . . . . . . . . 4 3 . 1 . 095 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.499 ' N ' ' C ' ' A' ' 3' ' ' GLY . 85.9 t90 -41.15 -20.32 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.394 179.859 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ARG . 7.4 tt -109.24 -25.33 10.66 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.359 179.279 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 51.4 mt-10 -99.43 25.43 7.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.388 179.875 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -50.77 140.55 14.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.639 -179.87 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.473 HG23 ' N ' ' A' ' 10' ' ' GLY . 14.3 tt -72.62 -40.45 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.368 179.867 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.473 ' N ' HG23 ' A' ' 9' ' ' ILE . . . 78.04 -56.07 3.94 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.048 179.914 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 13' ' ' GLY . 52.0 mtpt -60.98 101.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 110.518 -179.911 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.34 1.93 2.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.926 179.711 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 46.0 38.41 8.22 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.181 -179.996 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -166.81 -26.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 pt -154.45 59.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.914 0.388 . . . . 0.0 110.981 179.863 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.431 ' C ' ' H ' ' A' ' 18' ' ' GLY . 13.6 mm -150.67 -50.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.327 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.78 10.61 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.041 179.798 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 16' ' ' ILE . . . -173.35 -20.46 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.216 -0.516 . . . . 0.0 111.971 179.902 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.73 -28.57 46.35 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.095 -179.899 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' A' ' 22' ' ' ASP . . . -66.58 -76.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.737 0.303 . . . . 0.0 110.85 -179.795 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.1 mt 59.88 3.92 0.53 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.579 -179.639 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 24' ' ' LEU . 56.4 p-10 -76.72 -133.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.196 179.711 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 1.2 m-70 -76.41 35.77 0.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 110.428 179.682 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 22' ' ' ASP . 15.5 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.179 -179.797 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.064 -0.414 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 096 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -69.09 -134.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.515 179.866 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.494 ' O ' ' NE ' ' A' ' 4' ' ' ARG . . . 52.38 70.44 0.9 Allowed Glycine 1 CA--C 1.382 -8.251 0 CA-C-O 125.956 2.976 . . . . 0.0 112.955 -178.679 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 7' ' ' GLU . 7.0 mtm105 160.25 -10.04 0.0 OUTLIER 'General case' 1 N--CA 1.319 -7.004 1 CA-C-N 101.131 -7.535 . . . . 0.0 110.624 160.132 . . . . . . . . 4 3 . 1 . 096 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -39.82 -23.29 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.258 -179.294 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 6' ' ' LEU . 10.0 mp -97.3 -27.45 14.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.242 179.15 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 4' ' ' ARG . 29.1 mp0 -117.87 34.23 5.26 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.715 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 4' ' ' ARG . 56.6 ttm-85 -67.38 126.59 29.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.559 -179.989 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.8 pt -73.26 -30.76 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.56 56.4 20.22 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.898 -179.86 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -164.75 78.67 0.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.811 0.339 . . . . 0.0 110.553 -179.903 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.37 46.48 0.63 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.609 179.976 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.91 59.69 7.27 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.964 179.989 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.425 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 52.2 t80 57.34 35.03 25.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.621 0.248 . . . . 0.0 110.759 179.91 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt 62.19 71.94 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.482 0.658 . . . . 0.0 110.421 179.769 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.476 ' O ' ' N ' ' A' ' 20' ' ' ALA . 14.4 mt -146.75 -57.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.525 179.674 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.55 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.5 mp -58.9 -29.64 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.344 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.43 -45.83 2.9 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.147 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.55 -64.36 2.39 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.05 179.336 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 57.54 27.54 14.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.628 0.251 . . . . 0.0 110.628 -179.842 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.8 mt 53.43 -124.05 2.22 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.026 -179.747 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -82.87 63.96 7.24 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 179.692 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.403 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 50.3 t-80 56.49 19.02 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.141 -179.54 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.8 tp . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.424 -179.915 . . . . . . . . 0 0 . 1 . 097 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 097 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt 53.02 -100.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.725 0.298 . . . . 0.0 110.589 -179.988 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.46 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 95.89 -60.62 1.42 Allowed Glycine 1 CA--C 1.356 -9.895 0 CA-C-O 123.74 1.744 . . . . 0.0 115.279 -179.954 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' GLU . 77.0 mtm180 -60.68 -10.39 5.24 Favored 'General case' 1 N--CA 1.325 -6.725 1 CA-C-N 105.297 -5.452 . . . . 0.0 112.032 -157.572 . . . . . . . . 4 3 . 1 . 097 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.46 ' N ' ' C ' ' A' ' 3' ' ' GLY . 27.3 t90 -39.56 -21.7 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.798 -179.733 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 4' ' ' ARG . 32.8 mt -107.83 -24.44 11.67 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.84 179.646 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' ARG . 15.0 mp0 -86.87 29.38 0.81 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.63 0.252 . . . . 0.0 110.51 -179.894 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -87.74 -33.18 18.79 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.686 179.838 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 11' ' ' LYS . 3.6 tp -166.91 -3.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.157 0.503 . . . . 0.0 109.908 -179.568 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.446 ' H ' ' H ' ' A' ' 9' ' ' ILE . . . -36.17 -27.4 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.839 179.708 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 9' ' ' ILE . 63.2 mttp -54.64 107.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.381 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -67.65 3.9 1.26 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.6 -179.592 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 11' ' ' LYS . . . 46.51 14.03 0.1 OUTLIER Glycine 0 C--N 1.329 0.183 0 C-N-CA 121.312 -0.47 . . . . 0.0 112.25 -179.945 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.46 ' N ' ' O ' ' A' ' 12' ' ' ALA . 73.6 t80 -138.29 -4.4 1.68 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.577 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 17' ' ' ILE . 3.3 mt -146.13 -137.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.038 179.604 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.504 ' C ' ' H ' ' A' ' 18' ' ' GLY . 47.5 mm 41.54 -87.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.333 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.581 ' C ' HD12 ' A' ' 17' ' ' ILE . 2.4 pp -55.11 -1.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.416 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.568 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -132.59 -70.97 0.09 OUTLIER Glycine 0 C--N 1.338 0.655 0 N-CA-C 112.326 -0.31 . . . . 0.0 112.326 -179.855 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -51.82 -25.27 15.34 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.693 -179.382 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.89 -11.84 0.1 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.612 179.999 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 23' ' ' HIS . 27.2 tp -44.52 123.86 3.84 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.479 179.841 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 56.02 -81.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.611 -179.541 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 21' ' ' LEU . 23.2 t-80 -163.79 43.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.676 179.97 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 30.8 mt . . . . . 0 N--CA 1.469 0.513 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.262 179.852 . . . . . . . . 0 0 . 1 . 098 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 . . . . . . . . . 0 0 . 1 . 098 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -65.77 -169.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.831 0.348 . . . . 0.0 110.547 -179.981 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.509 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 97.84 -59.15 1.05 Allowed Glycine 1 CA--C 1.357 -9.823 0 CA-C-O 123.627 1.682 . . . . 0.0 115.332 -179.981 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 7' ' ' GLU . 69.4 mtm180 -60.59 -10.24 4.89 Favored 'General case' 1 N--CA 1.325 -6.725 1 CA-C-N 105.399 -5.401 . . . . 0.0 112.007 -157.484 . . . . . . . . 4 3 . 1 . 098 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.509 ' N ' ' C ' ' A' ' 3' ' ' GLY . 57.6 t-105 -39.59 -21.86 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.521 -179.944 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' ARG . 9.5 tp -107.74 -26.24 10.9 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.724 179.615 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' ARG . 33.9 tt0 -89.28 -3.01 58.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.103 0.477 . . . . 0.0 109.934 179.88 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -83.55 152.48 24.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.469 179.902 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.5 pt -55.72 -9.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.567 -179.979 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.22 31.32 4.52 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.145 179.96 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -151.4 70.37 0.96 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.972 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.03 48.98 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.567 -179.888 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.02 40.28 20.16 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.865 -179.976 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 t80 70.49 54.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.92 0.391 . . . . 0.0 110.493 -179.776 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 mm 62.05 75.57 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.157 179.703 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.9 mm -137.14 -51.65 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.686 179.244 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 mm -74.48 -49.86 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.042 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.01 -51.55 18.09 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.367 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -63.7 -43.02 98.45 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.796 179.62 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 70.11 -13.79 0.41 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.581 0.229 . . . . 0.0 110.957 179.943 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.473 ' H ' ' C ' ' A' ' 19' ' ' GLY . 4.8 tp 61.13 2.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.0 110.446 179.98 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 24' ' ' LEU . 74.7 m-20 -74.29 84.93 1.92 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.45 179.975 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 27.7 m170 56.73 5.92 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 -179.858 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 22' ' ' ASP . 37.6 mt . . . . . 0 N--CA 1.469 0.519 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.052 179.69 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -55.58 170.37 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.321 . . . . 0.0 110.461 179.959 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.493 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 104.14 -57.75 0.52 Allowed Glycine 1 CA--C 1.355 -9.911 0 CA-C-O 123.768 1.76 . . . . 0.0 115.203 -179.917 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' GLU . 70.7 mtp180 -60.22 -10.94 5.13 Favored 'General case' 1 N--CA 1.325 -6.703 1 CA-C-N 105.323 -5.438 . . . . 0.0 112.08 -157.486 . . . . . . . . 4 3 . 1 . 099 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' N ' ' C ' ' A' ' 3' ' ' GLY . 5.3 m-90 -42.25 -20.36 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.121 179.68 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' ARG . 42.8 tp -107.54 -25.12 11.52 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.363 179.618 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' ARG . 78.0 mt-10 -90.17 35.32 0.86 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -146.39 -37.2 0.24 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.25 -179.996 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.401 ' CG1' ' H ' ' A' ' 10' ' ' GLY . 3.3 pt -149.38 -105.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 65.22 -132.47 36.08 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.966 179.95 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 tttp 73.11 -35.56 0.33 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.611 0.243 . . . . 0.0 110.824 179.979 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.523 ' HB1' ' H ' ' A' ' 18' ' ' GLY . . . -163.91 13.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.931 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.14 66.02 2.66 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.419 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 14' ' ' PHE . 68.5 t80 57.83 32.33 21.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.075 -179.15 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 mt 62.03 63.69 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.584 0.707 . . . . 0.0 110.083 -179.73 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mm -130.19 -52.64 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.414 -179.827 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.57 -44.78 79.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.625 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' H ' ' HB1' ' A' ' 12' ' ' ALA . . . -74.35 -48.08 15.3 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.873 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 21' ' ' LEU . . . -59.79 -43.59 97.77 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.619 179.29 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 69.05 -14.91 0.28 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.509 0.195 . . . . 0.0 111.383 179.815 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.5 mm? 47.27 75.11 0.13 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.755 0.312 . . . . 0.0 110.429 179.934 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -171.17 -109.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.315 179.879 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -60.02 -28.17 67.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.834 0.349 . . . . 0.0 110.105 179.719 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.569 179.774 . . . . . . . . 0 0 . 1 . 100 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm 51.79 -151.59 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.5 -179.97 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.465 ' C ' ' N ' ' A' ' 5' ' ' TRP . . . 107.38 -61.22 0.32 Allowed Glycine 1 CA--C 1.356 -9.866 0 CA-C-O 123.651 1.695 . . . . 0.0 115.423 179.753 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.498 ' C ' ' N ' ' A' ' 6' ' ' LEU . 82.2 mtm180 -59.96 -12.26 7.52 Favored 'General case' 1 N--CA 1.325 -6.723 1 CA-C-N 105.462 -5.369 . . . . 0.0 112.069 -157.481 . . . . . . . . 4 3 . 1 . 100 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.465 ' N ' ' C ' ' A' ' 3' ' ' GLY . 72.6 t-105 -44.0 -17.03 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.321 179.922 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.498 ' N ' ' C ' ' A' ' 4' ' ' ARG . 30.0 mt -130.71 -4.78 4.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.857 179.561 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -84.71 -11.07 56.6 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.074 179.829 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 61.08 131.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.627 179.701 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.7 pt -61.3 -23.85 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.447 179.879 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.04 60.01 8.66 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.872 -179.909 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -169.65 57.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 110.421 -179.931 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.15 64.49 2.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.406 179.98 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 55.19 55.7 26.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.802 -179.857 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 58.59 36.51 25.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.474 -179.832 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 mt 61.18 62.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.405 -179.957 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 13' ' ' GLY . 4.1 tp -131.19 -44.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.447 179.672 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.469 ' N ' HG23 ' A' ' 16' ' ' ILE . 35.8 mm -77.22 -44.89 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.5 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.58 -43.05 38.09 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 178.448 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.78 -43.4 99.0 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.091 -0.575 . . . . 0.0 111.696 179.233 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.88 -55.54 6.06 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.396 179.895 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.1 tp 51.47 96.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 179.832 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 50.79 29.85 4.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.866 179.782 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 52.35 51.71 15.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.661 179.876 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 tp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.158 -179.928 . . . . . . . . 0 0 . 1 stop_ save_